data_1k2m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k2m _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -106.89 141.97 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -127.12 -61.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.9 tt -106.38 139.51 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 23.3 m -115.68 115.07 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.163 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -105.52 108.44 19.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.96 100.19 48.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 16.8 Cg_exo -46.86 100.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.783 1.655 . . . . 0.0 109.473 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.57 157.53 86.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.99 -29.2 26.62 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.701 2.934 . . . . 0.0 112.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -25.1 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.458 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.3 t -95.76 153.48 17.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.975 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.402 ' CG2' HG12 ' A' ' 690' ' ' ILE . 8.6 tt -53.97 -16.1 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 16.5 mt -108.49 136.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.587 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -121.33 55.91 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.976 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.3 mm-40 -124.6 169.62 11.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.11 118.73 20.93 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 111.508 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -113.47 145.53 41.03 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.33 123.37 40.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.515 HG22 ' CD1' ' A' ' 601' ' ' PHE . 89.5 mt -78.47 108.82 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -65.57 122.15 16.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.545 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.43 -28.48 2.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.166 0.508 . . . . 0.0 110.333 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.424 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.54 -22.74 78.81 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.805 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.94 117.74 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.093 0.947 . . . . 0.0 111.608 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -140.58 122.61 9.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -89.9 159.79 34.57 Favored 'Cis proline' 0 N--CA 1.46 -0.448 0 C-N-CA 124.299 -1.125 . . . . 0.0 111.618 -0.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.0 t80 -92.41 116.1 28.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.571 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 40.4 m-85 -92.72 138.27 31.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.169 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.6 mp -124.94 146.27 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.91 -173.95 35.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.245 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -66.84 -50.67 61.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.579 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.51 129.52 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.605 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -20.18 9.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.824 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -54.91 -31.72 60.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.172 0.51 . . . . 0.0 110.14 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 60.6 m -71.89 126.98 31.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.517 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.5 m120 -42.94 -33.77 0.85 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.318 0.58 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 34.8 t -104.93 141.14 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.894 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.36 104.81 13.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 692' ' ' PHE . 9.1 mm -138.95 109.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.957 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.45 106.6 17.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 112.346 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.448 ' C ' ' HD3' ' A' ' 605' ' ' ARG . 0.9 OUTLIER -129.52 107.42 9.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.58 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -38.8 -30.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -68.94 -41.99 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.471 ' CB ' ' ND1' ' A' ' 622' ' ' HIS . 1.6 pp -89.21 156.76 18.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.3 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 162.96 28.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.43 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -52.6 -26.08 12.45 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.071 0.462 . . . . 0.0 110.36 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.31 63.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.471 ' ND1' ' CB ' ' A' ' 618' ' ' LEU . 24.9 t60 -49.73 -44.31 48.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.8 p -169.86 161.58 9.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 111.716 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.571 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 40.2 p90 -143.59 148.77 36.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.949 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.22 130.71 51.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -121.39 134.74 55.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.53 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.8 ttmt -97.92 137.11 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.324 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 158.99 42.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.75 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -76.49 112.61 13.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 110.531 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.838 -0.105 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -99.83 -157.56 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 5.1 m-20 -122.19 146.66 47.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.461 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.24 160.35 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.115 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -106.71 123.3 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 112.085 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.533 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 80.3 m95 -106.4 128.42 54.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.413 ' CE2' HD13 ' A' ' 678' ' ' ILE . 17.3 t80 -90.89 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 624' ' ' PHE . 17.2 m -103.69 129.53 51.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.424 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 43.4 t60 -111.53 126.9 55.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 29.4 p -123.36 3.58 9.12 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.279 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.94 142.6 26.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.137 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.5 m -75.38 -19.94 59.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.418 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.5 m-20 -82.79 3.27 30.12 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.59 133.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.57 0.7 . . . . 0.0 112.38 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 96.3 p -103.92 166.48 10.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.153 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -127.36 119.8 27.06 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.559 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.2 OUTLIER -100.01 104.56 16.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.1 m120 60.11 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 659' ' ' LEU . 14.6 m-20 -139.35 7.99 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.65 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 4.1 m120 -107.97 141.48 39.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.68 141.46 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.43 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 0.2 OUTLIER -129.08 91.41 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.085 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 HG21 ' A' ' 668' ' ' THR . 37.3 pt -87.5 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.81 104.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.878 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.38 33.89 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.55 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 665' ' ' ILE . 3.0 p -125.37 162.17 25.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 111.897 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -135.33 149.91 49.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.2 OUTLIER -147.7 144.87 28.63 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.533 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.18 133.52 48.08 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.402 ' CB ' ' CD1' ' A' ' 647' ' ' ILE . 0.4 OUTLIER -106.31 109.21 21.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -98.83 132.9 43.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.047 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -37.01 120.52 0.74 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.98 38.57 5.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 2.3 t0 -95.44 120.55 35.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 0.0 111.441 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -97.41 113.88 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.3 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 27.0 pt -110.06 137.18 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.968 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -101.14 116.34 32.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.055 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.411 ' CG2' ' CD2' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -81.54 -38.24 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.43 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.45 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.29 133.96 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.42 124.48 22.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -125.96 117.57 23.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.792 0.329 . . . . 0.0 110.645 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -66.8 -46.52 74.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.899 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.22 -40.52 37.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.9 -11.92 56.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.5 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt 59.93 19.29 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.403 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 2.2 t80 -84.34 105.02 14.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -125.78 126.0 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.037 0.446 . . . . 0.0 111.925 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.45 ' HB ' HG22 ' A' ' 681' ' ' ILE . 11.8 mt -119.33 148.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.804 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.458 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -168.21 129.03 1.81 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.392 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.476 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.3 141.84 46.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.761 0.315 . . . . 0.0 110.28 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -101.29 116.45 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.83 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 2.3 t -82.96 120.04 33.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.453 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.37 109.32 10.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.958 0.409 . . . . 0.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 33.5 mt -75.99 105.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . 0.4 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.0 OUTLIER -83.67 -45.32 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -110.39 141.59 43.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.452 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.2 p -113.52 99.88 8.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.348 0.594 . . . . 0.0 109.957 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.0 t -77.1 62.52 2.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.486 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.42 49.34 70.86 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.818 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.472 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -88.18 133.55 34.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.337 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.529 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -33.84 -36.77 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.45 179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -171.98 30.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.862 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.472 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.113 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.76 0.314 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 88.8 t -80.83 122.8 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -95.47 163.22 13.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.51 146.5 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.2 160.02 14.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.84 -173.46 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.16 28.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -42.02 98.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.166 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.404 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 6.6 tm-20 -69.99 -51.07 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.464 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -54.33 -32.88 57.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -36.48 81.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.605 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 79.9 mt -55.8 -44.05 77.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.694 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' A' ' 624' ' ' PHE . 1.5 t -73.95 -23.15 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -36.53 80.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.71 -11.94 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.171 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 602' ' ' PHE . 8.1 tt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.444 0 CA-C-O 120.359 -0.134 . . . . 0.0 112.884 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.4 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 8.2 ttm180 -108.01 143.84 36.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.998 0.428 . . . . 0.0 111.452 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -128.82 -56.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.256 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 647' ' ' ILE . 5.7 tt -111.54 139.59 46.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.409 ' N ' ' CD2' ' A' ' 578' ' ' LEU . 1.9 m -120.97 114.19 21.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 111.495 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.5 mp -103.02 108.22 19.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.68 100.88 53.97 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.5 Cg_exo -45.96 101.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.893 1.729 . . . . 0.0 109.357 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.12 157.42 85.22 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.59 -27.19 14.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.467 2.778 . . . . 0.0 112.491 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -62.16 -25.93 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 18.0 p -95.76 154.07 17.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.805 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.449 HG12 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -58.87 -10.73 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.996 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 613' ' ' ILE . 43.3 mt -111.11 118.58 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 111.751 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.05 57.09 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.607 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 72.7 mt-10 -124.56 171.86 9.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.286 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.0 126.79 42.03 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.16 135.56 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.416 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mt-10 -124.5 118.27 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 601' ' ' PHE . 83.8 mt -79.88 108.6 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -62.77 118.1 7.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.76 -28.95 1.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.77 -14.23 82.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.908 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.02 118.07 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.941 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -140.46 123.52 10.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.736 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.492 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.2 Cg_endo -90.82 159.02 29.69 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.379 -1.092 . . . . 0.0 112.157 0.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.8 t80 -93.12 117.49 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.197 0.522 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.639 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 3.5 m-85 -93.53 138.65 31.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.393 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.498 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -129.61 142.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.43 -158.2 31.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.189 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.4 ttp85 -96.43 -0.63 48.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.13 133.04 46.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -56.76 -24.79 52.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.99 -27.92 63.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 56.2 m -78.14 131.02 37.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.1 m120 -47.65 -30.86 4.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.496 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 51.8 t -109.14 140.66 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.453 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.31 120.96 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 588' ' ' ILE . 29.2 mm -137.97 109.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.745 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 tt0 -86.91 102.32 14.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.703 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 618' ' ' LEU . 3.4 m-20 -133.24 111.47 10.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.37 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -42.5 -33.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.819 0.343 . . . . 0.0 111.48 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -77.76 -41.47 37.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.2 mp -59.97 158.95 9.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.97 174.19 6.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.66 -62.94 1.15 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.395 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.0 t -105.18 53.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.51 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 70.7 t60 -43.12 -39.96 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.515 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.36 173.15 12.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.415 0.626 . . . . 0.0 111.447 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.639 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.06 135.2 25.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.973 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 23.0 mt -131.81 117.12 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -135.16 144.49 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.549 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.3 ptpt -101.0 137.46 39.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.62 159.65 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.275 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.52 117.24 17.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.254 0.55 . . . . 0.0 110.672 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.805 -0.118 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -101.14 -157.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.36 147.11 46.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.061 0.457 . . . . 0.0 111.697 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.9 160.24 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.519 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 0.7 OUTLIER -106.97 128.14 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 112.359 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.532 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.7 m95 -112.15 120.57 42.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.402 ' CB ' HD21 ' A' ' 672' ' ' LEU . 1.3 t80 -92.71 117.63 30.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.9 m -111.22 145.07 39.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 42.3 t60 -119.55 125.36 48.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.436 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.2 5.59 11.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.19 134.55 13.35 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.998 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 54.7 m -65.64 -12.8 56.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.6 OUTLIER -82.35 -2.79 53.98 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.5 0.19 . . . . 0.0 111.339 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.32 128.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.265 0.555 . . . . 0.0 112.071 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.44 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 18.2 p -99.89 166.38 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.142 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.415 ' CZ ' HG21 ' A' ' 656' ' ' VAL . 3.9 m-85 -135.54 119.5 17.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.747 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 670' ' ' PHE . 0.4 OUTLIER -98.88 112.25 24.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.033 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.43 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -136.26 2.43 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.59 141.39 33.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.83 0.348 . . . . 0.0 111.024 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -81.11 141.34 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.738 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.405 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.9 mmm -121.58 100.43 7.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.973 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 665' ' ' ILE . 35.9 pt -87.5 149.39 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -44.43 112.67 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.406 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.79 5.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 716' ' ' VAL . 6.8 p -115.22 162.56 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.499 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.6 ttpm? -134.75 147.71 50.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.127 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.483 ' HB3' HD11 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.52 144.28 28.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.532 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 134.72 49.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.729 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 659' ' ' LEU . 1.3 mt -106.69 111.99 24.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.251 0.548 . . . . 0.0 111.27 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -98.33 143.19 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.172 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.414 ' CA ' HD12 ' A' ' 696' ' ' ILE . 26.3 p30 -43.14 111.85 0.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.73 37.94 5.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.64 118.41 29.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.069 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -96.17 108.5 20.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.413 HG22 ' HG ' ' A' ' 659' ' ' LEU . 7.7 pt -105.66 129.16 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.482 . . . . 0.0 111.971 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 5.7 mttt -89.77 115.77 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.717 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.464 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -76.05 -39.38 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.854 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' A' ' 690' ' ' ILE . 15.6 tt -155.88 136.75 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -135.89 127.79 29.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.119 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.3 116.94 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.245 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -67.03 -46.89 73.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.35 -40.32 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.404 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.38 -16.54 56.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.9 15.92 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.004 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 587' ' ' ILE . 1.2 t80 -77.03 104.61 7.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.1 p -118.99 122.24 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 587' ' ' ILE . 42.8 mm -128.29 119.7 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.572 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -146.31 133.29 4.84 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.165 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.8 m-30 -113.09 144.56 42.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 110.455 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.17 117.29 34.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 578' ' ' LEU . 3.2 t -81.74 114.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.78 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.94 108.58 12.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 0.0 110.372 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 18.4 mt -81.86 110.44 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.729 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.5 -45.29 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.54 140.43 46.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.101 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -114.65 100.37 8.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 596' ' ' GLN . 9.3 t -91.08 50.74 1.82 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.479 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 108.52 33.29 2.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.502 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 1.1 mm? -93.81 120.33 33.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 4.9 p90 -40.45 -34.33 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.474 0.654 . . . . 0.0 110.339 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -147.88 -44.69 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 16.1 pt-20 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 124.69 1.196 . . . . 0.0 108.148 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 668' ' ' THR . 59.7 t -79.71 129.67 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.379 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.423 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -102.17 172.52 6.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -101.24 157.87 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 0.0 111.189 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.93 152.07 19.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.4 p -126.41 -177.82 4.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.616 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -28.9 36.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.988 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.57 -48.81 78.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 1.1 mp0 -69.77 -50.04 47.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.592 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -60.5 -32.05 71.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.41 -40.45 93.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.621 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 1.2 mt -61.91 -44.4 96.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.49 -12.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.24 -28.53 7.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.984 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -102.08 -63.2 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 602' ' ' PHE . 1.1 tp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.937 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.409 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -106.54 143.14 35.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 3.7 t80 -132.69 -47.28 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.424 ' CD1' HG12 ' A' ' 696' ' ' ILE . 10.4 tp -121.27 142.44 49.93 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.896 0.379 . . . . 0.0 111.015 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.7 m -120.3 114.94 22.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -104.57 108.59 20.12 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 mtmp? -111.84 99.25 44.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.8 Cg_exo -47.66 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.849 1.699 . . . . 0.0 109.572 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.58 158.12 85.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.94 -25.17 8.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.509 2.806 . . . . 0.0 112.731 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.64 -28.26 69.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.427 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 6.4 t -95.65 154.01 17.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.816 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.464 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.2 pt -57.87 -11.49 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.406 ' CD1' HG12 ' A' ' 613' ' ' ILE . 19.6 mt -107.6 118.51 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.498 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -106.03 55.73 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.155 0.503 . . . . 0.0 110.332 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.647 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 19.7 mt-10 -125.03 171.67 10.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.192 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.48 129.9 49.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.845 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.21 141.96 45.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.403 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.2 mt-10 -124.02 110.52 14.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.298 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 601' ' ' PHE . 59.3 mt -76.83 109.3 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.6 mp0 -67.03 114.67 5.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.58 -30.61 1.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.217 0.532 . . . . 0.0 110.557 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -64.66 -23.57 68.99 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.149 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.0 119.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.489 0.644 . . . . 0.0 111.34 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 21.7 t30 -138.72 122.26 11.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.548 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.9 Cg_endo -90.5 160.34 31.87 Favored 'Cis proline' 0 C--N 1.345 0.383 0 C-N-CA 124.627 -0.989 . . . . 0.0 111.815 -0.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.5 t80 -91.36 114.7 27.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 13.9 m-85 -91.84 138.07 31.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.993 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -127.36 145.41 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.716 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.55 -172.77 33.69 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.945 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.3 OUTLIER -74.02 -6.83 49.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.496 0.319 . . . . 0.0 111.857 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.569 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -89.51 125.01 35.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.811 0.339 . . . . 0.0 111.12 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -59.01 -20.25 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.578 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -23.96 63.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 54.8 m -70.72 130.35 41.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -44.77 -32.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.512 . . . . 0.0 110.347 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.1 t -110.28 139.88 45.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.342 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.12 110.05 16.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.424 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -138.45 110.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.892 177.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 0.2 OUTLIER -85.73 106.41 16.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.296 0.569 . . . . 0.0 112.09 -178.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.492 ' HB2' ' CD2' ' A' ' 618' ' ' LEU . 1.6 m-20 -129.8 108.32 10.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.138 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -43.71 -37.65 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.327 . . . . 0.0 111.799 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.0 mmt180 -77.82 -34.18 52.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.855 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.16 128.11 34.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 111.336 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.4 p -57.16 159.65 4.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.663 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.569 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -58.14 -31.29 67.06 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.39 55.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.475 ' CD2' HG23 ' A' ' 680' ' ' ILE . 9.5 t60 -49.68 -49.18 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.172 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.7 p -164.08 160.3 21.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.23 0.538 . . . . 0.0 111.989 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 650' ' ' CYS . 42.1 p90 -143.4 147.61 34.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 594' ' ' ILE . 57.6 mt -102.18 132.65 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.5 t80 -123.9 131.47 53.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.499 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.9 tttt -97.73 136.33 38.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 157.84 45.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.981 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -77.83 113.57 15.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.722 -0.151 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.67 -156.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -122.19 147.51 46.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.414 ' HB3' HD22 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -136.6 141.71 43.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.319 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.474 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -94.67 121.19 45.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.345 0.593 . . . . 0.0 111.709 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.562 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -104.04 133.99 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.448 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 678' ' ' ILE . 12.4 t80 -93.14 117.39 30.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -102.84 136.4 42.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.13 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.445 ' CE1' ' N ' ' A' ' 657' ' ' SER . 14.9 t60 -115.42 126.28 54.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.16 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.421 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -122.89 6.49 9.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.47 157.78 40.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.167 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 41.1 m -89.65 -19.56 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.411 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.0 m120 -83.59 2.92 34.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.658 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 50.14 136.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.735 0.779 . . . . 0.0 112.588 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.445 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -108.55 165.96 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.062 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.52 120.65 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.001 0.429 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -102.69 100.19 10.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.897 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 60.76 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 87.3 m-20 -135.44 2.7 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 11.8 m120 -104.86 135.3 46.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.871 0.367 . . . . 0.0 111.402 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.63 141.47 46.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.713 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.419 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 44.2 mmm -120.86 88.66 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.144 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.402 HG12 ' CG2' ' A' ' 668' ' ' THR . 39.4 pt -87.31 153.26 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.867 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 652' ' ' THR . 13.7 tt0 -42.76 107.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.53 33.1 4.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.402 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.7 p -113.22 162.08 16.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 0.0 111.646 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.1 ttpm? -142.12 129.65 21.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.397 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -136.32 143.13 43.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 111.563 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.562 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -71.42 141.04 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 5.4 mt -104.43 148.81 26.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.026 0.441 . . . . 0.0 111.122 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -120.3 162.22 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.73 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.441 ' CA ' HD13 ' A' ' 696' ' ' ILE . 9.5 t70 -65.61 95.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.55 32.73 2.86 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.2 113.17 20.9 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.711 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -95.74 108.49 20.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.421 HD13 ' CE2' ' A' ' 649' ' ' TYR . 32.9 pt -105.16 134.87 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.772 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.0 mtpt -95.36 115.42 27.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.278 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.475 HG23 ' CD2' ' A' ' 622' ' ' HIS . 32.4 mt -84.55 -34.93 9.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.648 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.77 130.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.018 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -137.2 126.48 24.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.78 116.54 22.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.496 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -46.5 72.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.727 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.71 -40.41 33.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.562 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.46 -13.56 54.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.352 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 63.43 15.56 8.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.627 0.251 . . . . 0.0 110.959 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -76.94 104.65 7.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.33 126.47 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 0.0 111.873 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.464 ' CD1' HG12 ' A' ' 587' ' ' ILE . 21.4 mm -127.68 155.9 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.466 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.427 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.07 130.45 1.28 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.359 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.454 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.7 m-30 -113.31 146.23 39.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.354 . . . . 0.0 110.503 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttp -101.35 117.0 34.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.43 ' CG2' ' HG ' ' A' ' 580' ' ' LEU . 2.5 t -82.15 126.65 39.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.667 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.9 OUTLIER -133.45 108.84 8.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.942 0.401 . . . . 0.0 110.736 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 705' ' ' GLU . 22.8 mt -73.98 105.18 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.87 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.77 -47.67 10.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.766 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.433 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.54 140.34 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.029 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.7 p -115.0 99.83 7.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.415 ' HB ' ' NZ ' ' A' ' 627' ' ' LYS . 11.6 m -76.18 69.63 2.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.7 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.54 49.39 74.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.867 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -85.66 133.47 34.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.53 0.205 . . . . 0.0 111.158 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.3 p90 -44.88 -32.22 1.52 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.594 0.712 . . . . 0.0 109.842 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.3 t30 -148.4 -56.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.646 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.494 ' HB2' HD12 ' A' ' 696' ' ' ILE . 2.7 pt-20 . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.488 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.88 117.67 29.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.89 171.72 10.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 157.68 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.36 154.73 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.919 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 23.7 p -126.24 -176.55 3.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.73 64.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -63.61 -52.25 61.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -64.63 -46.95 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.73 -32.77 65.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.34 -36.92 82.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 31.4 mt -59.78 -44.07 94.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.003 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.9 -20.36 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -50.56 64.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -61.66 -29.12 69.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 602' ' ' PHE . 7.0 tt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.421 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -106.57 143.3 34.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.362 . . . . 0.0 111.123 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 1.1 t80 -132.96 -51.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.493 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 21.2 tp -114.52 142.59 46.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 7.9 m -122.62 116.6 24.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.202 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.468 HD21 ' CB ' ' A' ' 692' ' ' PHE . 5.7 mt -103.33 108.83 20.22 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 54.6 mttt -110.57 98.38 36.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -176.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.667 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.2 Cg_exo -49.67 106.86 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.793 1.662 . . . . 0.0 109.225 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 157.37 87.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 12.0 Cg_endo -54.74 -24.88 39.78 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.07 3.18 . . . . 0.0 113.457 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.11 -22.31 65.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.069 0.461 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.457 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 2.0 t -97.69 154.01 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.683 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.452 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 7.3 pt -51.22 -21.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.497 . . . . 0.0 110.014 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 38.9 mt -105.16 118.84 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.71 59.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.649 . . . . 0.0 110.264 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.667 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.78 172.56 9.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.727 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.18 131.55 53.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.62 143.96 42.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.207 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.05 116.61 23.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 111.708 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.53 HG12 ' CD2' ' A' ' 601' ' ' PHE . 73.0 mt -81.89 109.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.879 0.371 . . . . 0.0 110.443 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.08 115.63 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.478 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.34 -30.51 2.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.258 0.551 . . . . 0.0 110.681 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -20.21 72.76 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.23 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.24 118.92 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 117.35 0.575 . . . . 0.0 111.65 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -139.35 121.53 10.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.815 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.557 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -89.99 160.46 34.45 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 124.555 -1.019 . . . . 0.0 111.63 -0.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.6 t80 -91.42 116.63 29.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 20.8 m-85 -92.62 138.57 31.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.29 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -129.08 141.84 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.87 -170.2 38.31 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 119.964 -1.113 . . . . 0.0 113.92 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 ttp85 -80.33 1.44 28.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.356 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.428 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 14.4 t -101.19 119.78 39.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -51.72 -24.64 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.015 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -61.4 -26.71 68.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.991 0.424 . . . . 0.0 110.391 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.2 m -71.57 128.75 36.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.853 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -43.43 -34.63 1.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.289 0.566 . . . . 0.0 110.287 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.488 ' HB3' HG13 ' A' ' 603' ' ' ILE . 50.7 t -106.29 141.29 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.099 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 111.47 20.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.449 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 18.3 mm -137.73 108.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.127 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mp0 -104.19 106.6 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.662 . . . . 0.0 112.497 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 5.0 t70 -130.53 125.93 35.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.722 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -43.64 -34.18 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.778 0.323 . . . . 0.0 111.223 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.401 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 26.2 mmt180 -77.35 -39.06 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.682 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -59.54 158.21 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.06 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.07 163.92 13.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.304 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.428 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -46.04 -55.33 7.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.08 62.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.421 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.682 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.6 t60 -47.1 -48.09 22.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.576 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 603' ' ' ILE . 24.7 p -166.82 157.12 11.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 650' ' ' CYS . 41.2 p90 -144.12 143.67 31.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.889 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 45.5 mt -101.59 131.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.557 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -122.46 132.52 54.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.403 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 7.6 ttmt -98.07 136.53 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.545 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.453 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.8 158.66 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.197 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.94 113.47 14.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.536 0.684 . . . . 0.0 110.391 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.0 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.269 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.5 mp -93.95 -159.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -119.58 146.9 45.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 112.206 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -127.05 160.16 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.777 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.42 HG22 ' CE1' ' A' ' 577' ' ' PHE . 2.6 pt -111.22 120.98 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.587 . . . . 0.0 111.902 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.523 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -103.05 136.28 43.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -99.08 119.37 37.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 624' ' ' PHE . 6.9 m -110.0 141.87 42.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.035 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 34.0 t60 -121.74 122.76 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.15 11.36 15.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.326 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.44 139.72 15.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.811 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.3 m -72.49 -8.17 53.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.419 ' C ' ' CG1' ' A' ' 656' ' ' VAL . 1.5 m120 -85.43 2.78 43.05 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 658' ' ' TYR . 1.8 m 60.21 146.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 111.275 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.434 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 0.3 OUTLIER -116.16 162.61 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.085 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -137.44 120.37 16.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.362 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -108.6 116.67 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.131 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 60.24 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.95 2.12 2.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.23 141.24 35.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 141.71 28.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.501 ' HB2' ' OG1' ' A' ' 668' ' ' THR . 4.5 ptp -138.04 142.68 40.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.405 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.452 HD13 HG21 ' A' ' 665' ' ' ILE . 17.7 pt -112.12 165.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.393 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -47.15 117.59 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.955 0.407 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 101.58 23.08 9.7 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 664' ' ' MET . 10.9 p -112.24 162.37 15.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.462 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -134.94 145.04 47.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CD2' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -145.95 134.36 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.943 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -68.69 140.54 55.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.07 122.79 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 0.0 111.906 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 47.0 mt-30 -104.18 137.6 41.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.593 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -40.52 108.82 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.975 0.417 . . . . 0.0 111.007 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.92 35.55 4.79 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 3.0 t0 -95.55 122.81 38.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.329 . . . . 0.0 111.079 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.02 108.38 20.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.4 HG21 HD21 ' A' ' 659' ' ' LEU . 5.5 pt -106.55 131.95 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 112.141 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -104.01 127.03 51.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.02 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.521 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -95.11 -25.15 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.744 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.439 HG22 ' CZ ' ' A' ' 688' ' ' PHE . 7.6 tt -155.23 131.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -136.59 126.7 26.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.746 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.4 117.03 28.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.644 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -67.04 -46.53 74.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.877 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -79.87 -40.41 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.601 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -79.98 -20.24 45.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.294 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 8.97 6.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.223 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.452 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.7 t80 -77.02 105.15 7.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.3 p -119.64 121.87 67.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.451 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 690' ' ' ILE . 2.4 tt -120.8 121.44 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.5 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -140.39 137.95 8.69 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.331 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.468 ' CB ' HD21 ' A' ' 580' ' ' LEU . 10.3 m-30 -113.35 142.33 45.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -100.96 117.37 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.023 0.44 . . . . 0.0 110.925 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -83.66 122.51 37.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.565 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.09 109.59 9.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 27.5 mt -77.32 108.62 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.937 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.36 -43.36 9.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.08 141.54 42.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.5 OUTLIER -114.23 100.56 8.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.38 0.61 . . . . 0.0 109.671 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.4 57.83 4.21 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 81.56 37.97 15.68 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.24 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.47 134.55 38.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.522 0.201 . . . . 0.0 110.591 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.417 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 4.3 p90 -43.62 -33.27 1.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.472 0.653 . . . . 0.0 110.323 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -147.98 -61.25 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.676 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 16.6 pt-20 . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.043 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.915 0.388 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.29 118.43 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.32 172.02 8.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.52 154.31 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -91.29 156.31 17.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -126.02 -173.96 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.85 -33.5 64.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.23 -50.49 73.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.53 -50.26 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -32.93 68.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -63.57 -38.69 92.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.06 -44.52 97.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.5 -26.83 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -58.57 -30.93 67.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -86.67 -18.87 30.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.159 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.438 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 9.1 ttm180 -112.09 119.56 38.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 647' ' ' ILE . 1.2 t80 -100.91 -46.31 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 694' ' ' VAL . 7.9 tp -120.69 142.54 49.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 111.485 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 695' ' ' GLU . 15.0 m -122.26 114.56 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.488 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -103.66 108.59 19.94 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 25.4 mtmt -111.65 98.77 42.33 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_exo -46.84 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.838 1.692 . . . . 0.0 109.47 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 157.46 85.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.414 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.5 Cg_exo -49.73 -25.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.583 2.855 . . . . 0.0 112.704 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -27.52 68.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.418 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 4.2 t -95.63 153.94 17.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.749 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 690' ' ' ILE . 8.3 pt -54.94 -13.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 51.1 mt -108.78 128.7 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.802 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.414 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -113.99 56.43 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.212 0.529 . . . . 0.0 110.256 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -124.62 171.97 9.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.58 128.65 45.94 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 178.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.08 139.94 47.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.708 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.438 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.2 113.82 18.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.543 HG12 ' CD2' ' A' ' 601' ' ' PHE . 71.6 mt -78.71 109.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.321 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.76 116.09 6.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.814 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.489 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -44.97 -32.42 1.63 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.224 0.535 . . . . 0.0 110.293 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.489 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.7 -18.78 74.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.747 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 56.4 t -100.5 118.59 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 117.769 0.785 . . . . 0.0 111.686 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.83 121.96 9.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.914 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.1 Cg_endo -90.42 160.26 32.22 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.545 -1.023 . . . . 0.0 111.659 -0.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -91.64 116.32 28.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 59.7 m-85 -91.91 138.04 31.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.897 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.474 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -129.87 145.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.831 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.36 -169.15 36.82 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.462 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -83.21 3.39 31.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.768 -0.216 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 7.2 t -101.29 126.32 48.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -57.31 -22.72 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -64.12 -25.43 68.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.665 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 89.9 m -73.41 132.91 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 22.8 m-20 -48.48 -27.4 2.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.474 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 54.1 t -114.55 142.02 46.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 118.59 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.406 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 32.5 mm -138.16 109.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.216 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 14.0 tt0 -89.94 102.98 15.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.456 ' HB3' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.52 112.89 12.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.212 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -43.57 -34.08 1.31 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.733 0.302 . . . . 0.0 111.392 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -77.55 -39.67 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.688 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 680' ' ' ILE . 0.4 OUTLIER -61.12 159.2 12.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.541 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.1 m -110.29 167.21 10.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.415 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.3 OUTLIER -44.65 -55.51 5.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 110.229 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 18.5 t -112.66 57.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.477 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 653' ' ' GLY . 43.1 t60 -45.57 -46.02 13.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.617 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 7.0 p -167.1 155.86 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.474 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 40.3 p90 -143.32 147.96 35.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 86.1 mt -102.65 139.79 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.972 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.514 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -131.44 133.62 45.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.506 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.3 ttmt -97.57 136.1 38.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.559 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.478 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 159.55 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.861 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 630' ' ' HIS . 0.9 OUTLIER -76.08 139.61 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.2 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t-160 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.409 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.726 -0.149 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -102.78 -153.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.37 147.44 46.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.277 0.56 . . . . 0.0 112.099 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -130.09 154.57 47.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.502 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 4.0 pt -105.39 128.72 59.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.26 0.552 . . . . 0.0 111.844 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.483 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 78.8 m95 -111.74 140.79 46.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.426 ' CE2' HG23 ' A' ' 678' ' ' ILE . 13.4 t80 -104.62 117.25 33.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 624' ' ' PHE . 97.1 m -105.6 126.2 51.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.423 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 23.8 t60 -104.36 122.79 46.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.67 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.479 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.44 5.24 13.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.57 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.64 146.14 20.57 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.043 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 37.6 m -79.6 -1.11 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -87.08 0.42 55.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.442 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.42 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.348 0.594 . . . . 0.0 111.87 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 11.9 p -102.54 165.65 10.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.669 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.414 ' CZ ' HG23 ' A' ' 656' ' ' VAL . 2.3 m-85 -137.03 119.95 16.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.783 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -97.25 106.08 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.91 -81.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -131.36 -4.27 3.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -97.43 138.65 34.55 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -85.26 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 2.6 mtp -130.17 122.88 29.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 0.0 111.14 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.7 pt -103.4 165.18 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.656 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.1 tt0 -51.16 117.64 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 110.868 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.74 8.0 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.309 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.6 p -112.77 162.19 16.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.978 0.418 . . . . 0.0 111.419 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.3 ttpm? -136.48 144.06 44.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.536 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.518 ' HB3' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.27 144.82 29.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.483 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.65 136.72 53.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.458 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.6 mt -108.19 127.89 54.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 0.6 OUTLIER -118.1 161.26 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.132 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.424 ' HB2' HD11 ' A' ' 696' ' ' ILE . 60.1 t0 -58.37 104.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.303 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.72 32.84 4.95 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -86.71 115.61 24.27 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.673 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.83 108.91 21.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.426 HG23 ' CE2' ' A' ' 649' ' ' TYR . 4.7 mt -105.16 131.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 0.0 112.036 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -93.32 115.54 28.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.182 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.503 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -86.41 -37.89 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.136 -179.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.428 HG22 ' CZ ' ' A' ' 688' ' ' PHE . 43.9 mt -155.36 130.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.392 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -136.79 127.09 26.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -126.35 116.56 21.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.37 . . . . 0.0 110.686 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -67.81 -46.2 72.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -58.55 -40.28 82.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.128 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -96.22 -20.24 18.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.5 tptp 72.04 1.91 4.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.318 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.67 105.37 7.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 586' ' ' SER . 3.6 p -110.78 138.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.913 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 587' ' ' ILE . 8.3 mm -112.65 145.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.418 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.55 128.57 1.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.4 m-30 -113.2 148.31 35.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 110.323 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -101.62 117.02 34.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.05 0.453 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.8 t -81.66 126.11 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.4 tt0 -133.98 108.69 8.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 34.1 mt -74.0 105.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.674 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.92 -47.61 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.875 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.478 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.6 t0 -111.08 140.06 45.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -115.14 100.62 8.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.166 0.507 . . . . 0.0 109.726 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.2 t -69.79 65.34 0.22 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.64 57.22 20.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.754 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 0.4 OUTLIER -95.91 149.38 21.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 112.048 -179.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.526 ' CD2' ' CE1' ' A' ' 630' ' ' HIS . 0.1 OUTLIER -50.72 -26.95 6.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.189 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.461 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.2 t30 -160.13 -51.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.586 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 696' ' ' ILE . 9.6 pt-20 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.729 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.818 0.342 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.95 114.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.093 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.1 170.16 11.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.567 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -103.75 158.1 16.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -95.4 158.2 15.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.0 p -126.31 -176.49 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.56 -30.42 41.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.17 -45.01 96.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.585 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.84 -49.67 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.557 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -56.25 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -41.8 89.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.4 mt -55.68 -44.33 77.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.043 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.56 -29.31 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -37.53 67.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.62 28.63 3.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.655 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.393 -0.115 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.417 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 60.2 ttp180 -100.31 128.91 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -112.9 -57.55 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.364 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 647' ' ' ILE . 7.3 tt -108.82 137.56 46.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 9.7 m -116.95 114.6 24.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 592' ' ' LEU . 1.0 OUTLIER -103.56 108.03 19.13 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.32 100.46 53.48 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.8 Cg_exo -47.22 103.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.736 1.624 . . . . 0.0 109.545 176.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 158.36 86.09 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.426 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 7.6 Cg_endo -49.66 -26.18 12.52 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.512 2.808 . . . . 0.0 112.705 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.5 -19.83 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.012 0.434 . . . . 0.0 109.885 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 t -96.76 153.86 17.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.848 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.0 pt -55.49 -20.49 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 588' ' ' ILE . 59.7 mt -110.55 118.8 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.078 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.1 61.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.374 0.607 . . . . 0.0 110.307 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.93 171.95 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.835 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.28 132.61 53.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.026 0.441 . . . . 0.0 111.384 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.9 144.81 41.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.116 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.417 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.4 mt-10 -124.28 116.73 23.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 601' ' ' PHE . 66.7 mt -87.54 108.81 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -66.93 125.2 25.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.49 -30.02 2.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.286 0.565 . . . . 0.0 110.148 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.6 -21.4 79.58 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 114.085 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 63.5 t -98.95 117.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.253 1.026 . . . . 0.0 111.797 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.7 t30 -140.51 121.28 9.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.917 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.547 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 40.4 Cg_endo -90.43 159.71 31.91 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.606 -0.998 . . . . 0.0 111.375 -0.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.9 t80 -92.16 117.41 29.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.489 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 14.2 m-85 -92.22 137.9 31.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.173 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.527 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mp -128.45 146.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.412 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.81 -165.88 37.78 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.89 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.7 OUTLIER -85.86 -6.65 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.519 -0.34 . . . . 0.0 111.767 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.0 130.79 47.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.323 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.36 -24.73 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.55 -28.96 61.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 110.528 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 92.9 m -73.65 133.09 43.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.486 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -47.91 -27.03 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 41.3 t -114.48 141.31 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.489 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.82 114.48 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.481 HG23 HD11 ' A' ' 613' ' ' ILE . 27.6 mm -137.9 109.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.187 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.4 pt-20 -92.01 103.02 15.58 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.846 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.47 ' CB ' ' CD2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.88 110.94 10.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.318 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.97 -24.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.443 ' CG ' ' CD2' ' A' ' 688' ' ' PHE . 6.4 mmp_? -77.38 -41.38 40.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.75 158.7 20.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 111.535 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.8 t -93.55 178.25 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.719 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.404 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -47.13 -53.99 11.6 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.425 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 33.7 t -113.87 62.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.211 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 59.1 t60 -48.86 -51.06 31.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.535 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.55 157.49 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.446 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.5 p90 -143.52 150.53 39.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.436 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -102.08 126.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -120.38 133.98 55.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.417 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 25.0 ttmt -98.06 137.16 37.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.235 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.55 159.21 42.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.791 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -76.21 111.95 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.344 0.592 . . . . 0.0 110.112 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.536 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 630' ' ' HIS . 23.4 mt -106.93 -154.26 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.932 -0.158 . . . . 0.0 110.707 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 702' ' ' LEU . 4.6 m-20 -116.34 147.3 41.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.022 0.439 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.44 ' HA ' HD12 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -131.92 155.72 47.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.225 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -105.87 119.87 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 121.563 0.697 . . . . 0.0 112.346 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.628 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.4 m95 -103.59 128.29 50.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.636 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 6.7 t80 -90.16 115.72 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.8 m -98.25 137.59 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 111.549 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 23.0 t60 -121.55 121.62 37.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.509 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 22.6 p -119.48 3.18 11.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.49 146.7 29.03 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.883 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -13.59 59.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -83.43 2.35 37.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.48 137.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.612 0.72 . . . . 0.0 111.992 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.456 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 40.9 m -112.42 166.42 11.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.481 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.39 120.07 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.43 ' CD2' HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.69 99.67 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.5 m120 60.51 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.2 t30 -131.79 -0.38 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.683 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.91 141.05 36.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -77.01 141.88 40.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.5 mmm -121.2 91.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.1 pt -87.39 159.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 652' ' ' THR . 19.6 tt0 -55.3 108.06 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.236 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.0 34.48 2.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.918 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.0 p -134.68 159.77 40.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 111.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 16.0 pttm -136.78 139.8 42.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.45 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 14.3 t80 -131.64 144.61 51.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.628 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 1.2 mt -68.89 134.56 49.77 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.179 0.514 . . . . 0.0 111.849 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 647' ' ' ILE . 4.0 mt -104.46 135.31 46.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.219 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -119.7 146.7 45.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.307 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 696' ' ' ILE . 10.8 t70 -45.9 104.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.88 32.46 4.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 112.07 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -95.47 108.26 20.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 659' ' ' LEU . 36.3 pt -106.03 137.42 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.341 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.23 115.52 27.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.109 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.514 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.1 mt -81.68 -38.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.441 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 14.0 mt -155.3 131.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.931 0.396 . . . . 0.0 111.556 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.63 123.05 20.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 116.68 21.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.536 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -46.67 71.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.982 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -71.63 -40.56 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.799 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -89.81 -6.23 56.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.445 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 58.78 19.04 6.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.676 0.274 . . . . 0.0 110.798 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CD2' ' CG ' ' A' ' 617' ' ' ARG . 0.1 OUTLIER -79.05 104.34 9.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.88 121.79 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.194 0.521 . . . . 0.0 111.447 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 690' ' ' ILE . 33.3 mm -128.24 137.27 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.881 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -167.66 131.04 2.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.045 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.483 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.9 m-30 -113.14 144.72 42.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.664 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -101.7 117.23 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.068 0.461 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 675' ' ' GLY . 3.1 t -79.04 119.7 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.649 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.45 109.16 11.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.061 0.457 . . . . 0.0 110.233 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.494 HD11 ' O ' ' A' ' 705' ' ' GLU . 58.2 mt -79.79 105.46 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -49.01 8.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -111.38 138.44 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.796 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 68.9 p -116.14 99.87 7.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.4 t -77.42 61.0 2.15 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.42 43.43 58.14 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.067 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -97.1 32.9 2.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.953 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.682 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER 61.55 109.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 7.2 t30 56.14 -69.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.145 0.498 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 703' ' ' PHE . 9.1 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.765 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.589 0.233 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.405 ' CG2' ' HE1' ' A' ' 664' ' ' MET . 7.7 p -84.51 130.22 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.58 169.73 9.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 156.43 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.974 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.83 150.78 25.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -126.12 -178.44 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.52 57.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.187 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.06 -49.22 76.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -48.29 71.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.736 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -32.97 67.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.44 -36.85 85.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.51 -44.15 96.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -76.55 -24.03 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.65 -46.06 66.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -64.26 -25.97 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.422 HD13 ' CG ' ' A' ' 602' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.466 0 N-CA-C 112.83 -0.108 . . . . 0.0 112.83 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.425 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 58.4 ttp180 -112.03 143.33 43.22 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.306 -0.526 . . . . 0.0 111.209 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -128.07 -62.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.549 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.6 tt -106.46 125.68 51.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.307 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.8 m -109.23 118.49 36.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.532 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -105.56 108.25 19.67 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.27 99.22 39.23 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 50.4 Cg_exo -47.47 97.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.792 1.661 . . . . 0.0 109.607 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.79 158.14 85.04 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.409 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.0 Cg_endo -49.7 -25.55 11.6 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.55 2.833 . . . . 0.0 112.549 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.1 -25.43 67.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.8 t -95.61 153.93 17.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.691 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.422 ' CG1' ' CD1' ' A' ' 690' ' ' ILE . 0.9 OUTLIER -57.03 -12.34 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 0.0 111.284 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 613' ' ' ILE . 30.4 mt -112.44 129.62 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -111.46 57.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.486 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.615 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.9 mt-10 -124.64 172.04 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.127 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -125.9 130.47 51.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.6 OUTLIER -112.74 142.51 45.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.101 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.27 120.43 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 601' ' ' PHE . 78.6 mt -89.34 109.07 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -68.14 122.47 18.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.85 -29.95 2.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.221 0.534 . . . . 0.0 110.537 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.441 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.55 -22.04 77.79 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.942 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.07 118.26 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.934 0.867 . . . . 0.0 111.841 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 19.1 t30 -139.85 122.32 10.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.742 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.548 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -90.21 159.52 32.9 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.372 -1.095 . . . . 0.0 111.673 -0.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.2 t80 -92.07 114.28 26.78 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 3.3 m-85 -92.39 138.48 31.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.184 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -125.78 143.44 39.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.79 -174.08 43.39 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.375 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.428 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.5 ttp85 -82.03 -4.46 56.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.617 0.246 . . . . 0.0 111.455 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.98 126.43 47.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.777 0.322 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -49.94 -26.58 4.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.55 -28.85 48.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.958 0.408 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 35.2 m -75.02 133.4 41.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.5 m-20 -49.61 -26.95 4.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.457 . . . . 0.0 110.417 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 38.0 t -111.54 142.66 43.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 115.17 24.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 605' ' ' ARG . 24.6 mm -137.88 109.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.011 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 28.6 tt0 -89.29 104.1 16.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.249 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.479 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.85 113.24 13.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.228 178.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -41.23 -38.61 1.16 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.446 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.3 mmp_? -77.46 -35.11 54.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.64 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -58.99 157.94 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.73 164.43 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.96 -50.01 19.73 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.126 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.67 63.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.498 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.64 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.9 t60 -45.78 -48.22 15.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.477 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 31.7 p -172.39 162.88 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 650' ' ' CYS . 46.0 p90 -144.18 144.2 31.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.55 130.67 52.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.1 t80 -121.67 133.61 54.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 3.1 tppp? -97.94 136.03 38.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.769 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 158.7 43.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.84 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.19 112.96 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.451 0.644 . . . . 0.0 110.366 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.2 t60 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.131 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.272 0 CA-C-O 120.536 -0.036 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.9 mp -114.68 -156.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -118.4 146.84 44.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.049 0.452 . . . . 0.0 111.65 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.438 ' CG ' HD13 ' A' ' 671' ' ' LEU . 3.0 t0 -133.47 160.3 37.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.589 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 578' ' ' LEU . 1.3 pt -109.08 122.64 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.795 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.552 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 93.1 m95 -109.99 126.85 54.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.399 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -90.67 122.24 33.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.162 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 7.9 m -111.02 128.14 55.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.46 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 70.5 t60 -106.11 130.11 54.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.382 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -126.24 3.63 7.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.288 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.53 141.07 20.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.043 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 87.4 m -75.6 -5.6 46.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 617' ' ' ARG . 1.3 m120 -87.24 0.04 55.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.722 0.296 . . . . 0.0 111.316 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.3 t 67.59 146.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.46 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 0.9 OUTLIER -118.24 158.66 24.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.379 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -138.58 119.68 14.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.359 . . . . 0.0 110.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -108.06 112.49 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.83 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.46 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.02 0.19 1.53 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.474 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -96.65 141.82 29.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -79.51 141.91 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 34.9 mmm -124.78 102.77 7.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.118 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 44.2 pt -87.99 151.43 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -47.5 107.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.955 0.407 . . . . 0.0 111.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.51 36.18 2.69 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.132 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.9 p -122.69 162.2 22.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 111.519 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.433 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -129.42 153.23 48.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.02 143.31 28.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.552 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -73.23 123.08 22.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.217 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 671' ' ' LEU . 1.1 mt -98.71 140.48 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.432 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.408 ' HA ' HG13 ' A' ' 696' ' ' ILE . 29.1 t0 -43.04 113.76 0.52 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 95.95 35.51 5.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.42 121.61 36.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.356 . . . . 0.0 110.914 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -96.15 108.62 21.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.987 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.403 HG12 ' HG ' ' A' ' 659' ' ' LEU . 6.2 mt -108.13 136.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.07 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 20.0 mttt -107.83 116.59 32.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.812 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.503 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -88.02 -30.55 5.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.858 -178.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.446 HD13 ' HB3' ' A' ' 617' ' ' ARG . 15.8 tt -155.03 130.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.523 . . . . 0.0 112.193 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.43 128.34 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.375 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -126.72 116.38 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 0.0 111.152 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -68.5 -46.61 69.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.992 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -58.71 -40.64 84.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.054 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.94 -15.47 22.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.451 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 70.64 3.31 4.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.072 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.413 ' CE1' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.46 104.18 7.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.3 137.33 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.807 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 587' ' ' ILE . 28.8 mm -116.19 155.24 17.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.67 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.473 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 179.28 124.92 0.91 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.86 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.8 m-30 -112.67 143.26 44.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 0.0 110.552 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -101.09 117.55 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.113 0.482 . . . . 0.0 110.702 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.421 HG12 HD13 ' A' ' 578' ' ' LEU . 8.2 t -82.45 126.94 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.8 tt0 -133.76 109.44 9.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.491 HG22 HD13 ' A' ' 696' ' ' ILE . 67.7 mt -77.55 105.68 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.869 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -80.5 -44.55 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.247 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -110.44 140.82 44.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.032 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.8 p -114.78 99.81 7.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.093 0.473 . . . . 0.0 109.895 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 t -80.69 60.31 3.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.481 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.96 58.93 11.6 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.925 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.04 144.0 28.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.551 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.497 ' CD2' ' HB3' ' A' ' 704' ' ' ASN . 5.1 p90 -37.43 -47.99 0.92 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.695 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -143.51 5.74 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.19 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.2 pt-20 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 82.2 t -99.04 113.91 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.83 172.19 8.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.89 16.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -90.79 152.61 20.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 59.9 p -126.21 -175.21 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.35 65.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.51 -47.2 82.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -45.26 80.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.618 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -32.71 68.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.31 -37.82 83.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.61 -44.34 89.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.39 -22.1 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -40.08 66.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -75.56 -15.91 60.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.418 HD12 ' CD2' ' A' ' 602' ' ' PHE . 9.9 tt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.616 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 ttm180 -97.7 142.03 29.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 122.501 -0.411 . . . . 0.0 110.581 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -131.3 -60.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.429 ' CD1' HD13 ' A' ' 647' ' ' ILE . 6.7 tt -106.55 134.68 49.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.858 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 695' ' ' GLU . 26.1 m -115.5 114.66 25.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 592' ' ' LEU . 1.2 mp -105.18 108.04 19.35 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 pttp -113.46 100.32 51.53 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 53.2 Cg_exo -46.07 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.91 1.74 . . . . 0.0 109.795 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.485 ' N ' HD21 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -74.69 158.52 84.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.03 -24.72 5.68 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.493 2.795 . . . . 0.0 112.759 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -61.45 -23.37 65.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.4 t -95.49 153.59 17.62 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.92 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 690' ' ' ILE . 4.3 pt -54.46 -17.85 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 582' ' ' PRO . 6.4 tt -112.46 142.83 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.77 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.31 65.89 0.83 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.351 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.6 mm-40 -124.75 171.57 10.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.276 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.89 125.67 40.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.954 0.406 . . . . 0.0 111.084 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.65 138.66 49.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.771 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 8.7 mt-10 -124.25 122.4 37.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.549 HG12 ' CD2' ' A' ' 601' ' ' PHE . 67.8 mt -85.12 109.21 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.116 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -63.68 114.0 3.71 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.006 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.513 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.9 -32.72 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.9 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.499 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.63 -21.05 76.19 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.689 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.19 118.49 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.864 0.832 . . . . 0.0 111.917 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.18 123.08 10.14 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.981 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.06 159.31 33.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.334 -1.111 . . . . 0.0 111.799 0.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 610' ' ' ASN . 2.6 t80 -92.87 117.72 30.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.472 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.3 m-85 -92.79 138.2 31.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.648 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.582 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.4 mp -128.28 149.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.957 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.78 -176.69 40.55 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.962 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -79.25 -4.51 51.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.212 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 130.21 47.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 111.052 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -25.13 19.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.32 -29.01 46.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.783 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 58.1 m -77.77 136.88 38.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.876 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.4 OUTLIER -51.32 -23.77 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.582 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 51.5 t -117.29 143.38 45.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.696 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -120.43 119.77 34.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.48 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 25.4 mm -137.57 109.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.987 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.67 102.53 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.867 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.483 ' HB3' HD12 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.18 113.55 13.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.837 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -44.04 -36.43 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.821 0.343 . . . . 0.0 111.603 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -77.53 -31.19 53.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.087 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 615' ' ' ASP . 1.3 mp -59.51 159.48 8.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.8 p -114.02 164.52 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.173 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -45.8 -45.4 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.89 61.44 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.392 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.491 ' NE2' HG22 ' A' ' 680' ' ' ILE . 21.3 t60 -50.05 -48.57 52.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.951 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.5 p -166.89 158.4 12.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.472 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 47.9 p90 -143.39 146.89 33.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.909 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.2 130.96 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.918 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.525 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -124.34 131.58 53.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.618 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 20.1 ttmt -98.15 135.99 39.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.426 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.14 158.0 41.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.171 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.01 122.26 24.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 110.499 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.6 t60 . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.273 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -88.78 -155.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.83 147.12 46.9 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.413 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -125.65 160.26 30.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.457 HG22 ' CE2' ' A' ' 577' ' ' PHE . 1.3 pt -113.34 121.21 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.39 0.614 . . . . 0.0 111.927 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.512 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 89.2 m95 -107.26 126.56 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.417 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.03 117.74 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 624' ' ' PHE . 12.5 m -105.74 134.27 49.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.518 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.473 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 26.2 t60 -115.51 124.18 50.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -118.67 6.26 11.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.395 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.26 151.12 29.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.6 m -81.34 -10.16 59.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.524 ' O ' ' O ' ' A' ' 656' ' ' VAL . 61.1 m-20 -87.03 2.72 48.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.524 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 50.4 130.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.337 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.473 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 1.8 t -103.01 166.21 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.191 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -131.0 120.15 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.424 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -96.15 99.7 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.59 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.9 m120 61.31 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.748 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 70.0 m-20 -131.65 -2.1 3.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.722 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.61 135.02 42.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 111.325 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -73.65 141.8 46.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 657' ' ' SER . 14.9 mmm -126.52 93.0 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 665' ' ' ILE . 36.4 pt -87.21 158.38 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 652' ' ' THR . 26.6 tt0 -46.42 116.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.193 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.48 28.64 8.87 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.409 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.4 ' CG2' HG12 ' A' ' 665' ' ' ILE . 17.5 p -112.93 162.34 15.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.37 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.4 ttpm? -141.91 129.66 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 716' ' ' VAL . 9.5 t80 -134.04 144.25 48.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.439 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.512 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.49 140.36 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 112.051 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.437 ' HB2' HD13 ' A' ' 647' ' ' ILE . 1.5 mt -108.82 129.44 55.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.183 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 3.9 mt-30 -115.45 146.0 42.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.512 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -46.76 105.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.085 0.469 . . . . 0.0 110.463 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.2 33.17 4.36 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -92.79 111.96 23.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.803 0.335 . . . . 0.0 111.263 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.8 108.53 20.87 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.453 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 34.2 pt -105.53 137.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.135 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -93.17 115.97 28.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.275 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.491 HG22 ' NE2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -82.45 -32.07 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.722 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.452 HD12 ' CE1' ' A' ' 622' ' ' HIS . 21.3 mt -154.4 131.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 111.44 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.64 124.02 22.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.17 117.06 27.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.427 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -46.94 72.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.678 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -83.2 -40.33 19.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.326 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -15.16 58.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.34 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt 62.9 15.75 8.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.978 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.422 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.01 104.24 7.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.6 p -116.07 123.8 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 587' ' ' ILE . 6.4 mm -127.65 154.04 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 169.29 136.17 2.02 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.714 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.48 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.72 153.95 29.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.798 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -101.79 117.6 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 578' ' ' LEU . 5.0 t -79.08 125.9 38.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.4 OUTLIER -133.21 109.38 9.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.441 . . . . 0.0 110.409 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.43 HD11 ' HB2' ' A' ' 705' ' ' GLU . 58.6 mt -80.78 105.32 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.646 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -87.19 -46.08 10.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.66 140.96 44.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.715 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -113.83 99.97 8.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.316 0.579 . . . . 0.0 109.73 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 56.6 m -70.79 65.93 0.34 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.432 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.19 57.27 20.67 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.857 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 2.9 mt -99.88 145.28 27.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.413 ' CZ ' ' OD2' ' A' ' 646' ' ' ASP . 38.9 p90 -48.31 -31.38 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 109.765 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.469 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.1 t30 -155.99 -53.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.787 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.469 ' CG ' ' ND2' ' A' ' 704' ' ' ASN . 10.4 pt-20 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.179 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.731 0.301 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.8 p -85.15 128.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 171.71 7.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -103.12 157.41 17.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.161 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.8 152.0 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 2.7 p -126.11 -178.0 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.77 -35.02 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -57.86 -48.0 81.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.7 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.65 -48.14 70.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.795 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -32.95 70.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -39.44 93.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.261 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -60.47 -44.67 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.013 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.27 -27.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -56.05 -32.6 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -97.79 28.0 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.781 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.783 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.579 -0.208 . . . . 0.0 112.579 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.445 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.0 tmm_? -112.96 143.93 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 111.028 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.22 -63.57 1.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.05 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.5 tt -106.91 142.56 36.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 20.3 m -122.68 114.81 21.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.335 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 592' ' ' LEU . 6.6 mt -102.55 108.29 19.54 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 6.9 ptmm? -116.55 100.51 53.48 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.594 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.3 Cg_exo -47.11 105.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.635 1.557 . . . . 0.0 109.06 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.39 156.24 87.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.517 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 58.4 Cg_exo -51.31 -25.84 19.11 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.589 2.859 . . . . 0.0 113.108 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.38 -26.72 68.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.049 0.452 . . . . 0.0 110.034 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.417 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -97.58 153.66 18.03 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.235 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 14.4 pt -49.09 -23.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 110.1 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.401 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 51.2 mt -99.5 118.59 46.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -117.57 52.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.588 . . . . 0.0 110.453 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.594 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 16.0 mt-10 -124.58 171.82 9.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.379 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.64 132.31 53.42 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.122 0.487 . . . . 0.0 111.573 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.91 143.04 44.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.724 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -124.28 118.91 27.84 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 601' ' ' PHE . 74.9 mt -83.8 109.05 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.214 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.9 120.84 13.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.95 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.24 -28.12 1.79 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.091 0.472 . . . . 0.0 110.67 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -73.63 -19.3 79.69 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.746 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 55.0 t -100.74 117.95 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.968 0.884 . . . . 0.0 111.711 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.6 t30 -140.19 121.71 9.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.687 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.567 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.3 Cg_endo -89.96 159.86 34.31 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.493 -1.045 . . . . 0.0 111.519 -0.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CD2' HG12 ' A' ' 594' ' ' ILE . 3.7 t80 -91.5 114.7 27.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 20.5 m-85 -91.68 138.45 31.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.521 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.0 mp -126.32 146.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.71 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.09 -174.8 36.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.226 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -65.89 -48.62 70.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.831 0.348 . . . . 0.0 111.415 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.86 128.41 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.492 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.46 -17.73 23.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.766 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -56.95 -31.74 65.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.123 0.487 . . . . 0.0 110.112 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.3 m -70.58 134.02 47.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.501 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.532 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -48.08 -27.53 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.432 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 37.2 t -112.19 142.01 45.19 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 105.37 13.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.449 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 18.7 mm -138.62 108.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.764 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -106.18 105.91 16.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.469 0.652 . . . . 0.0 112.217 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.505 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.08 109.88 11.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.731 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -37.83 -30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -41.59 59.88 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 2.4 pp -88.24 136.98 32.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 163.84 4.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.461 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.444 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 1.3 ptp180 -54.08 -28.06 36.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.36 60.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.477 ' ND1' ' HB2' ' A' ' 618' ' ' LEU . 28.2 t60 -49.16 -47.25 45.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.133 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 8.2 p -168.06 161.09 12.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.539 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 42.8 p90 -143.36 148.52 36.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.62 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.23 128.16 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.324 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -118.48 134.47 55.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.423 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 33.3 ttmt -98.1 135.28 40.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.19 159.65 41.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.588 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.4 tpt180 -75.2 112.89 11.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.27 0.557 . . . . 0.0 110.862 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.476 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 7.7 t60 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 120.238 -0.201 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.476 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.3 mp -113.32 -175.5 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.205 0.502 . . . . 0.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.0 m-20 -106.33 146.24 30.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.455 0.645 . . . . 0.0 112.251 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.476 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -128.72 160.56 32.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.549 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.7 OUTLIER -108.35 120.85 60.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.63 0.729 . . . . 0.0 112.375 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.526 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 79.7 m95 -104.95 127.8 52.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.563 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -90.55 117.4 29.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.094 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 12.3 m -102.3 127.78 49.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -108.84 125.98 52.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 14.3 p -121.25 2.01 10.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.211 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.81 161.07 50.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.05 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.6 m -91.61 -19.86 22.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.633 0.254 . . . . 0.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 656' ' ' VAL . 47.7 m-20 -82.72 2.88 31.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.659 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.46 130.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.453 0.644 . . . . 0.0 112.278 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.422 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 86.5 p -100.98 166.34 10.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.136 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.42 120.76 26.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.755 0.312 . . . . 0.0 111.573 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.415 HD12 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.55 99.75 11.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.362 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 61.57 -80.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.687 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.18 -3.61 3.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.711 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.478 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.7 m-80 -97.0 142.01 29.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.381 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.406 ' O ' HG22 ' A' ' 716' ' ' VAL . 16.8 ttm105 -82.25 141.62 32.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.216 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.484 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.83 97.95 5.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.423 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 43.8 pt -88.5 156.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.3 tt0 -47.34 108.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.4 35.77 3.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.356 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.3 p -120.01 162.31 19.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.161 0.505 . . . . 0.0 111.964 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.0 ttpt -133.2 148.31 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.229 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.484 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 2.5 t80 -147.28 144.83 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.526 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 132.46 46.2 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.719 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.415 ' CB ' ' CD1' ' A' ' 647' ' ' ILE . 0.9 OUTLIER -110.37 122.22 47.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.577 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.11 138.78 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.315 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.408 ' HB2' HD13 ' A' ' 696' ' ' ILE . 19.2 t0 -39.04 123.33 1.31 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 37.45 8.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.21 115.13 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.81 108.58 20.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.0 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.415 HG12 HD12 ' A' ' 659' ' ' LEU . 7.8 mt -109.0 136.54 44.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.91 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -96.77 115.44 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.656 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.467 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.5 OUTLIER -80.08 -40.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.984 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 618' ' ' LEU . 2.4 mt -155.4 131.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.001 0.429 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.413 ' CG ' HG23 ' A' ' 689' ' ' VAL . 6.5 t90 -136.12 128.23 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 687' ' ' LYS . 20.4 t0 -122.15 116.78 24.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.403 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -46.41 72.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.868 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -60.51 -40.63 92.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.256 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.31 -20.25 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.65 0.262 . . . . 0.0 111.567 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.9 OUTLIER 72.69 1.94 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.425 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.68 105.37 7.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.413 HG23 ' CG ' ' A' ' 682' ' ' TRP . 2.4 p -114.71 134.13 58.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.465 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 690' ' ' ILE . 34.7 mt -119.82 120.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.95 141.07 9.93 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.856 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.449 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 9.1 m-30 -113.62 142.23 46.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.2 116.96 34.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.229 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 580' ' ' LEU . 3.0 t -79.9 125.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.8 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 109.45 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.655 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.444 HG23 HD12 ' A' ' 696' ' ' ILE . 57.3 mt -83.89 105.76 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.67 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.91 -43.55 12.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.318 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -109.9 141.55 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.337 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.9 p -113.53 100.02 8.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.405 0.621 . . . . 0.0 110.142 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.9 m -82.63 60.68 5.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 73.95 49.07 14.21 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.859 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.466 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -83.63 127.42 33.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.484 ' CD2' ' HB3' ' A' ' 704' ' ' ASN . 4.2 p90 -35.77 -48.14 0.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.254 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.95 8.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.373 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.9 pt-20 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 121.316 0.579 . . . . 0.0 110.085 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.425 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 9.6 t -77.47 116.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.952 0.406 . . . . 0.0 111.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.99 172.22 8.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 155.52 17.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -92.34 150.98 20.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -126.16 -175.57 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.94 68.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.52 -53.34 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.438 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 720' ' ' THR . 1.8 pp20? -70.81 -41.3 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.851 0.358 . . . . 0.0 110.586 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.533 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -67.61 -38.37 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.702 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.01 -44.22 78.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -78.54 -24.04 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -59.07 -37.79 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.06 -15.93 57.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 602' ' ' PHE . 10.0 tt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.402 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -96.58 109.95 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 110.443 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 1.5 t80 -95.11 -58.29 2.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.735 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 7.9 tp -106.84 142.87 35.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 0.0 111.624 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 40.6 m -117.68 113.85 22.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.431 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.62 109.34 21.27 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 37.5 pttt -117.09 99.34 52.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 28.0 Cg_exo -45.8 99.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.918 1.746 . . . . 0.0 109.825 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 157.47 85.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.4 Cg_exo -49.9 -25.7 12.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 112.948 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -28.24 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 0.4 OUTLIER -95.89 153.97 17.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.976 178.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 690' ' ' ILE . 16.7 pt -52.38 -15.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.669 0.271 . . . . 0.0 111.365 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 43.8 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 111.685 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 1.0 OUTLIER -125.71 55.25 1.45 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.3 mt-10 -124.72 170.24 11.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.052 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.49 121.06 25.09 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.43 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.8 OUTLIER -112.68 148.21 35.15 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.402 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 119.58 29.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.663 0.268 . . . . 0.0 111.697 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.532 HG12 ' CD2' ' A' ' 601' ' ' PHE . 47.1 mt -74.05 109.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.39 111.85 3.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.023 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.467 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -43.37 -36.49 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.469 0.652 . . . . 0.0 109.942 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -61.47 -23.85 63.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.233 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.4 t -101.14 118.86 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 117.516 0.658 . . . . 0.0 111.511 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.0 t30 -139.22 122.18 10.59 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.5 Cg_endo -89.6 160.24 36.24 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 124.413 -1.078 . . . . 0.0 111.674 -0.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -90.75 116.72 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.555 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 56.1 m-85 -92.45 138.01 31.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.49 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.8 mp -125.05 145.7 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.435 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.37 -174.98 41.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.566 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.4 ttp85 -80.64 -11.51 59.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.645 0.259 . . . . 0.0 111.315 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 132.23 42.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.13 -26.35 11.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -30.78 27.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.035 0.445 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 63.7 m -77.2 128.8 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -45.24 -34.72 2.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 39.8 t -101.88 138.67 38.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.059 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 113.73 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.334 0.588 . . . . 0.0 112.549 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.43 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 26.9 mm -137.6 109.86 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.658 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 pm0 -87.79 103.99 16.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.23 110.23 10.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.964 178.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -40.64 -36.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 2.0 mmt180 -77.64 -36.58 51.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.71 159.38 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 52.7 p -108.77 166.04 11.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.31 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -47.46 25.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.24 61.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.426 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 653' ' ' GLY . 24.4 t60 -50.08 -48.42 53.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.732 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -167.28 156.17 10.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.177 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 28.8 p90 -143.62 149.54 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.101 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 71.4 mt -101.79 134.09 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -124.7 132.99 53.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.627 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.41 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 9.1 ttmt -97.89 137.06 37.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.574 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.94 158.89 43.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.522 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.7 112.89 13.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.386 0.612 . . . . 0.0 110.41 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.91 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.863 -0.095 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 702' ' ' LEU . 4.4 mt -116.89 -153.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.22 147.27 43.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.32 148.81 51.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.606 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.453 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.1 pt -102.28 122.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.556 ' CH2' HD21 ' A' ' 671' ' ' LEU . 88.0 m95 -102.8 138.64 39.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.241 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.428 ' CE1' HD13 ' A' ' 678' ' ' ILE . 18.0 t80 -100.04 117.43 34.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 624' ' ' PHE . 6.5 m -105.65 133.84 49.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.495 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.408 ' CE1' ' N ' ' A' ' 657' ' ' SER . 44.1 t60 -115.58 125.72 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.454 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 15.6 p -123.18 7.97 9.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.68 151.62 29.44 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.033 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 7.5 m -80.16 -17.3 52.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.0 m-20 -83.72 2.69 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.94 128.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.43 0.633 . . . . 0.0 112.2 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.408 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 9.0 t -97.76 166.68 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -131.91 120.22 22.22 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.402 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.418 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -95.03 100.58 12.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.14 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.44 0.44 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.435 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.423 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 7.6 m-80 -100.6 141.51 33.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -82.43 141.12 33.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -122.69 98.08 5.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.77 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 652' ' ' THR . 29.1 tt0 -46.76 106.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.88 35.97 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.296 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -125.72 162.19 25.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 111.879 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.1 ttpm? -133.6 148.47 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.224 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.426 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 2.6 t80 -147.69 145.87 29.06 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.556 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.52 133.79 49.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.869 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -110.33 109.2 19.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.196 0.522 . . . . 0.0 111.339 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -97.94 153.95 18.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.333 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.439 ' N ' HD12 ' A' ' 696' ' ' ILE . 44.6 t0 -53.31 115.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.829 0.347 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.28 37.48 5.62 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -90.42 116.15 28.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.951 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -95.88 108.08 20.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.428 HD13 ' CE1' ' A' ' 649' ' ' TYR . 29.7 pt -109.29 133.67 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.088 0.47 . . . . 0.0 112.016 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 29.4 mttt -96.91 115.19 27.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.434 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.514 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 4.8 mt -75.81 -39.81 38.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.944 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.439 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 5.3 tt -155.7 133.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.714 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.416 ' CG ' HG22 ' A' ' 689' ' ' VAL . 8.4 t90 -136.04 125.98 25.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -118.77 116.93 27.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -67.49 -46.55 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.988 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -69.71 -40.51 76.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.945 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.9 t-20 -86.32 -20.27 28.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.68 0.276 . . . . 0.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt 68.38 4.82 4.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.34 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.1 OUTLIER -82.24 105.2 13.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 682' ' ' TRP . 2.2 p -114.33 137.0 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.097 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.437 ' CD1' HG12 ' A' ' 587' ' ' ILE . 2.5 mm -115.27 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.032 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.473 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.23 130.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.231 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.4 m-30 -113.09 146.16 39.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.548 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.03 116.82 33.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.906 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.456 HG13 ' CD1' ' A' ' 578' ' ' LEU . 2.5 t -82.86 123.59 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.45 108.74 8.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.034 0.445 . . . . 0.0 110.987 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 674' ' ' ASP . 25.1 mt -73.58 105.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.789 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -90.05 -46.04 8.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 6.1 t70 -111.28 141.03 45.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.171 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.94 101.67 9.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.8 m -68.02 62.41 0.08 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.66 51.39 48.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -117.29 174.05 6.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.973 0.415 . . . . 0.0 111.561 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.767 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -65.67 118.4 9.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.657 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 3.9 t30 51.39 -71.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.367 0.603 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 703' ' ' PHE . 21.1 pt-20 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 29.5 t -84.53 117.48 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.3 mp -90.2 161.43 15.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 148.3 25.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 160.17 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 26.7 p -119.3 -173.25 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.68 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.7 -45.5 93.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 7.7 tm-20 -67.62 -50.24 59.06 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -54.61 -32.52 58.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.661 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.38 -36.85 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.27 -44.61 79.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.97 -17.42 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.07 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -35.22 79.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.871 0.367 . . . . 0.0 110.75 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -96.79 23.98 6.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.442 HD12 ' CG ' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.76 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -98.29 108.38 21.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 1.6 t80 -90.84 -46.79 8.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 7.2 tp -122.49 142.22 50.81 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.967 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 17.8 m -120.06 115.7 24.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.641 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 592' ' ' LEU . 9.9 mt -102.05 107.85 19.09 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 17.9 mtpp -113.33 98.97 48.09 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -48.45 96.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.636 1.557 . . . . 0.0 109.434 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 581' ' ' LYS . 0.3 OUTLIER -74.76 157.64 85.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 77.9 Cg_exo -49.72 -27.83 16.08 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.338 2.692 . . . . 0.0 112.43 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -62.48 -26.37 68.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.41 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 9.3 t -95.47 153.74 17.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.935 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 10.4 tt -53.27 -14.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.456 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 582' ' ' PRO . 45.0 mt -111.47 133.51 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 111.876 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -114.85 51.81 0.88 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.605 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.7 mt-10 -123.94 171.75 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.795 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.09 132.7 50.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.11 0.481 . . . . 0.0 111.394 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.4 OUTLIER -112.62 142.48 45.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.01 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -123.75 111.68 16.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.526 HG12 ' CD2' ' A' ' 601' ' ' PHE . 66.8 mt -80.71 108.81 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.019 0.437 . . . . 0.0 110.044 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.0 117.67 9.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.69 -33.4 2.94 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.38 0.609 . . . . 0.0 110.016 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.485 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.17 -20.99 73.58 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.371 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.72 118.37 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 117.691 0.746 . . . . 0.0 111.396 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.3 t30 -139.97 121.49 9.62 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.032 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.54 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.2 Cg_endo -90.63 160.79 31.44 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.699 -0.959 . . . . 0.0 111.459 -0.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.6 t80 -91.85 115.07 27.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 10.8 m-85 -92.25 138.49 31.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.621 . . . . 0.0 112.588 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 1.9 mp -123.31 140.51 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.109 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 171.74 -174.81 45.23 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.418 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.7 ttp85 -83.71 -5.71 59.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.251 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.33 129.75 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.79 0.328 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.83 -26.99 6.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.121 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.97 -29.06 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 90.2 m -76.73 133.39 39.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.2 m-80 -49.09 -28.49 4.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 21.0 t -109.59 138.67 45.61 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 111.72 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.452 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 26.0 mm -137.91 109.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.65 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.5 mt-10 -88.81 104.45 16.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.976 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.443 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -130.82 113.27 13.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.081 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -43.39 -36.13 1.82 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.735 0.302 . . . . 0.0 111.62 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.403 ' HB3' HD12 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -77.71 -33.09 53.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.158 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.472 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -64.18 159.35 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 167.37 10.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -55.96 6.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.054 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 62.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.559 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 37.4 t60 -48.83 -49.24 40.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.935 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.7 p -166.71 159.37 13.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.92 0.391 . . . . 0.0 111.212 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.431 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.7 p90 -144.0 146.97 33.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.434 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 82.6 mt -101.87 132.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.719 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.4 t80 -123.26 133.1 54.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 577' ' ' PHE . 2.4 tppp? -97.94 136.43 38.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.237 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.43 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 157.95 45.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.469 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.57 123.53 26.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.0 110.591 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.8 t60 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.88 -0.088 . . . . 0.0 112.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -103.82 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -123.33 147.77 46.68 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.199 0.523 . . . . 0.0 112.279 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -131.88 158.3 41.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.886 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.46 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 4.9 pt -110.28 123.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 111.924 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.505 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 80.8 m95 -108.75 128.66 55.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.399 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.3 t80 -91.31 117.41 29.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 8.2 m -102.57 138.15 39.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.283 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.484 ' CG ' ' HB2' ' A' ' 657' ' ' SER . 84.3 t60 -116.55 129.36 56.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.418 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 3.2 p -125.61 -2.58 7.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.532 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.74 138.26 21.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.091 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 86.1 m -72.13 -8.3 53.88 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -86.93 2.55 48.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 0.0 111.43 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.95 143.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.023 0.439 . . . . 0.0 111.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.484 ' HB2' ' CG ' ' A' ' 651' ' ' HIS . 0.7 OUTLIER -115.57 162.03 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.6 119.43 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.99 99.69 10.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.573 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.656 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.47 -1.73 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.549 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.403 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 17.9 m120 -96.25 141.52 29.5 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.904 0.383 . . . . 0.0 111.179 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.49 141.57 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.158 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.4 mmm -123.03 99.34 6.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.418 ' O ' ' OG1' ' A' ' 668' ' ' THR . 35.0 pt -87.88 154.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -47.43 103.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.347 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.82 39.92 2.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.584 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 2.3 p -128.44 153.31 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.47 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.93 145.19 49.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.087 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.416 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 4.8 t80 -140.14 145.77 37.97 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.505 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.29 131.87 46.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.756 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.426 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -107.75 120.57 42.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.138 0.494 . . . . 0.0 110.845 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -110.04 162.24 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.001 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.409 ' HB2' HD11 ' A' ' 696' ' ' ILE . 24.8 t0 -58.3 108.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.655 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.58 33.5 5.86 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.31 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -86.43 114.94 23.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.691 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -95.75 108.37 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 8.4 mt -108.82 134.44 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -109.01 117.77 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.072 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.559 ' HB ' ' CD2' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -90.32 -22.15 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 618' ' ' LEU . 55.9 mt -152.87 130.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.206 0.527 . . . . 0.0 111.448 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -137.68 129.12 28.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.05 117.32 25.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.0 110.616 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -67.12 -46.56 73.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.016 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.56 -40.47 23.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.735 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -14.33 58.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.442 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 64.51 14.77 9.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 0.6 OUTLIER -77.82 104.67 8.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.0 p -118.44 121.85 68.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.148 0.499 . . . . 0.0 112.059 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.429 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 4.3 mm -112.21 144.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -170.96 123.48 1.04 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.468 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.11 146.11 39.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.341 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -101.56 117.06 34.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 578' ' ' LEU . 2.4 t -81.78 124.12 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.017 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -133.12 108.72 9.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 35.7 mt -73.91 104.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.16 -47.52 8.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.801 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.46 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 12.4 t0 -111.14 139.35 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.633 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -115.7 100.66 8.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.107 0.479 . . . . 0.0 109.712 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.4 t -70.3 63.53 0.25 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.621 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.32 59.45 10.63 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.821 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 0.4 OUTLIER -98.8 148.18 24.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.776 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.6 p90 -47.41 -34.67 7.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.571 0.7 . . . . 0.0 109.751 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.46 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.0 t30 -151.5 -51.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.762 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.46 ' CG ' ' ND2' ' A' ' 704' ' ' ASN . 9.0 pt-20 . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.146 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 30.8 t -77.68 128.37 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.115 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.41 167.9 10.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -103.03 154.75 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.58 155.8 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.12 -176.22 3.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.64 -31.04 63.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -64.76 -44.85 88.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.22 -51.07 57.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -55.41 -32.69 62.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -36.82 82.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.4 -44.26 92.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.936 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -74.55 -26.58 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -34.03 66.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -97.86 33.1 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.422 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.81 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.508 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.226 -0.398 0 CA-C-O 120.756 0.087 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.5 tmm_? -112.65 143.75 43.31 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.516 -0.403 . . . . 0.0 111.415 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -123.59 -58.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.9 tt -112.48 140.86 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.393 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 38.0 m -113.1 122.0 46.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.269 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 592' ' ' LEU . 7.4 mt -107.83 108.96 20.38 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.1 pttp -119.53 98.46 50.07 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -45.22 103.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.739 1.626 . . . . 0.0 108.918 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.94 160.47 81.76 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.567 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 82.0 Cg_exo -47.05 -30.21 9.76 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.715 2.943 . . . . 0.0 113.012 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.47 -17.82 63.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 109.677 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.558 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 38.7 t -95.22 149.22 21.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.936 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -55.73 -22.79 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 178.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.453 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 1.9 tt -113.34 122.22 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.567 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -108.14 69.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 0.0 110.835 -179.246 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.769 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 34.5 mt-10 -127.93 170.97 12.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.173 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 35.8 t -131.23 116.43 17.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 112.028 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 592' ' ' LEU . 0.0 OUTLIER -103.91 139.73 38.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 5.1 mt-10 -118.02 131.35 56.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 601' ' ' PHE . 89.9 mt -82.48 108.66 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.7 OUTLIER -65.5 120.99 13.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.72 -28.8 1.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.842 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.32 -18.71 79.91 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.084 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.02 117.92 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.142 0.971 . . . . 0.0 111.768 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.45 122.6 9.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.514 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.9 Cg_endo -90.25 159.85 32.88 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.5 -1.041 . . . . 0.0 111.519 -0.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.4 t80 -92.04 116.36 28.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.484 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 27.0 m-85 -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.695 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.5 mp -128.31 147.43 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.56 -157.55 30.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.417 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.1 OUTLIER -87.61 -35.85 17.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.733 0.301 . . . . 0.0 111.506 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -74.99 137.65 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.323 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -20.64 58.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.987 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -55.02 -31.53 61.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.5 m -73.22 132.08 42.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m120 -47.0 -29.71 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 110.542 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.539 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 41.5 t -109.29 137.52 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.64 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 110.84 20.68 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.518 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 3.4 mm -138.3 110.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.176 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.2 mt-10 -85.99 104.92 16.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.448 0.642 . . . . 0.0 111.67 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.503 ' O ' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -130.67 108.18 9.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.287 177.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -48.08 -34.9 10.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -78.05 -35.38 49.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.63 131.37 34.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.432 -178.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 8.5 t -57.24 166.33 1.17 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.49 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 1.0 OUTLIER -57.22 -34.92 69.06 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.295 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.96 58.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.949 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.547 ' O ' ' N ' ' A' ' 653' ' ' GLY . 13.9 t60 -49.89 -49.43 49.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.02 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 13.2 p -164.17 161.53 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 111.589 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.484 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.9 p90 -143.53 147.85 35.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.589 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.437 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.93 130.68 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.514 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -122.54 134.17 54.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.773 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 647' ' ' ILE . 5.2 ttmt -98.19 136.44 38.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.204 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.81 159.01 41.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.894 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.4 ' CZ ' ' HA2' ' A' ' 643' ' ' GLY . 3.7 tpt85 -76.59 112.15 12.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.3 t60 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.243 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . 0.4 ' HA2' ' CZ ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.736 -0.146 . . . . 0.0 112.736 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.5 mp -111.78 -162.43 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 m-20 -108.08 147.06 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 112.412 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.75 159.53 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.518 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 627' ' ' LYS . 5.3 pt -111.49 122.37 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.451 0.643 . . . . 0.0 112.249 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.494 ' CH2' HD23 ' A' ' 671' ' ' LEU . 66.7 m95 -108.85 136.19 48.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.085 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.432 ' CD1' HD11 ' A' ' 678' ' ' ILE . 22.7 t80 -94.08 117.77 30.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.27 124.91 49.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.468 ' CE1' ' N ' ' A' ' 657' ' ' SER . 72.0 t60 -101.94 134.38 45.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.148 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.0 p -133.55 4.01 3.61 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.982 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.35 137.69 18.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.394 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 45.0 m -70.37 -11.94 61.25 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.755 -0.262 . . . . 0.0 111.393 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 656' ' ' VAL . 4.6 m-20 -87.39 3.46 46.95 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.459 ' HA ' ' NE2' ' A' ' 651' ' ' HIS . 0.2 OUTLIER 53.56 128.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.283 0.564 . . . . 0.0 112.117 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.468 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 30.5 m -101.47 166.02 10.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.406 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.9 m-85 -130.68 120.19 23.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.333 . . . . 0.0 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -101.03 99.91 10.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 60.4 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.924 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -134.17 1.0 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.73 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.6 m-80 -104.69 132.92 50.36 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 111.077 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.9 139.96 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 41.1 mmm -118.26 97.43 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.3 pt -87.85 154.49 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.73 104.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 111.478 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.08 38.59 2.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -116.26 162.29 17.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.546 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -137.53 139.52 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.5 OUTLIER -147.4 145.78 29.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.829 0.347 . . . . 0.0 111.779 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.494 HD23 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.65 137.83 55.89 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.5 mt -110.54 99.39 8.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 0.0 111.614 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -80.45 147.32 30.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.473 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.425 ' CA ' HD12 ' A' ' 696' ' ' ILE . 13.5 p30 -48.17 112.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.305 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 94.53 36.0 5.76 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.3 117.15 28.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.891 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 109.54 21.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.432 HD11 ' CD1' ' A' ' 649' ' ' TYR . 21.6 pt -105.31 130.44 56.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 112.066 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.43 116.63 29.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.446 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.506 HG22 ' CD2' ' A' ' 622' ' ' HIS . 9.0 mt -89.87 -34.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.295 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 689' ' ' VAL . 0.1 OUTLIER -154.93 131.53 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.803 -179.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -136.96 127.54 26.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.07 116.84 28.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 110.325 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -67.36 -46.91 71.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -83.49 -40.49 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.84 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.4 -16.55 45.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.582 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.9 mttt 64.67 14.32 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.679 0.276 . . . . 0.0 110.91 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' A' ' 587' ' ' ILE . 11.3 t80 -78.36 105.23 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 0.9 OUTLIER -124.88 128.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.912 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.497 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 0.5 OUTLIER -128.58 119.77 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.737 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -151.33 139.9 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.314 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.518 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.18 149.03 36.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.786 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.01 117.22 34.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.485 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.417 HG21 ' HG ' ' A' ' 580' ' ' LEU . 2.1 t -75.07 123.11 30.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.693 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.8 mt-10 -130.32 109.39 10.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 0.0 110.731 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.425 HD12 ' CA ' ' A' ' 674' ' ' ASP . 11.2 mt -83.67 109.83 17.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.714 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -96.11 -46.51 6.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.946 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.35 140.31 46.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.54 101.44 9.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.0 t -69.23 61.47 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.179 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 55.28 45.95 81.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.806 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 0.4 OUTLIER -106.49 151.19 25.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.579 0.228 . . . . 0.0 110.769 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -45.22 128.71 7.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.47 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 5.6 t30 43.33 -79.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.49 . . . . 0.0 111.031 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.681 ' N ' ' O ' ' A' ' 703' ' ' PHE . 13.3 pt-20 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.41 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 4.0 m . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.763 0.316 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.3 125.04 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.257 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.74 172.29 8.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -102.48 157.88 16.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.6 156.41 18.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -126.1 -177.03 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.27 38.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.02 -50.93 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.549 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -65.44 -46.03 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -55.5 -32.95 63.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.55 -36.87 79.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 18.4 mt -59.08 -44.85 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.3 p -81.41 -16.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -32.66 74.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.74 -7.93 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.199 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.428 HD11 ' CG ' ' A' ' 602' ' ' PHE . 5.0 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.874 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.5 tmm_? -112.95 143.85 43.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.625 0.25 . . . . 0.0 111.031 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.506 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.35 -62.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.6 tt -106.38 142.34 36.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 12.5 m -123.62 114.47 20.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.559 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -103.89 108.21 19.43 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.26 100.65 52.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.6 Cg_exo -46.98 99.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.879 1.72 . . . . 0.0 109.722 176.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 158.33 84.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.68 -25.32 11.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.642 2.894 . . . . 0.0 112.612 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.01 -28.03 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 7.5 t -95.38 154.1 17.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.645 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.466 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.0 pt -56.2 -12.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.074 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.92 123.33 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 111.783 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.24 54.75 0.65 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.163 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.614 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.2 mm-40 -124.36 171.39 9.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.094 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.74 129.59 47.34 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.011 0.434 . . . . 0.0 111.262 179.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.35 140.77 46.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -124.24 116.87 23.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.73 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.493 HG12 ' CD2' ' A' ' 601' ' ' PHE . 89.5 mt -80.51 108.96 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.178 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.3 OUTLIER -64.57 120.48 12.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.085 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.62 -28.13 1.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 110.823 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -21.25 79.7 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.867 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.0 118.07 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 118.015 0.908 . . . . 0.0 111.854 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.22 121.99 9.62 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.766 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.7 159.78 35.53 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 124.465 -1.056 . . . . 0.0 111.599 -0.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.0 t80 -91.37 115.87 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.5 m-85 -92.26 138.11 31.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.891 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.525 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.9 mp -127.27 146.05 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.553 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.03 -175.37 40.94 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.543 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.461 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.5 ttp85 -77.51 -6.79 54.83 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.741 -0.229 . . . . 0.0 111.456 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.0 129.36 45.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.847 0.355 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.37 -23.54 24.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . 0.415 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.4 OUTLIER -56.41 -29.76 61.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.602 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 8.9 m -74.73 134.43 41.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.765 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m-80 -49.07 -26.79 2.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.702 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.525 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 46.7 t -112.85 142.87 45.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.532 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 115.05 23.9 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 28.5 mm -137.96 109.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.026 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.6 tt0 -89.01 103.85 16.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.798 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -131.79 113.43 13.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.252 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -43.03 -35.67 1.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.771 0.319 . . . . 0.0 111.514 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 681' ' ' ILE . 2.1 mpp_? -77.95 -36.31 49.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.488 HD13 ' CG2' ' A' ' 680' ' ' ILE . 0.3 OUTLIER -61.58 159.8 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.2 m -109.16 170.13 8.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -49.14 -45.48 43.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.27 0.557 . . . . 0.0 110.201 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 652' ' ' THR . 13.4 t -124.89 57.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.464 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 680' ' ' ILE . 27.7 t60 -43.85 -47.48 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.747 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 5.9 p -166.76 156.34 11.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.445 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.473 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 29.6 p90 -143.18 147.45 34.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.19 130.24 52.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.114 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.3 t80 -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 23.0 ttmt -97.71 136.78 37.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.536 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.68 159.72 39.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.445 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -75.82 115.95 16.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.9 t60 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.75 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . 0.408 ' HA3' ' NE ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.3 -153.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.9 m-20 -122.4 146.57 47.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.308 0.575 . . . . 0.0 112.471 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -126.74 160.14 31.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.423 HG21 ' CE2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -108.94 123.89 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.442 0.639 . . . . 0.0 112.463 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.519 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 90.0 m95 -106.19 125.68 51.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 678' ' ' ILE . 12.0 t80 -90.63 117.53 29.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -102.53 139.24 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.236 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.498 ' CG ' ' OG ' ' A' ' 657' ' ' SER . 46.7 t60 -125.68 121.56 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.571 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 621' ' ' VAL . 0.6 OUTLIER -116.47 5.69 13.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.747 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.03 137.33 20.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.799 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 95.6 m -72.64 -10.61 60.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -87.26 2.06 51.26 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 665' ' ' ILE . 11.6 t 64.31 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.524 . . . . 0.0 112.076 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.498 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 5.3 p -120.76 160.72 22.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 4.8 m-85 -137.48 120.07 16.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.278 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -94.46 105.19 17.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.01 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.44 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.579 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -134.99 0.42 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.698 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -97.77 141.21 31.05 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 658' ' ' TYR . 6.0 ttp180 -88.94 139.08 30.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.441 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -135.83 110.97 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.205 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.412 ' HA ' HG13 ' A' ' 656' ' ' VAL . 18.8 pt -89.78 162.98 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.947 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -46.78 115.56 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.576 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.81 8.45 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.97 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.3 p -112.76 161.74 16.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 111.583 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -135.6 149.18 49.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.422 ' HB3' HD21 ' A' ' 659' ' ' LEU . 2.8 t80 -147.75 146.09 29.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.519 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.74 132.4 46.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.283 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.44 111.82 23.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.311 0.577 . . . . 0.0 111.421 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -104.83 136.01 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.559 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 705' ' ' GLU . 12.3 t70 -37.0 118.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 111.022 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 89.26 36.52 7.52 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.85 118.13 31.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -96.0 109.08 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 649' ' ' TYR . 4.6 mt -105.65 130.03 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 112.004 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.63 116.15 27.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.418 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.488 ' CG2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -83.8 -37.28 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.425 HD11 ' CE1' ' A' ' 622' ' ' HIS . 54.1 mt -154.92 131.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -136.49 127.17 27.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.74 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 116.76 24.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.374 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -67.23 -46.8 72.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.798 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.17 -40.47 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.835 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.61 -14.5 59.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.443 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 64.94 14.07 9.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.634 0.254 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -78.4 104.46 9.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.87 123.64 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.069 0.461 . . . . 0.0 111.74 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.466 ' CD1' HG12 ' A' ' 587' ' ' ILE . 38.9 mm -125.4 153.11 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 175.84 128.61 1.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.121 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 8.5 m-30 -112.82 144.49 42.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.268 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -101.11 117.33 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.574 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.406 ' CG2' ' HG ' ' A' ' 580' ' ' LEU . 2.8 t -79.51 125.25 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -133.16 109.23 9.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 50.1 mt -79.67 105.77 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.665 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -86.83 -43.96 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.15 141.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -113.62 100.09 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.404 0.621 . . . . 0.0 109.899 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 28.7 m -80.93 65.57 6.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 71.3 46.56 41.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.923 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 131.77 34.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.498 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 5.6 p90 -41.8 -34.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.457 0.646 . . . . 0.0 110.266 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -146.64 -61.09 0.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.392 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 7.6 pt-20 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.949 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.735 0.302 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.88 122.27 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.69 161.58 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 136.77 42.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.612 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.31 150.16 24.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 p -110.54 -174.65 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -30.31 43.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -50.23 74.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -45.17 76.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.352 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -57.68 -32.93 67.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.598 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -66.73 -36.82 83.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.595 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.68 -44.25 85.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.8 p -76.16 -14.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.81 -39.4 76.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.564 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -93.79 11.24 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 602' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.659 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.404 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 8.4 ttm105 -113.61 143.39 44.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.26 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.2 OUTLIER -118.51 -57.89 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.331 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.434 ' CD1' HG12 ' A' ' 694' ' ' VAL . 5.1 tp -113.09 142.08 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.4 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.418 HG21 ' CG ' ' A' ' 581' ' ' LYS . 2.8 m -120.04 114.76 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.031 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 692' ' ' PHE . 5.8 mt -102.0 108.36 19.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 27.4 mtmt -114.16 99.27 50.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 34.7 Cg_exo -47.81 98.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.655 1.57 . . . . 0.0 109.463 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.36 158.1 84.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.79 -26.53 13.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.427 2.752 . . . . 0.0 112.573 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' A' ' 583' ' ' LEU . 2.8 m-20 -62.76 -28.12 69.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 93.2 p -95.69 153.21 17.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.839 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 690' ' ' ILE . 7.9 tt -53.15 -15.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.322 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 613' ' ' ILE . 71.2 mt -109.03 131.7 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.936 0.398 . . . . 0.0 111.795 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -116.93 54.62 0.86 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.254 0.549 . . . . 0.0 110.65 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.662 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.6 mt-10 -124.11 172.07 9.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.683 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.69 128.39 45.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.177 0.513 . . . . 0.0 111.221 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.41 139.74 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.788 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.04 113.22 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.544 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.52 HG12 ' CD2' ' A' ' 601' ' ' PHE . 76.4 mt -77.29 109.21 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.1 OUTLIER -67.34 118.13 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.022 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -27.93 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.822 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -70.85 -20.63 77.75 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.186 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.68 118.32 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 117.552 0.676 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.4 t30 -139.9 121.8 9.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.5 Cg_endo -89.48 160.49 36.96 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.535 -1.027 . . . . 0.0 111.492 -0.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.6 t80 -91.09 115.42 28.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.0 m-85 -91.98 137.52 32.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.027 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -124.84 144.83 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.39 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.41 -173.7 38.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.298 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -68.11 -46.8 69.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.853 0.359 . . . . 0.0 111.431 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.454 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.72 129.23 40.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.37 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -58.06 -18.36 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.762 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.63 -30.64 67.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 110.249 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 94.8 m -69.95 131.55 44.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.598 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -43.99 -32.43 1.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.322 0.582 . . . . 0.0 110.453 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 41.5 t -109.46 142.17 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.196 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.3 105.0 13.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.478 HG13 ' CE2' ' A' ' 692' ' ' PHE . 38.3 mm -139.26 109.5 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.467 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.36 106.23 16.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 112.256 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 4.7 t0 -129.88 107.69 9.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.571 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -39.44 -28.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.412 ' CB ' HD13 ' A' ' 681' ' ' ILE . 9.2 mmt180 -70.82 -41.77 71.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -89.3 158.74 17.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.6 m -76.71 164.61 25.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.454 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -52.41 -27.07 14.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.01 62.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.541 ' CD2' HG21 ' A' ' 680' ' ' ILE . 26.1 t60 -50.03 -48.66 52.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.211 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.84 162.22 26.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.5 p90 -143.61 148.39 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.442 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 81.5 mt -102.12 124.3 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.046 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -113.87 133.55 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.73 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 28.6 ttmt -97.88 136.52 38.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.69 158.59 44.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.827 -178.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.13 115.97 17.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 120.678 0.043 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.4 mp -115.75 -157.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.3 m-20 -117.56 146.72 43.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.08 0.467 . . . . 0.0 111.96 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -133.03 157.16 45.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 1.1 pt -106.8 119.23 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.543 0.687 . . . . 0.0 111.769 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.538 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 72.9 m95 -100.61 132.13 46.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.417 ' CB ' HD23 ' A' ' 672' ' ' LEU . 31.2 t80 -90.36 117.24 28.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -103.5 121.67 43.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.559 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.419 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 28.9 t60 -102.23 128.74 48.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 7.4 p -125.11 2.43 7.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.423 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.05 150.21 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.108 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 72.3 m -82.21 -18.97 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 111.518 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 656' ' ' VAL . 15.0 m-20 -82.56 3.35 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.79 137.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.644 0.735 . . . . 0.0 112.238 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 58.2 m -107.93 165.91 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.423 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 120.59 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.482 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -105.65 100.34 9.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.846 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.76 -82.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.87 6.19 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.652 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -110.27 138.45 46.64 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -74.74 138.34 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 45.7 mmm -117.68 88.01 2.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.579 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.403 ' O ' ' OG1' ' A' ' 668' ' ' THR . 48.5 pt -86.91 164.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 22.6 tt0 -54.92 105.53 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.34 40.52 2.39 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 2.6 p -124.45 162.39 24.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.497 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 6.3 ttpm? -138.07 144.93 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.482 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.64 145.09 28.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.8 0.334 . . . . 0.0 111.758 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.538 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.7 136.61 53.16 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 647' ' ' ILE . 0.1 OUTLIER -107.1 112.84 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.541 . . . . 0.0 111.869 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -104.13 137.95 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.894 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -39.11 123.11 1.31 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.936 0.398 . . . . 0.0 111.152 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 88.91 40.6 6.17 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 1.6 t0 -93.51 113.18 25.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.979 0.418 . . . . 0.0 111.434 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.34 111.38 23.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.865 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 9.2 mt -112.41 137.16 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -98.19 115.7 28.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.7 mt -82.8 -38.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.573 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 618' ' ' LEU . 6.7 mt -155.83 131.72 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.019 0.438 . . . . 0.0 111.873 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.24 124.75 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.669 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.18 117.88 29.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.642 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -66.36 -46.52 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.591 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -83.28 -40.36 19.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.351 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.06 -17.94 56.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.69 16.09 9.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.75 105.2 13.58 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.1 p -122.83 124.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.267 0.555 . . . . 0.0 112.147 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.44 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 6.6 mm -114.29 150.17 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.553 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.71 121.48 0.87 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.641 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.514 ' CB ' HD21 ' A' ' 580' ' ' LEU . 6.9 m-30 -113.78 143.18 45.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -101.78 117.81 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.6 t -79.69 123.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -133.67 108.99 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.287 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 578' ' ' LEU . 87.0 mt -72.93 105.76 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.76 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.75 -47.57 10.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.139 0.495 . . . . 0.0 109.949 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -111.49 141.91 44.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.6 p -113.63 100.09 8.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.141 0.496 . . . . 0.0 109.875 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -80.31 61.51 4.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.696 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.3 54.81 34.16 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.109 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -87.28 148.38 25.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.392 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -39.76 -32.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.989 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.454 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -178.95 33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.42 ' O ' ' CD1' ' A' ' 696' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.29 122.43 41.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.484 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.5 172.26 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -103.16 142.22 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -88.98 160.13 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.905 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.14 -173.49 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.74 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.81 -49.19 77.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.467 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -69.18 -49.84 53.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.574 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -57.26 -32.81 66.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.735 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.81 -44.24 86.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.86 -24.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -57.26 -41.14 79.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -74.1 -15.4 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.274 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 602' ' ' PHE . 7.9 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 tmm_? -105.93 140.19 39.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -129.16 -61.15 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.585 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 6.4 tt -106.56 141.36 37.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.181 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 19.5 m -119.48 119.67 34.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.362 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 592' ' ' LEU . 9.1 mt -104.79 108.29 19.69 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 98.68 44.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.8 Cg_exo -48.98 101.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.649 1.566 . . . . 0.0 109.15 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 158.26 85.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.447 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.94 -28.64 19.05 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.55 2.834 . . . . 0.0 112.594 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.48 -18.14 63.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 109.725 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.7 t -96.8 153.76 17.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.679 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.446 HG12 ' CD1' ' A' ' 690' ' ' ILE . 1.7 pt -55.62 -20.29 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.409 ' CD1' ' CG2' ' A' ' 613' ' ' ILE . 59.5 mt -110.27 118.66 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.382 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -106.74 57.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.394 0.616 . . . . 0.0 110.258 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.636 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -124.71 172.63 9.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.892 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.43 127.68 45.81 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.315 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.8 OUTLIER -113.11 147.22 37.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.083 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 7.4 mt-10 -125.35 125.56 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 601' ' ' PHE . 68.2 mt -86.1 109.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.0 mp0 -64.18 118.06 8.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.41 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.54 -29.79 1.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.583 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.27 -22.63 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.48 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 118.93 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.773 0.787 . . . . 0.0 111.726 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -139.56 121.82 10.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.781 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.9 Cg_endo -89.6 160.28 36.28 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.563 -1.015 . . . . 0.0 111.691 -0.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.9 t80 -91.52 116.19 28.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 25.4 m-85 -92.36 137.94 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.15 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -126.47 145.89 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.423 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.42 -176.28 41.66 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.481 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -78.52 -7.28 57.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.78 133.25 43.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -23.71 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -57.83 -25.4 60.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 55.2 m -78.75 132.06 36.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.4 m120 -46.1 -31.35 2.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.198 0.523 . . . . 0.0 110.413 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.523 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 40.5 t -108.53 142.76 38.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.6 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 115.59 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -138.02 109.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.284 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 19.2 tt0 -87.09 103.41 15.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.6 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.485 ' HB3' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -132.11 112.81 12.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.44 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -42.98 -33.69 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.761 0.315 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.55 -39.98 44.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.955 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 680' ' ' ILE . 0.8 OUTLIER -60.21 159.11 10.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.905 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 70.7 m -111.09 168.81 9.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.537 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -43.64 24.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.228 0.537 . . . . 0.0 110.031 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.17 61.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.467 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.499 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 36.3 t60 -49.78 -48.3 50.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.791 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -167.52 157.32 10.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 111.363 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.481 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.2 p90 -143.14 147.37 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.407 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 34.7 mt -102.13 128.33 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.086 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -119.78 131.3 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 20.2 ttmt -97.84 136.36 38.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.107 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.09 159.28 41.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.879 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.0 tpt180 -76.28 116.3 16.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.4 t60 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.209 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.8 mp -106.14 -159.71 0.71 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.1 m-20 -118.27 146.77 44.05 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.44 160.41 29.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.782 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.449 HG22 ' CE2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -109.65 121.98 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.46 0.647 . . . . 0.0 112.313 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.554 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 84.8 m95 -105.7 125.75 51.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 12.0 t80 -89.71 116.49 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 624' ' ' PHE . 16.3 m -102.95 137.13 41.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -116.87 122.97 45.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.35 7.92 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.272 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.78 145.18 19.94 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.832 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.4 m -75.29 -9.55 58.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 36.2 m-20 -87.14 2.09 50.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.59 127.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.395 0.617 . . . . 0.0 112.158 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 16.2 p -97.73 165.55 11.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.208 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -128.52 119.7 25.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.49 ' HB3' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -95.22 102.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 63.42 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.11 -2.08 1.5 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.51 141.75 30.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.909 0.385 . . . . 0.0 111.222 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -85.16 141.61 30.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.747 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.427 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 1.5 mtp -131.11 124.74 31.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.6 pt -95.08 156.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.779 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 652' ' ' THR . 32.9 tt0 -50.25 122.42 6.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 97.14 25.75 10.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 50.5 p -122.43 156.42 34.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.6 pttm -123.94 158.17 32.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.968 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.29 145.92 29.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.554 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.88 130.53 43.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.624 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -110.44 114.87 28.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.11 0.481 . . . . 0.0 111.665 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.15 135.29 40.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.849 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -40.96 109.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.584 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.11 34.55 4.52 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 115.17 27.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.469 -0.365 . . . . 0.0 111.087 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -96.25 108.51 21.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.838 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.437 HG21 ' CE2' ' A' ' 649' ' ' TYR . 7.1 mt -106.51 136.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 115.72 28.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.222 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -82.12 -36.16 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.197 -178.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 618' ' ' LEU . 41.4 mt -154.9 131.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -136.57 124.77 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.57 117.23 23.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.481 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -66.8 -46.56 74.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.808 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -77.83 -40.37 40.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.602 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.4 -13.73 51.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.543 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp 61.82 17.77 9.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.64 104.96 9.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.54 121.83 68.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 111.695 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 587' ' ' ILE . 30.5 mm -124.45 119.11 55.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.503 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -147.83 129.73 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 12.8 m-30 -113.18 142.82 45.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 110.255 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.27 116.91 33.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.332 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.41 HG23 ' CD2' ' A' ' 580' ' ' LEU . 2.4 t -80.73 123.97 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.73 110.22 11.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.0 110.868 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.46 105.64 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.788 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.08 -43.69 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.01 141.98 42.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -112.89 100.16 8.44 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.473 0.654 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.24 53.97 3.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.15 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 93.0 34.94 6.54 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.628 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 132.02 34.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.43 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 5.0 p90 -43.31 -33.32 0.97 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.515 0.674 . . . . 0.0 110.258 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -149.86 -55.8 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.124 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 10.4 pt-20 . . . . . 0 N--CA 1.464 0.253 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.886 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.656 0.265 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.44 HG21 ' CE2' ' A' ' 670' ' ' PHE . 51.9 t -77.42 128.45 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.462 . . . . 0.0 111.4 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.74 164.65 13.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.348 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.52 142.95 27.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.95 158.66 36.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.0 p -118.91 -178.41 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.978 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.59 -29.06 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.98 -49.96 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -50.71 67.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.72 -32.89 63.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.36 -36.88 84.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.07 -44.2 94.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.15 -29.26 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.87 -30.61 61.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -85.51 -24.06 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 8.7 tt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.055 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.407 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 22.9 ttp-105 -111.82 143.11 43.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.052 0.453 . . . . 0.0 111.524 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.488 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.69 -57.81 1.43 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.09 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 6.8 tt -110.26 137.93 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.084 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 7.4 m -118.55 114.18 22.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -103.92 108.06 19.22 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 16.3 ptpt -117.09 100.54 53.29 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.5 Cg_exo -46.08 104.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.87 1.714 . . . . 0.0 109.62 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 160.29 81.95 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.498 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 5.6 Cg_endo -48.17 -31.18 16.09 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.587 2.858 . . . . 0.0 112.495 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -63.73 -16.1 60.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.156 0.503 . . . . 0.0 109.726 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.596 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 9.1 t -94.18 145.0 25.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.412 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 3.5 pt -52.43 -24.26 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 110.178 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 588' ' ' ILE . 7.3 tt -112.99 118.97 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.983 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.498 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -100.69 71.16 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.331 0.586 . . . . 0.0 110.321 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.607 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 50.6 mt-10 -126.05 171.9 10.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.127 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.21 130.2 47.61 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 121.138 0.494 . . . . 0.0 110.962 178.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.44 140.03 47.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.936 179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.407 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.12 112.56 17.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.513 HG12 ' CD2' ' A' ' 601' ' ' PHE . 89.7 mt -81.09 108.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 110.03 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.9 mp0 -66.87 123.63 20.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.118 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.73 -26.71 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 110.819 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -75.68 -20.39 78.28 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.041 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 44.3 t -99.45 118.02 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.993 0.897 . . . . 0.0 111.776 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.0 t30 -140.23 122.49 9.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.5 Cg_endo -90.36 160.15 32.45 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.679 -0.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.1 t80 -92.58 117.48 30.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.441 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 19.4 m-85 -92.51 137.48 32.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.262 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.549 HG13 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mp -121.93 143.61 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.585 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.33 -165.09 38.39 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.949 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.21 -17.27 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.131 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -80.28 131.53 35.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.824 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.5 -23.85 11.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.001 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -59.84 -27.04 66.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 9.7 m -76.0 129.36 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -46.57 -32.47 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.231 0.539 . . . . 0.0 110.225 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.549 ' HB3' HG13 ' A' ' 603' ' ' ILE . 13.2 t -107.47 135.24 49.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.315 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.98 111.94 22.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.446 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 17.5 mm -137.78 110.14 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.974 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.57 102.85 10.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.066 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -132.84 109.13 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.42 178.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -44.58 -52.88 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -60.64 -19.76 58.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.897 0.379 . . . . 0.0 110.928 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -76.2 160.66 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.575 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.461 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 19.6 t -111.22 151.96 27.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.411 ' CA ' ' HB2' ' A' ' 606' ' ' SER . 7.7 mpt_? -39.0 -38.6 0.46 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 110.675 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.67 60.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.418 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.537 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 21.7 t60 -50.4 -48.81 55.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.077 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 22.8 p -165.64 161.11 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.688 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.6 p90 -143.83 144.95 32.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.629 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.97 128.87 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.1 t80 -119.43 134.04 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.42 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 6.7 ttpt -97.86 136.47 38.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.223 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.2 OUTLIER -135.21 159.88 40.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.473 -178.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.0 tpt85 -75.72 112.46 12.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.378 0.609 . . . . 0.0 110.371 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.8 t60 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.049 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 113.179 0.032 . . . . 0.0 113.179 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.2 mp -107.05 -161.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.1 m-20 -115.63 146.85 41.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.237 0.541 . . . . 0.0 112.39 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.6 m-20 -129.95 160.55 33.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.798 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.431 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.54 125.61 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.494 0.664 . . . . 0.0 112.461 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.5 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.5 m95 -108.93 128.05 54.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.607 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.456 ' CE1' HD13 ' A' ' 678' ' ' ILE . 35.1 t80 -90.47 119.4 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.642 0.258 . . . . 0.0 110.325 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 28.2 m -107.59 128.38 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.215 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -108.81 125.3 51.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.47 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -118.62 4.41 11.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.01 150.54 26.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.152 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 76.1 m -82.4 -10.97 58.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.553 0.216 . . . . 0.0 111.494 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -84.65 2.89 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 50.67 139.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.64 0.733 . . . . 0.0 112.353 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 656' ' ' VAL . 10.1 t -112.67 166.16 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.55 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -130.57 120.2 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.016 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.545 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -102.63 103.25 13.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 62.53 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.784 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.7 m-80 -139.89 -2.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.43 141.67 32.96 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.943 0.401 . . . . 0.0 111.406 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -75.29 141.51 43.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.057 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.42 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 12.1 mmm -125.68 89.3 3.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.0 pt -86.81 164.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 652' ' ' THR . 20.7 tt0 -50.65 117.77 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.454 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.22 30.26 9.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.789 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 23.8 p -114.01 162.18 16.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.5 ttpt -134.93 149.43 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.483 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.545 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.62 143.83 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.5 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -75.89 129.76 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.475 ' N ' HD11 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -99.87 143.79 29.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.329 0.585 . . . . 0.0 111.938 -179.426 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -130.34 136.17 48.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.511 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -40.27 118.55 0.93 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.55 37.42 5.85 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.83 117.66 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.167 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.06 108.71 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.456 HD13 ' CE1' ' A' ' 649' ' ' TYR . 28.2 pt -108.95 133.84 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -109.42 116.54 32.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.095 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' A' ' 622' ' ' HIS . 1.9 pt -89.51 -21.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.447 ' O ' HG21 ' A' ' 690' ' ' ILE . 41.1 mt -154.27 130.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.579 . . . . 0.0 111.674 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -137.71 127.31 25.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.57 116.76 24.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.552 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -67.56 -47.62 69.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.708 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.1 -40.48 18.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.472 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -13.4 60.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.419 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.56 18.74 8.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.813 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.77 104.63 15.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -122.13 121.59 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.272 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.596 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 0.8 OUTLIER -128.44 128.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.95 135.92 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.466 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.446 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -114.28 147.43 39.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.37 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -101.53 117.19 34.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.529 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.419 HG23 ' CD2' ' A' ' 580' ' ' LEU . 3.6 t -78.79 123.55 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.28 109.34 9.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.86 105.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.24 -43.67 10.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.115 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.199 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.3 p -112.73 100.22 8.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.576 0.703 . . . . 0.0 109.789 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.2 m -84.65 59.29 5.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 83.99 40.13 8.91 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.437 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.67 132.66 33.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.533 0.206 . . . . 0.0 110.619 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.426 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 4.0 p90 -42.92 -33.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.342 0.591 . . . . 0.0 110.606 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -148.39 -58.79 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.146 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.473 ' HA ' ' HD1' ' A' ' 670' ' ' PHE . 15.8 t -84.11 113.73 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.154 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.72 169.65 10.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.9 140.18 37.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.69 155.39 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 32.1 p -125.64 -176.16 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.86 -33.43 56.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -51.3 70.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.91 -48.12 77.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -58.27 -32.97 68.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -64.85 -37.01 86.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.91 -44.1 97.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -75.76 -28.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -33.17 52.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -98.68 26.23 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.833 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.428 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 11.6 ttm180 -113.46 143.82 43.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.706 0.288 . . . . 0.0 111.521 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 2.3 t80 -119.97 -55.29 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 12.4 tp -113.34 142.43 45.87 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -122.51 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 592' ' ' LEU . 4.7 mp -106.27 108.86 20.59 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 100.93 51.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 46.2 Cg_exo -45.94 99.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.98 1.787 . . . . 0.0 110.006 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 158.2 85.11 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.3 Cg_exo -48.84 -25.29 8.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.403 2.735 . . . . 0.0 112.921 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -27.27 68.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.425 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 8.7 t -95.73 154.11 17.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.892 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.452 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.6 pt -57.11 -12.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.69 0.281 . . . . 0.0 110.962 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 71.2 mt -110.27 123.0 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.746 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.404 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -108.16 57.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.197 0.522 . . . . 0.0 110.028 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.3 mt-10 -124.62 171.75 9.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.226 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.02 130.1 50.49 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 178.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.3 OUTLIER -112.28 139.45 47.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.037 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.17 112.99 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.659 0.266 . . . . 0.0 111.644 -179.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 601' ' ' PHE . 38.0 mt -77.22 109.76 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -67.71 114.66 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.76 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.19 -28.53 0.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.184 0.516 . . . . 0.0 110.809 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.83 -25.2 74.24 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.536 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 66.6 t -101.2 119.27 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 117.813 0.807 . . . . 0.0 111.61 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -139.07 122.91 11.09 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.786 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 47.3 Cg_endo -89.83 160.51 35.24 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 124.518 -1.034 . . . . 0.0 111.863 0.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.38 114.96 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.524 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.0 m-85 -92.12 138.19 31.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.168 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -125.1 145.77 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.83 -173.27 38.16 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.383 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.472 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.35 -53.48 29.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.656 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.6 129.82 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.292 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.39 -18.96 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -53.66 -30.02 41.25 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 30.4 m -73.55 134.45 43.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.3 m-80 -48.66 -27.36 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.973 0.415 . . . . 0.0 110.388 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.514 ' HB3' HG13 ' A' ' 603' ' ' ILE . 42.0 t -113.37 142.08 46.29 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 105.61 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.421 HG13 ' CE2' ' A' ' 692' ' ' PHE . 31.5 mm -138.52 109.91 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.161 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -103.69 106.7 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.489 0.662 . . . . 0.0 112.589 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.6 t0 -129.93 107.71 9.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.559 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -39.3 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.477 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.8 mmp_? -70.31 -41.42 73.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.535 ' CB ' ' CG ' ' A' ' 622' ' ' HIS . 0.8 OUTLIER -88.12 158.72 18.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.85 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.2 t -78.26 172.37 13.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.414 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -50.27 -37.24 34.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 110.253 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.09 67.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.265 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.535 ' CG ' ' CB ' ' A' ' 618' ' ' LEU . 12.7 t60 -49.05 -48.36 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.811 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 2.6 p -159.99 158.77 31.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.676 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.524 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 39.3 p90 -143.45 150.39 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.478 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.44 HD12 HD11 ' A' ' 594' ' ' ILE . 83.7 mt -102.53 132.42 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.215 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -124.97 132.92 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 36.2 ttmt -98.45 136.54 38.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.573 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.45 158.58 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -76.95 112.75 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.522 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.7 t60 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.628 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 1.2 mp -115.74 -149.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.547 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 4.7 m-20 -118.21 149.37 41.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.282 0.563 . . . . 0.0 112.338 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.03 129.32 35.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.734 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 672' ' ' LEU . 7.0 pt -86.81 123.55 39.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.323 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.504 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 80.6 m95 -108.98 129.32 55.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.046 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 12.2 t80 -90.34 115.7 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 624' ' ' PHE . 60.8 m -101.63 141.88 33.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 111.473 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.48 ' HB3' ' HG3' ' A' ' 664' ' ' MET . 24.8 t60 -124.13 131.64 53.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.514 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 9.3 p -124.24 2.63 8.52 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.37 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.84 142.48 24.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.037 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.3 m -75.55 -12.65 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.512 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.8 m120 -83.64 2.63 36.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.587 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.87 134.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.588 0.708 . . . . 0.0 112.281 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 43.5 p -105.49 165.89 10.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.355 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -127.61 119.85 26.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 111.283 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.64 99.72 10.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.702 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.33 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.8 t-20 -133.48 3.76 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.833 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.15 130.26 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.955 0.407 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.97 141.42 53.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.48 ' HG3' ' HB3' ' A' ' 651' ' ' HIS . 34.1 tpp -125.4 101.29 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.444 ' O ' ' OG1' ' A' ' 668' ' ' THR . 30.1 pt -87.94 165.61 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 652' ' ' THR . 16.1 tt0 -58.77 109.82 0.89 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.41 34.72 3.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 5.2 p -134.84 154.94 51.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.356 . . . . 0.0 111.591 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.2 pttm -128.23 156.08 43.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.488 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.52 145.77 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.501 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.504 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.38 134.57 51.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.481 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 3.3 mt -108.52 126.33 52.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -113.36 154.21 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.714 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.408 ' HB2' HD11 ' A' ' 696' ' ' ILE . 56.7 t0 -52.76 101.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.21 30.66 3.81 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 117.11 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.536 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -96.2 109.74 22.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.282 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 23.5 pt -105.94 130.48 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -94.5 116.13 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.711 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -38.7 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.522 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.408 HG23 ' HB ' ' A' ' 690' ' ' ILE . 0.7 OUTLIER -155.84 136.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -136.42 122.41 20.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -123.53 116.99 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.92 0.39 . . . . 0.0 110.583 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -67.27 -46.48 73.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.97 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -78.81 -40.49 32.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.793 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -83.08 -9.51 59.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 60.46 18.08 7.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.253 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.1 t80 -76.72 104.63 7.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.4 p -118.2 122.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.133 0.492 . . . . 0.0 111.746 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.452 ' CD1' HG12 ' A' ' 587' ' ' ILE . 22.5 mm -126.17 154.6 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.298 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.425 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 177.54 127.86 1.1 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.952 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.483 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 11.1 m-30 -113.04 145.28 41.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.43 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 116.53 33.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.022 0.439 . . . . 0.0 110.256 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.5 t -82.58 127.19 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.754 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -134.28 108.4 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.924 179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.48 HG12 HD11 ' A' ' 578' ' ' LEU . 11.5 mt -74.58 104.94 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.61 -50.84 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.899 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.6 t0 -112.47 138.36 49.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.211 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.0 OUTLIER -117.09 100.06 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 64.1 p -70.27 78.84 0.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.42 39.75 60.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.388 -0.91 . . . . 0.0 110.829 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 1.5 tt -97.08 143.65 27.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.867 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.655 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -58.25 112.66 1.62 Allowed 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.457 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 11.4 t30 59.73 -68.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.147 0.499 . . . . 0.0 109.932 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 703' ' ' PHE . 11.7 pt-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.989 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.78 0.324 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.3 130.16 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.4 mp -99.42 170.65 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.782 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -98.32 155.76 17.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -96.39 158.54 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.3 p -126.04 -176.58 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.197 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.42 46.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.14 -47.81 84.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.37 -50.42 63.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.663 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -55.7 -32.87 63.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -37.31 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.786 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -44.34 93.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -78.41 -21.49 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -37.75 81.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.6 -9.67 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.399 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.403 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.5 tt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.99 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.4 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.403 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.0 tmm_? -107.52 143.11 36.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 2.4 t80 -132.61 -47.98 0.89 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 694' ' ' VAL . 1.0 OUTLIER -112.65 143.25 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.16 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 33.0 m -123.07 114.01 19.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.982 0.42 . . . . 0.0 111.053 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.449 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -106.11 109.01 20.82 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.26 99.43 52.69 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 39.0 Cg_exo -46.91 101.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.916 1.744 . . . . 0.0 109.814 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.73 157.95 85.32 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.412 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 9.0 Cg_endo -50.14 -25.46 13.07 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.768 2.978 . . . . 0.0 113.21 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.97 -27.37 68.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 2.7 t -95.62 153.92 17.48 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.624 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 9.3 pt -56.51 -12.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.701 0.286 . . . . 0.0 111.193 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 39.9 mt -108.54 127.24 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.527 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -114.22 58.5 0.69 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.266 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.675 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 36.7 mt-10 -125.03 170.14 11.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.86 121.19 24.82 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.607 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.438 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -112.75 147.43 36.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -125.19 118.54 26.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.543 HG12 ' CD2' ' A' ' 601' ' ' PHE . 57.6 mt -73.48 109.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.912 0.387 . . . . 0.0 110.294 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.1 116.4 6.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.971 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.99 -29.84 1.59 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.163 0.506 . . . . 0.0 110.471 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.23 -22.72 76.28 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.589 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.04 118.79 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 117.884 0.842 . . . . 0.0 111.585 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.0 t30 -139.37 122.68 10.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.765 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.533 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.11 160.43 33.82 Favored 'Cis proline' 0 N--CA 1.462 -0.373 0 C-N-CA 124.451 -1.062 . . . . 0.0 111.917 0.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -91.46 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 41.6 m-85 -92.25 138.15 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.007 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.484 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.2 mp -129.84 145.69 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.678 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 156.72 -163.36 32.14 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.013 -1.089 . . . . 0.0 114.049 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.2 OUTLIER -82.85 3.42 29.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -101.3 123.94 46.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -57.84 -22.49 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.271 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.16 -26.63 67.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.905 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 92.3 m -68.51 129.43 39.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.319 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.2 m120 -44.07 -33.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.308 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 53.5 t -109.73 134.88 51.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.12 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 111.99 23.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 30.6 mm -137.62 110.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.619 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 6.1 tt0 -91.6 105.9 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.274 0.559 . . . . 0.0 111.523 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 618' ' ' LEU . 13.5 t0 -130.32 108.58 10.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.702 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -47.43 -29.8 2.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.821 0.343 . . . . 0.0 111.201 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.491 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 19.7 mmt180 -77.86 -41.29 37.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.75 151.71 24.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.94 161.4 23.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.165 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.423 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -47.65 -38.8 15.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.444 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 24.1 t -121.24 57.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 653' ' ' GLY . 6.0 t60 -50.42 -48.66 56.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.883 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.2 p -162.69 157.04 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.467 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 25.2 p90 -143.32 146.93 33.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.594 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 580' ' ' LEU . 23.9 mt -101.9 135.37 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.983 0.42 . . . . 0.0 109.914 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -127.34 134.94 49.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.746 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.2 ttmt -97.64 136.19 38.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.137 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 159.27 42.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.76 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -76.47 112.55 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.195 0.522 . . . . 0.0 110.595 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t-160 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.1 mp -102.47 -166.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -111.75 148.03 34.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.026 0.441 . . . . 0.0 111.926 -179.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -128.85 160.11 33.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.448 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 3.5 pt -110.64 121.59 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.317 0.579 . . . . 0.0 111.615 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.536 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 96.9 m95 -104.28 141.3 36.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.165 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.436 ' CE2' HG23 ' A' ' 678' ' ' ILE . 10.7 t80 -105.7 116.95 32.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.19 139.8 39.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.472 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -119.46 128.73 54.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.053 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.417 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 5.4 p -126.55 12.95 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.51 148.75 21.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.181 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 69.5 m -77.0 -21.89 53.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 617' ' ' ARG . 1.5 m120 -79.9 -0.52 35.27 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.5 OUTLIER 54.9 128.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.932 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.1 p -92.74 166.36 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.986 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' A' ' 679' ' ' LYS . 18.7 m-85 -133.15 120.6 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -105.3 112.57 25.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.142 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 59.03 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -139.86 7.6 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.22 141.06 36.93 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -79.33 141.02 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 13.9 mmm -120.96 101.27 7.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -88.27 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 652' ' ' THR . 34.6 tt0 -44.81 109.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.423 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.45 34.78 3.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 3.6 p -122.33 162.25 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.071 0.462 . . . . 0.0 111.667 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.5 ttpm? -131.61 149.71 52.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.344 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.468 ' HB3' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.3 143.74 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.536 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.37 137.74 53.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.437 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.7 mt -110.85 104.14 12.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.235 0.54 . . . . 0.0 111.573 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -90.94 137.91 32.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.197 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 705' ' ' GLU . 5.4 t70 -43.52 111.32 0.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.8 37.13 4.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.444 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -93.55 122.65 36.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.469 -0.366 . . . . 0.0 111.012 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.37 108.88 21.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.186 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.436 HG23 ' CE2' ' A' ' 649' ' ' TYR . 3.7 mt -106.15 136.36 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.904 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 658' ' ' TYR . 1.7 mttt -100.83 116.27 32.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.566 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -37.94 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.413 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.403 HG22 ' OD2' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -155.29 131.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.724 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -136.25 123.56 21.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.159 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -121.4 117.18 26.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.42 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -66.89 -46.51 74.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.943 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.41 -40.44 21.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.543 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -77.47 -14.0 59.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.334 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 15.09 9.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -78.6 104.76 9.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.6 p -120.18 121.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 111.972 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.427 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 3.4 mt -129.14 152.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.324 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 177.5 133.3 1.82 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.021 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 4.2 m-30 -112.93 150.92 31.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -101.27 116.82 33.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.953 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 578' ' ' LEU . 1.8 t -81.11 121.89 35.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.883 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.66 108.75 8.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.477 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 11.6 mt -79.21 107.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.32 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.68 -41.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -109.76 141.09 42.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.2 OUTLIER -114.88 100.41 8.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.418 0.627 . . . . 0.0 110.046 178.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.6 m -86.79 70.47 10.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 73.33 36.12 55.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.163 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -79.87 118.59 21.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.583 0.23 . . . . 0.0 111.171 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.535 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -32.8 -47.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.535 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -159.2 26.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.543 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.897 0.38 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.91 129.32 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.247 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.9 mt -102.64 166.13 10.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 137.99 40.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.02 159.88 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.4 p -121.11 -173.68 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.67 -28.82 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.16 -52.09 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.66 -49.32 63.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.628 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -56.35 -33.13 65.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 -38.24 89.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.8 mt -58.41 -44.01 88.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.548 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.18 -29.77 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -52.11 -29.31 21.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.057 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -105.29 27.22 8.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.449 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.3 tt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.679 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.9 tmm_? -102.29 126.13 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.564 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -109.2 -62.29 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.187 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 694' ' ' VAL . 6.8 tt -106.06 137.76 43.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 4.6 m -115.98 113.96 23.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.998 0.428 . . . . 0.0 111.434 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.6 OUTLIER -104.83 107.9 19.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 ptpt -114.83 100.02 52.84 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_exo -45.78 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.945 1.763 . . . . 0.0 109.565 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.16 157.83 86.3 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.8 Cg_exo -49.12 -25.25 8.98 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.381 2.72 . . . . 0.0 112.425 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -61.97 -22.61 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.0 t -95.31 153.11 17.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.03 -19.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.012 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 582' ' ' PRO . 2.6 tt -112.99 142.92 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.658 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -119.47 67.74 0.81 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 89.5 mt-10 -125.16 170.86 10.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.494 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.77 124.0 34.37 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.26 136.51 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.571 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.3 OUTLIER -124.48 116.6 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.851 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.542 HG12 ' CD2' ' A' ' 601' ' ' PHE . 81.2 mt -74.87 108.16 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.842 0.354 . . . . 0.0 110.144 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.2 mp0 -66.16 103.14 0.92 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -29.6 -54.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.27 0.557 . . . . 0.0 111.449 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -53.03 -16.39 4.24 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.017 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.37 118.05 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 117.873 0.837 . . . . 0.0 111.604 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' ND2' ' CD2' ' A' ' 626' ' ' PHE . 0.9 OUTLIER -140.46 124.35 10.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.997 178.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.5 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 37.2 Cg_endo -91.32 159.28 27.73 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.149 0.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.3 t80 -93.61 115.77 28.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 0.0 109.962 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.598 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.7 m-85 -92.94 138.61 31.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.917 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.8 mp -127.51 144.89 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 158.35 -165.0 33.71 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.877 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.02 17.92 11.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.41 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 1.1 t -101.78 131.68 47.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.642 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -21.71 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.763 0.316 . . . . 0.0 110.63 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.29 -21.33 60.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.9 m -76.52 127.41 32.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 23.3 m120 -45.76 -31.68 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.14 0.495 . . . . 0.0 110.434 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.524 ' HB3' HG13 ' A' ' 603' ' ' ILE . 45.0 t -110.55 138.72 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 117.83 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 34.2 mm -138.06 108.83 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.314 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.35 101.09 11.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.413 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.509 ' HB3' HD11 ' A' ' 618' ' ' LEU . 1.1 m-20 -133.54 113.36 12.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.937 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -50.42 -45.81 55.98 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.66 -19.05 63.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.549 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -88.17 160.81 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.593 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.408 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 2.6 m -109.92 153.74 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.03 -50.68 1.81 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.76 57.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.466 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 54.2 t60 -52.69 -37.55 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.344 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.529 0.68 . . . . 0.0 111.939 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.598 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.18 131.97 21.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.904 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 21.3 mt -131.79 116.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.458 ' CD2' ' ND2' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -136.78 149.02 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -178.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.458 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 34.6 ttmt -98.9 136.76 38.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 159.79 35.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.4 tpt180 -75.68 112.75 12.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.746 -0.141 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.8 mp -110.54 -163.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 9.8 m-20 -114.12 146.49 40.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.294 0.569 . . . . 0.0 112.197 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.434 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -128.8 160.61 32.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.647 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -103.33 128.29 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.6 0.714 . . . . 0.0 112.081 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.54 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.6 m95 -113.02 120.45 41.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.27 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.411 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 1.6 t80 -93.62 117.77 30.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 624' ' ' PHE . 3.9 m -113.74 143.87 43.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.437 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.447 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 42.5 t60 -110.58 130.12 55.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.0 0.428 . . . . 0.0 111.049 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.428 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 20.5 p -120.56 3.83 10.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . . . . . . . . . . . -81.58 146.22 25.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.847 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 37.5 m -75.94 -15.64 60.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 656' ' ' VAL . 29.3 m-20 -85.18 3.05 41.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.16 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.438 0.637 . . . . 0.0 112.283 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.447 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 33.1 p -99.31 166.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.302 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 5.8 m-85 -129.23 120.06 25.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.718 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.452 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -98.64 102.58 14.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 60.93 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.4 p30 -136.84 5.7 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.672 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.409 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 0.0 OUTLIER -107.44 139.75 41.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -76.4 141.36 41.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.408 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 25.1 mmm -124.61 97.44 5.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.4 pt -87.57 152.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 652' ' ' THR . 38.5 tt0 -48.7 112.05 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.91 0.386 . . . . 0.0 110.945 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.9 32.32 4.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.3 p -121.04 162.54 19.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.828 0.347 . . . . 0.0 111.203 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.9 ttpm? -133.69 147.81 51.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.452 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.69 28.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.54 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.04 133.72 48.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.593 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -108.9 104.71 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.35 139.26 30.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.621 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -41.28 112.4 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.28 37.08 4.43 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.78 116.11 28.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.252 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -96.26 108.72 21.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.485 HD11 HG23 ' A' ' 678' ' ' ILE . 25.5 pt -105.92 129.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.798 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 27.9 mttp -89.43 115.8 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.483 ' CG2' HD12 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -79.26 -35.47 17.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.811 -178.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.437 HG13 HG22 ' A' ' 680' ' ' ILE . 50.2 mt -155.0 131.59 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.704 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -136.37 123.45 21.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.5 116.96 25.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.505 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -67.03 -46.61 73.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.842 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -80.91 -40.07 25.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.1 t30 -83.06 -13.36 55.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.06 17.11 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 111.0 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.04 104.62 7.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.48 124.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.2 0.524 . . . . 0.0 111.914 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 59.5 mt -129.01 156.0 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.315 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 170.83 136.33 2.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.68 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.16 149.8 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.85 117.6 35.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.663 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 578' ' ' LEU . 3.5 t -80.03 124.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -133.2 109.71 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.413 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 52.1 mt -78.26 106.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.76 -44.71 9.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.176 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -110.4 141.87 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.54 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -113.07 99.92 8.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.431 0.634 . . . . 0.0 109.599 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.1 m -82.88 58.84 4.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.52 13.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.173 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.64 134.33 35.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.56 0.219 . . . . 0.0 110.668 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.434 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 4.8 p90 -43.36 -33.52 1.04 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.469 0.652 . . . . 0.0 110.266 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -148.1 -61.2 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.341 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 7.7 pt-20 . . . . . 0 N--CA 1.463 0.186 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.957 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.72 0.295 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 65.0 t -85.78 121.84 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.506 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.66 172.36 8.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.37 16.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -93.44 148.55 21.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -126.41 -175.96 3.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 111.669 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -30.15 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.198 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -56.61 -50.12 72.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.676 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 21.6 mm-40 -70.01 -49.5 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.57 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.477 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.43 -39.95 89.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.424 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 1.0 OUTLIER -63.35 -44.69 94.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.562 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.89 -19.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.254 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.98 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.039 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -108.11 24.24 13.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.777 179.922 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -106.12 141.47 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.549 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.66 -58.3 1.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.214 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.462 ' CD1' ' CG1' ' A' ' 696' ' ' ILE . 12.8 tp -110.92 134.93 52.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 7.5 m -115.24 114.72 25.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.432 ' CD2' HD13 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -105.28 108.7 20.35 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.96 100.33 52.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.2 Cg_exo -44.72 100.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.917 1.745 . . . . 0.0 109.806 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 158.29 85.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.43 -24.68 9.22 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.59 2.86 . . . . 0.0 112.387 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.42 -23.09 65.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 2.2 t -95.46 153.34 17.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.75 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.446 HG12 ' CD1' ' A' ' 690' ' ' ILE . 4.0 pt -54.42 -18.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 2.6 tt -112.84 142.95 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.815 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.02 68.81 0.84 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.194 0.521 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.587 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.3 mm-40 -124.91 171.38 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.494 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 127.33 42.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.0 0.428 . . . . 0.0 111.12 178.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.39 139.58 47.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.892 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -124.48 117.39 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 601' ' ' PHE . 88.0 mt -86.34 109.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.062 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -67.47 125.84 27.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.72 -28.5 3.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.123 0.487 . . . . 0.0 110.52 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.59 -17.7 80.04 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.982 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.4 t -100.94 117.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.05 0.925 . . . . 0.0 111.878 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -140.8 121.31 8.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.8 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.543 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 50.5 Cg_endo -89.63 160.65 36.32 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 124.772 -0.928 . . . . 0.0 111.499 -0.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -92.15 117.02 29.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 35.1 m-85 -92.21 137.51 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.039 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.597 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mp -124.94 143.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.59 -176.67 42.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.079 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.6 ttp85 -81.21 -2.96 50.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.662 0.268 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 135.71 42.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -24.91 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.059 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -28.36 60.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 51.5 m -77.06 132.52 38.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -47.31 -29.07 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.563 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.597 ' HB3' HG13 ' A' ' 603' ' ' ILE . 38.5 t -111.58 142.45 43.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.897 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 115.92 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.495 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 17.5 mm -137.78 110.29 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.441 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 22.2 mt-10 -81.88 103.2 11.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.511 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.499 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.43 108.43 9.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.161 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -42.5 -36.73 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -77.62 -36.86 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -60.3 158.91 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 83.9 p -110.68 168.89 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.553 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -46.17 -52.98 11.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.224 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.76 58.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.204 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 653' ' ' GLY . 35.6 t60 -49.35 -48.59 46.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.886 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -163.12 156.08 19.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 650' ' ' CYS . 43.9 p90 -143.22 148.05 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.38 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -102.59 141.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 179.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.0 t80 -130.91 134.15 46.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.418 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 27.9 ttmt -97.66 136.8 37.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.91 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.68 159.44 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.443 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.27 117.78 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.436 0.636 . . . . 0.0 110.79 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.484 ' C ' ' CD2' ' A' ' 630' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.444 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.751 -0.14 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.2 mm? -79.99 -160.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 m-20 -122.49 147.03 46.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.188 0.518 . . . . 0.0 112.037 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -129.18 159.72 35.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 671' ' ' LEU . 0.9 OUTLIER -105.92 134.94 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.362 0.601 . . . . 0.0 112.23 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.602 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 67.4 m95 -117.96 127.59 53.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.313 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 13.0 t80 -90.08 117.17 28.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.1 m -102.93 131.72 49.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.601 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 67.0 t60 -109.88 128.58 55.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.3 p -124.44 -1.14 8.1 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.451 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.36 137.95 21.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.029 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 91.4 m -69.78 -10.84 59.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.627 0.251 . . . . 0.0 111.456 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 656' ' ' VAL . 55.7 m-20 -85.03 3.75 37.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.59 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.57 137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.566 0.698 . . . . 0.0 112.182 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.444 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 5.9 t -108.74 166.2 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.387 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -129.38 120.36 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -101.84 99.64 9.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.562 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.9 m120 61.06 -81.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.2 p-10 -133.79 1.81 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.643 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.422 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.5 m120 -104.21 141.65 35.89 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.859 0.361 . . . . 0.0 111.069 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.55 141.27 38.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.058 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 57.4 mmm -115.66 98.68 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 668' ' ' THR . 48.3 pt -87.5 155.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.063 0.459 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -51.41 105.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.61 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 39.64 2.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.212 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.5 p -132.39 148.9 52.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.871 0.335 . . . . 0.0 111.549 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.9 pttm -123.88 136.35 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.671 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.484 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -131.94 141.61 49.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.602 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -69.37 141.26 54.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.945 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 16.2 mt -111.87 105.39 13.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 112.018 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -77.86 156.39 30.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.878 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.2 109.7 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.83 37.92 4.29 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 115.22 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.437 . . . . 0.0 111.184 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.12 109.78 22.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 659' ' ' LEU . 11.8 pt -105.57 120.61 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.155 0.502 . . . . 0.0 112.11 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -87.54 116.02 25.37 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.503 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -82.3 -33.46 11.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.885 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.454 ' CG2' ' CE1' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -155.15 132.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -136.04 124.33 23.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 687' ' ' LYS . 2.2 t0 -124.14 116.58 22.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -67.79 -46.68 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.064 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -40.36 96.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.134 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -93.69 -18.35 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.643 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.0 OUTLIER 65.91 13.06 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.0 111.029 -179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.1 OUTLIER -87.51 105.56 17.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.2 p -119.78 138.78 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.357 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 587' ' ' ILE . 18.4 mm -113.67 152.12 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.77 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.2 130.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.651 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 1.6 m-30 -113.9 145.06 42.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -101.1 116.92 33.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 578' ' ' LEU . 2.5 t -79.82 128.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.692 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.3 OUTLIER -133.29 108.58 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.124 0.488 . . . . 0.0 111.019 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 705' ' ' GLU . 13.8 mt -76.28 105.29 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.385 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -91.9 -50.13 5.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.041 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -112.62 139.57 48.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.142 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 100.56 8.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.207 0.527 . . . . 0.0 109.692 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 62.02 0.67 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.968 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.1 47.32 88.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.54 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 702' ' ' LEU . 0.3 OUTLIER -112.24 32.61 5.42 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.589 ' O ' ' C ' ' A' ' 704' ' ' ASN . 0.0 OUTLIER 67.85 175.67 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 703' ' ' PHE . 4.8 t30 -14.56 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.028 0.442 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 696' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.927 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.6 t -84.08 130.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.24 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.89 157.43 16.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 111.186 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.73 158.86 17.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.1 p -126.13 -175.29 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -33.69 57.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.27 -45.6 90.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.614 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -63.74 -50.97 66.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -54.24 -32.7 56.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.13 -37.09 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.097 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 13.2 mt -58.03 -44.37 87.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.82 -27.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -30.13 65.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.836 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -97.51 13.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.827 179.993 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -89.13 114.0 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.484 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -104.58 -59.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.394 -179.116 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.3 tt -106.67 142.0 37.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.352 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 695' ' ' GLU . 11.5 m -122.25 114.71 21.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 592' ' ' LEU . 6.2 mt -102.95 107.8 18.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 44.9 mtmt -111.6 99.46 44.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.7 Cg_exo -48.15 98.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.755 1.637 . . . . 0.0 109.535 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.73 157.63 85.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.401 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 77.6 Cg_exo -49.76 -28.43 17.65 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.458 2.772 . . . . 0.0 112.64 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.38 -24.99 67.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.472 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.9 t -95.44 153.97 17.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.413 HG22 HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -56.2 -11.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.237 179.586 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.429 ' CD1' ' CG2' ' A' ' 613' ' ' ILE . 20.3 mt -112.1 126.88 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.824 0.345 . . . . 0.0 111.741 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.34 52.38 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 110.148 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 14.1 mm-40 -124.49 172.01 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.96 131.35 51.1 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.941 0.4 . . . . 0.0 111.337 179.131 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.5 OUTLIER -112.58 141.94 45.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.778 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.438 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.63 116.32 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.149 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.527 HG12 ' CD2' ' A' ' 601' ' ' PHE . 63.9 mt -86.56 108.98 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -71.8 128.71 36.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.484 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.03 -30.34 1.81 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 109.877 179.084 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.74 -25.06 75.96 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.16 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 87.9 t -98.73 117.16 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 118.171 0.985 . . . . 0.0 111.842 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.2 t30 -141.16 121.92 8.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.034 177.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.553 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.8 Cg_endo -89.86 159.78 34.77 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.543 -1.024 . . . . 0.0 111.248 -0.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -91.88 114.98 27.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.5 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 25.3 m-85 -91.82 138.38 31.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.998 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -125.95 145.31 33.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.459 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.14 -178.3 41.37 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.573 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.442 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.8 ttp85 -76.97 -7.52 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.563 0.22 . . . . 0.0 111.466 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.48 131.96 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.758 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -56.1 -23.99 37.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.217 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -30.2 59.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.653 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 45.2 m -74.87 134.51 41.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 4.8 m-80 -48.11 -27.07 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.535 ' HB3' HG13 ' A' ' 603' ' ' ILE . 36.0 t -112.13 140.46 46.8 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.542 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.59 113.03 23.84 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 31.0 mm -137.8 109.67 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.774 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 25.8 tt0 -87.66 103.87 15.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.584 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.48 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -131.06 110.55 11.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.11 178.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -41.21 -35.65 0.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.728 0.299 . . . . 0.0 111.526 -178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -77.69 -38.64 46.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.69 159.48 8.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.178 -179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 167.59 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 -50.0 19.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.134 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.71 59.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.36 178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.524 ' CD2' ' CG2' ' A' ' 680' ' ' ILE . 24.7 t60 -48.5 -49.18 36.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.619 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.3 p -166.34 157.35 12.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 44.0 p90 -143.39 146.89 33.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 2.2 mp -102.17 125.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.775 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -116.79 133.72 55.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 -179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.426 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.2 ttmt -98.55 136.93 37.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.64 158.78 40.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.385 -179.164 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.47 115.72 16.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.384 0.612 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 4.2 t60 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.002 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 1.6 mm? -71.51 -160.82 0.06 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.662 0.231 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.32 146.46 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -179.536 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.451 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -125.23 160.21 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.775 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -110.01 121.9 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.619 0.723 . . . . 0.0 112.591 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.539 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 87.0 m95 -105.34 128.13 53.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.629 179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.425 ' CD2' HD13 ' A' ' 678' ' ' ILE . 22.0 t80 -90.57 117.75 29.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 36.7 m -106.35 128.09 53.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -110.29 126.34 54.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.855 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.487 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 13.4 p -123.46 7.24 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.516 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.46 146.82 25.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.954 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 32.8 m -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.611 0.243 . . . . 0.0 111.642 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 19.2 m-20 -85.23 3.25 40.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.44 135.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.733 0.777 . . . . 0.0 112.487 179.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 3.7 t -104.16 165.85 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.188 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 679' ' ' LYS . 37.3 m-85 -128.28 119.76 25.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.425 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -103.46 102.44 12.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.73 -82.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 659' ' ' LEU . 26.1 p30 -135.77 6.99 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -110.8 141.6 43.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.942 0.401 . . . . 0.0 110.918 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 8.9 ttp85 -75.19 141.19 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 23.4 mmm -122.66 86.06 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.472 ' O ' ' OG1' ' A' ' 668' ' ' THR . 30.7 pt -86.84 156.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.325 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.4 tt0 -49.12 107.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.234 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.16 32.44 4.02 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.586 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 2.5 p -121.72 161.84 21.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.6 ttpm? -135.66 147.87 48.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.45 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.3 OUTLIER -147.83 144.93 28.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.1 134.73 49.74 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.629 179.446 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.74 108.0 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.071 0.462 . . . . 0.0 111.783 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -95.8 157.28 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.227 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' A' ' 705' ' ' GLU . 4.0 p-10 -52.38 124.57 13.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.802 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 84.42 39.63 8.92 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.997 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.16 112.31 23.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.911 0.386 . . . . 0.0 111.152 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.81 108.77 21.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 649' ' ' TYR . 6.0 mt -109.7 128.83 65.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 0.0 112.035 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.4 OUTLIER -90.34 115.85 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.407 178.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.524 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 3.8 mt -77.02 -37.6 26.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.422 -179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 38.3 mt -155.39 131.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.773 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -135.87 121.09 19.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.748 178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.54 117.36 24.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -66.73 -46.67 74.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.609 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.23 -40.24 19.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.289 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.78 -11.32 59.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.8 20.59 8.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.735 0.303 . . . . 0.0 110.925 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.79 104.82 15.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.5 p -119.5 121.4 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.19 0.519 . . . . 0.0 111.81 -178.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.403 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 26.8 mm -128.5 150.14 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.536 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.472 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.54 127.55 1.17 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.411 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.487 ' CB ' HD22 ' A' ' 580' ' ' LEU . 8.7 m-30 -113.34 145.76 40.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.752 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -101.88 117.97 35.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.086 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.6 t -79.43 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 34.2 tt0 -131.26 108.39 9.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.028 0.442 . . . . 0.0 110.334 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 696' ' ' ILE . 27.8 mt -76.39 105.58 5.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.927 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . 0.407 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.6 m-80 -87.12 -46.14 10.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.484 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 21.2 t0 -110.77 139.4 46.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.7 p -115.72 99.99 7.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.22 0.533 . . . . 0.0 109.828 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 t -80.07 68.35 6.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.494 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 67.65 30.27 74.62 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.692 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.47 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -70.59 133.07 46.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.671 0.272 . . . . 0.0 111.198 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -39.15 -49.92 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.175 179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.537 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -157.56 20.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.857 178.182 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.0 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 62.4 t -86.82 130.29 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 111.391 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mt -104.84 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.17 148.54 25.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -84.8 151.17 24.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.823 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.09 -177.78 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.23 -30.54 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.193 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.82 -51.97 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -46.42 72.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -32.86 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -67.82 -38.42 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.49 -44.34 80.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.5 p -73.21 -26.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.34 -34.38 66.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.809 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -98.63 29.26 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.414 HD11 ' CG ' ' A' ' 602' ' ' PHE . 5.8 tt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 16.9 ttm180 -110.28 143.33 40.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 111.713 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 1.9 t80 -122.87 -40.28 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.459 HD13 HG12 ' A' ' 696' ' ' ILE . 12.0 tp -126.96 142.24 51.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 111.041 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 695' ' ' GLU . 22.1 m -124.9 114.19 18.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.052 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.465 ' CD1' HG13 ' A' ' 594' ' ' ILE . 2.9 mp -106.86 108.93 20.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.47 100.52 50.3 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 51.9 Cg_exo -44.53 103.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.083 1.855 . . . . 0.0 110.056 177.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.83 158.22 84.88 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.9 Cg_endo -49.71 -23.92 8.99 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.021 3.147 . . . . 0.0 113.199 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -26.29 66.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 2.7 t -95.97 153.5 17.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.72 178.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 13.1 pt -55.04 -14.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.45 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 582' ' ' PRO . 2.5 tt -112.67 131.9 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 111.822 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -113.67 69.54 0.7 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.577 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mt-10 -125.41 170.79 11.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.577 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.15 130.14 47.63 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 121.055 0.455 . . . . 0.0 111.045 178.483 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.63 136.57 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.267 179.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 13.8 mt-10 -123.95 110.7 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.544 HG12 ' CD1' ' A' ' 601' ' ' PHE . 63.1 mt -78.72 109.79 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.3 mp0 -67.8 115.27 7.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.73 -28.95 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 111.07 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.87 -22.31 73.78 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.484 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.48 119.45 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 117.657 0.728 . . . . 0.0 111.821 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.8 t30 -138.83 122.41 11.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.629 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.7 Cg_endo -90.33 160.59 32.84 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.632 -0.987 . . . . 0.0 111.908 0.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -91.89 119.58 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.421 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 29.2 m-85 -92.97 138.35 31.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.453 -177.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -129.69 141.14 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.99 -166.97 37.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.947 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.415 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 14.8 ttp85 -87.31 7.0 30.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.651 0.262 . . . . 0.0 111.275 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 2.4 t -101.35 125.79 48.03 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.52 -22.92 36.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -25.03 66.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.414 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 84.1 m -73.71 126.97 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.5 m120 -43.13 -33.71 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.524 ' HB3' HG13 ' A' ' 603' ' ' ILE . 51.4 t -106.97 136.17 47.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.606 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 115.5 25.18 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 13.5 mm -137.69 109.87 6.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.058 178.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mt-10 -83.96 103.33 13.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.867 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.473 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 5.1 m-20 -132.08 112.98 12.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.306 178.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -42.58 -45.96 4.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.413 ' HB3' HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.98 -30.95 69.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.382 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.526 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -65.26 159.08 24.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.828 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -114.31 167.34 10.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.024 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.434 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -44.48 -62.44 1.18 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.1 58.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.471 0.653 . . . . 0.0 109.476 178.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.526 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 56.0 t60 -47.09 -49.67 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.559 -179.026 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.2 p -162.99 157.19 20.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 650' ' ' CYS . 1.9 p90 -143.56 146.95 33.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 69.6 mt -101.74 131.51 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.878 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -123.9 135.46 53.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.458 ' HB2' HG21 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.49 134.06 41.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.47 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.85 159.51 41.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.074 -178.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -76.67 112.47 13.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 630' ' ' HIS . 6.9 mt -113.87 -156.88 0.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -114.61 148.41 38.12 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 4.8 m-20 -135.7 145.99 47.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.346 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 672' ' ' LEU . 3.2 pt -95.29 122.65 46.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.577 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.516 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 77.2 m95 -105.33 129.92 53.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.435 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 8.2 t80 -90.63 116.83 28.82 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 624' ' ' PHE . 5.9 m -102.36 142.53 33.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.362 . . . . 0.0 111.253 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.47 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 64.4 t60 -122.85 127.44 49.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -123.76 0.23 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.348 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.94 147.88 31.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -25.89 63.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.446 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.9 OUTLIER -68.6 -5.28 19.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.125 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.39 123.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.47 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 6.7 t -93.94 165.86 12.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.677 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 2.4 m-85 -135.67 120.74 18.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.42 HD23 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.62 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.614 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 62.49 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.21 -5.36 3.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.69 132.12 43.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' ' 658' ' ' TYR . 15.0 mtm-85 -75.23 141.69 43.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 3.8 mtp -119.3 110.46 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.919 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 46.0 pt -87.91 148.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -47.92 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.337 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 116.25 40.08 0.83 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.722 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.7 p -139.18 162.12 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.51 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 6.2 pttm -129.0 158.09 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 671' ' ' LEU . 9.9 t80 -147.18 146.72 29.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.516 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.45 131.75 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.254 0.55 . . . . 0.0 111.671 -179.024 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.469 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.6 OUTLIER -105.59 128.12 53.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.982 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.16 157.72 25.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.947 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 696' ' ' ILE . 7.2 t70 -57.15 99.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.182 0.515 . . . . 0.0 110.393 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.43 29.37 3.96 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.227 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.28 114.5 23.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -95.44 108.04 20.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.57 128.5 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.954 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.08 115.82 31.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.5 HG13 HD12 ' A' ' 618' ' ' LEU . 4.8 pt -87.87 -16.2 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.431 HD13 HG21 ' A' ' 681' ' ' ILE . 20.4 mt -154.83 130.22 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.136 178.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.419 ' CZ2' ' HG2' ' A' ' 684' ' ' LYS . 8.0 t90 -137.48 132.07 32.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 682' ' ' TRP . 0.2 OUTLIER -117.46 116.22 26.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -68.04 -47.42 68.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.273 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -83.43 -40.73 18.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -19.2 60.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.409 -179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.01 10.12 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.81 104.93 16.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.9 135.34 62.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.804 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 681' ' ' ILE . 0.6 OUTLIER -119.48 131.7 71.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.495 179.317 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.74 135.02 4.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.358 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.462 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.24 148.14 37.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -100.94 116.67 33.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.265 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.7 t -80.05 131.24 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 579' ' ' THR . 11.2 tt0 -134.82 108.66 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.459 HG12 HD13 ' A' ' 578' ' ' LEU . 13.0 mt -77.33 105.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.73 -46.79 8.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 10.7 t70 -111.39 140.38 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -115.34 100.66 8.27 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.586 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 t -65.42 66.41 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.306 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.62 47.68 36.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.373 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.48 ' CD2' ' HB ' ' A' ' 699' ' ' THR . 1.3 pt? -115.54 179.99 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.675 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -70.48 113.39 7.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.343 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 705' ' ' GLU . 16.9 t30 53.22 -73.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.521 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.675 ' N ' ' O ' ' A' ' 703' ' ' PHE . 4.6 pt-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.542 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.72 0.295 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p -81.36 123.71 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.49 163.19 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -103.36 148.79 25.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.95 159.77 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -173.26 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.124 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.79 -28.87 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.031 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -49.67 75.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -47.77 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -55.89 -32.57 63.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -66.85 -36.64 82.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.11 -44.93 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.29 -24.48 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -58.29 -32.49 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -112.88 27.11 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.911 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.587 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.634 -0.186 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -84.72 -19.7 32.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.735 0.302 . . . . 0.0 111.18 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 177.49 -31.19 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.521 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -106.89 141.97 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -127.12 -61.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.9 tt -106.38 139.51 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 23.3 m -115.68 115.07 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.163 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -105.52 108.44 19.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.96 100.19 48.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 16.8 Cg_exo -46.86 100.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.783 1.655 . . . . 0.0 109.473 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.57 157.53 86.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.99 -29.2 26.62 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.701 2.934 . . . . 0.0 112.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -25.1 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.458 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.3 t -95.76 153.48 17.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.975 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.402 ' CG2' HG12 ' A' ' 690' ' ' ILE . 8.6 tt -53.97 -16.1 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 16.5 mt -108.49 136.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.587 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -121.33 55.91 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.976 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.3 mm-40 -124.6 169.62 11.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.11 118.73 20.93 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 111.508 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -113.47 145.53 41.03 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.33 123.37 40.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.515 HG22 ' CD1' ' A' ' 601' ' ' PHE . 89.5 mt -78.47 108.82 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -65.57 122.15 16.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.545 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.43 -28.48 2.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.166 0.508 . . . . 0.0 110.333 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.424 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.54 -22.74 78.81 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.805 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.94 117.74 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.093 0.947 . . . . 0.0 111.608 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -140.58 122.61 9.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -89.9 159.79 34.57 Favored 'Cis proline' 0 N--CA 1.46 -0.448 0 C-N-CA 124.299 -1.125 . . . . 0.0 111.618 -0.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.0 t80 -92.41 116.1 28.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.571 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 40.4 m-85 -92.72 138.27 31.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.169 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.6 mp -124.94 146.27 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.91 -173.95 35.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.245 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -66.84 -50.67 61.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.579 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.51 129.52 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.605 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -20.18 9.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.824 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -54.91 -31.72 60.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.172 0.51 . . . . 0.0 110.14 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 60.6 m -71.89 126.98 31.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.517 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.5 m120 -42.94 -33.77 0.85 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.318 0.58 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 34.8 t -104.93 141.14 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.894 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.36 104.81 13.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 692' ' ' PHE . 9.1 mm -138.95 109.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.957 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.45 106.6 17.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 112.346 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.448 ' C ' ' HD3' ' A' ' 605' ' ' ARG . 0.9 OUTLIER -129.52 107.42 9.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.58 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -38.8 -30.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -68.94 -41.99 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.471 ' CB ' ' ND1' ' A' ' 622' ' ' HIS . 1.6 pp -89.21 156.76 18.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.3 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 162.96 28.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.43 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -52.6 -26.08 12.45 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.071 0.462 . . . . 0.0 110.36 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.31 63.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.471 ' ND1' ' CB ' ' A' ' 618' ' ' LEU . 24.9 t60 -49.73 -44.31 48.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.8 p -169.86 161.58 9.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 111.716 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.571 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 40.2 p90 -143.59 148.77 36.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.949 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.22 130.71 51.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -121.39 134.74 55.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.53 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.8 ttmt -97.92 137.11 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.324 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 158.99 42.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.75 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -76.49 112.61 13.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 110.531 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 -74.34 125.43 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.904 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.74 179.44 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.356 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.6 p -168.12 160.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.406 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -55.55 -101.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.82 172.26 7.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.24 31.36 5.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.973 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.2 121.25 14.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.86 -63.78 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.88 143.85 41.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.89 102.34 50.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.43 -164.68 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 112.1 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -119.49 40.09 3.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.33 -82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -168.19 76.46 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.838 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -99.83 -157.56 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 5.1 m-20 -122.19 146.66 47.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.461 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.24 160.35 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.115 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -106.71 123.3 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 112.085 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.533 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 80.3 m95 -106.4 128.42 54.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.413 ' CE2' HD13 ' A' ' 678' ' ' ILE . 17.3 t80 -90.89 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 624' ' ' PHE . 17.2 m -103.69 129.53 51.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.424 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 43.4 t60 -111.53 126.9 55.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 29.4 p -123.36 3.58 9.12 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.279 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.94 142.6 26.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.137 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.5 m -75.38 -19.94 59.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.418 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.5 m-20 -82.79 3.27 30.12 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.59 133.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.57 0.7 . . . . 0.0 112.38 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 96.3 p -103.92 166.48 10.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.153 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -127.36 119.8 27.06 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.559 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.2 OUTLIER -100.01 104.56 16.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.1 m120 60.11 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 659' ' ' LEU . 14.6 m-20 -139.35 7.99 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.65 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 4.1 m120 -107.97 141.48 39.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.68 141.46 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.43 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 0.2 OUTLIER -129.08 91.41 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.085 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 HG21 ' A' ' 668' ' ' THR . 37.3 pt -87.5 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.81 104.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.878 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.38 33.89 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.55 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 665' ' ' ILE . 3.0 p -125.37 162.17 25.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 111.897 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -135.33 149.91 49.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.451 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -147.7 144.87 28.63 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.533 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.18 133.52 48.08 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.402 ' CB ' ' CD1' ' A' ' 647' ' ' ILE . 0.4 OUTLIER -106.31 109.21 21.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 15.8 mt-30 -98.83 132.9 43.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.047 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 706' ' ' GLY . 7.5 t70 -37.01 120.52 0.74 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.98 38.57 5.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 2.3 t0 -95.44 120.55 35.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 0.0 111.441 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -97.41 113.88 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.3 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 27.0 pt -110.06 137.18 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.968 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -101.14 116.34 32.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.055 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.411 ' CG2' ' CD2' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -81.54 -38.24 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.43 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.45 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.29 133.96 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.42 124.48 22.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -125.96 117.57 23.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.792 0.329 . . . . 0.0 110.645 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -66.8 -46.52 74.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.899 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.22 -40.52 37.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.9 -11.92 56.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.5 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt 59.93 19.29 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.403 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 2.2 t80 -84.34 105.02 14.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -125.78 126.0 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.037 0.446 . . . . 0.0 111.925 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.45 ' HB ' HG22 ' A' ' 681' ' ' ILE . 11.8 mt -119.33 148.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.804 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.458 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -168.21 129.03 1.81 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.392 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.476 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.3 141.84 46.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.761 0.315 . . . . 0.0 110.28 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -101.29 116.45 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.83 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 676' ' ' ASP . 2.3 t -82.96 120.04 33.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.453 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.37 109.32 10.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.958 0.409 . . . . 0.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 33.5 mt -75.99 105.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . 0.4 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.0 OUTLIER -83.67 -45.32 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -110.39 141.59 43.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.452 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.2 p -113.52 99.88 8.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.348 0.594 . . . . 0.0 109.957 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.0 t -77.1 62.52 2.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.486 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.42 49.34 70.86 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.818 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.472 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -88.18 133.55 34.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.337 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.529 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -33.84 -36.77 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.45 179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -171.98 30.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.862 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.3 OUTLIER 68.31 -57.93 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.113 -178.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 151.95 76.87 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.831 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.424 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 1.9 mm? -104.74 -9.44 18.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.748 -0.266 . . . . 0.0 111.494 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 100.98 62.21 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.123 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -43.12 135.06 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.922 0.392 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 77.22 -64.17 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.92 112.88 26.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 714' ' ' ARG . 0.0 OUTLIER -82.84 99.73 9.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.997 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 713' ' ' GLN . 3.4 mmm-85 19.96 85.51 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.627 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.49 142.59 40.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.455 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 88.8 t -80.83 122.8 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -95.47 163.22 13.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.51 146.5 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.2 160.02 14.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.84 -173.46 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.16 28.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -42.02 98.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.166 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.404 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 6.6 tm-20 -69.99 -51.07 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.464 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -54.33 -32.88 57.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -36.48 81.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.605 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 79.9 mt -55.8 -44.05 77.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.694 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' A' ' 624' ' ' PHE . 1.5 t -73.95 -23.15 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -36.53 80.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.71 -11.94 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.171 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 602' ' ' PHE . 8.1 tt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.26 140.59 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 6.3 pt -131.56 80.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . 0.418 ' C ' ' CD1' ' P' ' 830' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' P' ' 829' ' ' PTR . 7.4 p90 -175.82 89.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.867 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.59 89.7 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.779 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.878 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -78.9 -7.01 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.491 0.186 . . . . 0.0 111.362 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 142.59 -8.92 2.34 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.4 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 8.2 ttm180 -108.01 143.84 36.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.998 0.428 . . . . 0.0 111.452 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -128.82 -56.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.256 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 647' ' ' ILE . 5.7 tt -111.54 139.59 46.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.409 ' N ' ' CD2' ' A' ' 578' ' ' LEU . 1.9 m -120.97 114.19 21.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 111.495 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.5 mp -103.02 108.22 19.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.68 100.88 53.97 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.5 Cg_exo -45.96 101.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.893 1.729 . . . . 0.0 109.357 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.12 157.42 85.22 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.59 -27.19 14.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.467 2.778 . . . . 0.0 112.491 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -62.16 -25.93 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 18.0 p -95.76 154.07 17.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.805 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.449 HG12 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -58.87 -10.73 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.996 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 613' ' ' ILE . 43.3 mt -111.11 118.58 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 111.751 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.05 57.09 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.607 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 72.7 mt-10 -124.56 171.86 9.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.286 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.0 126.79 42.03 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.16 135.56 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.416 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mt-10 -124.5 118.27 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 601' ' ' PHE . 83.8 mt -79.88 108.6 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -62.77 118.1 7.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.76 -28.95 1.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.77 -14.23 82.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.908 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.02 118.07 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.941 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -140.46 123.52 10.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.736 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.492 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.2 Cg_endo -90.82 159.02 29.69 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.379 -1.092 . . . . 0.0 112.157 0.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.8 t80 -93.12 117.49 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.197 0.522 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.639 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 3.5 m-85 -93.53 138.65 31.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.393 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.498 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -129.61 142.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.43 -158.2 31.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.189 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.4 ttp85 -96.43 -0.63 48.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.13 133.04 46.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -56.76 -24.79 52.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.99 -27.92 63.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 56.2 m -78.14 131.02 37.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.1 m120 -47.65 -30.86 4.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.496 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 51.8 t -109.14 140.66 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.453 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.31 120.96 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 588' ' ' ILE . 29.2 mm -137.97 109.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.745 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 tt0 -86.91 102.32 14.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.703 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 618' ' ' LEU . 3.4 m-20 -133.24 111.47 10.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.37 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -42.5 -33.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.819 0.343 . . . . 0.0 111.48 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -77.76 -41.47 37.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.2 mp -59.97 158.95 9.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.97 174.19 6.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.66 -62.94 1.15 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.395 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.0 t -105.18 53.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.51 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 70.7 t60 -43.12 -39.96 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.515 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.36 173.15 12.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.415 0.626 . . . . 0.0 111.447 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.639 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.06 135.2 25.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.973 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 23.0 mt -131.81 117.12 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -135.16 144.49 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.549 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.3 ptpt -101.0 137.46 39.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.62 159.65 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.275 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.52 117.24 17.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.254 0.55 . . . . 0.0 110.672 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 -83.65 128.85 34.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -141.32 125.58 17.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.54 166.11 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -61.99 -80.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.539 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -126.5 162.45 25.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.789 0.328 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.76 140.05 36.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.7 130.55 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 64.2 t80 66.85 -70.47 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -76.32 144.42 40.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.765 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.7 m -101.66 93.86 3.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.71 -163.36 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.521 2.148 . . . . 0.0 112.288 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -45.31 -32.79 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.55 -67.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -175.78 65.56 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.805 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -101.14 -157.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.36 147.11 46.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.061 0.457 . . . . 0.0 111.697 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.9 160.24 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.519 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 0.7 OUTLIER -106.97 128.14 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 112.359 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.532 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.7 m95 -112.15 120.57 42.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.402 ' CB ' HD21 ' A' ' 672' ' ' LEU . 1.3 t80 -92.71 117.63 30.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.9 m -111.22 145.07 39.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 42.3 t60 -119.55 125.36 48.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.436 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.2 5.59 11.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.19 134.55 13.35 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.998 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 54.7 m -65.64 -12.8 56.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.6 OUTLIER -82.35 -2.79 53.98 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.5 0.19 . . . . 0.0 111.339 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.32 128.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.265 0.555 . . . . 0.0 112.071 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.44 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 18.2 p -99.89 166.38 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.142 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.415 ' CZ ' HG21 ' A' ' 656' ' ' VAL . 3.9 m-85 -135.54 119.5 17.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.747 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 670' ' ' PHE . 0.4 OUTLIER -98.88 112.25 24.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.033 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.43 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -136.26 2.43 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.59 141.39 33.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.83 0.348 . . . . 0.0 111.024 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -81.11 141.34 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.738 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.405 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.9 mmm -121.58 100.43 7.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.973 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 665' ' ' ILE . 35.9 pt -87.5 149.39 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -44.43 112.67 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.406 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.79 5.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 716' ' ' VAL . 6.8 p -115.22 162.56 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.499 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.6 ttpm? -134.75 147.71 50.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.127 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.483 ' HB3' HD11 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.52 144.28 28.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.532 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 134.72 49.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.729 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 659' ' ' LEU . 1.3 mt -106.69 111.99 24.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.251 0.548 . . . . 0.0 111.27 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 24.6 mt-30 -98.33 143.19 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.172 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 706' ' ' GLY . 26.3 p30 -43.14 111.85 0.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.73 37.94 5.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.64 118.41 29.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.069 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -96.17 108.5 20.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.413 HG22 ' HG ' ' A' ' 659' ' ' LEU . 7.7 pt -105.66 129.16 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.482 . . . . 0.0 111.971 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 5.7 mttt -89.77 115.77 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.717 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.464 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -76.05 -39.38 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.854 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' A' ' 690' ' ' ILE . 15.6 tt -155.88 136.75 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -135.89 127.79 29.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.119 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.3 116.94 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.245 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -67.03 -46.89 73.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.35 -40.32 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.404 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.38 -16.54 56.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.9 15.92 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.004 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 587' ' ' ILE . 1.2 t80 -77.03 104.61 7.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.1 p -118.99 122.24 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 587' ' ' ILE . 42.8 mm -128.29 119.7 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.572 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -146.31 133.29 4.84 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.165 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.8 m-30 -113.09 144.56 42.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 110.455 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.17 117.29 34.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 578' ' ' LEU . 3.2 t -81.74 114.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.78 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.94 108.58 12.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 0.0 110.372 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 18.4 mt -81.86 110.44 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.729 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.5 -45.29 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.54 140.43 46.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.101 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -114.65 100.37 8.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 596' ' ' GLN . 9.3 t -91.08 50.74 1.82 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.479 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 108.52 33.29 2.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.502 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 1.1 mm? -93.81 120.33 33.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 4.9 p90 -40.45 -34.33 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.474 0.654 . . . . 0.0 110.339 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.5 OUTLIER -147.88 -44.69 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 16.1 pt-20 136.1 -34.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.69 1.196 . . . . 0.0 108.148 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.602 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 137.71 85.06 0.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.117 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.49 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.3 OUTLIER -105.68 -9.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.275 0.538 . . . . 0.0 111.667 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 81.41 64.55 1.75 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.437 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.6 mtm -116.21 114.07 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -179.36 170.88 1.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -59.51 -68.7 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.85 131.38 47.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.544 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -83.03 100.36 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.084 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.467 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 7.7 mmm-85 42.43 86.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.696 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.44 143.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 668' ' ' THR . 59.7 t -79.71 129.67 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.379 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.423 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -102.17 172.52 6.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -101.24 157.87 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 0.0 111.189 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.93 152.07 19.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.4 p -126.41 -177.82 4.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.616 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -28.9 36.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.988 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.57 -48.81 78.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 1.1 mp0 -69.77 -50.04 47.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.592 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -60.5 -32.05 71.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.41 -40.45 93.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.621 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 1.2 mt -61.91 -44.4 96.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.49 -12.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.24 -28.53 7.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.984 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -102.08 -63.2 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 602' ' ' PHE . 1.1 tp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.937 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.83 0.348 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.75 149.37 32.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . 0.497 HG23 HD13 ' P' ' 828' ' ' ILE . 13.7 mt -124.82 118.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 161.03 20.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.784 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 20.3 mt -148.68 93.27 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.975 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -95.08 -20.01 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.68 0.276 . . . . 0.0 111.122 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 140.13 -10.53 3.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.765 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.409 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -106.54 143.14 35.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 3.7 t80 -132.69 -47.28 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.424 ' CD1' HG12 ' A' ' 696' ' ' ILE . 10.4 tp -121.27 142.44 49.93 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.896 0.379 . . . . 0.0 111.015 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.7 m -120.3 114.94 22.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -104.57 108.59 20.12 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 mtmp? -111.84 99.25 44.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.8 Cg_exo -47.66 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.849 1.699 . . . . 0.0 109.572 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.58 158.12 85.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.94 -25.17 8.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.509 2.806 . . . . 0.0 112.731 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.64 -28.26 69.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.427 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 6.4 t -95.65 154.01 17.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.816 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.464 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.2 pt -57.87 -11.49 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.406 ' CD1' HG12 ' A' ' 613' ' ' ILE . 19.6 mt -107.6 118.51 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.498 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -106.03 55.73 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.155 0.503 . . . . 0.0 110.332 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.647 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 19.7 mt-10 -125.03 171.67 10.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.192 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.48 129.9 49.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.845 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.21 141.96 45.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.403 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.2 mt-10 -124.02 110.52 14.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.298 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 601' ' ' PHE . 59.3 mt -76.83 109.3 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.6 mp0 -67.03 114.67 5.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.58 -30.61 1.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.217 0.532 . . . . 0.0 110.557 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -64.66 -23.57 68.99 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.149 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.0 119.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.489 0.644 . . . . 0.0 111.34 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 21.7 t30 -138.72 122.26 11.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.548 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.9 Cg_endo -90.5 160.34 31.87 Favored 'Cis proline' 0 C--N 1.345 0.383 0 C-N-CA 124.627 -0.989 . . . . 0.0 111.815 -0.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.5 t80 -91.36 114.7 27.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 13.9 m-85 -91.84 138.07 31.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.993 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -127.36 145.41 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.716 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.55 -172.77 33.69 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.945 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.3 OUTLIER -74.02 -6.83 49.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.496 0.319 . . . . 0.0 111.857 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.569 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -89.51 125.01 35.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.811 0.339 . . . . 0.0 111.12 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -59.01 -20.25 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.578 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -23.96 63.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 54.8 m -70.72 130.35 41.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -44.77 -32.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.512 . . . . 0.0 110.347 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.1 t -110.28 139.88 45.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.342 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.12 110.05 16.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.424 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -138.45 110.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.892 177.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 0.2 OUTLIER -85.73 106.41 16.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.296 0.569 . . . . 0.0 112.09 -178.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.492 ' HB2' ' CD2' ' A' ' 618' ' ' LEU . 1.6 m-20 -129.8 108.32 10.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.138 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -43.71 -37.65 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.327 . . . . 0.0 111.799 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.0 mmt180 -77.82 -34.18 52.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.855 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.16 128.11 34.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 111.336 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.4 p -57.16 159.65 4.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.663 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.569 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -58.14 -31.29 67.06 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.39 55.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.475 ' CD2' HG23 ' A' ' 680' ' ' ILE . 9.5 t60 -49.68 -49.18 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.172 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.7 p -164.08 160.3 21.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.23 0.538 . . . . 0.0 111.989 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 650' ' ' CYS . 42.1 p90 -143.4 147.61 34.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 594' ' ' ILE . 57.6 mt -102.18 132.65 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.5 t80 -123.9 131.47 53.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.499 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.9 tttt -97.73 136.33 38.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.45 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 157.84 45.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.981 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -77.83 113.57 15.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 -78.94 123.29 27.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.05 150.62 51.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.026 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.21 166.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -86.77 73.53 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.576 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 56.2 mttt 60.07 105.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.9 p -83.63 117.2 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.84 123.25 47.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.784 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 67.43 -74.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.713 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -76.94 123.72 26.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 54.2 p -93.43 109.8 42.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.01 -149.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.553 2.168 . . . . 0.0 111.956 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 703' ' ' PHE . . . -79.22 1.52 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.808 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.95 -171.92 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -85.35 92.16 1.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.722 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.67 -156.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -122.19 147.51 46.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.414 ' HB3' HD22 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -136.6 141.71 43.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.319 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.474 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -94.67 121.19 45.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.345 0.593 . . . . 0.0 111.709 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.562 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -104.04 133.99 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.448 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 678' ' ' ILE . 12.4 t80 -93.14 117.39 30.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -102.84 136.4 42.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.13 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.445 ' CE1' ' N ' ' A' ' 657' ' ' SER . 14.9 t60 -115.42 126.28 54.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.16 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.421 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -122.89 6.49 9.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.47 157.78 40.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.167 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 41.1 m -89.65 -19.56 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.411 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.0 m120 -83.59 2.92 34.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.658 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 50.14 136.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.735 0.779 . . . . 0.0 112.588 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.445 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -108.55 165.96 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.062 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.52 120.65 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.001 0.429 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -102.69 100.19 10.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.897 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 60.76 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 87.3 m-20 -135.44 2.7 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 11.8 m120 -104.86 135.3 46.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.871 0.367 . . . . 0.0 111.402 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.63 141.47 46.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.713 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.419 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 44.2 mmm -120.86 88.66 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.144 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.402 HG12 ' CG2' ' A' ' 668' ' ' THR . 39.4 pt -87.31 153.26 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.867 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 652' ' ' THR . 13.7 tt0 -42.76 107.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.53 33.1 4.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.402 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.7 p -113.22 162.08 16.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 0.0 111.646 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.1 ttpm? -142.12 129.65 21.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.397 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -136.32 143.13 43.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 111.563 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.562 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -71.42 141.04 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 5.4 mt -104.43 148.81 26.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.026 0.441 . . . . 0.0 111.122 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.709 ' HB3' ' HA ' ' A' ' 707' ' ' LEU . 6.6 mt-30 -120.3 162.22 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.73 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.441 ' CA ' HD13 ' A' ' 696' ' ' ILE . 9.5 t70 -65.61 95.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.55 32.73 2.86 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.2 113.17 20.9 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.711 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -95.74 108.49 20.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.421 HD13 ' CE2' ' A' ' 649' ' ' TYR . 32.9 pt -105.16 134.87 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.772 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.0 mtpt -95.36 115.42 27.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.278 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.475 HG23 ' CD2' ' A' ' 622' ' ' HIS . 32.4 mt -84.55 -34.93 9.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.648 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.77 130.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.018 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -137.2 126.48 24.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.78 116.54 22.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.496 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -46.5 72.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.727 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.71 -40.41 33.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.562 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.46 -13.56 54.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.352 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 63.43 15.56 8.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.627 0.251 . . . . 0.0 110.959 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -76.94 104.65 7.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.33 126.47 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 0.0 111.873 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.464 ' CD1' HG12 ' A' ' 587' ' ' ILE . 21.4 mm -127.68 155.9 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.466 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.427 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.07 130.45 1.28 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.359 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.454 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.7 m-30 -113.31 146.23 39.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.354 . . . . 0.0 110.503 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttp -101.35 117.0 34.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.43 ' CG2' ' HG ' ' A' ' 580' ' ' LEU . 2.5 t -82.15 126.65 39.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.667 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.9 OUTLIER -133.45 108.84 8.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.942 0.401 . . . . 0.0 110.736 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 705' ' ' GLU . 22.8 mt -73.98 105.18 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.87 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.77 -47.67 10.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.766 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.433 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.54 140.34 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.029 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.7 p -115.0 99.83 7.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.415 ' HB ' ' NZ ' ' A' ' 627' ' ' LYS . 11.6 m -76.18 69.63 2.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.7 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.54 49.39 74.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.867 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -85.66 133.47 34.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.53 0.205 . . . . 0.0 111.158 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.3 p90 -44.88 -32.22 1.52 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.594 0.712 . . . . 0.0 109.842 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.3 t30 -148.4 -56.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.646 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.494 ' HB2' HD12 ' A' ' 696' ' ' ILE . 2.7 pt-20 156.14 -28.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.488 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 141.5 -7.08 2.5 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.678 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.709 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -81.3 7.76 10.73 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.92 8.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.899 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.416 ' HE2' ' CH2' ' A' ' 648' ' ' TRP . 6.0 tpt -110.2 146.93 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.914 0.388 . . . . 0.0 110.568 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -162.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.156 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -39.58 -46.96 1.86 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.738 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -74.11 139.87 44.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.717 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.85 100.36 10.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.477 ' NH1' ' HG3' ' A' ' 673' ' ' GLN . 2.0 mmm180 40.26 83.48 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.733 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.62 142.24 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.595 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.88 117.67 29.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.89 171.72 10.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 157.68 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.36 154.73 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.919 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 23.7 p -126.24 -176.55 3.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.73 64.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -63.61 -52.25 61.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -64.63 -46.95 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.73 -32.77 65.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.34 -36.92 82.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 31.4 mt -59.78 -44.07 94.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.003 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.9 -20.36 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -50.56 64.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -61.66 -29.12 69.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 602' ' ' PHE . 7.0 tt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 62.11 78.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 26.4 mt -99.36 37.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . 0.441 ' C ' ' CG ' ' P' ' 830' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.441 ' CG ' ' C ' ' P' ' 829' ' ' PTR . 0.1 OUTLIER -177.25 137.5 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 55.7 mt -138.63 -178.74 5.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.971 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -75.06 -22.24 58.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.661 0.267 . . . . 0.0 111.048 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 146.32 -17.01 1.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.643 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.421 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -106.57 143.3 34.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.362 . . . . 0.0 111.123 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 1.1 t80 -132.96 -51.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.493 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 21.2 tp -114.52 142.59 46.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 7.9 m -122.62 116.6 24.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.202 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.468 HD21 ' CB ' ' A' ' 692' ' ' PHE . 5.7 mt -103.33 108.83 20.22 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 54.6 mttt -110.57 98.38 36.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -176.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.667 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.2 Cg_exo -49.67 106.86 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.793 1.662 . . . . 0.0 109.225 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 157.37 87.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 12.0 Cg_endo -54.74 -24.88 39.78 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.07 3.18 . . . . 0.0 113.457 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.11 -22.31 65.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.069 0.461 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.457 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 2.0 t -97.69 154.01 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.683 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.452 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 7.3 pt -51.22 -21.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.497 . . . . 0.0 110.014 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 38.9 mt -105.16 118.84 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.71 59.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.649 . . . . 0.0 110.264 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.667 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.78 172.56 9.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.727 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.18 131.55 53.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.62 143.96 42.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.207 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.05 116.61 23.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 111.708 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.53 HG12 ' CD2' ' A' ' 601' ' ' PHE . 73.0 mt -81.89 109.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.879 0.371 . . . . 0.0 110.443 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.08 115.63 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.478 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.34 -30.51 2.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.258 0.551 . . . . 0.0 110.681 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -20.21 72.76 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.23 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.24 118.92 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 117.35 0.575 . . . . 0.0 111.65 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -139.35 121.53 10.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.815 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.557 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -89.99 160.46 34.45 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 124.555 -1.019 . . . . 0.0 111.63 -0.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.6 t80 -91.42 116.63 29.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 20.8 m-85 -92.62 138.57 31.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.29 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.488 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -129.08 141.84 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.87 -170.2 38.31 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 119.964 -1.113 . . . . 0.0 113.92 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 ttp85 -80.33 1.44 28.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.356 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.428 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 14.4 t -101.19 119.78 39.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -51.72 -24.64 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.015 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -61.4 -26.71 68.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.991 0.424 . . . . 0.0 110.391 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.2 m -71.57 128.75 36.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.853 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -43.43 -34.63 1.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.289 0.566 . . . . 0.0 110.287 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.488 ' HB3' HG13 ' A' ' 603' ' ' ILE . 50.7 t -106.29 141.29 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.099 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 111.47 20.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.449 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 18.3 mm -137.73 108.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.127 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mp0 -104.19 106.6 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.662 . . . . 0.0 112.497 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 5.0 t70 -130.53 125.93 35.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.722 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -43.64 -34.18 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.778 0.323 . . . . 0.0 111.223 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.401 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 26.2 mmt180 -77.35 -39.06 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.682 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -59.54 158.21 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.06 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.07 163.92 13.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.304 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.428 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -46.04 -55.33 7.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.08 62.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.421 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.682 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.6 t60 -47.1 -48.09 22.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.576 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 603' ' ' ILE . 24.7 p -166.82 157.12 11.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 650' ' ' CYS . 41.2 p90 -144.12 143.67 31.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.889 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 45.5 mt -101.59 131.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.557 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -122.46 132.52 54.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.403 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 7.6 ttmt -98.07 136.53 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.545 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.453 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.8 158.66 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.197 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.94 113.47 14.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.536 0.684 . . . . 0.0 110.391 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.0 t60 -70.01 122.97 20.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.269 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . 176.42 126.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.973 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.29 173.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -66.87 97.81 0.38 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.377 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.6 tttp 61.85 152.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 6.3 p -95.42 44.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.5 mtt -66.23 111.53 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.57 -62.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.79 143.13 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.04 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 96.8 p -115.29 93.28 35.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.95 -150.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.762 2.308 . . . . 0.0 111.897 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -92.35 36.01 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.466 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 67.9 -70.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 166.68 62.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.818 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.5 mp -93.95 -159.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -119.58 146.9 45.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 112.206 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -127.05 160.16 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.777 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.42 HG22 ' CE1' ' A' ' 577' ' ' PHE . 2.6 pt -111.22 120.98 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.587 . . . . 0.0 111.902 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.523 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -103.05 136.28 43.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -99.08 119.37 37.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 624' ' ' PHE . 6.9 m -110.0 141.87 42.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.035 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 34.0 t60 -121.74 122.76 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.15 11.36 15.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.326 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.44 139.72 15.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.811 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.3 m -72.49 -8.17 53.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.419 ' C ' ' CG1' ' A' ' 656' ' ' VAL . 1.5 m120 -85.43 2.78 43.05 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 658' ' ' TYR . 1.8 m 60.21 146.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 111.275 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.434 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 0.3 OUTLIER -116.16 162.61 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.085 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -137.44 120.37 16.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.362 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -108.6 116.67 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.131 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 60.24 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.95 2.12 2.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.23 141.24 35.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 141.71 28.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.501 ' HB2' ' OG1' ' A' ' 668' ' ' THR . 4.5 ptp -138.04 142.68 40.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.405 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.452 HD13 HG21 ' A' ' 665' ' ' ILE . 17.7 pt -112.12 165.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.393 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -47.15 117.59 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.955 0.407 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 101.58 23.08 9.7 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 664' ' ' MET . 10.9 p -112.24 162.37 15.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.462 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -134.94 145.04 47.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CD2' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -145.95 134.36 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.943 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -68.69 140.54 55.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.07 122.79 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 0.0 111.906 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.573 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 47.0 mt-30 -104.18 137.6 41.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.593 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 706' ' ' GLY . 9.7 t70 -40.52 108.82 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.975 0.417 . . . . 0.0 111.007 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.92 35.55 4.79 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 3.0 t0 -95.55 122.81 38.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.329 . . . . 0.0 111.079 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.02 108.38 20.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.4 HG21 HD21 ' A' ' 659' ' ' LEU . 5.5 pt -106.55 131.95 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 112.141 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -104.01 127.03 51.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.02 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.521 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -95.11 -25.15 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.744 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.439 HG22 ' CZ ' ' A' ' 688' ' ' PHE . 7.6 tt -155.23 131.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -136.59 126.7 26.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.746 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.4 117.03 28.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.644 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -67.04 -46.53 74.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.877 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -79.87 -40.41 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.601 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -79.98 -20.24 45.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.294 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 8.97 6.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.223 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.452 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.7 t80 -77.02 105.15 7.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.3 p -119.64 121.87 67.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.451 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 690' ' ' ILE . 2.4 tt -120.8 121.44 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.5 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -140.39 137.95 8.69 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.331 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.468 ' CB ' HD21 ' A' ' 580' ' ' LEU . 10.3 m-30 -113.35 142.33 45.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -100.96 117.37 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.023 0.44 . . . . 0.0 110.925 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -83.66 122.51 37.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.565 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.09 109.59 9.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 27.5 mt -77.32 108.62 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.937 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.36 -43.36 9.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.08 141.54 42.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.5 OUTLIER -114.23 100.56 8.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.38 0.61 . . . . 0.0 109.671 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.4 57.83 4.21 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 81.56 37.97 15.68 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.24 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.47 134.55 38.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.522 0.201 . . . . 0.0 110.591 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.417 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 4.3 p90 -43.62 -33.27 1.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.472 0.653 . . . . 0.0 110.323 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -147.98 -61.25 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.676 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 16.6 pt-20 145.36 33.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.043 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 71.74 68.87 1.51 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.053 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.567 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.6 OUTLIER -106.95 -9.78 16.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.087 0.443 . . . . 0.0 111.31 179.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 709' ' ' MET . . . 127.41 -116.68 2.47 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.752 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 165.22 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 111.08 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.36 -161.18 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.504 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -46.03 -94.59 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -114.86 98.81 7.05 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.871 0.367 . . . . 0.0 111.89 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 5.5 tp60 -116.58 136.23 53.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.017 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 713' ' ' GLN . 1.8 mmm-85 160.37 69.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.791 0.437 . . . . 0.0 110.071 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.77 149.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.29 118.43 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.32 172.02 8.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.52 154.31 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -91.29 156.31 17.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -126.02 -173.96 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.85 -33.5 64.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.23 -50.49 73.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -65.53 -50.26 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -32.93 68.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -63.57 -38.69 92.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 9.5 mt -61.06 -44.52 97.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.5 -26.83 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -58.57 -30.93 67.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -86.67 -18.87 30.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.159 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.89 141.41 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.82 172.07 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -178.48 126.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 15.9 mt -145.83 91.09 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.943 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.915 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.92 3.74 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.616 0.246 . . . . 0.0 111.528 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 120.72 21.65 3.21 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.717 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.438 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 9.1 ttm180 -112.09 119.56 38.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 647' ' ' ILE . 1.2 t80 -100.91 -46.31 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 694' ' ' VAL . 7.9 tp -120.69 142.54 49.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 111.485 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 695' ' ' GLU . 15.0 m -122.26 114.56 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.488 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -103.66 108.59 19.94 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 25.4 mtmt -111.65 98.77 42.33 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_exo -46.84 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.838 1.692 . . . . 0.0 109.47 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.64 157.46 85.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.414 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.5 Cg_exo -49.73 -25.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.583 2.855 . . . . 0.0 112.704 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -27.52 68.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.418 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 4.2 t -95.63 153.94 17.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.749 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 690' ' ' ILE . 8.3 pt -54.94 -13.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 51.1 mt -108.78 128.7 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.802 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.414 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -113.99 56.43 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.212 0.529 . . . . 0.0 110.256 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -124.62 171.97 9.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.58 128.65 45.94 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 178.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.08 139.94 47.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.708 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.438 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.2 113.82 18.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.543 HG12 ' CD2' ' A' ' 601' ' ' PHE . 71.6 mt -78.71 109.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.321 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.76 116.09 6.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.814 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.489 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -44.97 -32.42 1.63 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.224 0.535 . . . . 0.0 110.293 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.489 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.7 -18.78 74.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.747 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 56.4 t -100.5 118.59 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 117.769 0.785 . . . . 0.0 111.686 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.83 121.96 9.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.914 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 49.1 Cg_endo -90.42 160.26 32.22 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.545 -1.023 . . . . 0.0 111.659 -0.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -91.64 116.32 28.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 59.7 m-85 -91.91 138.04 31.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.897 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.474 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mp -129.87 145.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.831 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.36 -169.15 36.82 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.462 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -83.21 3.39 31.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.768 -0.216 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 7.2 t -101.29 126.32 48.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -57.31 -22.72 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -64.12 -25.43 68.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.665 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 89.9 m -73.41 132.91 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 22.8 m-20 -48.48 -27.4 2.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.474 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 54.1 t -114.55 142.02 46.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 118.59 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.406 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 32.5 mm -138.16 109.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.216 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 14.0 tt0 -89.94 102.98 15.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.456 ' HB3' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.52 112.89 12.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.212 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -43.57 -34.08 1.31 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.733 0.302 . . . . 0.0 111.392 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -77.55 -39.67 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.688 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 680' ' ' ILE . 0.4 OUTLIER -61.12 159.2 12.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.541 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.1 m -110.29 167.21 10.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.415 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.3 OUTLIER -44.65 -55.51 5.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 110.229 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 18.5 t -112.66 57.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.477 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 653' ' ' GLY . 43.1 t60 -45.57 -46.02 13.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.617 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 7.0 p -167.1 155.86 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.474 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 40.3 p90 -143.32 147.96 35.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 86.1 mt -102.65 139.79 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.972 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.514 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -131.44 133.62 45.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.506 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.3 ttmt -97.57 136.1 38.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.559 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.478 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 159.55 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.861 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 630' ' ' HIS . 0.9 OUTLIER -76.08 139.61 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.2 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t-160 -60.08 133.19 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -89.3 56.67 3.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.164 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.88 125.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.56 -146.94 6.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.429 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -76.85 157.21 31.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 110.754 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 1.5 t -129.83 167.13 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -123.84 112.96 17.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.638 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.74 -71.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.385 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.48 118.73 37.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.38 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.85 87.65 3.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.445 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.31 167.19 25.05 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.538 2.158 . . . . 0.0 111.809 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 70.68 -62.73 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 64.24 170.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -76.4 72.77 1.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.726 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -102.78 -153.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.37 147.44 46.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.277 0.56 . . . . 0.0 112.099 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -130.09 154.57 47.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.502 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 4.0 pt -105.39 128.72 59.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.26 0.552 . . . . 0.0 111.844 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.483 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 78.8 m95 -111.74 140.79 46.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.426 ' CE2' HG23 ' A' ' 678' ' ' ILE . 13.4 t80 -104.62 117.25 33.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 624' ' ' PHE . 97.1 m -105.6 126.2 51.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.423 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 23.8 t60 -104.36 122.79 46.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.67 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.479 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.44 5.24 13.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.57 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.64 146.14 20.57 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.043 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 37.6 m -79.6 -1.11 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -87.08 0.42 55.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.442 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.42 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.348 0.594 . . . . 0.0 111.87 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 11.9 p -102.54 165.65 10.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.669 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.414 ' CZ ' HG23 ' A' ' 656' ' ' VAL . 2.3 m-85 -137.03 119.95 16.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.783 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -97.25 106.08 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.91 -81.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -131.36 -4.27 3.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -97.43 138.65 34.55 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -85.26 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 2.6 mtp -130.17 122.88 29.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 0.0 111.14 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.7 pt -103.4 165.18 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.656 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.1 tt0 -51.16 117.64 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 110.868 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.74 8.0 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.309 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.6 p -112.77 162.19 16.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.978 0.418 . . . . 0.0 111.419 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.3 ttpm? -136.48 144.06 44.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.536 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.518 ' HB3' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.27 144.82 29.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.483 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.65 136.72 53.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.458 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.6 mt -108.19 127.89 54.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 706' ' ' GLY . 0.6 OUTLIER -118.1 161.26 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.132 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.424 ' HB2' HD11 ' A' ' 696' ' ' ILE . 60.1 t0 -58.37 104.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.303 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.72 32.84 4.95 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -86.71 115.61 24.27 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.673 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.83 108.91 21.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.426 HG23 ' CE2' ' A' ' 649' ' ' TYR . 4.7 mt -105.16 131.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 0.0 112.036 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -93.32 115.54 28.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.182 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.503 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -86.41 -37.89 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.136 -179.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.428 HG22 ' CZ ' ' A' ' 688' ' ' PHE . 43.9 mt -155.36 130.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.392 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -136.79 127.09 26.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -126.35 116.56 21.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.37 . . . . 0.0 110.686 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -67.81 -46.2 72.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -58.55 -40.28 82.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.128 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -96.22 -20.24 18.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.5 tptp 72.04 1.91 4.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.318 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.67 105.37 7.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 586' ' ' SER . 3.6 p -110.78 138.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.913 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 587' ' ' ILE . 8.3 mm -112.65 145.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.418 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.55 128.57 1.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 9.4 m-30 -113.2 148.31 35.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 110.323 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -101.62 117.02 34.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.05 0.453 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.8 t -81.66 126.11 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.4 tt0 -133.98 108.69 8.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 34.1 mt -74.0 105.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.674 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.92 -47.61 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.875 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.478 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.6 t0 -111.08 140.06 45.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -115.14 100.62 8.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.166 0.507 . . . . 0.0 109.726 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.2 t -69.79 65.34 0.22 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.64 57.22 20.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.754 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 0.4 OUTLIER -95.91 149.38 21.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 112.048 -179.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.526 ' CD2' ' CE1' ' A' ' 630' ' ' HIS . 0.1 OUTLIER -50.72 -26.95 6.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.189 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.461 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.2 t30 -160.13 -51.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.586 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 696' ' ' ILE . 9.6 pt-20 159.53 -31.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.729 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 145.26 40.68 0.05 OUTLIER Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.061 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.448 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 1.4 mm? -88.29 7.19 33.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.058 0.429 . . . . 0.0 112.087 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 67.45 -67.26 0.26 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.806 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 8.3 ptp 35.79 40.48 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.771 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.92 169.85 9.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.832 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.53 -30.02 18.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.88 130.58 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.429 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.85 100.41 10.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.095 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 39.9 84.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.732 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.71 142.84 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.95 114.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.093 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.1 170.16 11.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.567 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -103.75 158.1 16.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -95.4 158.2 15.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.0 p -126.31 -176.49 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.56 -30.42 41.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.17 -45.01 96.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.585 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.84 -49.67 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.557 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -56.25 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -41.8 89.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.4 mt -55.68 -44.33 77.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.043 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.56 -29.31 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -37.53 67.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.62 28.63 3.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.655 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.814 0.34 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.38 109.35 9.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.0 pt -60.83 159.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -174.87 162.61 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 96.9 mt -137.9 50.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -70.13 -22.15 63.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 145.08 -14.37 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.417 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 60.2 ttp180 -100.31 128.91 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -112.9 -57.55 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.364 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 647' ' ' ILE . 7.3 tt -108.82 137.56 46.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 9.7 m -116.95 114.6 24.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 592' ' ' LEU . 1.0 OUTLIER -103.56 108.03 19.13 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.32 100.46 53.48 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.8 Cg_exo -47.22 103.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.736 1.624 . . . . 0.0 109.545 176.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 158.36 86.09 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.426 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 7.6 Cg_endo -49.66 -26.18 12.52 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.512 2.808 . . . . 0.0 112.705 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.5 -19.83 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.012 0.434 . . . . 0.0 109.885 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 t -96.76 153.86 17.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.848 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.0 pt -55.49 -20.49 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 588' ' ' ILE . 59.7 mt -110.55 118.8 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.078 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.426 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.1 61.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.374 0.607 . . . . 0.0 110.307 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.93 171.95 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.835 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.28 132.61 53.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.026 0.441 . . . . 0.0 111.384 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.9 144.81 41.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.116 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.417 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.4 mt-10 -124.28 116.73 23.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 601' ' ' PHE . 66.7 mt -87.54 108.81 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -66.93 125.2 25.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.49 -30.02 2.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.286 0.565 . . . . 0.0 110.148 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.6 -21.4 79.58 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 114.085 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 63.5 t -98.95 117.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.253 1.026 . . . . 0.0 111.797 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.7 t30 -140.51 121.28 9.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.917 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.547 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 40.4 Cg_endo -90.43 159.71 31.91 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.606 -0.998 . . . . 0.0 111.375 -0.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.9 t80 -92.16 117.41 29.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.489 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 14.2 m-85 -92.22 137.9 31.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.173 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.527 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mp -128.45 146.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.412 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.81 -165.88 37.78 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.89 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.7 OUTLIER -85.86 -6.65 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.519 -0.34 . . . . 0.0 111.767 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.0 130.79 47.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.323 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.36 -24.73 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.55 -28.96 61.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 110.528 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 92.9 m -73.65 133.09 43.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.486 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -47.91 -27.03 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 41.3 t -114.48 141.31 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.489 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.82 114.48 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.481 HG23 HD11 ' A' ' 613' ' ' ILE . 27.6 mm -137.9 109.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.187 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.4 pt-20 -92.01 103.02 15.58 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.846 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.47 ' CB ' ' CD2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.88 110.94 10.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.318 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.97 -24.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.443 ' CG ' ' CD2' ' A' ' 688' ' ' PHE . 6.4 mmp_? -77.38 -41.38 40.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.75 158.7 20.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 111.535 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.8 t -93.55 178.25 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.719 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.404 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -47.13 -53.99 11.6 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.425 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 33.7 t -113.87 62.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.211 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 59.1 t60 -48.86 -51.06 31.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.535 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.55 157.49 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.446 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.5 p90 -143.52 150.53 39.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.436 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -102.08 126.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -120.38 133.98 55.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.417 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 25.0 ttmt -98.06 137.16 37.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.235 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.55 159.21 42.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.791 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -76.21 111.95 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.344 0.592 . . . . 0.0 110.112 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER -83.17 122.94 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.536 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -159.52 109.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.59 152.55 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -60.14 95.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.31 177.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.11 102.8 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 3.7 mtt -92.74 128.0 38.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 9.6 t80 69.26 -66.47 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.33 138.53 31.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.727 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 20.1 m -116.46 88.17 23.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.06 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.04 -151.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.657 2.238 . . . . 0.0 112.051 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -62.86 -14.32 44.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.74 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.0 OUTLIER 82.34 -71.06 0.05 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . -170.59 72.58 0.11 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 630' ' ' HIS . 23.4 mt -106.93 -154.26 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.932 -0.158 . . . . 0.0 110.707 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 702' ' ' LEU . 4.6 m-20 -116.34 147.3 41.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.022 0.439 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.44 ' HA ' HD12 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -131.92 155.72 47.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.225 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -105.87 119.87 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 121.563 0.697 . . . . 0.0 112.346 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.628 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.4 m95 -103.59 128.29 50.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.636 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 6.7 t80 -90.16 115.72 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.8 m -98.25 137.59 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 111.549 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 23.0 t60 -121.55 121.62 37.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.509 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 22.6 p -119.48 3.18 11.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.49 146.7 29.03 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.883 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -13.59 59.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -83.43 2.35 37.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.48 137.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.612 0.72 . . . . 0.0 111.992 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.456 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 40.9 m -112.42 166.42 11.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.481 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.39 120.07 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.43 ' CD2' HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.69 99.67 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.5 m120 60.51 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.2 t30 -131.79 -0.38 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.683 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.91 141.05 36.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -77.01 141.88 40.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.5 mmm -121.2 91.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.1 pt -87.39 159.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 652' ' ' THR . 19.6 tt0 -55.3 108.06 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.236 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.0 34.48 2.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.918 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.0 p -134.68 159.77 40.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 111.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 16.0 pttm -136.78 139.8 42.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.45 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 14.3 t80 -131.64 144.61 51.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.628 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 1.2 mt -68.89 134.56 49.77 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.179 0.514 . . . . 0.0 111.849 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 647' ' ' ILE . 4.0 mt -104.46 135.31 46.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.219 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 3.6 mt-30 -119.7 146.7 45.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.307 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 696' ' ' ILE . 10.8 t70 -45.9 104.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.88 32.46 4.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 112.07 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -95.47 108.26 20.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 659' ' ' LEU . 36.3 pt -106.03 137.42 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.341 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.23 115.52 27.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.109 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.514 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.1 mt -81.68 -38.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.441 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 14.0 mt -155.3 131.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.931 0.396 . . . . 0.0 111.556 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.63 123.05 20.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 116.68 21.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.536 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -46.67 71.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.982 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -71.63 -40.56 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.799 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -89.81 -6.23 56.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.445 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 58.78 19.04 6.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.676 0.274 . . . . 0.0 110.798 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CD2' ' CG ' ' A' ' 617' ' ' ARG . 0.1 OUTLIER -79.05 104.34 9.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.88 121.79 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.194 0.521 . . . . 0.0 111.447 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 690' ' ' ILE . 33.3 mm -128.24 137.27 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.881 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -167.66 131.04 2.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.045 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.483 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.9 m-30 -113.14 144.72 42.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.664 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -101.7 117.23 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.068 0.461 . . . . 0.0 110.563 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 675' ' ' GLY . 3.1 t -79.04 119.7 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.649 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.45 109.16 11.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.061 0.457 . . . . 0.0 110.233 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.494 HD11 ' O ' ' A' ' 705' ' ' GLU . 58.2 mt -79.79 105.46 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -49.01 8.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -111.38 138.44 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.796 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 68.9 p -116.14 99.87 7.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.4 t -77.42 61.0 2.15 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.42 43.43 58.14 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.067 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -97.1 32.9 2.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.953 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.682 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER 61.55 109.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 7.2 t30 56.14 -69.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.145 0.498 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 703' ' ' PHE . 9.1 pt-20 172.24 -22.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.765 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 137.71 40.65 0.11 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.834 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 0.9 OUTLIER -82.57 -3.53 56.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 42.48 82.25 0.03 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.349 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.471 ' HE2' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -98.36 29.71 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.159 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 164.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.844 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.5 -33.64 45.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.09 139.89 30.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.485 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -82.65 100.14 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.027 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 15.2 mmm-85 39.85 87.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.89 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.4 141.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.405 ' CG2' ' HE1' ' A' ' 664' ' ' MET . 7.7 p -84.51 130.22 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.58 169.73 9.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 156.43 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.974 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.83 150.78 25.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -126.12 -178.44 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.52 57.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.187 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.06 -49.22 76.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -48.29 71.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.736 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -32.97 67.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.44 -36.85 85.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.51 -44.15 96.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.0 p -76.55 -24.03 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.65 -46.06 66.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -64.26 -25.97 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.422 HD13 ' CG ' ' A' ' 602' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.8 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.73 47.47 8.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.46 105.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.84 -178.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.35 113.96 5.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.966 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -92.76 10.51 30.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.627 0.251 . . . . 0.0 111.171 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -158.36 -36.86 0.02 OUTLIER Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.83 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.425 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 58.4 ttp180 -112.03 143.33 43.22 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.306 -0.526 . . . . 0.0 111.209 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -128.07 -62.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.549 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.6 tt -106.46 125.68 51.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.307 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.8 m -109.23 118.49 36.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.532 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.3 OUTLIER -105.56 108.25 19.67 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.27 99.22 39.23 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 50.4 Cg_exo -47.47 97.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.792 1.661 . . . . 0.0 109.607 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.79 158.14 85.04 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.409 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.0 Cg_endo -49.7 -25.55 11.6 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.55 2.833 . . . . 0.0 112.549 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.1 -25.43 67.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.8 t -95.61 153.93 17.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.691 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.422 ' CG1' ' CD1' ' A' ' 690' ' ' ILE . 0.9 OUTLIER -57.03 -12.34 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 0.0 111.284 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 613' ' ' ILE . 30.4 mt -112.44 129.62 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -111.46 57.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.486 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.615 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.9 mt-10 -124.64 172.04 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.127 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -125.9 130.47 51.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.6 OUTLIER -112.74 142.51 45.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.101 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.27 120.43 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 601' ' ' PHE . 78.6 mt -89.34 109.07 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -68.14 122.47 18.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.85 -29.95 2.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.221 0.534 . . . . 0.0 110.537 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.441 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.55 -22.04 77.79 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.942 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.07 118.26 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.934 0.867 . . . . 0.0 111.841 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 19.1 t30 -139.85 122.32 10.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.742 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.548 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -90.21 159.52 32.9 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.372 -1.095 . . . . 0.0 111.673 -0.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.2 t80 -92.07 114.28 26.78 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 3.3 m-85 -92.39 138.48 31.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.184 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -125.78 143.44 39.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.79 -174.08 43.39 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.375 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.428 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.5 ttp85 -82.03 -4.46 56.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.617 0.246 . . . . 0.0 111.455 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.98 126.43 47.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.777 0.322 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -49.94 -26.58 4.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.55 -28.85 48.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.958 0.408 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 35.2 m -75.02 133.4 41.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.5 m-20 -49.61 -26.95 4.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.457 . . . . 0.0 110.417 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 38.0 t -111.54 142.66 43.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 115.17 24.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 605' ' ' ARG . 24.6 mm -137.88 109.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.011 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 28.6 tt0 -89.29 104.1 16.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.249 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.479 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.85 113.24 13.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.228 178.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -41.23 -38.61 1.16 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.446 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.3 mmp_? -77.46 -35.11 54.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.64 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -58.99 157.94 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.73 164.43 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.96 -50.01 19.73 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.126 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.67 63.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.498 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.64 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.9 t60 -45.78 -48.22 15.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.477 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 31.7 p -172.39 162.88 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 650' ' ' CYS . 46.0 p90 -144.18 144.2 31.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.55 130.67 52.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.1 t80 -121.67 133.61 54.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 3.1 tppp? -97.94 136.03 38.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.769 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 158.7 43.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.84 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.19 112.96 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.451 0.644 . . . . 0.0 110.366 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.2 t60 -68.22 133.39 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.131 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -127.95 160.51 31.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.054 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.1 p -140.35 159.48 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.403 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -67.13 -93.47 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.544 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.52 138.15 54.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 13.9 p -111.27 121.88 46.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 116.0 13.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.3 t80 72.6 -62.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -81.82 144.07 31.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 7.0 t -94.5 107.62 31.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.44 -165.25 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.534 2.156 . . . . 0.0 112.377 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 630' ' ' HIS . . . -56.37 -30.16 62.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.491 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.413 ' HB3' HD12 ' A' ' 644' ' ' LEU . 0.0 OUTLIER 64.38 -165.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -95.02 68.6 1.17 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.172 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.9 mp -114.68 -156.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -118.4 146.84 44.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.049 0.452 . . . . 0.0 111.65 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.438 ' CG ' HD13 ' A' ' 671' ' ' LEU . 3.0 t0 -133.47 160.3 37.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.589 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 578' ' ' LEU . 1.3 pt -109.08 122.64 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.795 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.552 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 93.1 m95 -109.99 126.85 54.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.399 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -90.67 122.24 33.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.162 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 7.9 m -111.02 128.14 55.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.46 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 70.5 t60 -106.11 130.11 54.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.382 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -126.24 3.63 7.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.288 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.53 141.07 20.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.043 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 87.4 m -75.6 -5.6 46.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 617' ' ' ARG . 1.3 m120 -87.24 0.04 55.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.722 0.296 . . . . 0.0 111.316 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.3 t 67.59 146.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.46 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 0.9 OUTLIER -118.24 158.66 24.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.379 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -138.58 119.68 14.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.359 . . . . 0.0 110.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -108.06 112.49 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.83 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.46 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.02 0.19 1.53 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.474 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -96.65 141.82 29.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -79.51 141.91 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 34.9 mmm -124.78 102.77 7.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.118 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 44.2 pt -87.99 151.43 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -47.5 107.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.955 0.407 . . . . 0.0 111.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.51 36.18 2.69 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.132 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.9 p -122.69 162.2 22.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 111.519 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.433 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -129.42 153.23 48.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.02 143.31 28.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.552 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -73.23 123.08 22.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.217 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 671' ' ' LEU . 1.1 mt -98.71 140.48 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.2 OUTLIER -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.432 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 706' ' ' GLY . 29.1 t0 -43.04 113.76 0.52 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 95.95 35.51 5.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.42 121.61 36.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.356 . . . . 0.0 110.914 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -96.15 108.62 21.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.987 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.403 HG12 ' HG ' ' A' ' 659' ' ' LEU . 6.2 mt -108.13 136.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.07 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 20.0 mttt -107.83 116.59 32.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.812 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.503 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -88.02 -30.55 5.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.858 -178.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.446 HD13 ' HB3' ' A' ' 617' ' ' ARG . 15.8 tt -155.03 130.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.523 . . . . 0.0 112.193 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.43 128.34 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.375 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -126.72 116.38 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 0.0 111.152 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -68.5 -46.61 69.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.992 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -58.71 -40.64 84.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.054 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.94 -15.47 22.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.451 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 70.64 3.31 4.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.072 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.413 ' CE1' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.46 104.18 7.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.3 137.33 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.807 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 587' ' ' ILE . 28.8 mm -116.19 155.24 17.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.67 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.473 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 179.28 124.92 0.91 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.86 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.8 m-30 -112.67 143.26 44.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 0.0 110.552 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -101.09 117.55 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.113 0.482 . . . . 0.0 110.702 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.421 HG12 HD13 ' A' ' 578' ' ' LEU . 8.2 t -82.45 126.94 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.8 tt0 -133.76 109.44 9.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.491 HG22 HD13 ' A' ' 696' ' ' ILE . 67.7 mt -77.55 105.68 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.869 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -80.5 -44.55 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.247 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -110.44 140.82 44.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.032 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.8 p -114.78 99.81 7.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.093 0.473 . . . . 0.0 109.895 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 t -80.69 60.31 3.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.481 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.96 58.93 11.6 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.925 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.04 144.0 28.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.551 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.497 ' CD2' ' HB3' ' A' ' 704' ' ' ASN . 5.1 p90 -37.43 -47.99 0.92 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.695 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -143.51 5.74 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.19 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.2 pt-20 87.69 -41.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 116.87 34.61 1.24 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -8.81 59.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.587 -0.361 . . . . 0.0 111.566 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.422 ' HA3' ' OE1' ' A' ' 673' ' ' GLN . . . 46.9 101.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.211 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.79 96.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 712' ' ' GLU . 0.4 OUTLIER 67.32 158.79 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.765 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -68.6 65.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.482 . . . . 0.0 110.26 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 710' ' ' LEU . 1.2 mm-40 -107.45 141.73 38.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.134 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -81.06 135.97 35.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.197 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.504 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -87.87 -143.3 0.13 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.281 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.91 143.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 82.2 t -99.04 113.91 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.83 172.19 8.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.89 16.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -90.79 152.61 20.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 59.9 p -126.21 -175.21 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.35 65.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.51 -47.2 82.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.41 -45.26 80.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.618 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -32.71 68.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.31 -37.82 83.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.61 -44.34 89.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.39 -22.1 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -40.08 66.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -75.56 -15.91 60.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.418 HD12 ' CD2' ' A' ' 602' ' ' PHE . 9.9 tt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -176.57 119.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.1 mt -143.81 94.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.35 123.8 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.92 37.42 4.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.864 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -93.02 10.36 31.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.599 0.238 . . . . 0.0 111.407 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.616 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -153.34 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.661 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 ttm180 -97.7 142.03 29.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 122.501 -0.411 . . . . 0.0 110.581 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -131.3 -60.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.429 ' CD1' HD13 ' A' ' 647' ' ' ILE . 6.7 tt -106.55 134.68 49.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.858 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 695' ' ' GLU . 26.1 m -115.5 114.66 25.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 592' ' ' LEU . 1.2 mp -105.18 108.04 19.35 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 pttp -113.46 100.32 51.53 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 53.2 Cg_exo -46.07 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.91 1.74 . . . . 0.0 109.795 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.485 ' N ' HD21 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -74.69 158.52 84.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.03 -24.72 5.68 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.493 2.795 . . . . 0.0 112.759 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -61.45 -23.37 65.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.4 t -95.49 153.59 17.62 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.92 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 690' ' ' ILE . 4.3 pt -54.46 -17.85 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 582' ' ' PRO . 6.4 tt -112.46 142.83 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.77 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.31 65.89 0.83 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.351 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.6 mm-40 -124.75 171.57 10.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.276 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.89 125.67 40.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.954 0.406 . . . . 0.0 111.084 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.65 138.66 49.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.771 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 8.7 mt-10 -124.25 122.4 37.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.549 HG12 ' CD2' ' A' ' 601' ' ' PHE . 67.8 mt -85.12 109.21 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.116 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -63.68 114.0 3.71 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.006 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.513 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.9 -32.72 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.9 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.499 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.63 -21.05 76.19 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.689 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.19 118.49 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.864 0.832 . . . . 0.0 111.917 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.18 123.08 10.14 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.981 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.6 Cg_endo -90.06 159.31 33.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.334 -1.111 . . . . 0.0 111.799 0.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 610' ' ' ASN . 2.6 t80 -92.87 117.72 30.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.472 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.3 m-85 -92.79 138.2 31.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.648 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.582 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.4 mp -128.28 149.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.957 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.78 -176.69 40.55 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.962 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -79.25 -4.51 51.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.212 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 130.21 47.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 111.052 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -25.13 19.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.32 -29.01 46.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.783 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 58.1 m -77.77 136.88 38.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.876 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.4 OUTLIER -51.32 -23.77 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.582 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 51.5 t -117.29 143.38 45.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.696 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -120.43 119.77 34.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.48 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 25.4 mm -137.57 109.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.987 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.67 102.53 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.867 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.483 ' HB3' HD12 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.18 113.55 13.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.837 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -44.04 -36.43 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.821 0.343 . . . . 0.0 111.603 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -77.53 -31.19 53.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.087 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 615' ' ' ASP . 1.3 mp -59.51 159.48 8.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.8 p -114.02 164.52 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.173 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -45.8 -45.4 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.89 61.44 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.392 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.491 ' NE2' HG22 ' A' ' 680' ' ' ILE . 21.3 t60 -50.05 -48.57 52.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.951 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.5 p -166.89 158.4 12.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.472 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 47.9 p90 -143.39 146.89 33.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.909 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.2 130.96 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.918 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.525 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -124.34 131.58 53.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.618 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 20.1 ttmt -98.15 135.99 39.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.426 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.14 158.0 41.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.171 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.01 122.26 24.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 110.499 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.458 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 6.6 t60 -78.67 129.86 35.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.273 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . 0.408 ' CB ' ' NH1' ' A' ' 629' ' ' ARG . . . -166.88 125.24 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 19.4 m -80.7 178.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -61.14 -72.83 0.57 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.483 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -132.55 141.86 48.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.81 113.6 27.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.25 123.32 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.8 t80 69.24 -66.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -82.33 142.33 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.39 102.89 15.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.06 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 -162.1 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.454 2.103 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.469 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -50.21 -24.43 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.3 tt0 82.81 -64.75 0.1 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.3 47.2 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.59 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -88.78 -155.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.83 147.12 46.9 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.413 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -125.65 160.26 30.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.457 HG22 ' CE2' ' A' ' 577' ' ' PHE . 1.3 pt -113.34 121.21 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.39 0.614 . . . . 0.0 111.927 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.512 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 89.2 m95 -107.26 126.56 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.417 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -91.03 117.74 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 624' ' ' PHE . 12.5 m -105.74 134.27 49.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.518 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.473 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 26.2 t60 -115.51 124.18 50.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -118.67 6.26 11.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.395 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.26 151.12 29.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.6 m -81.34 -10.16 59.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.524 ' O ' ' O ' ' A' ' 656' ' ' VAL . 61.1 m-20 -87.03 2.72 48.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.524 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 50.4 130.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.337 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.473 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 1.8 t -103.01 166.21 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.191 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -131.0 120.15 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.424 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -96.15 99.7 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.59 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.9 m120 61.31 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.748 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 70.0 m-20 -131.65 -2.1 3.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.722 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.61 135.02 42.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 111.325 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -73.65 141.8 46.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 657' ' ' SER . 14.9 mmm -126.52 93.0 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 665' ' ' ILE . 36.4 pt -87.21 158.38 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 652' ' ' THR . 26.6 tt0 -46.42 116.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.193 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.48 28.64 8.87 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.409 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.4 ' CG2' HG12 ' A' ' 665' ' ' ILE . 17.5 p -112.93 162.34 15.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.37 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.4 ttpm? -141.91 129.66 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 9.5 t80 -134.04 144.25 48.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.439 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.512 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.49 140.36 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 112.051 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.437 ' HB2' HD13 ' A' ' 647' ' ' ILE . 1.5 mt -108.82 129.44 55.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.183 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 3.9 mt-30 -115.45 146.0 42.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.512 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -46.76 105.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.085 0.469 . . . . 0.0 110.463 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.2 33.17 4.36 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -92.79 111.96 23.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.803 0.335 . . . . 0.0 111.263 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.8 108.53 20.87 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.453 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 34.2 pt -105.53 137.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.135 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -93.17 115.97 28.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.275 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.491 HG22 ' NE2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -82.45 -32.07 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.722 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.452 HD12 ' CE1' ' A' ' 622' ' ' HIS . 21.3 mt -154.4 131.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 111.44 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.64 124.02 22.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.17 117.06 27.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.427 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -46.94 72.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.678 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -83.2 -40.33 19.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.326 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -15.16 58.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.34 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt 62.9 15.75 8.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.978 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.422 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.01 104.24 7.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.6 p -116.07 123.8 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 587' ' ' ILE . 6.4 mm -127.65 154.04 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 169.29 136.17 2.02 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.714 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.48 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.72 153.95 29.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.798 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -101.79 117.6 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 578' ' ' LEU . 5.0 t -79.08 125.9 38.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.4 OUTLIER -133.21 109.38 9.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.441 . . . . 0.0 110.409 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.43 HD11 ' HB2' ' A' ' 705' ' ' GLU . 58.6 mt -80.78 105.32 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.646 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -87.19 -46.08 10.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.66 140.96 44.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.715 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -113.83 99.97 8.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.316 0.579 . . . . 0.0 109.73 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 56.6 m -70.79 65.93 0.34 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.432 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.19 57.27 20.67 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.857 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 2.9 mt -99.88 145.28 27.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.455 ' CE2' ' CE ' ' A' ' 709' ' ' MET . 38.9 p90 -48.31 -31.38 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 109.765 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.469 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.1 t30 -155.99 -53.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.787 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.469 ' CG ' ' ND2' ' A' ' 704' ' ' ASN . 10.4 pt-20 161.47 -26.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.179 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 139.81 35.72 0.13 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.23 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 1.7 mm? -83.83 -2.93 57.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.425 ' CA ' ' CD1' ' A' ' 671' ' ' LEU . . . 45.21 73.86 0.25 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.985 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.458 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -94.34 43.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.372 . . . . 0.0 111.003 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.34 -177.36 6.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -57.68 12.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.32 133.96 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.736 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.92 100.39 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 15.2 mmm-85 41.68 87.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.716 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.57 142.73 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.8 p -85.15 128.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 171.71 7.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -103.12 157.41 17.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.161 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.8 152.0 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 2.7 p -126.11 -178.0 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.77 -35.02 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -57.86 -48.0 81.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.7 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.65 -48.14 70.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.795 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -32.95 70.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -39.44 93.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.261 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -60.47 -44.67 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.013 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.4 p -71.27 -27.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -56.05 -32.6 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -97.79 28.0 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.781 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.783 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.861 0.362 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.47 165.82 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.7 mt -145.71 103.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -173.42 168.24 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 60.6 mt -132.98 68.65 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.878 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -90.75 -8.94 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.683 0.278 . . . . 0.0 111.309 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 134.01 -48.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.445 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.0 tmm_? -112.96 143.93 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 111.028 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.22 -63.57 1.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.05 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.5 tt -106.91 142.56 36.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 20.3 m -122.68 114.81 21.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.335 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 592' ' ' LEU . 6.6 mt -102.55 108.29 19.54 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 6.9 ptmm? -116.55 100.51 53.48 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.594 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 33.3 Cg_exo -47.11 105.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.635 1.557 . . . . 0.0 109.06 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.39 156.24 87.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.517 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 58.4 Cg_exo -51.31 -25.84 19.11 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.589 2.859 . . . . 0.0 113.108 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.38 -26.72 68.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.049 0.452 . . . . 0.0 110.034 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.417 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -97.58 153.66 18.03 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.235 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 14.4 pt -49.09 -23.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 110.1 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.401 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 51.2 mt -99.5 118.59 46.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -117.57 52.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.588 . . . . 0.0 110.453 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.594 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 16.0 mt-10 -124.58 171.82 9.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.379 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.64 132.31 53.42 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.122 0.487 . . . . 0.0 111.573 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.91 143.04 44.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.724 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -124.28 118.91 27.84 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 601' ' ' PHE . 74.9 mt -83.8 109.05 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.214 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.9 120.84 13.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.95 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.24 -28.12 1.79 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.091 0.472 . . . . 0.0 110.67 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -73.63 -19.3 79.69 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.746 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 55.0 t -100.74 117.95 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.968 0.884 . . . . 0.0 111.711 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.6 t30 -140.19 121.71 9.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.687 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.567 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.3 Cg_endo -89.96 159.86 34.31 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.493 -1.045 . . . . 0.0 111.519 -0.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CD2' HG12 ' A' ' 594' ' ' ILE . 3.7 t80 -91.5 114.7 27.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 20.5 m-85 -91.68 138.45 31.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.521 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.0 mp -126.32 146.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.71 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.09 -174.8 36.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.226 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -65.89 -48.62 70.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.831 0.348 . . . . 0.0 111.415 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.86 128.41 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.492 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.46 -17.73 23.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.766 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -56.95 -31.74 65.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.123 0.487 . . . . 0.0 110.112 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 84.3 m -70.58 134.02 47.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.501 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.532 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -48.08 -27.53 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.432 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 37.2 t -112.19 142.01 45.19 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 105.37 13.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.449 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 18.7 mm -138.62 108.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.764 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -106.18 105.91 16.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.469 0.652 . . . . 0.0 112.217 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.505 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.08 109.88 11.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.731 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -37.83 -30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -41.59 59.88 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 615' ' ' ASP . 2.4 pp -88.24 136.98 32.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 163.84 4.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.461 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.444 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 1.3 ptp180 -54.08 -28.06 36.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.36 60.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.477 ' ND1' ' HB2' ' A' ' 618' ' ' LEU . 28.2 t60 -49.16 -47.25 45.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.133 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 8.2 p -168.06 161.09 12.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.539 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 42.8 p90 -143.36 148.52 36.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.62 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.23 128.16 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.324 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -118.48 134.47 55.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.423 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 33.3 ttmt -98.1 135.28 40.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.457 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.19 159.65 41.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.588 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.4 tpt180 -75.2 112.89 11.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.27 0.557 . . . . 0.0 110.862 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.476 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 7.7 t60 -61.72 133.59 55.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -139.76 101.9 4.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.147 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.02 -176.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -91.37 -49.56 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.638 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.73 167.9 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 82.5 p -171.72 135.91 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 59.8 mmm -118.99 115.87 25.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.51 -72.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.36 144.34 40.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.5 m -101.31 105.16 38.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.924 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.37 -149.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.607 2.205 . . . . 0.0 111.986 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 630' ' ' HIS . . . -45.39 -29.2 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 111.556 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -52.45 102.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.329 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 137.41 -12.78 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.399 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.476 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.3 mp -113.32 -175.5 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.205 0.502 . . . . 0.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.0 m-20 -106.33 146.24 30.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.455 0.645 . . . . 0.0 112.251 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.476 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -128.72 160.56 32.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.549 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.7 OUTLIER -108.35 120.85 60.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.63 0.729 . . . . 0.0 112.375 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.526 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 79.7 m95 -104.95 127.8 52.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.563 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -90.55 117.4 29.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.094 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 12.3 m -102.3 127.78 49.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -108.84 125.98 52.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 14.3 p -121.25 2.01 10.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.211 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.81 161.07 50.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.05 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.6 m -91.61 -19.86 22.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.633 0.254 . . . . 0.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 656' ' ' VAL . 47.7 m-20 -82.72 2.88 31.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.659 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.46 130.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.453 0.644 . . . . 0.0 112.278 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.422 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 86.5 p -100.98 166.34 10.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.136 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.42 120.76 26.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.755 0.312 . . . . 0.0 111.573 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.415 HD12 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.55 99.75 11.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.362 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 61.57 -80.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.687 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.18 -3.61 3.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.711 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.478 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.7 m-80 -97.0 142.01 29.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.381 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.406 ' O ' HG22 ' A' ' 716' ' ' VAL . 16.8 ttm105 -82.25 141.62 32.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.216 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.484 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.83 97.95 5.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.423 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 43.8 pt -88.5 156.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.3 tt0 -47.34 108.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.4 35.77 3.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.356 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 4.3 p -120.01 162.31 19.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.161 0.505 . . . . 0.0 111.964 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.0 ttpt -133.2 148.31 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.229 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.484 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 2.5 t80 -147.28 144.83 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.526 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 132.46 46.2 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.719 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.415 ' CB ' ' CD1' ' A' ' 647' ' ' ILE . 0.9 OUTLIER -110.37 122.22 47.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.577 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.7 OUTLIER -115.11 138.78 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.315 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 706' ' ' GLY . 19.2 t0 -39.04 123.33 1.31 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 37.45 8.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.21 115.13 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.81 108.58 20.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.0 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.415 HG12 HD12 ' A' ' 659' ' ' LEU . 7.8 mt -109.0 136.54 44.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.91 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -96.77 115.44 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.656 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.467 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.5 OUTLIER -80.08 -40.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.984 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 618' ' ' LEU . 2.4 mt -155.4 131.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.001 0.429 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.413 ' CG ' HG23 ' A' ' 689' ' ' VAL . 6.5 t90 -136.12 128.23 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 687' ' ' LYS . 20.4 t0 -122.15 116.78 24.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.403 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -46.41 72.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.868 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -60.51 -40.63 92.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.256 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.31 -20.25 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.65 0.262 . . . . 0.0 111.567 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.9 OUTLIER 72.69 1.94 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.425 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.68 105.37 7.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.413 HG23 ' CG ' ' A' ' 682' ' ' TRP . 2.4 p -114.71 134.13 58.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.465 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 690' ' ' ILE . 34.7 mt -119.82 120.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.95 141.07 9.93 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.856 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.449 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 9.1 m-30 -113.62 142.23 46.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.2 116.96 34.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.229 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 580' ' ' LEU . 3.0 t -79.9 125.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.8 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 109.45 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.655 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.444 HG23 HD12 ' A' ' 696' ' ' ILE . 57.3 mt -83.89 105.76 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.67 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.91 -43.55 12.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.318 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -109.9 141.55 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.337 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.9 p -113.53 100.02 8.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.405 0.621 . . . . 0.0 110.142 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.9 m -82.63 60.68 5.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 73.95 49.07 14.21 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.859 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.466 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -83.63 127.42 33.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.484 ' CD2' ' HB3' ' A' ' 704' ' ' ASN . 4.2 p90 -35.77 -48.14 0.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.254 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.95 8.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.373 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.9 pt-20 88.68 -42.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.316 0.579 . . . . 0.0 110.085 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 121.38 26.37 2.02 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.354 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.94 25.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 56.95 88.83 0.01 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.14 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 19.8 mtm -49.03 94.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.666 0.27 . . . . 0.0 111.677 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 34.61 88.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 54.85 58.16 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.6 141.07 58.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.938 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.56 135.21 35.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.259 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -156.22 120.8 4.58 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 110.564 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.04 162.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.055 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.425 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 9.6 t -77.47 116.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.952 0.406 . . . . 0.0 111.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.99 172.22 8.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 155.52 17.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -92.34 150.98 20.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -126.16 -175.57 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.94 68.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.52 -53.34 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.438 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 720' ' ' THR . 1.8 pp20? -70.81 -41.3 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.851 0.358 . . . . 0.0 110.586 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.533 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -67.61 -38.37 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.702 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.01 -44.22 78.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -78.54 -24.04 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -59.07 -37.79 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.06 -15.93 57.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 602' ' ' PHE . 10.0 tt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.05 149.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.51 117.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -175.59 157.88 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 36.7 mt -132.04 123.34 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.891 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -71.3 -22.38 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.067 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -163.0 35.49 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.433 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.402 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -96.58 109.95 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 110.443 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 1.5 t80 -95.11 -58.29 2.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.735 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 7.9 tp -106.84 142.87 35.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 0.0 111.624 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 40.6 m -117.68 113.85 22.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.431 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.62 109.34 21.27 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 37.5 pttt -117.09 99.34 52.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 28.0 Cg_exo -45.8 99.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.918 1.746 . . . . 0.0 109.825 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 157.47 85.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.4 Cg_exo -49.9 -25.7 12.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 112.948 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -28.24 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 0.4 OUTLIER -95.89 153.97 17.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.976 178.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 690' ' ' ILE . 16.7 pt -52.38 -15.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.669 0.271 . . . . 0.0 111.365 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 43.8 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 111.685 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 1.0 OUTLIER -125.71 55.25 1.45 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.3 mt-10 -124.72 170.24 11.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.052 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.49 121.06 25.09 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.43 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.8 OUTLIER -112.68 148.21 35.15 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.402 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 119.58 29.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.663 0.268 . . . . 0.0 111.697 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.532 HG12 ' CD2' ' A' ' 601' ' ' PHE . 47.1 mt -74.05 109.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.39 111.85 3.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.023 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.467 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -43.37 -36.49 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.469 0.652 . . . . 0.0 109.942 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -61.47 -23.85 63.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.233 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.4 t -101.14 118.86 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 117.516 0.658 . . . . 0.0 111.511 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.0 t30 -139.22 122.18 10.59 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.5 Cg_endo -89.6 160.24 36.24 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 124.413 -1.078 . . . . 0.0 111.674 -0.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -90.75 116.72 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.555 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 56.1 m-85 -92.45 138.01 31.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.49 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.8 mp -125.05 145.7 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.435 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.37 -174.98 41.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.566 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.4 ttp85 -80.64 -11.51 59.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.645 0.259 . . . . 0.0 111.315 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 132.23 42.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.13 -26.35 11.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -30.78 27.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.035 0.445 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 63.7 m -77.2 128.8 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -45.24 -34.72 2.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 39.8 t -101.88 138.67 38.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.059 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 113.73 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.334 0.588 . . . . 0.0 112.549 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.43 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 26.9 mm -137.6 109.86 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.658 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 pm0 -87.79 103.99 16.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.23 110.23 10.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.964 178.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -40.64 -36.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 688' ' ' PHE . 2.0 mmt180 -77.64 -36.58 51.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.71 159.38 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 52.7 p -108.77 166.04 11.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.31 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -47.46 25.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 18.2 t -121.24 61.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.426 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 653' ' ' GLY . 24.4 t60 -50.08 -48.42 53.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.732 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -167.28 156.17 10.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.177 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 28.8 p90 -143.62 149.54 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.101 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 71.4 mt -101.79 134.09 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -124.7 132.99 53.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.627 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.41 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 9.1 ttmt -97.89 137.06 37.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.574 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.94 158.89 43.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.522 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.7 112.89 13.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.386 0.612 . . . . 0.0 110.41 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 -83.74 132.45 34.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.91 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . 0.403 ' CB ' ' NH1' ' A' ' 629' ' ' ARG . . . -155.46 120.35 4.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 9.8 m -60.2 157.96 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.71 97.58 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -171.74 112.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.79 92.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.8 mtm -107.62 118.04 35.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 70.11 -64.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.98 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -76.1 144.38 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.2 m -103.32 100.59 18.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.13 -159.11 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.705 2.27 . . . . 0.0 112.107 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 644' ' ' LEU . . . -81.63 4.73 20.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.759 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.26 -78.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.657 0.265 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -163.86 89.93 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 702' ' ' LEU . 4.4 mt -116.89 -153.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.22 147.27 43.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.32 148.81 51.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.606 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.453 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.1 pt -102.28 122.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.556 ' CH2' HD21 ' A' ' 671' ' ' LEU . 88.0 m95 -102.8 138.64 39.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.241 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.428 ' CE1' HD13 ' A' ' 678' ' ' ILE . 18.0 t80 -100.04 117.43 34.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 624' ' ' PHE . 6.5 m -105.65 133.84 49.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.495 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.408 ' CE1' ' N ' ' A' ' 657' ' ' SER . 44.1 t60 -115.58 125.72 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.454 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 15.6 p -123.18 7.97 9.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.68 151.62 29.44 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.033 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 7.5 m -80.16 -17.3 52.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.0 m-20 -83.72 2.69 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.94 128.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.43 0.633 . . . . 0.0 112.2 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.408 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 9.0 t -97.76 166.68 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -131.91 120.22 22.22 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.402 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.418 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -95.03 100.58 12.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.14 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.44 0.44 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.435 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.423 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 7.6 m-80 -100.6 141.51 33.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -82.43 141.12 33.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -122.69 98.08 5.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.77 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 652' ' ' THR . 29.1 tt0 -46.76 106.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.88 35.97 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.296 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -125.72 162.19 25.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 111.879 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.1 ttpm? -133.6 148.47 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.224 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.426 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 2.6 t80 -147.69 145.87 29.06 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.556 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.52 133.79 49.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.869 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -110.33 109.2 19.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.196 0.522 . . . . 0.0 111.339 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 46.1 mt-30 -97.94 153.95 18.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.333 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.439 ' N ' HD12 ' A' ' 696' ' ' ILE . 44.6 t0 -53.31 115.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.829 0.347 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.28 37.48 5.62 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -90.42 116.15 28.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.951 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -95.88 108.08 20.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.428 HD13 ' CE1' ' A' ' 649' ' ' TYR . 29.7 pt -109.29 133.67 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.088 0.47 . . . . 0.0 112.016 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 29.4 mttt -96.91 115.19 27.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.434 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.514 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 4.8 mt -75.81 -39.81 38.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.944 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.439 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 5.3 tt -155.7 133.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.714 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.416 ' CG ' HG22 ' A' ' 689' ' ' VAL . 8.4 t90 -136.04 125.98 25.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -118.77 116.93 27.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -67.49 -46.55 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.988 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -69.71 -40.51 76.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.945 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.9 t-20 -86.32 -20.27 28.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.68 0.276 . . . . 0.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt 68.38 4.82 4.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.34 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.1 OUTLIER -82.24 105.2 13.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 682' ' ' TRP . 2.2 p -114.33 137.0 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.097 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.437 ' CD1' HG12 ' A' ' 587' ' ' ILE . 2.5 mm -115.27 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.032 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.473 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.23 130.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.231 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.4 m-30 -113.09 146.16 39.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.548 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.03 116.82 33.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.906 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.456 HG13 ' CD1' ' A' ' 578' ' ' LEU . 2.5 t -82.86 123.59 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.45 108.74 8.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.034 0.445 . . . . 0.0 110.987 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 674' ' ' ASP . 25.1 mt -73.58 105.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.789 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -90.05 -46.04 8.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 6.1 t70 -111.28 141.03 45.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.171 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.94 101.67 9.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.8 m -68.02 62.41 0.08 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.66 51.39 48.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -117.29 174.05 6.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.973 0.415 . . . . 0.0 111.561 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.767 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -65.67 118.4 9.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.657 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 3.9 t30 51.39 -71.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.367 0.603 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 703' ' ' PHE . 21.1 pt-20 163.02 -43.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.577 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 166.58 82.43 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.285 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.429 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -105.17 -9.48 17.71 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.606 -0.349 . . . . 0.0 111.467 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.64 -110.65 3.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.533 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.449 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 5.8 tmm? 59.01 120.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.56 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 176.86 157.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.774 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -49.96 -56.74 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.34 140.53 36.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -82.38 100.13 9.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.94 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 41.83 81.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.648 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.6 m -124.79 150.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 29.5 t -84.53 117.48 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.3 mp -90.2 161.43 15.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 148.3 25.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 160.17 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 26.7 p -119.3 -173.25 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.68 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.7 -45.5 93.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 7.7 tm-20 -67.62 -50.24 59.06 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -54.61 -32.52 58.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.661 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.38 -36.85 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.27 -44.61 79.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.97 -17.42 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.07 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -35.22 79.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.871 0.367 . . . . 0.0 110.75 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -96.79 23.98 6.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.442 HD12 ' CG ' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.76 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.9 0.381 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.43 103.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.1 pt -124.2 81.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -179.33 132.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.25 179.7 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.011 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.92 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -85.1 -8.97 58.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.587 0.232 . . . . 0.0 111.337 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.7 57.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.653 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -98.29 108.38 21.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 1.6 t80 -90.84 -46.79 8.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 7.2 tp -122.49 142.22 50.81 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.967 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 17.8 m -120.06 115.7 24.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.641 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 592' ' ' LEU . 9.9 mt -102.05 107.85 19.09 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 17.9 mtpp -113.33 98.97 48.09 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -48.45 96.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.636 1.557 . . . . 0.0 109.434 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 581' ' ' LYS . 0.3 OUTLIER -74.76 157.64 85.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.418 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 77.9 Cg_exo -49.72 -27.83 16.08 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.338 2.692 . . . . 0.0 112.43 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -62.48 -26.37 68.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.41 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 9.3 t -95.47 153.74 17.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.935 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 10.4 tt -53.27 -14.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.456 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 582' ' ' PRO . 45.0 mt -111.47 133.51 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 111.876 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -114.85 51.81 0.88 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.605 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.7 mt-10 -123.94 171.75 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.795 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.09 132.7 50.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.11 0.481 . . . . 0.0 111.394 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.4 OUTLIER -112.62 142.48 45.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.01 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -123.75 111.68 16.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.526 HG12 ' CD2' ' A' ' 601' ' ' PHE . 66.8 mt -80.71 108.81 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.019 0.437 . . . . 0.0 110.044 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.0 117.67 9.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.69 -33.4 2.94 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.38 0.609 . . . . 0.0 110.016 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.485 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.17 -20.99 73.58 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.371 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.72 118.37 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 117.691 0.746 . . . . 0.0 111.396 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.3 t30 -139.97 121.49 9.62 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.032 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.54 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.2 Cg_endo -90.63 160.79 31.44 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.699 -0.959 . . . . 0.0 111.459 -0.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.6 t80 -91.85 115.07 27.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 10.8 m-85 -92.25 138.49 31.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.621 . . . . 0.0 112.588 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 1.9 mp -123.31 140.51 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.109 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 171.74 -174.81 45.23 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.418 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.7 ttp85 -83.71 -5.71 59.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.251 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.33 129.75 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.79 0.328 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.83 -26.99 6.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.121 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.97 -29.06 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 90.2 m -76.73 133.39 39.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.2 m-80 -49.09 -28.49 4.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 21.0 t -109.59 138.67 45.61 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 111.72 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.452 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 26.0 mm -137.91 109.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.65 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.5 mt-10 -88.81 104.45 16.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.976 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.443 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -130.82 113.27 13.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.081 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -43.39 -36.13 1.82 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.735 0.302 . . . . 0.0 111.62 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.403 ' HB3' HD12 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -77.71 -33.09 53.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.158 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.472 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -64.18 159.35 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 167.37 10.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -55.96 6.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.054 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 62.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.559 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 37.4 t60 -48.83 -49.24 40.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.935 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.7 p -166.71 159.37 13.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.92 0.391 . . . . 0.0 111.212 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.431 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.7 p90 -144.0 146.97 33.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.434 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 82.6 mt -101.87 132.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.719 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.4 t80 -123.26 133.1 54.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 577' ' ' PHE . 2.4 tppp? -97.94 136.43 38.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.237 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.43 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 157.95 45.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.469 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.57 123.53 26.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.0 110.591 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.482 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 8.8 t60 -79.1 130.92 36.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -165.07 141.47 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 9.0 m -109.01 132.2 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -58.88 106.19 0.84 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.601 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 5.9 tttt 63.28 133.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.914 0.387 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.2 122.97 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 37.9 mmm -129.32 138.15 51.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 67.28 -73.78 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -75.85 141.19 42.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 36.5 t -97.23 120.72 60.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.05 -161.21 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.677 2.251 . . . . 0.0 111.973 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -86.38 12.24 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.761 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 63.23 -82.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.639 0.257 . . . . 0.0 110.926 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -167.46 74.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.88 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -103.82 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -123.33 147.77 46.68 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.199 0.523 . . . . 0.0 112.279 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -131.88 158.3 41.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.886 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.46 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 4.9 pt -110.28 123.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 111.924 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.505 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 80.8 m95 -108.75 128.66 55.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.399 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 11.3 t80 -91.31 117.41 29.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 8.2 m -102.57 138.15 39.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.283 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.484 ' CG ' ' HB2' ' A' ' 657' ' ' SER . 84.3 t60 -116.55 129.36 56.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.418 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 3.2 p -125.61 -2.58 7.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.532 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.74 138.26 21.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.091 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 86.1 m -72.13 -8.3 53.88 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -86.93 2.55 48.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 0.0 111.43 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.95 143.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.023 0.439 . . . . 0.0 111.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.484 ' HB2' ' CG ' ' A' ' 651' ' ' HIS . 0.7 OUTLIER -115.57 162.03 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.6 119.43 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.99 99.69 10.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.573 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.656 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.47 -1.73 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.549 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.403 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 17.9 m120 -96.25 141.52 29.5 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.904 0.383 . . . . 0.0 111.179 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -81.49 141.57 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.158 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.4 mmm -123.03 99.34 6.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.418 ' O ' ' OG1' ' A' ' 668' ' ' THR . 35.0 pt -87.88 154.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -47.43 103.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.347 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.82 39.92 2.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.584 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 2.3 p -128.44 153.31 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.47 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.93 145.19 49.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.087 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.416 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 4.8 t80 -140.14 145.77 37.97 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.505 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.29 131.87 46.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.756 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.426 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -107.75 120.57 42.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.138 0.494 . . . . 0.0 110.845 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 2.8 mt-30 -110.04 162.24 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.001 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.409 ' HB2' HD11 ' A' ' 696' ' ' ILE . 24.8 t0 -58.3 108.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.655 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.58 33.5 5.86 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.31 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -86.43 114.94 23.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.691 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -95.75 108.37 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 8.4 mt -108.82 134.44 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -109.01 117.77 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.072 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.559 ' HB ' ' CD2' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -90.32 -22.15 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 618' ' ' LEU . 55.9 mt -152.87 130.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.206 0.527 . . . . 0.0 111.448 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -137.68 129.12 28.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.05 117.32 25.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.0 110.616 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -67.12 -46.56 73.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.016 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.56 -40.47 23.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.735 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -14.33 58.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.442 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 64.51 14.77 9.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 0.6 OUTLIER -77.82 104.67 8.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.0 p -118.44 121.85 68.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.148 0.499 . . . . 0.0 112.059 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.429 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 4.3 mm -112.21 144.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -170.96 123.48 1.04 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.468 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.11 146.11 39.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.341 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -101.56 117.06 34.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 578' ' ' LEU . 2.4 t -81.78 124.12 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.017 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -133.12 108.72 9.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 35.7 mt -73.91 104.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.16 -47.52 8.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.801 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.46 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 12.4 t0 -111.14 139.35 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.633 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -115.7 100.66 8.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.107 0.479 . . . . 0.0 109.712 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.4 t -70.3 63.53 0.25 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.621 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.32 59.45 10.63 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.821 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 0.4 OUTLIER -98.8 148.18 24.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.776 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 2.6 p90 -47.41 -34.67 7.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.571 0.7 . . . . 0.0 109.751 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.46 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.0 t30 -151.5 -51.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.762 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.46 ' CG ' ' ND2' ' A' ' 704' ' ' ASN . 9.0 pt-20 160.46 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.146 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 145.58 34.35 0.07 OUTLIER Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.083 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 13.6 mt -87.22 7.95 26.14 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.459 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 81.28 -90.3 1.41 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.459 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.482 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.1 OUTLIER 59.46 99.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.88 0.371 . . . . 0.0 110.429 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.02 -177.88 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -55.31 -51.83 65.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.47 139.99 42.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.0 100.95 10.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 47.1 76.26 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.412 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.72 143.38 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.524 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 30.8 t -77.68 128.37 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.115 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.41 167.9 10.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -103.03 154.75 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.58 155.8 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.12 -176.22 3.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.64 -31.04 63.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -64.76 -44.85 88.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.22 -51.07 57.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -55.41 -32.69 62.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -36.82 82.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.4 -44.26 92.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.936 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -74.55 -26.58 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -34.03 66.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -97.86 33.1 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.422 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.81 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.861 0.362 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -170.2 135.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' P' ' 830' ' ' TYR . 23.5 pt -71.76 177.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' P' ' 828' ' ' ILE . 0.2 OUTLIER -176.19 142.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 55.7 mt -141.16 71.76 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.786 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.5 p30 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.872 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -106.09 -11.37 16.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.521 0.201 . . . . 0.0 111.425 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.508 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -138.37 -56.72 0.05 OUTLIER Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.996 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.5 tmm_? -112.65 143.75 43.31 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.516 -0.403 . . . . 0.0 111.415 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -123.59 -58.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.9 tt -112.48 140.86 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.393 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 38.0 m -113.1 122.0 46.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.269 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 592' ' ' LEU . 7.4 mt -107.83 108.96 20.38 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.1 pttp -119.53 98.46 50.07 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -45.22 103.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.739 1.626 . . . . 0.0 108.918 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.94 160.47 81.76 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.567 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 82.0 Cg_exo -47.05 -30.21 9.76 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.715 2.943 . . . . 0.0 113.012 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.47 -17.82 63.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 109.677 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.558 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 38.7 t -95.22 149.22 21.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.936 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -55.73 -22.79 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 178.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.453 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 1.9 tt -113.34 122.22 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.567 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -108.14 69.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 0.0 110.835 -179.246 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.769 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 34.5 mt-10 -127.93 170.97 12.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.173 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 35.8 t -131.23 116.43 17.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 112.028 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 592' ' ' LEU . 0.0 OUTLIER -103.91 139.73 38.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 5.1 mt-10 -118.02 131.35 56.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 601' ' ' PHE . 89.9 mt -82.48 108.66 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.7 OUTLIER -65.5 120.99 13.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.72 -28.8 1.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.842 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.32 -18.71 79.91 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.084 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.02 117.92 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.142 0.971 . . . . 0.0 111.768 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.45 122.6 9.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.514 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.9 Cg_endo -90.25 159.85 32.88 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.5 -1.041 . . . . 0.0 111.519 -0.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.4 t80 -92.04 116.36 28.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.484 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 27.0 m-85 -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.695 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.5 mp -128.31 147.43 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.56 -157.55 30.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.417 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.1 OUTLIER -87.61 -35.85 17.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.733 0.301 . . . . 0.0 111.506 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -74.99 137.65 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.323 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -20.64 58.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.987 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -55.02 -31.53 61.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.5 m -73.22 132.08 42.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m120 -47.0 -29.71 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 110.542 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.539 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 41.5 t -109.29 137.52 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.64 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 110.84 20.68 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.518 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 3.4 mm -138.3 110.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.176 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.2 mt-10 -85.99 104.92 16.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.448 0.642 . . . . 0.0 111.67 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.503 ' O ' HD21 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -130.67 108.18 9.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.287 177.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -48.08 -34.9 10.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -78.05 -35.38 49.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.63 131.37 34.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.432 -178.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 8.5 t -57.24 166.33 1.17 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.49 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 1.0 OUTLIER -57.22 -34.92 69.06 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.295 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.96 58.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.949 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.547 ' O ' ' N ' ' A' ' 653' ' ' GLY . 13.9 t60 -49.89 -49.43 49.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.02 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 13.2 p -164.17 161.53 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 111.589 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.484 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 53.9 p90 -143.53 147.85 35.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.589 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.437 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.93 130.68 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.514 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -122.54 134.17 54.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.773 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 647' ' ' ILE . 5.2 ttmt -98.19 136.44 38.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.204 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.81 159.01 41.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.894 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.4 ' CZ ' ' HA2' ' A' ' 643' ' ' GLY . 3.7 tpt85 -76.59 112.15 12.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.3 t60 -76.49 133.21 39.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.243 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -147.81 119.11 7.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.134 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.38 179.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -127.26 54.73 0.76 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.553 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 97.95 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.7 p -146.76 54.82 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 25.4 mtm -60.57 117.64 5.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.754 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.97 -69.51 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.796 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.66 144.24 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.5 m -111.54 98.41 40.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.18 -154.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.883 2.389 . . . . 0.0 112.096 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 644' ' ' LEU . . . -86.17 68.9 10.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.48 23.65 11.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.4 ' HA2' ' CZ ' ' A' ' 629' ' ' ARG . . . -154.96 27.16 0.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.736 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.5 mp -111.78 -162.43 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 m-20 -108.08 147.06 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 112.412 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.75 159.53 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.518 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 627' ' ' LYS . 5.3 pt -111.49 122.37 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.451 0.643 . . . . 0.0 112.249 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.494 ' CH2' HD23 ' A' ' 671' ' ' LEU . 66.7 m95 -108.85 136.19 48.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.085 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.432 ' CD1' HD11 ' A' ' 678' ' ' ILE . 22.7 t80 -94.08 117.77 30.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.27 124.91 49.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.468 ' CE1' ' N ' ' A' ' 657' ' ' SER . 72.0 t60 -101.94 134.38 45.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.148 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.0 p -133.55 4.01 3.61 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.982 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.35 137.69 18.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.394 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 45.0 m -70.37 -11.94 61.25 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.755 -0.262 . . . . 0.0 111.393 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 656' ' ' VAL . 4.6 m-20 -87.39 3.46 46.95 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.459 ' HA ' ' NE2' ' A' ' 651' ' ' HIS . 0.2 OUTLIER 53.56 128.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.283 0.564 . . . . 0.0 112.117 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.468 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 30.5 m -101.47 166.02 10.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.406 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.9 m-85 -130.68 120.19 23.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.333 . . . . 0.0 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -101.03 99.91 10.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 60.4 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.924 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -134.17 1.0 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.73 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.6 m-80 -104.69 132.92 50.36 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 111.077 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.9 139.96 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 41.1 mmm -118.26 97.43 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.3 pt -87.85 154.49 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.73 104.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 111.478 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.08 38.59 2.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.1 p -116.26 162.29 17.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.546 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -137.53 139.52 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 662' ' ' ASN . 0.5 OUTLIER -147.4 145.78 29.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.829 0.347 . . . . 0.0 111.779 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.494 HD23 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.65 137.83 55.89 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.5 mt -110.54 99.39 8.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 0.0 111.614 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 17.4 mp0 -80.45 147.32 30.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.473 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 706' ' ' GLY . 13.5 p30 -48.17 112.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.305 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 94.53 36.0 5.76 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.3 117.15 28.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.891 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 109.54 21.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.432 HD11 ' CD1' ' A' ' 649' ' ' TYR . 21.6 pt -105.31 130.44 56.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 112.066 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.43 116.63 29.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.446 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.506 HG22 ' CD2' ' A' ' 622' ' ' HIS . 9.0 mt -89.87 -34.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.295 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 689' ' ' VAL . 0.1 OUTLIER -154.93 131.53 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.803 -179.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -136.96 127.54 26.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.07 116.84 28.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 110.325 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -67.36 -46.91 71.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -83.49 -40.49 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.84 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.4 -16.55 45.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.582 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.9 mttt 64.67 14.32 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.679 0.276 . . . . 0.0 110.91 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' A' ' 587' ' ' ILE . 11.3 t80 -78.36 105.23 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 0.9 OUTLIER -124.88 128.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.912 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.497 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 0.5 OUTLIER -128.58 119.77 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.737 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -151.33 139.9 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.314 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.518 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.18 149.03 36.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.786 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.01 117.22 34.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.485 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.417 HG21 ' HG ' ' A' ' 580' ' ' LEU . 2.1 t -75.07 123.11 30.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.693 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.8 mt-10 -130.32 109.39 10.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 0.0 110.731 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.425 HD12 ' CA ' ' A' ' 674' ' ' ASP . 11.2 mt -83.67 109.83 17.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.714 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -96.11 -46.51 6.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.946 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.35 140.31 46.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.54 101.44 9.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.0 t -69.23 61.47 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.179 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 55.28 45.95 81.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.806 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 0.4 OUTLIER -106.49 151.19 25.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.579 0.228 . . . . 0.0 110.769 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -45.22 128.71 7.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.47 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.637 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 5.6 t30 43.33 -79.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.49 . . . . 0.0 111.031 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.681 ' N ' ' O ' ' A' ' 703' ' ' PHE . 13.3 pt-20 164.77 -48.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.637 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 159.04 73.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.997 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.16 -3.02 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.225 -0.574 . . . . 0.0 111.793 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.432 ' N ' ' CG ' ' A' ' 673' ' ' GLN . . . 58.36 77.5 0.17 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 709' ' ' MET . 0.0 OUTLIER -136.55 132.05 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.182 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 712' ' ' GLU . 1.4 pt? 178.02 -174.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.81 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 5.9 mt-10 -97.63 134.45 40.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.86 100.14 10.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.956 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 2.9 mmm-85 40.37 86.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.905 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.41 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 4.0 m -124.75 142.44 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 13.9 p -93.3 125.04 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.257 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.74 172.29 8.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -102.48 157.88 16.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.6 156.41 18.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -126.1 -177.03 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.27 38.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.02 -50.93 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.549 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -65.44 -46.03 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -55.5 -32.95 63.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.55 -36.87 79.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 18.4 mt -59.08 -44.85 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.3 p -81.41 -16.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -32.66 74.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.74 -7.93 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.199 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.428 HD11 ' CG ' ' A' ' 602' ' ' PHE . 5.0 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.874 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.331 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.99 109.77 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . 0.418 HG21 ' CE2' ' P' ' 830' ' ' TYR . 6.6 mt -128.39 139.1 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.941 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' P' ' 828' ' ' ILE . 0.3 OUTLIER -170.53 151.69 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.808 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 59.1 mt -147.46 144.13 28.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -95.5 -21.77 18.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 130.69 -37.28 2.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.5 tmm_? -112.95 143.85 43.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.625 0.25 . . . . 0.0 111.031 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.506 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.35 -62.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.6 tt -106.38 142.34 36.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 12.5 m -123.62 114.47 20.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.559 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -103.89 108.21 19.43 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.26 100.65 52.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.6 Cg_exo -46.98 99.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.879 1.72 . . . . 0.0 109.722 176.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 158.33 84.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.68 -25.32 11.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.642 2.894 . . . . 0.0 112.612 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.01 -28.03 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 7.5 t -95.38 154.1 17.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.645 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.466 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.0 pt -56.2 -12.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.074 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.92 123.33 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 111.783 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.24 54.75 0.65 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.163 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.614 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.2 mm-40 -124.36 171.39 9.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.094 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.74 129.59 47.34 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.011 0.434 . . . . 0.0 111.262 179.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.35 140.77 46.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -124.24 116.87 23.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.73 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.493 HG12 ' CD2' ' A' ' 601' ' ' PHE . 89.5 mt -80.51 108.96 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.178 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.3 OUTLIER -64.57 120.48 12.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.085 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.62 -28.13 1.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 110.823 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -21.25 79.7 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.867 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.0 118.07 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 118.015 0.908 . . . . 0.0 111.854 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.22 121.99 9.62 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.766 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.7 159.78 35.53 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 124.465 -1.056 . . . . 0.0 111.599 -0.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.0 t80 -91.37 115.87 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.5 m-85 -92.26 138.11 31.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.891 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.525 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.9 mp -127.27 146.05 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.553 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.03 -175.37 40.94 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.543 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.461 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.5 ttp85 -77.51 -6.79 54.83 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.741 -0.229 . . . . 0.0 111.456 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.0 129.36 45.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.847 0.355 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.37 -23.54 24.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . 0.415 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.4 OUTLIER -56.41 -29.76 61.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.602 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 8.9 m -74.73 134.43 41.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.765 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m-80 -49.07 -26.79 2.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.702 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.525 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 46.7 t -112.85 142.87 45.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.532 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 115.05 23.9 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 28.5 mm -137.96 109.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.026 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.6 tt0 -89.01 103.85 16.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.798 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -131.79 113.43 13.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.252 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -43.03 -35.67 1.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.771 0.319 . . . . 0.0 111.514 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 681' ' ' ILE . 2.1 mpp_? -77.95 -36.31 49.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.488 HD13 ' CG2' ' A' ' 680' ' ' ILE . 0.3 OUTLIER -61.58 159.8 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.2 m -109.16 170.13 8.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -49.14 -45.48 43.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.27 0.557 . . . . 0.0 110.201 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 652' ' ' THR . 13.4 t -124.89 57.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.464 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 680' ' ' ILE . 27.7 t60 -43.85 -47.48 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.747 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 5.9 p -166.76 156.34 11.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.445 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.473 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 29.6 p90 -143.18 147.45 34.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.19 130.24 52.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.114 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.3 t80 -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 23.0 ttmt -97.71 136.78 37.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.536 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.68 159.72 39.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.445 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -75.82 115.95 16.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.9 t60 -82.42 126.0 31.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.75 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -164.48 122.54 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.172 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.5 m -70.06 -178.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.07 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -65.51 -61.02 6.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -132.87 -173.52 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.375 . . . . 0.0 110.964 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.94 52.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.1 ttm -99.6 31.56 3.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -165.26 -50.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 43.4 mt-10 -90.29 144.75 25.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.626 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 17.4 t -107.07 92.36 7.67 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 76.4 Cg_endo -85.55 -160.07 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.778 2.318 . . . . 0.0 111.965 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -95.3 26.71 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.257 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 60.86 -169.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.408 ' HA3' ' NE ' ' A' ' 629' ' ' ARG . . . -86.27 91.13 1.7 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.733 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.3 -153.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 3.9 m-20 -122.4 146.57 47.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.308 0.575 . . . . 0.0 112.471 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -126.74 160.14 31.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.423 HG21 ' CE2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -108.94 123.89 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.442 0.639 . . . . 0.0 112.463 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.519 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 90.0 m95 -106.19 125.68 51.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 678' ' ' ILE . 12.0 t80 -90.63 117.53 29.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -102.53 139.24 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.236 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.498 ' CG ' ' OG ' ' A' ' 657' ' ' SER . 46.7 t60 -125.68 121.56 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.571 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 621' ' ' VAL . 0.6 OUTLIER -116.47 5.69 13.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.747 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.03 137.33 20.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.799 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 95.6 m -72.64 -10.61 60.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.405 ' OD1' ' HG ' ' P' ' 831' ' ' LEU . 63.8 m-20 -87.26 2.06 51.26 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 665' ' ' ILE . 11.6 t 64.31 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.524 . . . . 0.0 112.076 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.498 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 5.3 p -120.76 160.72 22.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 4.8 m-85 -137.48 120.07 16.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.278 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -94.46 105.19 17.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.01 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.44 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.579 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -134.99 0.42 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.698 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -97.77 141.21 31.05 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 658' ' ' TYR . 6.0 ttp180 -88.94 139.08 30.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.441 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -135.83 110.97 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.205 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.412 ' HA ' HG13 ' A' ' 656' ' ' VAL . 18.8 pt -89.78 162.98 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.947 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -46.78 115.56 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.576 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.81 8.45 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.97 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.3 p -112.76 161.74 16.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 111.583 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -135.6 149.18 49.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.422 ' HB3' HD21 ' A' ' 659' ' ' LEU . 2.8 t80 -147.75 146.09 29.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.519 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.74 132.4 46.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.283 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.44 111.82 23.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.311 0.577 . . . . 0.0 111.421 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.8 mt-30 -104.83 136.01 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.559 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 706' ' ' GLY . 12.3 t70 -37.0 118.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 111.022 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 89.26 36.52 7.52 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.85 118.13 31.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -96.0 109.08 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 649' ' ' TYR . 4.6 mt -105.65 130.03 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 112.004 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.63 116.15 27.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.418 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.488 ' CG2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -83.8 -37.28 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.425 HD11 ' CE1' ' A' ' 622' ' ' HIS . 54.1 mt -154.92 131.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -136.49 127.17 27.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.74 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 116.76 24.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.374 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -67.23 -46.8 72.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.798 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.17 -40.47 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.835 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.61 -14.5 59.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.443 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 64.94 14.07 9.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.634 0.254 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -78.4 104.46 9.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.87 123.64 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.069 0.461 . . . . 0.0 111.74 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.466 ' CD1' HG12 ' A' ' 587' ' ' ILE . 38.9 mm -125.4 153.11 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 175.84 128.61 1.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.121 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 8.5 m-30 -112.82 144.49 42.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.268 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -101.11 117.33 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.574 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.406 ' CG2' ' HG ' ' A' ' 580' ' ' LEU . 2.8 t -79.51 125.25 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -133.16 109.23 9.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 50.1 mt -79.67 105.77 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.665 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -86.83 -43.96 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.15 141.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -113.62 100.09 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.404 0.621 . . . . 0.0 109.899 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 28.7 m -80.93 65.57 6.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 71.3 46.56 41.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.923 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 131.77 34.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.498 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 5.6 p90 -41.8 -34.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.457 0.646 . . . . 0.0 110.266 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -146.64 -61.09 0.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.392 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 7.6 pt-20 144.97 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.949 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 73.54 70.47 1.23 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.868 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.553 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.6 OUTLIER -106.5 -9.65 16.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.393 -0.474 . . . . 0.0 111.033 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 105.54 -120.8 6.58 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.924 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 61.23 120.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 111.255 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 178.25 164.24 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.66 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -55.72 -68.14 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -70.91 140.58 51.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.2 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -82.02 100.01 9.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.407 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 10.3 mmm-85 40.26 84.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.676 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.54 142.96 39.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.66 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.88 122.27 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.69 161.58 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 136.77 42.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.612 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.31 150.16 24.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 p -110.54 -174.65 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -30.31 43.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -50.23 74.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -45.17 76.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.352 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -57.68 -32.93 67.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.598 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -66.73 -36.82 83.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.595 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.68 -44.25 85.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.8 p -76.16 -14.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.81 -39.4 76.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.564 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -93.79 11.24 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 602' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.659 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -138.24 132.23 31.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 42.1 mt 65.44 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.98 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 0.0 OUTLIER -179.98 79.84 0.01 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.412 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . 0.405 ' HG ' ' OD1' ' A' ' 655' ' ' ASN . 14.5 mt -71.03 132.98 45.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.724 0.297 . . . . 0.0 110.699 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.946 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -83.94 -22.15 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.691 0.281 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 141.29 -42.4 1.17 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.513 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.404 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 8.4 ttm105 -113.61 143.39 44.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.26 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.2 OUTLIER -118.51 -57.89 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.331 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.434 ' CD1' HG12 ' A' ' 694' ' ' VAL . 5.1 tp -113.09 142.08 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.4 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.418 HG21 ' CG ' ' A' ' 581' ' ' LYS . 2.8 m -120.04 114.76 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.031 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 692' ' ' PHE . 5.8 mt -102.0 108.36 19.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 27.4 mtmt -114.16 99.27 50.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 34.7 Cg_exo -47.81 98.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.655 1.57 . . . . 0.0 109.463 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.36 158.1 84.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.79 -26.53 13.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.427 2.752 . . . . 0.0 112.573 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' A' ' 583' ' ' LEU . 2.8 m-20 -62.76 -28.12 69.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 93.2 p -95.69 153.21 17.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.839 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.44 ' CG2' ' CD1' ' A' ' 690' ' ' ILE . 7.9 tt -53.15 -15.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.322 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 613' ' ' ILE . 71.2 mt -109.03 131.7 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.936 0.398 . . . . 0.0 111.795 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -116.93 54.62 0.86 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.254 0.549 . . . . 0.0 110.65 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.662 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.6 mt-10 -124.11 172.07 9.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.683 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.69 128.39 45.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.177 0.513 . . . . 0.0 111.221 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.41 139.74 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.788 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.04 113.22 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.544 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.52 HG12 ' CD2' ' A' ' 601' ' ' PHE . 76.4 mt -77.29 109.21 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.1 OUTLIER -67.34 118.13 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.022 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -27.93 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.822 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -70.85 -20.63 77.75 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.186 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.68 118.32 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 117.552 0.676 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.4 t30 -139.9 121.8 9.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.5 Cg_endo -89.48 160.49 36.96 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.535 -1.027 . . . . 0.0 111.492 -0.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.6 t80 -91.09 115.42 28.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 26.0 m-85 -91.98 137.52 32.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.027 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -124.84 144.83 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.39 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.41 -173.7 38.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.298 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -68.11 -46.8 69.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.853 0.359 . . . . 0.0 111.431 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.454 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.72 129.23 40.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.37 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -58.06 -18.36 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.762 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.63 -30.64 67.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 110.249 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 94.8 m -69.95 131.55 44.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.598 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -43.99 -32.43 1.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.322 0.582 . . . . 0.0 110.453 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 41.5 t -109.46 142.17 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.196 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.3 105.0 13.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.478 HG13 ' CE2' ' A' ' 692' ' ' PHE . 38.3 mm -139.26 109.5 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.467 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.36 106.23 16.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 112.256 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 4.7 t0 -129.88 107.69 9.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.571 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -39.44 -28.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.412 ' CB ' HD13 ' A' ' 681' ' ' ILE . 9.2 mmt180 -70.82 -41.77 71.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -89.3 158.74 17.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.6 m -76.71 164.61 25.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.454 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -52.41 -27.07 14.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.01 62.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.541 ' CD2' HG21 ' A' ' 680' ' ' ILE . 26.1 t60 -50.03 -48.66 52.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.211 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.84 162.22 26.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.5 p90 -143.61 148.39 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.442 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 81.5 mt -102.12 124.3 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.046 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -113.87 133.55 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.73 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 28.6 ttmt -97.88 136.52 38.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.69 158.59 44.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.827 -178.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.13 115.97 17.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 -61.06 131.36 50.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.418 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -60.27 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.889 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 58.77 125.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 111.394 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -139.57 -87.54 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -62.79 116.18 5.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.11 162.68 27.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.769 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 115.55 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 50.2 t80 63.06 -80.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.54 126.24 30.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.85 0.357 . . . . 0.0 110.714 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.4 p -99.6 107.83 47.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.62 -149.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.542 2.161 . . . . 0.0 112.055 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.08 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 64.26 -176.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.033 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -90.32 72.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.104 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.4 mp -115.75 -157.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.3 m-20 -117.56 146.72 43.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.08 0.467 . . . . 0.0 111.96 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -133.03 157.16 45.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 1.1 pt -106.8 119.23 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.543 0.687 . . . . 0.0 111.769 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.538 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 72.9 m95 -100.61 132.13 46.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.417 ' CB ' HD23 ' A' ' 672' ' ' LEU . 31.2 t80 -90.36 117.24 28.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -103.5 121.67 43.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.559 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.419 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 28.9 t60 -102.23 128.74 48.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 7.4 p -125.11 2.43 7.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.423 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.05 150.21 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.108 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 72.3 m -82.21 -18.97 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 111.518 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 656' ' ' VAL . 15.0 m-20 -82.56 3.35 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.79 137.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.644 0.735 . . . . 0.0 112.238 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 58.2 m -107.93 165.91 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.423 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 120.59 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.482 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -105.65 100.34 9.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.846 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.76 -82.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.87 6.19 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.652 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -110.27 138.45 46.64 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -74.74 138.34 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 45.7 mmm -117.68 88.01 2.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.579 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.403 ' O ' ' OG1' ' A' ' 668' ' ' THR . 48.5 pt -86.91 164.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 22.6 tt0 -54.92 105.53 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.34 40.52 2.39 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 2.6 p -124.45 162.39 24.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.497 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 6.3 ttpm? -138.07 144.93 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.482 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.64 145.09 28.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.8 0.334 . . . . 0.0 111.758 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.538 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.7 136.61 53.16 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 647' ' ' ILE . 0.1 OUTLIER -107.1 112.84 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.541 . . . . 0.0 111.869 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 25.5 mt-30 -104.13 137.95 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.894 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 706' ' ' GLY . 39.7 t0 -39.11 123.11 1.31 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.936 0.398 . . . . 0.0 111.152 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 88.91 40.6 6.17 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 1.6 t0 -93.51 113.18 25.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.979 0.418 . . . . 0.0 111.434 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.34 111.38 23.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.865 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 9.2 mt -112.41 137.16 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -98.19 115.7 28.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.7 mt -82.8 -38.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.573 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 618' ' ' LEU . 6.7 mt -155.83 131.72 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.019 0.438 . . . . 0.0 111.873 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.24 124.75 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.669 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.18 117.88 29.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.642 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -66.36 -46.52 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.591 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -83.28 -40.36 19.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.351 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.06 -17.94 56.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.69 16.09 9.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.75 105.2 13.58 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 1.1 p -122.83 124.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.267 0.555 . . . . 0.0 112.147 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.44 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 6.6 mm -114.29 150.17 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.553 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.71 121.48 0.87 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.641 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.514 ' CB ' HD21 ' A' ' 580' ' ' LEU . 6.9 m-30 -113.78 143.18 45.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -101.78 117.81 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.6 t -79.69 123.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -133.67 108.99 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.287 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 578' ' ' LEU . 87.0 mt -72.93 105.76 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.76 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.75 -47.57 10.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.139 0.495 . . . . 0.0 109.949 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -111.49 141.91 44.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.6 p -113.63 100.09 8.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.141 0.496 . . . . 0.0 109.875 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -80.31 61.51 4.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.696 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.3 54.81 34.16 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.109 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -87.28 148.38 25.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.392 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -39.76 -32.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.989 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.454 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -178.95 33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.502 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER 69.28 -64.08 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 153.96 69.26 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -104.37 -9.52 18.42 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.794 -0.239 . . . . 0.0 111.446 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 103.46 60.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.263 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.81 136.12 6.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -161.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.082 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 78.46 -60.69 0.39 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.746 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.68 115.62 29.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.476 ' O ' ' C ' ' A' ' 714' ' ' ARG . 1.2 mt-30 -82.69 100.05 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 713' ' ' GLN . 1.1 mmm-85 16.02 82.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.869 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.8 m -123.98 141.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.181 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.29 122.43 41.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.484 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.5 172.26 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -103.16 142.22 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -88.98 160.13 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.905 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.14 -173.49 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.74 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.81 -49.19 77.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.467 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -69.18 -49.84 53.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.574 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -57.26 -32.81 66.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.735 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.81 -44.24 86.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.86 -24.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -57.26 -41.14 79.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -74.1 -15.4 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.274 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.432 HD11 ' CD1' ' A' ' 602' ' ' PHE . 7.9 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.04 175.73 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 16.1 pt -67.98 176.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -175.55 143.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 17.8 mt -131.96 151.76 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.919 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.666 -0.174 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -93.78 -22.33 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 111.12 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 152.66 -23.48 0.83 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 tmm_? -105.93 140.19 39.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -129.16 -61.15 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.585 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 6.4 tt -106.56 141.36 37.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.181 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 19.5 m -119.48 119.67 34.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.362 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 592' ' ' LEU . 9.1 mt -104.79 108.29 19.69 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 98.68 44.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.8 Cg_exo -48.98 101.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.649 1.566 . . . . 0.0 109.15 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.02 158.26 85.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.447 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.94 -28.64 19.05 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.55 2.834 . . . . 0.0 112.594 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.48 -18.14 63.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 109.725 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.7 t -96.8 153.76 17.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.679 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.446 HG12 ' CD1' ' A' ' 690' ' ' ILE . 1.7 pt -55.62 -20.29 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.409 ' CD1' ' CG2' ' A' ' 613' ' ' ILE . 59.5 mt -110.27 118.66 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.382 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -106.74 57.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.394 0.616 . . . . 0.0 110.258 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.636 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -124.71 172.63 9.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.892 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.43 127.68 45.81 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.315 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.8 OUTLIER -113.11 147.22 37.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.083 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 7.4 mt-10 -125.35 125.56 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 601' ' ' PHE . 68.2 mt -86.1 109.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.0 mp0 -64.18 118.06 8.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.41 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.54 -29.79 1.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.583 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.27 -22.63 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.48 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 118.93 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.773 0.787 . . . . 0.0 111.726 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -139.56 121.82 10.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.781 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.9 Cg_endo -89.6 160.28 36.28 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.563 -1.015 . . . . 0.0 111.691 -0.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.9 t80 -91.52 116.19 28.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 25.4 m-85 -92.36 137.94 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.15 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 2.7 mp -126.47 145.89 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.423 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.42 -176.28 41.66 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.481 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -78.52 -7.28 57.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.78 133.25 43.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -23.71 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -57.83 -25.4 60.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 55.2 m -78.75 132.06 36.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.4 m120 -46.1 -31.35 2.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.198 0.523 . . . . 0.0 110.413 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.523 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 40.5 t -108.53 142.76 38.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.6 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 115.59 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -138.02 109.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.284 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 19.2 tt0 -87.09 103.41 15.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.6 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.485 ' HB3' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -132.11 112.81 12.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.44 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -42.98 -33.69 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.761 0.315 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.55 -39.98 44.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.955 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 680' ' ' ILE . 0.8 OUTLIER -60.21 159.11 10.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.905 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 70.7 m -111.09 168.81 9.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.537 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -43.64 24.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.228 0.537 . . . . 0.0 110.031 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.17 61.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.467 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.499 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 36.3 t60 -49.78 -48.3 50.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.791 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -167.52 157.32 10.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 111.363 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.481 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.2 p90 -143.14 147.37 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.407 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 34.7 mt -102.13 128.33 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.086 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -119.78 131.3 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 20.2 ttmt -97.84 136.36 38.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.107 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.09 159.28 41.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.879 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.0 tpt180 -76.28 116.3 16.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.4 t60 -61.47 132.39 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.209 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -69.08 -165.61 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.941 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 6.9 p -156.39 159.61 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.42 . . . . 0.0 111.082 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -145.66 -139.44 3.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.432 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.69 135.46 57.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 25.1 p -129.16 49.28 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.989 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -62.42 102.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.11 -62.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.83 137.61 40.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.785 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 110.37 40.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 -162.94 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.391 2.06 . . . . 0.0 112.027 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -46.75 -28.55 1.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.563 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.4 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 175.73 60.32 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.8 mp -106.14 -159.71 0.71 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.1 m-20 -118.27 146.77 44.05 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.44 160.41 29.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.782 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.449 HG22 ' CE2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -109.65 121.98 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.46 0.647 . . . . 0.0 112.313 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.554 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 84.8 m95 -105.7 125.75 51.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 12.0 t80 -89.71 116.49 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 624' ' ' PHE . 16.3 m -102.95 137.13 41.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -116.87 122.97 45.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.35 7.92 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.272 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.78 145.18 19.94 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.832 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.4 m -75.29 -9.55 58.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 36.2 m-20 -87.14 2.09 50.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.59 127.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.395 0.617 . . . . 0.0 112.158 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 16.2 p -97.73 165.55 11.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.208 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -128.52 119.7 25.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.49 ' HB3' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -95.22 102.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 63.42 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.11 -2.08 1.5 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.51 141.75 30.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.909 0.385 . . . . 0.0 111.222 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -85.16 141.61 30.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.747 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.427 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 1.5 mtp -131.11 124.74 31.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.6 pt -95.08 156.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.779 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 652' ' ' THR . 32.9 tt0 -50.25 122.42 6.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 97.14 25.75 10.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 50.5 p -122.43 156.42 34.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.6 pttm -123.94 158.17 32.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.968 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.674 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.1 OUTLIER -147.29 145.92 29.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.554 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.88 130.53 43.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.624 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -110.44 114.87 28.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.11 0.481 . . . . 0.0 111.665 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 14.9 mt-30 -99.15 135.29 40.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.849 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.3 t70 -40.96 109.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.584 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.11 34.55 4.52 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 115.17 27.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.469 -0.365 . . . . 0.0 111.087 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -96.25 108.51 21.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.838 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.437 HG21 ' CE2' ' A' ' 649' ' ' TYR . 7.1 mt -106.51 136.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 115.72 28.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.222 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -82.12 -36.16 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.197 -178.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 618' ' ' LEU . 41.4 mt -154.9 131.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -136.57 124.77 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.57 117.23 23.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.481 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -66.8 -46.56 74.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.808 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -77.83 -40.37 40.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.602 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.4 -13.73 51.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.543 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp 61.82 17.77 9.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.64 104.96 9.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.54 121.83 68.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 111.695 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 587' ' ' ILE . 30.5 mm -124.45 119.11 55.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.503 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -147.83 129.73 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 12.8 m-30 -113.18 142.82 45.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 110.255 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.27 116.91 33.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.332 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.41 HG23 ' CD2' ' A' ' 580' ' ' LEU . 2.4 t -80.73 123.97 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.73 110.22 11.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.0 110.868 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.46 105.64 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.788 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.08 -43.69 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.01 141.98 42.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -112.89 100.16 8.44 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.473 0.654 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.24 53.97 3.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.15 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 93.0 34.94 6.54 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.628 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 132.02 34.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.43 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 5.0 p90 -43.31 -33.32 0.97 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.515 0.674 . . . . 0.0 110.258 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -149.86 -55.8 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.124 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 10.4 pt-20 141.36 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.886 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 67.24 74.17 0.59 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.257 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.24 -10.04 17.31 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 122.413 -0.463 . . . . 0.0 112.071 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 52.12 90.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.202 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.1 ptp -42.0 134.25 2.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.442 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 63.99 -168.41 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -96.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.641 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -114.84 97.95 6.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.864 0.364 . . . . 0.0 110.618 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.61 100.54 7.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.674 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 166.69 131.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.245 0.545 . . . . 0.0 110.194 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.0 158.06 27.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.486 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.44 HG21 ' CE2' ' A' ' 670' ' ' PHE . 51.9 t -77.42 128.45 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.462 . . . . 0.0 111.4 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.74 164.65 13.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.348 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.52 142.95 27.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.95 158.66 36.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.0 p -118.91 -178.41 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.978 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.59 -29.06 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.98 -49.96 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -50.71 67.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.72 -32.89 63.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.36 -36.88 84.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.07 -44.2 94.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.2 p -79.15 -29.26 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.87 -30.61 61.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -85.51 -24.06 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 8.7 tt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.055 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.731 0.3 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.26 -179.08 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 12.6 pt -112.02 71.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -171.56 141.26 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 12.8 mt -137.14 138.7 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.851 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.6 -10.67 26.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.587 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 147.66 -49.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.215 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.407 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 22.9 ttp-105 -111.82 143.11 43.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.052 0.453 . . . . 0.0 111.524 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.488 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.69 -57.81 1.43 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.09 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 6.8 tt -110.26 137.93 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.084 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 7.4 m -118.55 114.18 22.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -103.92 108.06 19.22 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 16.3 ptpt -117.09 100.54 53.29 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.5 Cg_exo -46.08 104.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.87 1.714 . . . . 0.0 109.62 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 160.29 81.95 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.498 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 5.6 Cg_endo -48.17 -31.18 16.09 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.587 2.858 . . . . 0.0 112.495 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -63.73 -16.1 60.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.156 0.503 . . . . 0.0 109.726 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.596 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 9.1 t -94.18 145.0 25.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.412 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 3.5 pt -52.43 -24.26 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 110.178 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 588' ' ' ILE . 7.3 tt -112.99 118.97 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.983 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.498 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -100.69 71.16 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.331 0.586 . . . . 0.0 110.321 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.607 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 50.6 mt-10 -126.05 171.9 10.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.127 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.21 130.2 47.61 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 121.138 0.494 . . . . 0.0 110.962 178.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.44 140.03 47.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.936 179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.407 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.12 112.56 17.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.513 HG12 ' CD2' ' A' ' 601' ' ' PHE . 89.7 mt -81.09 108.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 110.03 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.9 mp0 -66.87 123.63 20.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.118 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.73 -26.71 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 110.819 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -75.68 -20.39 78.28 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.041 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 44.3 t -99.45 118.02 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.993 0.897 . . . . 0.0 111.776 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.0 t30 -140.23 122.49 9.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.5 Cg_endo -90.36 160.15 32.45 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.679 -0.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.1 t80 -92.58 117.48 30.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.441 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 19.4 m-85 -92.51 137.48 32.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.262 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.549 HG13 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mp -121.93 143.61 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.585 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.33 -165.09 38.39 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.949 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.21 -17.27 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.131 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -80.28 131.53 35.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.824 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.5 -23.85 11.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.001 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -59.84 -27.04 66.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 9.7 m -76.0 129.36 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -46.57 -32.47 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.231 0.539 . . . . 0.0 110.225 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.549 ' HB3' HG13 ' A' ' 603' ' ' ILE . 13.2 t -107.47 135.24 49.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.315 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.98 111.94 22.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.446 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 17.5 mm -137.78 110.14 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.974 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.57 102.85 10.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.066 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 618' ' ' LEU . 0.8 OUTLIER -132.84 109.13 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.42 178.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -44.58 -52.88 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -60.64 -19.76 58.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.897 0.379 . . . . 0.0 110.928 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -76.2 160.66 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.575 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.461 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 19.6 t -111.22 151.96 27.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.411 ' CA ' ' HB2' ' A' ' 606' ' ' SER . 7.7 mpt_? -39.0 -38.6 0.46 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 110.675 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.67 60.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.418 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.537 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 21.7 t60 -50.4 -48.81 55.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.077 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 22.8 p -165.64 161.11 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.688 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.6 p90 -143.83 144.95 32.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.629 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.97 128.87 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.1 t80 -119.43 134.04 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.42 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 6.7 ttpt -97.86 136.47 38.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.223 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.2 OUTLIER -135.21 159.88 40.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.473 -178.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.0 tpt85 -75.72 112.46 12.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.378 0.609 . . . . 0.0 110.371 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.8 t60 -69.6 126.5 29.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.049 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -122.81 158.58 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.142 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.69 148.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.01 76.32 2.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.7 mttm 63.27 144.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.343 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 88.4 p -124.1 179.37 4.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.001 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 6.0 ptp -170.79 118.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.26 -66.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 15.2 mp0 -79.33 144.41 34.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.509 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.39 105.48 29.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.132 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 8.4 Cg_exo -71.73 -155.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.742 2.295 . . . . 0.0 112.0 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.27 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.04 -78.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 629' ' ' ARG . . . -176.34 65.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.338 -0.935 . . . . 0.0 113.179 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.2 mp -107.05 -161.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.1 m-20 -115.63 146.85 41.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.237 0.541 . . . . 0.0 112.39 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.6 m-20 -129.95 160.55 33.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.798 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.431 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.54 125.61 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.494 0.664 . . . . 0.0 112.461 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.5 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.5 m95 -108.93 128.05 54.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.607 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.456 ' CE1' HD13 ' A' ' 678' ' ' ILE . 35.1 t80 -90.47 119.4 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.642 0.258 . . . . 0.0 110.325 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 28.2 m -107.59 128.38 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.215 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -108.81 125.3 51.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.47 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -118.62 4.41 11.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.01 150.54 26.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.152 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 76.1 m -82.4 -10.97 58.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.553 0.216 . . . . 0.0 111.494 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -84.65 2.89 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 50.67 139.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.64 0.733 . . . . 0.0 112.353 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 656' ' ' VAL . 10.1 t -112.67 166.16 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.55 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -130.57 120.2 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.016 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.545 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -102.63 103.25 13.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 62.53 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.784 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.7 m-80 -139.89 -2.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.43 141.67 32.96 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.943 0.401 . . . . 0.0 111.406 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -75.29 141.51 43.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.057 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.42 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 12.1 mmm -125.68 89.3 3.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.0 pt -86.81 164.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 652' ' ' THR . 20.7 tt0 -50.65 117.77 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.454 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.22 30.26 9.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.789 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 23.8 p -114.01 162.18 16.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.5 ttpt -134.93 149.43 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.483 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.565 ' CE2' ' NE ' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -147.62 143.83 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.5 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -75.89 129.76 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.475 ' N ' HD11 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -99.87 143.79 29.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.329 0.585 . . . . 0.0 111.938 -179.426 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.535 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 1.2 mt-30 -130.34 136.17 48.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 706' ' ' GLY . 15.0 t70 -40.27 118.55 0.93 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.55 37.42 5.85 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.83 117.66 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.167 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.06 108.71 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.456 HD13 ' CE1' ' A' ' 649' ' ' TYR . 28.2 pt -108.95 133.84 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -109.42 116.54 32.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.095 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' A' ' 622' ' ' HIS . 1.9 pt -89.51 -21.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.447 ' O ' HG21 ' A' ' 690' ' ' ILE . 41.1 mt -154.27 130.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.579 . . . . 0.0 111.674 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -137.71 127.31 25.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.57 116.76 24.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.552 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -67.56 -47.62 69.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.708 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.1 -40.48 18.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.472 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -13.4 60.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.419 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.56 18.74 8.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.813 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.77 104.63 15.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -122.13 121.59 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.272 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.596 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 0.8 OUTLIER -128.44 128.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.95 135.92 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.466 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.446 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -114.28 147.43 39.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.37 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -101.53 117.19 34.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.529 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.419 HG23 ' CD2' ' A' ' 580' ' ' LEU . 3.6 t -78.79 123.55 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.28 109.34 9.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.86 105.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.24 -43.67 10.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.115 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.199 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.3 p -112.73 100.22 8.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.576 0.703 . . . . 0.0 109.789 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.2 m -84.65 59.29 5.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 83.99 40.13 8.91 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.437 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.67 132.66 33.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.533 0.206 . . . . 0.0 110.619 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.426 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 4.0 p90 -42.92 -33.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.342 0.591 . . . . 0.0 110.606 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -148.39 -58.79 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 5.9 pt-20 146.92 28.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.146 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 73.48 68.71 1.52 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.973 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.526 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.8 OUTLIER -105.67 -11.11 16.45 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.303 -0.527 . . . . 0.0 111.477 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.535 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 40.09 31.48 0.32 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.418 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.57 93.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.764 0.316 . . . . 0.0 111.261 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.405 ' CD1' ' O ' ' A' ' 710' ' ' LEU . 1.8 pp 29.51 66.88 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 46.81 70.47 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.732 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -114.39 142.16 46.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -80.08 135.42 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.565 ' NE ' ' CE2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -100.3 -148.66 0.36 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.081 0.467 . . . . 0.0 110.716 -178.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.48 142.72 41.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.413 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.473 ' HA ' ' HD1' ' A' ' 670' ' ' PHE . 15.8 t -84.11 113.73 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.154 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.72 169.65 10.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.9 140.18 37.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.69 155.39 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 32.1 p -125.64 -176.16 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.86 -33.43 56.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -51.3 70.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.91 -48.12 77.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -58.27 -32.97 68.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -64.85 -37.01 86.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.91 -44.1 97.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -75.76 -28.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -33.17 52.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -98.68 26.23 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.833 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.342 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.12 167.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . 0.439 ' HB ' ' CE2' ' P' ' 830' ' ' TYR . 26.8 mt -111.24 133.89 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.214 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.439 ' CE2' ' HB ' ' P' ' 828' ' ' ILE . 0.1 OUTLIER 178.68 67.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 20.6 mt -76.55 83.16 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.908 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.865 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -21.09 37.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.689 0.28 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 145.41 -43.78 0.91 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.428 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 11.6 ttm180 -113.46 143.82 43.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.706 0.288 . . . . 0.0 111.521 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 578' ' ' LEU . 2.3 t80 -119.97 -55.29 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 12.4 tp -113.34 142.43 45.87 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -122.51 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 592' ' ' LEU . 4.7 mp -106.27 108.86 20.59 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 100.93 51.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 46.2 Cg_exo -45.94 99.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.98 1.787 . . . . 0.0 110.006 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 158.2 85.11 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.404 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.3 Cg_exo -48.84 -25.29 8.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.403 2.735 . . . . 0.0 112.921 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -27.27 68.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.425 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 8.7 t -95.73 154.11 17.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.892 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.452 HG12 ' CD1' ' A' ' 690' ' ' ILE . 2.6 pt -57.11 -12.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.69 0.281 . . . . 0.0 110.962 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 71.2 mt -110.27 123.0 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.746 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.404 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -108.16 57.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.197 0.522 . . . . 0.0 110.028 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.3 mt-10 -124.62 171.75 9.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.226 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.02 130.1 50.49 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 178.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.3 OUTLIER -112.28 139.45 47.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.037 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.17 112.99 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.659 0.266 . . . . 0.0 111.644 -179.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 601' ' ' PHE . 38.0 mt -77.22 109.76 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -67.71 114.66 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.76 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.19 -28.53 0.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.184 0.516 . . . . 0.0 110.809 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.83 -25.2 74.24 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.536 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 66.6 t -101.2 119.27 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 117.813 0.807 . . . . 0.0 111.61 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -139.07 122.91 11.09 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.786 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 47.3 Cg_endo -89.83 160.51 35.24 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 124.518 -1.034 . . . . 0.0 111.863 0.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.38 114.96 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.524 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.0 m-85 -92.12 138.19 31.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.168 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -125.1 145.77 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.83 -173.27 38.16 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.383 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.472 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.35 -53.48 29.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.656 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.6 129.82 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.292 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.39 -18.96 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -53.66 -30.02 41.25 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 30.4 m -73.55 134.45 43.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 2.3 m-80 -48.66 -27.36 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.973 0.415 . . . . 0.0 110.388 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.514 ' HB3' HG13 ' A' ' 603' ' ' ILE . 42.0 t -113.37 142.08 46.29 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.52 105.61 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.421 HG13 ' CE2' ' A' ' 692' ' ' PHE . 31.5 mm -138.52 109.91 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.161 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -103.69 106.7 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.489 0.662 . . . . 0.0 112.589 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.6 t0 -129.93 107.71 9.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.559 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -39.3 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.477 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.8 mmp_? -70.31 -41.42 73.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.535 ' CB ' ' CG ' ' A' ' 622' ' ' HIS . 0.8 OUTLIER -88.12 158.72 18.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.85 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.2 t -78.26 172.37 13.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.414 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -50.27 -37.24 34.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 110.253 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.09 67.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.265 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.535 ' CG ' ' CB ' ' A' ' 618' ' ' LEU . 12.7 t60 -49.05 -48.36 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.811 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 2.6 p -159.99 158.77 31.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.676 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.524 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 39.3 p90 -143.45 150.39 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.478 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.44 HD12 HD11 ' A' ' 594' ' ' ILE . 83.7 mt -102.53 132.42 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.215 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -124.97 132.92 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 36.2 ttmt -98.45 136.54 38.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.573 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.45 158.58 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -76.95 112.75 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.522 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' CE1' ' HE2' ' A' ' 709' ' ' MET . 3.7 t60 -78.03 131.47 37.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -133.12 161.45 34.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.44 -179.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.026 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -95.81 -89.29 1.78 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -99.99 -174.93 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 110.829 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 45.9 p -176.51 110.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 34.3 mtt -101.35 108.18 19.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.7 t80 69.88 -63.99 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.55 143.59 42.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.581 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 7.4 m -104.43 104.47 45.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.4 -150.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.606 2.204 . . . . 0.0 111.971 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -47.92 -26.11 1.59 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.78 0.324 . . . . 0.0 111.491 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.6 -77.68 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 174.95 80.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.843 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 1.2 mp -115.74 -149.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.547 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 4.7 m-20 -118.21 149.37 41.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.282 0.563 . . . . 0.0 112.338 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.03 129.32 35.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.734 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 672' ' ' LEU . 7.0 pt -86.81 123.55 39.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.323 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.504 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 80.6 m95 -108.98 129.32 55.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.046 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 12.2 t80 -90.34 115.7 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 624' ' ' PHE . 60.8 m -101.63 141.88 33.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 111.473 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.48 ' HB3' ' HG3' ' A' ' 664' ' ' MET . 24.8 t60 -124.13 131.64 53.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.514 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 9.3 p -124.24 2.63 8.52 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.37 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.84 142.48 24.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.037 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.3 m -75.55 -12.65 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.512 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.8 m120 -83.64 2.63 36.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.587 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.87 134.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.588 0.708 . . . . 0.0 112.281 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 43.5 p -105.49 165.89 10.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.355 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -127.61 119.85 26.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 111.283 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.64 99.72 10.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.702 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.33 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.8 t-20 -133.48 3.76 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.833 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.15 130.26 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.955 0.407 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.97 141.42 53.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.48 ' HG3' ' HB3' ' A' ' 651' ' ' HIS . 34.1 tpp -125.4 101.29 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.444 ' O ' ' OG1' ' A' ' 668' ' ' THR . 30.1 pt -87.94 165.61 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 652' ' ' THR . 16.1 tt0 -58.77 109.82 0.89 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.41 34.72 3.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 5.2 p -134.84 154.94 51.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.356 . . . . 0.0 111.591 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.2 pttm -128.23 156.08 43.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.488 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.52 145.77 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.501 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.504 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.38 134.57 51.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.481 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 3.3 mt -108.52 126.33 52.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 707' ' ' LEU . 3.1 mt-30 -113.36 154.21 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.714 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.408 ' HB2' HD11 ' A' ' 696' ' ' ILE . 56.7 t0 -52.76 101.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.21 30.66 3.81 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 117.11 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.536 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -96.2 109.74 22.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.282 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 23.5 pt -105.94 130.48 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -94.5 116.13 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.711 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -38.7 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.522 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.408 HG23 ' HB ' ' A' ' 690' ' ' ILE . 0.7 OUTLIER -155.84 136.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -136.42 122.41 20.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -123.53 116.99 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.92 0.39 . . . . 0.0 110.583 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -67.27 -46.48 73.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.97 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -78.81 -40.49 32.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.793 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -83.08 -9.51 59.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 60.46 18.08 7.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.253 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.1 t80 -76.72 104.63 7.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.4 p -118.2 122.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.133 0.492 . . . . 0.0 111.746 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.452 ' CD1' HG12 ' A' ' 587' ' ' ILE . 22.5 mm -126.17 154.6 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.298 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.425 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 177.54 127.86 1.1 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.952 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.483 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 11.1 m-30 -113.04 145.28 41.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.43 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 116.53 33.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.022 0.439 . . . . 0.0 110.256 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.5 t -82.58 127.19 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.754 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -134.28 108.4 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.924 179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.48 HG12 HD11 ' A' ' 578' ' ' LEU . 11.5 mt -74.58 104.94 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.61 -50.84 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.899 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.6 t0 -112.47 138.36 49.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.211 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.0 OUTLIER -117.09 100.06 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 64.1 p -70.27 78.84 0.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.42 39.75 60.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.388 -0.91 . . . . 0.0 110.829 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 1.5 tt -97.08 143.65 27.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.867 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.655 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -58.25 112.66 1.62 Allowed 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.457 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 11.4 t30 59.73 -68.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.147 0.499 . . . . 0.0 109.932 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 703' ' ' PHE . 11.7 pt-20 171.39 -32.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.989 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.91 45.76 0.04 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.408 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -82.76 0.94 41.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.41 82.97 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.088 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.451 ' HE2' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -118.24 125.27 49.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.914 0.388 . . . . 0.0 111.021 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.81 -175.76 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.721 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -48.57 -34.48 11.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.172 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -85.63 134.04 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -97.03 100.02 11.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.004 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 34.8 79.02 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.69 142.49 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.3 130.16 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.4 mp -99.42 170.65 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.782 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -98.32 155.76 17.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -96.39 158.54 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.3 p -126.04 -176.58 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.197 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.42 46.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.14 -47.81 84.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.37 -50.42 63.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.663 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -55.7 -32.87 63.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -37.31 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.786 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -44.34 93.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -78.41 -21.49 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -37.75 81.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.6 -9.67 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.399 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.403 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.5 tt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.99 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -107.03 179.65 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.0 36.0 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -175.95 166.99 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 56.9 mt -148.75 37.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.848 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -77.97 -21.62 50.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.4 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 161.38 -24.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.518 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.403 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.0 tmm_? -107.52 143.11 36.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 2.4 t80 -132.61 -47.98 0.89 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 694' ' ' VAL . 1.0 OUTLIER -112.65 143.25 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.16 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 33.0 m -123.07 114.01 19.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.982 0.42 . . . . 0.0 111.053 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.449 ' HG ' ' CG2' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -106.11 109.01 20.82 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.26 99.43 52.69 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 39.0 Cg_exo -46.91 101.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.916 1.744 . . . . 0.0 109.814 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.73 157.95 85.32 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.412 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 9.0 Cg_endo -50.14 -25.46 13.07 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.768 2.978 . . . . 0.0 113.21 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.97 -27.37 68.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 2.7 t -95.62 153.92 17.48 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.624 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 9.3 pt -56.51 -12.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.701 0.286 . . . . 0.0 111.193 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 39.9 mt -108.54 127.24 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.527 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.412 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -114.22 58.5 0.69 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.266 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.675 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 36.7 mt-10 -125.03 170.14 11.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.86 121.19 24.82 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.607 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.438 ' CD2' ' CD ' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -112.75 147.43 36.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -125.19 118.54 26.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.543 HG12 ' CD2' ' A' ' 601' ' ' PHE . 57.6 mt -73.48 109.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.912 0.387 . . . . 0.0 110.294 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.1 116.4 6.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.971 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.99 -29.84 1.59 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.163 0.506 . . . . 0.0 110.471 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.23 -22.72 76.28 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.589 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.04 118.79 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 117.884 0.842 . . . . 0.0 111.585 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.0 t30 -139.37 122.68 10.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.765 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.533 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.11 160.43 33.82 Favored 'Cis proline' 0 N--CA 1.462 -0.373 0 C-N-CA 124.451 -1.062 . . . . 0.0 111.917 0.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -91.46 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 41.6 m-85 -92.25 138.15 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.007 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.484 ' CG1' ' HB3' ' A' ' 611' ' ' CYS . 3.2 mp -129.84 145.69 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.678 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 156.72 -163.36 32.14 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.013 -1.089 . . . . 0.0 114.049 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.2 OUTLIER -82.85 3.42 29.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -101.3 123.94 46.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -57.84 -22.49 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.271 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.16 -26.63 67.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.905 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 92.3 m -68.51 129.43 39.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.319 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.2 m120 -44.07 -33.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.308 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HB3' ' CG1' ' A' ' 603' ' ' ILE . 53.5 t -109.73 134.88 51.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.12 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 111.99 23.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 30.6 mm -137.62 110.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.619 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 6.1 tt0 -91.6 105.9 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.274 0.559 . . . . 0.0 111.523 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 618' ' ' LEU . 13.5 t0 -130.32 108.58 10.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.702 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -47.43 -29.8 2.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.821 0.343 . . . . 0.0 111.201 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.491 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 19.7 mmt180 -77.86 -41.29 37.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.75 151.71 24.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.94 161.4 23.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.165 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.423 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -47.65 -38.8 15.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.444 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 24.1 t -121.24 57.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 653' ' ' GLY . 6.0 t60 -50.42 -48.66 56.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.883 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.2 p -162.69 157.04 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.467 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 25.2 p90 -143.32 146.93 33.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.594 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 580' ' ' LEU . 23.9 mt -101.9 135.37 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.983 0.42 . . . . 0.0 109.914 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -127.34 134.94 49.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.746 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.2 ttmt -97.64 136.19 38.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.137 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 159.27 42.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.76 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -76.47 112.55 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.195 0.522 . . . . 0.0 110.595 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t-160 -81.38 122.85 28.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -157.52 114.7 3.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.06 122.44 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.7 -60.92 7.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.601 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -70.59 145.38 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 76.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 63.21 -80.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.24 122.82 26.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.672 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 12.6 m -107.36 87.73 3.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.193 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.18 167.45 27.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.519 2.146 . . . . 0.0 111.953 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.414 ' HB1' ' CD2' ' A' ' 630' ' ' HIS . . . 69.49 -61.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.346 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 74.55 -74.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 179.25 56.52 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.778 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 630' ' ' HIS . 2.1 mp -102.47 -166.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -111.75 148.03 34.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.026 0.441 . . . . 0.0 111.926 -179.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -128.85 160.11 33.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.448 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 3.5 pt -110.64 121.59 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.317 0.579 . . . . 0.0 111.615 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.536 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 96.9 m95 -104.28 141.3 36.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.165 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.436 ' CE2' HG23 ' A' ' 678' ' ' ILE . 10.7 t80 -105.7 116.95 32.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -105.19 139.8 39.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.472 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -119.46 128.73 54.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.053 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.417 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 5.4 p -126.55 12.95 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.51 148.75 21.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.181 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 69.5 m -77.0 -21.89 53.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 617' ' ' ARG . 1.5 m120 -79.9 -0.52 35.27 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.5 OUTLIER 54.9 128.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.932 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.1 p -92.74 166.36 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.986 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' A' ' 679' ' ' LYS . 18.7 m-85 -133.15 120.6 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -105.3 112.57 25.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.142 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 59.03 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -139.86 7.6 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.22 141.06 36.93 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -79.33 141.02 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 13.9 mmm -120.96 101.27 7.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -88.27 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 652' ' ' THR . 34.6 tt0 -44.81 109.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.423 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.45 34.78 3.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 3.6 p -122.33 162.25 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.071 0.462 . . . . 0.0 111.667 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.5 ttpm? -131.61 149.71 52.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.344 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.468 ' HB3' HD13 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.3 143.74 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.536 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.37 137.74 53.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.437 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 1.7 mt -110.85 104.14 12.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.235 0.54 . . . . 0.0 111.573 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.533 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 20.8 mt-30 -90.94 137.91 32.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.197 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 706' ' ' GLY . 5.4 t70 -43.52 111.32 0.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.8 37.13 4.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.444 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -93.55 122.65 36.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.469 -0.366 . . . . 0.0 111.012 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.37 108.88 21.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.186 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.436 HG23 ' CE2' ' A' ' 649' ' ' TYR . 3.7 mt -106.15 136.36 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.904 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 658' ' ' TYR . 1.7 mttt -100.83 116.27 32.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.566 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -37.94 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.413 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.403 HG22 ' OD2' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -155.29 131.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.724 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -136.25 123.56 21.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.159 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -121.4 117.18 26.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.42 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -66.89 -46.51 74.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.943 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.41 -40.44 21.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.543 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -77.47 -14.0 59.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.334 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 15.09 9.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.0 OUTLIER -78.6 104.76 9.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.6 p -120.18 121.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 111.972 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.427 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 3.4 mt -129.14 152.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.324 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 177.5 133.3 1.82 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.021 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 4.2 m-30 -112.93 150.92 31.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -101.27 116.82 33.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.953 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 578' ' ' LEU . 1.8 t -81.11 121.89 35.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.883 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.66 108.75 8.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.477 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 11.6 mt -79.21 107.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.32 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.68 -41.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -109.76 141.09 42.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.2 OUTLIER -114.88 100.41 8.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.418 0.627 . . . . 0.0 110.046 178.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.6 m -86.79 70.47 10.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 73.33 36.12 55.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.163 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -79.87 118.59 21.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.583 0.23 . . . . 0.0 111.171 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.535 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -32.8 -47.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.535 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -159.2 26.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.5 OUTLIER 71.55 -56.87 0.63 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.543 -178.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 149.29 81.04 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.772 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.52 -9.54 19.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.806 -0.232 . . . . 0.0 111.476 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 82.5 65.58 1.61 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.32 118.53 26.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.851 0.358 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -176.1 -170.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -79.63 -55.63 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.749 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.21 134.16 36.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.688 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.83 100.17 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.096 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 5.5 mmm-85 39.36 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.76 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.61 143.24 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.91 129.32 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.247 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.9 mt -102.64 166.13 10.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 137.99 40.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.02 159.88 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.4 p -121.11 -173.68 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.67 -28.82 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.16 -52.09 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.66 -49.32 63.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.628 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -56.35 -33.13 65.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 -38.24 89.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.8 mt -58.41 -44.01 88.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.548 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.18 -29.77 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -52.11 -29.31 21.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.057 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -105.29 27.22 8.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.449 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.3 tt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.679 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.73 73.06 0.49 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 4.1 mm -108.96 75.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 20.2 p90 179.31 150.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.789 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 58.9 mt -127.98 170.37 12.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.851 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -88.05 -22.04 24.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -165.52 30.64 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.813 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.9 tmm_? -102.29 126.13 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.564 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -109.2 -62.29 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.187 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 694' ' ' VAL . 6.8 tt -106.06 137.76 43.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 694' ' ' VAL . 4.6 m -115.98 113.96 23.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.998 0.428 . . . . 0.0 111.434 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.6 OUTLIER -104.83 107.9 19.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 ptpt -114.83 100.02 52.84 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_exo -45.78 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.945 1.763 . . . . 0.0 109.565 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.16 157.83 86.3 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.8 Cg_exo -49.12 -25.25 8.98 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.381 2.72 . . . . 0.0 112.425 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -61.97 -22.61 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.0 t -95.31 153.11 17.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.03 -19.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.012 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 582' ' ' PRO . 2.6 tt -112.99 142.92 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.658 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -119.47 67.74 0.81 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 89.5 mt-10 -125.16 170.86 10.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.494 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.77 124.0 34.37 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.26 136.51 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.571 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.3 OUTLIER -124.48 116.6 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.851 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.542 HG12 ' CD2' ' A' ' 601' ' ' PHE . 81.2 mt -74.87 108.16 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.842 0.354 . . . . 0.0 110.144 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.2 mp0 -66.16 103.14 0.92 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -29.6 -54.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.27 0.557 . . . . 0.0 111.449 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -53.03 -16.39 4.24 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.017 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.37 118.05 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 117.873 0.837 . . . . 0.0 111.604 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' ND2' ' CD2' ' A' ' 626' ' ' PHE . 0.9 OUTLIER -140.46 124.35 10.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.997 178.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.5 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 37.2 Cg_endo -91.32 159.28 27.73 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.149 0.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 1.3 t80 -93.61 115.77 28.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 0.0 109.962 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.598 ' CE2' ' CZ ' ' A' ' 624' ' ' PHE . 1.7 m-85 -92.94 138.61 31.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.917 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.8 mp -127.51 144.89 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 158.35 -165.0 33.71 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.877 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.02 17.92 11.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.41 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 1.1 t -101.78 131.68 47.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.642 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -21.71 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.763 0.316 . . . . 0.0 110.63 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.29 -21.33 60.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.9 m -76.52 127.41 32.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 23.3 m120 -45.76 -31.68 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.14 0.495 . . . . 0.0 110.434 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.524 ' HB3' HG13 ' A' ' 603' ' ' ILE . 45.0 t -110.55 138.72 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 117.83 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 34.2 mm -138.06 108.83 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.314 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.35 101.09 11.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.413 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.509 ' HB3' HD11 ' A' ' 618' ' ' LEU . 1.1 m-20 -133.54 113.36 12.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.937 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -50.42 -45.81 55.98 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.66 -19.05 63.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.549 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -88.17 160.81 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.593 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.408 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 2.6 m -109.92 153.74 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.03 -50.68 1.81 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.76 57.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.466 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 54.2 t60 -52.69 -37.55 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.344 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.529 0.68 . . . . 0.0 111.939 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.598 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.18 131.97 21.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.904 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 603' ' ' ILE . 21.3 mt -131.79 116.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.458 ' CD2' ' ND2' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -136.78 149.02 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -178.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.458 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 34.6 ttmt -98.9 136.76 38.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 159.79 35.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.4 tpt180 -75.68 112.75 12.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 -76.55 128.93 35.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -171.4 146.75 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.46 104.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 45.49 -121.28 4.74 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.53 144.43 51.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.738 0.304 . . . . 0.0 110.635 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.32 91.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.67 103.09 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 78.43 -55.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.04 144.15 40.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.1 m -104.42 102.69 35.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.12 -164.55 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.723 2.282 . . . . 0.0 112.202 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -97.13 29.71 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.309 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 64.48 -164.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.893 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -107.49 85.18 0.41 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.746 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 630' ' ' HIS . 4.8 mp -110.54 -163.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 9.8 m-20 -114.12 146.49 40.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.294 0.569 . . . . 0.0 112.197 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.434 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -128.8 160.61 32.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.647 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -103.33 128.29 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.6 0.714 . . . . 0.0 112.081 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.54 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 91.6 m95 -113.02 120.45 41.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.27 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.411 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 1.6 t80 -93.62 117.77 30.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 624' ' ' PHE . 3.9 m -113.74 143.87 43.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.437 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.447 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 42.5 t60 -110.58 130.12 55.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.0 0.428 . . . . 0.0 111.049 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.428 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 20.5 p -120.56 3.83 10.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . . . . . . . . . . . -81.58 146.22 25.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.847 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 37.5 m -75.94 -15.64 60.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 656' ' ' VAL . 29.3 m-20 -85.18 3.05 41.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.499 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.16 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.438 0.637 . . . . 0.0 112.283 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.447 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 33.1 p -99.31 166.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.302 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 5.8 m-85 -129.23 120.06 25.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.718 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.452 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER -98.64 102.58 14.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 60.93 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.4 p30 -136.84 5.7 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.672 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.409 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 0.0 OUTLIER -107.44 139.75 41.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -76.4 141.36 41.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.408 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 25.1 mmm -124.61 97.44 5.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.4 pt -87.57 152.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 652' ' ' THR . 38.5 tt0 -48.7 112.05 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.91 0.386 . . . . 0.0 110.945 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.9 32.32 4.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.3 p -121.04 162.54 19.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.828 0.347 . . . . 0.0 111.203 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.9 ttpm? -133.69 147.81 51.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.452 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.69 28.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.54 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.04 133.72 48.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.593 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -108.9 104.71 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.509 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 11.2 mt-30 -91.35 139.26 30.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.621 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 706' ' ' GLY . 44.2 t0 -41.28 112.4 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 110.708 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.28 37.08 4.43 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.78 116.11 28.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.252 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -96.26 108.72 21.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.485 HD11 HG23 ' A' ' 678' ' ' ILE . 25.5 pt -105.92 129.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.798 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 27.9 mttp -89.43 115.8 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.483 ' CG2' HD12 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -79.26 -35.47 17.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.811 -178.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.437 HG13 HG22 ' A' ' 680' ' ' ILE . 50.2 mt -155.0 131.59 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.704 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -136.37 123.45 21.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.5 116.96 25.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.505 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -67.03 -46.61 73.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.842 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -80.91 -40.07 25.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.1 t30 -83.06 -13.36 55.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.06 17.11 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 111.0 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.04 104.62 7.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.48 124.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.2 0.524 . . . . 0.0 111.914 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 59.5 mt -129.01 156.0 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.315 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 170.83 136.33 2.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.68 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.16 149.8 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.85 117.6 35.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.663 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 578' ' ' LEU . 3.5 t -80.03 124.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -133.2 109.71 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.413 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 52.1 mt -78.26 106.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.76 -44.71 9.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.176 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -110.4 141.87 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.54 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -113.07 99.92 8.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.431 0.634 . . . . 0.0 109.599 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.1 m -82.88 58.84 4.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.52 13.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.173 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.64 134.33 35.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.56 0.219 . . . . 0.0 110.668 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.434 ' CA ' ' HB2' ' A' ' 644' ' ' LEU . 4.8 p90 -43.36 -33.52 1.04 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.469 0.652 . . . . 0.0 110.266 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -148.1 -61.2 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.341 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 7.7 pt-20 145.42 32.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.957 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 68.12 74.09 0.62 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.592 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.516 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.41 -10.01 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.057 0.428 . . . . 0.0 111.557 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.539 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 93.15 -95.24 1.96 Allowed Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 39.36 -147.14 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.031 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.91 162.66 0.22 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.105 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -56.95 -66.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.63 123.75 19.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -82.83 100.01 10.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 4.3 mmm-85 41.48 89.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.842 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.44 143.54 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 65.0 t -85.78 121.84 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.506 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.66 172.36 8.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.37 16.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -93.44 148.55 21.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -126.41 -175.96 3.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 111.669 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -30.15 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.198 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -56.61 -50.12 72.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.676 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 21.6 mm-40 -70.01 -49.5 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.57 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.477 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.43 -39.95 89.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.424 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 1.0 OUTLIER -63.35 -44.69 94.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.562 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.89 -19.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.254 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.98 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.039 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -108.11 24.24 13.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.777 179.922 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -156.71 63.04 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 24.9 mt -98.69 130.86 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -176.04 154.1 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 28.3 mt -138.77 122.18 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.825 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -102.22 10.2 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.513 0.197 . . . . 0.0 111.278 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -144.71 -40.86 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -106.12 141.47 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.549 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.66 -58.3 1.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.214 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.462 ' CD1' ' CG1' ' A' ' 696' ' ' ILE . 12.8 tp -110.92 134.93 52.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 695' ' ' GLU . 7.5 m -115.24 114.72 25.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.432 ' CD2' HD13 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -105.28 108.7 20.35 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.96 100.33 52.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.2 Cg_exo -44.72 100.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.917 1.745 . . . . 0.0 109.806 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 158.29 85.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.43 -24.68 9.22 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.59 2.86 . . . . 0.0 112.387 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.42 -23.09 65.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 2.2 t -95.46 153.34 17.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.75 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.446 HG12 ' CD1' ' A' ' 690' ' ' ILE . 4.0 pt -54.42 -18.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 2.6 tt -112.84 142.95 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.815 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.02 68.81 0.84 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.194 0.521 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.587 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.3 mm-40 -124.91 171.38 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.494 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 127.33 42.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.0 0.428 . . . . 0.0 111.12 178.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.39 139.58 47.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.892 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -124.48 117.39 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 601' ' ' PHE . 88.0 mt -86.34 109.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.062 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -67.47 125.84 27.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.549 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.72 -28.5 3.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.123 0.487 . . . . 0.0 110.52 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.59 -17.7 80.04 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.982 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.4 t -100.94 117.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.05 0.925 . . . . 0.0 111.878 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -140.8 121.31 8.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.8 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.543 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 50.5 Cg_endo -89.63 160.65 36.32 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 124.772 -0.928 . . . . 0.0 111.499 -0.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.0 t80 -92.15 117.02 29.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 35.1 m-85 -92.21 137.51 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.039 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.597 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mp -124.94 143.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.59 -176.67 42.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.079 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.6 ttp85 -81.21 -2.96 50.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.662 0.268 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 135.71 42.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -24.91 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.059 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -28.36 60.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 51.5 m -77.06 132.52 38.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -47.31 -29.07 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.563 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.597 ' HB3' HG13 ' A' ' 603' ' ' ILE . 38.5 t -111.58 142.45 43.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.897 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 115.92 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.495 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 17.5 mm -137.78 110.29 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.441 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 22.2 mt-10 -81.88 103.2 11.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.511 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.499 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.43 108.43 9.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.161 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -42.5 -36.73 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -77.62 -36.86 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -60.3 158.91 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 83.9 p -110.68 168.89 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.553 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -46.17 -52.98 11.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.224 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.76 58.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.204 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 653' ' ' GLY . 35.6 t60 -49.35 -48.59 46.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.886 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -163.12 156.08 19.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 650' ' ' CYS . 43.9 p90 -143.22 148.05 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.38 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -102.59 141.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 179.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.0 t80 -130.91 134.15 46.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.418 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 27.9 ttmt -97.66 136.8 37.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.91 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.68 159.44 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.443 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.27 117.78 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.436 0.636 . . . . 0.0 110.79 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.484 ' C ' ' CD2' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -82.47 133.78 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.444 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.08 140.53 45.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 16.6 m -93.4 175.98 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -105.44 -69.69 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -96.96 157.06 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.3 p -165.63 78.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.27 117.49 9.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 63.82 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.785 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -86.63 126.23 34.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.28 87.75 4.31 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.84 172.97 15.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.56 2.173 . . . . 0.0 112.033 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 70.29 -62.71 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.161 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 65.05 -173.14 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -86.36 53.36 4.59 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.751 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.2 mm? -79.99 -160.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 m-20 -122.49 147.03 46.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.188 0.518 . . . . 0.0 112.037 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -129.18 159.72 35.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 671' ' ' LEU . 0.9 OUTLIER -105.92 134.94 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.362 0.601 . . . . 0.0 112.23 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.602 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 67.4 m95 -117.96 127.59 53.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.313 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 13.0 t80 -90.08 117.17 28.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.1 m -102.93 131.72 49.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.601 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 67.0 t60 -109.88 128.58 55.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.3 p -124.44 -1.14 8.1 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.451 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.36 137.95 21.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.029 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 91.4 m -69.78 -10.84 59.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.627 0.251 . . . . 0.0 111.456 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 656' ' ' VAL . 55.7 m-20 -85.03 3.75 37.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.59 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.57 137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.566 0.698 . . . . 0.0 112.182 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.444 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 5.9 t -108.74 166.2 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.387 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -129.38 120.36 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -101.84 99.64 9.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.562 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.9 m120 61.06 -81.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.2 p-10 -133.79 1.81 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.643 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.422 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.5 m120 -104.21 141.65 35.89 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.859 0.361 . . . . 0.0 111.069 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.55 141.27 38.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.058 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 57.4 mmm -115.66 98.68 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 668' ' ' THR . 48.3 pt -87.5 155.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.063 0.459 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -51.41 105.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.61 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 39.64 2.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.212 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.5 p -132.39 148.9 52.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.871 0.335 . . . . 0.0 111.549 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 15.9 pttm -123.88 136.35 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.671 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.484 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -131.94 141.61 49.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.602 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -69.37 141.26 54.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.945 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 16.2 mt -111.87 105.39 13.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 112.018 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 70.5 mt-30 -77.86 156.39 30.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.878 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -53.2 109.7 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.83 37.92 4.29 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.1 115.22 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.437 . . . . 0.0 111.184 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.12 109.78 22.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 659' ' ' LEU . 11.8 pt -105.57 120.61 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.155 0.502 . . . . 0.0 112.11 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -87.54 116.02 25.37 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.503 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -82.3 -33.46 11.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.885 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.454 ' CG2' ' CE1' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -155.15 132.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -136.04 124.33 23.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 687' ' ' LYS . 2.2 t0 -124.14 116.58 22.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -67.79 -46.68 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.064 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -40.36 96.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.134 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -93.69 -18.35 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.643 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.0 OUTLIER 65.91 13.06 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.0 111.029 -179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.1 OUTLIER -87.51 105.56 17.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.2 p -119.78 138.78 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.357 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 587' ' ' ILE . 18.4 mm -113.67 152.12 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.77 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.2 130.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.651 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 1.6 m-30 -113.9 145.06 42.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -101.1 116.92 33.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 578' ' ' LEU . 2.5 t -79.82 128.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.692 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.3 OUTLIER -133.29 108.58 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.124 0.488 . . . . 0.0 111.019 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 705' ' ' GLU . 13.8 mt -76.28 105.29 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.385 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -91.9 -50.13 5.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.041 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -112.62 139.57 48.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.142 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 100.56 8.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.207 0.527 . . . . 0.0 109.692 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 62.02 0.67 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.968 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.1 47.32 88.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.54 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 702' ' ' LEU . 0.3 OUTLIER -112.24 32.61 5.42 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.589 ' O ' ' C ' ' A' ' 704' ' ' ASN . 0.0 OUTLIER 67.85 175.67 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 703' ' ' PHE . 4.8 t30 -14.56 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.028 0.442 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 696' ' ' ILE . 0.7 OUTLIER 151.51 -38.16 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.927 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 164.36 81.87 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.613 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -10.14 17.14 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.518 -0.401 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.434 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 41.14 89.87 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.257 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.431 ' HE1' ' CE2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -153.64 116.82 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.26 -162.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -46.78 45.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.829 0.347 . . . . 0.0 111.063 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.09 137.46 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.659 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -91.91 100.6 13.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 7.0 mmm-85 43.38 86.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.564 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.47 143.18 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.982 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.6 t -84.08 130.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.24 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.89 157.43 16.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 111.186 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.73 158.86 17.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.1 p -126.13 -175.29 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -33.69 57.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.27 -45.6 90.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.614 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -63.74 -50.97 66.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -54.24 -32.7 56.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.13 -37.09 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.097 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' A' ' 723' ' ' GLU . 13.2 mt -58.03 -44.37 87.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.82 -27.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -30.13 65.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.836 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -97.51 13.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.827 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.81 0.338 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 58.72 175.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 4.9 pt -132.89 78.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.206 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.62 148.06 8.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.013 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 681' ' ' ILE . 27.6 mt -151.74 83.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.947 -179.975 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.4 -22.58 59.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.732 0.301 . . . . 0.0 111.205 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 170.04 70.76 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.412 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -89.13 114.0 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.484 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -104.58 -59.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.394 -179.116 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.3 tt -106.67 142.0 37.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.352 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 695' ' ' GLU . 11.5 m -122.25 114.71 21.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 592' ' ' LEU . 6.2 mt -102.95 107.8 18.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 44.9 mtmt -111.6 99.46 44.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.7 Cg_exo -48.15 98.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.755 1.637 . . . . 0.0 109.535 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.73 157.63 85.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.401 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 77.6 Cg_exo -49.76 -28.43 17.65 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.458 2.772 . . . . 0.0 112.64 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.38 -24.99 67.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.472 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.9 t -95.44 153.97 17.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.413 HG22 HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -56.2 -11.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.237 179.586 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.429 ' CD1' ' CG2' ' A' ' 613' ' ' ILE . 20.3 mt -112.1 126.88 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.824 0.345 . . . . 0.0 111.741 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.34 52.38 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 110.148 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 14.1 mm-40 -124.49 172.01 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.96 131.35 51.1 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.941 0.4 . . . . 0.0 111.337 179.131 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.5 OUTLIER -112.58 141.94 45.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.778 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.438 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.63 116.32 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.149 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.527 HG12 ' CD2' ' A' ' 601' ' ' PHE . 63.9 mt -86.56 108.98 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -71.8 128.71 36.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.484 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.03 -30.34 1.81 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 109.877 179.084 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.74 -25.06 75.96 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.16 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 87.9 t -98.73 117.16 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 118.171 0.985 . . . . 0.0 111.842 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.2 t30 -141.16 121.92 8.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.034 177.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.553 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.8 Cg_endo -89.86 159.78 34.77 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.543 -1.024 . . . . 0.0 111.248 -0.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.7 t80 -91.88 114.98 27.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.5 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 25.3 m-85 -91.82 138.38 31.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.998 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mp -125.95 145.31 33.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.459 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.14 -178.3 41.37 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.573 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.442 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.8 ttp85 -76.97 -7.52 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.563 0.22 . . . . 0.0 111.466 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.48 131.96 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.758 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -56.1 -23.99 37.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.217 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -30.2 59.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.653 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 45.2 m -74.87 134.51 41.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 4.8 m-80 -48.11 -27.07 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.535 ' HB3' HG13 ' A' ' 603' ' ' ILE . 36.0 t -112.13 140.46 46.8 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.542 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.59 113.03 23.84 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 31.0 mm -137.8 109.67 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.774 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 25.8 tt0 -87.66 103.87 15.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.584 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.48 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -131.06 110.55 11.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.11 178.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -41.21 -35.65 0.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.728 0.299 . . . . 0.0 111.526 -178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -77.69 -38.64 46.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.69 159.48 8.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.178 -179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 167.59 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 -50.0 19.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.134 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.71 59.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.36 178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.524 ' CD2' ' CG2' ' A' ' 680' ' ' ILE . 24.7 t60 -48.5 -49.18 36.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.619 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.3 p -166.34 157.35 12.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 44.0 p90 -143.39 146.89 33.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 2.2 mp -102.17 125.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.775 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -116.79 133.72 55.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 -179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.426 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.2 ttmt -98.55 136.93 37.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.64 158.78 40.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.385 -179.164 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.47 115.72 16.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.384 0.612 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 641' ' ' ALA . 4.2 t60 -84.1 130.96 34.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.002 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.63 155.4 39.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.7 168.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -68.04 -133.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -173.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.742 0.306 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 14.0 p -128.28 29.34 5.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.287 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 636' ' ' MET . . . . . 0.402 ' O ' ' CB ' ' A' ' 637' ' ' TYR . 0.8 OUTLIER -87.02 101.89 13.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.24 179.41 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.402 ' CB ' ' O ' ' A' ' 636' ' ' MET . 0.1 OUTLIER 81.17 -15.88 0.69 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.03 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -83.35 147.05 28.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 55.5 p -86.92 156.9 55.04 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -35.82 158.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.373 2.716 . . . . 0.0 113.857 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 630' ' ' HIS . . . 176.21 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.799 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.26 -91.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.718 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 641' ' ' ALA . . . -156.48 27.12 0.54 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.606 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 1.6 mm? -71.51 -160.82 0.06 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.662 0.231 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.32 146.46 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -179.536 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.451 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -125.23 160.21 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.775 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -110.01 121.9 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.619 0.723 . . . . 0.0 112.591 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.539 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 87.0 m95 -105.34 128.13 53.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.629 179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.425 ' CD2' HD13 ' A' ' 678' ' ' ILE . 22.0 t80 -90.57 117.75 29.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 36.7 m -106.35 128.09 53.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -110.29 126.34 54.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.855 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.487 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 13.4 p -123.46 7.24 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.516 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.46 146.82 25.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.954 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 32.8 m -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.611 0.243 . . . . 0.0 111.642 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 19.2 m-20 -85.23 3.25 40.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.44 135.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.733 0.777 . . . . 0.0 112.487 179.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 3.7 t -104.16 165.85 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.188 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 679' ' ' LYS . 37.3 m-85 -128.28 119.76 25.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.425 ' HG ' ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -103.46 102.44 12.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.73 -82.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 659' ' ' LEU . 26.1 p30 -135.77 6.99 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -110.8 141.6 43.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.942 0.401 . . . . 0.0 110.918 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 8.9 ttp85 -75.19 141.19 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 23.4 mmm -122.66 86.06 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.472 ' O ' ' OG1' ' A' ' 668' ' ' THR . 30.7 pt -86.84 156.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.325 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.4 tt0 -49.12 107.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.234 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.16 32.44 4.02 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.586 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 665' ' ' ILE . 2.5 p -121.72 161.84 21.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.6 ttpm? -135.66 147.87 48.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.45 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.3 OUTLIER -147.83 144.93 28.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.1 134.73 49.74 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.629 179.446 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.74 108.0 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.071 0.462 . . . . 0.0 111.783 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.543 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 18.3 mt-30 -95.8 157.28 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.227 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.0 p-10 -52.38 124.57 13.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.802 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 84.42 39.63 8.92 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.997 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.16 112.31 23.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.911 0.386 . . . . 0.0 111.152 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.81 108.77 21.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 649' ' ' TYR . 6.0 mt -109.7 128.83 65.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 0.0 112.035 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.4 OUTLIER -90.34 115.85 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.407 178.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.524 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 3.8 mt -77.02 -37.6 26.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.422 -179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 38.3 mt -155.39 131.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.773 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -135.87 121.09 19.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.748 178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.54 117.36 24.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -66.73 -46.67 74.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.609 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.23 -40.24 19.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.289 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.78 -11.32 59.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.8 20.59 8.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.735 0.303 . . . . 0.0 110.925 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.79 104.82 15.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.5 p -119.5 121.4 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.19 0.519 . . . . 0.0 111.81 -178.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.403 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 26.8 mm -128.5 150.14 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.536 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.472 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.54 127.55 1.17 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.411 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.487 ' CB ' HD22 ' A' ' 580' ' ' LEU . 8.7 m-30 -113.34 145.76 40.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.752 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -101.88 117.97 35.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.086 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.447 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.6 t -79.43 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 34.2 tt0 -131.26 108.39 9.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.028 0.442 . . . . 0.0 110.334 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 696' ' ' ILE . 27.8 mt -76.39 105.58 5.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.927 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . 0.407 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.6 m-80 -87.12 -46.14 10.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.484 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 21.2 t0 -110.77 139.4 46.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.7 p -115.72 99.99 7.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.22 0.533 . . . . 0.0 109.828 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 t -80.07 68.35 6.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.494 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 67.65 30.27 74.62 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.692 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.47 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -70.59 133.07 46.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.671 0.272 . . . . 0.0 111.198 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -39.15 -49.92 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.175 179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.537 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -157.56 20.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.857 178.182 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.513 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.3 OUTLIER 70.98 -57.52 0.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.0 -178.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 160.75 81.14 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.443 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.435 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 3.8 mm? -104.86 -9.42 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.896 0.348 . . . . 0.0 111.592 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.47 -36.48 4.19 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.714 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.32 -147.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 711' ' ' GLN . 0.9 OUTLIER -144.92 -159.61 1.02 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.783 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 710' ' ' LEU . 3.5 mt-30 69.46 -65.51 0.3 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -106.35 98.4 8.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.616 178.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.65 100.32 9.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.434 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 1.7 mmm-85 34.88 90.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.652 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.42 142.25 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.079 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 62.4 t -86.82 130.29 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 111.391 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mt -104.84 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.17 148.54 25.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -84.8 151.17 24.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.823 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.09 -177.78 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.23 -30.54 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.193 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.82 -51.97 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -46.42 72.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -32.86 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -67.82 -38.42 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.49 -44.34 80.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.5 p -73.21 -26.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.34 -34.38 66.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.809 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -98.63 29.26 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.414 HD11 ' CG ' ' A' ' 602' ' ' PHE . 5.8 tt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 62.46 150.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 22.9 mt -108.67 159.44 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.028 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 41.5 p90 179.8 142.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 45.5 mt -121.93 129.64 52.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.889 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.915 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.52 -22.26 32.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.685 0.279 . . . . 0.0 111.059 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 136.23 -32.45 2.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.332 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 16.9 ttm180 -110.28 143.33 40.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 111.713 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 1.9 t80 -122.87 -40.28 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.459 HD13 HG12 ' A' ' 696' ' ' ILE . 12.0 tp -126.96 142.24 51.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 111.041 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 695' ' ' GLU . 22.1 m -124.9 114.19 18.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.052 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.465 ' CD1' HG13 ' A' ' 594' ' ' ILE . 2.9 mp -106.86 108.93 20.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.47 100.52 50.3 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 51.9 Cg_exo -44.53 103.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.083 1.855 . . . . 0.0 110.056 177.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.83 158.22 84.88 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.9 Cg_endo -49.71 -23.92 8.99 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.021 3.147 . . . . 0.0 113.199 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.37 -26.29 66.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 2.7 t -95.97 153.5 17.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.72 178.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 13.1 pt -55.04 -14.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.45 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 582' ' ' PRO . 2.5 tt -112.67 131.9 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 111.822 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -113.67 69.54 0.7 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.577 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mt-10 -125.41 170.79 11.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.577 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.15 130.14 47.63 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 121.055 0.455 . . . . 0.0 111.045 178.483 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -112.63 136.57 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.267 179.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 13.8 mt-10 -123.95 110.7 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.544 HG12 ' CD1' ' A' ' 601' ' ' PHE . 63.1 mt -78.72 109.79 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.3 mp0 -67.8 115.27 7.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.73 -28.95 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 111.07 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.87 -22.31 73.78 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.484 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.48 119.45 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 117.657 0.728 . . . . 0.0 111.821 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.8 t30 -138.83 122.41 11.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.629 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.7 Cg_endo -90.33 160.59 32.84 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.632 -0.987 . . . . 0.0 111.908 0.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -91.89 119.58 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.421 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 29.2 m-85 -92.97 138.35 31.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.453 -177.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 611' ' ' CYS . 3.5 mp -129.69 141.14 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 163.99 -166.97 37.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.947 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.415 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 14.8 ttp85 -87.31 7.0 30.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.651 0.262 . . . . 0.0 111.275 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 2.4 t -101.35 125.79 48.03 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.52 -22.92 36.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -25.03 66.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.414 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 84.1 m -73.71 126.97 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.5 m120 -43.13 -33.71 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.524 ' HB3' HG13 ' A' ' 603' ' ' ILE . 51.4 t -106.97 136.17 47.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.606 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 115.5 25.18 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.431 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 13.5 mm -137.69 109.87 6.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.058 178.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mt-10 -83.96 103.33 13.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.867 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.473 ' CB ' ' HB2' ' A' ' 618' ' ' LEU . 5.1 m-20 -132.08 112.98 12.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.306 178.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -42.58 -45.96 4.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.413 ' HB3' HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.98 -30.95 69.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.382 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.526 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -65.26 159.08 24.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.828 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -114.31 167.34 10.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.024 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.434 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -44.48 -62.44 1.18 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.1 58.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.471 0.653 . . . . 0.0 109.476 178.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.526 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 56.0 t60 -47.09 -49.67 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.559 -179.026 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.2 p -162.99 157.19 20.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 650' ' ' CYS . 1.9 p90 -143.56 146.95 33.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 69.6 mt -101.74 131.51 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.878 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -123.9 135.46 53.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.458 ' HB2' HG21 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.49 134.06 41.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.47 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.85 159.51 41.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.074 -178.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -76.67 112.47 13.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 -79.74 129.91 34.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.74 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.22 144.71 33.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.044 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.57 134.29 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -85.58 -36.01 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.356 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 119.18 38.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.792 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.0 127.37 12.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.98 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -70.91 69.86 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 63.63 -78.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -100.11 105.41 17.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.27 152.09 77.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.24 176.0 9.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.592 2.195 . . . . 0.0 112.392 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 70.19 -65.07 0.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.16 -78.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -162.02 78.5 0.16 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.587 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 630' ' ' HIS . 6.9 mt -113.87 -156.88 0.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -114.61 148.41 38.12 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 4.8 m-20 -135.7 145.99 47.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.346 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 672' ' ' LEU . 3.2 pt -95.29 122.65 46.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.577 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.516 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 77.2 m95 -105.33 129.92 53.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.435 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 8.2 t80 -90.63 116.83 28.82 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 624' ' ' PHE . 5.9 m -102.36 142.53 33.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.362 . . . . 0.0 111.253 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.47 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 64.4 t60 -122.85 127.44 49.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -123.76 0.23 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.348 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.94 147.88 31.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -25.89 63.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.446 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.9 OUTLIER -68.6 -5.28 19.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.125 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.39 123.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.47 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 6.7 t -93.94 165.86 12.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.677 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 2.4 m-85 -135.67 120.74 18.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.42 HD23 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.62 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.614 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 62.49 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.21 -5.36 3.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.69 132.12 43.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' ' 658' ' ' TYR . 15.0 mtm-85 -75.23 141.69 43.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 3.8 mtp -119.3 110.46 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.919 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 46.0 pt -87.91 148.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -47.92 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.337 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 116.25 40.08 0.83 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.722 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.7 p -139.18 162.12 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.51 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 6.2 pttm -129.0 158.09 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 671' ' ' LEU . 9.9 t80 -147.18 146.72 29.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.516 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.45 131.75 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.254 0.55 . . . . 0.0 111.671 -179.024 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.469 ' HB2' ' CD1' ' A' ' 647' ' ' ILE . 0.6 OUTLIER -105.59 128.12 53.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.982 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 3.3 mt-30 -117.16 157.72 25.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.947 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 696' ' ' ILE . 7.2 t70 -57.15 99.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.182 0.515 . . . . 0.0 110.393 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.43 29.37 3.96 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.227 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.28 114.5 23.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -95.44 108.04 20.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.57 128.5 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.954 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.08 115.82 31.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.5 HG13 HD12 ' A' ' 618' ' ' LEU . 4.8 pt -87.87 -16.2 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.431 HD13 HG21 ' A' ' 681' ' ' ILE . 20.4 mt -154.83 130.22 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.136 178.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.419 ' CZ2' ' HG2' ' A' ' 684' ' ' LYS . 8.0 t90 -137.48 132.07 32.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 682' ' ' TRP . 0.2 OUTLIER -117.46 116.22 26.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -68.04 -47.42 68.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.273 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -83.43 -40.73 18.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -19.2 60.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.409 -179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.01 10.12 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.81 104.93 16.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.9 135.34 62.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.804 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 681' ' ' ILE . 0.6 OUTLIER -119.48 131.7 71.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.495 179.317 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.74 135.02 4.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.358 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.462 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.24 148.14 37.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -100.94 116.67 33.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.265 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.7 t -80.05 131.24 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 579' ' ' THR . 11.2 tt0 -134.82 108.66 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.459 HG12 HD13 ' A' ' 578' ' ' LEU . 13.0 mt -77.33 105.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.73 -46.79 8.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 10.7 t70 -111.39 140.38 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -115.34 100.66 8.27 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.586 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 t -65.42 66.41 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.306 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.62 47.68 36.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.373 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.48 ' CD2' ' HB ' ' A' ' 699' ' ' THR . 1.3 pt? -115.54 179.99 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.675 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -70.48 113.39 7.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.343 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 705' ' ' GLU . 16.9 t30 53.22 -73.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.521 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.675 ' N ' ' O ' ' A' ' 703' ' ' PHE . 4.6 pt-20 176.66 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.542 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 145.61 44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.446 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -81.99 -2.4 51.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.531 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 44.18 83.36 0.02 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.935 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.419 ' HE1' ' CZ ' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -121.42 103.39 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 110.841 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -151.39 -168.62 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -54.72 -45.05 73.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.051 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -82.94 126.8 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.886 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -84.31 100.64 11.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 46.49 81.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.534 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.65 142.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.512 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 8.3 p -81.36 123.71 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.3 mp -93.49 163.19 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -103.36 148.79 25.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.95 159.77 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -173.26 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.124 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.79 -28.87 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.031 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -49.67 75.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -47.77 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -55.89 -32.57 63.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -66.85 -36.64 82.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.11 -44.93 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.29 -24.48 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -58.29 -32.49 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -112.88 27.11 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.911 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.587 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.844 0.355 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.56 129.83 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 26.8 mt -117.83 134.62 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -178.64 126.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 6.5 mt -122.74 -169.13 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.82 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 16.4 t0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.905 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -106.89 141.97 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -127.12 -61.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.38 139.51 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.608 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.3 m -115.68 115.07 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.163 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.638 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -105.52 108.44 19.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.96 100.19 48.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 16.8 Cg_exo -46.86 100.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.783 1.655 . . . . 0.0 109.473 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.57 157.53 86.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.99 -29.2 26.62 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.701 2.934 . . . . 0.0 112.657 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.07 -25.1 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.3 t -95.76 153.48 17.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.975 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 689' ' ' VAL . 8.6 tt -53.97 -16.1 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 613' ' ' ILE . 16.5 mt -108.49 136.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.587 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 55.91 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.976 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.3 mm-40 -124.6 169.62 11.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.645 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.11 118.73 20.93 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 111.508 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.645 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.47 145.53 41.03 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.0 OUTLIER -124.33 123.37 40.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -78.47 108.82 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.4 mp0 -65.57 122.15 16.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.43 -28.48 2.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.166 0.508 . . . . 0.0 110.333 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.54 -22.74 78.81 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.805 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.437 HG11 ' ND2' ' A' ' 610' ' ' ASN . 62.0 t -98.94 117.74 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.093 0.947 . . . . 0.0 111.608 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -140.58 122.61 9.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -89.9 159.79 34.57 Favored 'Cis proline' 0 N--CA 1.46 -0.448 0 C-N-CA 124.299 -1.125 . . . . 0.0 111.618 -0.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.0 t80 -92.41 116.1 28.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 730' ' ' LEU . 40.4 m-85 -92.72 138.27 31.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.169 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.6 mp -124.94 146.27 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.91 -173.95 35.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.245 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -66.84 -50.67 61.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.579 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.51 129.52 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.605 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -20.18 9.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.824 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.575 ' HB3' HD21 ' A' ' 730' ' ' LEU . 3.4 t0 -54.91 -31.72 60.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.172 0.51 . . . . 0.0 110.14 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 621' ' ' VAL . 60.6 m -71.89 126.98 31.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.517 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.5 m120 -42.94 -33.77 0.85 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.318 0.58 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -104.93 141.14 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.894 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.693 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.36 104.81 13.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 612' ' ' LYS . 9.1 mm -138.95 109.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.957 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.45 106.6 17.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 112.346 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.636 ' H ' HD11 ' A' ' 618' ' ' LEU . 0.9 OUTLIER -129.52 107.42 9.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.58 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -38.8 -30.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 681' ' ' ILE . 5.9 tpp180 -68.94 -41.99 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.636 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.6 pp -89.21 156.76 18.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.3 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 162.96 28.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.558 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.6 -26.08 12.45 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.071 0.462 . . . . 0.0 110.36 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.558 HG23 ' HG2' ' A' ' 620' ' ' ARG . 41.2 t -131.31 63.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.471 ' ND1' ' CB ' ' A' ' 618' ' ' LEU . 24.9 t60 -49.73 -44.31 48.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.8 p -169.86 161.58 9.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 111.716 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 727' ' ' VAL . 40.2 p90 -143.59 148.77 36.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.949 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.71 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.1 mp -102.22 130.71 51.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -121.39 134.74 55.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.53 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.8 ttmt -97.92 137.11 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.324 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 158.99 42.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.75 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.9 tpt180 -76.49 112.61 13.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 110.531 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.578 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.838 -0.105 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -99.83 -157.56 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.698 ' O ' HD23 ' A' ' 702' ' ' LEU . 5.1 m-20 -122.19 146.66 47.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.461 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.24 160.35 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.115 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -106.71 123.3 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 112.085 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.83 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.3 m95 -106.4 128.42 54.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.475 ' CB ' HD21 ' A' ' 672' ' ' LEU . 17.3 t80 -90.89 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 17.2 m -103.69 129.53 51.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.424 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.441 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 43.4 t60 -111.53 126.9 55.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 29.4 p -123.36 3.58 9.12 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.279 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.94 142.6 26.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.137 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.5 m -75.38 -19.94 59.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.418 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.576 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m-20 -82.79 3.27 30.12 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.59 133.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.57 0.7 . . . . 0.0 112.38 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 96.3 p -103.92 166.48 10.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.153 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -127.36 119.8 27.06 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.559 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.688 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.01 104.56 16.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.512 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.1 m120 60.11 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.701 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 659' ' ' LEU . 14.6 m-20 -139.35 7.99 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.65 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 716' ' ' VAL . 4.1 m120 -107.97 141.48 39.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.574 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -74.68 141.46 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.2 OUTLIER -129.08 91.41 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.085 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.3 pt -87.5 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.81 104.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.878 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.38 33.89 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.55 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 3.0 p -125.37 162.17 25.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 111.897 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -135.33 149.91 49.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.7 144.87 28.63 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.83 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.18 133.52 48.08 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.748 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -106.31 109.21 21.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -98.83 132.9 43.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.047 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.763 ' HB2' HD12 ' A' ' 696' ' ' ILE . 7.5 t70 -37.01 120.52 0.74 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.98 38.57 5.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.3 t0 -95.44 120.55 35.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 0.0 111.441 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -97.41 113.88 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.3 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD13 ' A' ' 659' ' ' LEU . 27.0 pt -110.06 137.18 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.968 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.6 mttp -101.14 116.34 32.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.055 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.569 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -81.54 -38.24 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.43 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.29 133.96 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.42 124.48 22.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -125.96 117.57 23.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.792 0.329 . . . . 0.0 110.645 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -66.8 -46.52 74.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.899 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.22 -40.52 37.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.9 -11.92 56.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.5 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt 59.93 19.29 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.403 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 2.2 t80 -84.34 105.02 14.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.8 OUTLIER -125.78 126.0 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.037 0.446 . . . . 0.0 111.925 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 681' ' ' ILE . 11.8 mt -119.33 148.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.804 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -168.21 129.03 1.81 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.392 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.469 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.3 141.84 46.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.761 0.315 . . . . 0.0 110.28 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.696 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.9 tptp -101.29 116.45 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.83 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.802 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.96 120.04 33.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.453 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.37 109.32 10.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.958 0.409 . . . . 0.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 674' ' ' ASP . 33.5 mt -75.99 105.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ASN . . . . . 0.4 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.0 OUTLIER -83.67 -45.32 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 65.4 m-20 -110.39 141.59 43.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.452 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.2 p -113.52 99.88 8.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.348 0.594 . . . . 0.0 109.957 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 700' ' ' THR . 7.0 t -77.1 62.52 2.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.486 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.42 49.34 70.86 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.818 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -88.18 133.55 34.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.337 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.674 ' CD2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -33.84 -36.77 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.45 179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.674 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 15.3 p30 -171.98 30.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.862 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.113 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.76 0.314 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 663' ' ' ARG . 88.8 t -80.83 122.8 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -95.47 163.22 13.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.51 146.5 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.2 160.02 14.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.84 -173.46 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.16 28.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -42.02 98.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.166 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 726' ' ' LEU . 6.6 tm-20 -69.99 -51.07 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.464 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -54.33 -32.88 57.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -36.48 81.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.605 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 723' ' ' GLU . 79.9 mt -55.8 -44.05 77.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.694 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.61 HG22 ' CE1' ' A' ' 624' ' ' PHE . 1.5 t -73.95 -23.15 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -36.53 80.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.71 -11.94 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.171 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.785 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.1 tt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.463 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.444 0 CA-C-O 120.359 -0.134 . . . . 0.0 112.884 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 8.2 ttm180 -108.01 143.84 36.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.998 0.428 . . . . 0.0 111.452 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -128.82 -56.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.256 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -111.54 139.59 46.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.904 ' N ' HD23 ' A' ' 578' ' ' LEU . 1.9 m -120.97 114.19 21.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 111.495 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 594' ' ' ILE . 1.5 mp -103.02 108.22 19.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.68 100.88 53.97 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.5 Cg_exo -45.96 101.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.893 1.729 . . . . 0.0 109.357 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -75.12 157.42 85.22 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.59 -27.19 14.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.467 2.778 . . . . 0.0 112.491 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 583' ' ' LEU . 41.8 t0 -62.16 -25.93 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 18.0 p -95.76 154.07 17.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.805 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.456 HD13 ' CE1' ' A' ' 688' ' ' PHE . 0.4 OUTLIER -58.87 -10.73 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.996 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.764 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.3 mt -111.11 118.58 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 111.751 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.05 57.09 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 72.7 mt-10 -124.56 171.86 9.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.286 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.0 126.79 42.03 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.771 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.16 135.56 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.416 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mt-10 -124.5 118.27 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 601' ' ' PHE . 83.8 mt -79.88 108.6 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.9 mp0 -62.77 118.1 7.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -45.76 -28.95 1.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.77 -14.23 82.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.908 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.02 118.07 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.941 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 1.1 t30 -140.46 123.52 10.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.736 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.505 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.2 Cg_endo -90.82 159.02 29.69 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.379 -1.092 . . . . 0.0 112.157 0.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.65 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.8 t80 -93.12 117.49 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.197 0.522 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 730' ' ' LEU . 3.5 m-85 -93.53 138.65 31.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.393 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.8 HD11 HD12 ' A' ' 625' ' ' ILE . 3.5 mp -129.61 142.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.43 -158.2 31.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.189 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.4 ttp85 -96.43 -0.63 48.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.13 133.04 46.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -56.76 -24.79 52.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.99 -27.92 63.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 56.2 m -78.14 131.02 37.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.1 m120 -47.65 -30.86 4.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.496 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.8 t -109.14 140.66 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.453 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.31 120.96 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.764 HG23 ' CD1' ' A' ' 588' ' ' ILE . 29.2 mm -137.97 109.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.745 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 tt0 -86.91 102.32 14.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.703 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.813 ' HB2' HD13 ' A' ' 618' ' ' LEU . 3.4 m-20 -133.24 111.47 10.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.37 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -42.5 -33.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.819 0.343 . . . . 0.0 111.48 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -77.76 -41.47 37.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.813 HD13 ' HB2' ' A' ' 615' ' ' ASP . 1.2 mp -59.97 158.95 9.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.97 174.19 6.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.66 -62.94 1.15 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.395 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.0 t -105.18 53.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.519 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 70.7 t60 -43.12 -39.96 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.515 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.36 173.15 12.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.415 0.626 . . . . 0.0 111.447 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.639 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.06 135.2 25.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.973 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.8 HD12 HD11 ' A' ' 603' ' ' ILE . 23.0 mt -131.81 117.12 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -135.16 144.49 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.549 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.3 ptpt -101.0 137.46 39.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.62 159.65 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.275 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.52 117.24 17.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.254 0.55 . . . . 0.0 110.672 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.483 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.805 -0.118 . . . . 0.0 112.805 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -101.14 -157.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.9 OUTLIER -122.36 147.11 46.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.061 0.457 . . . . 0.0 111.697 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.9 160.24 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.519 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -106.97 128.14 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 112.359 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.916 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -112.15 120.57 42.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.574 ' HB3' HD21 ' A' ' 672' ' ' LEU . 1.3 t80 -92.71 117.63 30.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.9 m -111.22 145.07 39.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 42.3 t60 -119.55 125.36 48.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.436 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.2 5.59 11.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.19 134.55 13.35 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.998 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 654' ' ' THR . 54.7 m -65.64 -12.8 56.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.6 OUTLIER -82.35 -2.79 53.98 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.5 0.19 . . . . 0.0 111.339 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.32 128.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.265 0.555 . . . . 0.0 112.071 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.434 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 18.2 p -99.89 166.38 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.142 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 3.9 m-85 -135.54 119.5 17.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.747 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.81 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -98.88 112.25 24.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.033 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.43 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -136.26 2.43 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.889 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -100.59 141.39 33.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.83 0.348 . . . . 0.0 111.024 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 34.5 ttt180 -81.11 141.34 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.738 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.42 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.9 mmm -121.58 100.43 7.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.973 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.404 HG12 ' CG2' ' A' ' 668' ' ' THR . 35.9 pt -87.5 149.39 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -44.43 112.67 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.406 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.79 5.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.8 p -115.22 162.56 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.499 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 717' ' ' LEU . 4.6 ttpm? -134.75 147.71 50.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.127 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.5 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.52 144.28 28.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.916 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 134.72 49.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.729 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 694' ' ' VAL . 1.3 mt -106.69 111.99 24.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.251 0.548 . . . . 0.0 111.27 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -98.33 143.19 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.172 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.515 ' HB3' HD12 ' A' ' 696' ' ' ILE . 26.3 p30 -43.14 111.85 0.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.73 37.94 5.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.64 118.41 29.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.069 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -96.17 108.5 20.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.81 HG22 ' CD2' ' A' ' 659' ' ' LEU . 7.7 pt -105.66 129.16 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.482 . . . . 0.0 111.971 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 5.7 mttt -89.77 115.77 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.717 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.723 HD13 HD21 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -76.05 -39.38 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.854 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.649 HG22 ' CG1' ' A' ' 690' ' ' ILE . 15.6 tt -155.88 136.75 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -135.89 127.79 29.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.119 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.3 116.94 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.245 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -67.03 -46.89 73.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.35 -40.32 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.404 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.38 -16.54 56.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.9 15.92 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.004 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.456 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.2 t80 -77.03 104.61 7.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.1 p -118.99 122.24 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.649 ' CG1' HG22 ' A' ' 681' ' ' ILE . 42.8 mm -128.29 119.7 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.572 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -146.31 133.29 4.84 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.165 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.8 m-30 -113.09 144.56 42.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 110.455 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.713 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -101.17 117.29 34.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 672' ' ' LEU . 3.2 t -81.74 114.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.78 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -123.94 108.58 12.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 0.0 110.372 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.539 HD13 ' O ' ' A' ' 705' ' ' GLU . 18.4 mt -81.86 110.44 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.729 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.5 -45.29 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.54 140.43 46.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.101 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -114.65 100.37 8.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 596' ' ' GLN . 9.3 t -91.08 50.74 1.82 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.479 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 108.52 33.29 2.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.502 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.1 mm? -93.81 120.33 33.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.579 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 4.9 p90 -40.45 -34.33 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.474 0.654 . . . . 0.0 110.339 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -147.88 -44.69 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.539 ' O ' HD13 ' A' ' 696' ' ' ILE . 16.1 pt-20 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 124.69 1.196 . . . . 0.0 108.148 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.889 HG23 ' OD1' ' A' ' 662' ' ' ASN . 59.7 t -79.71 129.67 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.379 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.549 HD11 ' HZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -102.17 172.52 6.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -101.24 157.87 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 0.0 111.189 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.93 152.07 19.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.4 p -126.41 -177.82 4.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.616 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -28.9 36.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.988 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.57 -48.81 78.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.757 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.1 mp0 -69.77 -50.04 47.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.592 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -60.5 -32.05 71.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.41 -40.45 93.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.621 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.2 mt -61.91 -44.4 96.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.591 HG23 HD13 ' A' ' 730' ' ' LEU . 9.3 p -79.49 -12.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.24 -28.53 7.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.984 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -102.08 -63.2 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 602' ' ' PHE . 1.1 tp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.937 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -106.54 143.14 35.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.725 ' CE1' HG21 ' A' ' 647' ' ' ILE . 3.7 t80 -132.69 -47.28 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.748 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.4 tp -121.27 142.44 49.93 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.896 0.379 . . . . 0.0 111.015 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.7 m -120.3 114.94 22.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -104.57 108.59 20.12 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 mtmp? -111.84 99.25 44.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.8 Cg_exo -47.66 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.849 1.699 . . . . 0.0 109.572 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.567 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.58 158.12 85.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -176.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.94 -25.17 8.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.509 2.806 . . . . 0.0 112.731 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 m-20 -61.64 -28.26 69.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' HD13 ' A' ' 690' ' ' ILE . 6.4 t -95.65 154.01 17.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.816 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 690' ' ' ILE . 2.2 pt -57.87 -11.49 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.897 HD13 HG12 ' A' ' 613' ' ' ILE . 19.6 mt -107.6 118.51 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.498 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.03 55.73 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.155 0.503 . . . . 0.0 110.332 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.639 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 19.7 mt-10 -125.03 171.67 10.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.192 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.48 129.9 49.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.845 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.801 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.21 141.96 45.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.403 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.2 mt-10 -124.02 110.52 14.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.298 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.78 HD11 HD12 ' A' ' 625' ' ' ILE . 59.3 mt -76.83 109.3 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.7 mp0 -67.03 114.67 5.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.58 -30.61 1.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.217 0.532 . . . . 0.0 110.557 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -64.66 -23.57 68.99 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.149 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.0 119.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.489 0.644 . . . . 0.0 111.34 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 21.7 t30 -138.72 122.26 11.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.9 Cg_endo -90.5 160.34 31.87 Favored 'Cis proline' 0 C--N 1.345 0.383 0 C-N-CA 124.627 -0.989 . . . . 0.0 111.815 -0.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.695 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.36 114.7 27.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.526 ' CG ' HD12 ' A' ' 730' ' ' LEU . 13.9 m-85 -91.84 138.07 31.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.993 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.781 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -127.36 145.41 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.716 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.55 -172.77 33.69 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.945 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.3 OUTLIER -74.02 -6.83 49.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.496 0.319 . . . . 0.0 111.857 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.571 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -89.51 125.01 35.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.811 0.339 . . . . 0.0 111.12 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -59.01 -20.25 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.578 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -23.96 63.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 54.8 m -70.72 130.35 41.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -44.77 -32.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.512 . . . . 0.0 110.347 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.1 t -110.28 139.88 45.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.342 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.12 110.05 16.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.897 HG12 HD13 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -138.45 110.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.892 177.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.498 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 0.2 OUTLIER -85.73 106.41 16.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.296 0.569 . . . . 0.0 112.09 -178.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.998 ' HB2' HD22 ' A' ' 618' ' ' LEU . 1.6 m-20 -129.8 108.32 10.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.138 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -43.71 -37.65 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.327 . . . . 0.0 111.799 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.0 mmt180 -77.82 -34.18 52.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.855 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.998 HD22 ' HB2' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.16 128.11 34.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 111.336 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.4 p -57.16 159.65 4.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.663 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -58.14 -31.29 67.06 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 45.5 t -123.39 55.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.825 ' CD2' HG23 ' A' ' 680' ' ' ILE . 9.5 t60 -49.68 -49.18 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.172 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.7 p -164.08 160.3 21.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.23 0.538 . . . . 0.0 111.989 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 42.1 p90 -143.4 147.61 34.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 580' ' ' LEU . 57.6 mt -102.18 132.65 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.5 t80 -123.9 131.47 53.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.499 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.9 tttt -97.73 136.33 38.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 157.84 45.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.981 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -77.83 113.57 15.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 9.9 t-80 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.601 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.722 -0.151 . . . . 0.0 112.722 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.67 -156.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.836 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -122.19 147.51 46.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -136.6 141.71 43.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.319 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -94.67 121.19 45.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.345 0.593 . . . . 0.0 111.709 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.581 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -104.04 133.99 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.448 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 678' ' ' ILE . 12.4 t80 -93.14 117.39 30.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' CB ' ' CE1' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -102.84 136.4 42.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.13 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.445 ' CE1' ' N ' ' A' ' 657' ' ' SER . 14.9 t60 -115.42 126.28 54.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.16 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -122.89 6.49 9.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.47 157.78 40.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.167 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 41.1 m -89.65 -19.56 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.411 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.0 m120 -83.59 2.92 34.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.658 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 664' ' ' MET . 0.3 OUTLIER 50.14 136.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.735 0.779 . . . . 0.0 112.588 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.445 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -108.55 165.96 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.062 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.52 120.65 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.001 0.429 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 1.033 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.69 100.19 10.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.897 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 15.4 m-20 60.76 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 87.3 m-20 -135.44 2.7 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 11.8 m120 -104.86 135.3 46.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.871 0.367 . . . . 0.0 111.402 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.63 141.47 46.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.713 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.618 ' O ' HG23 ' A' ' 656' ' ' VAL . 44.2 mmm -120.86 88.66 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.144 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 668' ' ' THR . 39.4 pt -87.31 153.26 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.867 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -42.76 107.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.53 33.1 4.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.426 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.7 p -113.22 162.08 16.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 0.0 111.646 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.1 ttpm? -142.12 129.65 21.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.397 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -136.32 143.13 43.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 111.563 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.581 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -71.42 141.04 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 694' ' ' VAL . 5.4 mt -104.43 148.81 26.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.026 0.441 . . . . 0.0 111.122 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -120.3 162.22 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.73 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.5 t70 -65.61 95.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.55 32.73 2.86 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.2 113.17 20.9 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.711 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -95.74 108.49 20.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 1.033 HG22 HD13 ' A' ' 659' ' ' LEU . 32.9 pt -105.16 134.87 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.772 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.0 mtpt -95.36 115.42 27.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.278 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.825 HG23 ' CD2' ' A' ' 622' ' ' HIS . 32.4 mt -84.55 -34.93 9.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.648 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.57 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.77 130.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.018 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -137.2 126.48 24.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.78 116.54 22.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.496 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -46.5 72.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.727 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.71 -40.41 33.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.562 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.46 -13.56 54.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.352 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 63.43 15.56 8.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.627 0.251 . . . . 0.0 110.959 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -76.94 104.65 7.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.33 126.47 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 0.0 111.873 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.603 HD13 ' OG ' ' A' ' 586' ' ' SER . 21.4 mm -127.68 155.9 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.466 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.07 130.45 1.28 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.359 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 613' ' ' ILE . 10.7 m-30 -113.31 146.23 39.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.354 . . . . 0.0 110.503 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.567 ' HB2' HD22 ' A' ' 583' ' ' LEU . 18.6 tttp -101.35 117.0 34.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.15 126.65 39.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.667 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.9 OUTLIER -133.45 108.84 8.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.942 0.401 . . . . 0.0 110.736 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 705' ' ' GLU . 22.8 mt -73.98 105.18 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.87 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.77 -47.67 10.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.766 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.433 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.54 140.34 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.029 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.7 p -115.0 99.83 7.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.421 ' HB ' ' NZ ' ' A' ' 627' ' ' LYS . 11.6 m -76.18 69.63 2.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.7 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.54 49.39 74.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.867 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -85.66 133.47 34.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.53 0.205 . . . . 0.0 111.158 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.531 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.3 p90 -44.88 -32.22 1.52 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.594 0.712 . . . . 0.0 109.842 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.3 t-20 -148.4 -56.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.646 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.677 ' O ' HD13 ' A' ' 696' ' ' ILE . 2.7 pt-20 . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.488 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.8 p -82.88 117.67 29.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.89 171.72 10.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 157.68 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.36 154.73 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.919 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 23.7 p -126.24 -176.55 3.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.73 64.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -63.61 -52.25 61.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -64.63 -46.95 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.73 -32.77 65.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.34 -36.92 82.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 31.4 mt -59.78 -44.07 94.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.003 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.9 -20.36 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -50.56 64.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -61.66 -29.12 69.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.0 tt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -106.57 143.3 34.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.362 . . . . 0.0 111.123 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.711 ' HE1' HG21 ' A' ' 647' ' ' ILE . 1.1 t80 -132.96 -51.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.032 HD11 HG13 ' A' ' 694' ' ' VAL . 21.2 tp -114.52 142.59 46.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.555 HG21 ' HE2' ' A' ' 581' ' ' LYS . 7.9 m -122.62 116.6 24.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.945 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.7 mt -103.33 108.83 20.22 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 54.6 mttt -110.57 98.38 36.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -176.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.2 Cg_exo -49.67 106.86 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.793 1.662 . . . . 0.0 109.225 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.04 157.37 87.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 12.0 Cg_endo -54.74 -24.88 39.78 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.07 3.18 . . . . 0.0 113.457 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.542 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.4 m-20 -62.11 -22.31 65.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.069 0.461 . . . . 0.0 109.818 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.457 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 2.0 t -97.69 154.01 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.683 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.527 HD11 ' CE1' ' A' ' 688' ' ' PHE . 7.3 pt -51.22 -21.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.497 . . . . 0.0 110.014 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 690' ' ' ILE . 38.9 mt -105.16 118.84 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.71 59.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.649 . . . . 0.0 110.264 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.66 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.78 172.56 9.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.727 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.18 131.55 53.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.758 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.62 143.96 42.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.207 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.05 116.61 23.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 111.708 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.87 HD11 HD12 ' A' ' 625' ' ' ILE . 73.0 mt -81.89 109.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.879 0.371 . . . . 0.0 110.443 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.8 mp0 -65.08 115.63 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.34 -30.51 2.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.258 0.551 . . . . 0.0 110.681 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -20.21 72.76 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.23 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.24 118.92 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 117.35 0.575 . . . . 0.0 111.65 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.9 t30 -139.35 121.53 10.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.72 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -89.99 160.46 34.45 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 124.555 -1.019 . . . . 0.0 111.63 -0.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.664 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.42 116.63 29.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 20.8 m-85 -92.62 138.57 31.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.29 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -129.08 141.84 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.87 -170.2 38.31 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 119.964 -1.113 . . . . 0.0 113.92 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 ttp85 -80.33 1.44 28.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.356 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 14.4 t -101.19 119.78 39.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -51.72 -24.64 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.015 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -61.4 -26.71 68.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.991 0.424 . . . . 0.0 110.391 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.2 m -71.57 128.75 36.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.853 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -43.43 -34.63 1.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.289 0.566 . . . . 0.0 110.287 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 50.7 t -106.29 141.29 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.099 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 111.47 20.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.682 HG23 ' CD1' ' A' ' 588' ' ' ILE . 18.3 mm -137.73 108.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.127 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.19 106.6 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.662 . . . . 0.0 112.497 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.544 ' CB ' HD13 ' A' ' 618' ' ' LEU . 5.0 t70 -130.53 125.93 35.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.722 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -43.64 -34.18 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.778 0.323 . . . . 0.0 111.223 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB2' HD13 ' A' ' 681' ' ' ILE . 26.2 mmt180 -77.35 -39.06 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CE1' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -59.54 158.21 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.06 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.07 163.92 13.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.304 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.452 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -46.04 -55.33 7.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 730' ' ' LEU . 39.5 t -110.08 62.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.421 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 2.0 t-160 -47.1 -48.09 22.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.576 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 680' ' ' ILE . 24.7 p -166.82 157.12 11.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.2 p90 -144.12 143.67 31.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.889 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.87 HD12 HD11 ' A' ' 594' ' ' ILE . 45.5 mt -101.59 131.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -122.46 132.52 54.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 702' ' ' LEU . 7.6 ttmt -98.07 136.53 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.545 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.8 158.66 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.197 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.94 113.47 14.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.536 0.684 . . . . 0.0 110.391 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.0 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.269 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -93.95 -159.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 1.4 m-20 -119.58 146.9 45.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 112.206 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -127.05 160.16 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.777 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.837 HD13 HD22 ' A' ' 578' ' ' LEU . 2.6 pt -111.22 120.98 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.587 . . . . 0.0 111.902 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.54 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -103.05 136.28 43.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.483 ' HE2' ' HG ' ' A' ' 657' ' ' SER . 9.2 t80 -99.08 119.37 37.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.851 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 6.9 m -110.0 141.87 42.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.035 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 34.0 t60 -121.74 122.76 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 621' ' ' VAL . 0.6 OUTLIER -116.15 11.36 15.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.44 139.72 15.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.811 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 654' ' ' THR . 26.3 m -72.49 -8.17 53.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.58 ' C ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -85.43 2.78 43.05 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' C ' ' A' ' 655' ' ' ASN . 1.8 m 60.21 146.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 111.275 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.483 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 0.3 OUTLIER -116.16 162.61 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.085 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -137.44 120.37 16.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.362 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.856 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -108.6 116.67 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.131 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 60.24 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.95 2.12 2.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -102.23 141.24 35.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.638 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -94.11 141.71 28.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.505 ' HB2' ' OG1' ' A' ' 668' ' ' THR . 4.5 ptp -138.04 142.68 40.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.405 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.443 ' H ' HG21 ' A' ' 668' ' ' THR . 17.7 pt -112.12 165.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.393 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -47.15 117.59 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.955 0.407 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 101.58 23.08 9.7 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 664' ' ' MET . 10.9 p -112.24 162.37 15.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.462 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.408 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 3.2 ttpm? -134.94 145.04 47.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.659 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -145.95 134.36 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.943 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.54 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -68.69 140.54 55.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 1.001 HD13 HG21 ' A' ' 694' ' ' VAL . 9.3 mt -110.07 122.79 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 0.0 111.906 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 47.0 mt-30 -104.18 137.6 41.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.593 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.618 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.7 t70 -40.52 108.82 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.975 0.417 . . . . 0.0 111.007 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.92 35.55 4.79 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 3.0 t0 -95.55 122.81 38.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.329 . . . . 0.0 111.079 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.02 108.38 20.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.856 HG22 ' CD2' ' A' ' 659' ' ' LEU . 5.5 pt -106.55 131.95 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 112.141 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 3.1 mtmt -104.01 127.03 51.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.02 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.861 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -95.11 -25.15 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.744 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.678 HG22 ' CG2' ' A' ' 690' ' ' ILE . 7.6 tt -155.23 131.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -136.59 126.7 26.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.746 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.4 117.03 28.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.644 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -67.04 -46.53 74.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.877 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -79.87 -40.41 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.601 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -79.98 -20.24 45.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.294 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 8.97 6.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.223 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 587' ' ' ILE . 1.7 t80 -77.02 105.15 7.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.3 p -119.64 121.87 67.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.451 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 588' ' ' ILE . 2.4 tt -120.8 121.44 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.5 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -140.39 137.95 8.69 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.331 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.3 m-30 -113.35 142.33 45.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -100.96 117.37 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.023 0.44 . . . . 0.0 110.925 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -83.66 122.51 37.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.565 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.09 109.59 9.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 705' ' ' GLU . 27.5 mt -77.32 108.62 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.937 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.36 -43.36 9.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.08 141.54 42.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER -114.23 100.56 8.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.38 0.61 . . . . 0.0 109.671 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.4 57.83 4.21 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 81.56 37.97 15.68 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.24 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.47 134.55 38.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.522 0.201 . . . . 0.0 110.591 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.641 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.3 p90 -43.62 -33.27 1.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.472 0.653 . . . . 0.0 110.323 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -147.98 -61.25 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.676 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 696' ' ' ILE . 16.6 pt-20 . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.043 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.915 0.388 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.861 HG23 ' OD1' ' A' ' 662' ' ' ASN . 90.4 t -78.29 118.43 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.32 172.02 8.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.52 154.31 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -91.29 156.31 17.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -126.02 -173.96 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.85 -33.5 64.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.23 -50.49 73.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 726' ' ' LEU . 25.3 mm-40 -65.53 -50.26 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -57.93 -32.93 68.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -63.57 -38.69 92.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.72 HD22 ' HD3' ' A' ' 600' ' ' PRO . 9.5 mt -61.06 -44.52 97.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.3 p -73.5 -26.83 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -58.57 -30.93 67.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -86.67 -18.87 30.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.159 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 9.1 ttm180 -112.09 119.56 38.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.797 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.2 t80 -100.91 -46.31 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 647' ' ' ILE . 7.9 tp -120.69 142.54 49.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 111.485 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 695' ' ' GLU . 15.0 m -122.26 114.56 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.488 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.735 HD11 HD11 ' A' ' 625' ' ' ILE . 0.3 OUTLIER -103.66 108.59 19.94 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 25.4 mtmt -111.65 98.77 42.33 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_exo -46.84 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.838 1.692 . . . . 0.0 109.47 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.64 157.46 85.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.73 -25.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.583 2.855 . . . . 0.0 112.704 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.79 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -62.06 -27.52 68.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.421 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 4.2 t -95.63 153.94 17.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.749 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.436 HG12 ' CD1' ' A' ' 690' ' ' ILE . 8.3 pt -54.94 -13.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.649 ' CD1' HG23 ' A' ' 613' ' ' ILE . 51.1 mt -108.78 128.7 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.802 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.99 56.43 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.212 0.529 . . . . 0.0 110.256 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -124.62 171.97 9.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.58 128.65 45.94 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 178.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.764 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.08 139.94 47.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.708 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.2 113.82 18.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.021 HD11 HD12 ' A' ' 625' ' ' ILE . 71.6 mt -78.71 109.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.321 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.76 116.09 6.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.814 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -44.97 -32.42 1.63 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.224 0.535 . . . . 0.0 110.293 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.508 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.7 -18.78 74.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.747 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.413 HG11 ' OD1' ' A' ' 610' ' ' ASN . 56.4 t -100.5 118.59 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 117.769 0.785 . . . . 0.0 111.686 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.83 121.96 9.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.914 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.1 Cg_endo -90.42 160.26 32.22 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.545 -1.023 . . . . 0.0 111.659 -0.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -91.64 116.32 28.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 59.7 m-85 -91.91 138.04 31.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.897 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -129.87 145.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.831 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.36 -169.15 36.82 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -83.21 3.39 31.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.768 -0.216 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 7.2 t -101.29 126.32 48.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -57.31 -22.72 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.61 ' HB3' HD21 ' A' ' 730' ' ' LEU . 6.0 t0 -64.12 -25.43 68.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.665 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 89.9 m -73.41 132.91 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 5.7 m120 -48.48 -27.4 2.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.764 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -114.55 142.02 46.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 118.59 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 588' ' ' ILE . 32.5 mm -138.16 109.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.216 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 14.0 tt0 -89.94 102.98 15.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.797 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.52 112.89 12.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.212 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -43.57 -34.08 1.31 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.733 0.302 . . . . 0.0 111.392 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -77.55 -39.67 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.688 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.066 HD12 HD12 ' A' ' 681' ' ' ILE . 0.4 OUTLIER -61.12 159.2 12.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.541 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.1 m -110.29 167.21 10.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.44 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.3 OUTLIER -44.65 -55.51 5.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 110.229 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 727' ' ' VAL . 18.5 t -112.66 57.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.477 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 681' ' ' ILE . 43.1 t60 -45.57 -46.02 13.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.617 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 680' ' ' ILE . 7.0 p -167.1 155.86 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.3 p90 -143.32 147.96 35.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 594' ' ' ILE . 86.1 mt -102.65 139.79 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.972 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -131.44 133.62 45.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.506 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 700' ' ' THR . 29.3 ttmt -97.57 136.1 38.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.559 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 159.55 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.861 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 630' ' ' HIS . 0.9 OUTLIER -76.08 139.61 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.2 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.591 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.726 -0.149 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.822 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.3 OUTLIER -102.78 -153.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -122.37 147.44 46.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.277 0.56 . . . . 0.0 112.099 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -130.09 154.57 47.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 578' ' ' LEU . 4.0 pt -105.39 128.72 59.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.26 0.552 . . . . 0.0 111.844 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.868 ' CH2' HD22 ' A' ' 671' ' ' LEU . 78.8 m95 -111.74 140.79 46.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.756 ' CE2' HG21 ' A' ' 678' ' ' ILE . 13.4 t80 -104.62 117.25 33.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 97.1 m -105.6 126.2 51.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.423 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 23.8 t60 -104.36 122.79 46.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.67 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.44 5.24 13.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.57 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.64 146.14 20.57 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.043 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 654' ' ' THR . 37.6 m -79.6 -1.11 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.577 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -87.08 0.42 55.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.442 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.42 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.348 0.594 . . . . 0.0 111.87 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 11.9 p -102.54 165.65 10.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.669 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -137.03 119.95 16.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.783 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.76 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -97.25 106.08 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.91 -81.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -131.36 -4.27 3.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.592 ' HB3' HG23 ' A' ' 716' ' ' VAL . 6.1 m120 -97.43 138.65 34.55 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.751 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.9 ttm180 -85.26 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 2.6 mtp -130.17 122.88 29.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 0.0 111.14 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.506 ' H ' HG21 ' A' ' 668' ' ' THR . 20.7 pt -103.4 165.18 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.656 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -51.16 117.64 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 110.868 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.74 8.0 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.309 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.506 HG21 ' H ' ' A' ' 665' ' ' ILE . 16.6 p -112.77 162.19 16.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.978 0.418 . . . . 0.0 111.419 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.419 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.3 ttpm? -136.48 144.06 44.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.536 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.529 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.27 144.82 29.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.868 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.65 136.72 53.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.775 HD13 HG21 ' A' ' 694' ' ' VAL . 1.6 mt -108.19 127.89 54.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 0.6 OUTLIER -118.1 161.26 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.132 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.486 ' HB2' HD12 ' A' ' 696' ' ' ILE . 60.1 t0 -58.37 104.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.303 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.72 32.84 4.95 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -86.71 115.61 24.27 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.673 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.83 108.91 21.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.76 HG23 ' HG ' ' A' ' 659' ' ' LEU . 4.7 mt -105.16 131.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 0.0 112.036 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -93.32 115.54 28.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.182 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.627 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.3 OUTLIER -86.41 -37.89 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.136 -179.01 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.066 HD12 HD12 ' A' ' 618' ' ' LEU . 43.9 mt -155.36 130.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.392 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -136.79 127.09 26.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 4.0 t0 -126.35 116.56 21.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.37 . . . . 0.0 110.686 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -67.81 -46.2 72.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -58.55 -40.28 82.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.128 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -96.22 -20.24 18.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.5 tptp 72.04 1.91 4.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.318 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.67 105.37 7.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 586' ' ' SER . 3.6 p -110.78 138.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.913 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 587' ' ' ILE . 8.3 mm -112.65 145.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.55 128.57 1.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.4 m-30 -113.2 148.31 35.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 110.323 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.676 ' HB2' HD22 ' A' ' 583' ' ' LEU . 31.4 tttt -101.62 117.02 34.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.05 0.453 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.82 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.8 t -81.66 126.11 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.4 tt0 -133.98 108.69 8.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.746 HD13 ' HB2' ' A' ' 705' ' ' GLU . 34.1 mt -74.0 105.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.674 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.92 -47.61 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.875 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.478 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.6 t0 -111.08 140.06 45.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -115.14 100.62 8.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.166 0.507 . . . . 0.0 109.726 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.48 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.2 t -69.79 65.34 0.22 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.64 57.22 20.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.754 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.822 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -95.91 149.38 21.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 112.048 -179.028 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.547 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.72 -26.95 6.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.189 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.8 t-20 -160.13 -51.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.586 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.746 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.6 pt-20 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.729 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.818 0.342 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 663' ' ' ARG . 53.6 t -81.95 114.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.093 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 717' ' ' LEU . 4.2 mp -88.1 170.16 11.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.567 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -103.75 158.1 16.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -95.4 158.2 15.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.0 p -126.31 -176.49 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.56 -30.42 41.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.17 -45.01 96.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.585 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.9 mp0 -68.84 -49.67 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.557 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -56.25 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -41.8 89.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.4 mt -55.68 -44.33 77.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -76.56 -29.31 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -37.53 67.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.62 28.63 3.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 608' ' ' ASP . 4.3 tt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.655 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.393 -0.115 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.413 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 60.2 ttp180 -100.31 128.91 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.9 -57.55 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.364 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -108.82 137.56 46.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.75 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.7 m -116.95 114.6 24.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.012 HD12 HD11 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -103.56 108.03 19.13 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.32 100.46 53.48 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.8 Cg_exo -47.22 103.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.736 1.624 . . . . 0.0 109.545 176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.85 158.36 86.09 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.46 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 7.6 Cg_endo -49.66 -26.18 12.52 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.512 2.808 . . . . 0.0 112.705 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 583' ' ' LEU . 92.8 m-20 -63.5 -19.83 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.012 0.434 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 t -96.76 153.86 17.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.848 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.672 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -55.49 -20.49 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.695 HD12 HG23 ' A' ' 613' ' ' ILE . 59.7 mt -110.55 118.8 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.078 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.1 61.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.374 0.607 . . . . 0.0 110.307 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.93 171.95 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.835 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.28 132.61 53.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.026 0.441 . . . . 0.0 111.384 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.9 144.81 41.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.116 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.4 mt-10 -124.28 116.73 23.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 580' ' ' LEU . 66.7 mt -87.54 108.81 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -66.93 125.2 25.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 3.1 pt20 -46.49 -30.02 2.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.286 0.565 . . . . 0.0 110.148 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.454 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.6 -21.4 79.58 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 114.085 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.429 HG11 ' ND2' ' A' ' 610' ' ' ASN . 63.5 t -98.95 117.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.253 1.026 . . . . 0.0 111.797 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.7 t30 -140.51 121.28 9.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.917 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 40.4 Cg_endo -90.43 159.71 31.91 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.606 -0.998 . . . . 0.0 111.375 -0.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.663 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -92.16 117.41 29.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.499 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 14.2 m-85 -92.22 137.9 31.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.173 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.644 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -128.45 146.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.412 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.81 -165.88 37.78 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.89 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.7 OUTLIER -85.86 -6.65 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.519 -0.34 . . . . 0.0 111.767 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.0 130.79 47.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.323 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.36 -24.73 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.55 -28.96 61.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 110.528 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 92.9 m -73.65 133.09 43.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.486 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.515 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -47.91 -27.03 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.3 t -114.48 141.31 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.489 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.82 114.48 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.695 HG23 HD12 ' A' ' 588' ' ' ILE . 27.6 mm -137.9 109.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.187 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.4 pt-20 -92.01 103.02 15.58 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.846 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.672 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -132.88 110.94 10.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.318 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.97 -24.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.4 mmp_? -77.38 -41.38 40.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.937 HD23 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -84.75 158.7 20.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 111.535 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.8 t -93.55 178.25 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.719 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -47.13 -53.99 11.6 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.425 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 730' ' ' LEU . 33.7 t -113.87 62.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.211 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.7 ' CD2' HG23 ' A' ' 680' ' ' ILE . 59.1 t60 -48.86 -51.06 31.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.535 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 3.7 p -162.55 157.49 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.446 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.508 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.5 p90 -143.52 150.53 39.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.505 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -102.08 126.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -120.38 133.98 55.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 25.0 ttmt -98.06 137.16 37.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.235 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.55 159.21 42.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.791 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -76.21 111.95 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.344 0.592 . . . . 0.0 110.112 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.536 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 703' ' ' PHE . 23.4 mt -106.93 -154.26 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.932 -0.158 . . . . 0.0 110.707 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 702' ' ' LEU . 4.6 m-20 -116.34 147.3 41.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.022 0.439 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.875 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -131.92 155.72 47.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.225 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -105.87 119.87 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 121.563 0.697 . . . . 0.0 112.346 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.657 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.4 m95 -103.59 128.29 50.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.636 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.565 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.7 t80 -90.16 115.72 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.8 m -98.25 137.59 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 111.549 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 23.0 t60 -121.55 121.62 37.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.509 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 22.6 p -119.48 3.18 11.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.49 146.7 29.03 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.883 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -13.59 59.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -83.43 2.35 37.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.48 137.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.612 0.72 . . . . 0.0 111.992 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 680' ' ' ILE . 40.9 m -112.42 166.42 11.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.481 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.39 120.07 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.69 99.67 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.5 m120 60.51 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.2 t30 -131.79 -0.38 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.683 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.91 141.05 36.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -77.01 141.88 40.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.775 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.5 mmm -121.2 91.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.1 pt -87.39 159.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 652' ' ' THR . 19.6 tt0 -55.3 108.06 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.236 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.0 34.48 2.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.918 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.0 p -134.68 159.77 40.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 111.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 16.0 pttm -136.78 139.8 42.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.775 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 14.3 t80 -131.64 144.61 51.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.875 HD21 ' HB3' ' A' ' 646' ' ' ASP . 1.2 mt -68.89 134.56 49.77 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.179 0.514 . . . . 0.0 111.849 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 694' ' ' VAL . 4.0 mt -104.46 135.31 46.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.219 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -119.7 146.7 45.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.307 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 696' ' ' ILE . 10.8 t70 -45.9 104.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.88 32.46 4.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 112.07 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -95.47 108.26 20.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 659' ' ' LEU . 36.3 pt -106.03 137.42 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.341 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.23 115.52 27.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.109 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.7 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.1 mt -81.68 -38.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.441 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.937 HD12 HD23 ' A' ' 618' ' ' LEU . 14.0 mt -155.3 131.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.931 0.396 . . . . 0.0 111.556 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.63 123.05 20.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 116.68 21.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.536 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -46.67 71.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.982 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -71.63 -40.56 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.799 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -89.81 -6.23 56.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.445 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 58.78 19.04 6.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.676 0.274 . . . . 0.0 110.798 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CD2' ' CG ' ' A' ' 617' ' ' ARG . 0.1 OUTLIER -79.05 104.34 9.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.0 p -117.88 121.79 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.194 0.521 . . . . 0.0 111.447 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.425 HD11 HG12 ' A' ' 587' ' ' ILE . 33.3 mm -128.24 137.27 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.881 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -167.66 131.04 2.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.045 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.9 m-30 -113.14 144.72 42.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.664 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 22.1 ttpt -101.7 117.23 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.068 0.461 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 672' ' ' LEU . 3.1 t -79.04 119.7 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.649 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.7 tt0 -126.45 109.16 11.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.061 0.457 . . . . 0.0 110.233 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 705' ' ' GLU . 58.2 mt -79.79 105.46 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -49.01 8.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -111.38 138.44 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.796 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 68.9 p -116.14 99.87 7.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 700' ' ' THR . 8.4 t -77.42 61.0 2.15 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.42 43.43 58.14 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.067 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.867 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -97.1 32.9 2.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.953 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.687 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER 61.55 109.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.437 ' CG ' ' HG2' ' A' ' 705' ' ' GLU . 8.6 t-20 56.14 -69.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.145 0.498 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 702' ' ' LEU . 9.1 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.765 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.589 0.233 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.51 130.22 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.414 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.58 169.73 9.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 156.43 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.974 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.83 150.78 25.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -126.12 -178.44 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.52 57.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.187 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.06 -49.22 76.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -48.29 71.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.736 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.57 -32.97 67.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.44 -36.85 85.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.42 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.1 mt -60.51 -44.15 96.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.0 p -76.55 -24.03 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.65 -46.06 66.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -64.26 -25.97 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 621' ' ' VAL . 7.2 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.466 0 N-CA-C 112.83 -0.108 . . . . 0.0 112.83 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.421 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 58.4 ttp180 -112.03 143.33 43.22 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.306 -0.526 . . . . 0.0 111.209 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -128.07 -62.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.549 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.016 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.46 125.68 51.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.307 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.598 HG22 ' HG3' ' A' ' 581' ' ' LYS . 6.8 m -109.23 118.49 36.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.532 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.7 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.56 108.25 19.67 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.598 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.27 99.22 39.23 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 50.4 Cg_exo -47.47 97.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.792 1.661 . . . . 0.0 109.607 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.79 158.14 85.04 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.7 -25.55 11.6 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.55 2.833 . . . . 0.0 112.549 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 583' ' ' LEU . 23.7 t70 -62.1 -25.43 67.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.477 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.8 t -95.61 153.93 17.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.691 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.629 HG21 ' HD1' ' A' ' 688' ' ' PHE . 0.9 OUTLIER -57.03 -12.34 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 0.0 111.284 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.718 HD13 HG23 ' A' ' 613' ' ' ILE . 30.4 mt -112.44 129.62 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.46 57.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.486 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.9 mt-10 -124.64 172.04 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.127 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -125.9 130.47 51.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.6 OUTLIER -112.74 142.51 45.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.101 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.27 120.43 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.865 HD12 HD22 ' A' ' 578' ' ' LEU . 78.6 mt -89.34 109.07 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -68.14 122.47 18.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.85 -29.95 2.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.221 0.534 . . . . 0.0 110.537 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.55 -22.04 77.79 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.942 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.441 HG11 ' OD1' ' A' ' 610' ' ' ASN . 64.0 t -101.07 118.26 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.934 0.867 . . . . 0.0 111.841 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 19.1 t30 -139.85 122.32 10.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.742 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -90.21 159.52 32.9 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.372 -1.095 . . . . 0.0 111.673 -0.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.2 t80 -92.07 114.28 26.78 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.617 ' CG ' HD12 ' A' ' 730' ' ' LEU . 3.3 m-85 -92.39 138.48 31.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.184 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.765 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -125.78 143.44 39.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.79 -174.08 43.39 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.375 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.5 ttp85 -82.03 -4.46 56.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.617 0.246 . . . . 0.0 111.455 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.98 126.43 47.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.777 0.322 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -49.94 -26.58 4.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.55 -28.85 48.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.958 0.408 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 35.2 m -75.02 133.4 41.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 7.3 m120 -49.61 -26.95 4.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.457 . . . . 0.0 110.417 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.774 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.0 t -111.54 142.66 43.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 115.17 24.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.718 HG23 HD13 ' A' ' 588' ' ' ILE . 24.6 mm -137.88 109.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.011 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 28.6 tt0 -89.29 104.1 16.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.249 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.825 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.85 113.24 13.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.228 178.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -41.23 -38.61 1.16 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 681' ' ' ILE . 1.3 mmp_? -77.46 -35.11 54.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -58.99 157.94 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.73 164.43 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.96 -50.01 19.73 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.126 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 727' ' ' VAL . 54.7 t -115.67 63.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.498 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.628 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 2.1 t-160 -45.78 -48.22 15.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.477 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 31.7 p -172.39 162.88 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 650' ' ' CYS . 46.0 p90 -144.18 144.2 31.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.5 mp -102.55 130.67 52.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.1 t80 -121.67 133.61 54.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.1 tppp? -97.94 136.03 38.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.769 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 158.7 43.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.84 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.19 112.96 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.451 0.644 . . . . 0.0 110.366 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.2 t60 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.131 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.272 0 CA-C-O 120.536 -0.036 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.9 mp -114.68 -156.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.739 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -118.4 146.84 44.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.049 0.452 . . . . 0.0 111.65 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 3.0 t0 -133.47 160.3 37.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.589 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.016 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -109.08 122.64 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.795 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.945 ' CH2' HD22 ' A' ' 671' ' ' LEU . 93.1 m95 -109.99 126.85 54.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.399 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.57 ' HE2' ' HG ' ' A' ' 623' ' ' CYS . 9.9 t80 -90.67 122.24 33.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.162 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 7.9 m -111.02 128.14 55.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 657' ' ' SER . 70.5 t60 -106.11 130.11 54.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.382 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -126.24 3.63 7.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.288 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.53 141.07 20.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.043 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 654' ' ' THR . 87.4 m -75.6 -5.6 46.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.44 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.3 m120 -87.24 0.04 55.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.722 0.296 . . . . 0.0 111.316 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.3 t 67.59 146.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.461 ' HB3' ' CG ' ' A' ' 651' ' ' HIS . 0.9 OUTLIER -118.24 158.66 24.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.379 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -138.58 119.68 14.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.359 . . . . 0.0 110.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -108.06 112.49 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.83 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.46 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.02 0.19 1.53 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.474 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -96.65 141.82 29.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -79.51 141.91 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.482 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 34.9 mmm -124.78 102.77 7.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.118 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 44.2 pt -87.99 151.43 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -47.5 107.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.955 0.407 . . . . 0.0 111.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.51 36.18 2.69 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.132 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 665' ' ' ILE . 2.9 p -122.69 162.2 22.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 111.519 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.444 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -129.42 153.23 48.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.02 143.31 28.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.945 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -73.23 123.08 22.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.217 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.76 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.1 mt -98.71 140.48 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.432 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.554 ' HB2' HD12 ' A' ' 696' ' ' ILE . 29.1 t0 -43.04 113.76 0.52 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 95.95 35.51 5.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.42 121.61 36.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.356 . . . . 0.0 110.914 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -96.15 108.62 21.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.987 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.2 mt -108.13 136.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.07 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.499 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 20.0 mttt -107.83 116.59 32.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.812 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.652 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -88.02 -30.55 5.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.858 -178.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 617' ' ' ARG . 15.8 tt -155.03 130.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.523 . . . . 0.0 112.193 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.636 ' CD1' HG23 ' A' ' 689' ' ' VAL . 9.0 t90 -137.43 128.34 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.375 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -126.72 116.38 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 0.0 111.152 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -68.5 -46.61 69.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.992 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -58.71 -40.64 84.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.054 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.94 -15.47 22.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.451 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 70.64 3.31 4.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.072 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.629 ' HD1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.46 104.18 7.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.636 HG23 ' CD1' ' A' ' 682' ' ' TRP . 2.6 p -113.3 137.33 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.807 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 587' ' ' ILE . 28.8 mm -116.19 155.24 17.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.67 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . 179.28 124.92 0.91 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.86 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.8 m-30 -112.67 143.26 44.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 0.0 110.552 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.4 tptt -101.09 117.55 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.113 0.482 . . . . 0.0 110.702 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 578' ' ' LEU . 8.2 t -82.45 126.94 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.8 tt0 -133.76 109.44 9.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 674' ' ' ASP . 67.7 mt -77.55 105.68 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.869 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -80.5 -44.55 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.247 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -110.44 140.82 44.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.032 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.8 p -114.78 99.81 7.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.093 0.473 . . . . 0.0 109.895 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 t -80.69 60.31 3.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.481 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.96 58.93 11.6 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.925 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -85.04 144.0 28.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.551 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.644 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -37.43 -47.99 0.92 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.695 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.508 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -143.51 5.74 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.19 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.2 pt-20 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 82.2 t -99.04 113.91 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.83 172.19 8.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.89 16.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -90.79 152.61 20.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 59.9 p -126.21 -175.21 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.35 65.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.51 -47.2 82.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -66.41 -45.26 80.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -32.71 68.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.31 -37.82 83.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 723' ' ' GLU . 16.8 mt -58.61 -44.34 89.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 621' ' ' VAL . 12.0 p -81.39 -22.1 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -40.08 66.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -75.56 -15.91 60.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.617 HD12 ' CG ' ' A' ' 602' ' ' PHE . 9.9 tt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.814 ' N ' HE22 ' A' ' 596' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 ttm180 -97.7 142.03 29.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 122.501 -0.411 . . . . 0.0 110.581 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -131.3 -60.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 647' ' ' ILE . 6.7 tt -106.55 134.68 49.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.858 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.1 m -115.5 114.66 25.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.731 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.2 mp -105.18 108.04 19.35 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 pttp -113.46 100.32 51.53 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.62 ' CB ' HG23 ' A' ' 588' ' ' ILE . 53.2 Cg_exo -46.07 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.91 1.74 . . . . 0.0 109.795 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.69 158.52 84.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.03 -24.72 5.68 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.493 2.795 . . . . 0.0 112.759 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -61.45 -23.37 65.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 6.4 t -95.49 153.59 17.62 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.92 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.65 HD13 HD11 ' A' ' 690' ' ' ILE . 4.3 pt -54.46 -17.85 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 582' ' ' PRO . 6.4 tt -112.46 142.83 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.77 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 65.89 0.83 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.351 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.598 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.6 mm-40 -124.75 171.57 10.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.276 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.89 125.67 40.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.954 0.406 . . . . 0.0 111.084 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.65 138.66 49.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.771 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 8.7 mt-10 -124.25 122.4 37.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.828 HD11 HD13 ' A' ' 625' ' ' ILE . 67.8 mt -85.12 109.21 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.116 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.468 ' OE1' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -63.68 114.0 3.71 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.006 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.814 HE22 ' N ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -42.9 -32.72 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.9 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.509 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.63 -21.05 76.19 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.689 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.19 118.49 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.864 0.832 . . . . 0.0 111.917 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.18 123.08 10.14 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.981 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.567 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -90.06 159.31 33.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.334 -1.111 . . . . 0.0 111.799 0.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.575 ' CE1' ' ND2' ' A' ' 610' ' ' ASN . 2.6 t80 -92.87 117.72 30.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.673 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.3 m-85 -92.79 138.2 31.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.648 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 625' ' ' ILE . 2.4 mp -128.28 149.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.957 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.78 -176.69 40.55 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.962 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -79.25 -4.51 51.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.212 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 130.21 47.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 111.052 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -25.13 19.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.32 -29.01 46.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.783 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 730' ' ' LEU . 58.1 m -77.77 136.88 38.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.575 ' ND2' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -51.32 -23.77 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.793 ' SG ' HD13 ' A' ' 592' ' ' LEU . 51.5 t -117.29 143.38 45.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.696 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -120.43 119.77 34.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 592' ' ' LEU . 25.4 mm -137.57 109.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.987 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.67 102.53 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.867 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.613 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.18 113.55 13.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.837 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -44.04 -36.43 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.821 0.343 . . . . 0.0 111.603 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.573 ' CB ' HD13 ' A' ' 681' ' ' ILE . 1.4 mmt180 -77.53 -31.19 53.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.087 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.3 mp -59.51 159.48 8.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.8 p -114.02 164.52 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.173 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -45.8 -45.4 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.686 HG11 ' CG2' ' A' ' 727' ' ' VAL . 13.7 t -124.89 61.44 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.392 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.511 ' NE2' HG23 ' A' ' 680' ' ' ILE . 21.3 t60 -50.05 -48.57 52.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.951 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.545 ' SG ' HD11 ' A' ' 680' ' ' ILE . 6.5 p -166.89 158.4 12.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.621 ' HA ' HD12 ' A' ' 603' ' ' ILE . 47.9 p90 -143.39 146.89 33.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.909 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.828 HD13 HD11 ' A' ' 594' ' ' ILE . 2.6 mp -102.2 130.96 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.918 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -124.34 131.58 53.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.618 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 20.1 ttmt -98.15 135.99 39.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.14 158.0 41.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.171 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.01 122.26 24.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 110.499 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.6 t60 . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.273 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -88.78 -155.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.83 147.12 46.9 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.413 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -125.65 160.26 30.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.007 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -113.34 121.21 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.39 0.614 . . . . 0.0 111.927 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.534 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.2 m95 -107.26 126.56 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.417 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.533 ' CB ' HD21 ' A' ' 672' ' ' LEU . 8.6 t80 -91.03 117.74 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 12.5 m -105.74 134.27 49.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.518 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 26.2 t60 -115.51 124.18 50.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -118.67 6.26 11.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.395 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.26 151.12 29.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.6 m -81.34 -10.16 59.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.565 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.7 m120 -87.03 2.72 48.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 50.4 130.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.337 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.502 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 1.8 t -103.01 166.21 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.191 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -131.0 120.15 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.15 99.7 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.59 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.9 m120 61.31 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.748 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 70.0 m-20 -131.65 -2.1 3.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.722 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.61 135.02 42.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 111.325 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -73.65 141.8 46.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.42 ' O ' HG23 ' A' ' 656' ' ' VAL . 14.9 mmm -126.52 93.0 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 ' CG2' ' A' ' 668' ' ' THR . 36.4 pt -87.21 158.38 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 652' ' ' THR . 26.6 tt0 -46.42 116.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.193 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.48 28.64 8.87 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.409 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.424 ' CG2' HG12 ' A' ' 665' ' ' ILE . 17.5 p -112.93 162.34 15.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.37 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.489 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.4 ttpm? -141.91 129.66 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.645 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.5 t80 -134.04 144.25 48.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.439 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.534 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.49 140.36 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 112.051 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.916 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -108.82 129.44 55.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.183 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 3.9 mt-30 -115.45 146.0 42.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.512 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 696' ' ' ILE . 28.5 t0 -46.76 105.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.085 0.469 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.2 33.17 4.36 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -92.79 111.96 23.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.803 0.335 . . . . 0.0 111.263 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.8 108.53 20.87 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 1.031 HG22 HD13 ' A' ' 659' ' ' LEU . 34.2 pt -105.53 137.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.135 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -93.17 115.97 28.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.275 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -82.45 -32.07 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.722 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 618' ' ' LEU . 21.3 mt -154.4 131.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 111.44 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.64 124.02 22.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.17 117.06 27.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.427 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -46.94 72.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.678 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -83.2 -40.33 19.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.326 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -15.16 58.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.34 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt 62.9 15.75 8.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.978 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.422 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.01 104.24 7.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 690' ' ' ILE . 2.6 p -116.07 123.8 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.562 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.65 HD11 HD13 ' A' ' 587' ' ' ILE . 6.4 mm -127.65 154.04 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 169.29 136.17 2.02 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.714 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -114.72 153.95 29.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.798 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.838 ' HB2' HD12 ' A' ' 583' ' ' LEU . 9.2 tttt -101.79 117.6 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.916 HG21 HD13 ' A' ' 672' ' ' LEU . 5.0 t -79.08 125.9 38.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.4 OUTLIER -133.21 109.38 9.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.441 . . . . 0.0 110.409 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 577' ' ' PHE . 58.6 mt -80.78 105.32 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.646 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -87.19 -46.08 10.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.66 140.96 44.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.715 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -113.83 99.97 8.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.316 0.579 . . . . 0.0 109.73 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 56.6 m -70.79 65.93 0.34 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.432 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.19 57.27 20.67 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.857 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.816 ' C ' HD12 ' A' ' 644' ' ' LEU . 2.9 mt -99.88 145.28 27.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.619 ' N ' HD12 ' A' ' 644' ' ' LEU . 38.9 p90 -48.31 -31.38 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 109.765 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.414 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 2.6 t-20 -155.99 -53.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.787 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.516 ' O ' HD13 ' A' ' 696' ' ' ILE . 10.4 pt-20 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.179 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.731 0.301 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.8 p -85.15 128.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 171.71 7.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -103.12 157.41 17.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.161 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.8 152.0 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 2.7 p -126.11 -178.0 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.77 -35.02 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -57.86 -48.0 81.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.7 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 726' ' ' LEU . 11.1 mp0 -66.65 -48.14 70.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.795 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -59.11 -32.95 70.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -39.44 93.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.261 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 723' ' ' GLU . 5.4 mt -60.47 -44.67 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.013 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.686 ' CG2' HG11 ' A' ' 621' ' ' VAL . 11.4 p -71.27 -27.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -56.05 -32.6 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -97.79 28.0 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.781 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.783 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.579 -0.208 . . . . 0.0 112.579 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.0 tmm_? -112.96 143.93 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 111.028 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.22 -63.57 1.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.05 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.058 HD12 HD13 ' A' ' 647' ' ' ILE . 7.5 tt -106.91 142.56 36.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.3 m -122.68 114.81 21.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.335 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 594' ' ' ILE . 6.6 mt -102.55 108.29 19.54 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 6.9 ptmm? -116.55 100.51 53.48 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 588' ' ' ILE . 33.3 Cg_exo -47.11 105.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.635 1.557 . . . . 0.0 109.06 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.24 87.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.517 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 58.4 Cg_exo -51.31 -25.84 19.11 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.589 2.859 . . . . 0.0 113.108 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.635 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.3 m-20 -63.38 -26.72 68.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.049 0.452 . . . . 0.0 110.034 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.417 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -97.58 153.66 18.03 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.235 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 690' ' ' ILE . 14.4 pt -49.09 -23.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 110.1 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 613' ' ' ILE . 51.2 mt -99.5 118.59 46.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -117.57 52.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.588 . . . . 0.0 110.453 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 16.0 mt-10 -124.58 171.82 9.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.379 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.64 132.31 53.42 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.122 0.487 . . . . 0.0 111.573 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.744 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.91 143.04 44.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.724 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -124.28 118.91 27.84 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.958 HD12 HD22 ' A' ' 578' ' ' LEU . 74.9 mt -83.8 109.05 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.214 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.9 OUTLIER -65.9 120.84 13.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.95 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.24 -28.12 1.79 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.091 0.472 . . . . 0.0 110.67 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -73.63 -19.3 79.69 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.746 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 610' ' ' ASN . 55.0 t -100.74 117.95 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.968 0.884 . . . . 0.0 111.711 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.6 t30 -140.19 121.71 9.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.687 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.3 Cg_endo -89.96 159.86 34.31 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.493 -1.045 . . . . 0.0 111.519 -0.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.5 114.7 27.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.737 ' CG ' HD12 ' A' ' 730' ' ' LEU . 20.5 m-85 -91.68 138.45 31.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.769 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -126.32 146.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.71 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.09 -174.8 36.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.226 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -65.89 -48.62 70.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.831 0.348 . . . . 0.0 111.415 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.86 128.41 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.492 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.46 -17.73 23.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.766 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -56.95 -31.74 65.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.123 0.487 . . . . 0.0 110.112 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.3 m -70.58 134.02 47.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.501 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -48.08 -27.53 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.432 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.769 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.2 t -112.19 142.01 45.19 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 105.37 13.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.779 HD12 HD13 ' A' ' 588' ' ' ILE . 18.7 mm -138.62 108.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.764 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -106.18 105.91 16.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.469 0.652 . . . . 0.0 112.217 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.755 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -130.08 109.88 11.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.731 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -37.83 -30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.614 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -74.72 -41.59 59.88 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 615' ' ' ASP . 2.4 pp -88.24 136.98 32.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 163.84 4.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.461 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.494 ' CG ' HG23 ' A' ' 621' ' ' VAL . 1.3 ptp180 -54.08 -28.06 36.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.494 HG23 ' CG ' ' A' ' 620' ' ' ARG . 60.6 t -129.36 60.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.587 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.16 -47.25 45.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.133 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 8.2 p -168.06 161.09 12.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.8 p90 -143.36 148.52 36.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.62 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 580' ' ' LEU . 3.9 mp -102.23 128.16 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.324 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -118.48 134.47 55.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.423 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 33.3 ttmt -98.1 135.28 40.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.19 159.65 41.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.588 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.4 tpt180 -75.2 112.89 11.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.27 0.557 . . . . 0.0 110.862 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.476 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 7.7 t60 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 120.238 -0.201 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -113.32 -175.5 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.205 0.502 . . . . 0.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.0 m-20 -106.33 146.24 30.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.455 0.645 . . . . 0.0 112.251 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.476 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -128.72 160.56 32.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.549 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -108.35 120.85 60.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.63 0.729 . . . . 0.0 112.375 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.855 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.7 m95 -104.95 127.8 52.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.563 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.401 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.0 t80 -90.55 117.4 29.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.094 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 12.3 m -102.3 127.78 49.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -108.84 125.98 52.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 14.3 p -121.25 2.01 10.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.211 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.81 161.07 50.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.05 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.6 m -91.61 -19.86 22.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.633 0.254 . . . . 0.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.594 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.5 m120 -82.72 2.88 31.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.659 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.46 130.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.453 0.644 . . . . 0.0 112.278 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.422 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 86.5 p -100.98 166.34 10.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.136 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.42 120.76 26.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.755 0.312 . . . . 0.0 111.573 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.682 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.55 99.75 11.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.362 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 61.57 -80.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.687 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.18 -3.61 3.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.711 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.478 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.7 m-80 -97.0 142.01 29.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.381 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.8 ttm105 -82.25 141.62 32.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.216 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.83 97.95 5.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 43.8 pt -88.5 156.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.3 tt0 -47.34 108.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.4 35.77 3.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.356 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.421 ' CG2' HG12 ' A' ' 665' ' ' ILE . 4.3 p -120.01 162.31 19.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.161 0.505 . . . . 0.0 111.964 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.0 ttpt -133.2 148.31 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.229 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.738 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.5 t80 -147.28 144.83 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.855 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 132.46 46.2 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.719 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.803 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -110.37 122.22 47.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.577 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.11 138.78 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.315 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.2 t0 -39.04 123.33 1.31 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 37.45 8.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.21 115.13 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.81 108.58 20.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.0 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.682 HG12 HD13 ' A' ' 659' ' ' LEU . 7.8 mt -109.0 136.54 44.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.91 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -96.77 115.44 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.656 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.722 HD12 ' CE2' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -80.08 -40.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.984 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 617' ' ' ARG . 2.4 mt -155.4 131.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.001 0.429 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.618 ' HB2' HG23 ' A' ' 689' ' ' VAL . 6.5 t90 -136.12 128.23 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -122.15 116.78 24.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.403 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -46.41 72.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.868 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -60.51 -40.63 92.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.256 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.31 -20.25 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.65 0.262 . . . . 0.0 111.567 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 72.69 1.94 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.425 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.68 105.37 7.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 682' ' ' TRP . 2.4 p -114.71 134.13 58.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.465 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 587' ' ' ILE . 34.7 mt -119.82 120.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.95 141.07 9.93 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.856 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.722 ' CE2' HD12 ' A' ' 680' ' ' ILE . 9.1 m-30 -113.62 142.23 46.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.583 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.2 116.96 34.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.229 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.696 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.9 125.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.8 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 109.45 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.655 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.487 HG23 ' CD1' ' A' ' 577' ' ' PHE . 57.3 mt -83.89 105.76 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.67 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.91 -43.55 12.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.318 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -109.9 141.55 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.337 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.9 p -113.53 100.02 8.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.405 0.621 . . . . 0.0 110.142 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.9 m -82.63 60.68 5.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 73.95 49.07 14.21 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.859 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.574 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -83.63 127.42 33.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.654 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.2 p90 -35.77 -48.14 0.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.254 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.95 8.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.373 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.574 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 1.9 pt-20 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 121.316 0.579 . . . . 0.0 110.085 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.609 HG21 ' O ' ' A' ' 663' ' ' ARG . 9.6 t -77.47 116.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.952 0.406 . . . . 0.0 111.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.99 172.22 8.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 155.52 17.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -92.34 150.98 20.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -126.16 -175.57 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.94 68.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.52 -53.34 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.438 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.8 pp20? -70.81 -41.3 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.851 0.358 . . . . 0.0 110.586 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.533 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -67.61 -38.37 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.702 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 723' ' ' GLU . 18.0 mt -56.01 -44.22 78.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -78.54 -24.04 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -59.07 -37.79 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.06 -15.93 57.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.737 HD12 ' CG ' ' A' ' 602' ' ' PHE . 10.0 tt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -96.58 109.95 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 110.443 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.5 t80 -95.11 -58.29 2.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.735 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.837 HD11 ' CG1' ' A' ' 694' ' ' VAL . 7.9 tp -106.84 142.87 35.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 0.0 111.624 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 40.6 m -117.68 113.85 22.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -105.62 109.34 21.27 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 37.5 pttt -117.09 99.34 52.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 28.0 Cg_exo -45.8 99.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.918 1.746 . . . . 0.0 109.825 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.05 157.47 85.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.9 -25.7 12.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 112.948 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.83 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.09 -28.24 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 0.4 OUTLIER -95.89 153.97 17.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.976 178.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 688' ' ' PHE . 16.7 pt -52.38 -15.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.669 0.271 . . . . 0.0 111.365 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.8 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 111.685 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.71 55.25 1.45 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.618 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.3 mt-10 -124.72 170.24 11.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.052 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.49 121.06 25.09 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -112.68 148.21 35.15 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 119.58 29.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.663 0.268 . . . . 0.0 111.697 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 625' ' ' ILE . 47.1 mt -74.05 109.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 3.0 tp60 -65.39 111.85 3.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.023 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 2.9 pt20 -43.37 -36.49 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.469 0.652 . . . . 0.0 109.942 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -61.47 -23.85 63.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.233 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.4 t -101.14 118.86 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 117.516 0.658 . . . . 0.0 111.511 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.0 t30 -139.22 122.18 10.59 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.5 Cg_endo -89.6 160.24 36.24 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 124.413 -1.078 . . . . 0.0 111.674 -0.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -90.75 116.72 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 56.1 m-85 -92.45 138.01 31.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.05 145.7 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.435 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.37 -174.98 41.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.566 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.4 ttp85 -80.64 -11.51 59.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.645 0.259 . . . . 0.0 111.315 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 132.23 42.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.13 -26.35 11.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -30.78 27.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.035 0.445 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 63.7 m -77.2 128.8 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -45.24 -34.72 2.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 39.8 t -101.88 138.67 38.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.059 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 113.73 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.334 0.588 . . . . 0.0 112.549 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.9 mm -137.6 109.86 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.658 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 pm0 -87.79 103.99 16.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.693 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.23 110.23 10.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.964 178.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -40.64 -36.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' A' ' 681' ' ' ILE . 2.0 mmt180 -77.64 -36.58 51.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.693 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.71 159.38 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 52.7 p -108.77 166.04 11.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.31 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -47.46 25.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.573 HG11 HG23 ' A' ' 727' ' ' VAL . 18.2 t -121.24 61.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.426 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.571 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.4 t60 -50.08 -48.42 53.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.732 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -167.28 156.17 10.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.177 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.721 ' HA ' HD12 ' A' ' 603' ' ' ILE . 28.8 p90 -143.62 149.54 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.101 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 594' ' ' ILE . 71.4 mt -101.79 134.09 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -124.7 132.99 53.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.627 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HE3' HG23 ' A' ' 647' ' ' ILE . 9.1 ttmt -97.89 137.06 37.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.574 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.94 158.89 43.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.522 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.7 112.89 13.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.386 0.612 . . . . 0.0 110.41 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.91 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.863 -0.095 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.825 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.4 mt -116.89 -153.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.2 m-20 -118.22 147.27 43.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.32 148.81 51.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.606 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.1 pt -102.28 122.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.897 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -102.8 138.64 39.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.241 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CB ' HD21 ' A' ' 672' ' ' LEU . 18.0 t80 -100.04 117.43 34.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.65 133.84 49.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.409 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -115.58 125.72 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.454 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 15.6 p -123.18 7.97 9.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.68 151.62 29.44 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.033 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 7.5 m -80.16 -17.3 52.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.58 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.0 m120 -83.72 2.69 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.94 128.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.43 0.633 . . . . 0.0 112.2 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.408 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 9.0 t -97.76 166.68 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 39.2 m-85 -131.91 120.22 22.22 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.402 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.951 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -95.03 100.58 12.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.14 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.44 0.44 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.435 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.423 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 7.6 m-80 -100.6 141.51 33.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.801 ' O ' HG21 ' A' ' 716' ' ' VAL . 21.8 ttp180 -82.43 141.12 33.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.736 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -122.69 98.08 5.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 668' ' ' THR . 35.2 pt -87.77 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 652' ' ' THR . 29.1 tt0 -46.76 106.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.88 35.97 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.296 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.468 HG21 HG12 ' A' ' 665' ' ' ILE . 6.6 p -125.72 162.19 25.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 111.879 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.1 ttpm? -133.6 148.47 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.224 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.736 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.6 t80 -147.69 145.87 29.06 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.897 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.52 133.79 49.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.869 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -110.33 109.2 19.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.196 0.522 . . . . 0.0 111.339 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -97.94 153.95 18.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.333 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.6 t0 -53.31 115.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.829 0.347 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.28 37.48 5.62 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -90.42 116.15 28.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.951 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -95.88 108.08 20.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.951 HG22 HD13 ' A' ' 659' ' ' LEU . 29.7 pt -109.29 133.67 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.088 0.47 . . . . 0.0 112.016 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 29.4 mttt -96.91 115.19 27.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.434 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.8 mt -75.81 -39.81 38.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.944 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' A' ' 617' ' ' ARG . 5.3 tt -155.7 133.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.714 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -136.04 125.98 25.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.455 ' OD1' ' ND2' ' A' ' 685' ' ' ASN . 44.2 t0 -118.77 116.93 27.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -67.49 -46.55 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.988 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' ASN . . . . . 0.455 ' ND2' ' OD1' ' A' ' 683' ' ' ASP . 13.9 p30 -69.71 -40.51 76.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.945 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.32 -20.27 28.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.68 0.276 . . . . 0.0 111.41 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt 68.38 4.82 4.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.34 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.57 ' HD1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -82.24 105.2 13.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.33 137.0 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.097 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.452 HG21 ' HB ' ' A' ' 680' ' ' ILE . 2.5 mm -115.27 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.032 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.487 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.23 130.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.231 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.4 m-30 -113.09 146.16 39.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.548 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.674 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -101.03 116.82 33.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.906 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.837 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.5 t -82.86 123.59 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.45 108.74 8.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.034 0.445 . . . . 0.0 110.987 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.832 HG21 ' HB2' ' A' ' 705' ' ' GLU . 25.1 mt -73.58 105.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.789 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -90.05 -46.04 8.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 6.1 t70 -111.28 141.03 45.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.171 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.1 OUTLIER -114.94 101.67 9.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.8 m -68.02 62.41 0.08 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 53.66 51.39 48.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.183 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -117.29 174.05 6.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.973 0.415 . . . . 0.0 111.561 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -65.67 118.4 9.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.657 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 3.9 t30 51.39 -71.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.367 0.603 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.832 ' HB2' HG21 ' A' ' 696' ' ' ILE . 21.1 pt-20 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 663' ' ' ARG . 29.5 t -84.53 117.48 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.063 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.3 mp -90.2 161.43 15.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 148.3 25.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 160.17 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 26.7 p -119.3 -173.25 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.68 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.7 -45.5 93.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 7.7 tm-20 -67.62 -50.24 59.06 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.2 mttt -54.61 -32.52 58.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.38 -36.85 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.27 -44.61 79.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.573 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -74.97 -17.42 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.07 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -35.22 79.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.871 0.367 . . . . 0.0 110.75 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -96.79 23.98 6.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.76 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -98.29 108.38 21.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.6 t80 -90.84 -46.79 8.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.84 HD11 HG13 ' A' ' 694' ' ' VAL . 7.2 tp -122.49 142.22 50.81 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.967 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 581' ' ' LYS . 17.8 m -120.06 115.7 24.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.641 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.9 mt -102.05 107.85 19.09 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 17.9 mtpp -113.33 98.97 48.09 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -48.45 96.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.636 1.557 . . . . 0.0 109.434 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.76 157.64 85.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.72 -27.83 16.08 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.338 2.692 . . . . 0.0 112.43 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.484 ' CB ' HD12 ' A' ' 583' ' ' LEU . 21.9 t0 -62.48 -26.37 68.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 9.3 t -95.47 153.74 17.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.935 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 688' ' ' PHE . 10.4 tt -53.27 -14.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.456 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 613' ' ' ILE . 45.0 mt -111.47 133.51 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 111.876 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 51.81 0.88 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.617 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.7 mt-10 -123.94 171.75 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.795 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.09 132.7 50.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.11 0.481 . . . . 0.0 111.394 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.742 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.4 OUTLIER -112.62 142.48 45.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.01 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -123.75 111.68 16.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.919 HD11 HD12 ' A' ' 625' ' ' ILE . 66.8 mt -80.71 108.81 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.019 0.437 . . . . 0.0 110.044 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.6 OUTLIER -67.0 117.67 9.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.1 pt20 -45.69 -33.4 2.94 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.38 0.609 . . . . 0.0 110.016 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.17 -20.99 73.58 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.371 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.869 HG11 ' OD1' ' A' ' 610' ' ' ASN . 58.3 t -97.72 118.37 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 117.691 0.746 . . . . 0.0 111.396 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.3 t30 -139.97 121.49 9.62 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.032 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.2 Cg_endo -90.63 160.79 31.44 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.699 -0.959 . . . . 0.0 111.459 -0.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.85 115.07 27.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CD2' HD12 ' A' ' 730' ' ' LEU . 10.8 m-85 -92.25 138.49 31.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.621 . . . . 0.0 112.588 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.818 HG23 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mp -123.31 140.51 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.109 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 171.74 -174.81 45.23 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.418 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.7 ttp85 -83.71 -5.71 59.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.251 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.33 129.75 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.79 0.328 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.83 -26.99 6.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.121 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.97 -29.06 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 90.2 m -76.73 133.39 39.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.869 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.2 m-80 -49.09 -28.49 4.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.818 ' SG ' HG23 ' A' ' 603' ' ' ILE . 21.0 t -109.59 138.67 45.61 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 111.72 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.71 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.0 mm -137.91 109.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.65 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.5 mt-10 -88.81 104.45 16.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.976 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.751 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -130.82 113.27 13.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.081 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -43.39 -36.13 1.82 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.735 0.302 . . . . 0.0 111.62 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.946 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -77.71 -33.09 53.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.158 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.056 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -64.18 159.35 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 167.37 10.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -55.96 6.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.054 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 727' ' ' VAL . 45.8 t -113.06 62.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 37.4 t60 -48.83 -49.24 40.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.935 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 680' ' ' ILE . 7.7 p -166.71 159.37 13.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.92 0.391 . . . . 0.0 111.212 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 650' ' ' CYS . 1.7 p90 -144.0 146.97 33.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.919 HD12 HD11 ' A' ' 594' ' ' ILE . 82.6 mt -101.87 132.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.719 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.4 t80 -123.26 133.1 54.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 647' ' ' ILE . 2.4 tppp? -97.94 136.43 38.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.237 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 157.95 45.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.469 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.57 123.53 26.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.0 110.591 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.8 t60 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.88 -0.088 . . . . 0.0 112.88 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.1 OUTLIER -103.82 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.819 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -123.33 147.77 46.68 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.199 0.523 . . . . 0.0 112.279 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -131.88 158.3 41.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.886 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.823 HD13 HD13 ' A' ' 578' ' ' LEU . 4.9 pt -110.28 123.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 111.924 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.89 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.8 m95 -108.75 128.66 55.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.399 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -91.31 117.41 29.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 8.2 m -102.57 138.15 39.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.283 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 657' ' ' SER . 84.3 t60 -116.55 129.36 56.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.418 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 3.2 p -125.61 -2.58 7.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.532 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.74 138.26 21.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.091 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 654' ' ' THR . 86.1 m -72.13 -8.3 53.88 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -86.93 2.55 48.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 0.0 111.43 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.95 143.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.023 0.439 . . . . 0.0 111.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.774 ' OG ' HG22 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -115.57 162.03 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 664' ' ' MET . 17.1 m-85 -137.6 119.43 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -97.99 99.69 10.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.656 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.47 -1.73 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.549 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 17.9 m120 -96.25 141.52 29.5 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.904 0.383 . . . . 0.0 111.179 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.815 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.0 mtm180 -81.49 141.57 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.158 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.52 ' HE1' HG13 ' A' ' 716' ' ' VAL . 17.4 mmm -123.03 99.34 6.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 668' ' ' THR . 35.0 pt -87.88 154.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -47.43 103.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.347 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.82 39.92 2.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.584 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.493 HG21 HG12 ' A' ' 665' ' ' ILE . 2.3 p -128.44 153.31 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.47 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.93 145.19 49.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.087 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 659' ' ' LEU . 4.8 t80 -140.14 145.77 37.97 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.89 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.29 131.87 46.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.756 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.836 HD13 HG21 ' A' ' 694' ' ' VAL . 0.9 OUTLIER -107.75 120.57 42.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.138 0.494 . . . . 0.0 110.845 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -110.04 162.24 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.001 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' A' ' 696' ' ' ILE . 24.8 t0 -58.3 108.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.655 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.58 33.5 5.86 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.31 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -86.43 114.94 23.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.691 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -95.75 108.37 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 659' ' ' LEU . 8.4 mt -108.82 134.44 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -109.01 117.77 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.072 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.774 HG22 ' OG ' ' A' ' 657' ' ' SER . 0.7 OUTLIER -90.32 -22.15 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.056 HD12 HD12 ' A' ' 618' ' ' LEU . 55.9 mt -152.87 130.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.206 0.527 . . . . 0.0 111.448 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -137.68 129.12 28.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.05 117.32 25.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.0 110.616 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -67.12 -46.56 73.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.016 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.56 -40.47 23.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.735 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -14.33 58.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.442 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 64.51 14.77 9.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -77.82 104.67 8.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.0 p -118.44 121.85 68.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.148 0.499 . . . . 0.0 112.059 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.648 HG21 HG13 ' A' ' 680' ' ' ILE . 4.3 mm -112.21 144.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -170.96 123.48 1.04 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.468 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.519 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.6 m-30 -113.11 146.11 39.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.341 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.742 ' HB2' HD22 ' A' ' 583' ' ' LEU . 2.0 tptt -101.56 117.06 34.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.84 HG13 HD11 ' A' ' 578' ' ' LEU . 2.4 t -81.78 124.12 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.017 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -133.12 108.72 9.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 705' ' ' GLU . 35.7 mt -73.91 104.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.16 -47.52 8.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.801 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.46 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 12.4 t0 -111.14 139.35 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.633 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -115.7 100.66 8.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.107 0.479 . . . . 0.0 109.712 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.4 t -70.3 63.53 0.25 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.621 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.32 59.45 10.63 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.821 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.835 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -98.8 148.18 24.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.776 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.639 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.6 p90 -47.41 -34.67 7.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.571 0.7 . . . . 0.0 109.751 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.6 t-20 -151.5 -51.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.762 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.755 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.0 pt-20 . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.146 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 663' ' ' ARG . 30.8 t -77.68 128.37 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.115 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.462 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -100.41 167.9 10.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -103.03 154.75 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.58 155.8 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.12 -176.22 3.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.64 -31.04 63.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -64.76 -44.85 88.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.22 -51.07 57.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.2 mtmp? -55.41 -32.69 62.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -36.82 82.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.4 -44.26 92.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.936 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -74.55 -26.58 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -34.03 66.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -97.86 33.1 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.624 HD12 ' CD2' ' A' ' 602' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.81 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.226 -0.398 0 CA-C-O 120.756 0.087 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.5 tmm_? -112.65 143.75 43.31 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.516 -0.403 . . . . 0.0 111.415 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -123.59 -58.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 694' ' ' VAL . 9.9 tt -112.48 140.86 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.393 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 695' ' ' GLU . 38.0 m -113.1 122.0 46.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.269 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 625' ' ' ILE . 7.4 mt -107.83 108.96 20.38 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.1 pttp -119.53 98.46 50.07 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -45.22 103.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.739 1.626 . . . . 0.0 108.918 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 583' ' ' LEU . 0.2 OUTLIER -73.94 160.47 81.76 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -175.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 82.0 Cg_exo -47.05 -30.21 9.76 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.715 2.943 . . . . 0.0 113.012 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.47 -17.82 63.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 109.677 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.558 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 38.7 t -95.22 149.22 21.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.936 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 587' ' ' ILE . 0.0 OUTLIER -55.73 -22.79 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 178.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.549 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.9 tt -113.34 122.22 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.627 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -108.14 69.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 0.0 110.835 -179.246 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.769 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 34.5 mt-10 -127.93 170.97 12.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.173 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 35.8 t -131.23 116.43 17.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 112.028 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.733 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -103.91 139.73 38.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 5.1 mt-10 -118.02 131.35 56.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.868 HD12 HD22 ' A' ' 578' ' ' LEU . 89.9 mt -82.48 108.66 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 3.0 tt0 -65.5 120.99 13.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.72 -28.8 1.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.842 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.32 -18.71 79.91 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.084 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.02 117.92 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.142 0.971 . . . . 0.0 111.768 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.45 122.6 9.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.553 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.9 Cg_endo -90.25 159.85 32.88 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.5 -1.041 . . . . 0.0 111.519 -0.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.4 t80 -92.04 116.36 28.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.538 ' CG ' HD12 ' A' ' 730' ' ' LEU . 27.0 m-85 -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.695 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.759 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -128.31 147.43 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.56 -157.55 30.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.417 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.1 OUTLIER -87.61 -35.85 17.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.733 0.301 . . . . 0.0 111.506 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -74.99 137.65 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.323 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -20.64 58.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.987 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -55.02 -31.53 61.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.5 m -73.22 132.08 42.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m120 -47.0 -29.71 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 110.542 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.759 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.29 137.52 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.64 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 110.84 20.68 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.733 HD11 HD21 ' A' ' 592' ' ' LEU . 3.4 mm -138.3 110.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.176 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.2 mt-10 -85.99 104.92 16.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.448 0.642 . . . . 0.0 111.67 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.852 ' CB ' HD22 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -130.67 108.18 9.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.287 177.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -48.08 -34.9 10.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -78.05 -35.38 49.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.852 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.63 131.37 34.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.432 -178.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 8.5 t -57.24 166.33 1.17 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.49 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 1.0 OUTLIER -57.22 -34.92 69.06 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.295 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.0 t -125.96 58.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.949 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.821 ' CD2' HG23 ' A' ' 680' ' ' ILE . 13.9 t60 -49.89 -49.43 49.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.02 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 13.2 p -164.17 161.53 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 111.589 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.9 p90 -143.53 147.85 35.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.589 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.93 130.68 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -122.54 134.17 54.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.773 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 647' ' ' ILE . 5.2 ttmt -98.19 136.44 38.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.204 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.81 159.01 41.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.894 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 643' ' ' GLY . 3.7 tpt85 -76.59 112.15 12.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.3 t60 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.243 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.736 -0.146 . . . . 0.0 112.736 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.5 mp -111.78 -162.43 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 m-20 -108.08 147.06 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 112.412 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.4 OUTLIER -124.75 159.53 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.518 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.877 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 5.3 pt -111.49 122.37 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.451 0.643 . . . . 0.0 112.249 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 66.7 m95 -108.85 136.19 48.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.085 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.674 ' CE1' HD12 ' A' ' 678' ' ' ILE . 22.7 t80 -94.08 117.77 30.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.27 124.91 49.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 72.0 t60 -101.94 134.38 45.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.148 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.0 p -133.55 4.01 3.61 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.982 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.35 137.69 18.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.394 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 654' ' ' THR . 45.0 m -70.37 -11.94 61.25 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.755 -0.262 . . . . 0.0 111.393 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.612 ' O ' HG13 ' A' ' 656' ' ' VAL . 4.6 m-20 -87.39 3.46 46.95 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.56 128.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.283 0.564 . . . . 0.0 112.117 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.468 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 30.5 m -101.47 166.02 10.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.406 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.9 m-85 -130.68 120.19 23.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.333 . . . . 0.0 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.03 99.91 10.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 659' ' ' LEU . 20.4 t-20 60.4 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.924 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -134.17 1.0 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.73 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 8.4 m120 -104.69 132.92 50.36 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 111.077 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.9 139.96 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 41.1 mmm -118.26 97.43 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.446 HG13 HG23 ' A' ' 668' ' ' THR . 49.3 pt -87.85 154.49 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.73 104.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 111.478 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.08 38.59 2.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.446 HG23 HG13 ' A' ' 665' ' ' ILE . 1.1 p -116.26 162.29 17.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.546 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.494 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -137.53 139.52 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -147.4 145.78 29.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.829 0.347 . . . . 0.0 111.779 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.65 137.83 55.89 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -110.54 99.39 8.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 0.0 111.614 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -80.45 147.32 30.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.473 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.657 ' HB3' HD12 ' A' ' 696' ' ' ILE . 13.5 p30 -48.17 112.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.305 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 94.53 36.0 5.76 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.3 117.15 28.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.891 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 109.54 21.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.725 HG22 HD13 ' A' ' 659' ' ' LEU . 21.6 pt -105.31 130.44 56.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 112.066 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.43 116.63 29.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.446 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.821 HG23 ' CD2' ' A' ' 622' ' ' HIS . 9.0 mt -89.87 -34.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.295 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.93 131.53 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.803 -179.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -136.96 127.54 26.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.07 116.84 28.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 110.325 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -67.36 -46.91 71.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -83.49 -40.49 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.84 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.4 -16.55 45.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.582 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.9 mttt 64.67 14.32 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.679 0.276 . . . . 0.0 110.91 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -78.36 105.23 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -124.88 128.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.912 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 681' ' ' ILE . 0.5 OUTLIER -128.58 119.77 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.737 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -151.33 139.9 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.314 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.18 149.03 36.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.786 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.416 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -102.01 117.22 34.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.485 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.07 123.11 30.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.693 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.8 mt-10 -130.32 109.39 10.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 0.0 110.731 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 674' ' ' ASP . 11.2 mt -83.67 109.83 17.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.714 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -96.11 -46.51 6.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.946 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.35 140.31 46.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.54 101.44 9.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 700' ' ' THR . 8.0 t -69.23 61.47 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.28 45.95 81.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.806 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -106.49 151.19 25.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.579 0.228 . . . . 0.0 110.769 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -45.22 128.71 7.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.47 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 5.6 t30 43.33 -79.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.49 . . . . 0.0 111.031 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.681 ' N ' ' O ' ' A' ' 703' ' ' PHE . 13.3 pt-20 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.41 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 4.0 m . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.763 0.316 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 716' ' ' VAL . 13.9 p -93.3 125.04 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -94.74 172.29 8.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -102.48 157.88 16.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.6 156.41 18.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -126.1 -177.03 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.27 38.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.02 -50.93 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.549 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -65.44 -46.03 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -55.5 -32.95 63.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.55 -36.87 79.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 18.4 mt -59.08 -44.85 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.3 p -81.41 -16.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -32.66 74.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.74 -7.93 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.199 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 730' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.874 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.501 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.5 tmm_? -112.95 143.85 43.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.625 0.25 . . . . 0.0 111.031 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.35 -62.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.076 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.38 142.34 36.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 12.5 m -123.62 114.47 20.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.559 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.686 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.5 OUTLIER -103.89 108.21 19.43 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.26 100.65 52.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.6 Cg_exo -46.98 99.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.879 1.72 . . . . 0.0 109.722 176.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.33 84.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -176.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.68 -25.32 11.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.642 2.894 . . . . 0.0 112.612 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 583' ' ' LEU . 22.5 m-20 -62.01 -28.03 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 7.5 t -95.38 154.1 17.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.645 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.494 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -56.2 -12.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.074 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 613' ' ' ILE . 19.0 mt -108.92 123.33 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 111.783 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.24 54.75 0.65 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.163 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.603 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.2 mm-40 -124.36 171.39 9.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.094 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.74 129.59 47.34 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.011 0.434 . . . . 0.0 111.262 179.019 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.35 140.77 46.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -124.24 116.87 23.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.73 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.76 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -80.51 108.96 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.178 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -64.57 120.48 12.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.62 -28.13 1.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 110.823 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.4 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -21.25 79.7 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.867 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 52.9 t -101.0 118.07 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 118.015 0.908 . . . . 0.0 111.854 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.22 121.99 9.62 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.766 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.7 159.78 35.53 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 124.465 -1.056 . . . . 0.0 111.599 -0.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.651 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.0 t80 -91.37 115.87 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.88 ' CG ' HD12 ' A' ' 730' ' ' LEU . 33.5 m-85 -92.26 138.11 31.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.891 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.718 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mp -127.27 146.05 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.553 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.03 -175.37 40.94 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.543 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.5 ttp85 -77.51 -6.79 54.83 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.741 -0.229 . . . . 0.0 111.456 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.0 129.36 45.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.847 0.355 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.37 -23.54 24.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -29.76 61.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.602 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 730' ' ' LEU . 8.9 m -74.73 134.43 41.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.765 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m-80 -49.07 -26.79 2.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.702 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 46.7 t -112.85 142.87 45.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.532 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 115.05 23.9 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 588' ' ' ILE . 28.5 mm -137.96 109.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.026 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.6 tt0 -89.01 103.85 16.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.798 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.803 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.7 OUTLIER -131.79 113.43 13.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.252 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -43.03 -35.67 1.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.771 0.319 . . . . 0.0 111.514 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.664 ' HB3' HD13 ' A' ' 681' ' ' ILE . 2.1 mpp_? -77.95 -36.31 49.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.112 HD12 HD12 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -61.58 159.8 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.2 m -109.16 170.13 8.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -49.14 -45.48 43.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.27 0.557 . . . . 0.0 110.201 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.769 HG11 HG23 ' A' ' 727' ' ' VAL . 13.4 t -124.89 57.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.464 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.64 ' CE1' HD11 ' A' ' 681' ' ' ILE . 27.7 t60 -43.85 -47.48 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.747 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.9 p -166.76 156.34 11.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.445 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 603' ' ' ILE . 29.6 p90 -143.18 147.45 34.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.415 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.7 mp -102.19 130.24 52.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.114 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.3 t80 -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 23.0 ttmt -97.71 136.78 37.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.536 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.68 159.72 39.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.445 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -75.82 115.95 16.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.9 t60 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.75 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.3 -153.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.711 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.9 m-20 -122.4 146.57 47.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.308 0.575 . . . . 0.0 112.471 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -126.74 160.14 31.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.076 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -108.94 123.89 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.442 0.639 . . . . 0.0 112.463 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.85 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 90.0 m95 -106.19 125.68 51.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -90.63 117.53 29.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -102.53 139.24 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.236 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.498 ' CG ' ' OG ' ' A' ' 657' ' ' SER . 46.7 t60 -125.68 121.56 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.571 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.47 5.69 13.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.747 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.03 137.33 20.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.799 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 654' ' ' THR . 95.6 m -72.64 -10.61 60.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -87.26 2.06 51.26 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 664' ' ' MET . 11.6 t 64.31 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.524 . . . . 0.0 112.076 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.498 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 5.3 p -120.76 160.72 22.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 4.8 m-85 -137.48 120.07 16.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.278 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.625 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.46 105.19 17.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.01 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.44 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.579 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -134.99 0.42 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.698 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.455 ' HB3' HG23 ' A' ' 716' ' ' VAL . 7.5 m120 -97.77 141.21 31.05 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.912 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.0 ttp180 -88.94 139.08 30.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -135.83 110.97 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.205 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.456 ' HA ' HG13 ' A' ' 656' ' ' VAL . 18.8 pt -89.78 162.98 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.947 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -46.78 115.56 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.576 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.81 8.45 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.97 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.3 p -112.76 161.74 16.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 111.583 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -135.6 149.18 49.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD1' HD23 ' A' ' 659' ' ' LEU . 2.8 t80 -147.75 146.09 29.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.85 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.74 132.4 46.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.283 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.799 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.44 111.82 23.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.311 0.577 . . . . 0.0 111.421 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -104.83 136.01 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.559 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.609 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.3 t70 -37.0 118.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 111.022 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 89.26 36.52 7.52 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.85 118.13 31.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 693' ' ' LYS . 21.8 mt-10 -96.0 109.08 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 649' ' ' TYR . 4.6 mt -105.65 130.03 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 112.004 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.63 116.15 27.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.418 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.495 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -83.8 -37.28 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.112 HD12 HD12 ' A' ' 618' ' ' LEU . 54.1 mt -154.92 131.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -136.49 127.17 27.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.74 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 116.76 24.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.374 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -67.23 -46.8 72.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.798 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -83.17 -40.47 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.835 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.61 -14.5 59.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.443 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 64.94 14.07 9.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.634 0.254 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -78.4 104.46 9.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.87 123.64 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.069 0.461 . . . . 0.0 111.74 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 587' ' ' ILE . 38.9 mm -125.4 153.11 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 175.84 128.61 1.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.121 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 592' ' ' LEU . 8.5 m-30 -112.82 144.49 42.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.268 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.58 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tttp -101.11 117.33 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.574 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 578' ' ' LEU . 2.8 t -79.51 125.25 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -133.16 109.23 9.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 705' ' ' GLU . 50.1 mt -79.67 105.77 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.665 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -86.83 -43.96 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.15 141.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -113.62 100.09 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.404 0.621 . . . . 0.0 109.899 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 28.7 m -80.93 65.57 6.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 71.3 46.56 41.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.923 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -87.84 131.77 34.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.62 ' N ' HD12 ' A' ' 644' ' ' LEU . 5.6 p90 -41.8 -34.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.457 0.646 . . . . 0.0 110.266 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -146.64 -61.09 0.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.392 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.813 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.6 pt-20 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.949 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.735 0.302 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.912 HG21 ' O ' ' A' ' 663' ' ' ARG . 39.6 t -77.88 122.27 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.69 161.58 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 136.77 42.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.612 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -87.31 150.16 24.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 p -110.54 -174.65 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -30.31 43.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -50.23 74.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -45.17 76.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.352 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.519 ' O ' HG12 ' A' ' 727' ' ' VAL . 44.9 tttp -57.68 -32.93 67.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.598 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -66.73 -36.82 83.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.595 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.68 -44.25 85.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.769 HG23 HG11 ' A' ' 621' ' ' VAL . 10.8 p -76.16 -14.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.81 -39.4 76.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.564 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -93.79 11.24 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.88 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.659 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 8.4 ttm105 -113.61 143.39 44.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.26 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.794 ' CZ ' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -118.51 -57.89 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.331 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.809 HD11 ' CG1' ' A' ' 694' ' ' VAL . 5.1 tp -113.09 142.08 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.4 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 2.8 m -120.04 114.76 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.904 HD21 HG23 ' A' ' 694' ' ' VAL . 5.8 mt -102.0 108.36 19.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 27.4 mtmt -114.16 99.27 50.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 34.7 Cg_exo -47.81 98.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.655 1.57 . . . . 0.0 109.463 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.822 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.36 158.1 84.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.79 -26.53 13.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.427 2.752 . . . . 0.0 112.573 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.822 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.8 m-20 -62.76 -28.12 69.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 93.2 p -95.69 153.21 17.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.839 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.719 ' CG2' HD13 ' A' ' 690' ' ' ILE . 7.9 tt -53.15 -15.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.322 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.613 HG13 HG23 ' A' ' 587' ' ' ILE . 71.2 mt -109.03 131.7 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.936 0.398 . . . . 0.0 111.795 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.93 54.62 0.86 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.254 0.549 . . . . 0.0 110.65 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.656 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.6 mt-10 -124.11 172.07 9.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.683 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.69 128.39 45.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.177 0.513 . . . . 0.0 111.221 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.41 139.74 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.788 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.04 113.22 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.544 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 625' ' ' ILE . 76.4 mt -77.29 109.21 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -67.34 118.13 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.022 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -27.93 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.822 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -70.85 -20.63 77.75 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.186 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.568 HG11 ' ND2' ' A' ' 610' ' ' ASN . 41.2 t -100.68 118.32 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 117.552 0.676 . . . . 0.0 111.618 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.4 t30 -139.9 121.8 9.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.5 Cg_endo -89.48 160.49 36.96 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.535 -1.027 . . . . 0.0 111.492 -0.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.677 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.09 115.42 28.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.745 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.0 m-85 -91.98 137.52 32.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.027 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.771 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -124.84 144.83 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.39 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.41 -173.7 38.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.298 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -68.11 -46.8 69.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.853 0.359 . . . . 0.0 111.431 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.72 129.23 40.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.37 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -58.06 -18.36 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.762 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.63 -30.64 67.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 110.249 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.568 ' SG ' HG22 ' A' ' 621' ' ' VAL . 94.8 m -69.95 131.55 44.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.598 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -43.99 -32.43 1.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.322 0.582 . . . . 0.0 110.453 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.771 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.46 142.17 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.196 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.503 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -111.3 105.0 13.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 38.3 mm -139.26 109.5 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.467 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.36 106.23 16.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 112.256 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.587 ' H ' HD11 ' A' ' 618' ' ' LEU . 4.7 t0 -129.88 107.69 9.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.571 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -39.44 -28.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -70.82 -41.77 71.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.587 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -89.3 158.74 17.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.6 m -76.71 164.61 25.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.41 -27.07 14.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.568 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.2 t -131.01 62.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' HG23 ' A' ' 680' ' ' ILE . 26.1 t60 -50.03 -48.66 52.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.211 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.84 162.22 26.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.5 p90 -143.61 148.39 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 594' ' ' ILE . 81.5 mt -102.12 124.3 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.046 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -113.87 133.55 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.73 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 28.6 ttmt -97.88 136.52 38.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.69 158.59 44.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.827 -178.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.13 115.97 17.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 120.678 0.043 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.4 mp -115.75 -157.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.748 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.3 m-20 -117.56 146.72 43.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.08 0.467 . . . . 0.0 111.96 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -133.03 157.16 45.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.781 ' CD1' HD13 ' A' ' 578' ' ' LEU . 1.1 pt -106.8 119.23 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.543 0.687 . . . . 0.0 111.769 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.882 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.9 m95 -100.61 132.13 46.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.476 ' CB ' HD21 ' A' ' 672' ' ' LEU . 31.2 t80 -90.36 117.24 28.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -103.5 121.67 43.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.559 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.419 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 28.9 t60 -102.23 128.74 48.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 7.4 p -125.11 2.43 7.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.423 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.05 150.21 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.108 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 72.3 m -82.21 -18.97 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 111.518 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.7 OUTLIER -82.56 3.35 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.79 137.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.644 0.735 . . . . 0.0 112.238 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 58.2 m -107.93 165.91 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.423 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 120.59 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.72 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.65 100.34 9.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.846 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.9 m120 60.76 -82.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.87 6.19 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.652 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -110.27 138.45 46.64 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -74.74 138.34 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.472 ' O ' HG23 ' A' ' 656' ' ' VAL . 45.7 mmm -117.68 88.01 2.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.579 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 668' ' ' THR . 48.5 pt -86.91 164.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 22.6 tt0 -54.92 105.53 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.34 40.52 2.39 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.409 HG21 HG12 ' A' ' 665' ' ' ILE . 2.6 p -124.45 162.39 24.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 6.3 ttpm? -138.07 144.93 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.491 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.64 145.09 28.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.8 0.334 . . . . 0.0 111.758 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.882 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.7 136.61 53.16 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.579 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -107.1 112.84 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.541 . . . . 0.0 111.869 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -104.13 137.95 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.894 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.695 ' HB2' HD12 ' A' ' 696' ' ' ILE . 39.7 t0 -39.11 123.11 1.31 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.936 0.398 . . . . 0.0 111.152 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 88.91 40.6 6.17 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.432 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 1.6 t0 -93.51 113.18 25.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.979 0.418 . . . . 0.0 111.434 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.34 111.38 23.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.865 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.72 HG12 HD13 ' A' ' 659' ' ' LEU . 9.2 mt -112.41 137.16 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 689' ' ' VAL . 8.3 tptt -98.19 115.7 28.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.7 mt -82.8 -38.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.573 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 618' ' ' LEU . 6.7 mt -155.83 131.72 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.019 0.438 . . . . 0.0 111.873 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.24 124.75 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.669 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.18 117.88 29.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.642 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -66.36 -46.52 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.591 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -83.28 -40.36 19.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.351 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.06 -17.94 56.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.69 16.09 9.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.75 105.2 13.58 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 587' ' ' ILE . 1.1 p -122.83 124.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.267 0.555 . . . . 0.0 112.147 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 587' ' ' ILE . 6.6 mm -114.29 150.17 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.553 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.71 121.48 0.87 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.641 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 580' ' ' LEU . 6.9 m-30 -113.78 143.18 45.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.746 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.5 tttt -101.78 117.81 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.904 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.69 123.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -133.67 108.99 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.287 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 674' ' ' ASP . 87.0 mt -72.93 105.76 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.76 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.75 -47.57 10.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.139 0.495 . . . . 0.0 109.949 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -111.49 141.91 44.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.6 p -113.63 100.09 8.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.141 0.496 . . . . 0.0 109.875 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -80.31 61.51 4.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.696 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.3 54.81 34.16 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.109 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.794 HD11 ' CZ ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -87.28 148.38 25.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.392 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.72 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -39.76 -32.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.989 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.454 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -178.95 33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.443 ' HG3' HD12 ' A' ' 696' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.6 p -90.29 122.43 41.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.484 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.5 172.26 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -103.16 142.22 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -88.98 160.13 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.905 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.14 -173.49 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.74 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.81 -49.19 77.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.467 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.5 mp0 -69.18 -49.84 53.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.574 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 727' ' ' VAL . 24.7 mtmt -57.26 -32.81 66.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.735 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 6.9 mt -57.81 -44.24 86.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.8 p -75.86 -24.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.27 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -57.26 -41.14 79.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -74.1 -15.4 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.274 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.745 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.9 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.434 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 tmm_? -105.93 140.19 39.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -129.16 -61.15 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.585 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 6.4 tt -106.56 141.36 37.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.181 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.882 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.5 m -119.48 119.67 34.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.362 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.1 mt -104.79 108.29 19.69 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 98.68 44.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.8 Cg_exo -48.98 101.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.649 1.566 . . . . 0.0 109.15 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.02 158.26 85.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.456 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.94 -28.64 19.05 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.55 2.834 . . . . 0.0 112.594 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.48 -18.14 63.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 109.725 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.7 t -96.8 153.76 17.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.679 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.858 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.7 pt -55.62 -20.29 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.847 ' CD1' HG23 ' A' ' 613' ' ' ILE . 59.5 mt -110.27 118.66 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.382 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -106.74 57.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.394 0.616 . . . . 0.0 110.258 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.628 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -124.71 172.63 9.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.892 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.43 127.68 45.81 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.315 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.869 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.11 147.22 37.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.083 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 7.4 mt-10 -125.35 125.56 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.872 HD11 HD12 ' A' ' 625' ' ' ILE . 68.2 mt -86.1 109.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.9 mp0 -64.18 118.06 8.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.41 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.521 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.54 -29.79 1.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.583 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.27 -22.63 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.48 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 118.93 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.773 0.787 . . . . 0.0 111.726 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 17.1 t30 -139.56 121.82 10.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.781 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.9 Cg_endo -89.6 160.28 36.28 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.563 -1.015 . . . . 0.0 111.691 -0.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.9 t80 -91.52 116.19 28.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.744 ' CG ' HD12 ' A' ' 730' ' ' LEU . 25.4 m-85 -92.36 137.94 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.15 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.74 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.47 145.89 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.423 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.42 -176.28 41.66 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.481 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -78.52 -7.28 57.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.78 133.25 43.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -23.71 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 730' ' ' LEU . 6.8 p30 -57.83 -25.4 60.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 55.2 m -78.75 132.06 36.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.4 m120 -46.1 -31.35 2.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.198 0.523 . . . . 0.0 110.413 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.869 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.5 t -108.53 142.76 38.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.6 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 115.59 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -138.02 109.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.284 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 19.2 tt0 -87.09 103.41 15.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.6 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -132.11 112.81 12.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.44 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -42.98 -33.69 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.761 0.315 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.543 ' HB2' HD13 ' A' ' 681' ' ' ILE . 31.5 mmt180 -77.55 -39.98 44.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.071 HD12 HD12 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -60.21 159.11 10.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.905 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 70.7 m -111.09 168.81 9.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.537 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -43.64 24.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.228 0.537 . . . . 0.0 110.031 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.541 HG11 HG23 ' A' ' 727' ' ' VAL . 39.1 t -125.17 61.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.467 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.511 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 36.3 t60 -49.78 -48.3 50.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.791 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -167.52 157.32 10.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 111.363 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.2 p90 -143.14 147.37 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 580' ' ' LEU . 34.7 mt -102.13 128.33 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.086 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.612 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -119.78 131.3 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 20.2 ttmt -97.84 136.36 38.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.107 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.09 159.28 41.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.879 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.0 tpt180 -76.28 116.3 16.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.4 t60 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.209 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.671 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.8 mp -106.14 -159.71 0.71 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -118.27 146.77 44.05 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.44 160.41 29.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.782 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.65 121.98 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.46 0.647 . . . . 0.0 112.313 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.96 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -105.7 125.75 51.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.632 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -89.71 116.49 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 624' ' ' PHE . 16.3 m -102.95 137.13 41.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.403 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 41.4 t60 -116.87 122.97 45.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.787 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.35 7.92 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.272 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.78 145.18 19.94 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.832 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.4 m -75.29 -9.55 58.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.558 ' O ' HG13 ' A' ' 656' ' ' VAL . 36.2 m-20 -87.14 2.09 50.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.59 127.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.395 0.617 . . . . 0.0 112.158 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.403 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 16.2 p -97.73 165.55 11.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.208 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -128.52 119.7 25.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -95.22 102.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 63.42 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.11 -2.08 1.5 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.51 141.75 30.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.909 0.385 . . . . 0.0 111.222 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.1 ttp85 -85.16 141.61 30.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.5 mtp -131.11 124.74 31.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.522 HG12 HG21 ' A' ' 668' ' ' THR . 22.6 pt -95.08 156.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.779 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 652' ' ' THR . 32.9 tt0 -50.25 122.42 6.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 97.14 25.75 10.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.522 HG21 HG12 ' A' ' 665' ' ' ILE . 50.5 p -122.43 156.42 34.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.6 pttm -123.94 158.17 32.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.968 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.553 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.29 145.92 29.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.96 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.88 130.53 43.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.624 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.743 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -110.44 114.87 28.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.11 0.481 . . . . 0.0 111.665 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.15 135.29 40.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.849 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.47 ' HB2' HD12 ' A' ' 696' ' ' ILE . 4.3 t70 -40.96 109.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.584 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 101.11 34.55 4.52 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.424 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -93.45 115.17 27.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.469 -0.365 . . . . 0.0 111.087 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -96.25 108.51 21.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.838 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.632 HG21 ' CE2' ' A' ' 649' ' ' TYR . 7.1 mt -106.51 136.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 115.72 28.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.222 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.573 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -82.12 -36.16 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.197 -178.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.071 HD12 HD12 ' A' ' 618' ' ' LEU . 41.4 mt -154.9 131.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -136.57 124.77 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.57 117.23 23.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.481 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -66.8 -46.56 74.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.808 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -77.83 -40.37 40.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.602 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.4 -13.73 51.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.543 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp 61.82 17.77 9.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.64 104.96 9.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.3 p -117.54 121.83 68.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 111.695 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.5 mm -124.45 119.11 55.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.503 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -147.83 129.73 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 12.8 m-30 -113.18 142.82 45.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 110.255 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.592 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.27 116.91 33.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.332 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.88 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.73 123.97 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.73 110.22 11.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.0 110.868 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 705' ' ' GLU . 64.0 mt -81.46 105.64 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.788 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.08 -43.69 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.01 141.98 42.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -112.89 100.16 8.44 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.473 0.654 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 596' ' ' GLN . 0.6 OUTLIER -87.24 53.97 3.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.15 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 93.0 34.94 6.54 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.628 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -83.84 132.02 34.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.671 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.0 p90 -43.31 -33.32 0.97 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.515 0.674 . . . . 0.0 110.258 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -149.86 -55.8 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.124 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.81 ' O ' HD12 ' A' ' 696' ' ' ILE . 10.4 pt-20 . . . . . 0 N--CA 1.464 0.253 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.886 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.656 0.265 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 663' ' ' ARG . 51.9 t -77.42 128.45 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.462 . . . . 0.0 111.4 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.403 ' H ' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -113.74 164.65 13.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.348 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.52 142.95 27.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.95 158.66 36.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.0 p -118.91 -178.41 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.978 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.59 -29.06 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.98 -49.96 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -50.71 67.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.72 -32.89 63.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.36 -36.88 84.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.07 -44.2 94.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.541 HG23 HG11 ' A' ' 621' ' ' VAL . 11.2 p -79.15 -29.26 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.87 -30.61 61.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -85.51 -24.06 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.744 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.7 tt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.581 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.406 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 22.9 ttp-105 -111.82 143.11 43.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.052 0.453 . . . . 0.0 111.524 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.505 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.69 -57.81 1.43 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.09 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -110.26 137.93 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.084 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.739 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.4 m -118.55 114.18 22.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.678 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -103.92 108.06 19.22 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 16.3 ptpt -117.09 100.54 53.29 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.5 Cg_exo -46.08 104.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.87 1.714 . . . . 0.0 109.62 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.12 160.29 81.95 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.547 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 5.6 Cg_endo -48.17 -31.18 16.09 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.587 2.858 . . . . 0.0 112.495 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -63.73 -16.1 60.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.156 0.503 . . . . 0.0 109.726 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 9.1 t -94.18 145.0 25.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.601 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 3.5 pt -52.43 -24.26 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 110.178 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.647 HG21 HD12 ' A' ' 613' ' ' ILE . 7.3 tt -112.99 118.97 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.983 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.547 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -100.69 71.16 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.331 0.586 . . . . 0.0 110.321 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 50.6 mt-10 -126.05 171.9 10.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.127 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.21 130.2 47.61 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 121.138 0.494 . . . . 0.0 110.962 178.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.757 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.44 140.03 47.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.936 179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.449 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 1.5 mp0 -124.12 112.56 17.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 578' ' ' LEU . 89.7 mt -81.09 108.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 110.03 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.5 mp0 -66.87 123.63 20.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.118 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.73 -26.71 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 110.819 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -75.68 -20.39 78.28 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.041 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 44.3 t -99.45 118.02 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.993 0.897 . . . . 0.0 111.776 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.0 t30 -140.23 122.49 9.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.583 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.5 Cg_endo -90.36 160.15 32.45 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.679 -0.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.1 t80 -92.58 117.48 30.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 730' ' ' LEU . 19.4 m-85 -92.51 137.48 32.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.262 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.3 mp -121.93 143.61 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.585 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 167.33 -165.09 38.39 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.949 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.21 -17.27 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.131 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -80.28 131.53 35.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.824 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.5 -23.85 11.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.001 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -59.84 -27.04 66.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 9.7 m -76.0 129.36 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -46.57 -32.47 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.231 0.539 . . . . 0.0 110.225 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 603' ' ' ILE . 13.2 t -107.47 135.24 49.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.315 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.98 111.94 22.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 588' ' ' ILE . 17.5 mm -137.78 110.14 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.974 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -81.57 102.85 10.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.066 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.816 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.8 OUTLIER -132.84 109.13 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.42 178.247 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -44.58 -52.88 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.989 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -60.64 -19.76 58.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.897 0.379 . . . . 0.0 110.928 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.008 HD12 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -76.2 160.66 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.575 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.456 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 19.6 t -111.22 151.96 27.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.411 ' CA ' ' HB2' ' A' ' 606' ' ' SER . 7.7 mpt_? -39.0 -38.6 0.46 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 110.675 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.539 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.9 t -128.67 60.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.418 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 21.7 t60 -50.4 -48.81 55.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.077 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.553 ' SG ' HG21 ' A' ' 680' ' ' ILE . 22.8 p -165.64 161.11 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.688 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.6 p90 -143.83 144.95 32.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.629 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.649 HD13 HD11 ' A' ' 580' ' ' LEU . 2.4 mp -101.97 128.87 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.1 t80 -119.43 134.04 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 6.7 ttpt -97.86 136.47 38.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.223 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.2 OUTLIER -135.21 159.88 40.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.473 -178.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.0 tpt85 -75.72 112.46 12.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.378 0.609 . . . . 0.0 110.371 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.8 t60 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.049 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 643' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 113.179 0.032 . . . . 0.0 113.179 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.2 mp -107.05 -161.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.828 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -115.63 146.85 41.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.237 0.541 . . . . 0.0 112.39 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.6 m-20 -129.95 160.55 33.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.798 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.54 125.61 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.494 0.664 . . . . 0.0 112.461 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.968 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.5 m95 -108.93 128.05 54.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.607 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.441 ' OH ' HG22 ' A' ' 680' ' ' ILE . 35.1 t80 -90.47 119.4 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.642 0.258 . . . . 0.0 110.325 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 28.2 m -107.59 128.38 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.215 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.407 ' HA ' ' CB ' ' A' ' 623' ' ' CYS . 20.5 t60 -108.81 125.3 51.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -118.62 4.41 11.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.613 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.01 150.54 26.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.152 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 654' ' ' THR . 76.1 m -82.4 -10.97 58.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.553 0.216 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -84.65 2.89 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 50.67 139.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.64 0.733 . . . . 0.0 112.353 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 10.1 t -112.67 166.16 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.55 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -130.57 120.2 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.016 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.677 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -102.63 103.25 13.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.438 ' N ' HD12 ' A' ' 659' ' ' LEU . 29.6 t-20 62.53 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.784 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.7 m-80 -139.89 -2.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.43 141.67 32.96 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.943 0.401 . . . . 0.0 111.406 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.618 ' O ' HG21 ' A' ' 716' ' ' VAL . 20.7 ttm180 -75.29 141.51 43.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.057 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.53 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.1 mmm -125.68 89.3 3.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.499 HG12 HG21 ' A' ' 668' ' ' THR . 30.0 pt -86.81 164.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.996 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -50.65 117.77 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.454 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.22 30.26 9.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.789 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.499 HG21 HG12 ' A' ' 665' ' ' ILE . 23.8 p -114.01 162.18 16.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.5 ttpt -134.93 149.43 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.483 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 716' ' ' VAL . 0.7 OUTLIER -147.62 143.83 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.968 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -75.89 129.76 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.682 ' N ' HD12 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -99.87 143.79 29.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.329 0.585 . . . . 0.0 111.938 -179.426 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -130.34 136.17 48.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.511 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 696' ' ' ILE . 15.0 t70 -40.27 118.55 0.93 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.55 37.42 5.85 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -94.83 117.66 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.167 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.06 108.71 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.677 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -108.95 133.84 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -109.42 116.54 32.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.095 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.66 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 1.9 pt -89.51 -21.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.008 HD12 HD12 ' A' ' 618' ' ' LEU . 41.1 mt -154.27 130.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.579 . . . . 0.0 111.674 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -137.71 127.31 25.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.57 116.76 24.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.552 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -67.56 -47.62 69.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.708 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.1 -40.48 18.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.472 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -13.4 60.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.419 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.56 18.74 8.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.813 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.77 104.63 15.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -122.13 121.59 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.272 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.657 HD13 ' CG ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -128.44 128.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.95 135.92 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.466 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -114.28 147.43 39.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.37 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.4 tttt -101.53 117.19 34.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.529 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 3.6 t -78.79 123.55 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.28 109.34 9.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 705' ' ' GLU . 42.9 mt -80.86 105.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.24 -43.67 10.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.115 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.199 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.3 p -112.73 100.22 8.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.576 0.703 . . . . 0.0 109.789 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.2 m -84.65 59.29 5.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 83.99 40.13 8.91 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.437 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -86.67 132.66 33.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.533 0.206 . . . . 0.0 110.619 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -42.92 -33.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.342 0.591 . . . . 0.0 110.606 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -148.39 -58.79 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.808 ' O ' HD12 ' A' ' 696' ' ' ILE . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.146 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.62 HG22 ' CE1' ' A' ' 670' ' ' PHE . 15.8 t -84.11 113.73 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.154 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -90.72 169.65 10.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.9 140.18 37.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.69 155.39 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 32.1 p -125.64 -176.16 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.86 -33.43 56.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -51.3 70.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.454 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -63.91 -48.12 77.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -58.27 -32.97 68.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -64.85 -37.01 86.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.2 mt -62.91 -44.1 97.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.539 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.4 p -75.76 -28.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -33.17 52.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -98.68 26.23 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.485 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.2 tt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 11.6 ttm180 -113.46 143.82 43.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.706 0.288 . . . . 0.0 111.521 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.883 ' CE2' HD13 ' A' ' 702' ' ' LEU . 2.3 t80 -119.97 -55.29 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.4 tp -113.34 142.43 45.87 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -122.51 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 625' ' ' ILE . 4.7 mp -106.27 108.86 20.59 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 100.93 51.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 46.2 Cg_exo -45.94 99.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.98 1.787 . . . . 0.0 110.006 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.2 85.11 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -48.84 -25.29 8.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.403 2.735 . . . . 0.0 112.921 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.858 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -61.83 -27.27 68.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.508 ' OG ' HD13 ' A' ' 690' ' ' ILE . 8.7 t -95.73 154.11 17.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.892 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.679 HD13 ' CE1' ' A' ' 688' ' ' PHE . 2.6 pt -57.11 -12.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.69 0.281 . . . . 0.0 110.962 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.646 ' CD1' HG23 ' A' ' 613' ' ' ILE . 71.2 mt -110.27 123.0 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.746 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.16 57.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.197 0.522 . . . . 0.0 110.028 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.3 mt-10 -124.62 171.75 9.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.226 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.02 130.1 50.49 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 178.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.748 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.28 139.45 47.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.037 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.17 112.99 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.659 0.266 . . . . 0.0 111.644 -179.354 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.011 HD11 HD12 ' A' ' 625' ' ' ILE . 38.0 mt -77.22 109.76 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.1 tp60 -67.71 114.66 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.76 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.19 -28.53 0.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.184 0.516 . . . . 0.0 110.809 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.427 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.83 -25.2 74.24 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.536 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.903 HG11 ' OD1' ' A' ' 610' ' ' ASN . 66.6 t -101.2 119.27 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 117.813 0.807 . . . . 0.0 111.61 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 18.5 t30 -139.07 122.91 11.09 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.786 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 47.3 Cg_endo -89.83 160.51 35.24 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 124.518 -1.034 . . . . 0.0 111.863 0.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.38 114.96 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.535 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.0 m-85 -92.12 138.19 31.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.168 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.1 145.77 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.83 -173.27 38.16 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.383 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.35 -53.48 29.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.656 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.6 129.82 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.292 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.39 -18.96 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -53.66 -30.02 41.25 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 30.4 m -73.55 134.45 43.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.903 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.3 m-80 -48.66 -27.36 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.973 0.415 . . . . 0.0 110.388 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.0 t -113.37 142.08 46.29 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -110.52 105.61 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.5 mm -138.52 109.91 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.161 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -103.69 106.7 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.489 0.662 . . . . 0.0 112.589 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.697 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.6 t0 -129.93 107.71 9.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.559 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -39.3 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.477 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.8 mmp_? -70.31 -41.42 73.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.623 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.12 158.72 18.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.85 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.2 t -78.26 172.37 13.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.418 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -50.27 -37.24 34.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 110.253 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.09 67.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.265 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.7 t60 -49.05 -48.36 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.811 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' A' ' 680' ' ' ILE . 2.6 p -159.99 158.77 31.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.676 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 603' ' ' ILE . 39.3 p90 -143.45 150.39 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.478 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.011 HD12 HD11 ' A' ' 594' ' ' ILE . 83.7 mt -102.53 132.42 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.215 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -124.97 132.92 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 36.2 ttmt -98.45 136.54 38.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.573 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.45 158.58 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -76.95 112.75 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.522 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.7 t60 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.628 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 701' ' ' GLY . 1.2 mp -115.74 -149.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.551 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 4.7 m-20 -118.21 149.37 41.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.282 0.563 . . . . 0.0 112.338 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.54 ' OD2' HD21 ' A' ' 671' ' ' LEU . 3.9 m-20 -134.03 129.32 35.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.734 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.779 HG21 ' CE1' ' A' ' 577' ' ' PHE . 7.0 pt -86.81 123.55 39.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.323 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.6 m95 -108.98 129.32 55.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.046 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.2 t80 -90.34 115.7 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 624' ' ' PHE . 60.8 m -101.63 141.88 33.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 111.473 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 664' ' ' MET . 24.8 t60 -124.13 131.64 53.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 9.3 p -124.24 2.63 8.52 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.37 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.84 142.48 24.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.037 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 654' ' ' THR . 28.3 m -75.55 -12.65 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.536 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.8 m120 -83.64 2.63 36.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.587 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.87 134.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.588 0.708 . . . . 0.0 112.281 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.403 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 43.5 p -105.49 165.89 10.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.355 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 20.2 m-85 -127.61 119.85 26.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 111.283 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.673 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.64 99.72 10.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.702 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.33 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.8 t-20 -133.48 3.76 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.833 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.705 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -110.15 130.26 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.955 0.407 . . . . 0.0 111.147 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.489 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -69.97 141.42 53.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.787 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.513 ' HG3' ' HB3' ' A' ' 651' ' ' HIS . 34.1 tpp -125.4 101.29 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.1 pt -87.94 165.61 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.77 109.82 0.89 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 110.958 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.41 34.72 3.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 716' ' ' VAL . 5.2 p -134.84 154.94 51.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.356 . . . . 0.0 111.591 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.2 pttm -128.23 156.08 43.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.617 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.52 145.77 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.501 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.38 134.57 51.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.481 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.873 HD13 HG21 ' A' ' 694' ' ' VAL . 3.3 mt -108.52 126.33 52.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -113.36 154.21 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.714 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.48 ' N ' HD12 ' A' ' 696' ' ' ILE . 56.7 t0 -52.76 101.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.21 30.66 3.81 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 117.11 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.536 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -96.2 109.74 22.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.282 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.673 HG22 HD13 ' A' ' 659' ' ' LEU . 23.5 pt -105.94 130.48 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 5.2 mttp -94.5 116.13 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.711 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.588 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -79.3 -38.7 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.522 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.697 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -155.84 136.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -136.42 122.41 20.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -123.53 116.99 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.92 0.39 . . . . 0.0 110.583 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -67.27 -46.48 73.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.97 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -78.81 -40.49 32.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.793 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -83.08 -9.51 59.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 60.46 18.08 7.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.253 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.679 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -76.72 104.63 7.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.4 p -118.2 122.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.133 0.492 . . . . 0.0 111.746 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.588 HG21 ' CG2' ' A' ' 680' ' ' ILE . 22.5 mm -126.17 154.6 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.298 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.432 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 177.54 127.86 1.1 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.952 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 592' ' ' LEU . 11.1 m-30 -113.04 145.28 41.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.43 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.693 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.2 116.53 33.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.022 0.439 . . . . 0.0 110.256 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.873 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.58 127.19 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.754 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -134.28 108.4 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.924 179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 705' ' ' GLU . 11.5 mt -74.58 104.94 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.61 -50.84 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.899 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.6 t0 -112.47 138.36 49.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.211 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.09 100.06 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.55 HG21 ' HG3' ' A' ' 596' ' ' GLN . 64.1 p -70.27 78.84 0.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.336 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 53.42 39.75 60.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.388 -0.91 . . . . 0.0 110.829 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.883 HD13 ' CE2' ' A' ' 577' ' ' PHE . 1.5 tt -97.08 143.65 27.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.867 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.663 ' CB ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.25 112.66 1.62 Allowed 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.43 ' CG ' ' HG2' ' A' ' 705' ' ' GLU . 10.9 t-20 59.73 -68.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.147 0.499 . . . . 0.0 109.932 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.682 ' HB2' HD13 ' A' ' 696' ' ' ILE . 11.7 pt-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.989 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.78 0.324 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.705 HG23 ' OD1' ' A' ' 662' ' ' ASN . 70.8 t -79.3 130.16 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.415 HD13 ' HE2' ' A' ' 669' ' ' LYS . 1.4 mp -99.42 170.65 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -98.32 155.76 17.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -96.39 158.54 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.3 p -126.04 -176.58 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.197 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.42 46.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.14 -47.81 84.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.37 -50.42 63.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.663 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -55.7 -32.87 63.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -37.31 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.786 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -44.34 93.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -78.41 -21.49 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -37.75 81.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.6 -9.67 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.399 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.99 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.0 tmm_? -107.52 143.11 36.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.603 ' HE1' HG21 ' A' ' 647' ' ' ILE . 2.4 t80 -132.61 -47.98 0.89 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.854 HD11 ' CD1' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -112.65 143.25 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.16 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.0 m -123.07 114.01 19.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.982 0.42 . . . . 0.0 111.053 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -106.11 109.01 20.82 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.26 99.43 52.69 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 39.0 Cg_exo -46.91 101.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.916 1.744 . . . . 0.0 109.814 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.815 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.73 157.95 85.32 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.14 -25.46 13.07 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.768 2.978 . . . . 0.0 113.21 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -61.97 -27.37 68.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 2.7 t -95.62 153.92 17.48 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.624 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 688' ' ' PHE . 9.3 pt -56.51 -12.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.701 0.286 . . . . 0.0 111.193 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 39.9 mt -108.54 127.24 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.527 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.22 58.5 0.69 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.668 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 36.7 mt-10 -125.03 170.14 11.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.86 121.19 24.82 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.607 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -112.75 147.43 36.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -125.19 118.54 26.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 625' ' ' ILE . 57.6 mt -73.48 109.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.912 0.387 . . . . 0.0 110.294 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.8 mp0 -65.1 116.4 6.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.971 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.99 -29.84 1.59 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.163 0.506 . . . . 0.0 110.471 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.23 -22.72 76.28 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.589 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.505 HG11 ' ND2' ' A' ' 610' ' ' ASN . 79.3 t -101.04 118.79 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 117.884 0.842 . . . . 0.0 111.585 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.0 t30 -139.37 122.68 10.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.765 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.11 160.43 33.82 Favored 'Cis proline' 0 N--CA 1.462 -0.373 0 C-N-CA 124.451 -1.062 . . . . 0.0 111.917 0.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.46 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.611 ' CG ' HD12 ' A' ' 730' ' ' LEU . 41.6 m-85 -92.25 138.15 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.007 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.2 mp -129.84 145.69 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.678 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.41 ' HA2' HD11 ' A' ' 618' ' ' LEU . . . 156.72 -163.36 32.14 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.013 -1.089 . . . . 0.0 114.049 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.2 OUTLIER -82.85 3.42 29.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.456 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -101.3 123.94 46.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -57.84 -22.49 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.271 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.16 -26.63 67.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.905 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 92.3 m -68.51 129.43 39.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.319 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.2 m120 -44.07 -33.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.308 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.756 ' SG ' HG23 ' A' ' 603' ' ' ILE . 53.5 t -109.73 134.88 51.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.12 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 111.99 23.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 30.6 mm -137.62 110.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.619 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 6.1 tt0 -91.6 105.9 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.274 0.559 . . . . 0.0 111.523 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 618' ' ' LEU . 13.5 t0 -130.32 108.58 10.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.702 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -47.43 -29.8 2.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.821 0.343 . . . . 0.0 111.201 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.491 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 19.7 mmt180 -77.86 -41.29 37.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -84.75 151.71 24.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.94 161.4 23.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.165 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.448 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -47.65 -38.8 15.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.444 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 24.1 t -121.24 57.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.0 t60 -50.42 -48.66 56.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.883 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.48 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.2 p -162.69 157.04 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 111.422 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.792 ' HA ' HD12 ' A' ' 603' ' ' ILE . 25.2 p90 -143.32 146.93 33.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.594 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 594' ' ' ILE . 23.9 mt -101.9 135.37 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.983 0.42 . . . . 0.0 109.914 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -127.34 134.94 49.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.746 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.2 ttmt -97.64 136.19 38.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.137 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 159.27 42.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.76 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.47 112.55 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.195 0.522 . . . . 0.0 110.595 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t-160 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.695 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.1 mp -102.47 -166.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -111.75 148.03 34.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.026 0.441 . . . . 0.0 111.926 -179.211 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -128.85 160.11 33.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.854 ' CD1' HD11 ' A' ' 578' ' ' LEU . 3.5 pt -110.64 121.59 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.317 0.579 . . . . 0.0 111.615 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.854 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.9 m95 -104.28 141.3 36.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.165 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.7 t80 -105.7 116.95 32.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.19 139.8 39.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.472 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 62.2 t60 -119.46 128.73 54.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.417 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 5.4 p -126.55 12.95 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.51 148.75 21.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.181 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 69.5 m -77.0 -21.89 53.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -79.9 -0.52 35.27 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.5 OUTLIER 54.9 128.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.932 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.1 p -92.74 166.36 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.986 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 679' ' ' LYS . 18.7 m-85 -133.15 120.6 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.779 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -105.3 112.57 25.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.142 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 59.03 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -139.86 7.6 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -104.22 141.06 36.93 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.924 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.1 ttt180 -79.33 141.02 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 13.9 mmm -120.96 101.27 7.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.446 HG12 HG21 ' A' ' 668' ' ' THR . 34.2 pt -88.27 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 652' ' ' THR . 34.6 tt0 -44.81 109.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.423 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.45 34.78 3.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.446 HG21 HG12 ' A' ' 665' ' ' ILE . 3.6 p -122.33 162.25 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.071 0.462 . . . . 0.0 111.667 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.419 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 4.5 ttpm? -131.61 149.71 52.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.344 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.484 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.3 143.74 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.854 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.37 137.74 53.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.437 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -110.85 104.14 12.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.235 0.54 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -90.94 137.91 32.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.197 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.566 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.4 t70 -43.52 111.32 0.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.8 37.13 4.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -93.55 122.65 36.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.469 -0.366 . . . . 0.0 111.012 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.37 108.88 21.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.186 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.779 HG23 ' HG ' ' A' ' 659' ' ' LEU . 3.7 mt -106.15 136.36 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.904 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 658' ' ' TYR . 1.7 mttt -100.83 116.27 32.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.566 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.525 HG22 ' CG2' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -78.68 -37.94 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.413 -179.008 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.52 HD11 ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -155.29 131.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.724 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -136.25 123.56 21.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.159 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -121.4 117.18 26.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.42 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -66.89 -46.51 74.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.943 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.41 -40.44 21.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.543 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -77.47 -14.0 59.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.334 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 15.09 9.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -78.6 104.76 9.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 689' ' ' VAL . 1.6 p -120.18 121.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 111.972 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.585 HD12 ' OD2' ' A' ' 615' ' ' ASP . 3.4 mt -129.14 152.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.324 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 177.5 133.3 1.82 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.021 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 4.2 m-30 -112.93 150.92 31.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.553 ' HB2' HD22 ' A' ' 583' ' ' LEU . 5.7 ttpt -101.27 116.82 33.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.953 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.759 HG13 ' CD2' ' A' ' 578' ' ' LEU . 1.8 t -81.11 121.89 35.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.883 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.66 108.75 8.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.477 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 674' ' ' ASP . 11.6 mt -79.21 107.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.32 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.68 -41.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -109.76 141.09 42.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.2 OUTLIER -114.88 100.41 8.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.418 0.627 . . . . 0.0 110.046 178.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.6 m -86.79 70.47 10.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 73.33 36.12 55.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.163 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.608 HD12 ' CA ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -79.87 118.59 21.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.583 0.23 . . . . 0.0 111.171 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.695 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -32.8 -47.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.679 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 15.4 p30 -159.2 26.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.608 ' CA ' HD12 ' A' ' 702' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.543 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.897 0.38 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.924 HG21 ' O ' ' A' ' 663' ' ' ARG . 59.4 t -78.91 129.32 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.9 mt -102.64 166.13 10.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 137.99 40.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.02 159.88 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.4 p -121.11 -173.68 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.67 -28.82 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.16 -52.09 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.66 -49.32 63.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.628 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -56.35 -33.13 65.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 -38.24 89.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.8 mt -58.41 -44.01 88.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.548 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.6 p -83.18 -29.77 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -52.11 -29.31 21.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.057 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -105.29 27.22 8.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.611 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.3 tt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.679 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.9 tmm_? -102.29 126.13 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.564 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -109.2 -62.29 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.187 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.06 137.76 43.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.72 ' N ' HD23 ' A' ' 578' ' ' LEU . 4.6 m -115.98 113.96 23.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.998 0.428 . . . . 0.0 111.434 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.721 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -104.83 107.9 19.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 ptpt -114.83 100.02 52.84 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_exo -45.78 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.945 1.763 . . . . 0.0 109.565 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.16 157.83 86.3 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.401 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.8 Cg_exo -49.12 -25.25 8.98 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.381 2.72 . . . . 0.0 112.425 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.726 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.2 t0 -61.97 -22.61 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.0 t -95.31 153.11 17.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.847 HD11 ' OD1' ' A' ' 615' ' ' ASP . 20.7 pt -53.03 -19.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.012 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.58 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.99 142.92 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.658 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -119.47 67.74 0.81 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.589 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 89.5 mt-10 -125.16 170.86 10.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.494 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.77 124.0 34.37 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 1.084 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.26 136.51 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.571 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.462 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.3 OUTLIER -124.48 116.6 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.851 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.716 HG23 ' CD1' ' A' ' 601' ' ' PHE . 81.2 mt -74.87 108.16 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.842 0.354 . . . . 0.0 110.144 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.1 mp0 -66.16 103.14 0.92 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -29.6 -54.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.27 0.557 . . . . 0.0 111.449 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -53.03 -16.39 4.24 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.017 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.37 118.05 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 117.873 0.837 . . . . 0.0 111.604 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' ND2' ' CD2' ' A' ' 626' ' ' PHE . 0.9 OUTLIER -140.46 124.35 10.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.997 178.423 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 37.2 Cg_endo -91.32 159.28 27.73 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.149 0.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.716 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.3 t80 -93.61 115.77 28.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 0.0 109.962 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 730' ' ' LEU . 1.7 m-85 -92.94 138.61 31.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.917 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.804 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -127.51 144.89 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 158.35 -165.0 33.71 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.877 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.02 17.92 11.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.41 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 1.1 t -101.78 131.68 47.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.642 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -21.71 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.763 0.316 . . . . 0.0 110.63 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.29 -21.33 60.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.9 m -76.52 127.41 32.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 23.3 m120 -45.76 -31.68 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.14 0.495 . . . . 0.0 110.434 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.804 ' SG ' HG23 ' A' ' 603' ' ' ILE . 45.0 t -110.55 138.72 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 117.83 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 1.084 HD11 HD21 ' A' ' 592' ' ' LEU . 34.2 mm -138.06 108.83 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.314 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.35 101.09 11.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.413 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD1' HD11 ' A' ' 587' ' ' ILE . 1.1 m-20 -133.54 113.36 12.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.937 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -50.42 -45.81 55.98 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' A' ' 681' ' ' ILE . 2.4 mpp_? -62.66 -19.05 63.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.549 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.982 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -88.17 160.81 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.593 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.403 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 2.6 m -109.92 153.74 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -39.03 -50.68 1.81 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.76 57.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.606 ' CB ' HD23 ' A' ' 618' ' ' LEU . 54.2 t60 -52.69 -37.55 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.344 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.529 0.68 . . . . 0.0 111.939 -178.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.598 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.18 131.97 21.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.904 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 603' ' ' ILE . 21.3 mt -131.79 116.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.458 ' CD2' ' ND2' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -136.78 149.02 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -178.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 34.6 ttmt -98.9 136.76 38.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 159.79 35.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.4 tpt180 -75.68 112.75 12.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.746 -0.141 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.638 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.8 mp -110.54 -163.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.822 ' O ' HD13 ' A' ' 702' ' ' LEU . 9.8 m-20 -114.12 146.49 40.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.294 0.569 . . . . 0.0 112.197 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.434 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -128.8 160.61 32.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.647 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.092 HD13 HD12 ' A' ' 578' ' ' LEU . 0.6 OUTLIER -103.33 128.29 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.6 0.714 . . . . 0.0 112.081 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.6 m95 -113.02 120.45 41.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.27 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.647 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.6 t80 -93.62 117.77 30.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 624' ' ' PHE . 3.9 m -113.74 143.87 43.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.437 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 42.5 t60 -110.58 130.12 55.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.0 0.428 . . . . 0.0 111.049 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.428 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 20.5 p -120.56 3.83 10.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLY . . . . . . . . . . . . . . . -81.58 146.22 25.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.847 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 37.5 m -75.94 -15.64 60.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 656' ' ' VAL . 29.3 m-20 -85.18 3.05 41.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.16 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.438 0.637 . . . . 0.0 112.283 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.58 ' CB ' ' HH ' ' A' ' 649' ' ' TYR . 33.1 p -99.31 166.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.302 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 5.8 m-85 -129.23 120.06 25.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.718 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 1.029 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -98.64 102.58 14.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 60.93 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.4 p30 -136.84 5.7 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.672 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.533 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -107.44 139.75 41.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.626 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.1 ttp180 -76.4 141.36 41.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.423 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 25.1 mmm -124.61 97.44 5.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 45.4 pt -87.57 152.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 652' ' ' THR . 38.5 tt0 -48.7 112.05 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.91 0.386 . . . . 0.0 110.945 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.9 32.32 4.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.3 p -121.04 162.54 19.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.828 0.347 . . . . 0.0 111.203 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.9 ttpm? -133.69 147.81 51.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.769 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.69 28.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.04 133.72 48.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.593 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.88 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -108.9 104.71 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.35 139.26 30.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.621 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.644 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.2 t0 -41.28 112.4 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 110.708 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.28 37.08 4.43 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.78 116.11 28.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.252 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -96.26 108.72 21.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 659' ' ' LEU . 25.5 pt -105.92 129.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.798 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 27.9 mttp -89.43 115.8 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.834 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -79.26 -35.47 17.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.811 -178.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.982 HD12 HD12 ' A' ' 618' ' ' LEU . 50.2 mt -155.0 131.59 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.704 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -136.37 123.45 21.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.5 116.96 25.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.505 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -67.03 -46.61 73.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.842 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -80.91 -40.07 25.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -83.06 -13.36 55.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.06 17.11 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 111.0 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.04 104.62 7.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.5 p -117.48 124.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.2 0.524 . . . . 0.0 111.914 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 681' ' ' ILE . 59.5 mt -129.01 156.0 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.315 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 170.83 136.33 2.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.68 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.834 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -114.16 149.8 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.53 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.85 117.6 35.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.663 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 672' ' ' LEU . 3.5 t -80.03 124.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -133.2 109.71 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.413 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 705' ' ' GLU . 52.1 mt -78.26 106.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.76 -44.71 9.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.176 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -110.4 141.87 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.54 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -113.07 99.92 8.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.431 0.634 . . . . 0.0 109.599 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.1 m -82.88 58.84 4.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.52 13.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.173 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -80.64 134.33 35.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.56 0.219 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.638 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.8 p90 -43.36 -33.52 1.04 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.469 0.652 . . . . 0.0 110.266 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.493 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -148.1 -61.2 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.341 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.745 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.7 pt-20 . . . . . 0 N--CA 1.463 0.186 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.957 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.72 0.295 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 663' ' ' ARG . 65.0 t -85.78 121.84 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.506 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.66 172.36 8.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.37 16.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 650' ' ' CYS . 42.1 mt-30 -93.44 148.55 21.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -126.41 -175.96 3.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 111.669 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -30.15 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.198 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -56.61 -50.12 72.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.676 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.79 ' HA ' HD12 ' A' ' 726' ' ' LEU . 21.6 mm-40 -70.01 -49.5 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.57 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.477 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.43 -39.95 89.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.0 OUTLIER -63.35 -44.69 94.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.562 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.89 -19.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.254 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.98 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.039 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -108.11 24.24 13.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 730' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 52.1 ttp180 -106.12 141.47 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -125.66 -58.3 1.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.214 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 647' ' ' ILE . 12.8 tp -110.92 134.93 52.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.439 ' C ' HD23 ' A' ' 580' ' ' LEU . 7.5 m -115.24 114.72 25.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD11 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -105.28 108.7 20.35 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.96 100.33 52.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.2 Cg_exo -44.72 100.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.917 1.745 . . . . 0.0 109.806 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.35 158.29 85.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.43 -24.68 9.22 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.59 2.86 . . . . 0.0 112.387 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.764 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.42 -23.09 65.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 2.2 t -95.46 153.34 17.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.75 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.534 HD13 ' HD1' ' A' ' 688' ' ' PHE . 4.0 pt -54.42 -18.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.84 142.95 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.815 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.02 68.81 0.84 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.194 0.521 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.3 mm-40 -124.91 171.38 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.494 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 127.33 42.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.0 0.428 . . . . 0.0 111.12 178.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.952 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.39 139.58 47.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.892 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.472 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 6.1 mp0 -124.48 117.39 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.045 HD11 HD11 ' A' ' 580' ' ' LEU . 88.0 mt -86.34 109.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.062 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -67.47 125.84 27.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.72 -28.5 3.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.123 0.487 . . . . 0.0 110.52 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.59 -17.7 80.04 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.982 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.4 t -100.94 117.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.05 0.925 . . . . 0.0 111.878 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -140.8 121.31 8.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.8 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 50.5 Cg_endo -89.63 160.65 36.32 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 124.772 -0.928 . . . . 0.0 111.499 -0.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.0 t80 -92.15 117.02 29.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 730' ' ' LEU . 35.1 m-85 -92.21 137.51 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.039 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.773 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -124.94 143.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.59 -176.67 42.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.079 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.6 ttp85 -81.21 -2.96 50.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.662 0.268 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 135.71 42.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -24.91 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.059 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -28.36 60.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 51.5 m -77.06 132.52 38.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -47.31 -29.07 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.563 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.773 ' SG ' HG23 ' A' ' 603' ' ' ILE . 38.5 t -111.58 142.45 43.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.897 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 115.92 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.952 HD11 HD21 ' A' ' 592' ' ' LEU . 17.5 mm -137.78 110.29 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.441 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 22.2 mt-10 -81.88 103.2 11.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.511 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.737 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.43 108.43 9.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.161 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -42.5 -36.73 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.2 mpp_? -77.62 -36.86 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.737 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -60.3 158.91 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 83.9 p -110.68 168.89 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.553 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -46.17 -52.98 11.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.224 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.6 t -116.76 58.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.204 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' HG23 ' A' ' 680' ' ' ILE . 35.6 t60 -49.35 -48.59 46.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.886 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -163.12 156.08 19.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.502 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.9 p90 -143.22 148.05 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.38 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -102.59 141.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 179.357 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.0 t80 -130.91 134.15 46.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.418 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 27.9 ttmt -97.66 136.8 37.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.91 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.68 159.44 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.443 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.27 117.78 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.436 0.636 . . . . 0.0 110.79 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.444 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.751 -0.14 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.71 HD12 ' H ' ' A' ' 703' ' ' PHE . 1.2 mm? -79.99 -160.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 m-20 -122.49 147.03 46.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.188 0.518 . . . . 0.0 112.037 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.8 ' HB3' HD21 ' A' ' 671' ' ' LEU . 1.9 m-20 -129.18 159.72 35.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -105.92 134.94 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.362 0.601 . . . . 0.0 112.23 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.625 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 67.4 m95 -117.96 127.59 53.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.313 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.656 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -90.08 117.17 28.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.1 m -102.93 131.72 49.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.601 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 67.0 t60 -109.88 128.58 55.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.3 p -124.44 -1.14 8.1 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.451 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.36 137.95 21.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.029 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 654' ' ' THR . 91.4 m -69.78 -10.84 59.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.627 0.251 . . . . 0.0 111.456 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.532 ' O ' HG13 ' A' ' 656' ' ' VAL . 55.7 m-20 -85.03 3.75 37.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.59 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.57 137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.566 0.698 . . . . 0.0 112.182 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.444 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 5.9 t -108.74 166.2 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.387 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -129.38 120.36 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -101.84 99.64 9.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.562 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.9 m120 61.06 -81.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.2 p-10 -133.79 1.81 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.643 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.434 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.5 m120 -104.21 141.65 35.89 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.859 0.361 . . . . 0.0 111.069 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.55 141.27 38.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.058 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 656' ' ' VAL . 57.4 mmm -115.66 98.68 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.3 pt -87.5 155.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.063 0.459 . . . . 0.0 111.226 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -51.41 105.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.61 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 39.64 2.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.212 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.5 p -132.39 148.9 52.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.871 0.335 . . . . 0.0 111.549 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.66 ' HE2' HD13 ' A' ' 717' ' ' LEU . 15.9 pttm -123.88 136.35 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.671 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -131.94 141.61 49.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.6 OUTLIER -69.37 141.26 54.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.945 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 694' ' ' VAL . 16.2 mt -111.87 105.39 13.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 112.018 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -77.86 156.39 30.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.878 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.7 ' CB ' HD12 ' A' ' 696' ' ' ILE . 7.0 t0 -53.2 109.7 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.83 37.92 4.29 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -88.1 115.22 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.437 . . . . 0.0 111.184 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.12 109.78 22.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.626 HG22 HD13 ' A' ' 659' ' ' LEU . 11.8 pt -105.57 120.61 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.155 0.502 . . . . 0.0 112.11 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -87.54 116.02 25.37 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -82.3 -33.46 11.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.885 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -155.15 132.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.523 ' CB ' HG23 ' A' ' 689' ' ' VAL . 9.5 t90 -136.04 124.33 23.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 687' ' ' LYS . 2.2 t0 -124.14 116.58 22.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -67.79 -46.68 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.064 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -40.36 96.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.134 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -93.69 -18.35 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.643 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.0 OUTLIER 65.91 13.06 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.0 111.029 -179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -87.51 105.56 17.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.523 HG23 ' CB ' ' A' ' 682' ' ' TRP . 1.2 p -119.78 138.78 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.357 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.616 ' CG1' HG22 ' A' ' 681' ' ' ILE . 18.4 mm -113.67 152.12 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.77 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.2 130.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.651 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 680' ' ' ILE . 1.6 m-30 -113.9 145.06 42.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.735 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.0 tttm -101.1 116.92 33.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.033 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -79.82 128.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.692 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.3 OUTLIER -133.29 108.58 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.124 0.488 . . . . 0.0 111.019 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.8 mt -76.28 105.29 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.385 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -91.9 -50.13 5.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.041 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -112.62 139.57 48.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.142 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.466 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -116.2 100.56 8.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.207 0.527 . . . . 0.0 109.692 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 62.02 0.67 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.968 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.1 47.32 88.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.54 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -112.24 32.61 5.42 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.71 ' H ' HD12 ' A' ' 644' ' ' LEU . 0.0 OUTLIER 67.85 175.67 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 703' ' ' PHE . 4.8 t30 -14.56 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.028 0.442 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 696' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.927 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.6 t -84.08 130.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.66 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -101.24 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.89 157.43 16.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 111.186 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.73 158.86 17.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.1 p -126.13 -175.29 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -33.69 57.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.27 -45.6 90.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.614 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -63.74 -50.97 66.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -54.24 -32.7 56.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.13 -37.09 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.097 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 723' ' ' GLU . 13.2 mt -58.03 -44.37 87.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.7 p -78.82 -27.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -30.13 65.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.836 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -97.51 13.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.659 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.9 tt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -89.13 114.0 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -104.58 -59.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.394 -179.116 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.145 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -106.67 142.0 37.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.352 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.735 ' N ' HD23 ' A' ' 578' ' ' LEU . 11.5 m -122.25 114.71 21.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 694' ' ' VAL . 6.2 mt -102.95 107.8 18.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 44.9 mtmt -111.6 99.46 44.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.7 Cg_exo -48.15 98.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.755 1.637 . . . . 0.0 109.535 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.749 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.73 157.63 85.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.626 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.76 -28.43 17.65 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.458 2.772 . . . . 0.0 112.64 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.454 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.3 t70 -62.38 -24.99 67.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.9 t -95.44 153.97 17.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -56.2 -11.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.237 179.586 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.844 ' CD1' HG23 ' A' ' 613' ' ' ILE . 20.3 mt -112.1 126.88 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.824 0.345 . . . . 0.0 111.741 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.34 52.38 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 14.1 mm-40 -124.49 172.01 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.96 131.35 51.1 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.941 0.4 . . . . 0.0 111.337 179.131 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.731 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.5 OUTLIER -112.58 141.94 45.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.778 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.63 116.32 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.149 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.054 HD12 HD22 ' A' ' 578' ' ' LEU . 63.9 mt -86.56 108.98 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 8.6 mm100 -71.8 128.71 36.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 3.1 pt20 -46.03 -30.34 1.81 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 109.877 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.43 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.74 -25.06 75.96 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.16 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.481 HG11 ' CG ' ' A' ' 610' ' ' ASN . 87.9 t -98.73 117.16 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 118.171 0.985 . . . . 0.0 111.842 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.2 t30 -141.16 121.92 8.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.034 177.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.593 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.8 Cg_endo -89.86 159.78 34.77 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.543 -1.024 . . . . 0.0 111.248 -0.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.578 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.7 t80 -91.88 114.98 27.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 25.3 m-85 -91.82 138.38 31.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.998 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.763 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.95 145.31 33.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.459 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.14 -178.3 41.37 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.573 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.451 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.8 ttp85 -76.97 -7.52 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.563 0.22 . . . . 0.0 111.466 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.48 131.96 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.758 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -56.1 -23.99 37.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.217 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.602 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.5 OUTLIER -55.04 -30.2 59.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.653 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 45.2 m -74.87 134.51 41.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 4.8 m-80 -48.11 -27.07 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 603' ' ' ILE . 36.0 t -112.13 140.46 46.8 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.542 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.59 113.03 23.84 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.844 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -137.8 109.67 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.774 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 25.8 tt0 -87.66 103.87 15.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.584 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.758 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -131.06 110.55 11.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.11 178.345 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -41.21 -35.65 0.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.728 0.299 . . . . 0.0 111.526 -178.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.528 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.9 mmt180 -77.69 -38.64 46.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.05 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -59.69 159.48 8.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.178 -179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 167.59 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 -50.0 19.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.134 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 727' ' ' VAL . 38.9 t -119.71 59.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.36 178.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.7 t60 -48.5 -49.18 36.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.619 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.3 p -166.34 157.35 12.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.595 ' HA ' HD12 ' A' ' 603' ' ' ILE . 44.0 p90 -143.39 146.89 33.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 603' ' ' ILE . 2.2 mp -102.17 125.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.775 179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -116.79 133.72 55.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 -179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 15.2 ttmt -98.55 136.93 37.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.64 158.78 40.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.385 -179.164 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.47 115.72 16.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.384 0.612 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 4.2 t60 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.002 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 701' ' ' GLY . 1.6 mm? -71.51 -160.82 0.06 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.662 0.231 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.32 146.46 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -179.536 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.451 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -125.23 160.21 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.775 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.145 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -110.01 121.9 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.619 0.723 . . . . 0.0 112.591 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.0 m95 -105.34 128.13 53.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.629 179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.463 ' CB ' HD21 ' A' ' 672' ' ' LEU . 22.0 t80 -90.57 117.75 29.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 36.7 m -106.35 128.09 53.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 33.8 t60 -110.29 126.34 54.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.855 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.487 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 13.4 p -123.46 7.24 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.516 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.46 146.82 25.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.954 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 32.8 m -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.611 0.243 . . . . 0.0 111.642 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.519 ' O ' HG13 ' A' ' 656' ' ' VAL . 19.2 m-20 -85.23 3.25 40.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.44 135.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.733 0.777 . . . . 0.0 112.487 179.766 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.427 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 3.7 t -104.16 165.85 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.188 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 679' ' ' LYS . 37.3 m-85 -128.28 119.76 25.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.46 102.44 12.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.8 m120 59.73 -82.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.898 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 659' ' ' LEU . 26.1 p30 -135.77 6.99 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.638 ' CG ' HG23 ' A' ' 716' ' ' VAL . 1.2 m-20 -110.8 141.6 43.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.942 0.401 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.458 ' HG2' HG23 ' A' ' 665' ' ' ILE . 8.9 ttp85 -75.19 141.19 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.462 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 23.4 mmm -122.66 86.06 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.354 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' A' ' 663' ' ' ARG . 30.7 pt -86.84 156.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.325 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.4 tt0 -49.12 107.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.234 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.16 32.44 4.02 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.586 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 665' ' ' ILE . 2.5 p -121.72 161.84 21.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.6 ttpm? -135.66 147.87 48.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.45 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.93 28.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.1 134.73 49.74 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.629 179.446 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.736 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.74 108.0 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.071 0.462 . . . . 0.0 111.783 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -95.8 157.28 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.227 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 705' ' ' GLU . 4.0 p-10 -52.38 124.57 13.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.802 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 84.42 39.63 8.92 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.997 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.16 112.31 23.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.911 0.386 . . . . 0.0 111.152 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.81 108.77 21.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 6.0 mt -109.7 128.83 65.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 0.0 112.035 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.4 OUTLIER -90.34 115.85 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.407 178.392 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.8 mt -77.02 -37.6 26.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.422 -179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.05 HD12 HD12 ' A' ' 618' ' ' LEU . 38.3 mt -155.39 131.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.773 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -135.87 121.09 19.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.748 178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.54 117.36 24.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -66.73 -46.67 74.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.609 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.23 -40.24 19.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.289 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.78 -11.32 59.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.8 20.59 8.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.735 0.303 . . . . 0.0 110.925 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.79 104.82 15.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -119.5 121.4 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.19 0.519 . . . . 0.0 111.81 -178.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.65 ' CD1' HG22 ' A' ' 587' ' ' ILE . 26.8 mm -128.5 150.14 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.536 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.54 127.55 1.17 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.411 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.565 ' HB2' HD22 ' A' ' 580' ' ' LEU . 8.7 m-30 -113.34 145.76 40.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.752 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.749 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.2 ttpt -101.88 117.97 35.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.086 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.884 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.43 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 34.2 tt0 -131.26 108.39 9.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.028 0.442 . . . . 0.0 110.334 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.86 HD12 ' HG3' ' A' ' 705' ' ' GLU . 27.8 mt -76.39 105.58 5.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.927 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 697' ' ' ASN . . . . . 0.407 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.6 m-80 -87.12 -46.14 10.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.484 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 21.2 t0 -110.77 139.4 46.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.7 p -115.72 99.99 7.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.22 0.533 . . . . 0.0 109.828 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -80.07 68.35 6.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.494 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 67.65 30.27 74.62 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.692 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -70.59 133.07 46.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.671 0.272 . . . . 0.0 111.198 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.685 ' CD2' ' ND2' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -39.15 -49.92 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.175 179.862 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.685 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 18.1 p30 -157.56 20.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.857 178.182 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.86 ' HG3' HD12 ' A' ' 696' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.0 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' A' ' 662' ' ' ASN . 62.4 t -86.82 130.29 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 111.391 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mt -104.84 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.17 148.54 25.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -84.8 151.17 24.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.823 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.09 -177.78 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.23 -30.54 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.193 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.82 -51.97 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.3 OUTLIER -67.55 -46.42 72.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.546 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -56.51 -32.86 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -67.82 -38.42 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 723' ' ' GLU . 26.8 mt -56.49 -44.34 80.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.636 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.5 p -73.21 -26.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.34 -34.38 66.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.809 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -98.63 29.26 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 608' ' ' ASP . 5.8 tt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 16.9 ttm180 -110.28 143.33 40.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 111.713 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.9 t80 -122.87 -40.28 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.81 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.0 tp -126.96 142.24 51.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 111.041 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 695' ' ' GLU . 22.1 m -124.9 114.19 18.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.052 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.794 ' HG ' HG22 ' A' ' 694' ' ' VAL . 2.9 mp -106.86 108.93 20.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.47 100.52 50.3 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 51.9 Cg_exo -44.53 103.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.083 1.855 . . . . 0.0 110.056 177.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.83 158.22 84.88 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.874 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.4 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.9 Cg_endo -49.71 -23.92 8.99 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.021 3.147 . . . . 0.0 113.199 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -60.37 -26.29 66.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 2.7 t -95.97 153.5 17.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.72 178.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 13.1 pt -55.04 -14.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.45 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.5 tt -112.67 131.9 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 111.822 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -113.67 69.54 0.7 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mt-10 -125.41 170.79 11.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.577 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.15 130.14 47.63 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 121.055 0.455 . . . . 0.0 111.045 178.483 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.766 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.63 136.57 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.267 179.806 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 13.8 mt-10 -123.95 110.7 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.08 HD11 HD12 ' A' ' 625' ' ' ILE . 63.1 mt -78.72 109.79 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.6 mp0 -67.8 115.27 7.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.73 -28.95 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 111.07 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.87 -22.31 73.78 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.484 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.48 119.45 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 117.657 0.728 . . . . 0.0 111.821 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.8 t30 -138.83 122.41 11.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.629 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.7 Cg_endo -90.33 160.59 32.84 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.632 -0.987 . . . . 0.0 111.908 0.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.89 119.58 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.595 ' CG ' HD12 ' A' ' 730' ' ' LEU . 29.2 m-85 -92.97 138.35 31.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.453 -177.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.778 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -129.69 141.14 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 163.99 -166.97 37.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.947 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 14.8 ttp85 -87.31 7.0 30.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.651 0.262 . . . . 0.0 111.275 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 2.4 t -101.35 125.79 48.03 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.52 -22.92 36.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -25.03 66.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.414 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 84.1 m -73.71 126.97 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.5 m120 -43.13 -33.71 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.778 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.4 t -106.97 136.17 47.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.606 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 115.5 25.18 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 592' ' ' LEU . 13.5 mm -137.69 109.87 6.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.058 178.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.42 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mt-10 -83.96 103.33 13.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.867 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.845 ' OD2' HD13 ' A' ' 690' ' ' ILE . 5.1 m-20 -132.08 112.98 12.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.306 178.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -42.58 -45.96 4.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.909 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.98 -30.95 69.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.382 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 1.087 HD12 HD12 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -65.26 159.08 24.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.828 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -114.31 167.34 10.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.024 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.46 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -44.48 -62.44 1.18 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.521 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.5 t -106.1 58.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.471 0.653 . . . . 0.0 109.476 178.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.581 ' CE1' HD11 ' A' ' 681' ' ' ILE . 56.0 t60 -47.09 -49.67 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.559 -179.026 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.2 p -162.99 157.19 20.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.9 p90 -143.56 146.95 33.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.08 HD12 HD11 ' A' ' 594' ' ' ILE . 69.6 mt -101.74 131.51 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.878 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -123.9 135.46 53.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.49 134.06 41.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.85 159.51 41.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.074 -178.851 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -76.67 112.47 13.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.937 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 703' ' ' PHE . 6.9 mt -113.87 -156.88 0.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.843 ' O ' HD12 ' A' ' 702' ' ' LEU . 1.7 m-20 -114.61 148.41 38.12 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 4.8 m-20 -135.7 145.99 47.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.346 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.678 ' CD1' HD22 ' A' ' 578' ' ' LEU . 3.2 pt -95.29 122.65 46.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.577 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 77.2 m95 -105.33 129.92 53.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.435 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 8.2 t80 -90.63 116.83 28.82 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 5.9 m -102.36 142.53 33.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.362 . . . . 0.0 111.253 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.47 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 64.4 t60 -122.85 127.44 49.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -123.76 0.23 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.348 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.94 147.88 31.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -25.89 63.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.446 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -68.6 -5.28 19.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.125 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.39 123.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.47 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 6.7 t -93.94 165.86 12.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.677 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 663' ' ' ARG . 2.4 m-85 -135.67 120.74 18.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.725 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.62 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.614 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 62.49 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.21 -5.36 3.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.69 132.12 43.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 658' ' ' TYR . 15.0 mtm-85 -75.23 141.69 43.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.8 mtp -119.3 110.46 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.919 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 46.0 pt -87.91 148.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -47.92 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.337 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 116.25 40.08 0.83 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.722 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.7 p -139.18 162.12 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.51 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 6.2 pttm -129.0 158.09 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.571 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.9 t80 -147.18 146.72 29.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.45 131.75 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.254 0.55 . . . . 0.0 111.671 -179.024 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -105.59 128.12 53.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.982 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.16 157.72 25.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.947 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.665 ' N ' HD12 ' A' ' 696' ' ' ILE . 7.2 t70 -57.15 99.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.182 0.515 . . . . 0.0 110.393 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.43 29.37 3.96 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.227 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.28 114.5 23.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 583' ' ' LEU . 48.1 tt0 -95.44 108.04 20.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.568 HG12 HD13 ' A' ' 659' ' ' LEU . 3.1 mt -110.57 128.5 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.954 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.08 115.82 31.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.784 ' CD1' HD21 ' A' ' 618' ' ' LEU . 4.8 pt -87.87 -16.2 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 1.087 HD12 HD12 ' A' ' 618' ' ' LEU . 20.4 mt -154.83 130.22 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.136 178.359 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.443 ' CZ2' ' HG2' ' A' ' 684' ' ' LYS . 8.0 t90 -137.48 132.07 32.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 682' ' ' TRP . 0.2 OUTLIER -117.46 116.22 26.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 684' ' ' LYS . . . . . 0.443 ' HG2' ' CZ2' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -68.04 -47.42 68.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.273 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -83.43 -40.73 18.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -19.2 60.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.409 -179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.01 10.12 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.81 104.93 16.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.9 135.34 62.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.804 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.845 HD13 ' OD2' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -119.48 131.7 71.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.495 179.317 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.74 135.02 4.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.358 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.24 148.14 37.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.542 ' HB2' HD22 ' A' ' 583' ' ' LEU . 19.1 tttm -100.94 116.67 33.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -80.05 131.24 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 579' ' ' THR . 11.2 tt0 -134.82 108.66 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.0 mt -77.33 105.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.73 -46.79 8.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 10.7 t70 -111.39 140.38 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -115.34 100.66 8.27 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.586 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -65.42 66.41 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.306 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.62 47.68 36.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.373 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 645' ' ' ASP . 1.3 pt? -115.54 179.99 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.776 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -70.48 113.39 7.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.343 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 53.22 -73.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.841 ' HA ' HD21 ' A' ' 702' ' ' LEU . 4.6 pt-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.542 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.72 0.295 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 716' ' ' VAL . 8.3 p -81.36 123.71 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.648 HD13 ' CZ3' ' A' ' 648' ' ' TRP . 1.3 mp -93.49 163.19 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -103.36 148.79 25.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.95 159.77 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -173.26 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.124 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.79 -28.87 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.031 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -49.67 75.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -47.77 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.582 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.2 tptt -55.89 -32.57 63.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -66.85 -36.64 82.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 11.7 mt -58.11 -44.93 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 724' ' ' LYS . 9.0 p -71.29 -24.48 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -58.29 -32.49 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -112.88 27.11 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.911 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.595 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.587 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.634 -0.186 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -84.72 -19.7 32.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.735 0.302 . . . . 0.0 111.18 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 177.49 -31.19 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.521 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -106.89 141.97 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -127.12 -61.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.38 139.51 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.608 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.3 m -115.68 115.07 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.163 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.638 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -105.52 108.44 19.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.96 100.19 48.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 16.8 Cg_exo -46.86 100.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.783 1.655 . . . . 0.0 109.473 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.57 157.53 86.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.99 -29.2 26.62 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.701 2.934 . . . . 0.0 112.657 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.07 -25.1 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.3 t -95.76 153.48 17.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.975 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 689' ' ' VAL . 8.6 tt -53.97 -16.1 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 613' ' ' ILE . 16.5 mt -108.49 136.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.587 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 55.91 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.976 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.3 mm-40 -124.6 169.62 11.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.645 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.11 118.73 20.93 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 111.508 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.645 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.47 145.53 41.03 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.0 OUTLIER -124.33 123.37 40.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -78.47 108.82 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.4 mp0 -65.57 122.15 16.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.43 -28.48 2.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.166 0.508 . . . . 0.0 110.333 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.54 -22.74 78.81 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.805 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.437 HG11 ' ND2' ' A' ' 610' ' ' ASN . 62.0 t -98.94 117.74 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.093 0.947 . . . . 0.0 111.608 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -140.58 122.61 9.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -89.9 159.79 34.57 Favored 'Cis proline' 0 N--CA 1.46 -0.448 0 C-N-CA 124.299 -1.125 . . . . 0.0 111.618 -0.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.0 t80 -92.41 116.1 28.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 730' ' ' LEU . 40.4 m-85 -92.72 138.27 31.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.169 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.6 mp -124.94 146.27 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.91 -173.95 35.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.245 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -66.84 -50.67 61.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.579 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.51 129.52 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.605 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -20.18 9.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.824 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.575 ' HB3' HD21 ' A' ' 730' ' ' LEU . 3.4 t0 -54.91 -31.72 60.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.172 0.51 . . . . 0.0 110.14 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 621' ' ' VAL . 60.6 m -71.89 126.98 31.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.517 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.5 m120 -42.94 -33.77 0.85 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.318 0.58 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -104.93 141.14 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.894 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.693 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.36 104.81 13.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 612' ' ' LYS . 9.1 mm -138.95 109.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.957 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.45 106.6 17.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 112.346 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.636 ' H ' HD11 ' A' ' 618' ' ' LEU . 0.9 OUTLIER -129.52 107.42 9.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.58 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -38.8 -30.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 681' ' ' ILE . 5.9 tpp180 -68.94 -41.99 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.636 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.6 pp -89.21 156.76 18.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.3 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 162.96 28.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.558 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.6 -26.08 12.45 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.071 0.462 . . . . 0.0 110.36 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.558 HG23 ' HG2' ' A' ' 620' ' ' ARG . 41.2 t -131.31 63.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.471 ' ND1' ' CB ' ' A' ' 618' ' ' LEU . 24.9 t60 -49.73 -44.31 48.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.8 p -169.86 161.58 9.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 111.716 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 727' ' ' VAL . 40.2 p90 -143.59 148.77 36.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.949 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.71 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.1 mp -102.22 130.71 51.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -121.39 134.74 55.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.53 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.8 ttmt -97.92 137.11 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.324 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 158.99 42.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.75 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.9 tpt180 -76.49 112.61 13.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 110.531 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 -74.34 125.43 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.904 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.74 179.44 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.356 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.6 p -168.12 160.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -55.55 -101.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.82 172.26 7.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.24 31.36 5.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.973 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.2 121.25 14.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.86 -63.78 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.88 143.85 41.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.89 102.34 50.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.43 -164.68 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 112.1 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -119.49 40.09 3.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.33 -82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.578 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -168.19 76.46 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.838 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -99.83 -157.56 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.698 ' O ' HD23 ' A' ' 702' ' ' LEU . 5.1 m-20 -122.19 146.66 47.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.461 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.24 160.35 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.115 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -106.71 123.3 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 112.085 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.83 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.3 m95 -106.4 128.42 54.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.475 ' CB ' HD21 ' A' ' 672' ' ' LEU . 17.3 t80 -90.89 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 17.2 m -103.69 129.53 51.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.424 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.441 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 43.4 t60 -111.53 126.9 55.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 29.4 p -123.36 3.58 9.12 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.279 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.94 142.6 26.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.137 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.5 m -75.38 -19.94 59.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.418 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.576 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m-20 -82.79 3.27 30.12 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.59 133.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.57 0.7 . . . . 0.0 112.38 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 96.3 p -103.92 166.48 10.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.153 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -127.36 119.8 27.06 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.559 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.688 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.01 104.56 16.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.512 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.1 m120 60.11 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.701 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 659' ' ' LEU . 14.6 m-20 -139.35 7.99 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.65 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 716' ' ' VAL . 4.1 m120 -107.97 141.48 39.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.574 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -74.68 141.46 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.2 OUTLIER -129.08 91.41 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.085 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.3 pt -87.5 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.81 104.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.878 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.38 33.89 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.55 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 3.0 p -125.37 162.17 25.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 111.897 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -135.33 149.91 49.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.7 144.87 28.63 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.83 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.18 133.52 48.08 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.748 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -106.31 109.21 21.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 15.8 mt-30 -98.83 132.9 43.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.047 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.763 ' HB2' HD12 ' A' ' 696' ' ' ILE . 7.5 t70 -37.01 120.52 0.74 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.98 38.57 5.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.3 t0 -95.44 120.55 35.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 0.0 111.441 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -97.41 113.88 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.3 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD13 ' A' ' 659' ' ' LEU . 27.0 pt -110.06 137.18 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.968 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.6 mttp -101.14 116.34 32.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.055 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.569 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -81.54 -38.24 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.43 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.29 133.96 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.42 124.48 22.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -125.96 117.57 23.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.792 0.329 . . . . 0.0 110.645 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -66.8 -46.52 74.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.899 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.22 -40.52 37.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.9 -11.92 56.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.5 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt 59.93 19.29 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.403 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 2.2 t80 -84.34 105.02 14.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.8 OUTLIER -125.78 126.0 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.037 0.446 . . . . 0.0 111.925 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 681' ' ' ILE . 11.8 mt -119.33 148.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.804 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -168.21 129.03 1.81 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.392 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.469 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.3 141.84 46.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.761 0.315 . . . . 0.0 110.28 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.696 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.9 tptp -101.29 116.45 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.83 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.802 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.96 120.04 33.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.453 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.37 109.32 10.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.958 0.409 . . . . 0.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 674' ' ' ASP . 33.5 mt -75.99 105.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ASN . . . . . 0.4 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.0 OUTLIER -83.67 -45.32 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 65.4 m-20 -110.39 141.59 43.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.452 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.2 p -113.52 99.88 8.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.348 0.594 . . . . 0.0 109.957 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 700' ' ' THR . 7.0 t -77.1 62.52 2.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.486 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.42 49.34 70.86 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.818 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -88.18 133.55 34.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.337 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.674 ' CD2' ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -33.84 -36.77 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.45 179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.674 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 15.3 p30 -171.98 30.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.862 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.3 OUTLIER 68.31 -57.93 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.113 -178.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 151.95 76.87 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.831 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -104.74 -9.44 18.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.748 -0.266 . . . . 0.0 111.494 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 100.98 62.21 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.123 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -43.12 135.06 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.922 0.392 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 77.22 -64.17 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.92 112.88 26.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 714' ' ' ARG . 0.0 OUTLIER -82.84 99.73 9.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.997 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 713' ' ' GLN . 3.4 mmm-85 19.96 85.51 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.627 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.1 m -124.49 142.59 40.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 663' ' ' ARG . 88.8 t -80.83 122.8 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -95.47 163.22 13.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.51 146.5 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.2 160.02 14.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.84 -173.46 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.16 28.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -42.02 98.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.166 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 726' ' ' LEU . 6.6 tm-20 -69.99 -51.07 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.464 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -54.33 -32.88 57.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -36.48 81.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.605 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 723' ' ' GLU . 79.9 mt -55.8 -44.05 77.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.694 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.61 HG22 ' CE1' ' A' ' 624' ' ' PHE . 1.5 t -73.95 -23.15 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -36.53 80.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.71 -11.94 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.171 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.785 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.1 tt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.26 140.59 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 6.3 pt -131.56 80.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.418 ' C ' ' CD1' ' P' ' 830' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' P' ' 829' ' ' PTR . 7.4 p90 -175.82 89.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.867 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 681' ' ' ILE . 9.1 mt -85.59 89.7 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.779 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.878 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -78.9 -7.01 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.491 0.186 . . . . 0.0 111.362 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.463 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 142.59 -8.92 2.34 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 8.2 ttm180 -108.01 143.84 36.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.998 0.428 . . . . 0.0 111.452 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -128.82 -56.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.256 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -111.54 139.59 46.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.904 ' N ' HD23 ' A' ' 578' ' ' LEU . 1.9 m -120.97 114.19 21.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 111.495 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 594' ' ' ILE . 1.5 mp -103.02 108.22 19.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.68 100.88 53.97 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.5 Cg_exo -45.96 101.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.893 1.729 . . . . 0.0 109.357 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -75.12 157.42 85.22 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.59 -27.19 14.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.467 2.778 . . . . 0.0 112.491 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 583' ' ' LEU . 41.8 t0 -62.16 -25.93 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 18.0 p -95.76 154.07 17.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.805 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.456 HD13 ' CE1' ' A' ' 688' ' ' PHE . 0.4 OUTLIER -58.87 -10.73 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.996 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.764 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.3 mt -111.11 118.58 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 111.751 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.05 57.09 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 72.7 mt-10 -124.56 171.86 9.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.286 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.0 126.79 42.03 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.771 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.16 135.56 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.416 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mt-10 -124.5 118.27 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 601' ' ' PHE . 83.8 mt -79.88 108.6 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.9 mp0 -62.77 118.1 7.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -45.76 -28.95 1.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.77 -14.23 82.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.908 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.02 118.07 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.941 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 1.1 t30 -140.46 123.52 10.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.736 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.505 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.2 Cg_endo -90.82 159.02 29.69 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.379 -1.092 . . . . 0.0 112.157 0.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.65 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.8 t80 -93.12 117.49 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.197 0.522 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 730' ' ' LEU . 3.5 m-85 -93.53 138.65 31.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.393 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.8 HD11 HD12 ' A' ' 625' ' ' ILE . 3.5 mp -129.61 142.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.43 -158.2 31.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.189 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.4 ttp85 -96.43 -0.63 48.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.13 133.04 46.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -56.76 -24.79 52.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.99 -27.92 63.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 56.2 m -78.14 131.02 37.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.1 m120 -47.65 -30.86 4.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.496 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.8 t -109.14 140.66 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.453 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.31 120.96 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.764 HG23 ' CD1' ' A' ' 588' ' ' ILE . 29.2 mm -137.97 109.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.745 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 tt0 -86.91 102.32 14.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.703 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.813 ' HB2' HD13 ' A' ' 618' ' ' LEU . 3.4 m-20 -133.24 111.47 10.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.37 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -42.5 -33.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.819 0.343 . . . . 0.0 111.48 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -77.76 -41.47 37.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.813 HD13 ' HB2' ' A' ' 615' ' ' ASP . 1.2 mp -59.97 158.95 9.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.97 174.19 6.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.66 -62.94 1.15 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.395 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.0 t -105.18 53.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.519 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 70.7 t60 -43.12 -39.96 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.515 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.36 173.15 12.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.415 0.626 . . . . 0.0 111.447 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.639 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.06 135.2 25.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.973 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.8 HD12 HD11 ' A' ' 603' ' ' ILE . 23.0 mt -131.81 117.12 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -135.16 144.49 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.549 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.3 ptpt -101.0 137.46 39.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.62 159.65 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.275 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.52 117.24 17.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.254 0.55 . . . . 0.0 110.672 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 -83.65 128.85 34.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -141.32 125.58 17.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.54 166.11 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -61.99 -80.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.539 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -126.5 162.45 25.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.789 0.328 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.76 140.05 36.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.7 130.55 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 64.2 t80 66.85 -70.47 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -76.32 144.42 40.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.765 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.7 m -101.66 93.86 3.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.71 -163.36 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.521 2.148 . . . . 0.0 112.288 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -45.31 -32.79 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 70.55 -67.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.483 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -175.78 65.56 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.805 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -101.14 -157.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.9 OUTLIER -122.36 147.11 46.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.061 0.457 . . . . 0.0 111.697 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.9 160.24 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.519 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -106.97 128.14 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 112.359 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.916 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -112.15 120.57 42.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.574 ' HB3' HD21 ' A' ' 672' ' ' LEU . 1.3 t80 -92.71 117.63 30.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.9 m -111.22 145.07 39.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 42.3 t60 -119.55 125.36 48.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.436 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.2 5.59 11.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.19 134.55 13.35 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.998 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 654' ' ' THR . 54.7 m -65.64 -12.8 56.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.6 OUTLIER -82.35 -2.79 53.98 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.5 0.19 . . . . 0.0 111.339 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.32 128.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.265 0.555 . . . . 0.0 112.071 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.434 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 18.2 p -99.89 166.38 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.142 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 3.9 m-85 -135.54 119.5 17.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.747 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.81 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -98.88 112.25 24.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.033 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.43 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -136.26 2.43 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.889 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -100.59 141.39 33.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.83 0.348 . . . . 0.0 111.024 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 34.5 ttt180 -81.11 141.34 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.738 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.42 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.9 mmm -121.58 100.43 7.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.973 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.404 HG12 ' CG2' ' A' ' 668' ' ' THR . 35.9 pt -87.5 149.39 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -44.43 112.67 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.406 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.79 5.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.8 p -115.22 162.56 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.499 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 717' ' ' LEU . 4.6 ttpm? -134.75 147.71 50.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.127 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.5 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.52 144.28 28.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.916 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 134.72 49.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.729 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 694' ' ' VAL . 1.3 mt -106.69 111.99 24.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.251 0.548 . . . . 0.0 111.27 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 5.1 mt-30 -98.33 143.19 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.172 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 706' ' ' GLY . 26.3 p30 -43.14 111.85 0.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.73 37.94 5.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.64 118.41 29.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.069 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -96.17 108.5 20.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.81 HG22 ' CD2' ' A' ' 659' ' ' LEU . 7.7 pt -105.66 129.16 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.482 . . . . 0.0 111.971 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 5.7 mttt -89.77 115.77 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.717 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.723 HD13 HD21 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -76.05 -39.38 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.854 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.756 HD11 HD11 ' P' ' 831' ' ' LEU . 15.6 tt -155.88 136.75 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -135.89 127.79 29.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.119 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.608 ' OD2' HD22 ' P' ' 831' ' ' LEU . 0.4 OUTLIER -124.3 116.94 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.245 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -67.03 -46.89 73.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.35 -40.32 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.404 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.38 -16.54 56.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.9 15.92 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.004 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.456 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.2 t80 -77.03 104.61 7.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.1 p -118.99 122.24 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.649 ' CG1' HG22 ' A' ' 681' ' ' ILE . 42.8 mm -128.29 119.7 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.572 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -146.31 133.29 4.84 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.165 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.8 m-30 -113.09 144.56 42.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 110.455 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.713 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -101.17 117.29 34.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 672' ' ' LEU . 3.2 t -81.74 114.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.78 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -123.94 108.58 12.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 0.0 110.372 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.539 HD13 ' O ' ' A' ' 705' ' ' GLU . 18.4 mt -81.86 110.44 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.729 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.5 -45.29 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.54 140.43 46.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.101 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -114.65 100.37 8.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 596' ' ' GLN . 9.3 t -91.08 50.74 1.82 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.479 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 108.52 33.29 2.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.502 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.1 mm? -93.81 120.33 33.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.579 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 4.9 p90 -40.45 -34.33 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.474 0.654 . . . . 0.0 110.339 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.794 HD22 HD23 ' A' ' 707' ' ' LEU . 0.2 OUTLIER -147.88 -44.69 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.539 ' O ' HD13 ' A' ' 696' ' ' ILE . 16.1 pt-20 136.1 -34.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.69 1.196 . . . . 0.0 108.148 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 137.71 85.06 0.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.117 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.794 HD23 HD22 ' A' ' 704' ' ' ASN . 0.3 OUTLIER -105.68 -9.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.275 0.538 . . . . 0.0 111.667 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 81.41 64.55 1.75 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.437 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.575 ' C ' HD23 ' A' ' 710' ' ' LEU . 1.6 mtm -116.21 114.07 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.575 HD23 ' C ' ' A' ' 709' ' ' MET . 1.1 pt? -179.36 170.88 1.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -59.51 -68.7 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.85 131.38 47.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.544 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -83.03 100.36 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.084 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 7.7 mmm-85 42.43 86.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.696 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.44 143.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.889 HG23 ' OD1' ' A' ' 662' ' ' ASN . 59.7 t -79.71 129.67 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.379 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.549 HD11 ' HZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -102.17 172.52 6.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -101.24 157.87 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 0.0 111.189 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.93 152.07 19.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.4 p -126.41 -177.82 4.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.616 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -28.9 36.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.988 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.57 -48.81 78.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.757 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.1 mp0 -69.77 -50.04 47.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.592 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -60.5 -32.05 71.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.41 -40.45 93.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.621 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.2 mt -61.91 -44.4 96.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.591 HG23 HD13 ' A' ' 730' ' ' LEU . 9.3 p -79.49 -12.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.24 -28.53 7.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.984 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -102.08 -63.2 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 602' ' ' PHE . 1.1 tp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.937 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.83 0.348 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.75 149.37 32.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.82 118.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 161.03 20.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.784 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.756 HD11 HD11 ' A' ' 681' ' ' ILE . 20.3 mt -148.68 93.27 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.975 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -20.01 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.68 0.276 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 140.13 -10.53 3.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.765 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -106.54 143.14 35.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.725 ' CE1' HG21 ' A' ' 647' ' ' ILE . 3.7 t80 -132.69 -47.28 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.748 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.4 tp -121.27 142.44 49.93 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.896 0.379 . . . . 0.0 111.015 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.7 m -120.3 114.94 22.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -104.57 108.59 20.12 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 mtmp? -111.84 99.25 44.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.8 Cg_exo -47.66 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.849 1.699 . . . . 0.0 109.572 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.567 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.58 158.12 85.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -176.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.94 -25.17 8.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.509 2.806 . . . . 0.0 112.731 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 m-20 -61.64 -28.26 69.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' HD13 ' A' ' 690' ' ' ILE . 6.4 t -95.65 154.01 17.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.816 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 690' ' ' ILE . 2.2 pt -57.87 -11.49 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.897 HD13 HG12 ' A' ' 613' ' ' ILE . 19.6 mt -107.6 118.51 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.498 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.03 55.73 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.155 0.503 . . . . 0.0 110.332 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.639 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 19.7 mt-10 -125.03 171.67 10.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.192 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.48 129.9 49.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.845 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.801 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.21 141.96 45.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.403 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.2 mt-10 -124.02 110.52 14.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.298 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.78 HD11 HD12 ' A' ' 625' ' ' ILE . 59.3 mt -76.83 109.3 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.7 mp0 -67.03 114.67 5.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.58 -30.61 1.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.217 0.532 . . . . 0.0 110.557 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -64.66 -23.57 68.99 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.149 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.0 119.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.489 0.644 . . . . 0.0 111.34 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 21.7 t30 -138.72 122.26 11.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.9 Cg_endo -90.5 160.34 31.87 Favored 'Cis proline' 0 C--N 1.345 0.383 0 C-N-CA 124.627 -0.989 . . . . 0.0 111.815 -0.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.695 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.36 114.7 27.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.526 ' CG ' HD12 ' A' ' 730' ' ' LEU . 13.9 m-85 -91.84 138.07 31.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.993 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.781 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -127.36 145.41 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.716 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.55 -172.77 33.69 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.945 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.3 OUTLIER -74.02 -6.83 49.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.496 0.319 . . . . 0.0 111.857 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.571 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -89.51 125.01 35.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.811 0.339 . . . . 0.0 111.12 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -59.01 -20.25 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.578 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -23.96 63.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 54.8 m -70.72 130.35 41.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -44.77 -32.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.512 . . . . 0.0 110.347 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.1 t -110.28 139.88 45.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.342 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.12 110.05 16.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.897 HG12 HD13 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -138.45 110.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.892 177.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.498 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 0.2 OUTLIER -85.73 106.41 16.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.296 0.569 . . . . 0.0 112.09 -178.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.998 ' HB2' HD22 ' A' ' 618' ' ' LEU . 1.6 m-20 -129.8 108.32 10.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.138 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -43.71 -37.65 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.327 . . . . 0.0 111.799 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.0 mmt180 -77.82 -34.18 52.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.855 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.998 HD22 ' HB2' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.16 128.11 34.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 111.336 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.4 p -57.16 159.65 4.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.663 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -58.14 -31.29 67.06 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 45.5 t -123.39 55.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.825 ' CD2' HG23 ' A' ' 680' ' ' ILE . 9.5 t60 -49.68 -49.18 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.172 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.7 p -164.08 160.3 21.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.23 0.538 . . . . 0.0 111.989 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 42.1 p90 -143.4 147.61 34.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 580' ' ' LEU . 57.6 mt -102.18 132.65 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.5 t80 -123.9 131.47 53.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.499 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.9 tttt -97.73 136.33 38.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 157.84 45.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.981 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -77.83 113.57 15.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 9.9 t-80 -78.94 123.29 27.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.05 150.62 51.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.026 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.21 166.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -86.77 73.53 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.576 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 56.2 mttt 60.07 105.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.9 p -83.63 117.2 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.84 123.25 47.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.784 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 67.43 -74.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.713 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -76.94 123.72 26.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 54.2 p -93.43 109.8 42.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.01 -149.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.553 2.168 . . . . 0.0 111.956 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 703' ' ' PHE . . . -79.22 1.52 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.808 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.95 -171.92 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.601 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -85.35 92.16 1.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.722 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.67 -156.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.836 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -122.19 147.51 46.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -136.6 141.71 43.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.319 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -94.67 121.19 45.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.345 0.593 . . . . 0.0 111.709 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.581 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -104.04 133.99 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.448 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 678' ' ' ILE . 12.4 t80 -93.14 117.39 30.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' CB ' ' CE1' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -102.84 136.4 42.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.13 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.445 ' CE1' ' N ' ' A' ' 657' ' ' SER . 14.9 t60 -115.42 126.28 54.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.16 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -122.89 6.49 9.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.47 157.78 40.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.167 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 41.1 m -89.65 -19.56 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.411 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.0 m120 -83.59 2.92 34.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.658 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 664' ' ' MET . 0.3 OUTLIER 50.14 136.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.735 0.779 . . . . 0.0 112.588 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.445 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -108.55 165.96 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.062 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.52 120.65 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.001 0.429 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 1.033 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.69 100.19 10.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.897 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 15.4 m-20 60.76 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 87.3 m-20 -135.44 2.7 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 11.8 m120 -104.86 135.3 46.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.871 0.367 . . . . 0.0 111.402 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.63 141.47 46.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.713 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.618 ' O ' HG23 ' A' ' 656' ' ' VAL . 44.2 mmm -120.86 88.66 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.144 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 668' ' ' THR . 39.4 pt -87.31 153.26 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.867 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -42.76 107.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.53 33.1 4.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.426 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.7 p -113.22 162.08 16.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 0.0 111.646 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.1 ttpm? -142.12 129.65 21.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.397 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -136.32 143.13 43.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 111.563 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.714 HD12 ' HE1' ' A' ' 709' ' ' MET . 0.2 OUTLIER -71.42 141.04 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 694' ' ' VAL . 5.4 mt -104.43 148.81 26.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.026 0.441 . . . . 0.0 111.122 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.93 ' HB3' HD22 ' A' ' 707' ' ' LEU . 6.6 mt-30 -120.3 162.22 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.73 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.5 t70 -65.61 95.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.55 32.73 2.86 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.2 113.17 20.9 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.711 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -95.74 108.49 20.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 1.033 HG22 HD13 ' A' ' 659' ' ' LEU . 32.9 pt -105.16 134.87 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.772 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.0 mtpt -95.36 115.42 27.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.278 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.825 HG23 ' CD2' ' A' ' 622' ' ' HIS . 32.4 mt -84.55 -34.93 9.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.648 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.57 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.77 130.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.018 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -137.2 126.48 24.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.78 116.54 22.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.496 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -46.5 72.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.727 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.71 -40.41 33.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.562 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.46 -13.56 54.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.352 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 63.43 15.56 8.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.627 0.251 . . . . 0.0 110.959 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -76.94 104.65 7.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.33 126.47 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 0.0 111.873 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.603 HD13 ' OG ' ' A' ' 586' ' ' SER . 21.4 mm -127.68 155.9 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.466 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.07 130.45 1.28 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.359 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 613' ' ' ILE . 10.7 m-30 -113.31 146.23 39.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.354 . . . . 0.0 110.503 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.567 ' HB2' HD22 ' A' ' 583' ' ' LEU . 18.6 tttp -101.35 117.0 34.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.15 126.65 39.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.667 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.9 OUTLIER -133.45 108.84 8.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.942 0.401 . . . . 0.0 110.736 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 705' ' ' GLU . 22.8 mt -73.98 105.18 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.87 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.77 -47.67 10.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.766 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.433 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.54 140.34 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.029 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.7 p -115.0 99.83 7.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.421 ' HB ' ' NZ ' ' A' ' 627' ' ' LYS . 11.6 m -76.18 69.63 2.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.7 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.54 49.39 74.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.867 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -85.66 133.47 34.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.53 0.205 . . . . 0.0 111.158 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.531 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.3 p90 -44.88 -32.22 1.52 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.594 0.712 . . . . 0.0 109.842 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.3 t-20 -148.4 -56.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.646 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.677 ' O ' HD13 ' A' ' 696' ' ' ILE . 2.7 pt-20 156.14 -28.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.488 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 141.5 -7.08 2.5 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.678 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.93 HD22 ' HB3' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -81.3 7.76 10.73 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.92 8.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.899 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.714 ' HE1' HD12 ' A' ' 671' ' ' LEU . 6.0 tpt -110.2 146.93 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.914 0.388 . . . . 0.0 110.568 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.466 ' H ' ' HE3' ' A' ' 709' ' ' MET . 0.6 OUTLIER -55.27 -162.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.156 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -39.58 -46.96 1.86 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.738 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -74.11 139.87 44.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.717 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.85 100.36 10.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.504 ' NH1' ' HG3' ' A' ' 673' ' ' GLN . 2.0 mmm180 40.26 83.48 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.733 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.62 142.24 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.595 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.8 p -82.88 117.67 29.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.89 171.72 10.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 157.68 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.36 154.73 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.919 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 23.7 p -126.24 -176.55 3.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.73 64.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -63.61 -52.25 61.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -64.63 -46.95 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.73 -32.77 65.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.34 -36.92 82.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 31.4 mt -59.78 -44.07 94.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.003 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.9 -20.36 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -50.56 64.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -61.66 -29.12 69.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.0 tt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 62.11 78.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.579 ' O ' HG22 ' P' ' 828' ' ' ILE . 26.4 mt -99.36 37.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.441 ' C ' ' CG ' ' P' ' 830' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.441 ' CG ' ' C ' ' P' ' 829' ' ' PTR . 0.1 OUTLIER -177.25 137.5 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 655' ' ' ASN . 55.7 mt -138.63 -178.74 5.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.971 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -75.06 -22.24 58.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.661 0.267 . . . . 0.0 111.048 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 146.32 -17.01 1.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.643 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -106.57 143.3 34.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.362 . . . . 0.0 111.123 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.711 ' HE1' HG21 ' A' ' 647' ' ' ILE . 1.1 t80 -132.96 -51.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.032 HD11 HG13 ' A' ' 694' ' ' VAL . 21.2 tp -114.52 142.59 46.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.555 HG21 ' HE2' ' A' ' 581' ' ' LYS . 7.9 m -122.62 116.6 24.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.945 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.7 mt -103.33 108.83 20.22 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 54.6 mttt -110.57 98.38 36.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -176.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.2 Cg_exo -49.67 106.86 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.793 1.662 . . . . 0.0 109.225 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.04 157.37 87.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 12.0 Cg_endo -54.74 -24.88 39.78 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.07 3.18 . . . . 0.0 113.457 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.542 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.4 m-20 -62.11 -22.31 65.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.069 0.461 . . . . 0.0 109.818 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.457 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 2.0 t -97.69 154.01 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.683 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.527 HD11 ' CE1' ' A' ' 688' ' ' PHE . 7.3 pt -51.22 -21.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.497 . . . . 0.0 110.014 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 690' ' ' ILE . 38.9 mt -105.16 118.84 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.71 59.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.649 . . . . 0.0 110.264 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.66 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.78 172.56 9.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.727 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.18 131.55 53.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.758 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.62 143.96 42.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.207 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.05 116.61 23.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 111.708 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.87 HD11 HD12 ' A' ' 625' ' ' ILE . 73.0 mt -81.89 109.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.879 0.371 . . . . 0.0 110.443 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 2.8 mp0 -65.08 115.63 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.34 -30.51 2.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.258 0.551 . . . . 0.0 110.681 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -20.21 72.76 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.23 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.24 118.92 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 117.35 0.575 . . . . 0.0 111.65 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.9 t30 -139.35 121.53 10.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.72 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -89.99 160.46 34.45 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 124.555 -1.019 . . . . 0.0 111.63 -0.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.664 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.42 116.63 29.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 20.8 m-85 -92.62 138.57 31.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.29 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -129.08 141.84 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.87 -170.2 38.31 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 119.964 -1.113 . . . . 0.0 113.92 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 ttp85 -80.33 1.44 28.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.356 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 14.4 t -101.19 119.78 39.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -51.72 -24.64 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.015 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -61.4 -26.71 68.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.991 0.424 . . . . 0.0 110.391 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.2 m -71.57 128.75 36.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.853 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -43.43 -34.63 1.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.289 0.566 . . . . 0.0 110.287 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 50.7 t -106.29 141.29 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.099 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 111.47 20.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.682 HG23 ' CD1' ' A' ' 588' ' ' ILE . 18.3 mm -137.73 108.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.127 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.19 106.6 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.662 . . . . 0.0 112.497 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.544 ' CB ' HD13 ' A' ' 618' ' ' LEU . 5.0 t70 -130.53 125.93 35.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.722 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -43.64 -34.18 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.778 0.323 . . . . 0.0 111.223 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB2' HD13 ' A' ' 681' ' ' ILE . 26.2 mmt180 -77.35 -39.06 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CE1' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -59.54 158.21 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.06 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.07 163.92 13.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.304 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.452 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -46.04 -55.33 7.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 730' ' ' LEU . 39.5 t -110.08 62.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.421 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 2.0 t-160 -47.1 -48.09 22.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.576 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 680' ' ' ILE . 24.7 p -166.82 157.12 11.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.2 p90 -144.12 143.67 31.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.889 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.87 HD12 HD11 ' A' ' 594' ' ' ILE . 45.5 mt -101.59 131.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -122.46 132.52 54.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 702' ' ' LEU . 7.6 ttmt -98.07 136.53 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.545 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.8 158.66 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.197 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.94 113.47 14.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.536 0.684 . . . . 0.0 110.391 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.0 t60 -70.01 122.97 20.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.269 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.492 ' HB3' ' NH1' ' A' ' 629' ' ' ARG . . . 176.42 126.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.973 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 640' ' ' PRO . 33.9 m -80.29 173.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -66.87 97.81 0.38 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.377 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.6 tttp 61.85 152.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 6.3 p -95.42 44.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.5 mtt -66.23 111.53 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.57 -62.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.79 143.13 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.04 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 96.8 p -115.29 93.28 35.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.533 ' HG2' HG22 ' A' ' 632' ' ' VAL . 17.3 Cg_exo -66.95 -150.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.762 2.308 . . . . 0.0 111.897 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -92.35 36.01 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.466 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 67.9 -70.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 166.68 62.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.818 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -93.95 -159.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 1.4 m-20 -119.58 146.9 45.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 112.206 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -127.05 160.16 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.777 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.837 HD13 HD22 ' A' ' 578' ' ' LEU . 2.6 pt -111.22 120.98 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.587 . . . . 0.0 111.902 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.54 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -103.05 136.28 43.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.483 ' HE2' ' HG ' ' A' ' 657' ' ' SER . 9.2 t80 -99.08 119.37 37.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.851 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 6.9 m -110.0 141.87 42.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.035 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 34.0 t60 -121.74 122.76 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 621' ' ' VAL . 0.6 OUTLIER -116.15 11.36 15.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.44 139.72 15.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.811 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 654' ' ' THR . 26.3 m -72.49 -8.17 53.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.58 ' C ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -85.43 2.78 43.05 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' C ' ' A' ' 655' ' ' ASN . 1.8 m 60.21 146.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 111.275 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.483 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 0.3 OUTLIER -116.16 162.61 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.085 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -137.44 120.37 16.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.362 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.856 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -108.6 116.67 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.131 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 13.7 t-20 60.24 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.95 2.12 2.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -102.23 141.24 35.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.638 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -94.11 141.71 28.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.505 ' HB2' ' OG1' ' A' ' 668' ' ' THR . 4.5 ptp -138.04 142.68 40.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.405 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.443 ' H ' HG21 ' A' ' 668' ' ' THR . 17.7 pt -112.12 165.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.393 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -47.15 117.59 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.955 0.407 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 101.58 23.08 9.7 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 664' ' ' MET . 10.9 p -112.24 162.37 15.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.462 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.408 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 3.2 ttpm? -134.94 145.04 47.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.659 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -145.95 134.36 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.943 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.54 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -68.69 140.54 55.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 1.001 HD13 HG21 ' A' ' 694' ' ' VAL . 9.3 mt -110.07 122.79 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 0.0 111.906 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 12.3 mt-30 -104.18 137.6 41.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.593 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.618 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.7 t70 -40.52 108.82 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.975 0.417 . . . . 0.0 111.007 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.92 35.55 4.79 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 3.0 t0 -95.55 122.81 38.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.329 . . . . 0.0 111.079 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.02 108.38 20.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.856 HG22 ' CD2' ' A' ' 659' ' ' LEU . 5.5 pt -106.55 131.95 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 112.141 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 3.1 mtmt -104.01 127.03 51.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.02 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.861 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -95.11 -25.15 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.744 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.678 HG22 ' CG2' ' A' ' 690' ' ' ILE . 7.6 tt -155.23 131.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -136.59 126.7 26.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.746 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.519 ' OD2' HD21 ' P' ' 831' ' ' LEU . 1.1 m-20 -116.4 117.03 28.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.644 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -67.04 -46.53 74.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.877 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -79.87 -40.41 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.601 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -79.98 -20.24 45.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.294 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 8.97 6.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.223 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 587' ' ' ILE . 1.7 t80 -77.02 105.15 7.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.3 p -119.64 121.87 67.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.451 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 588' ' ' ILE . 2.4 tt -120.8 121.44 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.5 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -140.39 137.95 8.69 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.331 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.3 m-30 -113.35 142.33 45.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -100.96 117.37 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.023 0.44 . . . . 0.0 110.925 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -83.66 122.51 37.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.565 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.09 109.59 9.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 705' ' ' GLU . 27.5 mt -77.32 108.62 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.937 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.36 -43.36 9.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.08 141.54 42.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER -114.23 100.56 8.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.38 0.61 . . . . 0.0 109.671 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.4 57.83 4.21 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 81.56 37.97 15.68 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.24 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.47 134.55 38.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.522 0.201 . . . . 0.0 110.591 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.641 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.3 p90 -43.62 -33.27 1.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.472 0.653 . . . . 0.0 110.323 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.734 HD22 HD23 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -147.98 -61.25 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.676 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 696' ' ' ILE . 16.6 pt-20 145.36 33.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.043 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 71.74 68.87 1.51 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.053 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.734 HD23 HD22 ' A' ' 704' ' ' ASN . 0.6 OUTLIER -106.95 -9.78 16.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.087 0.443 . . . . 0.0 111.31 179.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 709' ' ' MET . . . 127.41 -116.68 2.47 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.752 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 165.22 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 111.08 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.36 -161.18 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.504 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -46.03 -94.59 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -114.86 98.81 7.05 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.871 0.367 . . . . 0.0 111.89 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 5.5 tp60 -116.58 136.23 53.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.017 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.744 ' NH2' HD22 ' A' ' 659' ' ' LEU . 1.8 mmm-85 160.37 69.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.791 0.437 . . . . 0.0 110.071 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.77 149.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.861 HG23 ' OD1' ' A' ' 662' ' ' ASN . 90.4 t -78.29 118.43 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.32 172.02 8.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.52 154.31 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -91.29 156.31 17.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -126.02 -173.96 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.85 -33.5 64.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.23 -50.49 73.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 726' ' ' LEU . 25.3 mm-40 -65.53 -50.26 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -57.93 -32.93 68.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -63.57 -38.69 92.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.72 HD22 ' HD3' ' A' ' 600' ' ' PRO . 9.5 mt -61.06 -44.52 97.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.3 p -73.5 -26.83 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -58.57 -30.93 67.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -86.67 -18.87 30.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.159 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.89 141.41 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.82 172.07 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -178.48 126.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 655' ' ' ASN . 15.9 mt -145.83 91.09 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.915 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.92 3.74 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.616 0.246 . . . . 0.0 111.528 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 120.72 21.65 3.21 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.717 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 9.1 ttm180 -112.09 119.56 38.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.797 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.2 t80 -100.91 -46.31 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 647' ' ' ILE . 7.9 tp -120.69 142.54 49.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 111.485 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 695' ' ' GLU . 15.0 m -122.26 114.56 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.488 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.735 HD11 HD11 ' A' ' 625' ' ' ILE . 0.3 OUTLIER -103.66 108.59 19.94 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 25.4 mtmt -111.65 98.77 42.33 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_exo -46.84 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.838 1.692 . . . . 0.0 109.47 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.64 157.46 85.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.73 -25.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.583 2.855 . . . . 0.0 112.704 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.79 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -62.06 -27.52 68.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.421 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 4.2 t -95.63 153.94 17.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.749 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.436 HG12 ' CD1' ' A' ' 690' ' ' ILE . 8.3 pt -54.94 -13.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.649 ' CD1' HG23 ' A' ' 613' ' ' ILE . 51.1 mt -108.78 128.7 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.802 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.99 56.43 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.212 0.529 . . . . 0.0 110.256 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -124.62 171.97 9.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.58 128.65 45.94 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 178.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.764 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.08 139.94 47.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.708 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.2 113.82 18.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.021 HD11 HD12 ' A' ' 625' ' ' ILE . 71.6 mt -78.71 109.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.321 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.76 116.09 6.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.814 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -44.97 -32.42 1.63 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.224 0.535 . . . . 0.0 110.293 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.508 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.7 -18.78 74.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.747 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.413 HG11 ' OD1' ' A' ' 610' ' ' ASN . 56.4 t -100.5 118.59 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 117.769 0.785 . . . . 0.0 111.686 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.83 121.96 9.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.914 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.1 Cg_endo -90.42 160.26 32.22 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.545 -1.023 . . . . 0.0 111.659 -0.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -91.64 116.32 28.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 59.7 m-85 -91.91 138.04 31.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.897 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -129.87 145.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.831 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.36 -169.15 36.82 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -83.21 3.39 31.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.768 -0.216 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 7.2 t -101.29 126.32 48.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -57.31 -22.72 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.61 ' HB3' HD21 ' A' ' 730' ' ' LEU . 6.0 t0 -64.12 -25.43 68.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.665 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 89.9 m -73.41 132.91 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 5.7 m120 -48.48 -27.4 2.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.764 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -114.55 142.02 46.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 118.59 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 588' ' ' ILE . 32.5 mm -138.16 109.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.216 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 14.0 tt0 -89.94 102.98 15.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.797 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.52 112.89 12.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.212 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -43.57 -34.08 1.31 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.733 0.302 . . . . 0.0 111.392 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -77.55 -39.67 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.688 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.066 HD12 HD12 ' A' ' 681' ' ' ILE . 0.4 OUTLIER -61.12 159.2 12.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.541 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.1 m -110.29 167.21 10.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.44 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.3 OUTLIER -44.65 -55.51 5.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 110.229 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 727' ' ' VAL . 18.5 t -112.66 57.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.477 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 681' ' ' ILE . 43.1 t60 -45.57 -46.02 13.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.617 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 680' ' ' ILE . 7.0 p -167.1 155.86 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.3 p90 -143.32 147.96 35.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 594' ' ' ILE . 86.1 mt -102.65 139.79 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.972 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -131.44 133.62 45.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.506 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 700' ' ' THR . 29.3 ttmt -97.57 136.1 38.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.559 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 159.55 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.861 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 630' ' ' HIS . 0.9 OUTLIER -76.08 139.61 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.2 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t-160 -60.08 133.19 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -89.3 56.67 3.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.164 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.755 HG21 ' C ' ' A' ' 642' ' ' GLN . 12.1 m -84.88 125.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.56 -146.94 6.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.429 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -76.85 157.21 31.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 110.754 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 1.5 t -129.83 167.13 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -123.84 112.96 17.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.638 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.74 -71.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.385 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.48 118.73 37.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.38 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.85 87.65 3.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.445 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 73.5 Cg_endo -77.31 167.19 25.05 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.538 2.158 . . . . 0.0 111.809 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 70.68 -62.73 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.092 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.755 ' C ' HG21 ' A' ' 632' ' ' VAL . 6.9 mm-40 64.24 170.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.591 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -76.4 72.77 1.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.726 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.822 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.3 OUTLIER -102.78 -153.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -122.37 147.44 46.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.277 0.56 . . . . 0.0 112.099 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -130.09 154.57 47.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 578' ' ' LEU . 4.0 pt -105.39 128.72 59.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.26 0.552 . . . . 0.0 111.844 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.868 ' CH2' HD22 ' A' ' 671' ' ' LEU . 78.8 m95 -111.74 140.79 46.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.756 ' CE2' HG21 ' A' ' 678' ' ' ILE . 13.4 t80 -104.62 117.25 33.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 97.1 m -105.6 126.2 51.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.423 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 23.8 t60 -104.36 122.79 46.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.67 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.44 5.24 13.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.57 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.64 146.14 20.57 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.043 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 654' ' ' THR . 37.6 m -79.6 -1.11 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.577 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -87.08 0.42 55.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.442 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.42 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.348 0.594 . . . . 0.0 111.87 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 11.9 p -102.54 165.65 10.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.669 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -137.03 119.95 16.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.783 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.76 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -97.25 106.08 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.91 -81.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -131.36 -4.27 3.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.592 ' HB3' HG23 ' A' ' 716' ' ' VAL . 6.1 m120 -97.43 138.65 34.55 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.751 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.9 ttm180 -85.26 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 2.6 mtp -130.17 122.88 29.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 0.0 111.14 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.506 ' H ' HG21 ' A' ' 668' ' ' THR . 20.7 pt -103.4 165.18 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.656 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -51.16 117.64 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 110.868 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.74 8.0 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.309 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.506 HG21 ' H ' ' A' ' 665' ' ' ILE . 16.6 p -112.77 162.19 16.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.978 0.418 . . . . 0.0 111.419 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.419 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.3 ttpm? -136.48 144.06 44.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.536 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.529 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.27 144.82 29.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.868 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.65 136.72 53.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.775 HD13 HG21 ' A' ' 694' ' ' VAL . 1.6 mt -108.19 127.89 54.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.952 ' HB3' HD22 ' A' ' 707' ' ' LEU . 0.6 OUTLIER -118.1 161.26 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.132 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.486 ' HB2' HD12 ' A' ' 696' ' ' ILE . 60.1 t0 -58.37 104.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.303 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.72 32.84 4.95 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -86.71 115.61 24.27 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.673 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.83 108.91 21.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.76 HG23 ' HG ' ' A' ' 659' ' ' LEU . 4.7 mt -105.16 131.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 0.0 112.036 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -93.32 115.54 28.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.182 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.627 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.3 OUTLIER -86.41 -37.89 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.136 -179.01 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.066 HD12 HD12 ' A' ' 618' ' ' LEU . 43.9 mt -155.36 130.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.392 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -136.79 127.09 26.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 4.0 t0 -126.35 116.56 21.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.37 . . . . 0.0 110.686 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -67.81 -46.2 72.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -58.55 -40.28 82.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.128 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -96.22 -20.24 18.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.5 tptp 72.04 1.91 4.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.318 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.67 105.37 7.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 586' ' ' SER . 3.6 p -110.78 138.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.913 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 587' ' ' ILE . 8.3 mm -112.65 145.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.55 128.57 1.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.4 m-30 -113.2 148.31 35.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 110.323 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.676 ' HB2' HD22 ' A' ' 583' ' ' LEU . 31.4 tttt -101.62 117.02 34.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.05 0.453 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.82 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.8 t -81.66 126.11 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.4 tt0 -133.98 108.69 8.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.746 HD13 ' HB2' ' A' ' 705' ' ' GLU . 34.1 mt -74.0 105.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.674 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.92 -47.61 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.875 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.478 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.6 t0 -111.08 140.06 45.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -115.14 100.62 8.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.166 0.507 . . . . 0.0 109.726 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.48 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.2 t -69.79 65.34 0.22 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.64 57.22 20.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.754 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.822 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -95.91 149.38 21.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 112.048 -179.028 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.547 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.72 -26.95 6.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.189 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.8 t-20 -160.13 -51.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.586 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.746 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.6 pt-20 159.53 -31.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.729 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 145.26 40.68 0.05 OUTLIER Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.061 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.952 HD22 ' HB3' ' A' ' 673' ' ' GLN . 1.4 mm? -88.29 7.19 33.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.058 0.429 . . . . 0.0 112.087 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 67.45 -67.26 0.26 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.806 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 8.3 ptp 35.79 40.48 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.771 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 711' ' ' GLN . 0.2 OUTLIER -96.92 169.85 9.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.832 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.529 ' H ' HD23 ' A' ' 710' ' ' LEU . 4.8 mt-30 -51.53 -30.02 18.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.88 130.58 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.429 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.85 100.41 10.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.095 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 39.9 84.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.732 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.71 142.84 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 663' ' ' ARG . 53.6 t -81.95 114.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.093 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 717' ' ' LEU . 4.2 mp -88.1 170.16 11.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.567 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -103.75 158.1 16.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -95.4 158.2 15.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.0 p -126.31 -176.49 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.56 -30.42 41.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.17 -45.01 96.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.585 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.9 mp0 -68.84 -49.67 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.557 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -56.25 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -41.8 89.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.4 mt -55.68 -44.33 77.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -76.56 -29.31 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -37.53 67.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.62 28.63 3.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 608' ' ' ASP . 4.3 tt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.655 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.814 0.34 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.38 109.35 9.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.0 pt -60.83 159.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -174.87 162.61 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.666 HD11 HG23 ' A' ' 681' ' ' ILE . 96.9 mt -137.9 50.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -70.13 -22.15 63.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 145.08 -14.37 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.413 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 60.2 ttp180 -100.31 128.91 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.9 -57.55 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.364 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -108.82 137.56 46.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.75 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.7 m -116.95 114.6 24.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.012 HD12 HD11 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -103.56 108.03 19.13 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.32 100.46 53.48 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.8 Cg_exo -47.22 103.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.736 1.624 . . . . 0.0 109.545 176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.85 158.36 86.09 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.46 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 7.6 Cg_endo -49.66 -26.18 12.52 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.512 2.808 . . . . 0.0 112.705 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 583' ' ' LEU . 92.8 m-20 -63.5 -19.83 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.012 0.434 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 t -96.76 153.86 17.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.848 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.672 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -55.49 -20.49 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.695 HD12 HG23 ' A' ' 613' ' ' ILE . 59.7 mt -110.55 118.8 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.078 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.1 61.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.374 0.607 . . . . 0.0 110.307 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.93 171.95 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.835 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.28 132.61 53.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.026 0.441 . . . . 0.0 111.384 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.9 144.81 41.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.116 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.4 mt-10 -124.28 116.73 23.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 580' ' ' LEU . 66.7 mt -87.54 108.81 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -66.93 125.2 25.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 3.1 pt20 -46.49 -30.02 2.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.286 0.565 . . . . 0.0 110.148 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.454 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.6 -21.4 79.58 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 114.085 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.429 HG11 ' ND2' ' A' ' 610' ' ' ASN . 63.5 t -98.95 117.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.253 1.026 . . . . 0.0 111.797 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.7 t30 -140.51 121.28 9.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.917 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 40.4 Cg_endo -90.43 159.71 31.91 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.606 -0.998 . . . . 0.0 111.375 -0.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.663 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -92.16 117.41 29.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.499 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 14.2 m-85 -92.22 137.9 31.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.173 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.644 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -128.45 146.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.412 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.81 -165.88 37.78 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.89 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.7 OUTLIER -85.86 -6.65 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.519 -0.34 . . . . 0.0 111.767 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.0 130.79 47.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.323 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.36 -24.73 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.55 -28.96 61.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 110.528 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 92.9 m -73.65 133.09 43.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.486 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.515 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -47.91 -27.03 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.3 t -114.48 141.31 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.489 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.82 114.48 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.695 HG23 HD12 ' A' ' 588' ' ' ILE . 27.6 mm -137.9 109.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.187 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.4 pt-20 -92.01 103.02 15.58 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.846 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.672 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -132.88 110.94 10.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.318 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.97 -24.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.4 mmp_? -77.38 -41.38 40.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.937 HD23 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -84.75 158.7 20.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 111.535 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.8 t -93.55 178.25 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.719 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -47.13 -53.99 11.6 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.425 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 730' ' ' LEU . 33.7 t -113.87 62.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.211 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.7 ' CD2' HG23 ' A' ' 680' ' ' ILE . 59.1 t60 -48.86 -51.06 31.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.535 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 3.7 p -162.55 157.49 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.446 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.508 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.5 p90 -143.52 150.53 39.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.505 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -102.08 126.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -120.38 133.98 55.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 25.0 ttmt -98.06 137.16 37.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.235 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.55 159.21 42.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.791 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -76.21 111.95 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.344 0.592 . . . . 0.0 110.112 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 709' ' ' MET . 1.0 OUTLIER -83.17 122.94 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.536 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -159.52 109.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.59 152.55 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -60.14 95.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.31 177.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.11 102.8 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 3.7 mtt -92.74 128.0 38.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 9.6 t80 69.26 -66.47 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.33 138.53 31.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.727 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 20.1 m -116.46 88.17 23.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.06 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.04 -151.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.657 2.238 . . . . 0.0 112.051 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -62.86 -14.32 44.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.74 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.0 OUTLIER 82.34 -71.06 0.05 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . -170.59 72.58 0.11 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 703' ' ' PHE . 23.4 mt -106.93 -154.26 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.932 -0.158 . . . . 0.0 110.707 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 702' ' ' LEU . 4.6 m-20 -116.34 147.3 41.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.022 0.439 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.875 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -131.92 155.72 47.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.225 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -105.87 119.87 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 121.563 0.697 . . . . 0.0 112.346 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.657 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.4 m95 -103.59 128.29 50.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.636 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.565 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.7 t80 -90.16 115.72 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.8 m -98.25 137.59 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 111.549 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 23.0 t60 -121.55 121.62 37.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.509 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 22.6 p -119.48 3.18 11.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.49 146.7 29.03 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.883 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 0.3 OUTLIER -77.33 -13.59 59.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -83.43 2.35 37.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.48 137.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.612 0.72 . . . . 0.0 111.992 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 680' ' ' ILE . 40.9 m -112.42 166.42 11.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.481 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.39 120.07 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.69 99.67 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.5 m120 60.51 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.2 t30 -131.79 -0.38 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.683 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.91 141.05 36.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -77.01 141.88 40.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.775 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.5 mmm -121.2 91.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.1 pt -87.39 159.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 652' ' ' THR . 19.6 tt0 -55.3 108.06 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.236 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.0 34.48 2.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.918 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.0 p -134.68 159.77 40.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 111.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 16.0 pttm -136.78 139.8 42.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.775 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 14.3 t80 -131.64 144.61 51.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.875 HD21 ' HB3' ' A' ' 646' ' ' ASP . 1.2 mt -68.89 134.56 49.77 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.179 0.514 . . . . 0.0 111.849 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 694' ' ' VAL . 4.0 mt -104.46 135.31 46.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.219 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.938 ' HB3' HD12 ' A' ' 707' ' ' LEU . 0.5 OUTLIER -119.7 146.7 45.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.307 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 696' ' ' ILE . 10.8 t70 -45.9 104.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.88 32.46 4.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 112.07 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -95.47 108.26 20.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 659' ' ' LEU . 36.3 pt -106.03 137.42 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.341 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.23 115.52 27.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.109 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.7 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.1 mt -81.68 -38.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.441 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.937 HD12 HD23 ' A' ' 618' ' ' LEU . 14.0 mt -155.3 131.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.931 0.396 . . . . 0.0 111.556 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.63 123.05 20.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 116.68 21.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.536 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -46.67 71.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.982 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -71.63 -40.56 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.799 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -89.81 -6.23 56.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.445 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 58.78 19.04 6.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.676 0.274 . . . . 0.0 110.798 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CD2' ' CG ' ' A' ' 617' ' ' ARG . 0.1 OUTLIER -79.05 104.34 9.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.0 p -117.88 121.79 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.194 0.521 . . . . 0.0 111.447 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.425 HD11 HG12 ' A' ' 587' ' ' ILE . 33.3 mm -128.24 137.27 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.881 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -167.66 131.04 2.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.045 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.9 m-30 -113.14 144.72 42.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.664 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 22.1 ttpt -101.7 117.23 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.068 0.461 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 672' ' ' LEU . 3.1 t -79.04 119.7 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.649 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.7 tt0 -126.45 109.16 11.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.061 0.457 . . . . 0.0 110.233 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 705' ' ' GLU . 58.2 mt -79.79 105.46 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -49.01 8.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -111.38 138.44 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.796 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 68.9 p -116.14 99.87 7.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 700' ' ' THR . 8.4 t -77.42 61.0 2.15 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.42 43.43 58.14 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.067 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.867 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -97.1 32.9 2.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.953 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.687 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER 61.55 109.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.437 ' CG ' ' HG2' ' A' ' 705' ' ' GLU . 8.6 t-20 56.14 -69.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.145 0.498 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 702' ' ' LEU . 9.1 pt-20 172.24 -22.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.765 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 137.71 40.65 0.11 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.834 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.938 HD12 ' HB3' ' A' ' 673' ' ' GLN . 0.9 OUTLIER -82.57 -3.53 56.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.518 ' CA ' HD13 ' A' ' 671' ' ' LEU . . . 42.48 82.25 0.03 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.349 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.522 ' HE2' ' CZ ' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -98.36 29.71 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.159 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.2 OUTLIER -57.65 164.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.844 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.5 -33.64 45.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.543 ' HB2' HD12 ' A' ' 710' ' ' LEU . 2.9 mt-10 -86.09 139.89 30.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -82.65 100.14 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.027 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 15.2 mmm-85 39.85 87.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.89 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.4 141.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.51 130.22 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.414 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.58 169.73 9.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 156.43 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.974 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.83 150.78 25.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -126.12 -178.44 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.52 57.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.187 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.06 -49.22 76.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -48.29 71.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.736 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.57 -32.97 67.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.44 -36.85 85.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.42 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.1 mt -60.51 -44.15 96.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.0 p -76.55 -24.03 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.65 -46.06 66.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -64.26 -25.97 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 621' ' ' VAL . 7.2 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.8 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.73 47.47 8.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.46 105.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.84 -178.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.35 113.96 5.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.966 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -92.76 10.51 30.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.627 0.251 . . . . 0.0 111.171 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -158.36 -36.86 0.02 OUTLIER Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.83 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.421 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 58.4 ttp180 -112.03 143.33 43.22 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.306 -0.526 . . . . 0.0 111.209 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -128.07 -62.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.549 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.016 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.46 125.68 51.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.307 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.598 HG22 ' HG3' ' A' ' 581' ' ' LYS . 6.8 m -109.23 118.49 36.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.532 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.7 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.56 108.25 19.67 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.598 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.27 99.22 39.23 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 50.4 Cg_exo -47.47 97.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.792 1.661 . . . . 0.0 109.607 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.79 158.14 85.04 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.7 -25.55 11.6 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.55 2.833 . . . . 0.0 112.549 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 583' ' ' LEU . 23.7 t70 -62.1 -25.43 67.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.477 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.8 t -95.61 153.93 17.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.691 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.629 HG21 ' HD1' ' A' ' 688' ' ' PHE . 0.9 OUTLIER -57.03 -12.34 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 0.0 111.284 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.718 HD13 HG23 ' A' ' 613' ' ' ILE . 30.4 mt -112.44 129.62 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.46 57.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.486 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.9 mt-10 -124.64 172.04 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.127 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -125.9 130.47 51.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.6 OUTLIER -112.74 142.51 45.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.101 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.27 120.43 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.865 HD12 HD22 ' A' ' 578' ' ' LEU . 78.6 mt -89.34 109.07 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -68.14 122.47 18.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.85 -29.95 2.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.221 0.534 . . . . 0.0 110.537 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.55 -22.04 77.79 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.942 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.441 HG11 ' OD1' ' A' ' 610' ' ' ASN . 64.0 t -101.07 118.26 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.934 0.867 . . . . 0.0 111.841 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 19.1 t30 -139.85 122.32 10.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.742 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -90.21 159.52 32.9 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.372 -1.095 . . . . 0.0 111.673 -0.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.2 t80 -92.07 114.28 26.78 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.617 ' CG ' HD12 ' A' ' 730' ' ' LEU . 3.3 m-85 -92.39 138.48 31.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.184 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.765 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -125.78 143.44 39.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.79 -174.08 43.39 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.375 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.5 ttp85 -82.03 -4.46 56.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.617 0.246 . . . . 0.0 111.455 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.98 126.43 47.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.777 0.322 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -49.94 -26.58 4.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.55 -28.85 48.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.958 0.408 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 35.2 m -75.02 133.4 41.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 7.3 m120 -49.61 -26.95 4.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.457 . . . . 0.0 110.417 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.774 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.0 t -111.54 142.66 43.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 115.17 24.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.718 HG23 HD13 ' A' ' 588' ' ' ILE . 24.6 mm -137.88 109.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.011 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 28.6 tt0 -89.29 104.1 16.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.249 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.825 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.85 113.24 13.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.228 178.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -41.23 -38.61 1.16 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 681' ' ' ILE . 1.3 mmp_? -77.46 -35.11 54.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -58.99 157.94 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.73 164.43 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.96 -50.01 19.73 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.126 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 727' ' ' VAL . 54.7 t -115.67 63.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.498 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.628 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 2.1 t-160 -45.78 -48.22 15.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.477 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 31.7 p -172.39 162.88 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 650' ' ' CYS . 46.0 p90 -144.18 144.2 31.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.5 mp -102.55 130.67 52.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.1 t80 -121.67 133.61 54.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.1 tppp? -97.94 136.03 38.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.769 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 158.7 43.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.84 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.19 112.96 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.451 0.644 . . . . 0.0 110.366 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.2 t60 -68.22 133.39 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.131 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -127.95 160.51 31.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.054 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.1 p -140.35 159.48 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -67.13 -93.47 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.544 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.52 138.15 54.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' SER . . . . . 0.4 ' HB3' ' HG3' ' A' ' 640' ' ' PRO . 13.9 p -111.27 121.88 46.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 116.0 13.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.3 t80 72.6 -62.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -81.82 144.07 31.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 7.0 t -94.5 107.62 31.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.434 ' HG2' HG11 ' A' ' 632' ' ' VAL . 96.7 Cg_endo -80.44 -165.25 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.534 2.156 . . . . 0.0 112.377 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.716 ' O ' HD13 ' A' ' 644' ' ' LEU . . . -56.37 -30.16 62.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.491 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 644' ' ' LEU . 0.0 OUTLIER 64.38 -165.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -95.02 68.6 1.17 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.172 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 641' ' ' ALA . 5.9 mp -114.68 -156.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.739 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -118.4 146.84 44.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.049 0.452 . . . . 0.0 111.65 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 3.0 t0 -133.47 160.3 37.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.589 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.016 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -109.08 122.64 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.795 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.945 ' CH2' HD22 ' A' ' 671' ' ' LEU . 93.1 m95 -109.99 126.85 54.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.399 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.57 ' HE2' ' HG ' ' A' ' 623' ' ' CYS . 9.9 t80 -90.67 122.24 33.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.162 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 7.9 m -111.02 128.14 55.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 657' ' ' SER . 70.5 t60 -106.11 130.11 54.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.382 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -126.24 3.63 7.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.288 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.53 141.07 20.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.043 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 654' ' ' THR . 87.4 m -75.6 -5.6 46.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.44 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.3 m120 -87.24 0.04 55.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.722 0.296 . . . . 0.0 111.316 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.3 t 67.59 146.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.461 ' HB3' ' CG ' ' A' ' 651' ' ' HIS . 0.9 OUTLIER -118.24 158.66 24.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.379 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -138.58 119.68 14.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.359 . . . . 0.0 110.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -108.06 112.49 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.83 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.46 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.02 0.19 1.53 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.474 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -96.65 141.82 29.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -79.51 141.91 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.482 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 34.9 mmm -124.78 102.77 7.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.118 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 44.2 pt -87.99 151.43 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -47.5 107.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.955 0.407 . . . . 0.0 111.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.51 36.18 2.69 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.132 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 665' ' ' ILE . 2.9 p -122.69 162.2 22.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 111.519 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.444 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -129.42 153.23 48.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.02 143.31 28.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.945 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -73.23 123.08 22.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.217 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.76 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.1 mt -98.71 140.48 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.2 OUTLIER -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.432 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 706' ' ' GLY . 29.1 t0 -43.04 113.76 0.52 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 95.95 35.51 5.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.42 121.61 36.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.356 . . . . 0.0 110.914 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -96.15 108.62 21.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.987 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.2 mt -108.13 136.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.07 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.499 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 20.0 mttt -107.83 116.59 32.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.812 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.652 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -88.02 -30.55 5.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.858 -178.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.655 HD11 HD11 ' P' ' 831' ' ' LEU . 15.8 tt -155.03 130.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.523 . . . . 0.0 112.193 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.636 ' CD1' HG23 ' A' ' 689' ' ' VAL . 9.0 t90 -137.43 128.34 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.375 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -126.72 116.38 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 0.0 111.152 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -68.5 -46.61 69.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.992 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -58.71 -40.64 84.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.054 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.94 -15.47 22.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.451 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 70.64 3.31 4.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.072 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.629 ' HD1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.46 104.18 7.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.636 HG23 ' CD1' ' A' ' 682' ' ' TRP . 2.6 p -113.3 137.33 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.807 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 587' ' ' ILE . 28.8 mm -116.19 155.24 17.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.67 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . 179.28 124.92 0.91 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.86 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.8 m-30 -112.67 143.26 44.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 0.0 110.552 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.4 tptt -101.09 117.55 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.113 0.482 . . . . 0.0 110.702 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 578' ' ' LEU . 8.2 t -82.45 126.94 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.8 tt0 -133.76 109.44 9.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 674' ' ' ASP . 67.7 mt -77.55 105.68 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.869 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -80.5 -44.55 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.247 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -110.44 140.82 44.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.032 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.8 p -114.78 99.81 7.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.093 0.473 . . . . 0.0 109.895 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 t -80.69 60.31 3.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.481 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.96 58.93 11.6 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.925 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -85.04 144.0 28.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.551 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.644 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -37.43 -47.99 0.92 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.695 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.508 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -143.51 5.74 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.19 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.737 ' CD ' HD23 ' A' ' 707' ' ' LEU . 1.2 pt-20 87.69 -41.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 116.87 34.61 1.24 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.737 HD23 ' CD ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -80.9 -8.81 59.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.587 -0.361 . . . . 0.0 111.566 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.434 ' HA3' ' OE1' ' A' ' 673' ' ' GLN . . . 46.9 101.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.211 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.79 96.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 711' ' ' GLN . 0.4 OUTLIER 67.32 158.79 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.765 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.607 ' H ' HD23 ' A' ' 710' ' ' LEU . 6.9 mt-30 -68.6 65.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.482 . . . . 0.0 110.26 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 710' ' ' LEU . 1.2 mm-40 -107.45 141.73 38.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.134 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -81.06 135.97 35.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.197 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.508 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -87.87 -143.3 0.13 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.281 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.91 143.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 82.2 t -99.04 113.91 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.83 172.19 8.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.89 16.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -90.79 152.61 20.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 59.9 p -126.21 -175.21 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.35 65.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.51 -47.2 82.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -66.41 -45.26 80.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -32.71 68.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.31 -37.82 83.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 723' ' ' GLU . 16.8 mt -58.61 -44.34 89.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 621' ' ' VAL . 12.0 p -81.39 -22.1 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -40.08 66.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -75.56 -15.91 60.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.617 HD12 ' CG ' ' A' ' 602' ' ' PHE . 9.9 tt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -176.57 119.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.1 mt -143.81 94.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.35 123.8 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 681' ' ' ILE . 38.9 mt -119.92 37.42 4.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.864 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -93.02 10.36 31.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.599 0.238 . . . . 0.0 111.407 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 595' ' ' GLN . . . -153.34 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.661 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 ttm180 -97.7 142.03 29.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 122.501 -0.411 . . . . 0.0 110.581 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -131.3 -60.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 647' ' ' ILE . 6.7 tt -106.55 134.68 49.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.858 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.1 m -115.5 114.66 25.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.731 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.2 mp -105.18 108.04 19.35 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 pttp -113.46 100.32 51.53 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.62 ' CB ' HG23 ' A' ' 588' ' ' ILE . 53.2 Cg_exo -46.07 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.91 1.74 . . . . 0.0 109.795 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.69 158.52 84.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.03 -24.72 5.68 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.493 2.795 . . . . 0.0 112.759 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -61.45 -23.37 65.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 6.4 t -95.49 153.59 17.62 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.92 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.65 HD13 HD11 ' A' ' 690' ' ' ILE . 4.3 pt -54.46 -17.85 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 582' ' ' PRO . 6.4 tt -112.46 142.83 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.77 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 65.89 0.83 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.351 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.598 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.6 mm-40 -124.75 171.57 10.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.276 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.89 125.67 40.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.954 0.406 . . . . 0.0 111.084 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.65 138.66 49.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.771 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 8.7 mt-10 -124.25 122.4 37.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.828 HD11 HD13 ' A' ' 625' ' ' ILE . 67.8 mt -85.12 109.21 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.116 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.468 ' OE1' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -63.68 114.0 3.71 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.006 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.534 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.9 -32.72 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.9 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.509 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.63 -21.05 76.19 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.689 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.19 118.49 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.864 0.832 . . . . 0.0 111.917 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.18 123.08 10.14 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.981 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.567 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -90.06 159.31 33.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.334 -1.111 . . . . 0.0 111.799 0.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.575 ' CE1' ' ND2' ' A' ' 610' ' ' ASN . 2.6 t80 -92.87 117.72 30.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.673 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.3 m-85 -92.79 138.2 31.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.648 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 625' ' ' ILE . 2.4 mp -128.28 149.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.957 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.78 -176.69 40.55 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.962 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -79.25 -4.51 51.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.212 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 130.21 47.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 111.052 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -25.13 19.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.32 -29.01 46.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.783 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 730' ' ' LEU . 58.1 m -77.77 136.88 38.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.575 ' ND2' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -51.32 -23.77 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.793 ' SG ' HD13 ' A' ' 592' ' ' LEU . 51.5 t -117.29 143.38 45.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.696 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -120.43 119.77 34.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 592' ' ' LEU . 25.4 mm -137.57 109.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.987 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.67 102.53 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.867 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.613 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.18 113.55 13.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.837 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -44.04 -36.43 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.821 0.343 . . . . 0.0 111.603 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.573 ' CB ' HD13 ' A' ' 681' ' ' ILE . 1.4 mmt180 -77.53 -31.19 53.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.087 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.3 mp -59.51 159.48 8.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.8 p -114.02 164.52 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.173 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -45.8 -45.4 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.686 HG11 ' CG2' ' A' ' 727' ' ' VAL . 13.7 t -124.89 61.44 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.392 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.511 ' NE2' HG23 ' A' ' 680' ' ' ILE . 21.3 t60 -50.05 -48.57 52.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.951 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.545 ' SG ' HD11 ' A' ' 680' ' ' ILE . 6.5 p -166.89 158.4 12.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.621 ' HA ' HD12 ' A' ' 603' ' ' ILE . 47.9 p90 -143.39 146.89 33.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.909 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.828 HD13 HD11 ' A' ' 594' ' ' ILE . 2.6 mp -102.2 130.96 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.918 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -124.34 131.58 53.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.618 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 20.1 ttmt -98.15 135.99 39.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.14 158.0 41.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.171 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.01 122.26 24.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 110.499 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.458 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 6.6 t60 -78.67 129.86 35.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.273 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.408 ' CB ' ' NH1' ' A' ' 629' ' ' ARG . . . -166.88 125.24 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 19.4 m -80.7 178.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -61.14 -72.83 0.57 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.483 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -132.55 141.86 48.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.81 113.6 27.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.25 123.32 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.8 t80 69.24 -66.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -82.33 142.33 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.39 102.89 15.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.06 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 -162.1 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.454 2.103 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.469 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -50.21 -24.43 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 2.6 tt0 82.81 -64.75 0.1 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.3 47.2 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.59 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -88.78 -155.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.83 147.12 46.9 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.413 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -125.65 160.26 30.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.007 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -113.34 121.21 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.39 0.614 . . . . 0.0 111.927 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.534 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.2 m95 -107.26 126.56 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.417 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.533 ' CB ' HD21 ' A' ' 672' ' ' LEU . 8.6 t80 -91.03 117.74 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 12.5 m -105.74 134.27 49.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.518 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 26.2 t60 -115.51 124.18 50.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -118.67 6.26 11.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.395 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.26 151.12 29.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.6 m -81.34 -10.16 59.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.565 ' O ' HG13 ' A' ' 656' ' ' VAL . 61.1 m-20 -87.03 2.72 48.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 50.4 130.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.337 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.502 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 1.8 t -103.01 166.21 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.191 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -131.0 120.15 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.15 99.7 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.59 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.9 m120 61.31 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.748 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 70.0 m-20 -131.65 -2.1 3.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.722 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.61 135.02 42.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 111.325 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -73.65 141.8 46.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.42 ' O ' HG23 ' A' ' 656' ' ' VAL . 14.9 mmm -126.52 93.0 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 ' CG2' ' A' ' 668' ' ' THR . 36.4 pt -87.21 158.38 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 652' ' ' THR . 26.6 tt0 -46.42 116.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.193 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.48 28.64 8.87 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.409 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.424 ' CG2' HG12 ' A' ' 665' ' ' ILE . 17.5 p -112.93 162.34 15.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.37 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.489 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.4 ttpm? -141.91 129.66 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.645 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.5 t80 -134.04 144.25 48.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.439 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.534 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.49 140.36 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 112.051 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.916 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -108.82 129.44 55.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.183 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.871 ' HB3' HD22 ' A' ' 707' ' ' LEU . 3.9 mt-30 -115.45 146.0 42.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.512 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 696' ' ' ILE . 28.5 t0 -46.76 105.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.085 0.469 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.2 33.17 4.36 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -92.79 111.96 23.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.803 0.335 . . . . 0.0 111.263 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.8 108.53 20.87 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 1.031 HG22 HD13 ' A' ' 659' ' ' LEU . 34.2 pt -105.53 137.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.135 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -93.17 115.97 28.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.275 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -82.45 -32.07 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.722 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 618' ' ' LEU . 21.3 mt -154.4 131.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 111.44 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.64 124.02 22.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.17 117.06 27.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.427 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -46.94 72.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.678 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -83.2 -40.33 19.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.326 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -15.16 58.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.34 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt 62.9 15.75 8.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.978 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.422 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.01 104.24 7.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 690' ' ' ILE . 2.6 p -116.07 123.8 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.562 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.65 HD11 HD13 ' A' ' 587' ' ' ILE . 6.4 mm -127.65 154.04 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 169.29 136.17 2.02 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.714 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -114.72 153.95 29.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.798 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.838 ' HB2' HD12 ' A' ' 583' ' ' LEU . 9.2 tttt -101.79 117.6 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.916 HG21 HD13 ' A' ' 672' ' ' LEU . 5.0 t -79.08 125.9 38.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.4 OUTLIER -133.21 109.38 9.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.441 . . . . 0.0 110.409 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 577' ' ' PHE . 58.6 mt -80.78 105.32 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.646 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -87.19 -46.08 10.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.66 140.96 44.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.715 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -113.83 99.97 8.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.316 0.579 . . . . 0.0 109.73 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 56.6 m -70.79 65.93 0.34 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.432 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.19 57.27 20.67 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.857 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.816 ' C ' HD12 ' A' ' 644' ' ' LEU . 2.9 mt -99.88 145.28 27.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.619 ' N ' HD12 ' A' ' 644' ' ' LEU . 38.9 p90 -48.31 -31.38 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 109.765 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.414 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 2.6 t-20 -155.99 -53.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.787 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.516 ' O ' HD13 ' A' ' 696' ' ' ILE . 10.4 pt-20 161.47 -26.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.179 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 139.81 35.72 0.13 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.23 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 673' ' ' GLN . 1.7 mm? -83.83 -2.93 57.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.493 ' HA3' HD12 ' A' ' 671' ' ' LEU . . . 45.21 73.86 0.25 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.985 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.458 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -94.34 43.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.372 . . . . 0.0 111.003 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 710' ' ' LEU . 0.9 OUTLIER -82.34 -177.36 6.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -57.68 12.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.32 133.96 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.736 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.92 100.39 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 15.2 mmm-85 41.68 87.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.716 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.57 142.73 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.8 p -85.15 128.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 171.71 7.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -103.12 157.41 17.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.161 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.8 152.0 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 2.7 p -126.11 -178.0 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.77 -35.02 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -57.86 -48.0 81.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.7 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 726' ' ' LEU . 11.1 mp0 -66.65 -48.14 70.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.795 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -59.11 -32.95 70.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -39.44 93.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.261 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 723' ' ' GLU . 5.4 mt -60.47 -44.67 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.013 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.686 ' CG2' HG11 ' A' ' 621' ' ' VAL . 11.4 p -71.27 -27.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -56.05 -32.6 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -97.79 28.0 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.781 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.783 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.861 0.362 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.47 165.82 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.7 mt -145.71 103.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -173.42 168.24 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.676 HD11 HG23 ' A' ' 681' ' ' ILE . 60.6 mt -132.98 68.65 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.878 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -90.75 -8.94 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.683 0.278 . . . . 0.0 111.309 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 134.01 -48.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.0 tmm_? -112.96 143.93 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 111.028 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.22 -63.57 1.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.05 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.058 HD12 HD13 ' A' ' 647' ' ' ILE . 7.5 tt -106.91 142.56 36.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.3 m -122.68 114.81 21.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.335 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 594' ' ' ILE . 6.6 mt -102.55 108.29 19.54 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 6.9 ptmm? -116.55 100.51 53.48 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 588' ' ' ILE . 33.3 Cg_exo -47.11 105.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.635 1.557 . . . . 0.0 109.06 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.24 87.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.517 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 58.4 Cg_exo -51.31 -25.84 19.11 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.589 2.859 . . . . 0.0 113.108 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.635 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.3 m-20 -63.38 -26.72 68.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.049 0.452 . . . . 0.0 110.034 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.417 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -97.58 153.66 18.03 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.235 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 690' ' ' ILE . 14.4 pt -49.09 -23.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 110.1 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 613' ' ' ILE . 51.2 mt -99.5 118.59 46.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -117.57 52.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.588 . . . . 0.0 110.453 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 16.0 mt-10 -124.58 171.82 9.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.379 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.64 132.31 53.42 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.122 0.487 . . . . 0.0 111.573 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.744 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.91 143.04 44.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.724 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -124.28 118.91 27.84 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.958 HD12 HD22 ' A' ' 578' ' ' LEU . 74.9 mt -83.8 109.05 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.214 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.9 OUTLIER -65.9 120.84 13.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.95 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.24 -28.12 1.79 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.091 0.472 . . . . 0.0 110.67 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -73.63 -19.3 79.69 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.746 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 610' ' ' ASN . 55.0 t -100.74 117.95 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.968 0.884 . . . . 0.0 111.711 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.6 t30 -140.19 121.71 9.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.687 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.3 Cg_endo -89.96 159.86 34.31 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.493 -1.045 . . . . 0.0 111.519 -0.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.5 114.7 27.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.737 ' CG ' HD12 ' A' ' 730' ' ' LEU . 20.5 m-85 -91.68 138.45 31.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.769 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -126.32 146.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.71 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.09 -174.8 36.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.226 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -65.89 -48.62 70.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.831 0.348 . . . . 0.0 111.415 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.86 128.41 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.492 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.46 -17.73 23.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.766 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -56.95 -31.74 65.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.123 0.487 . . . . 0.0 110.112 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.3 m -70.58 134.02 47.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.501 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -48.08 -27.53 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.432 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.769 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.2 t -112.19 142.01 45.19 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 105.37 13.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.779 HD12 HD13 ' A' ' 588' ' ' ILE . 18.7 mm -138.62 108.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.764 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -106.18 105.91 16.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.469 0.652 . . . . 0.0 112.217 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.755 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -130.08 109.88 11.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.731 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -37.83 -30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.614 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -74.72 -41.59 59.88 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 615' ' ' ASP . 2.4 pp -88.24 136.98 32.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 163.84 4.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.461 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.494 ' CG ' HG23 ' A' ' 621' ' ' VAL . 1.3 ptp180 -54.08 -28.06 36.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.494 HG23 ' CG ' ' A' ' 620' ' ' ARG . 60.6 t -129.36 60.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.587 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.16 -47.25 45.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.133 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 8.2 p -168.06 161.09 12.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.8 p90 -143.36 148.52 36.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.62 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 580' ' ' LEU . 3.9 mp -102.23 128.16 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.324 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -118.48 134.47 55.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.423 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 33.3 ttmt -98.1 135.28 40.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.19 159.65 41.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.588 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.4 tpt180 -75.2 112.89 11.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.27 0.557 . . . . 0.0 110.862 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.476 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 7.7 t60 -61.72 133.59 55.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.415 ' HB1' ' OE1' ' A' ' 642' ' ' GLN . . . -139.76 101.9 4.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.147 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 642' ' ' GLN . 34.0 m -60.02 -176.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -91.37 -49.56 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.638 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.73 167.9 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 82.5 p -171.72 135.91 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 59.8 mmm -118.99 115.87 25.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.51 -72.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 0.6 OUTLIER -76.36 144.34 40.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.5 m -101.31 105.16 38.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.924 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 29.6 Cg_exo -61.37 -149.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.607 2.205 . . . . 0.0 111.986 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 630' ' ' HIS . . . -45.39 -29.2 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 111.556 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.8 ' HB2' HG22 ' A' ' 632' ' ' VAL . 1.9 tp-100 -52.45 102.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 137.41 -12.78 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.399 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -113.32 -175.5 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.205 0.502 . . . . 0.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.0 m-20 -106.33 146.24 30.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.455 0.645 . . . . 0.0 112.251 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.476 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -128.72 160.56 32.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.549 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -108.35 120.85 60.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.63 0.729 . . . . 0.0 112.375 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.855 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.7 m95 -104.95 127.8 52.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.563 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.401 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.0 t80 -90.55 117.4 29.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.094 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 12.3 m -102.3 127.78 49.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -108.84 125.98 52.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 14.3 p -121.25 2.01 10.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.211 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.81 161.07 50.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.05 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 38.6 m -91.61 -19.86 22.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.633 0.254 . . . . 0.0 111.627 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.594 ' O ' HG13 ' A' ' 656' ' ' VAL . 47.7 m-20 -82.72 2.88 31.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.659 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.46 130.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.453 0.644 . . . . 0.0 112.278 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.422 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 86.5 p -100.98 166.34 10.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.136 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.42 120.76 26.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.755 0.312 . . . . 0.0 111.573 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.682 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.55 99.75 11.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.362 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 61.57 -80.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.687 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.18 -3.61 3.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.711 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.478 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.7 m-80 -97.0 142.01 29.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.381 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.8 ttm105 -82.25 141.62 32.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.216 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.83 97.95 5.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 43.8 pt -88.5 156.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.3 tt0 -47.34 108.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.4 35.77 3.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.356 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.421 ' CG2' HG12 ' A' ' 665' ' ' ILE . 4.3 p -120.01 162.31 19.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.161 0.505 . . . . 0.0 111.964 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.0 ttpt -133.2 148.31 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.229 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.738 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.5 t80 -147.28 144.83 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.855 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 132.46 46.2 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.719 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.803 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -110.37 122.22 47.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.577 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.7 OUTLIER -115.11 138.78 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.315 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 706' ' ' GLY . 19.2 t0 -39.04 123.33 1.31 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 37.45 8.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.21 115.13 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.81 108.58 20.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.0 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.682 HG12 HD13 ' A' ' 659' ' ' LEU . 7.8 mt -109.0 136.54 44.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.91 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -96.77 115.44 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.656 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.722 HD12 ' CE2' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -80.08 -40.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.984 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 617' ' ' ARG . 2.4 mt -155.4 131.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.001 0.429 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.618 ' HB2' HG23 ' A' ' 689' ' ' VAL . 6.5 t90 -136.12 128.23 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -122.15 116.78 24.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.403 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -46.41 72.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.868 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -60.51 -40.63 92.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.256 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.31 -20.25 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.65 0.262 . . . . 0.0 111.567 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 72.69 1.94 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.425 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.68 105.37 7.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 682' ' ' TRP . 2.4 p -114.71 134.13 58.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.465 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 587' ' ' ILE . 34.7 mt -119.82 120.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.95 141.07 9.93 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.856 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.722 ' CE2' HD12 ' A' ' 680' ' ' ILE . 9.1 m-30 -113.62 142.23 46.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.583 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.2 116.96 34.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.229 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.696 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.9 125.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.8 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 109.45 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.655 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.487 HG23 ' CD1' ' A' ' 577' ' ' PHE . 57.3 mt -83.89 105.76 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.67 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.91 -43.55 12.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.318 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -109.9 141.55 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.337 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.9 p -113.53 100.02 8.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.405 0.621 . . . . 0.0 110.142 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.9 m -82.63 60.68 5.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 73.95 49.07 14.21 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.859 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.574 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -83.63 127.42 33.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.654 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.2 p90 -35.77 -48.14 0.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.254 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -141.95 8.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.373 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' OE2' HD23 ' A' ' 707' ' ' LEU . 1.9 pt-20 88.68 -42.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.316 0.579 . . . . 0.0 110.085 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 121.38 26.37 2.02 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.354 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.576 HD23 ' OE2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -86.92 7.94 25.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 56.95 88.83 0.01 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.14 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.401 ' C ' HD23 ' A' ' 710' ' ' LEU . 19.8 mtm -49.03 94.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.666 0.27 . . . . 0.0 111.677 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 709' ' ' MET . 0.6 OUTLIER 34.61 88.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 54.85 58.16 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.6 141.07 58.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.938 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.56 135.21 35.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.259 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -156.22 120.8 4.58 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 110.564 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.04 162.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.055 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.609 HG21 ' O ' ' A' ' 663' ' ' ARG . 9.6 t -77.47 116.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.952 0.406 . . . . 0.0 111.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.99 172.22 8.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 155.52 17.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -92.34 150.98 20.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -126.16 -175.57 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.94 68.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.52 -53.34 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.438 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.8 pp20? -70.81 -41.3 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.851 0.358 . . . . 0.0 110.586 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.533 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -67.61 -38.37 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.702 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 723' ' ' GLU . 18.0 mt -56.01 -44.22 78.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -78.54 -24.04 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -59.07 -37.79 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.06 -15.93 57.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.737 HD12 ' CG ' ' A' ' 602' ' ' PHE . 10.0 tt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.05 149.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.51 117.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.417 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.439 ' O ' HD23 ' P' ' 831' ' ' LEU . 8.5 p90 -175.59 157.88 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 682' ' ' TRP . 36.7 mt -132.04 123.34 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.891 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -71.3 -22.38 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.067 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -163.0 35.49 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.433 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -96.58 109.95 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 110.443 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.5 t80 -95.11 -58.29 2.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.735 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.837 HD11 ' CG1' ' A' ' 694' ' ' VAL . 7.9 tp -106.84 142.87 35.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 0.0 111.624 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 40.6 m -117.68 113.85 22.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -105.62 109.34 21.27 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 37.5 pttt -117.09 99.34 52.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 28.0 Cg_exo -45.8 99.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.918 1.746 . . . . 0.0 109.825 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.05 157.47 85.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.9 -25.7 12.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 112.948 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.83 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.09 -28.24 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 0.4 OUTLIER -95.89 153.97 17.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.976 178.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 688' ' ' PHE . 16.7 pt -52.38 -15.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.669 0.271 . . . . 0.0 111.365 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.8 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 111.685 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.71 55.25 1.45 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.618 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.3 mt-10 -124.72 170.24 11.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.052 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.49 121.06 25.09 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -112.68 148.21 35.15 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 119.58 29.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.663 0.268 . . . . 0.0 111.697 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 625' ' ' ILE . 47.1 mt -74.05 109.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.39 111.85 3.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.023 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 2.9 pt20 -43.37 -36.49 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.469 0.652 . . . . 0.0 109.942 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -61.47 -23.85 63.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.233 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.4 t -101.14 118.86 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 117.516 0.658 . . . . 0.0 111.511 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.0 t30 -139.22 122.18 10.59 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.5 Cg_endo -89.6 160.24 36.24 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 124.413 -1.078 . . . . 0.0 111.674 -0.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -90.75 116.72 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 56.1 m-85 -92.45 138.01 31.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.05 145.7 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.435 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.37 -174.98 41.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.566 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.4 ttp85 -80.64 -11.51 59.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.645 0.259 . . . . 0.0 111.315 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 132.23 42.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.13 -26.35 11.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -30.78 27.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.035 0.445 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 63.7 m -77.2 128.8 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -45.24 -34.72 2.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 39.8 t -101.88 138.67 38.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.059 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 113.73 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.334 0.588 . . . . 0.0 112.549 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.9 mm -137.6 109.86 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.658 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 pm0 -87.79 103.99 16.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.693 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.23 110.23 10.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.964 178.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -40.64 -36.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' A' ' 681' ' ' ILE . 2.0 mmt180 -77.64 -36.58 51.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.693 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.71 159.38 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 52.7 p -108.77 166.04 11.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.31 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -47.46 25.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.573 HG11 HG23 ' A' ' 727' ' ' VAL . 18.2 t -121.24 61.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.426 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.571 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.4 t60 -50.08 -48.42 53.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.732 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -167.28 156.17 10.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.177 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.721 ' HA ' HD12 ' A' ' 603' ' ' ILE . 28.8 p90 -143.62 149.54 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.101 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 594' ' ' ILE . 71.4 mt -101.79 134.09 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -124.7 132.99 53.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.627 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HE3' HG23 ' A' ' 647' ' ' ILE . 9.1 ttmt -97.89 137.06 37.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.574 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.94 158.89 43.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.522 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.461 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.7 112.89 13.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.386 0.612 . . . . 0.0 110.41 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 -83.74 132.45 34.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.91 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.461 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -155.46 120.35 4.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.623 HG21 ' HG3' ' A' ' 640' ' ' PRO . 9.8 m -60.2 157.96 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.71 97.58 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -171.74 112.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.79 92.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.8 mtm -107.62 118.04 35.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 70.11 -64.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.98 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -76.1 144.38 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.2 m -103.32 100.59 18.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.623 ' HG3' HG21 ' A' ' 632' ' ' VAL . 91.8 Cg_endo -84.13 -159.11 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.705 2.27 . . . . 0.0 112.107 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 1.025 ' HB1' HD12 ' A' ' 644' ' ' LEU . . . -81.63 4.73 20.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.759 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.26 -78.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.657 0.265 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -163.86 89.93 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 1.025 HD12 ' HB1' ' A' ' 641' ' ' ALA . 4.4 mt -116.89 -153.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.2 m-20 -118.22 147.27 43.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.32 148.81 51.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.606 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.1 pt -102.28 122.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.897 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -102.8 138.64 39.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.241 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CB ' HD21 ' A' ' 672' ' ' LEU . 18.0 t80 -100.04 117.43 34.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.65 133.84 49.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.409 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -115.58 125.72 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.454 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 15.6 p -123.18 7.97 9.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.68 151.62 29.44 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.033 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 7.5 m -80.16 -17.3 52.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.58 ' O ' HG13 ' A' ' 656' ' ' VAL . 14.0 m-20 -83.72 2.69 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.94 128.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.43 0.633 . . . . 0.0 112.2 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.408 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 9.0 t -97.76 166.68 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 39.2 m-85 -131.91 120.22 22.22 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.402 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.951 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -95.03 100.58 12.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.14 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.44 0.44 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.435 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.423 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 7.6 m-80 -100.6 141.51 33.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.801 ' O ' HG21 ' A' ' 716' ' ' VAL . 21.8 ttp180 -82.43 141.12 33.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.736 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -122.69 98.08 5.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 668' ' ' THR . 35.2 pt -87.77 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 652' ' ' THR . 29.1 tt0 -46.76 106.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.88 35.97 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.296 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.468 HG21 HG12 ' A' ' 665' ' ' ILE . 6.6 p -125.72 162.19 25.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 111.879 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.1 ttpm? -133.6 148.47 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.224 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.736 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.6 t80 -147.69 145.87 29.06 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.897 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.52 133.79 49.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.869 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -110.33 109.2 19.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.196 0.522 . . . . 0.0 111.339 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 46.1 mt-30 -97.94 153.95 18.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.333 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.6 t0 -53.31 115.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.829 0.347 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.28 37.48 5.62 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -90.42 116.15 28.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.951 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -95.88 108.08 20.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.951 HG22 HD13 ' A' ' 659' ' ' LEU . 29.7 pt -109.29 133.67 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.088 0.47 . . . . 0.0 112.016 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 29.4 mttt -96.91 115.19 27.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.434 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.8 mt -75.81 -39.81 38.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.944 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.782 HD11 HD11 ' P' ' 831' ' ' LEU . 5.3 tt -155.7 133.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.714 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -136.04 125.98 25.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.455 ' OD1' ' ND2' ' A' ' 685' ' ' ASN . 44.2 t0 -118.77 116.93 27.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -67.49 -46.55 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.988 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' ASN . . . . . 0.455 ' ND2' ' OD1' ' A' ' 683' ' ' ASP . 13.9 p30 -69.71 -40.51 76.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.945 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.32 -20.27 28.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.68 0.276 . . . . 0.0 111.41 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt 68.38 4.82 4.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.34 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.57 ' HD1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -82.24 105.2 13.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.33 137.0 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.097 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.452 HG21 ' HB ' ' A' ' 680' ' ' ILE . 2.5 mm -115.27 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.032 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.487 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.23 130.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.231 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.4 m-30 -113.09 146.16 39.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.548 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.674 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -101.03 116.82 33.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.906 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.837 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.5 t -82.86 123.59 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.45 108.74 8.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.034 0.445 . . . . 0.0 110.987 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.832 HG21 ' HB2' ' A' ' 705' ' ' GLU . 25.1 mt -73.58 105.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.789 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -90.05 -46.04 8.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 6.1 t70 -111.28 141.03 45.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.171 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.1 OUTLIER -114.94 101.67 9.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.8 m -68.02 62.41 0.08 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 53.66 51.39 48.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.183 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -117.29 174.05 6.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.973 0.415 . . . . 0.0 111.561 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -65.67 118.4 9.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.657 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 3.0 t-20 51.39 -71.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.367 0.603 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.832 ' HB2' HG21 ' A' ' 696' ' ' ILE . 21.1 pt-20 163.02 -43.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 166.58 82.43 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.285 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.17 -9.48 17.71 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.606 -0.349 . . . . 0.0 111.467 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.64 -110.65 3.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.533 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.709 ' C ' HD23 ' A' ' 710' ' ' LEU . 5.8 tmm? 59.01 120.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.56 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.709 HD23 ' C ' ' A' ' 709' ' ' MET . 0.3 OUTLIER 176.86 157.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.774 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -49.96 -56.74 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.441 ' CB ' HG21 ' A' ' 715' ' ' VAL . 0.4 OUTLIER -80.34 140.53 36.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.558 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -82.38 100.13 9.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.94 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 41.83 81.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.648 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.441 HG21 ' CB ' ' A' ' 712' ' ' GLU . 6.6 m -124.79 150.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 663' ' ' ARG . 29.5 t -84.53 117.48 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.063 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.3 mp -90.2 161.43 15.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 148.3 25.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 160.17 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 26.7 p -119.3 -173.25 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.68 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.7 -45.5 93.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 7.7 tm-20 -67.62 -50.24 59.06 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.2 mttt -54.61 -32.52 58.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.38 -36.85 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.27 -44.61 79.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.573 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -74.97 -17.42 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.07 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -35.22 79.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.871 0.367 . . . . 0.0 110.75 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -96.79 23.98 6.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.76 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.9 0.381 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.43 103.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.1 pt -124.2 81.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -179.33 132.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 681' ' ' ILE . 18.7 mt -139.25 179.7 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.011 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.92 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -85.1 -8.97 58.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.587 0.232 . . . . 0.0 111.337 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 99.57 -2.7 57.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.653 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -98.29 108.38 21.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.6 t80 -90.84 -46.79 8.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.84 HD11 HG13 ' A' ' 694' ' ' VAL . 7.2 tp -122.49 142.22 50.81 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.967 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 581' ' ' LYS . 17.8 m -120.06 115.7 24.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.641 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.9 mt -102.05 107.85 19.09 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 17.9 mtpp -113.33 98.97 48.09 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -48.45 96.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.636 1.557 . . . . 0.0 109.434 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.76 157.64 85.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.72 -27.83 16.08 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.338 2.692 . . . . 0.0 112.43 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.484 ' CB ' HD12 ' A' ' 583' ' ' LEU . 21.9 t0 -62.48 -26.37 68.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 9.3 t -95.47 153.74 17.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.935 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 688' ' ' PHE . 10.4 tt -53.27 -14.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.456 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 613' ' ' ILE . 45.0 mt -111.47 133.51 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 111.876 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 51.81 0.88 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.617 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.7 mt-10 -123.94 171.75 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.795 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.09 132.7 50.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.11 0.481 . . . . 0.0 111.394 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.742 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.4 OUTLIER -112.62 142.48 45.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.01 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -123.75 111.68 16.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.919 HD11 HD12 ' A' ' 625' ' ' ILE . 66.8 mt -80.71 108.81 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.019 0.437 . . . . 0.0 110.044 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.6 OUTLIER -67.0 117.67 9.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 1.1 pt20 -45.69 -33.4 2.94 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.38 0.609 . . . . 0.0 110.016 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.17 -20.99 73.58 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.371 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.869 HG11 ' OD1' ' A' ' 610' ' ' ASN . 58.3 t -97.72 118.37 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 117.691 0.746 . . . . 0.0 111.396 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.3 t30 -139.97 121.49 9.62 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.032 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.2 Cg_endo -90.63 160.79 31.44 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.699 -0.959 . . . . 0.0 111.459 -0.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.85 115.07 27.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CD2' HD12 ' A' ' 730' ' ' LEU . 10.8 m-85 -92.25 138.49 31.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.621 . . . . 0.0 112.588 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.818 HG23 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mp -123.31 140.51 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.109 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 171.74 -174.81 45.23 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.418 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.7 ttp85 -83.71 -5.71 59.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.251 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.33 129.75 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.79 0.328 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.83 -26.99 6.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.121 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.97 -29.06 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 90.2 m -76.73 133.39 39.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.869 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.2 m-80 -49.09 -28.49 4.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.818 ' SG ' HG23 ' A' ' 603' ' ' ILE . 21.0 t -109.59 138.67 45.61 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 111.72 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.71 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.0 mm -137.91 109.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.65 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.5 mt-10 -88.81 104.45 16.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.976 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.751 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -130.82 113.27 13.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.081 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -43.39 -36.13 1.82 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.735 0.302 . . . . 0.0 111.62 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.946 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -77.71 -33.09 53.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.158 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.056 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -64.18 159.35 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 167.37 10.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -55.96 6.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.054 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 727' ' ' VAL . 45.8 t -113.06 62.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 37.4 t60 -48.83 -49.24 40.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.935 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 680' ' ' ILE . 7.7 p -166.71 159.37 13.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.92 0.391 . . . . 0.0 111.212 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 650' ' ' CYS . 1.7 p90 -144.0 146.97 33.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.919 HD12 HD11 ' A' ' 594' ' ' ILE . 82.6 mt -101.87 132.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.719 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.4 t80 -123.26 133.1 54.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 647' ' ' ILE . 2.4 tppp? -97.94 136.43 38.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.237 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 157.95 45.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.469 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.57 123.53 26.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.0 110.591 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.482 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 8.8 t60 -79.1 130.92 36.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -165.07 141.47 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 9.0 m -109.01 132.2 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -58.88 106.19 0.84 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.601 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 5.9 tttt 63.28 133.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.914 0.387 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.2 122.97 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 37.9 mmm -129.32 138.15 51.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 67.28 -73.78 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -75.85 141.19 42.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 36.5 t -97.23 120.72 60.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.05 -161.21 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.677 2.251 . . . . 0.0 111.973 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 703' ' ' PHE . . . -86.38 12.24 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.761 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 63.23 -82.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.639 0.257 . . . . 0.0 110.926 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -167.46 74.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.88 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.1 OUTLIER -103.82 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.819 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -123.33 147.77 46.68 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.199 0.523 . . . . 0.0 112.279 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -131.88 158.3 41.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.886 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.823 HD13 HD13 ' A' ' 578' ' ' LEU . 4.9 pt -110.28 123.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 111.924 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.89 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.8 m95 -108.75 128.66 55.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.399 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -91.31 117.41 29.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 8.2 m -102.57 138.15 39.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.283 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 657' ' ' SER . 84.3 t60 -116.55 129.36 56.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.418 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 3.2 p -125.61 -2.58 7.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.532 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.74 138.26 21.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.091 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 654' ' ' THR . 86.1 m -72.13 -8.3 53.88 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -86.93 2.55 48.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 0.0 111.43 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.95 143.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.023 0.439 . . . . 0.0 111.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.774 ' OG ' HG22 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -115.57 162.03 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 664' ' ' MET . 17.1 m-85 -137.6 119.43 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -97.99 99.69 10.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.656 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.47 -1.73 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.549 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 17.9 m120 -96.25 141.52 29.5 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.904 0.383 . . . . 0.0 111.179 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.815 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.0 mtm180 -81.49 141.57 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.158 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.52 ' HE1' HG13 ' A' ' 716' ' ' VAL . 17.4 mmm -123.03 99.34 6.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 668' ' ' THR . 35.0 pt -87.88 154.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -47.43 103.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.347 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.82 39.92 2.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.584 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.493 HG21 HG12 ' A' ' 665' ' ' ILE . 2.3 p -128.44 153.31 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.47 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.93 145.19 49.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.087 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 659' ' ' LEU . 4.8 t80 -140.14 145.77 37.97 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.89 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.29 131.87 46.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.756 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.836 HD13 HG21 ' A' ' 694' ' ' VAL . 0.9 OUTLIER -107.75 120.57 42.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.138 0.494 . . . . 0.0 110.845 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.555 ' HB3' HD23 ' A' ' 707' ' ' LEU . 2.8 mt-30 -110.04 162.24 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.001 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' A' ' 696' ' ' ILE . 24.8 t0 -58.3 108.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.655 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.58 33.5 5.86 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.31 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -86.43 114.94 23.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.691 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -95.75 108.37 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 659' ' ' LEU . 8.4 mt -108.82 134.44 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -109.01 117.77 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.072 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.774 HG22 ' OG ' ' A' ' 657' ' ' SER . 0.7 OUTLIER -90.32 -22.15 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.056 HD12 HD12 ' A' ' 618' ' ' LEU . 55.9 mt -152.87 130.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.206 0.527 . . . . 0.0 111.448 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -137.68 129.12 28.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.05 117.32 25.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.0 110.616 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -67.12 -46.56 73.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.016 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.56 -40.47 23.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.735 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -14.33 58.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.442 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 64.51 14.77 9.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -77.82 104.67 8.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.0 p -118.44 121.85 68.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.148 0.499 . . . . 0.0 112.059 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.648 HG21 HG13 ' A' ' 680' ' ' ILE . 4.3 mm -112.21 144.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -170.96 123.48 1.04 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.468 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.519 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.6 m-30 -113.11 146.11 39.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.341 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.742 ' HB2' HD22 ' A' ' 583' ' ' LEU . 2.0 tptt -101.56 117.06 34.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.84 HG13 HD11 ' A' ' 578' ' ' LEU . 2.4 t -81.78 124.12 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.017 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -133.12 108.72 9.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 705' ' ' GLU . 35.7 mt -73.91 104.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.16 -47.52 8.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.801 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.46 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 12.4 t0 -111.14 139.35 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.633 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -115.7 100.66 8.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.107 0.479 . . . . 0.0 109.712 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.4 t -70.3 63.53 0.25 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.621 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.32 59.45 10.63 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.821 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.835 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -98.8 148.18 24.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.776 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.639 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.6 p90 -47.41 -34.67 7.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.571 0.7 . . . . 0.0 109.751 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.6 t-20 -151.5 -51.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.762 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.755 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.0 pt-20 160.46 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.146 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 145.58 34.35 0.07 OUTLIER Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.083 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 673' ' ' GLN . 13.6 mt -87.22 7.95 26.14 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.446 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 81.28 -90.3 1.41 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.459 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.522 ' HE2' ' CE2' ' A' ' 703' ' ' PHE . 0.1 OUTLIER 59.46 99.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.88 0.371 . . . . 0.0 110.429 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 712' ' ' GLU . 0.4 OUTLIER 179.02 -177.88 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.829 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -55.31 -51.83 65.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 710' ' ' LEU . 23.3 mt-10 -75.47 139.99 42.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.77 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.0 100.95 10.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 47.1 76.26 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.412 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 712' ' ' GLU . 12.4 m -124.72 143.38 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.524 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 663' ' ' ARG . 30.8 t -77.68 128.37 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.115 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.462 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -100.41 167.9 10.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -103.03 154.75 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.58 155.8 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.12 -176.22 3.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.64 -31.04 63.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -64.76 -44.85 88.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.22 -51.07 57.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.2 mtmp? -55.41 -32.69 62.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -36.82 82.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.4 -44.26 92.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.936 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -74.55 -26.58 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -34.03 66.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -97.86 33.1 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.624 HD12 ' CD2' ' A' ' 602' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.81 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.861 0.362 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -170.2 135.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.406 HG13 ' CE2' ' P' ' 830' ' ' TYR . 23.5 pt -71.76 177.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' P' ' 828' ' ' ILE . 0.2 OUTLIER -176.19 142.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.915 HD11 HG23 ' A' ' 681' ' ' ILE . 55.7 mt -141.16 71.76 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.5 p30 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.872 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -106.09 -11.37 16.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.521 0.201 . . . . 0.0 111.425 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -138.37 -56.72 0.05 OUTLIER Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.996 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.5 tmm_? -112.65 143.75 43.31 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.516 -0.403 . . . . 0.0 111.415 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -123.59 -58.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 694' ' ' VAL . 9.9 tt -112.48 140.86 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.393 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 695' ' ' GLU . 38.0 m -113.1 122.0 46.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.269 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 625' ' ' ILE . 7.4 mt -107.83 108.96 20.38 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.1 pttp -119.53 98.46 50.07 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -45.22 103.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.739 1.626 . . . . 0.0 108.918 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 583' ' ' LEU . 0.2 OUTLIER -73.94 160.47 81.76 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -175.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 82.0 Cg_exo -47.05 -30.21 9.76 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.715 2.943 . . . . 0.0 113.012 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.47 -17.82 63.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 109.677 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.558 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 38.7 t -95.22 149.22 21.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.936 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 587' ' ' ILE . 0.0 OUTLIER -55.73 -22.79 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 178.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.549 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.9 tt -113.34 122.22 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.627 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -108.14 69.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 0.0 110.835 -179.246 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.769 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 34.5 mt-10 -127.93 170.97 12.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.173 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 35.8 t -131.23 116.43 17.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 112.028 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.733 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -103.91 139.73 38.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 5.1 mt-10 -118.02 131.35 56.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.868 HD12 HD22 ' A' ' 578' ' ' LEU . 89.9 mt -82.48 108.66 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 3.0 tt0 -65.5 120.99 13.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.72 -28.8 1.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.842 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.32 -18.71 79.91 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.084 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.02 117.92 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.142 0.971 . . . . 0.0 111.768 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.45 122.6 9.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.553 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.9 Cg_endo -90.25 159.85 32.88 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.5 -1.041 . . . . 0.0 111.519 -0.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.4 t80 -92.04 116.36 28.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.538 ' CG ' HD12 ' A' ' 730' ' ' LEU . 27.0 m-85 -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.695 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.759 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -128.31 147.43 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.56 -157.55 30.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.417 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.1 OUTLIER -87.61 -35.85 17.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.733 0.301 . . . . 0.0 111.506 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -74.99 137.65 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.323 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -20.64 58.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.987 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -55.02 -31.53 61.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.5 m -73.22 132.08 42.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m120 -47.0 -29.71 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 110.542 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.759 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.29 137.52 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.64 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 110.84 20.68 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.733 HD11 HD21 ' A' ' 592' ' ' LEU . 3.4 mm -138.3 110.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.176 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.2 mt-10 -85.99 104.92 16.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.448 0.642 . . . . 0.0 111.67 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.852 ' CB ' HD22 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -130.67 108.18 9.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.287 177.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -48.08 -34.9 10.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -78.05 -35.38 49.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.852 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.63 131.37 34.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.432 -178.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 8.5 t -57.24 166.33 1.17 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.49 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 1.0 OUTLIER -57.22 -34.92 69.06 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.295 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.0 t -125.96 58.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.949 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.821 ' CD2' HG23 ' A' ' 680' ' ' ILE . 13.9 t60 -49.89 -49.43 49.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.02 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 13.2 p -164.17 161.53 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 111.589 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.9 p90 -143.53 147.85 35.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.589 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.93 130.68 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -122.54 134.17 54.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.773 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 647' ' ' ILE . 5.2 ttmt -98.19 136.44 38.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.204 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.81 159.01 41.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.894 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 643' ' ' GLY . 3.7 tpt85 -76.59 112.15 12.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.3 t60 -76.49 133.21 39.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.243 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -147.81 119.11 7.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.134 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.38 179.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -127.26 54.73 0.76 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.553 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 97.95 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.7 p -146.76 54.82 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 25.4 mtm -60.57 117.64 5.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.754 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.97 -69.51 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.796 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.66 144.24 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.5 m -111.54 98.41 40.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.18 -154.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.883 2.389 . . . . 0.0 112.096 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.883 ' HB1' HD13 ' A' ' 644' ' ' LEU . . . -86.17 68.9 10.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.48 23.65 11.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 629' ' ' ARG . . . -154.96 27.16 0.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.736 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.883 HD13 ' HB1' ' A' ' 641' ' ' ALA . 3.5 mp -111.78 -162.43 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 m-20 -108.08 147.06 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 112.412 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.4 OUTLIER -124.75 159.53 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.518 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.877 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 5.3 pt -111.49 122.37 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.451 0.643 . . . . 0.0 112.249 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 66.7 m95 -108.85 136.19 48.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.085 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.674 ' CE1' HD12 ' A' ' 678' ' ' ILE . 22.7 t80 -94.08 117.77 30.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.27 124.91 49.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 72.0 t60 -101.94 134.38 45.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.148 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.0 p -133.55 4.01 3.61 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.982 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.35 137.69 18.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.394 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 654' ' ' THR . 45.0 m -70.37 -11.94 61.25 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.755 -0.262 . . . . 0.0 111.393 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.612 ' O ' HG13 ' A' ' 656' ' ' VAL . 4.6 m-20 -87.39 3.46 46.95 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.56 128.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.283 0.564 . . . . 0.0 112.117 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.468 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 30.5 m -101.47 166.02 10.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.406 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.9 m-85 -130.68 120.19 23.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.333 . . . . 0.0 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.03 99.91 10.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 659' ' ' LEU . 20.4 t-20 60.4 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.924 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -134.17 1.0 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.73 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 8.4 m120 -104.69 132.92 50.36 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 111.077 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.9 139.96 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 41.1 mmm -118.26 97.43 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.446 HG13 HG23 ' A' ' 668' ' ' THR . 49.3 pt -87.85 154.49 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.73 104.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 111.478 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.08 38.59 2.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.446 HG23 HG13 ' A' ' 665' ' ' ILE . 1.1 p -116.26 162.29 17.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.546 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.494 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -137.53 139.52 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -147.4 145.78 29.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.829 0.347 . . . . 0.0 111.779 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.65 137.83 55.89 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -110.54 99.39 8.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 0.0 111.614 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 17.4 mp0 -80.45 147.32 30.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.473 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.657 ' HB3' HD12 ' A' ' 696' ' ' ILE . 13.5 p30 -48.17 112.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.305 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 94.53 36.0 5.76 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.3 117.15 28.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.891 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 109.54 21.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.725 HG22 HD13 ' A' ' 659' ' ' LEU . 21.6 pt -105.31 130.44 56.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 112.066 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.43 116.63 29.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.446 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.821 HG23 ' CD2' ' A' ' 622' ' ' HIS . 9.0 mt -89.87 -34.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.295 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.93 131.53 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.803 -179.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -136.96 127.54 26.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.07 116.84 28.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 110.325 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -67.36 -46.91 71.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -83.49 -40.49 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.84 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.4 -16.55 45.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.582 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.9 mttt 64.67 14.32 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.679 0.276 . . . . 0.0 110.91 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -78.36 105.23 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -124.88 128.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.912 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 681' ' ' ILE . 0.5 OUTLIER -128.58 119.77 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.737 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -151.33 139.9 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.314 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.18 149.03 36.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.786 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.416 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -102.01 117.22 34.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.485 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.07 123.11 30.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.693 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.8 mt-10 -130.32 109.39 10.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 0.0 110.731 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 674' ' ' ASP . 11.2 mt -83.67 109.83 17.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.714 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -96.11 -46.51 6.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.946 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.35 140.31 46.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.54 101.44 9.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 700' ' ' THR . 8.0 t -69.23 61.47 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.28 45.95 81.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.806 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -106.49 151.19 25.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.579 0.228 . . . . 0.0 110.769 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -45.22 128.71 7.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.47 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.761 HD22 HD23 ' A' ' 707' ' ' LEU . 4.8 t-20 43.33 -79.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.49 . . . . 0.0 111.031 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.681 ' N ' ' O ' ' A' ' 703' ' ' PHE . 13.3 pt-20 164.77 -48.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 159.04 73.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.997 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.761 HD23 HD22 ' A' ' 704' ' ' ASN . 1.0 OUTLIER -107.16 -3.02 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.225 -0.574 . . . . 0.0 111.793 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.432 ' N ' ' CG ' ' A' ' 673' ' ' GLN . . . 58.36 77.5 0.17 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.465 ' HE1' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -136.55 132.05 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.182 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 709' ' ' MET . 1.4 pt? 178.02 -174.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.81 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 5.9 mt-10 -97.63 134.45 40.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.86 100.14 10.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.956 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.411 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 2.9 mmm-85 40.37 86.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.905 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.41 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 4.0 m -124.75 142.44 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 716' ' ' VAL . 13.9 p -93.3 125.04 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -94.74 172.29 8.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -102.48 157.88 16.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.6 156.41 18.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -126.1 -177.03 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.27 38.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.02 -50.93 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.549 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -65.44 -46.03 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -55.5 -32.95 63.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.55 -36.87 79.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 18.4 mt -59.08 -44.85 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.3 p -81.41 -16.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -32.66 74.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.74 -7.93 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.199 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 730' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.874 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.331 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.99 109.77 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.39 139.1 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.53 151.69 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.611 HD11 HG12 ' A' ' 681' ' ' ILE . 59.1 mt -147.46 144.13 28.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -95.5 -21.77 18.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 130.69 -37.28 2.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.501 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.5 tmm_? -112.95 143.85 43.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.625 0.25 . . . . 0.0 111.031 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.35 -62.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.076 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.38 142.34 36.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 12.5 m -123.62 114.47 20.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.559 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.686 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.5 OUTLIER -103.89 108.21 19.43 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.26 100.65 52.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.6 Cg_exo -46.98 99.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.879 1.72 . . . . 0.0 109.722 176.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.33 84.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -176.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.68 -25.32 11.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.642 2.894 . . . . 0.0 112.612 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 583' ' ' LEU . 22.5 m-20 -62.01 -28.03 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 7.5 t -95.38 154.1 17.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.645 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.494 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -56.2 -12.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.074 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 613' ' ' ILE . 19.0 mt -108.92 123.33 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 111.783 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.24 54.75 0.65 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.163 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.603 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.2 mm-40 -124.36 171.39 9.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.094 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.74 129.59 47.34 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.011 0.434 . . . . 0.0 111.262 179.019 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.35 140.77 46.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -124.24 116.87 23.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.73 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.76 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -80.51 108.96 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.178 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -64.57 120.48 12.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.085 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.62 -28.13 1.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 110.823 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.4 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -21.25 79.7 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.867 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 52.9 t -101.0 118.07 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 118.015 0.908 . . . . 0.0 111.854 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.22 121.99 9.62 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.766 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.7 159.78 35.53 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 124.465 -1.056 . . . . 0.0 111.599 -0.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.651 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.0 t80 -91.37 115.87 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.88 ' CG ' HD12 ' A' ' 730' ' ' LEU . 33.5 m-85 -92.26 138.11 31.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.891 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.718 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mp -127.27 146.05 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.553 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.03 -175.37 40.94 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.543 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.5 ttp85 -77.51 -6.79 54.83 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.741 -0.229 . . . . 0.0 111.456 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.0 129.36 45.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.847 0.355 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.37 -23.54 24.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -29.76 61.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.602 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 730' ' ' LEU . 8.9 m -74.73 134.43 41.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.765 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m-80 -49.07 -26.79 2.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.702 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 46.7 t -112.85 142.87 45.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.532 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 115.05 23.9 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 588' ' ' ILE . 28.5 mm -137.96 109.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.026 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.6 tt0 -89.01 103.85 16.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.798 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.803 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.7 OUTLIER -131.79 113.43 13.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.252 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -43.03 -35.67 1.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.771 0.319 . . . . 0.0 111.514 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.782 ' HG2' HD21 ' P' ' 831' ' ' LEU . 2.1 mpp_? -77.95 -36.31 49.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.112 HD12 HD12 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -61.58 159.8 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.2 m -109.16 170.13 8.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -49.14 -45.48 43.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.27 0.557 . . . . 0.0 110.201 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.769 HG11 HG23 ' A' ' 727' ' ' VAL . 13.4 t -124.89 57.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.464 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.64 ' CE1' HD11 ' A' ' 681' ' ' ILE . 27.7 t60 -43.85 -47.48 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.747 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.9 p -166.76 156.34 11.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.445 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 603' ' ' ILE . 29.6 p90 -143.18 147.45 34.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.415 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.7 mp -102.19 130.24 52.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.114 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.3 t80 -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 23.0 ttmt -97.71 136.78 37.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.536 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.68 159.72 39.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.445 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.624 ' HE ' ' HB2' ' A' ' 631' ' ' ALA . 0.9 OUTLIER -75.82 115.95 16.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.9 t60 -82.42 126.0 31.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.75 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.624 ' HB2' ' HE ' ' A' ' 629' ' ' ARG . . . -164.48 122.54 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.172 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.5 m -70.06 -178.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.07 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -65.51 -61.02 6.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -132.87 -173.52 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.375 . . . . 0.0 110.964 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.94 52.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.1 ttm -99.6 31.56 3.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -165.26 -50.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 43.4 mt-10 -90.29 144.75 25.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.626 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 17.4 t -107.07 92.36 7.67 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 76.4 Cg_endo -85.55 -160.07 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.778 2.318 . . . . 0.0 111.965 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.741 ' HB3' ' HB2' ' A' ' 703' ' ' PHE . . . -95.3 26.71 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.257 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 60.86 -169.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -86.27 91.13 1.7 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.733 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.3 -153.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.711 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.9 m-20 -122.4 146.57 47.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.308 0.575 . . . . 0.0 112.471 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -126.74 160.14 31.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.076 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -108.94 123.89 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.442 0.639 . . . . 0.0 112.463 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.85 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 90.0 m95 -106.19 125.68 51.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -90.63 117.53 29.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -102.53 139.24 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.236 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.498 ' CG ' ' OG ' ' A' ' 657' ' ' SER . 46.7 t60 -125.68 121.56 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.571 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.47 5.69 13.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.747 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.03 137.33 20.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.799 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 654' ' ' THR . 95.6 m -72.64 -10.61 60.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.411 ' OD1' ' HG ' ' P' ' 831' ' ' LEU . 63.8 m-20 -87.26 2.06 51.26 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 664' ' ' MET . 11.6 t 64.31 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.524 . . . . 0.0 112.076 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.498 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 5.3 p -120.76 160.72 22.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 4.8 m-85 -137.48 120.07 16.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.278 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.625 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.46 105.19 17.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.01 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.44 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.579 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -134.99 0.42 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.698 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.455 ' HB3' HG23 ' A' ' 716' ' ' VAL . 7.5 m120 -97.77 141.21 31.05 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.912 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.0 ttp180 -88.94 139.08 30.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -135.83 110.97 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.205 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.456 ' HA ' HG13 ' A' ' 656' ' ' VAL . 18.8 pt -89.78 162.98 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.947 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -46.78 115.56 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.576 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.81 8.45 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.97 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.3 p -112.76 161.74 16.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 111.583 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -135.6 149.18 49.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD1' HD23 ' A' ' 659' ' ' LEU . 2.8 t80 -147.75 146.09 29.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.85 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.74 132.4 46.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.283 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.799 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.44 111.82 23.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.311 0.577 . . . . 0.0 111.421 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.514 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.8 mt-30 -104.83 136.01 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.559 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.609 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.3 t70 -37.0 118.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 111.022 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 89.26 36.52 7.52 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.85 118.13 31.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 693' ' ' LYS . 21.8 mt-10 -96.0 109.08 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 649' ' ' TYR . 4.6 mt -105.65 130.03 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 112.004 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.63 116.15 27.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.418 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.495 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -83.8 -37.28 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.112 HD12 HD12 ' A' ' 618' ' ' LEU . 54.1 mt -154.92 131.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -136.49 127.17 27.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.74 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.655 ' CG ' HD22 ' P' ' 831' ' ' LEU . 0.8 OUTLIER -121.87 116.76 24.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.374 179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -67.23 -46.8 72.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.798 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -83.17 -40.47 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.835 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.61 -14.5 59.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.443 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 64.94 14.07 9.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.634 0.254 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -78.4 104.46 9.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.87 123.64 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.069 0.461 . . . . 0.0 111.74 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 587' ' ' ILE . 38.9 mm -125.4 153.11 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 175.84 128.61 1.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.121 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 592' ' ' LEU . 8.5 m-30 -112.82 144.49 42.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.268 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.58 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tttp -101.11 117.33 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.574 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 578' ' ' LEU . 2.8 t -79.51 125.25 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -133.16 109.23 9.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 705' ' ' GLU . 50.1 mt -79.67 105.77 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.665 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -86.83 -43.96 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.15 141.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -113.62 100.09 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.404 0.621 . . . . 0.0 109.899 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 28.7 m -80.93 65.57 6.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 71.3 46.56 41.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.923 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -87.84 131.77 34.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.741 ' HB2' ' HB3' ' A' ' 641' ' ' ALA . 5.6 p90 -41.8 -34.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.457 0.646 . . . . 0.0 110.266 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.766 HD22 HD23 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -146.64 -61.09 0.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.392 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.813 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.6 pt-20 144.97 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.949 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 73.54 70.47 1.23 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.868 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.766 HD23 HD22 ' A' ' 704' ' ' ASN . 0.6 OUTLIER -106.5 -9.65 16.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.393 -0.474 . . . . 0.0 111.033 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 105.54 -120.8 6.58 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.924 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.622 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.3 OUTLIER 61.23 120.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 111.255 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 709' ' ' MET . 0.8 OUTLIER 178.25 164.24 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.66 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -55.72 -68.14 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -70.91 140.58 51.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.2 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -82.02 100.01 9.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.409 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 10.3 mmm-85 40.26 84.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.676 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.54 142.96 39.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.66 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.912 HG21 ' O ' ' A' ' 663' ' ' ARG . 39.6 t -77.88 122.27 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.69 161.58 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 136.77 42.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.612 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -87.31 150.16 24.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 p -110.54 -174.65 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -30.31 43.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -50.23 74.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -45.17 76.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.352 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.519 ' O ' HG12 ' A' ' 727' ' ' VAL . 44.9 tttp -57.68 -32.93 67.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.598 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -66.73 -36.82 83.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.595 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.68 -44.25 85.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.769 HG23 HG11 ' A' ' 621' ' ' VAL . 10.8 p -76.16 -14.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.81 -39.4 76.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.564 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -93.79 11.24 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.88 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.659 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -138.24 132.23 31.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 42.1 mt 65.44 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.98 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 0.0 OUTLIER -179.98 79.84 0.01 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.412 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.782 HD21 ' HG2' ' A' ' 617' ' ' ARG . 14.5 mt -71.03 132.98 45.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.724 0.297 . . . . 0.0 110.699 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.946 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -83.94 -22.15 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.691 0.281 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 141.29 -42.4 1.17 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.513 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 8.4 ttm105 -113.61 143.39 44.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.26 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.794 ' CZ ' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -118.51 -57.89 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.331 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.809 HD11 ' CG1' ' A' ' 694' ' ' VAL . 5.1 tp -113.09 142.08 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.4 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 2.8 m -120.04 114.76 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.904 HD21 HG23 ' A' ' 694' ' ' VAL . 5.8 mt -102.0 108.36 19.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 27.4 mtmt -114.16 99.27 50.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 34.7 Cg_exo -47.81 98.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.655 1.57 . . . . 0.0 109.463 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.822 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.36 158.1 84.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.79 -26.53 13.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.427 2.752 . . . . 0.0 112.573 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.822 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.8 m-20 -62.76 -28.12 69.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 93.2 p -95.69 153.21 17.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.839 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.719 ' CG2' HD13 ' A' ' 690' ' ' ILE . 7.9 tt -53.15 -15.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.322 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.613 HG13 HG23 ' A' ' 587' ' ' ILE . 71.2 mt -109.03 131.7 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.936 0.398 . . . . 0.0 111.795 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.93 54.62 0.86 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.254 0.549 . . . . 0.0 110.65 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.656 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.6 mt-10 -124.11 172.07 9.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.683 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.69 128.39 45.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.177 0.513 . . . . 0.0 111.221 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.41 139.74 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.788 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.04 113.22 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.544 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 625' ' ' ILE . 76.4 mt -77.29 109.21 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -67.34 118.13 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.022 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -27.93 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.822 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -70.85 -20.63 77.75 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.186 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.568 HG11 ' ND2' ' A' ' 610' ' ' ASN . 41.2 t -100.68 118.32 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 117.552 0.676 . . . . 0.0 111.618 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.4 t30 -139.9 121.8 9.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.5 Cg_endo -89.48 160.49 36.96 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.535 -1.027 . . . . 0.0 111.492 -0.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.677 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.09 115.42 28.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.745 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.0 m-85 -91.98 137.52 32.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.027 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.771 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -124.84 144.83 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.39 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.41 -173.7 38.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.298 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -68.11 -46.8 69.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.853 0.359 . . . . 0.0 111.431 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.72 129.23 40.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.37 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -58.06 -18.36 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.762 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.63 -30.64 67.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 110.249 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.568 ' SG ' HG22 ' A' ' 621' ' ' VAL . 94.8 m -69.95 131.55 44.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.598 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -43.99 -32.43 1.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.322 0.582 . . . . 0.0 110.453 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.771 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.46 142.17 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.196 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.503 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -111.3 105.0 13.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 38.3 mm -139.26 109.5 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.467 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.36 106.23 16.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 112.256 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.587 ' H ' HD11 ' A' ' 618' ' ' LEU . 4.7 t0 -129.88 107.69 9.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.571 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -39.44 -28.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 9.2 mmt180 -70.82 -41.77 71.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.587 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -89.3 158.74 17.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.6 m -76.71 164.61 25.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.41 -27.07 14.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.568 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.2 t -131.01 62.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' HG23 ' A' ' 680' ' ' ILE . 26.1 t60 -50.03 -48.66 52.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.211 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.84 162.22 26.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.5 p90 -143.61 148.39 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 594' ' ' ILE . 81.5 mt -102.12 124.3 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.046 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -113.87 133.55 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.73 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 28.6 ttmt -97.88 136.52 38.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.69 158.59 44.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.827 -178.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.13 115.97 17.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 -61.06 131.36 50.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.418 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.511 ' C ' HG13 ' A' ' 632' ' ' VAL . . . -60.27 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.889 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 631' ' ' ALA . 0.9 OUTLIER 58.77 125.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 111.394 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -139.57 -87.54 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -62.79 116.18 5.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.11 162.68 27.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.769 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 115.55 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 50.2 t80 63.06 -80.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.54 126.24 30.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.85 0.357 . . . . 0.0 110.714 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.4 p -99.6 107.83 47.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.62 -149.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.542 2.161 . . . . 0.0 112.055 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 644' ' ' LEU . . . -47.89 -25.08 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 64.26 -176.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.033 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -90.32 72.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.104 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.4 mp -115.75 -157.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.748 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.3 m-20 -117.56 146.72 43.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.08 0.467 . . . . 0.0 111.96 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -133.03 157.16 45.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.781 ' CD1' HD13 ' A' ' 578' ' ' LEU . 1.1 pt -106.8 119.23 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.543 0.687 . . . . 0.0 111.769 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.882 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.9 m95 -100.61 132.13 46.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.476 ' CB ' HD21 ' A' ' 672' ' ' LEU . 31.2 t80 -90.36 117.24 28.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -103.5 121.67 43.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.559 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.419 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 28.9 t60 -102.23 128.74 48.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 7.4 p -125.11 2.43 7.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.423 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.05 150.21 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.108 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 72.3 m -82.21 -18.97 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 111.518 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 656' ' ' VAL . 15.0 m-20 -82.56 3.35 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.79 137.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.644 0.735 . . . . 0.0 112.238 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 58.2 m -107.93 165.91 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.423 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 120.59 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.72 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.65 100.34 9.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.846 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.9 m120 60.76 -82.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.87 6.19 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.652 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -110.27 138.45 46.64 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -74.74 138.34 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.472 ' O ' HG23 ' A' ' 656' ' ' VAL . 45.7 mmm -117.68 88.01 2.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.579 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 668' ' ' THR . 48.5 pt -86.91 164.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 22.6 tt0 -54.92 105.53 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.34 40.52 2.39 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.409 HG21 HG12 ' A' ' 665' ' ' ILE . 2.6 p -124.45 162.39 24.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 6.3 ttpm? -138.07 144.93 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.491 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.64 145.09 28.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.8 0.334 . . . . 0.0 111.758 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.882 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.7 136.61 53.16 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.579 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -107.1 112.84 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.541 . . . . 0.0 111.869 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 25.5 mt-30 -104.13 137.95 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.894 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.695 ' HB2' HD12 ' A' ' 696' ' ' ILE . 39.7 t0 -39.11 123.11 1.31 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.936 0.398 . . . . 0.0 111.152 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 88.91 40.6 6.17 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.432 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 1.6 t0 -93.51 113.18 25.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.979 0.418 . . . . 0.0 111.434 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.34 111.38 23.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.865 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.72 HG12 HD13 ' A' ' 659' ' ' LEU . 9.2 mt -112.41 137.16 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 689' ' ' VAL . 8.3 tptt -98.19 115.7 28.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.7 mt -82.8 -38.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.573 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 618' ' ' LEU . 6.7 mt -155.83 131.72 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.019 0.438 . . . . 0.0 111.873 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.24 124.75 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.669 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.18 117.88 29.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.642 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -66.36 -46.52 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.591 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -83.28 -40.36 19.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.351 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.06 -17.94 56.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.69 16.09 9.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.75 105.2 13.58 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 587' ' ' ILE . 1.1 p -122.83 124.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.267 0.555 . . . . 0.0 112.147 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 587' ' ' ILE . 6.6 mm -114.29 150.17 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.553 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.71 121.48 0.87 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.641 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 580' ' ' LEU . 6.9 m-30 -113.78 143.18 45.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.746 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.5 tttt -101.78 117.81 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.904 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.69 123.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -133.67 108.99 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.287 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 674' ' ' ASP . 87.0 mt -72.93 105.76 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.76 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.75 -47.57 10.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.139 0.495 . . . . 0.0 109.949 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -111.49 141.91 44.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.6 p -113.63 100.09 8.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.141 0.496 . . . . 0.0 109.875 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -80.31 61.51 4.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.696 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.3 54.81 34.16 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.109 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.794 HD11 ' CZ ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -87.28 148.38 25.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.392 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.72 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -39.76 -32.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.989 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.454 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -178.95 33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.502 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER 69.28 -64.08 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 153.96 69.26 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -104.37 -9.52 18.42 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.794 -0.239 . . . . 0.0 111.446 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 103.46 60.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.263 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.81 136.12 6.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -161.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.082 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 78.46 -60.69 0.39 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.746 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.68 115.62 29.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.618 ' O ' HG13 ' A' ' 715' ' ' VAL . 1.2 mt-30 -82.69 100.05 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 713' ' ' GLN . 1.1 mmm-85 16.02 82.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.869 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 713' ' ' GLN . 5.8 m -123.98 141.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.181 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.6 p -90.29 122.43 41.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.484 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.5 172.26 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -103.16 142.22 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -88.98 160.13 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.905 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.14 -173.49 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.74 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.81 -49.19 77.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.467 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.5 mp0 -69.18 -49.84 53.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.574 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 727' ' ' VAL . 24.7 mtmt -57.26 -32.81 66.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.735 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 6.9 mt -57.81 -44.24 86.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.8 p -75.86 -24.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.27 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -57.26 -41.14 79.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -74.1 -15.4 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.274 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.745 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.9 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.04 175.73 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 16.1 pt -67.98 176.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.657 ' O ' HD23 ' P' ' 831' ' ' LEU . 31.7 p90 -175.55 143.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.657 HD23 ' O ' ' P' ' 830' ' ' TYR . 17.8 mt -131.96 151.76 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.919 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.666 -0.174 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -93.78 -22.33 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 111.12 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 152.66 -23.48 0.83 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.434 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 tmm_? -105.93 140.19 39.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -129.16 -61.15 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.585 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 6.4 tt -106.56 141.36 37.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.181 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.882 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.5 m -119.48 119.67 34.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.362 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.1 mt -104.79 108.29 19.69 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 98.68 44.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.8 Cg_exo -48.98 101.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.649 1.566 . . . . 0.0 109.15 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.02 158.26 85.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.456 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.94 -28.64 19.05 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.55 2.834 . . . . 0.0 112.594 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.48 -18.14 63.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 109.725 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.7 t -96.8 153.76 17.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.679 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.858 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.7 pt -55.62 -20.29 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.847 ' CD1' HG23 ' A' ' 613' ' ' ILE . 59.5 mt -110.27 118.66 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.382 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -106.74 57.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.394 0.616 . . . . 0.0 110.258 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.628 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -124.71 172.63 9.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.892 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.43 127.68 45.81 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.315 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.869 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.11 147.22 37.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.083 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 7.4 mt-10 -125.35 125.56 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.872 HD11 HD12 ' A' ' 625' ' ' ILE . 68.2 mt -86.1 109.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.9 mp0 -64.18 118.06 8.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.41 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.521 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.54 -29.79 1.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.583 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.27 -22.63 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.48 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 118.93 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.773 0.787 . . . . 0.0 111.726 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 17.1 t30 -139.56 121.82 10.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.781 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.9 Cg_endo -89.6 160.28 36.28 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.563 -1.015 . . . . 0.0 111.691 -0.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.9 t80 -91.52 116.19 28.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.744 ' CG ' HD12 ' A' ' 730' ' ' LEU . 25.4 m-85 -92.36 137.94 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.15 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.74 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.47 145.89 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.423 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.42 -176.28 41.66 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.481 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -78.52 -7.28 57.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.78 133.25 43.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -23.71 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 730' ' ' LEU . 6.8 p30 -57.83 -25.4 60.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 55.2 m -78.75 132.06 36.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.4 m120 -46.1 -31.35 2.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.198 0.523 . . . . 0.0 110.413 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.869 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.5 t -108.53 142.76 38.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.6 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 115.59 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -138.02 109.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.284 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 19.2 tt0 -87.09 103.41 15.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.6 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -132.11 112.81 12.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.44 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -42.98 -33.69 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.761 0.315 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.543 ' HB2' HD13 ' A' ' 681' ' ' ILE . 31.5 mmt180 -77.55 -39.98 44.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.071 HD12 HD12 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -60.21 159.11 10.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.905 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 70.7 m -111.09 168.81 9.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.537 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -43.64 24.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.228 0.537 . . . . 0.0 110.031 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.541 HG11 HG23 ' A' ' 727' ' ' VAL . 39.1 t -125.17 61.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.467 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.511 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 36.3 t60 -49.78 -48.3 50.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.791 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -167.52 157.32 10.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 111.363 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.2 p90 -143.14 147.37 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 580' ' ' LEU . 34.7 mt -102.13 128.33 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.086 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.612 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -119.78 131.3 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 20.2 ttmt -97.84 136.36 38.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.107 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.09 159.28 41.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.879 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.0 tpt180 -76.28 116.3 16.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.4 t60 -61.47 132.39 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.209 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -69.08 -165.61 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.941 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.9 p -156.39 159.61 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.42 . . . . 0.0 111.082 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -145.66 -139.44 3.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.432 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.69 135.46 57.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 25.1 p -129.16 49.28 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.989 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -62.42 102.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.11 -62.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.83 137.61 40.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.785 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 110.37 40.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 -162.94 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.391 2.06 . . . . 0.0 112.027 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.473 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -46.75 -28.55 1.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.563 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.4 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 175.73 60.32 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.671 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.8 mp -106.14 -159.71 0.71 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -118.27 146.77 44.05 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.44 160.41 29.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.782 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.65 121.98 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.46 0.647 . . . . 0.0 112.313 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.96 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -105.7 125.75 51.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.632 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -89.71 116.49 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 624' ' ' PHE . 16.3 m -102.95 137.13 41.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.403 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 41.4 t60 -116.87 122.97 45.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.787 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.35 7.92 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.272 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.78 145.18 19.94 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.832 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.4 m -75.29 -9.55 58.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.558 ' O ' HG13 ' A' ' 656' ' ' VAL . 36.2 m-20 -87.14 2.09 50.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.59 127.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.395 0.617 . . . . 0.0 112.158 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.403 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 16.2 p -97.73 165.55 11.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.208 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -128.52 119.7 25.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -95.22 102.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 63.42 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.11 -2.08 1.5 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.51 141.75 30.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.909 0.385 . . . . 0.0 111.222 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.1 ttp85 -85.16 141.61 30.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.5 mtp -131.11 124.74 31.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.522 HG12 HG21 ' A' ' 668' ' ' THR . 22.6 pt -95.08 156.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.779 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 652' ' ' THR . 32.9 tt0 -50.25 122.42 6.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 97.14 25.75 10.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.522 HG21 HG12 ' A' ' 665' ' ' ILE . 50.5 p -122.43 156.42 34.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.6 pttm -123.94 158.17 32.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.968 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.706 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.1 OUTLIER -147.29 145.92 29.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.96 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.88 130.53 43.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.624 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.743 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -110.44 114.87 28.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.11 0.481 . . . . 0.0 111.665 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.543 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 14.9 mt-30 -99.15 135.29 40.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.849 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.3 t70 -40.96 109.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.584 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 101.11 34.55 4.52 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.424 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -93.45 115.17 27.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.469 -0.365 . . . . 0.0 111.087 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -96.25 108.51 21.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.838 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.632 HG21 ' CE2' ' A' ' 649' ' ' TYR . 7.1 mt -106.51 136.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 115.72 28.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.222 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.573 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -82.12 -36.16 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.197 -178.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.071 HD12 HD12 ' A' ' 618' ' ' LEU . 41.4 mt -154.9 131.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -136.57 124.77 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.61 ' OD1' HD22 ' P' ' 831' ' ' LEU . 0.7 OUTLIER -124.57 117.23 23.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.481 179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -66.8 -46.56 74.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.808 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -77.83 -40.37 40.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.602 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.4 -13.73 51.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.543 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp 61.82 17.77 9.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.64 104.96 9.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 689' ' ' VAL . 2.3 p -117.54 121.83 68.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 111.695 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.5 mm -124.45 119.11 55.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.503 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -147.83 129.73 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 12.8 m-30 -113.18 142.82 45.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 110.255 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.592 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.27 116.91 33.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.332 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.88 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.73 123.97 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.73 110.22 11.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.0 110.868 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 705' ' ' GLU . 64.0 mt -81.46 105.64 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.788 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.08 -43.69 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.01 141.98 42.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -112.89 100.16 8.44 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.473 0.654 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 596' ' ' GLN . 0.6 OUTLIER -87.24 53.97 3.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.15 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 93.0 34.94 6.54 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.628 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -83.84 132.02 34.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.671 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.0 p90 -43.31 -33.32 0.97 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.515 0.674 . . . . 0.0 110.258 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.792 HD22 HD23 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -149.86 -55.8 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.124 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.81 ' O ' HD12 ' A' ' 696' ' ' ILE . 10.4 pt-20 141.36 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.886 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 67.24 74.17 0.59 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.257 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.792 HD23 HD22 ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.24 -10.04 17.31 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 122.413 -0.463 . . . . 0.0 112.071 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 52.12 90.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.202 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.1 ptp -42.0 134.25 2.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.442 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 63.99 -168.41 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -96.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.641 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -114.84 97.95 6.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.864 0.364 . . . . 0.0 110.618 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.61 100.54 7.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.706 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 166.69 131.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.245 0.545 . . . . 0.0 110.194 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.0 158.06 27.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.486 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 663' ' ' ARG . 51.9 t -77.42 128.45 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.462 . . . . 0.0 111.4 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.403 ' H ' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -113.74 164.65 13.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.348 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.52 142.95 27.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.95 158.66 36.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.0 p -118.91 -178.41 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.978 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.59 -29.06 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.98 -49.96 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -50.71 67.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.72 -32.89 63.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.36 -36.88 84.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.07 -44.2 94.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.541 HG23 HG11 ' A' ' 621' ' ' VAL . 11.2 p -79.15 -29.26 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.87 -30.61 61.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -85.51 -24.06 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.744 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.7 tt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.731 0.3 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.26 -179.08 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 12.6 pt -112.02 71.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.807 ' O ' HD23 ' P' ' 831' ' ' LEU . 1.3 p90 -171.56 141.26 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.807 HD23 ' O ' ' P' ' 830' ' ' TYR . 12.8 mt -137.14 138.7 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.851 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.6 -10.67 26.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.581 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 147.66 -49.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.215 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.406 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 22.9 ttp-105 -111.82 143.11 43.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.052 0.453 . . . . 0.0 111.524 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.505 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.69 -57.81 1.43 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.09 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -110.26 137.93 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.084 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.739 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.4 m -118.55 114.18 22.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.678 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -103.92 108.06 19.22 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 16.3 ptpt -117.09 100.54 53.29 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.5 Cg_exo -46.08 104.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.87 1.714 . . . . 0.0 109.62 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.12 160.29 81.95 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.547 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 5.6 Cg_endo -48.17 -31.18 16.09 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.587 2.858 . . . . 0.0 112.495 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -63.73 -16.1 60.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.156 0.503 . . . . 0.0 109.726 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 9.1 t -94.18 145.0 25.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.601 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 3.5 pt -52.43 -24.26 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 110.178 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.647 HG21 HD12 ' A' ' 613' ' ' ILE . 7.3 tt -112.99 118.97 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.983 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.547 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -100.69 71.16 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.331 0.586 . . . . 0.0 110.321 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 50.6 mt-10 -126.05 171.9 10.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.127 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.21 130.2 47.61 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 121.138 0.494 . . . . 0.0 110.962 178.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.757 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.44 140.03 47.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.936 179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.449 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 1.5 mp0 -124.12 112.56 17.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 578' ' ' LEU . 89.7 mt -81.09 108.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 110.03 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.5 mp0 -66.87 123.63 20.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.118 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.73 -26.71 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 110.819 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -75.68 -20.39 78.28 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.041 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 44.3 t -99.45 118.02 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.993 0.897 . . . . 0.0 111.776 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.0 t30 -140.23 122.49 9.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.583 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.5 Cg_endo -90.36 160.15 32.45 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.679 -0.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.1 t80 -92.58 117.48 30.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 730' ' ' LEU . 19.4 m-85 -92.51 137.48 32.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.262 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.3 mp -121.93 143.61 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.585 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 167.33 -165.09 38.39 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.949 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.21 -17.27 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.131 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -80.28 131.53 35.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.824 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.5 -23.85 11.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.001 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -59.84 -27.04 66.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 9.7 m -76.0 129.36 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -46.57 -32.47 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.231 0.539 . . . . 0.0 110.225 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 603' ' ' ILE . 13.2 t -107.47 135.24 49.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.315 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.98 111.94 22.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 588' ' ' ILE . 17.5 mm -137.78 110.14 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.974 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -81.57 102.85 10.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.066 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.816 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.8 OUTLIER -132.84 109.13 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.42 178.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -44.58 -52.88 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.989 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -60.64 -19.76 58.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.897 0.379 . . . . 0.0 110.928 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.008 HD12 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -76.2 160.66 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.575 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.456 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 19.6 t -111.22 151.96 27.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.411 ' CA ' ' HB2' ' A' ' 606' ' ' SER . 7.7 mpt_? -39.0 -38.6 0.46 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 110.675 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.539 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.9 t -128.67 60.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.418 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 21.7 t60 -50.4 -48.81 55.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.077 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.553 ' SG ' HG21 ' A' ' 680' ' ' ILE . 22.8 p -165.64 161.11 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.688 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.6 p90 -143.83 144.95 32.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.629 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.649 HD13 HD11 ' A' ' 580' ' ' LEU . 2.4 mp -101.97 128.87 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.1 t80 -119.43 134.04 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 6.7 ttpt -97.86 136.47 38.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.223 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.2 OUTLIER -135.21 159.88 40.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.473 -178.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.551 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 3.0 tpt85 -75.72 112.46 12.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.378 0.609 . . . . 0.0 110.371 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.8 t60 -69.6 126.5 29.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.049 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.551 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -122.81 158.58 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.142 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.775 HG11 ' HB2' ' A' ' 640' ' ' PRO . 10.4 m -118.69 148.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.171 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.01 76.32 2.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.7 mttm 63.27 144.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.343 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 88.4 p -124.1 179.37 4.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.001 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 6.0 ptp -170.79 118.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.26 -66.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 15.2 mp0 -79.33 144.41 34.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.509 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.39 105.48 29.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.132 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.775 ' HB2' HG11 ' A' ' 632' ' ' VAL . 8.4 Cg_exo -71.73 -155.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.742 2.295 . . . . 0.0 112.0 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 703' ' ' PHE . . . -56.72 -22.27 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 72.04 -78.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 629' ' ' ARG . . . -176.34 65.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.338 -0.935 . . . . 0.0 113.179 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.2 mp -107.05 -161.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.828 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -115.63 146.85 41.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.237 0.541 . . . . 0.0 112.39 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.6 m-20 -129.95 160.55 33.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.798 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.54 125.61 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.494 0.664 . . . . 0.0 112.461 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.968 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.5 m95 -108.93 128.05 54.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.607 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.441 ' OH ' HG22 ' A' ' 680' ' ' ILE . 35.1 t80 -90.47 119.4 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.642 0.258 . . . . 0.0 110.325 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 28.2 m -107.59 128.38 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.215 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.407 ' HA ' ' CB ' ' A' ' 623' ' ' CYS . 20.5 t60 -108.81 125.3 51.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -118.62 4.41 11.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.613 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.01 150.54 26.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.152 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 654' ' ' THR . 76.1 m -82.4 -10.97 58.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.553 0.216 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -84.65 2.89 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 50.67 139.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.64 0.733 . . . . 0.0 112.353 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 10.1 t -112.67 166.16 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.55 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -130.57 120.2 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.016 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.677 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -102.63 103.25 13.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.438 ' N ' HD12 ' A' ' 659' ' ' LEU . 29.6 t-20 62.53 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.784 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.7 m-80 -139.89 -2.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.43 141.67 32.96 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.943 0.401 . . . . 0.0 111.406 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.618 ' O ' HG21 ' A' ' 716' ' ' VAL . 20.7 ttm180 -75.29 141.51 43.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.057 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.53 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.1 mmm -125.68 89.3 3.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.499 HG12 HG21 ' A' ' 668' ' ' THR . 30.0 pt -86.81 164.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.996 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -50.65 117.77 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.454 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.22 30.26 9.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.789 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.499 HG21 HG12 ' A' ' 665' ' ' ILE . 23.8 p -114.01 162.18 16.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.5 ttpt -134.93 149.43 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.483 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 716' ' ' VAL . 0.7 OUTLIER -147.62 143.83 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.968 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -75.89 129.76 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.682 ' N ' HD12 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -99.87 143.79 29.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.329 0.585 . . . . 0.0 111.938 -179.426 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.55 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 1.2 mt-30 -130.34 136.17 48.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 696' ' ' ILE . 15.0 t70 -40.27 118.55 0.93 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.55 37.42 5.85 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -94.83 117.66 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.167 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.06 108.71 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.677 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -108.95 133.84 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -109.42 116.54 32.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.095 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.66 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 1.9 pt -89.51 -21.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.008 HD12 HD12 ' A' ' 618' ' ' LEU . 41.1 mt -154.27 130.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.579 . . . . 0.0 111.674 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -137.71 127.31 25.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.57 116.76 24.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.552 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -67.56 -47.62 69.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.708 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.1 -40.48 18.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.472 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -13.4 60.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.419 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.56 18.74 8.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.813 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.77 104.63 15.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -122.13 121.59 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.272 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.657 HD13 ' CG ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -128.44 128.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.95 135.92 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.466 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -114.28 147.43 39.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.37 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.4 tttt -101.53 117.19 34.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.529 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 3.6 t -78.79 123.55 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.28 109.34 9.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 705' ' ' GLU . 42.9 mt -80.86 105.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.24 -43.67 10.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.115 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.199 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.3 p -112.73 100.22 8.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.576 0.703 . . . . 0.0 109.789 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.2 m -84.65 59.29 5.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 83.99 40.13 8.91 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.437 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -86.67 132.66 33.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.533 0.206 . . . . 0.0 110.619 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -42.92 -33.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.342 0.591 . . . . 0.0 110.606 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.794 HD22 HD23 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -148.39 -58.79 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.808 ' O ' HD12 ' A' ' 696' ' ' ILE . 5.9 pt-20 146.92 28.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.146 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 73.48 68.71 1.52 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.973 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.794 HD23 HD22 ' A' ' 704' ' ' ASN . 0.8 OUTLIER -105.67 -11.11 16.45 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.303 -0.527 . . . . 0.0 111.477 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.55 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 40.09 31.48 0.32 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.418 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 712' ' ' GLU . 0.0 OUTLIER 62.57 93.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.764 0.316 . . . . 0.0 111.261 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 710' ' ' LEU . 1.8 pp 29.51 66.88 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 46.81 70.47 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.732 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 709' ' ' MET . 3.6 tt0 -114.39 142.16 46.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -80.08 135.42 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.565 ' NE ' ' CE2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -100.3 -148.66 0.36 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.081 0.467 . . . . 0.0 110.716 -178.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.48 142.72 41.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.413 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.62 HG22 ' CE1' ' A' ' 670' ' ' PHE . 15.8 t -84.11 113.73 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.154 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -90.72 169.65 10.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.9 140.18 37.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.69 155.39 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 32.1 p -125.64 -176.16 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.86 -33.43 56.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -51.3 70.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.454 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -63.91 -48.12 77.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -58.27 -32.97 68.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -64.85 -37.01 86.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.2 mt -62.91 -44.1 97.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.539 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.4 p -75.76 -28.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -33.17 52.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -98.68 26.23 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.485 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.2 tt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.833 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.342 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.12 167.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' P' ' 830' ' ' TYR . 26.8 mt -111.24 133.89 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.214 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' P' ' 828' ' ' ILE . 0.1 OUTLIER 178.68 67.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.991 HD11 HG23 ' A' ' 681' ' ' ILE . 20.6 mt -76.55 83.16 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.865 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -21.09 37.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.689 0.28 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 145.41 -43.78 0.91 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 11.6 ttm180 -113.46 143.82 43.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.706 0.288 . . . . 0.0 111.521 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.883 ' CE2' HD13 ' A' ' 702' ' ' LEU . 2.3 t80 -119.97 -55.29 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.4 tp -113.34 142.43 45.87 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -122.51 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 625' ' ' ILE . 4.7 mp -106.27 108.86 20.59 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 100.93 51.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 46.2 Cg_exo -45.94 99.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.98 1.787 . . . . 0.0 110.006 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.2 85.11 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -48.84 -25.29 8.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.403 2.735 . . . . 0.0 112.921 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.858 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -61.83 -27.27 68.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.508 ' OG ' HD13 ' A' ' 690' ' ' ILE . 8.7 t -95.73 154.11 17.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.892 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.679 HD13 ' CE1' ' A' ' 688' ' ' PHE . 2.6 pt -57.11 -12.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.69 0.281 . . . . 0.0 110.962 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.646 ' CD1' HG23 ' A' ' 613' ' ' ILE . 71.2 mt -110.27 123.0 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.746 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.16 57.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.197 0.522 . . . . 0.0 110.028 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.3 mt-10 -124.62 171.75 9.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.226 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.02 130.1 50.49 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 178.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.748 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.28 139.45 47.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.037 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.17 112.99 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.659 0.266 . . . . 0.0 111.644 -179.354 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.011 HD11 HD12 ' A' ' 625' ' ' ILE . 38.0 mt -77.22 109.76 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.1 tp60 -67.71 114.66 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.76 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.19 -28.53 0.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.184 0.516 . . . . 0.0 110.809 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.427 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.83 -25.2 74.24 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.536 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.903 HG11 ' OD1' ' A' ' 610' ' ' ASN . 66.6 t -101.2 119.27 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 117.813 0.807 . . . . 0.0 111.61 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 18.5 t30 -139.07 122.91 11.09 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.786 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 47.3 Cg_endo -89.83 160.51 35.24 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 124.518 -1.034 . . . . 0.0 111.863 0.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.38 114.96 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.535 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.0 m-85 -92.12 138.19 31.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.168 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.1 145.77 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.83 -173.27 38.16 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.383 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.35 -53.48 29.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.656 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.6 129.82 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.292 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.39 -18.96 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -53.66 -30.02 41.25 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 30.4 m -73.55 134.45 43.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.903 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.3 m-80 -48.66 -27.36 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.973 0.415 . . . . 0.0 110.388 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.0 t -113.37 142.08 46.29 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -110.52 105.61 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.5 mm -138.52 109.91 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.161 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -103.69 106.7 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.489 0.662 . . . . 0.0 112.589 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.697 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.6 t0 -129.93 107.71 9.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.559 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -39.3 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.477 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.8 mmp_? -70.31 -41.42 73.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.623 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.12 158.72 18.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.85 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.2 t -78.26 172.37 13.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.418 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -50.27 -37.24 34.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 110.253 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.09 67.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.265 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.7 t60 -49.05 -48.36 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.811 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' A' ' 680' ' ' ILE . 2.6 p -159.99 158.77 31.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.676 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 603' ' ' ILE . 39.3 p90 -143.45 150.39 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.478 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.011 HD12 HD11 ' A' ' 594' ' ' ILE . 83.7 mt -102.53 132.42 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.215 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -124.97 132.92 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 36.2 ttmt -98.45 136.54 38.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.573 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.45 158.58 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -76.95 112.75 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.522 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.484 ' CE1' ' HE1' ' A' ' 709' ' ' MET . 3.7 t60 -78.03 131.47 37.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -133.12 161.45 34.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 640' ' ' PRO . 10.5 m -113.44 -179.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -95.81 -89.29 1.78 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -99.99 -174.93 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 110.829 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 45.9 p -176.51 110.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 34.3 mtt -101.35 108.18 19.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.7 t80 69.88 -63.99 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.55 143.59 42.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.581 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 7.4 m -104.43 104.47 45.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.579 ' HB2' HG11 ' A' ' 632' ' ' VAL . 32.5 Cg_exo -59.4 -150.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.606 2.204 . . . . 0.0 111.971 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.444 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -47.92 -26.11 1.59 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.78 0.324 . . . . 0.0 111.491 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 74.6 -77.68 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 174.95 80.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.843 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 701' ' ' GLY . 1.2 mp -115.74 -149.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.551 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 4.7 m-20 -118.21 149.37 41.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.282 0.563 . . . . 0.0 112.338 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.54 ' OD2' HD21 ' A' ' 671' ' ' LEU . 3.9 m-20 -134.03 129.32 35.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.734 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.779 HG21 ' CE1' ' A' ' 577' ' ' PHE . 7.0 pt -86.81 123.55 39.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.323 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.6 m95 -108.98 129.32 55.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.046 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.2 t80 -90.34 115.7 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 624' ' ' PHE . 60.8 m -101.63 141.88 33.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 111.473 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 664' ' ' MET . 24.8 t60 -124.13 131.64 53.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 9.3 p -124.24 2.63 8.52 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.37 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.84 142.48 24.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.037 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 654' ' ' THR . 28.3 m -75.55 -12.65 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.536 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.8 m120 -83.64 2.63 36.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.587 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.87 134.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.588 0.708 . . . . 0.0 112.281 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.403 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 43.5 p -105.49 165.89 10.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.355 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 20.2 m-85 -127.61 119.85 26.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 111.283 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.673 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.64 99.72 10.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.702 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.33 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.8 t-20 -133.48 3.76 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.833 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.705 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -110.15 130.26 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.955 0.407 . . . . 0.0 111.147 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.489 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -69.97 141.42 53.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.787 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.513 ' HG3' ' HB3' ' A' ' 651' ' ' HIS . 34.1 tpp -125.4 101.29 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.1 pt -87.94 165.61 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.77 109.82 0.89 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 110.958 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.41 34.72 3.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 716' ' ' VAL . 5.2 p -134.84 154.94 51.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.356 . . . . 0.0 111.591 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.2 pttm -128.23 156.08 43.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.617 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.52 145.77 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.501 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.38 134.57 51.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.481 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.873 HD13 HG21 ' A' ' 694' ' ' VAL . 3.3 mt -108.52 126.33 52.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.965 ' HB3' HD12 ' A' ' 707' ' ' LEU . 0.3 OUTLIER -113.36 154.21 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.714 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.48 ' N ' HD12 ' A' ' 696' ' ' ILE . 56.7 t0 -52.76 101.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.21 30.66 3.81 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 117.11 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.536 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -96.2 109.74 22.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.282 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.673 HG22 HD13 ' A' ' 659' ' ' LEU . 23.5 pt -105.94 130.48 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 5.2 mttp -94.5 116.13 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.711 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.588 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -79.3 -38.7 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.522 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.697 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -155.84 136.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -136.42 122.41 20.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -123.53 116.99 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.92 0.39 . . . . 0.0 110.583 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -67.27 -46.48 73.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.97 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -78.81 -40.49 32.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.793 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -83.08 -9.51 59.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 60.46 18.08 7.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.253 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.679 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -76.72 104.63 7.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.4 p -118.2 122.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.133 0.492 . . . . 0.0 111.746 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.588 HG21 ' CG2' ' A' ' 680' ' ' ILE . 22.5 mm -126.17 154.6 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.298 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.432 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 177.54 127.86 1.1 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.952 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 592' ' ' LEU . 11.1 m-30 -113.04 145.28 41.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.43 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.693 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.2 116.53 33.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.022 0.439 . . . . 0.0 110.256 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.873 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.58 127.19 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.754 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -134.28 108.4 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.924 179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 705' ' ' GLU . 11.5 mt -74.58 104.94 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.61 -50.84 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.899 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.6 t0 -112.47 138.36 49.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.211 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.09 100.06 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.55 HG21 ' HG3' ' A' ' 596' ' ' GLN . 64.1 p -70.27 78.84 0.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.336 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 53.42 39.75 60.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.388 -0.91 . . . . 0.0 110.829 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.883 HD13 ' CE2' ' A' ' 577' ' ' PHE . 1.5 tt -97.08 143.65 27.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.867 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.663 ' CB ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.25 112.66 1.62 Allowed 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.43 ' CG ' ' HG2' ' A' ' 705' ' ' GLU . 10.9 t-20 59.73 -68.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.147 0.499 . . . . 0.0 109.932 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.682 ' HB2' HD13 ' A' ' 696' ' ' ILE . 11.7 pt-20 171.39 -32.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.989 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.91 45.76 0.04 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.408 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.965 HD12 ' HB3' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -82.76 0.94 41.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.41 82.97 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.088 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.503 ' O ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -118.24 125.27 49.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.914 0.388 . . . . 0.0 111.021 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 709' ' ' MET . 0.1 OUTLIER -177.81 -175.76 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.721 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -48.57 -34.48 11.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.172 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -85.63 134.04 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -97.03 100.02 11.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.004 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 34.8 79.02 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.69 142.49 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.705 HG23 ' OD1' ' A' ' 662' ' ' ASN . 70.8 t -79.3 130.16 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.415 HD13 ' HE2' ' A' ' 669' ' ' LYS . 1.4 mp -99.42 170.65 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -98.32 155.76 17.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -96.39 158.54 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.3 p -126.04 -176.58 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.197 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.42 46.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.14 -47.81 84.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.37 -50.42 63.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.663 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -55.7 -32.87 63.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -37.31 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.786 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -44.34 93.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -78.41 -21.49 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -37.75 81.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.6 -9.67 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.399 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.99 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -107.03 179.65 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.455 ' O ' HD12 ' P' ' 828' ' ' ILE . 2.6 pp -131.0 36.0 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.492 ' O ' HD23 ' P' ' 831' ' ' LEU . 2.1 p90 -175.95 166.99 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 681' ' ' ILE . 56.9 mt -148.75 37.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.848 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -77.97 -21.62 50.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 161.38 -24.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.518 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.0 tmm_? -107.52 143.11 36.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.603 ' HE1' HG21 ' A' ' 647' ' ' ILE . 2.4 t80 -132.61 -47.98 0.89 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.854 HD11 ' CD1' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -112.65 143.25 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.16 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.0 m -123.07 114.01 19.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.982 0.42 . . . . 0.0 111.053 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -106.11 109.01 20.82 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.26 99.43 52.69 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 39.0 Cg_exo -46.91 101.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.916 1.744 . . . . 0.0 109.814 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.815 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.73 157.95 85.32 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.14 -25.46 13.07 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.768 2.978 . . . . 0.0 113.21 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -61.97 -27.37 68.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 2.7 t -95.62 153.92 17.48 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.624 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 688' ' ' PHE . 9.3 pt -56.51 -12.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.701 0.286 . . . . 0.0 111.193 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 39.9 mt -108.54 127.24 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.527 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.22 58.5 0.69 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.668 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 36.7 mt-10 -125.03 170.14 11.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.86 121.19 24.82 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.607 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -112.75 147.43 36.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -125.19 118.54 26.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 625' ' ' ILE . 57.6 mt -73.48 109.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.912 0.387 . . . . 0.0 110.294 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.8 mp0 -65.1 116.4 6.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.971 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.99 -29.84 1.59 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.163 0.506 . . . . 0.0 110.471 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.23 -22.72 76.28 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.589 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.505 HG11 ' ND2' ' A' ' 610' ' ' ASN . 79.3 t -101.04 118.79 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 117.884 0.842 . . . . 0.0 111.585 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.0 t30 -139.37 122.68 10.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.765 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.11 160.43 33.82 Favored 'Cis proline' 0 N--CA 1.462 -0.373 0 C-N-CA 124.451 -1.062 . . . . 0.0 111.917 0.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.46 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.611 ' CG ' HD12 ' A' ' 730' ' ' LEU . 41.6 m-85 -92.25 138.15 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.007 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.2 mp -129.84 145.69 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.678 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.41 ' HA2' HD11 ' A' ' 618' ' ' LEU . . . 156.72 -163.36 32.14 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.013 -1.089 . . . . 0.0 114.049 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.2 OUTLIER -82.85 3.42 29.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.456 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -101.3 123.94 46.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -57.84 -22.49 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.271 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.16 -26.63 67.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.905 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 92.3 m -68.51 129.43 39.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.319 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.2 m120 -44.07 -33.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.308 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.756 ' SG ' HG23 ' A' ' 603' ' ' ILE . 53.5 t -109.73 134.88 51.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.12 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 111.99 23.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 30.6 mm -137.62 110.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.619 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 6.1 tt0 -91.6 105.9 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.274 0.559 . . . . 0.0 111.523 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 618' ' ' LEU . 13.5 t0 -130.32 108.58 10.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.702 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -47.43 -29.8 2.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.821 0.343 . . . . 0.0 111.201 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.491 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 19.7 mmt180 -77.86 -41.29 37.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -84.75 151.71 24.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.94 161.4 23.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.165 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.448 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -47.65 -38.8 15.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.444 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 24.1 t -121.24 57.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.0 t60 -50.42 -48.66 56.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.883 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.48 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.2 p -162.69 157.04 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 111.422 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.792 ' HA ' HD12 ' A' ' 603' ' ' ILE . 25.2 p90 -143.32 146.93 33.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.594 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 594' ' ' ILE . 23.9 mt -101.9 135.37 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.983 0.42 . . . . 0.0 109.914 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -127.34 134.94 49.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.746 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.2 ttmt -97.64 136.19 38.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.137 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 159.27 42.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.76 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.47 112.55 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.195 0.522 . . . . 0.0 110.595 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t-160 -81.38 122.85 28.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -157.52 114.7 3.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 632' ' ' VAL . 33.5 m -92.06 122.44 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.7 -60.92 7.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.601 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -70.59 145.38 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 76.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 63.21 -80.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.24 122.82 26.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.672 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 12.6 m -107.36 87.73 3.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.193 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 71.4 Cg_endo -74.18 167.45 27.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.519 2.146 . . . . 0.0 111.953 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.665 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 69.49 -61.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.346 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 74.55 -74.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 179.25 56.52 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.778 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.695 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.1 mp -102.47 -166.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -111.75 148.03 34.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.026 0.441 . . . . 0.0 111.926 -179.211 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -128.85 160.11 33.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.854 ' CD1' HD11 ' A' ' 578' ' ' LEU . 3.5 pt -110.64 121.59 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.317 0.579 . . . . 0.0 111.615 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.854 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.9 m95 -104.28 141.3 36.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.165 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.7 t80 -105.7 116.95 32.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.19 139.8 39.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.472 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 62.2 t60 -119.46 128.73 54.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.417 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 5.4 p -126.55 12.95 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.51 148.75 21.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.181 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 69.5 m -77.0 -21.89 53.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -79.9 -0.52 35.27 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.5 OUTLIER 54.9 128.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.932 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.1 p -92.74 166.36 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.986 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 679' ' ' LYS . 18.7 m-85 -133.15 120.6 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.779 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -105.3 112.57 25.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.142 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 59.03 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -139.86 7.6 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -104.22 141.06 36.93 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.924 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.1 ttt180 -79.33 141.02 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 13.9 mmm -120.96 101.27 7.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.446 HG12 HG21 ' A' ' 668' ' ' THR . 34.2 pt -88.27 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 652' ' ' THR . 34.6 tt0 -44.81 109.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.423 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.45 34.78 3.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.446 HG21 HG12 ' A' ' 665' ' ' ILE . 3.6 p -122.33 162.25 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.071 0.462 . . . . 0.0 111.667 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.419 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 4.5 ttpm? -131.61 149.71 52.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.344 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.484 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.3 143.74 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.854 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.37 137.74 53.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.437 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -110.85 104.14 12.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.235 0.54 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.554 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 20.8 mt-30 -90.94 137.91 32.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.197 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.566 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.4 t70 -43.52 111.32 0.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.8 37.13 4.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -93.55 122.65 36.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.469 -0.366 . . . . 0.0 111.012 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.37 108.88 21.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.186 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.779 HG23 ' HG ' ' A' ' 659' ' ' LEU . 3.7 mt -106.15 136.36 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.904 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 658' ' ' TYR . 1.7 mttt -100.83 116.27 32.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.566 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.525 HG22 ' CG2' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -78.68 -37.94 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.413 -179.008 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.52 HD11 ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -155.29 131.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.724 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.638 ' O ' HD13 ' P' ' 831' ' ' LEU . 11.0 t90 -136.25 123.56 21.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.159 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.477 ' CG ' HD22 ' P' ' 831' ' ' LEU . 1.5 t0 -121.4 117.18 26.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.42 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -66.89 -46.51 74.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.943 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.41 -40.44 21.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.543 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -77.47 -14.0 59.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.334 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 15.09 9.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -78.6 104.76 9.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 689' ' ' VAL . 1.6 p -120.18 121.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 111.972 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.585 HD12 ' OD2' ' A' ' 615' ' ' ASP . 3.4 mt -129.14 152.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.324 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 177.5 133.3 1.82 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.021 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 4.2 m-30 -112.93 150.92 31.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.553 ' HB2' HD22 ' A' ' 583' ' ' LEU . 5.7 ttpt -101.27 116.82 33.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.953 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.759 HG13 ' CD2' ' A' ' 578' ' ' LEU . 1.8 t -81.11 121.89 35.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.883 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.66 108.75 8.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.477 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 674' ' ' ASP . 11.6 mt -79.21 107.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.32 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.68 -41.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -109.76 141.09 42.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.2 OUTLIER -114.88 100.41 8.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.418 0.627 . . . . 0.0 110.046 178.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.6 m -86.79 70.47 10.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 73.33 36.12 55.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.163 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.608 HD12 ' CA ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -79.87 118.59 21.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.583 0.23 . . . . 0.0 111.171 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.695 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -32.8 -47.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.679 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 15.4 p30 -159.2 26.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.608 ' CA ' HD12 ' A' ' 702' ' ' LEU . 0.5 OUTLIER 71.55 -56.87 0.63 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.543 -178.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 149.29 81.04 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.772 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 707' ' ' LEU . 3.6 mm? -103.52 -9.54 19.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.806 -0.232 . . . . 0.0 111.476 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 82.5 65.58 1.61 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.32 118.53 26.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.851 0.358 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.404 HD11 ' O ' ' A' ' 712' ' ' GLU . 1.4 pt? -176.1 -170.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -79.63 -55.63 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.749 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.404 ' O ' HD11 ' A' ' 710' ' ' LEU . 4.3 mm-40 -80.21 134.16 36.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.688 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.83 100.17 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.096 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.766 HH21 HD22 ' A' ' 659' ' ' LEU . 5.5 mmm-85 39.36 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.76 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.61 143.24 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.924 HG21 ' O ' ' A' ' 663' ' ' ARG . 59.4 t -78.91 129.32 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.9 mt -102.64 166.13 10.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 137.99 40.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.02 159.88 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.4 p -121.11 -173.68 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.67 -28.82 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.16 -52.09 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.66 -49.32 63.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.628 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -56.35 -33.13 65.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 -38.24 89.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.8 mt -58.41 -44.01 88.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.548 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.6 p -83.18 -29.77 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -52.11 -29.31 21.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.057 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -105.29 27.22 8.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.611 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.3 tt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.679 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.73 73.06 0.49 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 4.1 mm -108.96 75.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.426 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 20.2 p90 179.31 150.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.789 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 682' ' ' TRP . 58.9 mt -127.98 170.37 12.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.851 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -88.05 -22.04 24.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -165.52 30.64 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.813 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.9 tmm_? -102.29 126.13 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.564 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -109.2 -62.29 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.187 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.06 137.76 43.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.72 ' N ' HD23 ' A' ' 578' ' ' LEU . 4.6 m -115.98 113.96 23.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.998 0.428 . . . . 0.0 111.434 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.721 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -104.83 107.9 19.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 ptpt -114.83 100.02 52.84 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_exo -45.78 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.945 1.763 . . . . 0.0 109.565 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.16 157.83 86.3 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.401 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 73.8 Cg_exo -49.12 -25.25 8.98 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.381 2.72 . . . . 0.0 112.425 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.726 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.2 t0 -61.97 -22.61 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.0 t -95.31 153.11 17.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.847 HD11 ' OD1' ' A' ' 615' ' ' ASP . 20.7 pt -53.03 -19.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.012 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.58 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.99 142.92 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.658 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.401 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -119.47 67.74 0.81 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.589 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 89.5 mt-10 -125.16 170.86 10.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.494 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.77 124.0 34.37 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 1.084 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.26 136.51 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.571 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.462 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.3 OUTLIER -124.48 116.6 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.851 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.716 HG23 ' CD1' ' A' ' 601' ' ' PHE . 81.2 mt -74.87 108.16 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.842 0.354 . . . . 0.0 110.144 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 593' ' ' GLU . 2.1 mp0 -66.16 103.14 0.92 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -29.6 -54.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.27 0.557 . . . . 0.0 111.449 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -53.03 -16.39 4.24 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.017 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.37 118.05 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 117.873 0.837 . . . . 0.0 111.604 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' ND2' ' CD2' ' A' ' 626' ' ' PHE . 0.9 OUTLIER -140.46 124.35 10.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.997 178.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 37.2 Cg_endo -91.32 159.28 27.73 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.149 0.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.716 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.3 t80 -93.61 115.77 28.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 0.0 109.962 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 730' ' ' LEU . 1.7 m-85 -92.94 138.61 31.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.917 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.804 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -127.51 144.89 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 158.35 -165.0 33.71 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.877 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.02 17.92 11.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.41 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 1.1 t -101.78 131.68 47.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.642 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -21.71 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.763 0.316 . . . . 0.0 110.63 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.29 -21.33 60.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.9 m -76.52 127.41 32.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 23.3 m120 -45.76 -31.68 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.14 0.495 . . . . 0.0 110.434 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.804 ' SG ' HG23 ' A' ' 603' ' ' ILE . 45.0 t -110.55 138.72 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 117.83 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 1.084 HD11 HD21 ' A' ' 592' ' ' LEU . 34.2 mm -138.06 108.83 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.314 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.35 101.09 11.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.413 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD1' HD11 ' A' ' 587' ' ' ILE . 1.1 m-20 -133.54 113.36 12.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.937 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -50.42 -45.81 55.98 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' A' ' 681' ' ' ILE . 2.4 mpp_? -62.66 -19.05 63.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.549 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.982 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -88.17 160.81 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.593 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.403 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 2.6 m -109.92 153.74 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -39.03 -50.68 1.81 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.76 57.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.606 ' CB ' HD23 ' A' ' 618' ' ' LEU . 54.2 t60 -52.69 -37.55 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.344 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.529 0.68 . . . . 0.0 111.939 -178.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.598 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.18 131.97 21.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.904 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 603' ' ' ILE . 21.3 mt -131.79 116.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.458 ' CD2' ' ND2' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -136.78 149.02 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -178.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 34.6 ttmt -98.9 136.76 38.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 159.79 35.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.4 tpt180 -75.68 112.75 12.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 -76.55 128.93 35.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -171.4 146.75 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 632' ' ' VAL . 4.3 m -125.46 104.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 45.49 -121.28 4.74 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.53 144.43 51.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.738 0.304 . . . . 0.0 110.635 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.32 91.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.67 103.09 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 78.43 -55.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.04 144.15 40.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.1 m -104.42 102.69 35.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.12 -164.55 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.723 2.282 . . . . 0.0 112.202 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -97.13 29.71 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.309 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 64.48 -164.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.893 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -107.49 85.18 0.41 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.746 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.638 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.8 mp -110.54 -163.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.822 ' O ' HD13 ' A' ' 702' ' ' LEU . 9.8 m-20 -114.12 146.49 40.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.294 0.569 . . . . 0.0 112.197 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.434 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -128.8 160.61 32.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.647 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.092 HD13 HD12 ' A' ' 578' ' ' LEU . 0.6 OUTLIER -103.33 128.29 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.6 0.714 . . . . 0.0 112.081 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.6 m95 -113.02 120.45 41.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.27 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.647 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.6 t80 -93.62 117.77 30.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 624' ' ' PHE . 3.9 m -113.74 143.87 43.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.437 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 42.5 t60 -110.58 130.12 55.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.0 0.428 . . . . 0.0 111.049 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.428 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 20.5 p -120.56 3.83 10.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLY . . . . . . . . . . . . . . . -81.58 146.22 25.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.847 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 37.5 m -75.94 -15.64 60.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 656' ' ' VAL . 29.3 m-20 -85.18 3.05 41.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.16 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.438 0.637 . . . . 0.0 112.283 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.58 ' CB ' ' HH ' ' A' ' 649' ' ' TYR . 33.1 p -99.31 166.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.302 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 5.8 m-85 -129.23 120.06 25.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.718 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 1.029 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -98.64 102.58 14.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 60.93 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.4 p30 -136.84 5.7 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.672 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.533 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -107.44 139.75 41.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.626 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.1 ttp180 -76.4 141.36 41.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.423 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 25.1 mmm -124.61 97.44 5.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 45.4 pt -87.57 152.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 652' ' ' THR . 38.5 tt0 -48.7 112.05 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.91 0.386 . . . . 0.0 110.945 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.9 32.32 4.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.3 p -121.04 162.54 19.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.828 0.347 . . . . 0.0 111.203 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.9 ttpm? -133.69 147.81 51.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.769 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.69 28.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.04 133.72 48.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.593 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.88 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -108.9 104.71 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 2.2 mt-30 -91.35 139.26 30.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.621 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.644 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.2 t0 -41.28 112.4 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 110.708 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.28 37.08 4.43 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.78 116.11 28.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.252 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -96.26 108.72 21.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 659' ' ' LEU . 25.5 pt -105.92 129.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.798 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 27.9 mttp -89.43 115.8 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.834 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -79.26 -35.47 17.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.811 -178.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.982 HD12 HD12 ' A' ' 618' ' ' LEU . 50.2 mt -155.0 131.59 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.704 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -136.37 123.45 21.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.5 116.96 25.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.505 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -67.03 -46.61 73.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.842 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -80.91 -40.07 25.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.1 t30 -83.06 -13.36 55.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.06 17.11 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 111.0 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.04 104.62 7.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.5 p -117.48 124.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.2 0.524 . . . . 0.0 111.914 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 681' ' ' ILE . 59.5 mt -129.01 156.0 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.315 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 170.83 136.33 2.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.68 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.834 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -114.16 149.8 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.53 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.85 117.6 35.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.663 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 672' ' ' LEU . 3.5 t -80.03 124.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -133.2 109.71 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.413 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 705' ' ' GLU . 52.1 mt -78.26 106.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.76 -44.71 9.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.176 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -110.4 141.87 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.54 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -113.07 99.92 8.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.431 0.634 . . . . 0.0 109.599 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.1 m -82.88 58.84 4.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.52 13.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.173 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -80.64 134.33 35.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.56 0.219 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.638 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.8 p90 -43.36 -33.52 1.04 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.469 0.652 . . . . 0.0 110.266 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.798 HD22 HD23 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -148.1 -61.2 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.341 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.745 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.7 pt-20 145.42 32.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.957 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 68.12 74.09 0.62 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.592 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.798 HD23 HD22 ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.41 -10.01 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.057 0.428 . . . . 0.0 111.557 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 93.15 -95.24 1.96 Allowed Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 39.36 -147.14 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.031 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 711' ' ' GLN . 0.2 OUTLIER 77.91 162.66 0.22 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.105 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.597 ' H ' HD23 ' A' ' 710' ' ' LEU . 11.9 mt-30 -56.95 -66.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.421 ' HB3' HG22 ' A' ' 715' ' ' VAL . 1.4 mp0 -63.63 123.75 19.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -82.83 100.01 10.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.437 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.3 mmm-85 41.48 89.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.842 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 712' ' ' GLU . 3.0 m -124.44 143.54 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 663' ' ' ARG . 65.0 t -85.78 121.84 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.506 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.66 172.36 8.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.37 16.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 650' ' ' CYS . 42.1 mt-30 -93.44 148.55 21.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -126.41 -175.96 3.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 111.669 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -30.15 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.198 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -56.61 -50.12 72.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.676 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.79 ' HA ' HD12 ' A' ' 726' ' ' LEU . 21.6 mm-40 -70.01 -49.5 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.57 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.477 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.43 -39.95 89.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.0 OUTLIER -63.35 -44.69 94.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.562 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.89 -19.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.254 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.98 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.039 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -108.11 24.24 13.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 730' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -156.71 63.04 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 24.9 mt -98.69 130.86 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -176.04 154.1 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.526 ' CD1' HG23 ' A' ' 681' ' ' ILE . 28.3 mt -138.77 122.18 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.825 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -102.22 10.2 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.513 0.197 . . . . 0.0 111.278 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -144.71 -40.86 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 52.1 ttp180 -106.12 141.47 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -125.66 -58.3 1.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.214 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 647' ' ' ILE . 12.8 tp -110.92 134.93 52.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.439 ' C ' HD23 ' A' ' 580' ' ' LEU . 7.5 m -115.24 114.72 25.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD11 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -105.28 108.7 20.35 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.96 100.33 52.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.2 Cg_exo -44.72 100.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.917 1.745 . . . . 0.0 109.806 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.35 158.29 85.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.43 -24.68 9.22 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.59 2.86 . . . . 0.0 112.387 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.764 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.42 -23.09 65.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 2.2 t -95.46 153.34 17.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.75 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.534 HD13 ' HD1' ' A' ' 688' ' ' PHE . 4.0 pt -54.42 -18.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.84 142.95 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.815 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.02 68.81 0.84 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.194 0.521 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.3 mm-40 -124.91 171.38 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.494 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 127.33 42.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.0 0.428 . . . . 0.0 111.12 178.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.952 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.39 139.58 47.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.892 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.472 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 6.1 mp0 -124.48 117.39 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.045 HD11 HD11 ' A' ' 580' ' ' LEU . 88.0 mt -86.34 109.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.062 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -67.47 125.84 27.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.72 -28.5 3.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.123 0.487 . . . . 0.0 110.52 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.59 -17.7 80.04 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.982 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.4 t -100.94 117.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.05 0.925 . . . . 0.0 111.878 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -140.8 121.31 8.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.8 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 50.5 Cg_endo -89.63 160.65 36.32 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 124.772 -0.928 . . . . 0.0 111.499 -0.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.0 t80 -92.15 117.02 29.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 730' ' ' LEU . 35.1 m-85 -92.21 137.51 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.039 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.773 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -124.94 143.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.59 -176.67 42.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.079 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.6 ttp85 -81.21 -2.96 50.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.662 0.268 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 135.71 42.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -24.91 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.059 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -28.36 60.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 51.5 m -77.06 132.52 38.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -47.31 -29.07 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.563 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.773 ' SG ' HG23 ' A' ' 603' ' ' ILE . 38.5 t -111.58 142.45 43.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.897 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 115.92 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.952 HD11 HD21 ' A' ' 592' ' ' LEU . 17.5 mm -137.78 110.29 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.441 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 22.2 mt-10 -81.88 103.2 11.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.511 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.737 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.43 108.43 9.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.161 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -42.5 -36.73 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.2 mpp_? -77.62 -36.86 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.737 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -60.3 158.91 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 83.9 p -110.68 168.89 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.553 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -46.17 -52.98 11.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.224 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.6 t -116.76 58.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.204 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' HG23 ' A' ' 680' ' ' ILE . 35.6 t60 -49.35 -48.59 46.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.886 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -163.12 156.08 19.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.502 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.9 p90 -143.22 148.05 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.38 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -102.59 141.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 179.357 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.0 t80 -130.91 134.15 46.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.418 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 27.9 ttmt -97.66 136.8 37.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.91 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.68 159.44 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.443 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.27 117.78 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.436 0.636 . . . . 0.0 110.79 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.484 ' CD2' ' C ' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -82.47 133.78 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.444 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.08 140.53 45.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 641' ' ' ALA . 16.6 m -93.4 175.98 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -105.44 -69.69 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -96.96 157.06 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.3 p -165.63 78.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.27 117.49 9.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 63.82 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.785 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -86.63 126.23 34.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.28 87.75 4.31 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 71.9 Cg_endo -76.84 172.97 15.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.56 2.173 . . . . 0.0 112.033 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.591 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 70.29 -62.71 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.161 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 65.05 -173.14 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -86.36 53.36 4.59 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.751 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.71 HD12 ' H ' ' A' ' 703' ' ' PHE . 1.2 mm? -79.99 -160.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 m-20 -122.49 147.03 46.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.188 0.518 . . . . 0.0 112.037 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.8 ' HB3' HD21 ' A' ' 671' ' ' LEU . 1.9 m-20 -129.18 159.72 35.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -105.92 134.94 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.362 0.601 . . . . 0.0 112.23 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.625 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 67.4 m95 -117.96 127.59 53.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.313 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.656 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -90.08 117.17 28.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.1 m -102.93 131.72 49.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.601 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 67.0 t60 -109.88 128.58 55.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.3 p -124.44 -1.14 8.1 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.451 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.36 137.95 21.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.029 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 654' ' ' THR . 91.4 m -69.78 -10.84 59.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.627 0.251 . . . . 0.0 111.456 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.532 ' O ' HG13 ' A' ' 656' ' ' VAL . 55.7 m-20 -85.03 3.75 37.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.59 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.57 137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.566 0.698 . . . . 0.0 112.182 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.444 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 5.9 t -108.74 166.2 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.387 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -129.38 120.36 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -101.84 99.64 9.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.562 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.9 m120 61.06 -81.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.2 p-10 -133.79 1.81 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.643 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.434 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.5 m120 -104.21 141.65 35.89 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.859 0.361 . . . . 0.0 111.069 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.55 141.27 38.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.058 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 656' ' ' VAL . 57.4 mmm -115.66 98.68 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.3 pt -87.5 155.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.063 0.459 . . . . 0.0 111.226 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -51.41 105.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.61 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 39.64 2.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.212 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.5 p -132.39 148.9 52.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.871 0.335 . . . . 0.0 111.549 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.66 ' HE2' HD13 ' A' ' 717' ' ' LEU . 15.9 pttm -123.88 136.35 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.671 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -131.94 141.61 49.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.6 OUTLIER -69.37 141.26 54.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.945 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 694' ' ' VAL . 16.2 mt -111.87 105.39 13.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 112.018 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 26.5 mt-30 -77.86 156.39 30.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.878 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.7 ' CB ' HD12 ' A' ' 696' ' ' ILE . 7.0 t0 -53.2 109.7 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.83 37.92 4.29 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -88.1 115.22 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.437 . . . . 0.0 111.184 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.12 109.78 22.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.626 HG22 HD13 ' A' ' 659' ' ' LEU . 11.8 pt -105.57 120.61 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.155 0.502 . . . . 0.0 112.11 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -87.54 116.02 25.37 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -82.3 -33.46 11.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.885 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -155.15 132.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.523 ' CB ' HG23 ' A' ' 689' ' ' VAL . 9.5 t90 -136.04 124.33 23.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' P' ' 831' ' ' LEU . 2.2 t0 -124.14 116.58 22.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -67.79 -46.68 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.064 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -40.36 96.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.134 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -93.69 -18.35 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.643 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.0 OUTLIER 65.91 13.06 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.0 111.029 -179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -87.51 105.56 17.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.523 HG23 ' CB ' ' A' ' 682' ' ' TRP . 1.2 p -119.78 138.78 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.357 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.616 ' CG1' HG22 ' A' ' 681' ' ' ILE . 18.4 mm -113.67 152.12 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.77 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.2 130.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.651 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 680' ' ' ILE . 1.6 m-30 -113.9 145.06 42.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.735 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.0 tttm -101.1 116.92 33.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.033 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -79.82 128.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.692 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.3 OUTLIER -133.29 108.58 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.124 0.488 . . . . 0.0 111.019 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.8 mt -76.28 105.29 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.385 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -91.9 -50.13 5.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.041 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -112.62 139.57 48.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.142 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.466 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -116.2 100.56 8.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.207 0.527 . . . . 0.0 109.692 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 62.02 0.67 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.968 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.1 47.32 88.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.54 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -112.24 32.61 5.42 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.71 ' H ' HD12 ' A' ' 644' ' ' LEU . 0.0 OUTLIER 67.85 175.67 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 703' ' ' PHE . 4.0 t-20 -14.56 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.028 0.442 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 696' ' ' ILE . 0.7 OUTLIER 151.51 -38.16 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.927 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 164.36 81.87 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.613 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.454 HD23 ' OD1' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -105.39 -10.14 17.14 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.518 -0.401 . . . . 0.0 111.587 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.14 89.87 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.257 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.64 116.82 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.26 -162.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -46.78 45.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.829 0.347 . . . . 0.0 111.063 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.09 137.46 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.659 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -91.91 100.6 13.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 7.0 mmm-85 43.38 86.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.564 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.47 143.18 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.982 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.6 t -84.08 130.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.66 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -101.24 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.89 157.43 16.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 111.186 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.73 158.86 17.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.1 p -126.13 -175.29 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -33.69 57.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.27 -45.6 90.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.614 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -63.74 -50.97 66.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -54.24 -32.7 56.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.13 -37.09 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.097 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 723' ' ' GLU . 13.2 mt -58.03 -44.37 87.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.7 p -78.82 -27.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -30.13 65.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.836 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -97.51 13.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.659 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.9 tt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.81 0.338 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 58.72 175.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 4.9 pt -132.89 78.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.206 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.62 148.06 8.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.013 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.435 HD22 ' OD2' ' A' ' 683' ' ' ASP . 27.6 mt -151.74 83.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.947 -179.975 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.4 -22.58 59.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.732 0.301 . . . . 0.0 111.205 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 170.04 70.76 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.412 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -89.13 114.0 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -104.58 -59.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.394 -179.116 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.145 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -106.67 142.0 37.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.352 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.735 ' N ' HD23 ' A' ' 578' ' ' LEU . 11.5 m -122.25 114.71 21.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 694' ' ' VAL . 6.2 mt -102.95 107.8 18.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 44.9 mtmt -111.6 99.46 44.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.7 Cg_exo -48.15 98.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.755 1.637 . . . . 0.0 109.535 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.749 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.73 157.63 85.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.626 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.76 -28.43 17.65 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.458 2.772 . . . . 0.0 112.64 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.454 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.3 t70 -62.38 -24.99 67.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.9 t -95.44 153.97 17.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -56.2 -11.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.237 179.586 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.844 ' CD1' HG23 ' A' ' 613' ' ' ILE . 20.3 mt -112.1 126.88 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.824 0.345 . . . . 0.0 111.741 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.34 52.38 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 14.1 mm-40 -124.49 172.01 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.96 131.35 51.1 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.941 0.4 . . . . 0.0 111.337 179.131 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.731 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.5 OUTLIER -112.58 141.94 45.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.778 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.63 116.32 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.149 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.054 HD12 HD22 ' A' ' 578' ' ' LEU . 63.9 mt -86.56 108.98 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 8.6 mm100 -71.8 128.71 36.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 3.1 pt20 -46.03 -30.34 1.81 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 109.877 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.43 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.74 -25.06 75.96 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.16 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.481 HG11 ' CG ' ' A' ' 610' ' ' ASN . 87.9 t -98.73 117.16 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 118.171 0.985 . . . . 0.0 111.842 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.2 t30 -141.16 121.92 8.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.034 177.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.593 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.8 Cg_endo -89.86 159.78 34.77 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.543 -1.024 . . . . 0.0 111.248 -0.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.578 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.7 t80 -91.88 114.98 27.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 25.3 m-85 -91.82 138.38 31.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.998 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.763 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.95 145.31 33.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.459 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.14 -178.3 41.37 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.573 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.451 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.8 ttp85 -76.97 -7.52 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.563 0.22 . . . . 0.0 111.466 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.48 131.96 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.758 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -56.1 -23.99 37.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.217 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.602 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.5 OUTLIER -55.04 -30.2 59.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.653 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 45.2 m -74.87 134.51 41.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 4.8 m-80 -48.11 -27.07 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 603' ' ' ILE . 36.0 t -112.13 140.46 46.8 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.542 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.59 113.03 23.84 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.844 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -137.8 109.67 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.774 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 25.8 tt0 -87.66 103.87 15.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.584 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.758 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -131.06 110.55 11.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.11 178.345 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -41.21 -35.65 0.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.728 0.299 . . . . 0.0 111.526 -178.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.528 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.9 mmt180 -77.69 -38.64 46.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.05 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -59.69 159.48 8.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.178 -179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 167.59 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 -50.0 19.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.134 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 727' ' ' VAL . 38.9 t -119.71 59.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.36 178.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.7 t60 -48.5 -49.18 36.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.619 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.3 p -166.34 157.35 12.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.595 ' HA ' HD12 ' A' ' 603' ' ' ILE . 44.0 p90 -143.39 146.89 33.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 603' ' ' ILE . 2.2 mp -102.17 125.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.775 179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -116.79 133.72 55.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 -179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 15.2 ttmt -98.55 136.93 37.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.64 158.78 40.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.385 -179.164 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.451 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.47 115.72 16.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.384 0.612 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.68 ' CD2' ' HB1' ' A' ' 641' ' ' ALA . 4.2 t60 -84.1 130.96 34.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.002 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.451 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -150.63 155.4 39.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 633' ' ' GLY . 9.8 p -152.7 168.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.536 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -68.04 -133.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.668 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -173.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.742 0.306 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 14.0 p -128.28 29.34 5.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.287 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 636' ' ' MET . . . . . 0.402 ' O ' ' CB ' ' A' ' 637' ' ' TYR . 0.8 OUTLIER -87.02 101.89 13.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.24 179.41 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.402 ' CB ' ' O ' ' A' ' 636' ' ' MET . 0.1 OUTLIER 81.17 -15.88 0.69 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.03 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -83.35 147.05 28.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 55.5 p -86.92 156.9 55.04 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 641' ' ' ALA . 25.1 Cg_exo -35.82 158.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.373 2.716 . . . . 0.0 113.857 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.68 ' HB1' ' CD2' ' A' ' 630' ' ' HIS . . . 176.21 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.799 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.26 -91.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.718 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 641' ' ' ALA . . . -156.48 27.12 0.54 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.606 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 701' ' ' GLY . 1.6 mm? -71.51 -160.82 0.06 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.662 0.231 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.32 146.46 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -179.536 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.451 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -125.23 160.21 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.775 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.145 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -110.01 121.9 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.619 0.723 . . . . 0.0 112.591 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.0 m95 -105.34 128.13 53.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.629 179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.463 ' CB ' HD21 ' A' ' 672' ' ' LEU . 22.0 t80 -90.57 117.75 29.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 36.7 m -106.35 128.09 53.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 33.8 t60 -110.29 126.34 54.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.855 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.487 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 13.4 p -123.46 7.24 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.516 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.46 146.82 25.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.954 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 32.8 m -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.611 0.243 . . . . 0.0 111.642 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.523 ' O ' HD12 ' P' ' 831' ' ' LEU . 19.2 m-20 -85.23 3.25 40.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.44 135.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.733 0.777 . . . . 0.0 112.487 179.766 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.427 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 3.7 t -104.16 165.85 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.188 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 679' ' ' LYS . 37.3 m-85 -128.28 119.76 25.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.46 102.44 12.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.8 m120 59.73 -82.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.898 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 659' ' ' LEU . 26.1 p30 -135.77 6.99 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.638 ' CG ' HG23 ' A' ' 716' ' ' VAL . 1.2 m-20 -110.8 141.6 43.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.942 0.401 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.458 ' HG2' HG23 ' A' ' 665' ' ' ILE . 8.9 ttp85 -75.19 141.19 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.462 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 23.4 mmm -122.66 86.06 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.354 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' A' ' 663' ' ' ARG . 30.7 pt -86.84 156.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.325 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.4 tt0 -49.12 107.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.234 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.16 32.44 4.02 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.586 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 665' ' ' ILE . 2.5 p -121.72 161.84 21.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.6 ttpm? -135.66 147.87 48.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.45 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.93 28.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.1 134.73 49.74 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.629 179.446 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.736 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.74 108.0 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.071 0.462 . . . . 0.0 111.783 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.566 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 18.3 mt-30 -95.8 157.28 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.227 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 705' ' ' GLU . 4.0 p-10 -52.38 124.57 13.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.802 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 84.42 39.63 8.92 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.997 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.16 112.31 23.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.911 0.386 . . . . 0.0 111.152 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.81 108.77 21.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 6.0 mt -109.7 128.83 65.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 0.0 112.035 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.4 OUTLIER -90.34 115.85 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.407 178.392 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.8 mt -77.02 -37.6 26.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.422 -179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.05 HD12 HD12 ' A' ' 618' ' ' LEU . 38.3 mt -155.39 131.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.773 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -135.87 121.09 19.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.748 178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.54 117.36 24.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -66.73 -46.67 74.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.609 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.23 -40.24 19.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.289 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.78 -11.32 59.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.8 20.59 8.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.735 0.303 . . . . 0.0 110.925 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.79 104.82 15.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -119.5 121.4 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.19 0.519 . . . . 0.0 111.81 -178.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.65 ' CD1' HG22 ' A' ' 587' ' ' ILE . 26.8 mm -128.5 150.14 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.536 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.54 127.55 1.17 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.411 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.565 ' HB2' HD22 ' A' ' 580' ' ' LEU . 8.7 m-30 -113.34 145.76 40.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.752 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.749 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.2 ttpt -101.88 117.97 35.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.086 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.884 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.43 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 34.2 tt0 -131.26 108.39 9.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.028 0.442 . . . . 0.0 110.334 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.86 HD12 ' HG3' ' A' ' 705' ' ' GLU . 27.8 mt -76.39 105.58 5.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.927 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 697' ' ' ASN . . . . . 0.407 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.6 m-80 -87.12 -46.14 10.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.484 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 21.2 t0 -110.77 139.4 46.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.7 p -115.72 99.99 7.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.22 0.533 . . . . 0.0 109.828 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -80.07 68.35 6.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.494 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 67.65 30.27 74.62 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.692 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -70.59 133.07 46.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.671 0.272 . . . . 0.0 111.198 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.685 ' CD2' ' ND2' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -39.15 -49.92 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.175 179.862 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.685 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 18.1 p30 -157.56 20.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.857 178.182 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.86 ' HG3' HD12 ' A' ' 696' ' ' ILE . 0.3 OUTLIER 70.98 -57.52 0.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.0 -178.992 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 160.75 81.14 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.443 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 707' ' ' LEU . 3.8 mm? -104.86 -9.42 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.896 0.348 . . . . 0.0 111.592 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.47 -36.48 4.19 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.714 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.32 -147.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 711' ' ' GLN . 0.9 OUTLIER -144.92 -159.61 1.02 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.783 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.743 ' N ' HD12 ' A' ' 710' ' ' LEU . 3.5 mt-30 69.46 -65.51 0.3 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -106.35 98.4 8.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.616 178.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.65 100.32 9.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.434 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 1.7 mmm-85 34.88 90.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.652 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.42 142.25 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.079 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' A' ' 662' ' ' ASN . 62.4 t -86.82 130.29 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 111.391 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mt -104.84 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.17 148.54 25.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -84.8 151.17 24.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.823 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.09 -177.78 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.23 -30.54 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.193 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.82 -51.97 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.3 OUTLIER -67.55 -46.42 72.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.546 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -56.51 -32.86 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -67.82 -38.42 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 723' ' ' GLU . 26.8 mt -56.49 -44.34 80.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.636 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.5 p -73.21 -26.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.34 -34.38 66.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.809 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -98.63 29.26 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 608' ' ' ASP . 5.8 tt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 62.46 150.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.477 HG22 ' N ' ' P' ' 829' ' ' PTR . 22.9 mt -108.67 159.44 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.028 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.477 ' N ' HG22 ' P' ' 828' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 41.5 p90 179.8 142.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 1.024 HD11 HG23 ' A' ' 681' ' ' ILE . 45.5 mt -121.93 129.64 52.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.915 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.52 -22.26 32.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.685 0.279 . . . . 0.0 111.059 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 136.23 -32.45 2.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.332 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 16.9 ttm180 -110.28 143.33 40.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 111.713 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.9 t80 -122.87 -40.28 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.81 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.0 tp -126.96 142.24 51.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 111.041 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 695' ' ' GLU . 22.1 m -124.9 114.19 18.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.052 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.794 ' HG ' HG22 ' A' ' 694' ' ' VAL . 2.9 mp -106.86 108.93 20.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.47 100.52 50.3 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 51.9 Cg_exo -44.53 103.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.083 1.855 . . . . 0.0 110.056 177.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.83 158.22 84.88 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.874 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.4 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.9 Cg_endo -49.71 -23.92 8.99 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.021 3.147 . . . . 0.0 113.199 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -60.37 -26.29 66.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 2.7 t -95.97 153.5 17.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.72 178.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 13.1 pt -55.04 -14.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.45 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.5 tt -112.67 131.9 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 111.822 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -113.67 69.54 0.7 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mt-10 -125.41 170.79 11.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.577 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.15 130.14 47.63 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 121.055 0.455 . . . . 0.0 111.045 178.483 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.766 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.63 136.57 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.267 179.806 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 13.8 mt-10 -123.95 110.7 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.08 HD11 HD12 ' A' ' 625' ' ' ILE . 63.1 mt -78.72 109.79 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.6 mp0 -67.8 115.27 7.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.73 -28.95 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 111.07 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.87 -22.31 73.78 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.484 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.48 119.45 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 117.657 0.728 . . . . 0.0 111.821 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.8 t30 -138.83 122.41 11.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.629 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.7 Cg_endo -90.33 160.59 32.84 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.632 -0.987 . . . . 0.0 111.908 0.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.89 119.58 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.595 ' CG ' HD12 ' A' ' 730' ' ' LEU . 29.2 m-85 -92.97 138.35 31.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.453 -177.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.778 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -129.69 141.14 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 163.99 -166.97 37.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.947 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 14.8 ttp85 -87.31 7.0 30.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.651 0.262 . . . . 0.0 111.275 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 2.4 t -101.35 125.79 48.03 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.52 -22.92 36.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -25.03 66.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.414 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 84.1 m -73.71 126.97 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.5 m120 -43.13 -33.71 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.778 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.4 t -106.97 136.17 47.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.606 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 115.5 25.18 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 592' ' ' LEU . 13.5 mm -137.69 109.87 6.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.058 178.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.42 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mt-10 -83.96 103.33 13.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.867 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.845 ' OD2' HD13 ' A' ' 690' ' ' ILE . 5.1 m-20 -132.08 112.98 12.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.306 178.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -42.58 -45.96 4.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.909 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.98 -30.95 69.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.382 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 1.087 HD12 HD12 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -65.26 159.08 24.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.828 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -114.31 167.34 10.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.024 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.46 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -44.48 -62.44 1.18 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.521 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.5 t -106.1 58.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.471 0.653 . . . . 0.0 109.476 178.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.581 ' CE1' HD11 ' A' ' 681' ' ' ILE . 56.0 t60 -47.09 -49.67 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.559 -179.026 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.2 p -162.99 157.19 20.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.9 p90 -143.56 146.95 33.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.08 HD12 HD11 ' A' ' 594' ' ' ILE . 69.6 mt -101.74 131.51 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.878 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -123.9 135.46 53.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.49 134.06 41.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.85 159.51 41.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.074 -178.851 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -76.67 112.47 13.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.937 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 -79.74 129.91 34.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.74 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.22 144.71 33.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.044 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.57 134.29 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -85.58 -36.01 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.356 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 119.18 38.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.792 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.0 127.37 12.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.98 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -70.91 69.86 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 63.63 -78.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -100.11 105.41 17.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.27 152.09 77.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 62.1 Cg_endo -73.24 176.0 9.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.592 2.195 . . . . 0.0 112.392 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 70.19 -65.07 0.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.16 -78.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -162.02 78.5 0.16 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.587 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 703' ' ' PHE . 6.9 mt -113.87 -156.88 0.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.843 ' O ' HD12 ' A' ' 702' ' ' LEU . 1.7 m-20 -114.61 148.41 38.12 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 4.8 m-20 -135.7 145.99 47.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.346 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.678 ' CD1' HD22 ' A' ' 578' ' ' LEU . 3.2 pt -95.29 122.65 46.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.577 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 77.2 m95 -105.33 129.92 53.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.435 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 8.2 t80 -90.63 116.83 28.82 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 5.9 m -102.36 142.53 33.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.362 . . . . 0.0 111.253 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.47 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 64.4 t60 -122.85 127.44 49.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -123.76 0.23 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.348 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.94 147.88 31.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.403 HG22 ' HD1' ' P' ' 829' ' ' PTR . 0.7 OUTLIER -70.24 -25.89 63.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.446 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -68.6 -5.28 19.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.125 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.39 123.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.47 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 6.7 t -93.94 165.86 12.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.677 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 663' ' ' ARG . 2.4 m-85 -135.67 120.74 18.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.725 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.62 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.614 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 62.49 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.21 -5.36 3.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.69 132.12 43.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 658' ' ' TYR . 15.0 mtm-85 -75.23 141.69 43.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.8 mtp -119.3 110.46 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.919 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 46.0 pt -87.91 148.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -47.92 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.337 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 116.25 40.08 0.83 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.722 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.7 p -139.18 162.12 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.51 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 6.2 pttm -129.0 158.09 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.571 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.9 t80 -147.18 146.72 29.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.45 131.75 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.254 0.55 . . . . 0.0 111.671 -179.024 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -105.59 128.12 53.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.982 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.695 ' HB3' HD12 ' A' ' 707' ' ' LEU . 0.3 OUTLIER -117.16 157.72 25.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.947 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.665 ' N ' HD12 ' A' ' 696' ' ' ILE . 7.2 t70 -57.15 99.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.182 0.515 . . . . 0.0 110.393 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.43 29.37 3.96 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.227 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.28 114.5 23.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 583' ' ' LEU . 48.1 tt0 -95.44 108.04 20.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.568 HG12 HD13 ' A' ' 659' ' ' LEU . 3.1 mt -110.57 128.5 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.954 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.08 115.82 31.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.784 ' CD1' HD21 ' A' ' 618' ' ' LEU . 4.8 pt -87.87 -16.2 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 1.087 HD12 HD12 ' A' ' 618' ' ' LEU . 20.4 mt -154.83 130.22 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.136 178.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.443 ' CZ2' ' HG2' ' A' ' 684' ' ' LYS . 8.0 t90 -137.48 132.07 32.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 682' ' ' TRP . 0.2 OUTLIER -117.46 116.22 26.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 684' ' ' LYS . . . . . 0.443 ' HG2' ' CZ2' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -68.04 -47.42 68.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.273 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -83.43 -40.73 18.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -19.2 60.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.409 -179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.01 10.12 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.81 104.93 16.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.9 135.34 62.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.804 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.845 HD13 ' OD2' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -119.48 131.7 71.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.495 179.317 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.74 135.02 4.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.358 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.24 148.14 37.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.542 ' HB2' HD22 ' A' ' 583' ' ' LEU . 19.1 tttm -100.94 116.67 33.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -80.05 131.24 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 579' ' ' THR . 11.2 tt0 -134.82 108.66 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.0 mt -77.33 105.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.73 -46.79 8.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 10.7 t70 -111.39 140.38 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -115.34 100.66 8.27 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.586 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -65.42 66.41 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.306 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.62 47.68 36.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.373 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 645' ' ' ASP . 1.3 pt? -115.54 179.99 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.776 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -70.48 113.39 7.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.343 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 53.22 -73.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.521 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.841 ' HA ' HD21 ' A' ' 702' ' ' LEU . 4.6 pt-20 176.66 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.542 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 145.61 44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.446 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -81.99 -2.4 51.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.531 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 44.18 83.36 0.02 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.935 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.409 ' HE3' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -121.42 103.39 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 110.841 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -151.39 -168.62 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -54.72 -45.05 73.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.051 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.468 ' CB ' HG21 ' A' ' 715' ' ' VAL . 3.0 mm-40 -82.94 126.8 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -84.31 100.64 11.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 46.49 81.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.534 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 712' ' ' GLU . 3.0 m -124.65 142.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.512 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 716' ' ' VAL . 8.3 p -81.36 123.71 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.648 HD13 ' CZ3' ' A' ' 648' ' ' TRP . 1.3 mp -93.49 163.19 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -103.36 148.79 25.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.95 159.77 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -173.26 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.124 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.79 -28.87 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.031 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -49.67 75.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -47.77 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.582 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.2 tptt -55.89 -32.57 63.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -66.85 -36.64 82.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 11.7 mt -58.11 -44.93 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 724' ' ' LYS . 9.0 p -71.29 -24.48 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -58.29 -32.49 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -112.88 27.11 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.911 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.595 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.587 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.844 0.355 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.56 129.83 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 26.8 mt -117.83 134.62 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.403 ' HD1' HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -178.64 126.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.652 HD21 ' HG2' ' A' ' 617' ' ' ARG . 6.5 mt -122.74 -169.13 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.82 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 16.4 t0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.905 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -106.89 141.97 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -127.12 -61.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.38 139.51 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.608 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.3 m -115.68 115.07 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.163 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.638 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -105.52 108.44 19.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.96 100.19 48.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 16.8 Cg_exo -46.86 100.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.783 1.655 . . . . 0.0 109.473 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.57 157.53 86.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.99 -29.2 26.62 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.701 2.934 . . . . 0.0 112.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.07 -25.1 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.3 t -95.76 153.48 17.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.975 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 689' ' ' VAL . 8.6 tt -53.97 -16.1 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 613' ' ' ILE . 16.5 mt -108.49 136.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.587 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -121.33 55.91 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.976 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.3 mm-40 -124.6 169.62 11.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.645 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.11 118.73 20.93 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 111.508 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.645 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.47 145.53 41.03 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.33 123.37 40.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -78.47 108.82 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -65.57 122.15 16.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.43 -28.48 2.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.166 0.508 . . . . 0.0 110.333 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.54 -22.74 78.81 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.805 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.437 HG11 ' ND2' ' A' ' 610' ' ' ASN . 62.0 t -98.94 117.74 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.093 0.947 . . . . 0.0 111.608 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -140.58 122.61 9.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -89.9 159.79 34.57 Favored 'Cis proline' 0 N--CA 1.46 -0.448 0 C-N-CA 124.299 -1.125 . . . . 0.0 111.618 -0.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.0 t80 -92.41 116.1 28.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 730' ' ' LEU . 40.4 m-85 -92.72 138.27 31.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.169 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.6 mp -124.94 146.27 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.91 -173.95 35.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.245 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -66.84 -50.67 61.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.579 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.51 129.52 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.605 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -20.18 9.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.824 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.575 ' HB3' HD21 ' A' ' 730' ' ' LEU . 3.4 t0 -54.91 -31.72 60.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.172 0.51 . . . . 0.0 110.14 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 621' ' ' VAL . 60.6 m -71.89 126.98 31.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.517 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.5 m120 -42.94 -33.77 0.85 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.318 0.58 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -104.93 141.14 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.894 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.693 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.36 104.81 13.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 612' ' ' LYS . 9.1 mm -138.95 109.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.957 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.45 106.6 17.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 112.346 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.636 ' H ' HD11 ' A' ' 618' ' ' LEU . 0.9 OUTLIER -129.52 107.42 9.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.58 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -38.8 -30.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 681' ' ' ILE . 5.9 tpp180 -68.94 -41.99 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.636 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.6 pp -89.21 156.76 18.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.3 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 162.96 28.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.558 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.6 -26.08 12.45 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.071 0.462 . . . . 0.0 110.36 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.558 HG23 ' HG2' ' A' ' 620' ' ' ARG . 41.2 t -131.31 63.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.471 ' ND1' ' CB ' ' A' ' 618' ' ' LEU . 24.9 t60 -49.73 -44.31 48.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.8 p -169.86 161.58 9.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 111.716 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 727' ' ' VAL . 40.2 p90 -143.59 148.77 36.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.949 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.71 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.1 mp -102.22 130.71 51.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -121.39 134.74 55.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.53 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.8 ttmt -97.92 137.11 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.324 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 158.99 42.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.75 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.9 tpt180 -76.49 112.61 13.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 110.531 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.578 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.838 -0.105 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -99.83 -157.56 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.698 ' O ' HD23 ' A' ' 702' ' ' LEU . 5.1 m-20 -122.19 146.66 47.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.461 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.24 160.35 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.115 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -106.71 123.3 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 112.085 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.83 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.3 m95 -106.4 128.42 54.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.475 ' CB ' HD21 ' A' ' 672' ' ' LEU . 17.3 t80 -90.89 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 17.2 m -103.69 129.53 51.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.424 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.441 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 43.4 t60 -111.53 126.9 55.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 29.4 p -123.36 3.58 9.12 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.279 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.94 142.6 26.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.137 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.5 m -75.38 -19.94 59.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.418 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.576 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m-20 -82.79 3.27 30.12 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.59 133.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.57 0.7 . . . . 0.0 112.38 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 96.3 p -103.92 166.48 10.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.153 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -127.36 119.8 27.06 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.559 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.688 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.01 104.56 16.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.512 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.1 m120 60.11 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.701 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 659' ' ' LEU . 14.6 m-20 -139.35 7.99 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.65 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 716' ' ' VAL . 4.1 m120 -107.97 141.48 39.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.574 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -74.68 141.46 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.2 OUTLIER -129.08 91.41 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.085 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.3 pt -87.5 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.81 104.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.878 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.38 33.89 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.55 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 3.0 p -125.37 162.17 25.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 111.897 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -135.33 149.91 49.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.7 144.87 28.63 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.83 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.18 133.52 48.08 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.748 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -106.31 109.21 21.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -98.83 132.9 43.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.047 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.763 ' HB2' HD12 ' A' ' 696' ' ' ILE . 7.5 t70 -37.01 120.52 0.74 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.98 38.57 5.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.3 t0 -95.44 120.55 35.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 0.0 111.441 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -97.41 113.88 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.3 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD13 ' A' ' 659' ' ' LEU . 27.0 pt -110.06 137.18 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.968 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.6 mttp -101.14 116.34 32.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.055 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.569 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -81.54 -38.24 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.43 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.29 133.96 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.42 124.48 22.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -125.96 117.57 23.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.792 0.329 . . . . 0.0 110.645 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -66.8 -46.52 74.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.899 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.22 -40.52 37.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.9 -11.92 56.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.5 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt 59.93 19.29 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.403 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 2.2 t80 -84.34 105.02 14.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.8 OUTLIER -125.78 126.0 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.037 0.446 . . . . 0.0 111.925 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 681' ' ' ILE . 11.8 mt -119.33 148.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.804 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -168.21 129.03 1.81 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.392 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.469 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.3 141.84 46.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.761 0.315 . . . . 0.0 110.28 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.696 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.9 tptp -101.29 116.45 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.83 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.802 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.96 120.04 33.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.453 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.37 109.32 10.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.958 0.409 . . . . 0.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 674' ' ' ASP . 33.5 mt -75.99 105.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . 0.4 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.0 OUTLIER -83.67 -45.32 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 65.4 m-20 -110.39 141.59 43.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.452 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.2 p -113.52 99.88 8.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.348 0.594 . . . . 0.0 109.957 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 700' ' ' THR . 7.0 t -77.1 62.52 2.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.486 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.42 49.34 70.86 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.818 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -88.18 133.55 34.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.337 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.67 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -33.84 -36.77 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.45 179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -171.98 30.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.862 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.113 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.76 0.314 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 663' ' ' ARG . 88.8 t -80.83 122.8 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -95.47 163.22 13.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.51 146.5 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.2 160.02 14.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.84 -173.46 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.16 28.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -42.02 98.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.166 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 726' ' ' LEU . 6.6 tm-20 -69.99 -51.07 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.464 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -54.33 -32.88 57.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -36.48 81.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.605 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 723' ' ' GLU . 79.9 mt -55.8 -44.05 77.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.694 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.61 HG22 ' CE1' ' A' ' 624' ' ' PHE . 1.5 t -73.95 -23.15 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -36.53 80.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.71 -11.94 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.171 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.785 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.1 tt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.463 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.444 0 CA-C-O 120.359 -0.134 . . . . 0.0 112.884 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 8.2 ttm180 -108.01 143.84 36.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.998 0.428 . . . . 0.0 111.452 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -128.82 -56.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.256 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -111.54 139.59 46.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.904 ' N ' HD23 ' A' ' 578' ' ' LEU . 1.9 m -120.97 114.19 21.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 111.495 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 594' ' ' ILE . 1.5 mp -103.02 108.22 19.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.68 100.88 53.97 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.5 Cg_exo -45.96 101.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.893 1.729 . . . . 0.0 109.357 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -75.12 157.42 85.22 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.59 -27.19 14.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.467 2.778 . . . . 0.0 112.491 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 583' ' ' LEU . 41.8 t0 -62.16 -25.93 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 18.0 p -95.76 154.07 17.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.805 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.456 HD13 ' CE1' ' A' ' 688' ' ' PHE . 0.4 OUTLIER -58.87 -10.73 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.996 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.764 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.3 mt -111.11 118.58 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 111.751 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.05 57.09 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 72.7 mt-10 -124.56 171.86 9.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.286 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.0 126.79 42.03 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.771 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.16 135.56 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.416 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mt-10 -124.5 118.27 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 601' ' ' PHE . 83.8 mt -79.88 108.6 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -62.77 118.1 7.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -45.76 -28.95 1.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.77 -14.23 82.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.908 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.02 118.07 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.941 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 1.1 t30 -140.46 123.52 10.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.736 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.505 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.2 Cg_endo -90.82 159.02 29.69 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.379 -1.092 . . . . 0.0 112.157 0.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.65 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.8 t80 -93.12 117.49 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.197 0.522 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 730' ' ' LEU . 3.5 m-85 -93.53 138.65 31.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.393 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.8 HD11 HD12 ' A' ' 625' ' ' ILE . 3.5 mp -129.61 142.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.43 -158.2 31.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.189 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.4 ttp85 -96.43 -0.63 48.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.13 133.04 46.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -56.76 -24.79 52.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.99 -27.92 63.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 56.2 m -78.14 131.02 37.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.1 m120 -47.65 -30.86 4.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.496 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.8 t -109.14 140.66 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.453 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.31 120.96 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.764 HG23 ' CD1' ' A' ' 588' ' ' ILE . 29.2 mm -137.97 109.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.745 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 tt0 -86.91 102.32 14.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.703 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.813 ' HB2' HD13 ' A' ' 618' ' ' LEU . 3.4 m-20 -133.24 111.47 10.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.37 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -42.5 -33.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.819 0.343 . . . . 0.0 111.48 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -77.76 -41.47 37.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.813 HD13 ' HB2' ' A' ' 615' ' ' ASP . 1.2 mp -59.97 158.95 9.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.97 174.19 6.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.66 -62.94 1.15 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.395 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.0 t -105.18 53.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.519 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 70.7 t60 -43.12 -39.96 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.515 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.36 173.15 12.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.415 0.626 . . . . 0.0 111.447 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.639 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.06 135.2 25.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.973 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.8 HD12 HD11 ' A' ' 603' ' ' ILE . 23.0 mt -131.81 117.12 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -135.16 144.49 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.549 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.3 ptpt -101.0 137.46 39.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.62 159.65 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.275 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.52 117.24 17.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.254 0.55 . . . . 0.0 110.672 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.483 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.805 -0.118 . . . . 0.0 112.805 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -101.14 -157.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.9 OUTLIER -122.36 147.11 46.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.061 0.457 . . . . 0.0 111.697 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.9 160.24 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.519 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -106.97 128.14 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 112.359 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.916 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -112.15 120.57 42.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.574 ' HB3' HD21 ' A' ' 672' ' ' LEU . 1.3 t80 -92.71 117.63 30.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.9 m -111.22 145.07 39.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 42.3 t60 -119.55 125.36 48.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.436 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.2 5.59 11.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.19 134.55 13.35 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.998 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 654' ' ' THR . 54.7 m -65.64 -12.8 56.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.6 OUTLIER -82.35 -2.79 53.98 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.5 0.19 . . . . 0.0 111.339 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.32 128.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.265 0.555 . . . . 0.0 112.071 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.434 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 18.2 p -99.89 166.38 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.142 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 3.9 m-85 -135.54 119.5 17.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.747 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.81 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -98.88 112.25 24.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.033 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.43 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -136.26 2.43 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.889 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -100.59 141.39 33.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.83 0.348 . . . . 0.0 111.024 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 34.5 ttt180 -81.11 141.34 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.738 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.42 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.9 mmm -121.58 100.43 7.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.973 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.404 HG12 ' CG2' ' A' ' 668' ' ' THR . 35.9 pt -87.5 149.39 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -44.43 112.67 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.406 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.79 5.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.8 p -115.22 162.56 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.499 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 717' ' ' LEU . 4.6 ttpm? -134.75 147.71 50.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.127 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.5 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.52 144.28 28.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.916 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 134.72 49.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.729 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 694' ' ' VAL . 1.3 mt -106.69 111.99 24.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.251 0.548 . . . . 0.0 111.27 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -98.33 143.19 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.172 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.515 ' HB3' HD12 ' A' ' 696' ' ' ILE . 26.3 p30 -43.14 111.85 0.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.73 37.94 5.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.64 118.41 29.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.069 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -96.17 108.5 20.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.81 HG22 ' CD2' ' A' ' 659' ' ' LEU . 7.7 pt -105.66 129.16 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.482 . . . . 0.0 111.971 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 5.7 mttt -89.77 115.77 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.717 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.723 HD13 HD21 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -76.05 -39.38 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.854 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.649 HG22 ' CG1' ' A' ' 690' ' ' ILE . 15.6 tt -155.88 136.75 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -135.89 127.79 29.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.119 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.3 116.94 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.245 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -67.03 -46.89 73.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.35 -40.32 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.404 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.38 -16.54 56.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.9 15.92 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.004 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.456 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.2 t80 -77.03 104.61 7.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.1 p -118.99 122.24 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.649 ' CG1' HG22 ' A' ' 681' ' ' ILE . 42.8 mm -128.29 119.7 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.572 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -146.31 133.29 4.84 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.165 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.8 m-30 -113.09 144.56 42.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 110.455 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.713 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -101.17 117.29 34.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 672' ' ' LEU . 3.2 t -81.74 114.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.78 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -123.94 108.58 12.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 0.0 110.372 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.539 HD13 ' O ' ' A' ' 705' ' ' GLU . 18.4 mt -81.86 110.44 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.729 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.5 -45.29 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.54 140.43 46.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.101 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -114.65 100.37 8.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 596' ' ' GLN . 9.3 t -91.08 50.74 1.82 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.479 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 108.52 33.29 2.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.502 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.1 mm? -93.81 120.33 33.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.579 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 4.9 p90 -40.45 -34.33 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.474 0.654 . . . . 0.0 110.339 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -147.88 -44.69 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.539 ' O ' HD13 ' A' ' 696' ' ' ILE . 16.1 pt-20 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 124.69 1.196 . . . . 0.0 108.148 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.889 HG23 ' OD1' ' A' ' 662' ' ' ASN . 59.7 t -79.71 129.67 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.379 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.549 HD11 ' HZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -102.17 172.52 6.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -101.24 157.87 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 0.0 111.189 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.93 152.07 19.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.4 p -126.41 -177.82 4.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.616 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -28.9 36.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.988 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.57 -48.81 78.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.757 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.1 mp0 -69.77 -50.04 47.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.592 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -60.5 -32.05 71.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.41 -40.45 93.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.621 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.2 mt -61.91 -44.4 96.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.591 HG23 HD13 ' A' ' 730' ' ' LEU . 9.3 p -79.49 -12.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.24 -28.53 7.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.984 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -102.08 -63.2 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 602' ' ' PHE . 1.1 tp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.937 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -106.54 143.14 35.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.725 ' CE1' HG21 ' A' ' 647' ' ' ILE . 3.7 t80 -132.69 -47.28 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.748 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.4 tp -121.27 142.44 49.93 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.896 0.379 . . . . 0.0 111.015 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.7 m -120.3 114.94 22.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -104.57 108.59 20.12 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 mtmp? -111.84 99.25 44.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.8 Cg_exo -47.66 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.849 1.699 . . . . 0.0 109.572 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.567 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.58 158.12 85.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -176.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.94 -25.17 8.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.509 2.806 . . . . 0.0 112.731 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 m-20 -61.64 -28.26 69.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' HD13 ' A' ' 690' ' ' ILE . 6.4 t -95.65 154.01 17.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.816 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 690' ' ' ILE . 2.2 pt -57.87 -11.49 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.897 HD13 HG12 ' A' ' 613' ' ' ILE . 19.6 mt -107.6 118.51 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.498 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -106.03 55.73 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.155 0.503 . . . . 0.0 110.332 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.639 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 19.7 mt-10 -125.03 171.67 10.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.192 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.48 129.9 49.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.845 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.801 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.21 141.96 45.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.403 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.2 mt-10 -124.02 110.52 14.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.298 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.78 HD11 HD12 ' A' ' 625' ' ' ILE . 59.3 mt -76.83 109.3 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.6 mp0 -67.03 114.67 5.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.58 -30.61 1.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.217 0.532 . . . . 0.0 110.557 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -64.66 -23.57 68.99 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.149 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.0 119.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.489 0.644 . . . . 0.0 111.34 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 21.7 t30 -138.72 122.26 11.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.9 Cg_endo -90.5 160.34 31.87 Favored 'Cis proline' 0 C--N 1.345 0.383 0 C-N-CA 124.627 -0.989 . . . . 0.0 111.815 -0.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.695 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.36 114.7 27.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.526 ' CG ' HD12 ' A' ' 730' ' ' LEU . 13.9 m-85 -91.84 138.07 31.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.993 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.781 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -127.36 145.41 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.716 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.55 -172.77 33.69 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.945 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.3 OUTLIER -74.02 -6.83 49.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.496 0.319 . . . . 0.0 111.857 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.571 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -89.51 125.01 35.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.811 0.339 . . . . 0.0 111.12 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -59.01 -20.25 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.578 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -23.96 63.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 54.8 m -70.72 130.35 41.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -44.77 -32.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.512 . . . . 0.0 110.347 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.1 t -110.28 139.88 45.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.342 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.12 110.05 16.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.897 HG12 HD13 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -138.45 110.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.892 177.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.498 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 0.2 OUTLIER -85.73 106.41 16.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.296 0.569 . . . . 0.0 112.09 -178.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.998 ' HB2' HD22 ' A' ' 618' ' ' LEU . 1.6 m-20 -129.8 108.32 10.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.138 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -43.71 -37.65 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.327 . . . . 0.0 111.799 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.0 mmt180 -77.82 -34.18 52.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.855 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.998 HD22 ' HB2' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.16 128.11 34.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 111.336 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.4 p -57.16 159.65 4.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.663 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -58.14 -31.29 67.06 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 45.5 t -123.39 55.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.825 ' CD2' HG23 ' A' ' 680' ' ' ILE . 9.5 t60 -49.68 -49.18 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.172 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.7 p -164.08 160.3 21.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.23 0.538 . . . . 0.0 111.989 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 42.1 p90 -143.4 147.61 34.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 580' ' ' LEU . 57.6 mt -102.18 132.65 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.5 t80 -123.9 131.47 53.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.499 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.9 tttt -97.73 136.33 38.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 157.84 45.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.981 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -77.83 113.57 15.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.601 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.722 -0.151 . . . . 0.0 112.722 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.67 -156.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.836 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -122.19 147.51 46.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -136.6 141.71 43.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.319 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -94.67 121.19 45.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.345 0.593 . . . . 0.0 111.709 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.581 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -104.04 133.99 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.448 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 678' ' ' ILE . 12.4 t80 -93.14 117.39 30.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' CB ' ' CE1' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -102.84 136.4 42.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.13 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.445 ' CE1' ' N ' ' A' ' 657' ' ' SER . 14.9 t60 -115.42 126.28 54.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.16 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.421 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -122.89 6.49 9.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.47 157.78 40.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.167 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 41.1 m -89.65 -19.56 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.411 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.0 m120 -83.59 2.92 34.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.658 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 664' ' ' MET . 0.3 OUTLIER 50.14 136.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.735 0.779 . . . . 0.0 112.588 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.445 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -108.55 165.96 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.062 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.52 120.65 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.001 0.429 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 1.033 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.69 100.19 10.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.897 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 15.4 m-20 60.76 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 87.3 m-20 -135.44 2.7 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 11.8 m120 -104.86 135.3 46.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.871 0.367 . . . . 0.0 111.402 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.63 141.47 46.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.713 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.618 ' O ' HG23 ' A' ' 656' ' ' VAL . 44.2 mmm -120.86 88.66 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.144 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 668' ' ' THR . 39.4 pt -87.31 153.26 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.867 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 652' ' ' THR . 13.7 tt0 -42.76 107.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.53 33.1 4.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.426 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.7 p -113.22 162.08 16.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 0.0 111.646 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.1 ttpm? -142.12 129.65 21.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.397 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -136.32 143.13 43.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 111.563 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.581 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -71.42 141.04 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 694' ' ' VAL . 5.4 mt -104.43 148.81 26.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.026 0.441 . . . . 0.0 111.122 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -120.3 162.22 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.73 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.5 t70 -65.61 95.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.55 32.73 2.86 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.2 113.17 20.9 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.711 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -95.74 108.49 20.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 1.033 HG22 HD13 ' A' ' 659' ' ' LEU . 32.9 pt -105.16 134.87 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.772 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.0 mtpt -95.36 115.42 27.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.278 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.825 HG23 ' CD2' ' A' ' 622' ' ' HIS . 32.4 mt -84.55 -34.93 9.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.648 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.57 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.77 130.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.018 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -137.2 126.48 24.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.78 116.54 22.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.496 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -46.5 72.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.727 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.71 -40.41 33.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.562 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.46 -13.56 54.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.352 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 63.43 15.56 8.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.627 0.251 . . . . 0.0 110.959 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -76.94 104.65 7.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.33 126.47 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 0.0 111.873 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.603 HD13 ' OG ' ' A' ' 586' ' ' SER . 21.4 mm -127.68 155.9 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.466 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.07 130.45 1.28 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.359 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 613' ' ' ILE . 10.7 m-30 -113.31 146.23 39.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.354 . . . . 0.0 110.503 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.567 ' HB2' HD22 ' A' ' 583' ' ' LEU . 18.6 tttp -101.35 117.0 34.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.15 126.65 39.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.667 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.9 OUTLIER -133.45 108.84 8.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.942 0.401 . . . . 0.0 110.736 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 705' ' ' GLU . 22.8 mt -73.98 105.18 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.87 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.77 -47.67 10.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.766 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.433 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.54 140.34 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.029 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.7 p -115.0 99.83 7.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.421 ' HB ' ' NZ ' ' A' ' 627' ' ' LYS . 11.6 m -76.18 69.63 2.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.7 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.54 49.39 74.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.867 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -85.66 133.47 34.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.53 0.205 . . . . 0.0 111.158 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.531 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.3 p90 -44.88 -32.22 1.52 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.594 0.712 . . . . 0.0 109.842 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.3 t30 -148.4 -56.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.646 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.677 ' O ' HD13 ' A' ' 696' ' ' ILE . 2.7 pt-20 . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.488 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.785 0.326 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.8 p -82.88 117.67 29.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.89 171.72 10.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 157.68 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.36 154.73 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.919 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 23.7 p -126.24 -176.55 3.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.73 64.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -63.61 -52.25 61.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -64.63 -46.95 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.73 -32.77 65.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.34 -36.92 82.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 31.4 mt -59.78 -44.07 94.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.003 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.9 -20.36 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -50.56 64.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -61.66 -29.12 69.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.0 tt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -106.57 143.3 34.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.362 . . . . 0.0 111.123 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.711 ' HE1' HG21 ' A' ' 647' ' ' ILE . 1.1 t80 -132.96 -51.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.032 HD11 HG13 ' A' ' 694' ' ' VAL . 21.2 tp -114.52 142.59 46.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.555 HG21 ' HE2' ' A' ' 581' ' ' LYS . 7.9 m -122.62 116.6 24.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.945 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.7 mt -103.33 108.83 20.22 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 54.6 mttt -110.57 98.38 36.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -176.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.2 Cg_exo -49.67 106.86 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.793 1.662 . . . . 0.0 109.225 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.04 157.37 87.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 12.0 Cg_endo -54.74 -24.88 39.78 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.07 3.18 . . . . 0.0 113.457 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.542 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.4 m-20 -62.11 -22.31 65.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.069 0.461 . . . . 0.0 109.818 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.457 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 2.0 t -97.69 154.01 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.683 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.527 HD11 ' CE1' ' A' ' 688' ' ' PHE . 7.3 pt -51.22 -21.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.497 . . . . 0.0 110.014 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 690' ' ' ILE . 38.9 mt -105.16 118.84 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.71 59.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.649 . . . . 0.0 110.264 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.66 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.78 172.56 9.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.727 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.18 131.55 53.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.758 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.62 143.96 42.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.207 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.05 116.61 23.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 111.708 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.87 HD11 HD12 ' A' ' 625' ' ' ILE . 73.0 mt -81.89 109.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.879 0.371 . . . . 0.0 110.443 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 1.4 mp0 -65.08 115.63 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.34 -30.51 2.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.258 0.551 . . . . 0.0 110.681 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -20.21 72.76 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.23 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.24 118.92 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 117.35 0.575 . . . . 0.0 111.65 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.9 t30 -139.35 121.53 10.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.72 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -89.99 160.46 34.45 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 124.555 -1.019 . . . . 0.0 111.63 -0.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.664 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.42 116.63 29.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 20.8 m-85 -92.62 138.57 31.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.29 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -129.08 141.84 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.87 -170.2 38.31 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 119.964 -1.113 . . . . 0.0 113.92 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 ttp85 -80.33 1.44 28.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.356 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 14.4 t -101.19 119.78 39.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -51.72 -24.64 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.015 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -61.4 -26.71 68.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.991 0.424 . . . . 0.0 110.391 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.2 m -71.57 128.75 36.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.853 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -43.43 -34.63 1.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.289 0.566 . . . . 0.0 110.287 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 50.7 t -106.29 141.29 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.099 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 111.47 20.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.682 HG23 ' CD1' ' A' ' 588' ' ' ILE . 18.3 mm -137.73 108.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.127 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.19 106.6 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.662 . . . . 0.0 112.497 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.544 ' CB ' HD13 ' A' ' 618' ' ' LEU . 5.0 t70 -130.53 125.93 35.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.722 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -43.64 -34.18 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.778 0.323 . . . . 0.0 111.223 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB2' HD13 ' A' ' 681' ' ' ILE . 26.2 mmt180 -77.35 -39.06 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.686 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -59.54 158.21 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.06 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.07 163.92 13.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.304 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.452 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -46.04 -55.33 7.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 730' ' ' LEU . 39.5 t -110.08 62.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.421 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.686 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.6 t60 -47.1 -48.09 22.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.576 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 680' ' ' ILE . 24.7 p -166.82 157.12 11.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.2 p90 -144.12 143.67 31.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.889 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.87 HD12 HD11 ' A' ' 594' ' ' ILE . 45.5 mt -101.59 131.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -122.46 132.52 54.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 702' ' ' LEU . 7.6 ttmt -98.07 136.53 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.545 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.8 158.66 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.197 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.94 113.47 14.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.536 0.684 . . . . 0.0 110.391 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.0 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.269 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -93.95 -159.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 1.4 m-20 -119.58 146.9 45.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 112.206 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -127.05 160.16 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.777 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.837 HD13 HD22 ' A' ' 578' ' ' LEU . 2.6 pt -111.22 120.98 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.587 . . . . 0.0 111.902 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.54 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -103.05 136.28 43.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.483 ' HE2' ' HG ' ' A' ' 657' ' ' SER . 9.2 t80 -99.08 119.37 37.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.851 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 6.9 m -110.0 141.87 42.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.035 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 34.0 t60 -121.74 122.76 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 621' ' ' VAL . 0.6 OUTLIER -116.15 11.36 15.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.44 139.72 15.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.811 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 654' ' ' THR . 26.3 m -72.49 -8.17 53.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.58 ' C ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -85.43 2.78 43.05 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' C ' ' A' ' 655' ' ' ASN . 1.8 m 60.21 146.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 111.275 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.483 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 0.3 OUTLIER -116.16 162.61 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.085 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -137.44 120.37 16.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.362 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.856 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -108.6 116.67 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.131 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 60.24 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.95 2.12 2.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -102.23 141.24 35.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.638 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -94.11 141.71 28.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.505 ' HB2' ' OG1' ' A' ' 668' ' ' THR . 4.5 ptp -138.04 142.68 40.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.405 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.443 ' H ' HG21 ' A' ' 668' ' ' THR . 17.7 pt -112.12 165.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.393 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -47.15 117.59 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.955 0.407 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 101.58 23.08 9.7 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 664' ' ' MET . 10.9 p -112.24 162.37 15.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.462 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.408 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 3.2 ttpm? -134.94 145.04 47.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.659 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -145.95 134.36 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.943 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.54 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -68.69 140.54 55.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 1.001 HD13 HG21 ' A' ' 694' ' ' VAL . 9.3 mt -110.07 122.79 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 0.0 111.906 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 47.0 mt-30 -104.18 137.6 41.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.593 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.618 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.7 t70 -40.52 108.82 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.975 0.417 . . . . 0.0 111.007 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.92 35.55 4.79 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 3.0 t0 -95.55 122.81 38.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.329 . . . . 0.0 111.079 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.02 108.38 20.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.856 HG22 ' CD2' ' A' ' 659' ' ' LEU . 5.5 pt -106.55 131.95 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 112.141 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 3.1 mtmt -104.01 127.03 51.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.02 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.861 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -95.11 -25.15 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.744 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.678 HG22 ' CG2' ' A' ' 690' ' ' ILE . 7.6 tt -155.23 131.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -136.59 126.7 26.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.746 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.4 117.03 28.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.644 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -67.04 -46.53 74.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.877 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -79.87 -40.41 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.601 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -79.98 -20.24 45.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.294 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 8.97 6.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.223 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 587' ' ' ILE . 1.7 t80 -77.02 105.15 7.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.3 p -119.64 121.87 67.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.451 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 588' ' ' ILE . 2.4 tt -120.8 121.44 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.5 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -140.39 137.95 8.69 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.331 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.3 m-30 -113.35 142.33 45.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -100.96 117.37 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.023 0.44 . . . . 0.0 110.925 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -83.66 122.51 37.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.565 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.09 109.59 9.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 705' ' ' GLU . 27.5 mt -77.32 108.62 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.937 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.36 -43.36 9.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.08 141.54 42.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER -114.23 100.56 8.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.38 0.61 . . . . 0.0 109.671 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.4 57.83 4.21 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 81.56 37.97 15.68 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.24 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.47 134.55 38.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.522 0.201 . . . . 0.0 110.591 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.641 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.3 p90 -43.62 -33.27 1.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.472 0.653 . . . . 0.0 110.323 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -147.98 -61.25 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.676 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 696' ' ' ILE . 16.6 pt-20 . . . . . 0 N--CA 1.463 0.188 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.043 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.915 0.388 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.861 HG23 ' OD1' ' A' ' 662' ' ' ASN . 90.4 t -78.29 118.43 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.32 172.02 8.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.52 154.31 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -91.29 156.31 17.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -126.02 -173.96 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.85 -33.5 64.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.23 -50.49 73.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 726' ' ' LEU . 25.3 mm-40 -65.53 -50.26 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -57.93 -32.93 68.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -63.57 -38.69 92.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.72 HD22 ' HD3' ' A' ' 600' ' ' PRO . 9.5 mt -61.06 -44.52 97.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.3 p -73.5 -26.83 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -58.57 -30.93 67.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -86.67 -18.87 30.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.159 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 9.1 ttm180 -112.09 119.56 38.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.797 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.2 t80 -100.91 -46.31 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 647' ' ' ILE . 7.9 tp -120.69 142.54 49.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 111.485 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 695' ' ' GLU . 15.0 m -122.26 114.56 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.488 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.735 HD11 HD11 ' A' ' 625' ' ' ILE . 0.3 OUTLIER -103.66 108.59 19.94 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 25.4 mtmt -111.65 98.77 42.33 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_exo -46.84 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.838 1.692 . . . . 0.0 109.47 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.64 157.46 85.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.435 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.5 Cg_exo -49.73 -25.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.583 2.855 . . . . 0.0 112.704 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.79 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -62.06 -27.52 68.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 4.2 t -95.63 153.94 17.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.749 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.436 HG12 ' CD1' ' A' ' 690' ' ' ILE . 8.3 pt -54.94 -13.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.649 ' CD1' HG23 ' A' ' 613' ' ' ILE . 51.1 mt -108.78 128.7 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.802 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -113.99 56.43 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.212 0.529 . . . . 0.0 110.256 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -124.62 171.97 9.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.58 128.65 45.94 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 178.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.764 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.08 139.94 47.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.708 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.2 113.82 18.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.021 HD11 HD12 ' A' ' 625' ' ' ILE . 71.6 mt -78.71 109.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.321 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.76 116.09 6.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.814 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -44.97 -32.42 1.63 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.224 0.535 . . . . 0.0 110.293 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.508 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.7 -18.78 74.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.747 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.563 HG11 ' ND2' ' A' ' 610' ' ' ASN . 56.4 t -100.5 118.59 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 117.769 0.785 . . . . 0.0 111.686 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.83 121.96 9.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.914 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.1 Cg_endo -90.42 160.26 32.22 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.545 -1.023 . . . . 0.0 111.659 -0.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -91.64 116.32 28.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 59.7 m-85 -91.91 138.04 31.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.897 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -129.87 145.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.831 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.36 -169.15 36.82 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -83.21 3.39 31.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.768 -0.216 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 7.2 t -101.29 126.32 48.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -57.31 -22.72 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.61 ' HB3' HD21 ' A' ' 730' ' ' LEU . 6.0 t0 -64.12 -25.43 68.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.665 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 89.9 m -73.41 132.91 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 22.8 m-20 -48.48 -27.4 2.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.764 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -114.55 142.02 46.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 118.59 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 588' ' ' ILE . 32.5 mm -138.16 109.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.216 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 14.0 tt0 -89.94 102.98 15.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.797 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.52 112.89 12.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.212 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -43.57 -34.08 1.31 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.733 0.302 . . . . 0.0 111.392 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -77.55 -39.67 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.688 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.066 HD12 HD12 ' A' ' 681' ' ' ILE . 0.4 OUTLIER -61.12 159.2 12.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.541 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.1 m -110.29 167.21 10.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.44 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.3 OUTLIER -44.65 -55.51 5.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 110.229 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 727' ' ' VAL . 18.5 t -112.66 57.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.477 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 681' ' ' ILE . 43.1 t60 -45.57 -46.02 13.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.617 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 680' ' ' ILE . 7.0 p -167.1 155.86 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.3 p90 -143.32 147.96 35.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 594' ' ' ILE . 86.1 mt -102.65 139.79 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.972 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -131.44 133.62 45.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.506 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 700' ' ' THR . 29.3 ttmt -97.57 136.1 38.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.559 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 159.55 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.861 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 630' ' ' HIS . 0.9 OUTLIER -76.08 139.61 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.2 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t-160 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.409 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.591 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.726 -0.149 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.822 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.3 OUTLIER -102.78 -153.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -122.37 147.44 46.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.277 0.56 . . . . 0.0 112.099 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -130.09 154.57 47.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 578' ' ' LEU . 4.0 pt -105.39 128.72 59.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.26 0.552 . . . . 0.0 111.844 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.868 ' CH2' HD22 ' A' ' 671' ' ' LEU . 78.8 m95 -111.74 140.79 46.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.756 ' CE2' HG21 ' A' ' 678' ' ' ILE . 13.4 t80 -104.62 117.25 33.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 97.1 m -105.6 126.2 51.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.423 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 23.8 t60 -104.36 122.79 46.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.67 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.479 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.44 5.24 13.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.57 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.64 146.14 20.57 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.043 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 654' ' ' THR . 37.6 m -79.6 -1.11 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.577 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -87.08 0.42 55.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.442 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.42 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.348 0.594 . . . . 0.0 111.87 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 11.9 p -102.54 165.65 10.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.669 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -137.03 119.95 16.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.783 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.76 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -97.25 106.08 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.91 -81.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -131.36 -4.27 3.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.592 ' HB3' HG23 ' A' ' 716' ' ' VAL . 6.1 m120 -97.43 138.65 34.55 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.751 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.9 ttm180 -85.26 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 2.6 mtp -130.17 122.88 29.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 0.0 111.14 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.506 ' H ' HG21 ' A' ' 668' ' ' THR . 20.7 pt -103.4 165.18 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.656 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.1 tt0 -51.16 117.64 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 110.868 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.74 8.0 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.309 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.506 HG21 ' H ' ' A' ' 665' ' ' ILE . 16.6 p -112.77 162.19 16.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.978 0.418 . . . . 0.0 111.419 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.419 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.3 ttpm? -136.48 144.06 44.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.536 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.529 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.27 144.82 29.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.868 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.65 136.72 53.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.775 HD13 HG21 ' A' ' 694' ' ' VAL . 1.6 mt -108.19 127.89 54.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 0.6 OUTLIER -118.1 161.26 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.132 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.486 ' HB2' HD12 ' A' ' 696' ' ' ILE . 60.1 t0 -58.37 104.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.303 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.72 32.84 4.95 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -86.71 115.61 24.27 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.673 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.83 108.91 21.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.76 HG23 ' HG ' ' A' ' 659' ' ' LEU . 4.7 mt -105.16 131.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 0.0 112.036 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -93.32 115.54 28.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.182 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.627 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.3 OUTLIER -86.41 -37.89 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.136 -179.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.066 HD12 HD12 ' A' ' 618' ' ' LEU . 43.9 mt -155.36 130.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.392 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -136.79 127.09 26.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 4.0 t0 -126.35 116.56 21.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.37 . . . . 0.0 110.686 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -67.81 -46.2 72.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -58.55 -40.28 82.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.128 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -96.22 -20.24 18.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.5 tptp 72.04 1.91 4.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.318 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.67 105.37 7.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 586' ' ' SER . 3.6 p -110.78 138.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.913 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 587' ' ' ILE . 8.3 mm -112.65 145.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.55 128.57 1.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.4 m-30 -113.2 148.31 35.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 110.323 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.676 ' HB2' HD22 ' A' ' 583' ' ' LEU . 31.4 tttt -101.62 117.02 34.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.05 0.453 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.82 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.8 t -81.66 126.11 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.4 tt0 -133.98 108.69 8.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.746 HD13 ' HB2' ' A' ' 705' ' ' GLU . 34.1 mt -74.0 105.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.674 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.92 -47.61 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.875 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.478 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.6 t0 -111.08 140.06 45.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -115.14 100.62 8.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.166 0.507 . . . . 0.0 109.726 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.48 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.2 t -69.79 65.34 0.22 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.64 57.22 20.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.754 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.822 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -95.91 149.38 21.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 112.048 -179.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.547 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.72 -26.95 6.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.189 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.461 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.2 t30 -160.13 -51.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.586 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.746 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.6 pt-20 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.729 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.818 0.342 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 663' ' ' ARG . 53.6 t -81.95 114.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.093 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 717' ' ' LEU . 4.2 mp -88.1 170.16 11.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.567 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -103.75 158.1 16.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -95.4 158.2 15.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.0 p -126.31 -176.49 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.56 -30.42 41.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.17 -45.01 96.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.585 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.9 mp0 -68.84 -49.67 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.557 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -56.25 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -41.8 89.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.4 mt -55.68 -44.33 77.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -76.56 -29.31 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -37.53 67.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.62 28.63 3.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 608' ' ' ASP . 4.3 tt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.655 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.393 -0.115 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.413 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 60.2 ttp180 -100.31 128.91 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.9 -57.55 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.364 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -108.82 137.56 46.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.75 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.7 m -116.95 114.6 24.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.012 HD12 HD11 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -103.56 108.03 19.13 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.32 100.46 53.48 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.8 Cg_exo -47.22 103.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.736 1.624 . . . . 0.0 109.545 176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.85 158.36 86.09 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.46 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 7.6 Cg_endo -49.66 -26.18 12.52 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.512 2.808 . . . . 0.0 112.705 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 583' ' ' LEU . 92.8 m-20 -63.5 -19.83 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.012 0.434 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 t -96.76 153.86 17.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.848 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.672 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -55.49 -20.49 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.695 HD12 HG23 ' A' ' 613' ' ' ILE . 59.7 mt -110.55 118.8 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.078 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.1 61.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.374 0.607 . . . . 0.0 110.307 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.93 171.95 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.835 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.28 132.61 53.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.026 0.441 . . . . 0.0 111.384 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.9 144.81 41.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.116 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.4 mt-10 -124.28 116.73 23.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 580' ' ' LEU . 66.7 mt -87.54 108.81 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -66.93 125.2 25.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.49 -30.02 2.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.286 0.565 . . . . 0.0 110.148 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.454 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.6 -21.4 79.58 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 114.085 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.429 HG11 ' ND2' ' A' ' 610' ' ' ASN . 63.5 t -98.95 117.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.253 1.026 . . . . 0.0 111.797 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.7 t30 -140.51 121.28 9.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.917 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 40.4 Cg_endo -90.43 159.71 31.91 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.606 -0.998 . . . . 0.0 111.375 -0.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.663 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -92.16 117.41 29.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.499 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 14.2 m-85 -92.22 137.9 31.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.173 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.644 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -128.45 146.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.412 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.81 -165.88 37.78 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.89 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.7 OUTLIER -85.86 -6.65 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.519 -0.34 . . . . 0.0 111.767 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.0 130.79 47.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.323 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.36 -24.73 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.55 -28.96 61.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 110.528 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 92.9 m -73.65 133.09 43.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.486 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.515 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -47.91 -27.03 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.3 t -114.48 141.31 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.489 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.82 114.48 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.695 HG23 HD12 ' A' ' 588' ' ' ILE . 27.6 mm -137.9 109.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.187 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.4 pt-20 -92.01 103.02 15.58 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.846 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.672 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -132.88 110.94 10.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.318 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.97 -24.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.4 mmp_? -77.38 -41.38 40.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.937 HD23 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -84.75 158.7 20.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 111.535 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.8 t -93.55 178.25 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.719 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -47.13 -53.99 11.6 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.425 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 730' ' ' LEU . 33.7 t -113.87 62.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.211 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.7 ' CD2' HG23 ' A' ' 680' ' ' ILE . 59.1 t60 -48.86 -51.06 31.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.535 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 3.7 p -162.55 157.49 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.446 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.508 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.5 p90 -143.52 150.53 39.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.505 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -102.08 126.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -120.38 133.98 55.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 25.0 ttmt -98.06 137.16 37.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.235 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.55 159.21 42.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.791 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -76.21 111.95 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.344 0.592 . . . . 0.0 110.112 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.536 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 703' ' ' PHE . 23.4 mt -106.93 -154.26 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.932 -0.158 . . . . 0.0 110.707 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 702' ' ' LEU . 4.6 m-20 -116.34 147.3 41.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.022 0.439 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.875 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -131.92 155.72 47.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.225 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -105.87 119.87 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 121.563 0.697 . . . . 0.0 112.346 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.657 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.4 m95 -103.59 128.29 50.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.636 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.565 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.7 t80 -90.16 115.72 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.8 m -98.25 137.59 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 111.549 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 23.0 t60 -121.55 121.62 37.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.509 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 22.6 p -119.48 3.18 11.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.49 146.7 29.03 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.883 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.33 -13.59 59.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -83.43 2.35 37.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.48 137.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.612 0.72 . . . . 0.0 111.992 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 680' ' ' ILE . 40.9 m -112.42 166.42 11.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.481 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.39 120.07 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.69 99.67 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.5 m120 60.51 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.2 t30 -131.79 -0.38 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.683 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.91 141.05 36.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -77.01 141.88 40.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.775 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.5 mmm -121.2 91.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.1 pt -87.39 159.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 652' ' ' THR . 19.6 tt0 -55.3 108.06 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.236 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.0 34.48 2.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.918 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.0 p -134.68 159.77 40.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 111.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 16.0 pttm -136.78 139.8 42.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.775 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 14.3 t80 -131.64 144.61 51.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.875 HD21 ' HB3' ' A' ' 646' ' ' ASP . 1.2 mt -68.89 134.56 49.77 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.179 0.514 . . . . 0.0 111.849 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 694' ' ' VAL . 4.0 mt -104.46 135.31 46.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.219 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -119.7 146.7 45.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.307 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 696' ' ' ILE . 10.8 t70 -45.9 104.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.88 32.46 4.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 112.07 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -95.47 108.26 20.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 659' ' ' LEU . 36.3 pt -106.03 137.42 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.341 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.23 115.52 27.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.109 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.7 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.1 mt -81.68 -38.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.441 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.937 HD12 HD23 ' A' ' 618' ' ' LEU . 14.0 mt -155.3 131.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.931 0.396 . . . . 0.0 111.556 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.63 123.05 20.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 116.68 21.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.536 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -46.67 71.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.982 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -71.63 -40.56 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.799 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -89.81 -6.23 56.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.445 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 58.78 19.04 6.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.676 0.274 . . . . 0.0 110.798 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CD2' ' CG ' ' A' ' 617' ' ' ARG . 0.1 OUTLIER -79.05 104.34 9.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.0 p -117.88 121.79 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.194 0.521 . . . . 0.0 111.447 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.425 HD11 HG12 ' A' ' 587' ' ' ILE . 33.3 mm -128.24 137.27 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.881 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -167.66 131.04 2.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.045 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.9 m-30 -113.14 144.72 42.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.664 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 22.1 ttpt -101.7 117.23 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.068 0.461 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 672' ' ' LEU . 3.1 t -79.04 119.7 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.649 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.7 tt0 -126.45 109.16 11.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.061 0.457 . . . . 0.0 110.233 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 705' ' ' GLU . 58.2 mt -79.79 105.46 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -49.01 8.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -111.38 138.44 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.796 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 68.9 p -116.14 99.87 7.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 700' ' ' THR . 8.4 t -77.42 61.0 2.15 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.42 43.43 58.14 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.067 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.867 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -97.1 32.9 2.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.953 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.687 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER 61.55 109.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 7.2 t30 56.14 -69.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.145 0.498 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 702' ' ' LEU . 9.1 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.765 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.589 0.233 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.51 130.22 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.414 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.58 169.73 9.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 156.43 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.974 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.83 150.78 25.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -126.12 -178.44 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.52 57.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.187 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.06 -49.22 76.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -48.29 71.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.736 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.57 -32.97 67.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.44 -36.85 85.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.42 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.1 mt -60.51 -44.15 96.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.0 p -76.55 -24.03 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.65 -46.06 66.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -64.26 -25.97 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 621' ' ' VAL . 7.2 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.466 0 N-CA-C 112.83 -0.108 . . . . 0.0 112.83 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.421 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 58.4 ttp180 -112.03 143.33 43.22 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.306 -0.526 . . . . 0.0 111.209 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -128.07 -62.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.549 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.016 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.46 125.68 51.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.307 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.598 HG22 ' HG3' ' A' ' 581' ' ' LYS . 6.8 m -109.23 118.49 36.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.532 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.7 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.56 108.25 19.67 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.598 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.27 99.22 39.23 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 50.4 Cg_exo -47.47 97.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.792 1.661 . . . . 0.0 109.607 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.79 158.14 85.04 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.408 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.0 Cg_endo -49.7 -25.55 11.6 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.55 2.833 . . . . 0.0 112.549 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 583' ' ' LEU . 23.7 t70 -62.1 -25.43 67.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.477 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.8 t -95.61 153.93 17.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.691 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.629 HG21 ' HD1' ' A' ' 688' ' ' PHE . 0.9 OUTLIER -57.03 -12.34 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 0.0 111.284 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.718 HD13 HG23 ' A' ' 613' ' ' ILE . 30.4 mt -112.44 129.62 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -111.46 57.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.486 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.9 mt-10 -124.64 172.04 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.127 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -125.9 130.47 51.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.6 OUTLIER -112.74 142.51 45.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.101 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.27 120.43 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.865 HD12 HD22 ' A' ' 578' ' ' LEU . 78.6 mt -89.34 109.07 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -68.14 122.47 18.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.85 -29.95 2.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.221 0.534 . . . . 0.0 110.537 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.55 -22.04 77.79 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.942 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.584 HG11 ' ND2' ' A' ' 610' ' ' ASN . 64.0 t -101.07 118.26 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.934 0.867 . . . . 0.0 111.841 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 19.1 t30 -139.85 122.32 10.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.742 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -90.21 159.52 32.9 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.372 -1.095 . . . . 0.0 111.673 -0.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.2 t80 -92.07 114.28 26.78 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.617 ' CG ' HD12 ' A' ' 730' ' ' LEU . 3.3 m-85 -92.39 138.48 31.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.184 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.765 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -125.78 143.44 39.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.79 -174.08 43.39 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.375 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.5 ttp85 -82.03 -4.46 56.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.617 0.246 . . . . 0.0 111.455 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.98 126.43 47.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.777 0.322 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -49.94 -26.58 4.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.55 -28.85 48.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.958 0.408 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 35.2 m -75.02 133.4 41.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.5 m-20 -49.61 -26.95 4.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.457 . . . . 0.0 110.417 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.774 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.0 t -111.54 142.66 43.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 115.17 24.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.718 HG23 HD13 ' A' ' 588' ' ' ILE . 24.6 mm -137.88 109.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.011 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 28.6 tt0 -89.29 104.1 16.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.249 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.825 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.85 113.24 13.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.228 178.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -41.23 -38.61 1.16 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 681' ' ' ILE . 1.3 mmp_? -77.46 -35.11 54.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -58.99 157.94 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.73 164.43 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.96 -50.01 19.73 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.126 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 727' ' ' VAL . 54.7 t -115.67 63.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.498 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.643 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.9 t60 -45.78 -48.22 15.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.477 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 31.7 p -172.39 162.88 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 650' ' ' CYS . 46.0 p90 -144.18 144.2 31.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.5 mp -102.55 130.67 52.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.1 t80 -121.67 133.61 54.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.1 tppp? -97.94 136.03 38.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.769 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 158.7 43.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.84 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.19 112.96 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.451 0.644 . . . . 0.0 110.366 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.2 t60 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.131 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.272 0 CA-C-O 120.536 -0.036 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.9 mp -114.68 -156.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.739 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -118.4 146.84 44.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.049 0.452 . . . . 0.0 111.65 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 3.0 t0 -133.47 160.3 37.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.589 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.016 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -109.08 122.64 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.795 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.945 ' CH2' HD22 ' A' ' 671' ' ' LEU . 93.1 m95 -109.99 126.85 54.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.399 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.57 ' HE2' ' HG ' ' A' ' 623' ' ' CYS . 9.9 t80 -90.67 122.24 33.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.162 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 7.9 m -111.02 128.14 55.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 657' ' ' SER . 70.5 t60 -106.11 130.11 54.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.382 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -126.24 3.63 7.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.288 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.53 141.07 20.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.043 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.516 ' O ' HG22 ' A' ' 654' ' ' THR . 87.4 m -75.6 -5.6 46.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.44 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.3 m120 -87.24 0.04 55.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.722 0.296 . . . . 0.0 111.316 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.3 t 67.59 146.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.461 ' HB3' ' CG ' ' A' ' 651' ' ' HIS . 0.9 OUTLIER -118.24 158.66 24.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.379 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -138.58 119.68 14.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.359 . . . . 0.0 110.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -108.06 112.49 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.83 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.46 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.02 0.19 1.53 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.474 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -96.65 141.82 29.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -79.51 141.91 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.482 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 34.9 mmm -124.78 102.77 7.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.118 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 44.2 pt -87.99 151.43 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -47.5 107.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.955 0.407 . . . . 0.0 111.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.51 36.18 2.69 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.132 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 665' ' ' ILE . 2.9 p -122.69 162.2 22.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 111.519 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.444 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -129.42 153.23 48.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.02 143.31 28.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.945 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -73.23 123.08 22.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.217 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.76 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.1 mt -98.71 140.48 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.432 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.554 ' HB2' HD12 ' A' ' 696' ' ' ILE . 29.1 t0 -43.04 113.76 0.52 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 95.95 35.51 5.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.42 121.61 36.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.356 . . . . 0.0 110.914 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -96.15 108.62 21.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.987 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.2 mt -108.13 136.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.07 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.499 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 20.0 mttt -107.83 116.59 32.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.812 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.652 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -88.02 -30.55 5.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.858 -178.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 617' ' ' ARG . 15.8 tt -155.03 130.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.523 . . . . 0.0 112.193 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.636 ' CD1' HG23 ' A' ' 689' ' ' VAL . 9.0 t90 -137.43 128.34 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.375 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -126.72 116.38 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 0.0 111.152 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -68.5 -46.61 69.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.992 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -58.71 -40.64 84.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.054 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.94 -15.47 22.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.451 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 70.64 3.31 4.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.072 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.629 ' HD1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.46 104.18 7.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.636 HG23 ' CD1' ' A' ' 682' ' ' TRP . 2.6 p -113.3 137.33 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.807 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 587' ' ' ILE . 28.8 mm -116.19 155.24 17.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.67 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . 179.28 124.92 0.91 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.86 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.8 m-30 -112.67 143.26 44.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 0.0 110.552 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.4 tptt -101.09 117.55 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.113 0.482 . . . . 0.0 110.702 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 578' ' ' LEU . 8.2 t -82.45 126.94 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.8 tt0 -133.76 109.44 9.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 674' ' ' ASP . 67.7 mt -77.55 105.68 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.869 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -80.5 -44.55 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.247 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -110.44 140.82 44.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.032 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.8 p -114.78 99.81 7.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.093 0.473 . . . . 0.0 109.895 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 t -80.69 60.31 3.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.481 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.96 58.93 11.6 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.925 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -85.04 144.0 28.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.551 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.644 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -37.43 -47.99 0.92 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.695 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.508 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -143.51 5.74 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.19 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.2 pt-20 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 82.2 t -99.04 113.91 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.83 172.19 8.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.89 16.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -90.79 152.61 20.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 59.9 p -126.21 -175.21 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.35 65.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.51 -47.2 82.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -66.41 -45.26 80.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -32.71 68.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.31 -37.82 83.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 723' ' ' GLU . 16.8 mt -58.61 -44.34 89.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 621' ' ' VAL . 12.0 p -81.39 -22.1 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -40.08 66.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -75.56 -15.91 60.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.617 HD12 ' CG ' ' A' ' 602' ' ' PHE . 9.9 tt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.616 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 ttm180 -97.7 142.03 29.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 122.501 -0.411 . . . . 0.0 110.581 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -131.3 -60.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 647' ' ' ILE . 6.7 tt -106.55 134.68 49.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.858 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.1 m -115.5 114.66 25.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.731 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.2 mp -105.18 108.04 19.35 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 pttp -113.46 100.32 51.53 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.62 ' CB ' HG23 ' A' ' 588' ' ' ILE . 53.2 Cg_exo -46.07 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.91 1.74 . . . . 0.0 109.795 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.69 158.52 84.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.441 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 83.7 Cg_exo -48.03 -24.72 5.68 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.493 2.795 . . . . 0.0 112.759 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -61.45 -23.37 65.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 6.4 t -95.49 153.59 17.62 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.92 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.65 HD13 HD11 ' A' ' 690' ' ' ILE . 4.3 pt -54.46 -17.85 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 582' ' ' PRO . 6.4 tt -112.46 142.83 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.77 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.8 OUTLIER -120.31 65.89 0.83 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.351 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.598 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.6 mm-40 -124.75 171.57 10.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.276 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.89 125.67 40.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.954 0.406 . . . . 0.0 111.084 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.65 138.66 49.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.771 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 8.7 mt-10 -124.25 122.4 37.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.828 HD11 HD13 ' A' ' 625' ' ' ILE . 67.8 mt -85.12 109.21 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.116 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -63.68 114.0 3.71 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.006 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.534 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.9 -32.72 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.9 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.509 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.63 -21.05 76.19 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.689 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.19 118.49 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.864 0.832 . . . . 0.0 111.917 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.18 123.08 10.14 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.981 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.567 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -90.06 159.31 33.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.334 -1.111 . . . . 0.0 111.799 0.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 610' ' ' ASN . 2.6 t80 -92.87 117.72 30.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.673 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.3 m-85 -92.79 138.2 31.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.648 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 625' ' ' ILE . 2.4 mp -128.28 149.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.957 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.78 -176.69 40.55 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.962 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -79.25 -4.51 51.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.212 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 130.21 47.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 111.052 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -25.13 19.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.32 -29.01 46.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.783 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 730' ' ' LEU . 58.1 m -77.77 136.88 38.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.4 OUTLIER -51.32 -23.77 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.793 ' SG ' HD13 ' A' ' 592' ' ' LEU . 51.5 t -117.29 143.38 45.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.696 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -120.43 119.77 34.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 592' ' ' LEU . 25.4 mm -137.57 109.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.987 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.67 102.53 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.867 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.613 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.18 113.55 13.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.837 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -44.04 -36.43 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.821 0.343 . . . . 0.0 111.603 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.573 ' CB ' HD13 ' A' ' 681' ' ' ILE . 1.4 mmt180 -77.53 -31.19 53.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.087 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.3 mp -59.51 159.48 8.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.8 p -114.02 164.52 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.173 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -45.8 -45.4 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.686 HG11 ' CG2' ' A' ' 727' ' ' VAL . 13.7 t -124.89 61.44 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.392 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.511 ' NE2' HG23 ' A' ' 680' ' ' ILE . 21.3 t60 -50.05 -48.57 52.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.951 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.545 ' SG ' HD11 ' A' ' 680' ' ' ILE . 6.5 p -166.89 158.4 12.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.621 ' HA ' HD12 ' A' ' 603' ' ' ILE . 47.9 p90 -143.39 146.89 33.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.909 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.828 HD13 HD11 ' A' ' 594' ' ' ILE . 2.6 mp -102.2 130.96 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.918 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -124.34 131.58 53.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.618 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 20.1 ttmt -98.15 135.99 39.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.14 158.0 41.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.171 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.01 122.26 24.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 110.499 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.6 t60 . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.273 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -88.78 -155.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.83 147.12 46.9 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.413 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -125.65 160.26 30.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.007 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -113.34 121.21 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.39 0.614 . . . . 0.0 111.927 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.534 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.2 m95 -107.26 126.56 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.417 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.533 ' CB ' HD21 ' A' ' 672' ' ' LEU . 8.6 t80 -91.03 117.74 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 12.5 m -105.74 134.27 49.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.518 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 26.2 t60 -115.51 124.18 50.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -118.67 6.26 11.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.395 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.26 151.12 29.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.6 m -81.34 -10.16 59.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.565 ' O ' HG13 ' A' ' 656' ' ' VAL . 61.1 m-20 -87.03 2.72 48.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 50.4 130.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.337 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.502 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 1.8 t -103.01 166.21 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.191 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -131.0 120.15 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.15 99.7 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.59 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.9 m120 61.31 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.748 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 70.0 m-20 -131.65 -2.1 3.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.722 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.61 135.02 42.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 111.325 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -73.65 141.8 46.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.42 ' O ' HG23 ' A' ' 656' ' ' VAL . 14.9 mmm -126.52 93.0 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 ' CG2' ' A' ' 668' ' ' THR . 36.4 pt -87.21 158.38 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 652' ' ' THR . 26.6 tt0 -46.42 116.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.193 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.48 28.64 8.87 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.409 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.424 ' CG2' HG12 ' A' ' 665' ' ' ILE . 17.5 p -112.93 162.34 15.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.37 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.489 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.4 ttpm? -141.91 129.66 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.645 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.5 t80 -134.04 144.25 48.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.439 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.534 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.49 140.36 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 112.051 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.916 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -108.82 129.44 55.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.183 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 3.9 mt-30 -115.45 146.0 42.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.512 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 696' ' ' ILE . 28.5 t0 -46.76 105.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.085 0.469 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.2 33.17 4.36 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -92.79 111.96 23.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.803 0.335 . . . . 0.0 111.263 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.8 108.53 20.87 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 1.031 HG22 HD13 ' A' ' 659' ' ' LEU . 34.2 pt -105.53 137.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.135 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -93.17 115.97 28.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.275 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -82.45 -32.07 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.722 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 618' ' ' LEU . 21.3 mt -154.4 131.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 111.44 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.64 124.02 22.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.17 117.06 27.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.427 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -46.94 72.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.678 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -83.2 -40.33 19.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.326 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -15.16 58.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.34 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt 62.9 15.75 8.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.978 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.422 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.01 104.24 7.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 690' ' ' ILE . 2.6 p -116.07 123.8 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.562 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.65 HD11 HD13 ' A' ' 587' ' ' ILE . 6.4 mm -127.65 154.04 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 169.29 136.17 2.02 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.714 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -114.72 153.95 29.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.798 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.838 ' HB2' HD12 ' A' ' 583' ' ' LEU . 9.2 tttt -101.79 117.6 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.916 HG21 HD13 ' A' ' 672' ' ' LEU . 5.0 t -79.08 125.9 38.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.4 OUTLIER -133.21 109.38 9.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.441 . . . . 0.0 110.409 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 577' ' ' PHE . 58.6 mt -80.78 105.32 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.646 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -87.19 -46.08 10.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.66 140.96 44.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.715 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -113.83 99.97 8.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.316 0.579 . . . . 0.0 109.73 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 56.6 m -70.79 65.93 0.34 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.432 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.19 57.27 20.67 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.857 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.816 ' C ' HD12 ' A' ' 644' ' ' LEU . 2.9 mt -99.88 145.28 27.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.619 ' N ' HD12 ' A' ' 644' ' ' LEU . 38.9 p90 -48.31 -31.38 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 109.765 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.469 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.1 t30 -155.99 -53.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.787 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.516 ' O ' HD13 ' A' ' 696' ' ' ILE . 10.4 pt-20 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.179 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.731 0.301 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.8 p -85.15 128.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 171.71 7.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -103.12 157.41 17.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.161 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.8 152.0 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 2.7 p -126.11 -178.0 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.77 -35.02 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -57.86 -48.0 81.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.7 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 726' ' ' LEU . 11.1 mp0 -66.65 -48.14 70.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.795 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -59.11 -32.95 70.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -39.44 93.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.261 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 723' ' ' GLU . 5.4 mt -60.47 -44.67 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.013 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.686 ' CG2' HG11 ' A' ' 621' ' ' VAL . 11.4 p -71.27 -27.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -56.05 -32.6 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -97.79 28.0 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.781 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.783 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.579 -0.208 . . . . 0.0 112.579 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.0 tmm_? -112.96 143.93 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 111.028 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.22 -63.57 1.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.05 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.058 HD12 HD13 ' A' ' 647' ' ' ILE . 7.5 tt -106.91 142.56 36.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.3 m -122.68 114.81 21.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.335 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 594' ' ' ILE . 6.6 mt -102.55 108.29 19.54 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 6.9 ptmm? -116.55 100.51 53.48 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 588' ' ' ILE . 33.3 Cg_exo -47.11 105.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.635 1.557 . . . . 0.0 109.06 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.24 87.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.517 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 58.4 Cg_exo -51.31 -25.84 19.11 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.589 2.859 . . . . 0.0 113.108 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.635 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.3 m-20 -63.38 -26.72 68.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.049 0.452 . . . . 0.0 110.034 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.417 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -97.58 153.66 18.03 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.235 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 690' ' ' ILE . 14.4 pt -49.09 -23.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 110.1 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 613' ' ' ILE . 51.2 mt -99.5 118.59 46.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -117.57 52.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.588 . . . . 0.0 110.453 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 16.0 mt-10 -124.58 171.82 9.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.379 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.64 132.31 53.42 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.122 0.487 . . . . 0.0 111.573 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.744 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.91 143.04 44.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.724 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -124.28 118.91 27.84 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.958 HD12 HD22 ' A' ' 578' ' ' LEU . 74.9 mt -83.8 109.05 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.214 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.9 120.84 13.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.95 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.24 -28.12 1.79 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.091 0.472 . . . . 0.0 110.67 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -73.63 -19.3 79.69 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.746 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 610' ' ' ASN . 55.0 t -100.74 117.95 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.968 0.884 . . . . 0.0 111.711 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.6 t30 -140.19 121.71 9.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.687 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.3 Cg_endo -89.96 159.86 34.31 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.493 -1.045 . . . . 0.0 111.519 -0.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.5 114.7 27.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.737 ' CG ' HD12 ' A' ' 730' ' ' LEU . 20.5 m-85 -91.68 138.45 31.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.769 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -126.32 146.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.71 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.09 -174.8 36.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.226 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -65.89 -48.62 70.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.831 0.348 . . . . 0.0 111.415 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.86 128.41 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.492 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.46 -17.73 23.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.766 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -56.95 -31.74 65.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.123 0.487 . . . . 0.0 110.112 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.3 m -70.58 134.02 47.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.501 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -48.08 -27.53 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.432 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.769 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.2 t -112.19 142.01 45.19 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 105.37 13.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.779 HD12 HD13 ' A' ' 588' ' ' ILE . 18.7 mm -138.62 108.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.764 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -106.18 105.91 16.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.469 0.652 . . . . 0.0 112.217 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.755 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -130.08 109.88 11.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.731 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -37.83 -30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.614 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -74.72 -41.59 59.88 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 615' ' ' ASP . 2.4 pp -88.24 136.98 32.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 163.84 4.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.461 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.494 ' CG ' HG23 ' A' ' 621' ' ' VAL . 1.3 ptp180 -54.08 -28.06 36.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.494 HG23 ' CG ' ' A' ' 620' ' ' ARG . 60.6 t -129.36 60.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.587 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.16 -47.25 45.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.133 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 8.2 p -168.06 161.09 12.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.8 p90 -143.36 148.52 36.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.62 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 580' ' ' LEU . 3.9 mp -102.23 128.16 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.324 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -118.48 134.47 55.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.423 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 33.3 ttmt -98.1 135.28 40.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.19 159.65 41.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.588 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.4 tpt180 -75.2 112.89 11.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.27 0.557 . . . . 0.0 110.862 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.476 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 7.7 t60 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 120.238 -0.201 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -113.32 -175.5 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.205 0.502 . . . . 0.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.0 m-20 -106.33 146.24 30.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.455 0.645 . . . . 0.0 112.251 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.476 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -128.72 160.56 32.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.549 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -108.35 120.85 60.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.63 0.729 . . . . 0.0 112.375 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.855 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.7 m95 -104.95 127.8 52.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.563 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.401 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.0 t80 -90.55 117.4 29.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.094 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 12.3 m -102.3 127.78 49.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -108.84 125.98 52.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 14.3 p -121.25 2.01 10.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.211 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.81 161.07 50.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.05 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.6 m -91.61 -19.86 22.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.633 0.254 . . . . 0.0 111.627 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.594 ' O ' HG13 ' A' ' 656' ' ' VAL . 47.7 m-20 -82.72 2.88 31.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.659 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.46 130.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.453 0.644 . . . . 0.0 112.278 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.422 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 86.5 p -100.98 166.34 10.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.136 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.42 120.76 26.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.755 0.312 . . . . 0.0 111.573 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.682 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.55 99.75 11.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.362 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 61.57 -80.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.687 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.18 -3.61 3.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.711 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.478 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.7 m-80 -97.0 142.01 29.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.381 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.8 ttm105 -82.25 141.62 32.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.216 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.83 97.95 5.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 43.8 pt -88.5 156.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.3 tt0 -47.34 108.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.4 35.77 3.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.356 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.421 ' CG2' HG12 ' A' ' 665' ' ' ILE . 4.3 p -120.01 162.31 19.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.161 0.505 . . . . 0.0 111.964 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.0 ttpt -133.2 148.31 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.229 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.738 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.5 t80 -147.28 144.83 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.855 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 132.46 46.2 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.719 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.803 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -110.37 122.22 47.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.577 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.11 138.78 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.315 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 696' ' ' ILE . 19.2 t0 -39.04 123.33 1.31 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 37.45 8.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.21 115.13 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.81 108.58 20.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.0 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.682 HG12 HD13 ' A' ' 659' ' ' LEU . 7.8 mt -109.0 136.54 44.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.91 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -96.77 115.44 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.656 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.722 HD12 ' CE2' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -80.08 -40.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.984 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 617' ' ' ARG . 2.4 mt -155.4 131.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.001 0.429 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.618 ' HB2' HG23 ' A' ' 689' ' ' VAL . 6.5 t90 -136.12 128.23 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -122.15 116.78 24.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.403 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -46.41 72.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.868 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -60.51 -40.63 92.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.256 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.31 -20.25 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.65 0.262 . . . . 0.0 111.567 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 72.69 1.94 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.425 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.68 105.37 7.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 682' ' ' TRP . 2.4 p -114.71 134.13 58.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.465 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 587' ' ' ILE . 34.7 mt -119.82 120.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.95 141.07 9.93 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.856 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.722 ' CE2' HD12 ' A' ' 680' ' ' ILE . 9.1 m-30 -113.62 142.23 46.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.583 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.2 116.96 34.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.229 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.696 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.9 125.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.8 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 109.45 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.655 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.487 HG23 ' CD1' ' A' ' 577' ' ' PHE . 57.3 mt -83.89 105.76 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.67 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.91 -43.55 12.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.318 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -109.9 141.55 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.337 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.9 p -113.53 100.02 8.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.405 0.621 . . . . 0.0 110.142 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.9 m -82.63 60.68 5.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 73.95 49.07 14.21 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.859 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.574 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -83.63 127.42 33.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.654 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.2 p90 -35.77 -48.14 0.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.254 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.95 8.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.373 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.574 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 1.9 pt-20 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 121.316 0.579 . . . . 0.0 110.085 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.609 HG21 ' O ' ' A' ' 663' ' ' ARG . 9.6 t -77.47 116.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.952 0.406 . . . . 0.0 111.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.99 172.22 8.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 155.52 17.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -92.34 150.98 20.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -126.16 -175.57 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.94 68.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.52 -53.34 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.438 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.8 pp20? -70.81 -41.3 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.851 0.358 . . . . 0.0 110.586 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.533 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -67.61 -38.37 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.702 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 723' ' ' GLU . 18.0 mt -56.01 -44.22 78.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -78.54 -24.04 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -59.07 -37.79 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.06 -15.93 57.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.737 HD12 ' CG ' ' A' ' 602' ' ' PHE . 10.0 tt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -96.58 109.95 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 110.443 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.5 t80 -95.11 -58.29 2.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.735 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.837 HD11 ' CG1' ' A' ' 694' ' ' VAL . 7.9 tp -106.84 142.87 35.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 0.0 111.624 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 40.6 m -117.68 113.85 22.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -105.62 109.34 21.27 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 37.5 pttt -117.09 99.34 52.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 28.0 Cg_exo -45.8 99.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.918 1.746 . . . . 0.0 109.825 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.05 157.47 85.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.4 Cg_exo -49.9 -25.7 12.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 112.948 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.83 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.09 -28.24 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 0.4 OUTLIER -95.89 153.97 17.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.976 178.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 688' ' ' PHE . 16.7 pt -52.38 -15.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.669 0.271 . . . . 0.0 111.365 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.8 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 111.685 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 1.0 OUTLIER -125.71 55.25 1.45 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.618 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.3 mt-10 -124.72 170.24 11.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.052 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.49 121.06 25.09 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -112.68 148.21 35.15 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 119.58 29.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.663 0.268 . . . . 0.0 111.697 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 625' ' ' ILE . 47.1 mt -74.05 109.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.39 111.85 3.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.023 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.37 -36.49 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.469 0.652 . . . . 0.0 109.942 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -61.47 -23.85 63.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.233 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.4 t -101.14 118.86 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 117.516 0.658 . . . . 0.0 111.511 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.0 t30 -139.22 122.18 10.59 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.5 Cg_endo -89.6 160.24 36.24 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 124.413 -1.078 . . . . 0.0 111.674 -0.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -90.75 116.72 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 56.1 m-85 -92.45 138.01 31.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.05 145.7 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.435 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.37 -174.98 41.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.566 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.4 ttp85 -80.64 -11.51 59.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.645 0.259 . . . . 0.0 111.315 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 132.23 42.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.13 -26.35 11.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -30.78 27.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.035 0.445 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 63.7 m -77.2 128.8 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -45.24 -34.72 2.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 39.8 t -101.88 138.67 38.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.059 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 113.73 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.334 0.588 . . . . 0.0 112.549 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.9 mm -137.6 109.86 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.658 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 pm0 -87.79 103.99 16.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.693 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.23 110.23 10.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.964 178.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -40.64 -36.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' A' ' 681' ' ' ILE . 2.0 mmt180 -77.64 -36.58 51.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.693 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.71 159.38 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 52.7 p -108.77 166.04 11.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.31 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -47.46 25.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.573 HG11 HG23 ' A' ' 727' ' ' VAL . 18.2 t -121.24 61.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.426 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.571 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.4 t60 -50.08 -48.42 53.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.732 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -167.28 156.17 10.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.177 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.721 ' HA ' HD12 ' A' ' 603' ' ' ILE . 28.8 p90 -143.62 149.54 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.101 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 594' ' ' ILE . 71.4 mt -101.79 134.09 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -124.7 132.99 53.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.627 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HE3' HG23 ' A' ' 647' ' ' ILE . 9.1 ttmt -97.89 137.06 37.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.574 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.94 158.89 43.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.522 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -76.7 112.89 13.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.386 0.612 . . . . 0.0 110.41 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.91 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.863 -0.095 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.825 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.4 mt -116.89 -153.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.2 m-20 -118.22 147.27 43.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.32 148.81 51.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.606 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.1 pt -102.28 122.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.897 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -102.8 138.64 39.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.241 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CB ' HD21 ' A' ' 672' ' ' LEU . 18.0 t80 -100.04 117.43 34.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.65 133.84 49.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.409 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -115.58 125.72 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.454 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 15.6 p -123.18 7.97 9.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.68 151.62 29.44 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.033 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 7.5 m -80.16 -17.3 52.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.58 ' O ' HG13 ' A' ' 656' ' ' VAL . 14.0 m-20 -83.72 2.69 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.94 128.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.43 0.633 . . . . 0.0 112.2 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.408 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 9.0 t -97.76 166.68 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 39.2 m-85 -131.91 120.22 22.22 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.402 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.951 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -95.03 100.58 12.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.14 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.44 0.44 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.435 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.423 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 7.6 m-80 -100.6 141.51 33.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.801 ' O ' HG21 ' A' ' 716' ' ' VAL . 21.8 ttp180 -82.43 141.12 33.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.736 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -122.69 98.08 5.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 668' ' ' THR . 35.2 pt -87.77 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 652' ' ' THR . 29.1 tt0 -46.76 106.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.88 35.97 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.296 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.468 HG21 HG12 ' A' ' 665' ' ' ILE . 6.6 p -125.72 162.19 25.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 111.879 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.1 ttpm? -133.6 148.47 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.224 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.736 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.6 t80 -147.69 145.87 29.06 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.897 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.52 133.79 49.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.869 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -110.33 109.2 19.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.196 0.522 . . . . 0.0 111.339 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -97.94 153.95 18.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.333 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.6 t0 -53.31 115.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.829 0.347 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.28 37.48 5.62 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -90.42 116.15 28.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.951 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -95.88 108.08 20.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.951 HG22 HD13 ' A' ' 659' ' ' LEU . 29.7 pt -109.29 133.67 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.088 0.47 . . . . 0.0 112.016 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 29.4 mttt -96.91 115.19 27.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.434 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.8 mt -75.81 -39.81 38.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.944 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' A' ' 617' ' ' ARG . 5.3 tt -155.7 133.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.714 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -136.04 125.98 25.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -118.77 116.93 27.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -67.49 -46.55 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.988 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -69.71 -40.51 76.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.945 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.9 t-20 -86.32 -20.27 28.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.68 0.276 . . . . 0.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt 68.38 4.82 4.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.34 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.57 ' HD1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -82.24 105.2 13.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.33 137.0 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.097 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.452 HG21 ' HB ' ' A' ' 680' ' ' ILE . 2.5 mm -115.27 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.032 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.487 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.23 130.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.231 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.4 m-30 -113.09 146.16 39.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.548 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.674 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -101.03 116.82 33.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.906 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.837 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.5 t -82.86 123.59 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.45 108.74 8.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.034 0.445 . . . . 0.0 110.987 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.832 HG21 ' HB2' ' A' ' 705' ' ' GLU . 25.1 mt -73.58 105.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.789 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -90.05 -46.04 8.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 6.1 t70 -111.28 141.03 45.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.171 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.1 OUTLIER -114.94 101.67 9.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.8 m -68.02 62.41 0.08 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 53.66 51.39 48.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.183 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -117.29 174.05 6.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.973 0.415 . . . . 0.0 111.561 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -65.67 118.4 9.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.657 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 3.9 t30 51.39 -71.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.367 0.603 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.832 ' HB2' HG21 ' A' ' 696' ' ' ILE . 21.1 pt-20 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 663' ' ' ARG . 29.5 t -84.53 117.48 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.063 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.3 mp -90.2 161.43 15.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 148.3 25.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 160.17 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 26.7 p -119.3 -173.25 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.68 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.7 -45.5 93.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 7.7 tm-20 -67.62 -50.24 59.06 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.2 mttt -54.61 -32.52 58.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.38 -36.85 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.27 -44.61 79.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.573 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -74.97 -17.42 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.07 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -35.22 79.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.871 0.367 . . . . 0.0 110.75 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -96.79 23.98 6.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.76 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -98.29 108.38 21.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.6 t80 -90.84 -46.79 8.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.84 HD11 HG13 ' A' ' 694' ' ' VAL . 7.2 tp -122.49 142.22 50.81 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.967 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 581' ' ' LYS . 17.8 m -120.06 115.7 24.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.641 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.9 mt -102.05 107.85 19.09 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 17.9 mtpp -113.33 98.97 48.09 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -48.45 96.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.636 1.557 . . . . 0.0 109.434 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.76 157.64 85.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.445 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.9 Cg_exo -49.72 -27.83 16.08 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.338 2.692 . . . . 0.0 112.43 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.484 ' CB ' HD12 ' A' ' 583' ' ' LEU . 21.9 t0 -62.48 -26.37 68.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 9.3 t -95.47 153.74 17.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.935 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 688' ' ' PHE . 10.4 tt -53.27 -14.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.456 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 613' ' ' ILE . 45.0 mt -111.47 133.51 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 111.876 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -114.85 51.81 0.88 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.605 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.617 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.7 mt-10 -123.94 171.75 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.795 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.09 132.7 50.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.11 0.481 . . . . 0.0 111.394 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.742 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.4 OUTLIER -112.62 142.48 45.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.01 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -123.75 111.68 16.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.919 HD11 HD12 ' A' ' 625' ' ' ILE . 66.8 mt -80.71 108.81 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.019 0.437 . . . . 0.0 110.044 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -67.0 117.67 9.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.69 -33.4 2.94 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.38 0.609 . . . . 0.0 110.016 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.17 -20.99 73.58 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.371 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.869 HG11 ' OD1' ' A' ' 610' ' ' ASN . 58.3 t -97.72 118.37 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 117.691 0.746 . . . . 0.0 111.396 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.3 t30 -139.97 121.49 9.62 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.032 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.2 Cg_endo -90.63 160.79 31.44 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.699 -0.959 . . . . 0.0 111.459 -0.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.85 115.07 27.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CD2' HD12 ' A' ' 730' ' ' LEU . 10.8 m-85 -92.25 138.49 31.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.621 . . . . 0.0 112.588 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.818 HG23 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mp -123.31 140.51 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.109 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 171.74 -174.81 45.23 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.418 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.7 ttp85 -83.71 -5.71 59.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.251 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.33 129.75 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.79 0.328 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.83 -26.99 6.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.121 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.97 -29.06 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 90.2 m -76.73 133.39 39.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.869 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.2 m-80 -49.09 -28.49 4.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.818 ' SG ' HG23 ' A' ' 603' ' ' ILE . 21.0 t -109.59 138.67 45.61 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 111.72 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.71 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.0 mm -137.91 109.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.65 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.5 mt-10 -88.81 104.45 16.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.976 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.751 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -130.82 113.27 13.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.081 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -43.39 -36.13 1.82 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.735 0.302 . . . . 0.0 111.62 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.946 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -77.71 -33.09 53.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.158 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.056 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -64.18 159.35 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 167.37 10.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -55.96 6.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.054 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 727' ' ' VAL . 45.8 t -113.06 62.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 37.4 t60 -48.83 -49.24 40.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.935 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 680' ' ' ILE . 7.7 p -166.71 159.37 13.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.92 0.391 . . . . 0.0 111.212 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 650' ' ' CYS . 1.7 p90 -144.0 146.97 33.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.919 HD12 HD11 ' A' ' 594' ' ' ILE . 82.6 mt -101.87 132.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.719 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.4 t80 -123.26 133.1 54.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 647' ' ' ILE . 2.4 tppp? -97.94 136.43 38.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.237 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 157.95 45.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.469 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.57 123.53 26.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.0 110.591 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.8 t60 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.88 -0.088 . . . . 0.0 112.88 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.1 OUTLIER -103.82 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.819 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -123.33 147.77 46.68 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.199 0.523 . . . . 0.0 112.279 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -131.88 158.3 41.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.886 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.823 HD13 HD13 ' A' ' 578' ' ' LEU . 4.9 pt -110.28 123.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 111.924 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.89 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.8 m95 -108.75 128.66 55.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.399 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -91.31 117.41 29.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 8.2 m -102.57 138.15 39.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.283 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 657' ' ' SER . 84.3 t60 -116.55 129.36 56.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.418 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 3.2 p -125.61 -2.58 7.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.532 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.74 138.26 21.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.091 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 654' ' ' THR . 86.1 m -72.13 -8.3 53.88 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -86.93 2.55 48.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 0.0 111.43 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.95 143.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.023 0.439 . . . . 0.0 111.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.774 ' OG ' HG22 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -115.57 162.03 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 664' ' ' MET . 17.1 m-85 -137.6 119.43 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -97.99 99.69 10.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.656 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.47 -1.73 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.549 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 17.9 m120 -96.25 141.52 29.5 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.904 0.383 . . . . 0.0 111.179 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.815 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.0 mtm180 -81.49 141.57 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.158 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.52 ' HE1' HG13 ' A' ' 716' ' ' VAL . 17.4 mmm -123.03 99.34 6.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 668' ' ' THR . 35.0 pt -87.88 154.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -47.43 103.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.347 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.82 39.92 2.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.584 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.493 HG21 HG12 ' A' ' 665' ' ' ILE . 2.3 p -128.44 153.31 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.47 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.93 145.19 49.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.087 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 659' ' ' LEU . 4.8 t80 -140.14 145.77 37.97 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.89 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.29 131.87 46.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.756 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.836 HD13 HG21 ' A' ' 694' ' ' VAL . 0.9 OUTLIER -107.75 120.57 42.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.138 0.494 . . . . 0.0 110.845 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -110.04 162.24 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.001 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' A' ' 696' ' ' ILE . 24.8 t0 -58.3 108.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.655 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.58 33.5 5.86 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.31 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -86.43 114.94 23.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.691 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -95.75 108.37 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 659' ' ' LEU . 8.4 mt -108.82 134.44 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -109.01 117.77 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.072 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.774 HG22 ' OG ' ' A' ' 657' ' ' SER . 0.7 OUTLIER -90.32 -22.15 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.056 HD12 HD12 ' A' ' 618' ' ' LEU . 55.9 mt -152.87 130.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.206 0.527 . . . . 0.0 111.448 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -137.68 129.12 28.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.05 117.32 25.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.0 110.616 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -67.12 -46.56 73.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.016 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.56 -40.47 23.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.735 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -14.33 58.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.442 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 64.51 14.77 9.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -77.82 104.67 8.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.0 p -118.44 121.85 68.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.148 0.499 . . . . 0.0 112.059 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.648 HG21 HG13 ' A' ' 680' ' ' ILE . 4.3 mm -112.21 144.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -170.96 123.48 1.04 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.468 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.519 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.6 m-30 -113.11 146.11 39.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.341 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.742 ' HB2' HD22 ' A' ' 583' ' ' LEU . 2.0 tptt -101.56 117.06 34.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.84 HG13 HD11 ' A' ' 578' ' ' LEU . 2.4 t -81.78 124.12 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.017 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -133.12 108.72 9.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 705' ' ' GLU . 35.7 mt -73.91 104.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.16 -47.52 8.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.801 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.46 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 12.4 t0 -111.14 139.35 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.633 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -115.7 100.66 8.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.107 0.479 . . . . 0.0 109.712 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.4 t -70.3 63.53 0.25 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.621 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.32 59.45 10.63 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.821 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.835 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -98.8 148.18 24.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.776 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.639 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.6 p90 -47.41 -34.67 7.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.571 0.7 . . . . 0.0 109.751 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.46 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.0 t30 -151.5 -51.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.762 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.755 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.0 pt-20 . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.146 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.706 0.288 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 663' ' ' ARG . 30.8 t -77.68 128.37 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.115 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.462 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -100.41 167.9 10.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -103.03 154.75 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.58 155.8 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.12 -176.22 3.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.64 -31.04 63.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -64.76 -44.85 88.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.22 -51.07 57.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.2 mtmp? -55.41 -32.69 62.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -36.82 82.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.4 -44.26 92.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.936 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -74.55 -26.58 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -34.03 66.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -97.86 33.1 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.624 HD12 ' CD2' ' A' ' 602' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.81 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.508 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.226 -0.398 0 CA-C-O 120.756 0.087 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.5 tmm_? -112.65 143.75 43.31 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.516 -0.403 . . . . 0.0 111.415 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -123.59 -58.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 694' ' ' VAL . 9.9 tt -112.48 140.86 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.393 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 695' ' ' GLU . 38.0 m -113.1 122.0 46.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.269 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 625' ' ' ILE . 7.4 mt -107.83 108.96 20.38 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.1 pttp -119.53 98.46 50.07 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -45.22 103.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.739 1.626 . . . . 0.0 108.918 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -73.94 160.47 81.76 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -175.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 82.0 Cg_exo -47.05 -30.21 9.76 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.715 2.943 . . . . 0.0 113.012 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.47 -17.82 63.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 109.677 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.558 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 38.7 t -95.22 149.22 21.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.936 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 587' ' ' ILE . 0.0 OUTLIER -55.73 -22.79 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 178.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.549 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.9 tt -113.34 122.22 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.627 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -108.14 69.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 0.0 110.835 -179.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.769 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 34.5 mt-10 -127.93 170.97 12.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.173 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 35.8 t -131.23 116.43 17.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 112.028 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.733 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -103.91 139.73 38.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 5.1 mt-10 -118.02 131.35 56.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.868 HD12 HD22 ' A' ' 578' ' ' LEU . 89.9 mt -82.48 108.66 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.7 OUTLIER -65.5 120.99 13.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.72 -28.8 1.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.842 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.32 -18.71 79.91 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.084 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.02 117.92 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.142 0.971 . . . . 0.0 111.768 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.45 122.6 9.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.553 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.9 Cg_endo -90.25 159.85 32.88 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.5 -1.041 . . . . 0.0 111.519 -0.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.4 t80 -92.04 116.36 28.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.538 ' CG ' HD12 ' A' ' 730' ' ' LEU . 27.0 m-85 -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.695 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.759 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -128.31 147.43 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.56 -157.55 30.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.417 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.1 OUTLIER -87.61 -35.85 17.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.733 0.301 . . . . 0.0 111.506 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -74.99 137.65 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.323 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -20.64 58.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.987 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -55.02 -31.53 61.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.5 m -73.22 132.08 42.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m120 -47.0 -29.71 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 110.542 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.759 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.29 137.52 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.64 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 110.84 20.68 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.733 HD11 HD21 ' A' ' 592' ' ' LEU . 3.4 mm -138.3 110.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.176 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.2 mt-10 -85.99 104.92 16.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.448 0.642 . . . . 0.0 111.67 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.852 ' CB ' HD22 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -130.67 108.18 9.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.287 177.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -48.08 -34.9 10.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -78.05 -35.38 49.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.852 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.63 131.37 34.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.432 -178.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 8.5 t -57.24 166.33 1.17 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.49 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 1.0 OUTLIER -57.22 -34.92 69.06 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.295 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.0 t -125.96 58.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.949 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.821 ' CD2' HG23 ' A' ' 680' ' ' ILE . 13.9 t60 -49.89 -49.43 49.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.02 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 13.2 p -164.17 161.53 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 111.589 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.9 p90 -143.53 147.85 35.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.589 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.93 130.68 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -122.54 134.17 54.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.773 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 647' ' ' ILE . 5.2 ttmt -98.19 136.44 38.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.204 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.81 159.01 41.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.894 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 643' ' ' GLY . 3.7 tpt85 -76.59 112.15 12.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.3 t60 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.243 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.736 -0.146 . . . . 0.0 112.736 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 630' ' ' HIS . 3.5 mp -111.78 -162.43 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 m-20 -108.08 147.06 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 112.412 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.4 OUTLIER -124.75 159.53 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.518 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.877 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 5.3 pt -111.49 122.37 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.451 0.643 . . . . 0.0 112.249 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 66.7 m95 -108.85 136.19 48.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.085 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.674 ' CE1' HD12 ' A' ' 678' ' ' ILE . 22.7 t80 -94.08 117.77 30.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.27 124.91 49.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 72.0 t60 -101.94 134.38 45.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.148 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.0 p -133.55 4.01 3.61 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.982 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.35 137.69 18.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.394 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 654' ' ' THR . 45.0 m -70.37 -11.94 61.25 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.755 -0.262 . . . . 0.0 111.393 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.612 ' O ' HG13 ' A' ' 656' ' ' VAL . 4.6 m-20 -87.39 3.46 46.95 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.56 128.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.283 0.564 . . . . 0.0 112.117 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.468 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 30.5 m -101.47 166.02 10.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.406 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.9 m-85 -130.68 120.19 23.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.333 . . . . 0.0 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.03 99.91 10.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 659' ' ' LEU . 20.4 t-20 60.4 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.924 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -134.17 1.0 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.73 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.6 m-80 -104.69 132.92 50.36 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 111.077 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.9 139.96 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 41.1 mmm -118.26 97.43 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.446 HG13 HG23 ' A' ' 668' ' ' THR . 49.3 pt -87.85 154.49 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.73 104.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 111.478 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.08 38.59 2.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.446 HG23 HG13 ' A' ' 665' ' ' ILE . 1.1 p -116.26 162.29 17.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.546 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.494 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -137.53 139.52 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -147.4 145.78 29.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.829 0.347 . . . . 0.0 111.779 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.65 137.83 55.89 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -110.54 99.39 8.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 0.0 111.614 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -80.45 147.32 30.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.473 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.657 ' HB3' HD12 ' A' ' 696' ' ' ILE . 13.5 p30 -48.17 112.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.305 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 94.53 36.0 5.76 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.3 117.15 28.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.891 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 109.54 21.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.725 HG22 HD13 ' A' ' 659' ' ' LEU . 21.6 pt -105.31 130.44 56.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 112.066 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.43 116.63 29.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.446 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.821 HG23 ' CD2' ' A' ' 622' ' ' HIS . 9.0 mt -89.87 -34.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.295 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.93 131.53 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.803 -179.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -136.96 127.54 26.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.07 116.84 28.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 110.325 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -67.36 -46.91 71.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -83.49 -40.49 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.84 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.4 -16.55 45.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.582 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.9 mttt 64.67 14.32 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.679 0.276 . . . . 0.0 110.91 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -78.36 105.23 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -124.88 128.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.912 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 681' ' ' ILE . 0.5 OUTLIER -128.58 119.77 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.737 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -151.33 139.9 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.314 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.18 149.03 36.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.786 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.416 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -102.01 117.22 34.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.485 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.07 123.11 30.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.693 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.8 mt-10 -130.32 109.39 10.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 0.0 110.731 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 674' ' ' ASP . 11.2 mt -83.67 109.83 17.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.714 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -96.11 -46.51 6.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.946 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.35 140.31 46.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.54 101.44 9.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 700' ' ' THR . 8.0 t -69.23 61.47 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.28 45.95 81.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.806 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -106.49 151.19 25.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.579 0.228 . . . . 0.0 110.769 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -45.22 128.71 7.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.47 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 5.6 t30 43.33 -79.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.49 . . . . 0.0 111.031 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.681 ' N ' ' O ' ' A' ' 703' ' ' PHE . 13.3 pt-20 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.41 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 4.0 m . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.763 0.316 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 716' ' ' VAL . 13.9 p -93.3 125.04 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -94.74 172.29 8.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -102.48 157.88 16.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.6 156.41 18.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -126.1 -177.03 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.27 38.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.02 -50.93 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.549 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -65.44 -46.03 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -55.5 -32.95 63.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.55 -36.87 79.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 18.4 mt -59.08 -44.85 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.3 p -81.41 -16.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -32.66 74.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.74 -7.93 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.199 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 730' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.874 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.501 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.5 tmm_? -112.95 143.85 43.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.625 0.25 . . . . 0.0 111.031 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.35 -62.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.076 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.38 142.34 36.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 12.5 m -123.62 114.47 20.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.559 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.686 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.5 OUTLIER -103.89 108.21 19.43 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.26 100.65 52.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.6 Cg_exo -46.98 99.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.879 1.72 . . . . 0.0 109.722 176.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.33 84.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -176.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.423 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.2 Cg_endo -49.68 -25.32 11.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.642 2.894 . . . . 0.0 112.612 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 583' ' ' LEU . 22.5 m-20 -62.01 -28.03 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 7.5 t -95.38 154.1 17.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.645 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.494 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -56.2 -12.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.074 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 613' ' ' ILE . 19.0 mt -108.92 123.33 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 111.783 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -108.24 54.75 0.65 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.163 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.603 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.2 mm-40 -124.36 171.39 9.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.094 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.74 129.59 47.34 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.011 0.434 . . . . 0.0 111.262 179.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.35 140.77 46.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -124.24 116.87 23.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.73 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.76 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -80.51 108.96 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.178 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.3 OUTLIER -64.57 120.48 12.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.085 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.62 -28.13 1.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 110.823 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.4 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -21.25 79.7 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.867 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 52.9 t -101.0 118.07 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 118.015 0.908 . . . . 0.0 111.854 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.22 121.99 9.62 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.766 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.7 159.78 35.53 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 124.465 -1.056 . . . . 0.0 111.599 -0.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.651 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.0 t80 -91.37 115.87 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.88 ' CG ' HD12 ' A' ' 730' ' ' LEU . 33.5 m-85 -92.26 138.11 31.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.891 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.718 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mp -127.27 146.05 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.553 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.03 -175.37 40.94 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.543 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.5 ttp85 -77.51 -6.79 54.83 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.741 -0.229 . . . . 0.0 111.456 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.0 129.36 45.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.847 0.355 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.37 -23.54 24.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -29.76 61.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.602 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 730' ' ' LEU . 8.9 m -74.73 134.43 41.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.765 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m-80 -49.07 -26.79 2.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.702 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 46.7 t -112.85 142.87 45.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.532 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 115.05 23.9 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 588' ' ' ILE . 28.5 mm -137.96 109.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.026 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.6 tt0 -89.01 103.85 16.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.798 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.803 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.7 OUTLIER -131.79 113.43 13.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.252 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -43.03 -35.67 1.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.771 0.319 . . . . 0.0 111.514 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.664 ' HB3' HD13 ' A' ' 681' ' ' ILE . 2.1 mpp_? -77.95 -36.31 49.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.112 HD12 HD12 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -61.58 159.8 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.2 m -109.16 170.13 8.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -49.14 -45.48 43.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.27 0.557 . . . . 0.0 110.201 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.769 HG11 HG23 ' A' ' 727' ' ' VAL . 13.4 t -124.89 57.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.464 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.64 ' CE1' HD11 ' A' ' 681' ' ' ILE . 27.7 t60 -43.85 -47.48 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.747 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.9 p -166.76 156.34 11.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.445 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 603' ' ' ILE . 29.6 p90 -143.18 147.45 34.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.415 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.7 mp -102.19 130.24 52.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.114 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.3 t80 -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 23.0 ttmt -97.71 136.78 37.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.536 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.68 159.72 39.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.445 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -75.82 115.95 16.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.9 t60 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.75 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 644' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.3 -153.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.711 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.9 m-20 -122.4 146.57 47.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.308 0.575 . . . . 0.0 112.471 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -126.74 160.14 31.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.076 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -108.94 123.89 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.442 0.639 . . . . 0.0 112.463 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.85 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 90.0 m95 -106.19 125.68 51.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -90.63 117.53 29.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -102.53 139.24 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.236 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.498 ' CG ' ' OG ' ' A' ' 657' ' ' SER . 46.7 t60 -125.68 121.56 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.571 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.47 5.69 13.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.747 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.03 137.33 20.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.799 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 654' ' ' THR . 95.6 m -72.64 -10.61 60.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -87.26 2.06 51.26 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 664' ' ' MET . 11.6 t 64.31 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.524 . . . . 0.0 112.076 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.498 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 5.3 p -120.76 160.72 22.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 4.8 m-85 -137.48 120.07 16.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.278 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.625 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.46 105.19 17.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.01 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.44 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.579 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -134.99 0.42 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.698 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.455 ' HB3' HG23 ' A' ' 716' ' ' VAL . 7.5 m120 -97.77 141.21 31.05 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.912 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.0 ttp180 -88.94 139.08 30.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -135.83 110.97 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.205 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.456 ' HA ' HG13 ' A' ' 656' ' ' VAL . 18.8 pt -89.78 162.98 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.947 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -46.78 115.56 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.576 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.81 8.45 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.97 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.3 p -112.76 161.74 16.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 111.583 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -135.6 149.18 49.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD1' HD23 ' A' ' 659' ' ' LEU . 2.8 t80 -147.75 146.09 29.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.85 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.74 132.4 46.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.283 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.799 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.44 111.82 23.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.311 0.577 . . . . 0.0 111.421 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -104.83 136.01 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.559 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.609 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.3 t70 -37.0 118.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 111.022 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 89.26 36.52 7.52 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.85 118.13 31.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 693' ' ' LYS . 21.8 mt-10 -96.0 109.08 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 649' ' ' TYR . 4.6 mt -105.65 130.03 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 112.004 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.63 116.15 27.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.418 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.495 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -83.8 -37.28 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.112 HD12 HD12 ' A' ' 618' ' ' LEU . 54.1 mt -154.92 131.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -136.49 127.17 27.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.74 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 116.76 24.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.374 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -67.23 -46.8 72.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.798 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.17 -40.47 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.835 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.61 -14.5 59.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.443 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 64.94 14.07 9.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.634 0.254 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -78.4 104.46 9.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.87 123.64 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.069 0.461 . . . . 0.0 111.74 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 587' ' ' ILE . 38.9 mm -125.4 153.11 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 175.84 128.61 1.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.121 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 592' ' ' LEU . 8.5 m-30 -112.82 144.49 42.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.268 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.58 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tttp -101.11 117.33 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.574 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 578' ' ' LEU . 2.8 t -79.51 125.25 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -133.16 109.23 9.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 705' ' ' GLU . 50.1 mt -79.67 105.77 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.665 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -86.83 -43.96 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.15 141.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -113.62 100.09 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.404 0.621 . . . . 0.0 109.899 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 28.7 m -80.93 65.57 6.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 71.3 46.56 41.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.923 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -87.84 131.77 34.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.62 ' N ' HD12 ' A' ' 644' ' ' LEU . 5.6 p90 -41.8 -34.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.457 0.646 . . . . 0.0 110.266 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -146.64 -61.09 0.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.392 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.813 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.6 pt-20 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.949 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.735 0.302 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.912 HG21 ' O ' ' A' ' 663' ' ' ARG . 39.6 t -77.88 122.27 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.69 161.58 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 136.77 42.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.612 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.31 150.16 24.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 p -110.54 -174.65 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -30.31 43.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -50.23 74.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -45.17 76.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.352 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.519 ' O ' HG12 ' A' ' 727' ' ' VAL . 44.9 tttp -57.68 -32.93 67.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.598 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -66.73 -36.82 83.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.595 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.68 -44.25 85.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.769 HG23 HG11 ' A' ' 621' ' ' VAL . 10.8 p -76.16 -14.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.81 -39.4 76.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.564 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -93.79 11.24 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.88 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.659 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 8.4 ttm105 -113.61 143.39 44.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.26 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.794 ' CZ ' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -118.51 -57.89 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.331 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.809 HD11 ' CG1' ' A' ' 694' ' ' VAL . 5.1 tp -113.09 142.08 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.4 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 2.8 m -120.04 114.76 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.904 HD21 HG23 ' A' ' 694' ' ' VAL . 5.8 mt -102.0 108.36 19.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 27.4 mtmt -114.16 99.27 50.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 34.7 Cg_exo -47.81 98.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.655 1.57 . . . . 0.0 109.463 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.822 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.36 158.1 84.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.79 -26.53 13.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.427 2.752 . . . . 0.0 112.573 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.822 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.8 m-20 -62.76 -28.12 69.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 93.2 p -95.69 153.21 17.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.839 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.719 ' CG2' HD13 ' A' ' 690' ' ' ILE . 7.9 tt -53.15 -15.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.322 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.613 HG13 HG23 ' A' ' 587' ' ' ILE . 71.2 mt -109.03 131.7 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.936 0.398 . . . . 0.0 111.795 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -116.93 54.62 0.86 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.254 0.549 . . . . 0.0 110.65 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.656 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.6 mt-10 -124.11 172.07 9.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.683 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.69 128.39 45.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.177 0.513 . . . . 0.0 111.221 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.41 139.74 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.788 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.04 113.22 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.544 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 625' ' ' ILE . 76.4 mt -77.29 109.21 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.1 OUTLIER -67.34 118.13 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.022 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -27.93 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.822 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -70.85 -20.63 77.75 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.186 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.568 HG11 ' ND2' ' A' ' 610' ' ' ASN . 41.2 t -100.68 118.32 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 117.552 0.676 . . . . 0.0 111.618 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.4 t30 -139.9 121.8 9.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.5 Cg_endo -89.48 160.49 36.96 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.535 -1.027 . . . . 0.0 111.492 -0.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.677 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.09 115.42 28.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.745 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.0 m-85 -91.98 137.52 32.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.027 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.771 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -124.84 144.83 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.39 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.41 -173.7 38.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.298 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -68.11 -46.8 69.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.853 0.359 . . . . 0.0 111.431 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.72 129.23 40.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.37 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -58.06 -18.36 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.762 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.63 -30.64 67.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 110.249 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.568 ' SG ' HG22 ' A' ' 621' ' ' VAL . 94.8 m -69.95 131.55 44.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.598 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -43.99 -32.43 1.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.322 0.582 . . . . 0.0 110.453 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.771 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.46 142.17 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.196 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.503 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -111.3 105.0 13.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 38.3 mm -139.26 109.5 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.467 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.36 106.23 16.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 112.256 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.587 ' H ' HD11 ' A' ' 618' ' ' LEU . 4.7 t0 -129.88 107.69 9.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.571 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -39.44 -28.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 9.2 mmt180 -70.82 -41.77 71.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.587 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -89.3 158.74 17.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.6 m -76.71 164.61 25.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.41 -27.07 14.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.568 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.2 t -131.01 62.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' HG23 ' A' ' 680' ' ' ILE . 26.1 t60 -50.03 -48.66 52.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.211 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.84 162.22 26.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.5 p90 -143.61 148.39 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 594' ' ' ILE . 81.5 mt -102.12 124.3 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.046 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -113.87 133.55 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.73 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 28.6 ttmt -97.88 136.52 38.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.69 158.59 44.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.827 -178.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.13 115.97 17.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 120.678 0.043 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.4 mp -115.75 -157.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.748 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.3 m-20 -117.56 146.72 43.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.08 0.467 . . . . 0.0 111.96 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -133.03 157.16 45.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.781 ' CD1' HD13 ' A' ' 578' ' ' LEU . 1.1 pt -106.8 119.23 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.543 0.687 . . . . 0.0 111.769 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.882 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.9 m95 -100.61 132.13 46.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.476 ' CB ' HD21 ' A' ' 672' ' ' LEU . 31.2 t80 -90.36 117.24 28.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -103.5 121.67 43.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.559 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.419 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 28.9 t60 -102.23 128.74 48.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 7.4 p -125.11 2.43 7.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.423 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.05 150.21 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.108 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 72.3 m -82.21 -18.97 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 111.518 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 656' ' ' VAL . 15.0 m-20 -82.56 3.35 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.79 137.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.644 0.735 . . . . 0.0 112.238 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 58.2 m -107.93 165.91 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.423 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 120.59 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.72 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.65 100.34 9.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.846 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.9 m120 60.76 -82.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.87 6.19 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.652 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -110.27 138.45 46.64 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -74.74 138.34 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.472 ' O ' HG23 ' A' ' 656' ' ' VAL . 45.7 mmm -117.68 88.01 2.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.579 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 668' ' ' THR . 48.5 pt -86.91 164.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 22.6 tt0 -54.92 105.53 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.34 40.52 2.39 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.409 HG21 HG12 ' A' ' 665' ' ' ILE . 2.6 p -124.45 162.39 24.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 6.3 ttpm? -138.07 144.93 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.491 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.64 145.09 28.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.8 0.334 . . . . 0.0 111.758 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.882 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.7 136.61 53.16 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.579 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -107.1 112.84 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.541 . . . . 0.0 111.869 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -104.13 137.95 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.894 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.695 ' HB2' HD12 ' A' ' 696' ' ' ILE . 39.7 t0 -39.11 123.11 1.31 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.936 0.398 . . . . 0.0 111.152 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 88.91 40.6 6.17 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.432 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 1.6 t0 -93.51 113.18 25.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.979 0.418 . . . . 0.0 111.434 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.34 111.38 23.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.865 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.72 HG12 HD13 ' A' ' 659' ' ' LEU . 9.2 mt -112.41 137.16 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 689' ' ' VAL . 8.3 tptt -98.19 115.7 28.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.7 mt -82.8 -38.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.573 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 618' ' ' LEU . 6.7 mt -155.83 131.72 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.019 0.438 . . . . 0.0 111.873 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.24 124.75 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.669 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.18 117.88 29.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.642 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -66.36 -46.52 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.591 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -83.28 -40.36 19.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.351 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.06 -17.94 56.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.69 16.09 9.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.75 105.2 13.58 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 587' ' ' ILE . 1.1 p -122.83 124.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.267 0.555 . . . . 0.0 112.147 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 587' ' ' ILE . 6.6 mm -114.29 150.17 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.553 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.71 121.48 0.87 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.641 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 580' ' ' LEU . 6.9 m-30 -113.78 143.18 45.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.746 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.5 tttt -101.78 117.81 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.904 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.69 123.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -133.67 108.99 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.287 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 674' ' ' ASP . 87.0 mt -72.93 105.76 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.76 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.75 -47.57 10.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.139 0.495 . . . . 0.0 109.949 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -111.49 141.91 44.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.6 p -113.63 100.09 8.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.141 0.496 . . . . 0.0 109.875 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -80.31 61.51 4.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.696 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.3 54.81 34.16 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.109 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.794 HD11 ' CZ ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -87.28 148.38 25.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.392 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.72 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -39.76 -32.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.989 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.454 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -178.95 33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.443 ' HG3' HD12 ' A' ' 696' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.6 p -90.29 122.43 41.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.484 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.5 172.26 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -103.16 142.22 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -88.98 160.13 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.905 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.14 -173.49 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.74 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.81 -49.19 77.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.467 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.5 mp0 -69.18 -49.84 53.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.574 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 727' ' ' VAL . 24.7 mtmt -57.26 -32.81 66.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.735 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 6.9 mt -57.81 -44.24 86.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.8 p -75.86 -24.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.27 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -57.26 -41.14 79.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -74.1 -15.4 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.274 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.745 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.9 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.434 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 tmm_? -105.93 140.19 39.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -129.16 -61.15 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.585 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 6.4 tt -106.56 141.36 37.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.181 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.882 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.5 m -119.48 119.67 34.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.362 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.1 mt -104.79 108.29 19.69 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 98.68 44.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.8 Cg_exo -48.98 101.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.649 1.566 . . . . 0.0 109.15 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.02 158.26 85.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.456 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.94 -28.64 19.05 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.55 2.834 . . . . 0.0 112.594 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.48 -18.14 63.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 109.725 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.7 t -96.8 153.76 17.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.679 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.858 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.7 pt -55.62 -20.29 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.847 ' CD1' HG23 ' A' ' 613' ' ' ILE . 59.5 mt -110.27 118.66 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.382 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -106.74 57.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.394 0.616 . . . . 0.0 110.258 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.628 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -124.71 172.63 9.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.892 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.43 127.68 45.81 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.315 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.869 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.11 147.22 37.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.083 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 7.4 mt-10 -125.35 125.56 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.872 HD11 HD12 ' A' ' 625' ' ' ILE . 68.2 mt -86.1 109.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.0 mp0 -64.18 118.06 8.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.41 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.521 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.54 -29.79 1.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.583 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.27 -22.63 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.48 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 118.93 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.773 0.787 . . . . 0.0 111.726 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 17.1 t30 -139.56 121.82 10.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.781 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.9 Cg_endo -89.6 160.28 36.28 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.563 -1.015 . . . . 0.0 111.691 -0.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.9 t80 -91.52 116.19 28.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.744 ' CG ' HD12 ' A' ' 730' ' ' LEU . 25.4 m-85 -92.36 137.94 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.15 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.74 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.47 145.89 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.423 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.42 -176.28 41.66 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.481 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -78.52 -7.28 57.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.78 133.25 43.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -23.71 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 730' ' ' LEU . 6.8 p30 -57.83 -25.4 60.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 55.2 m -78.75 132.06 36.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.4 m120 -46.1 -31.35 2.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.198 0.523 . . . . 0.0 110.413 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.869 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.5 t -108.53 142.76 38.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.6 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 115.59 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -138.02 109.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.284 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 19.2 tt0 -87.09 103.41 15.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.6 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -132.11 112.81 12.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.44 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -42.98 -33.69 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.761 0.315 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.543 ' HB2' HD13 ' A' ' 681' ' ' ILE . 31.5 mmt180 -77.55 -39.98 44.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.071 HD12 HD12 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -60.21 159.11 10.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.905 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 70.7 m -111.09 168.81 9.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.537 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -43.64 24.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.228 0.537 . . . . 0.0 110.031 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.541 HG11 HG23 ' A' ' 727' ' ' VAL . 39.1 t -125.17 61.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.467 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.511 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 36.3 t60 -49.78 -48.3 50.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.791 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -167.52 157.32 10.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 111.363 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.2 p90 -143.14 147.37 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 580' ' ' LEU . 34.7 mt -102.13 128.33 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.086 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.612 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -119.78 131.3 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 20.2 ttmt -97.84 136.36 38.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.107 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.09 159.28 41.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.879 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.0 tpt180 -76.28 116.3 16.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.4 t60 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.209 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.918 -0.073 . . . . 0.0 112.918 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.671 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.8 mp -106.14 -159.71 0.71 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -118.27 146.77 44.05 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.44 160.41 29.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.782 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.65 121.98 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.46 0.647 . . . . 0.0 112.313 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.96 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -105.7 125.75 51.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.632 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -89.71 116.49 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 624' ' ' PHE . 16.3 m -102.95 137.13 41.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.403 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 41.4 t60 -116.87 122.97 45.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.787 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.35 7.92 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.272 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.78 145.18 19.94 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.832 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.4 m -75.29 -9.55 58.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.558 ' O ' HG13 ' A' ' 656' ' ' VAL . 36.2 m-20 -87.14 2.09 50.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.59 127.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.395 0.617 . . . . 0.0 112.158 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.403 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 16.2 p -97.73 165.55 11.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.208 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -128.52 119.7 25.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -95.22 102.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 63.42 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.11 -2.08 1.5 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.51 141.75 30.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.909 0.385 . . . . 0.0 111.222 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.1 ttp85 -85.16 141.61 30.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.5 mtp -131.11 124.74 31.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.522 HG12 HG21 ' A' ' 668' ' ' THR . 22.6 pt -95.08 156.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.779 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 652' ' ' THR . 32.9 tt0 -50.25 122.42 6.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 97.14 25.75 10.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.522 HG21 HG12 ' A' ' 665' ' ' ILE . 50.5 p -122.43 156.42 34.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.6 pttm -123.94 158.17 32.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.968 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.553 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.29 145.92 29.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.96 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.88 130.53 43.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.624 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.743 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -110.44 114.87 28.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.11 0.481 . . . . 0.0 111.665 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -99.15 135.29 40.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.849 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.47 ' HB2' HD12 ' A' ' 696' ' ' ILE . 4.3 t70 -40.96 109.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.584 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 101.11 34.55 4.52 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.424 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -93.45 115.17 27.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.469 -0.365 . . . . 0.0 111.087 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -96.25 108.51 21.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.838 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.632 HG21 ' CE2' ' A' ' 649' ' ' TYR . 7.1 mt -106.51 136.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 115.72 28.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.222 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.573 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -82.12 -36.16 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.197 -178.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.071 HD12 HD12 ' A' ' 618' ' ' LEU . 41.4 mt -154.9 131.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -136.57 124.77 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.57 117.23 23.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.481 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -66.8 -46.56 74.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.808 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -77.83 -40.37 40.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.602 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.4 -13.73 51.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.543 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp 61.82 17.77 9.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.64 104.96 9.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.3 p -117.54 121.83 68.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 111.695 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.5 mm -124.45 119.11 55.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.503 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -147.83 129.73 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 12.8 m-30 -113.18 142.82 45.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 110.255 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.592 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.27 116.91 33.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.332 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.88 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.73 123.97 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.73 110.22 11.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.0 110.868 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 705' ' ' GLU . 64.0 mt -81.46 105.64 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.788 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.08 -43.69 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.01 141.98 42.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -112.89 100.16 8.44 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.473 0.654 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 596' ' ' GLN . 0.6 OUTLIER -87.24 53.97 3.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.15 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 93.0 34.94 6.54 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.628 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -83.84 132.02 34.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.671 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.0 p90 -43.31 -33.32 0.97 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.515 0.674 . . . . 0.0 110.258 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -149.86 -55.8 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.124 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.81 ' O ' HD12 ' A' ' 696' ' ' ILE . 10.4 pt-20 . . . . . 0 N--CA 1.464 0.253 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.886 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.656 0.265 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 663' ' ' ARG . 51.9 t -77.42 128.45 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.462 . . . . 0.0 111.4 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.403 ' H ' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -113.74 164.65 13.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.348 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.52 142.95 27.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.95 158.66 36.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.0 p -118.91 -178.41 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.978 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.59 -29.06 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.98 -49.96 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -50.71 67.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.72 -32.89 63.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.36 -36.88 84.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.07 -44.2 94.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.541 HG23 HG11 ' A' ' 621' ' ' VAL . 11.2 p -79.15 -29.26 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.87 -30.61 61.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -85.51 -24.06 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.744 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.7 tt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.581 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.406 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 22.9 ttp-105 -111.82 143.11 43.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.052 0.453 . . . . 0.0 111.524 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.505 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.69 -57.81 1.43 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.09 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -110.26 137.93 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.084 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.739 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.4 m -118.55 114.18 22.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.678 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -103.92 108.06 19.22 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 16.3 ptpt -117.09 100.54 53.29 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.5 Cg_exo -46.08 104.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.87 1.714 . . . . 0.0 109.62 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.12 160.29 81.95 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.547 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 5.6 Cg_endo -48.17 -31.18 16.09 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.587 2.858 . . . . 0.0 112.495 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -63.73 -16.1 60.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.156 0.503 . . . . 0.0 109.726 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 9.1 t -94.18 145.0 25.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.601 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 3.5 pt -52.43 -24.26 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 110.178 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.647 HG21 HD12 ' A' ' 613' ' ' ILE . 7.3 tt -112.99 118.97 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.983 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.547 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -100.69 71.16 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.331 0.586 . . . . 0.0 110.321 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 50.6 mt-10 -126.05 171.9 10.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.127 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.21 130.2 47.61 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 121.138 0.494 . . . . 0.0 110.962 178.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.757 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.44 140.03 47.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.936 179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.406 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.12 112.56 17.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 578' ' ' LEU . 89.7 mt -81.09 108.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 110.03 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.9 mp0 -66.87 123.63 20.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.118 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.73 -26.71 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 110.819 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -75.68 -20.39 78.28 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.041 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 44.3 t -99.45 118.02 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.993 0.897 . . . . 0.0 111.776 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.0 t30 -140.23 122.49 9.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.583 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.5 Cg_endo -90.36 160.15 32.45 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.679 -0.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.1 t80 -92.58 117.48 30.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 730' ' ' LEU . 19.4 m-85 -92.51 137.48 32.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.262 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.3 mp -121.93 143.61 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.585 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 167.33 -165.09 38.39 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.949 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.21 -17.27 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.131 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -80.28 131.53 35.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.824 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.5 -23.85 11.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.001 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -59.84 -27.04 66.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 9.7 m -76.0 129.36 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -46.57 -32.47 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.231 0.539 . . . . 0.0 110.225 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 603' ' ' ILE . 13.2 t -107.47 135.24 49.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.315 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.98 111.94 22.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 588' ' ' ILE . 17.5 mm -137.78 110.14 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.974 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -81.57 102.85 10.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.066 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.816 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.8 OUTLIER -132.84 109.13 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.42 178.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -44.58 -52.88 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.989 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -60.64 -19.76 58.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.897 0.379 . . . . 0.0 110.928 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.008 HD12 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -76.2 160.66 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.575 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.456 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 19.6 t -111.22 151.96 27.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.411 ' CA ' ' HB2' ' A' ' 606' ' ' SER . 7.7 mpt_? -39.0 -38.6 0.46 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 110.675 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.539 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.9 t -128.67 60.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.418 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 21.7 t60 -50.4 -48.81 55.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.077 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.553 ' SG ' HG21 ' A' ' 680' ' ' ILE . 22.8 p -165.64 161.11 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.688 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.6 p90 -143.83 144.95 32.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.629 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.649 HD13 HD11 ' A' ' 580' ' ' LEU . 2.4 mp -101.97 128.87 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.1 t80 -119.43 134.04 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 6.7 ttpt -97.86 136.47 38.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.223 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.2 OUTLIER -135.21 159.88 40.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.473 -178.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.0 tpt85 -75.72 112.46 12.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.378 0.609 . . . . 0.0 110.371 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.8 t60 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.049 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 629' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 113.179 0.032 . . . . 0.0 113.179 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.2 mp -107.05 -161.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.828 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -115.63 146.85 41.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.237 0.541 . . . . 0.0 112.39 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.6 m-20 -129.95 160.55 33.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.798 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.54 125.61 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.494 0.664 . . . . 0.0 112.461 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.968 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.5 m95 -108.93 128.05 54.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.607 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.441 ' OH ' HG22 ' A' ' 680' ' ' ILE . 35.1 t80 -90.47 119.4 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.642 0.258 . . . . 0.0 110.325 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 28.2 m -107.59 128.38 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.215 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.407 ' HA ' ' CB ' ' A' ' 623' ' ' CYS . 20.5 t60 -108.81 125.3 51.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.47 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -118.62 4.41 11.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.01 150.54 26.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.152 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 654' ' ' THR . 76.1 m -82.4 -10.97 58.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.553 0.216 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -84.65 2.89 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 50.67 139.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.64 0.733 . . . . 0.0 112.353 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 10.1 t -112.67 166.16 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.55 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -130.57 120.2 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.016 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.677 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -102.63 103.25 13.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.438 ' N ' HD12 ' A' ' 659' ' ' LEU . 29.6 t-20 62.53 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.784 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.7 m-80 -139.89 -2.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.43 141.67 32.96 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.943 0.401 . . . . 0.0 111.406 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.618 ' O ' HG21 ' A' ' 716' ' ' VAL . 20.7 ttm180 -75.29 141.51 43.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.057 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.53 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.1 mmm -125.68 89.3 3.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.499 HG12 HG21 ' A' ' 668' ' ' THR . 30.0 pt -86.81 164.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.996 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 652' ' ' THR . 20.7 tt0 -50.65 117.77 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.454 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.22 30.26 9.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.789 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.499 HG21 HG12 ' A' ' 665' ' ' ILE . 23.8 p -114.01 162.18 16.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.5 ttpt -134.93 149.43 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.483 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 716' ' ' VAL . 0.7 OUTLIER -147.62 143.83 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.968 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -75.89 129.76 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.682 ' N ' HD12 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -99.87 143.79 29.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.329 0.585 . . . . 0.0 111.938 -179.426 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -130.34 136.17 48.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.511 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 696' ' ' ILE . 15.0 t70 -40.27 118.55 0.93 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.55 37.42 5.85 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -94.83 117.66 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.167 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.06 108.71 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.677 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -108.95 133.84 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -109.42 116.54 32.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.095 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.66 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 1.9 pt -89.51 -21.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.008 HD12 HD12 ' A' ' 618' ' ' LEU . 41.1 mt -154.27 130.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.579 . . . . 0.0 111.674 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -137.71 127.31 25.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.57 116.76 24.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.552 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -67.56 -47.62 69.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.708 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.1 -40.48 18.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.472 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -13.4 60.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.419 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.56 18.74 8.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.813 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.77 104.63 15.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -122.13 121.59 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.272 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.657 HD13 ' CG ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -128.44 128.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.95 135.92 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.466 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -114.28 147.43 39.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.37 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.4 tttt -101.53 117.19 34.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.529 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 3.6 t -78.79 123.55 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.28 109.34 9.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 705' ' ' GLU . 42.9 mt -80.86 105.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.24 -43.67 10.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.115 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.199 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.3 p -112.73 100.22 8.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.576 0.703 . . . . 0.0 109.789 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.2 m -84.65 59.29 5.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 83.99 40.13 8.91 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.437 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -86.67 132.66 33.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.533 0.206 . . . . 0.0 110.619 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -42.92 -33.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.342 0.591 . . . . 0.0 110.606 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -148.39 -58.79 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.808 ' O ' HD12 ' A' ' 696' ' ' ILE . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.146 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.62 HG22 ' CE1' ' A' ' 670' ' ' PHE . 15.8 t -84.11 113.73 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.154 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -90.72 169.65 10.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.9 140.18 37.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.69 155.39 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 32.1 p -125.64 -176.16 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.86 -33.43 56.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -51.3 70.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.454 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -63.91 -48.12 77.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -58.27 -32.97 68.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -64.85 -37.01 86.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.2 mt -62.91 -44.1 97.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.539 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.4 p -75.76 -28.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -33.17 52.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -98.68 26.23 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.485 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.2 tt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 11.6 ttm180 -113.46 143.82 43.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.706 0.288 . . . . 0.0 111.521 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.883 ' CE2' HD13 ' A' ' 702' ' ' LEU . 2.3 t80 -119.97 -55.29 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.4 tp -113.34 142.43 45.87 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -122.51 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 625' ' ' ILE . 4.7 mp -106.27 108.86 20.59 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 100.93 51.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 46.2 Cg_exo -45.94 99.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.98 1.787 . . . . 0.0 110.006 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.2 85.11 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -48.84 -25.29 8.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.403 2.735 . . . . 0.0 112.921 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.858 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -61.83 -27.27 68.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.508 ' OG ' HD13 ' A' ' 690' ' ' ILE . 8.7 t -95.73 154.11 17.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.892 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.679 HD13 ' CE1' ' A' ' 688' ' ' PHE . 2.6 pt -57.11 -12.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.69 0.281 . . . . 0.0 110.962 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.646 ' CD1' HG23 ' A' ' 613' ' ' ILE . 71.2 mt -110.27 123.0 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.746 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.16 57.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.197 0.522 . . . . 0.0 110.028 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.3 mt-10 -124.62 171.75 9.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.226 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.02 130.1 50.49 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 178.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.748 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.28 139.45 47.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.037 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.17 112.99 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.659 0.266 . . . . 0.0 111.644 -179.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.011 HD11 HD12 ' A' ' 625' ' ' ILE . 38.0 mt -77.22 109.76 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -67.71 114.66 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.76 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.19 -28.53 0.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.184 0.516 . . . . 0.0 110.809 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.427 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.83 -25.2 74.24 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.536 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.903 HG11 ' OD1' ' A' ' 610' ' ' ASN . 66.6 t -101.2 119.27 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 117.813 0.807 . . . . 0.0 111.61 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 18.5 t30 -139.07 122.91 11.09 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.786 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 47.3 Cg_endo -89.83 160.51 35.24 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 124.518 -1.034 . . . . 0.0 111.863 0.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.38 114.96 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.535 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.0 m-85 -92.12 138.19 31.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.168 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.1 145.77 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.83 -173.27 38.16 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.383 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.35 -53.48 29.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.656 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.6 129.82 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.292 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.39 -18.96 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -53.66 -30.02 41.25 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 30.4 m -73.55 134.45 43.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.903 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.3 m-80 -48.66 -27.36 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.973 0.415 . . . . 0.0 110.388 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.0 t -113.37 142.08 46.29 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -110.52 105.61 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.5 mm -138.52 109.91 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.161 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -103.69 106.7 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.489 0.662 . . . . 0.0 112.589 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.697 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.6 t0 -129.93 107.71 9.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.559 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -39.3 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.477 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.8 mmp_? -70.31 -41.42 73.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.623 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.12 158.72 18.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.85 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.2 t -78.26 172.37 13.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.418 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -50.27 -37.24 34.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 110.253 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.09 67.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.265 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.7 t60 -49.05 -48.36 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.811 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' A' ' 680' ' ' ILE . 2.6 p -159.99 158.77 31.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.676 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 603' ' ' ILE . 39.3 p90 -143.45 150.39 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.478 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.011 HD12 HD11 ' A' ' 594' ' ' ILE . 83.7 mt -102.53 132.42 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.215 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -124.97 132.92 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 36.2 ttmt -98.45 136.54 38.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.573 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.45 158.58 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -76.95 112.75 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.522 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.7 t60 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.628 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 701' ' ' GLY . 1.2 mp -115.74 -149.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.551 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 4.7 m-20 -118.21 149.37 41.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.282 0.563 . . . . 0.0 112.338 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.54 ' OD2' HD21 ' A' ' 671' ' ' LEU . 3.9 m-20 -134.03 129.32 35.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.734 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.779 HG21 ' CE1' ' A' ' 577' ' ' PHE . 7.0 pt -86.81 123.55 39.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.323 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.6 m95 -108.98 129.32 55.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.046 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.2 t80 -90.34 115.7 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 624' ' ' PHE . 60.8 m -101.63 141.88 33.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 111.473 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 664' ' ' MET . 24.8 t60 -124.13 131.64 53.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.514 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 9.3 p -124.24 2.63 8.52 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.37 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.84 142.48 24.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.037 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 654' ' ' THR . 28.3 m -75.55 -12.65 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.536 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.8 m120 -83.64 2.63 36.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.587 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.87 134.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.588 0.708 . . . . 0.0 112.281 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.403 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 43.5 p -105.49 165.89 10.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.355 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 20.2 m-85 -127.61 119.85 26.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 111.283 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.673 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.64 99.72 10.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.702 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.33 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.8 t-20 -133.48 3.76 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.833 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.705 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -110.15 130.26 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.955 0.407 . . . . 0.0 111.147 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.489 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -69.97 141.42 53.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.787 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.513 ' HG3' ' HB3' ' A' ' 651' ' ' HIS . 34.1 tpp -125.4 101.29 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.1 pt -87.94 165.61 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 652' ' ' THR . 16.1 tt0 -58.77 109.82 0.89 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.41 34.72 3.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 716' ' ' VAL . 5.2 p -134.84 154.94 51.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.356 . . . . 0.0 111.591 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.2 pttm -128.23 156.08 43.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.617 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.52 145.77 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.501 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.38 134.57 51.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.481 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.873 HD13 HG21 ' A' ' 694' ' ' VAL . 3.3 mt -108.52 126.33 52.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -113.36 154.21 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.714 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.48 ' N ' HD12 ' A' ' 696' ' ' ILE . 56.7 t0 -52.76 101.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.21 30.66 3.81 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 117.11 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.536 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -96.2 109.74 22.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.282 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.673 HG22 HD13 ' A' ' 659' ' ' LEU . 23.5 pt -105.94 130.48 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 5.2 mttp -94.5 116.13 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.711 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.588 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -79.3 -38.7 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.522 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.697 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -155.84 136.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -136.42 122.41 20.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -123.53 116.99 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.92 0.39 . . . . 0.0 110.583 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -67.27 -46.48 73.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.97 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -78.81 -40.49 32.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.793 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -83.08 -9.51 59.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 60.46 18.08 7.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.253 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.679 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -76.72 104.63 7.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.4 p -118.2 122.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.133 0.492 . . . . 0.0 111.746 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.588 HG21 ' CG2' ' A' ' 680' ' ' ILE . 22.5 mm -126.17 154.6 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.298 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.432 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 177.54 127.86 1.1 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.952 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 592' ' ' LEU . 11.1 m-30 -113.04 145.28 41.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.43 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.693 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.2 116.53 33.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.022 0.439 . . . . 0.0 110.256 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.873 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.58 127.19 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.754 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -134.28 108.4 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.924 179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 705' ' ' GLU . 11.5 mt -74.58 104.94 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.61 -50.84 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.899 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.6 t0 -112.47 138.36 49.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.211 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.09 100.06 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.55 HG21 ' HG3' ' A' ' 596' ' ' GLN . 64.1 p -70.27 78.84 0.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.336 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 53.42 39.75 60.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.388 -0.91 . . . . 0.0 110.829 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.883 HD13 ' CE2' ' A' ' 577' ' ' PHE . 1.5 tt -97.08 143.65 27.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.867 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.663 ' CB ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.25 112.66 1.62 Allowed 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.49 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 11.4 t30 59.73 -68.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.147 0.499 . . . . 0.0 109.932 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.682 ' HB2' HD13 ' A' ' 696' ' ' ILE . 11.7 pt-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.989 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.78 0.324 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.705 HG23 ' OD1' ' A' ' 662' ' ' ASN . 70.8 t -79.3 130.16 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.415 HD13 ' HE2' ' A' ' 669' ' ' LYS . 1.4 mp -99.42 170.65 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -98.32 155.76 17.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -96.39 158.54 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.3 p -126.04 -176.58 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.197 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.42 46.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.14 -47.81 84.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.37 -50.42 63.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.663 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -55.7 -32.87 63.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -37.31 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.786 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -44.34 93.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -78.41 -21.49 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -37.75 81.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.6 -9.67 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.399 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.99 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.0 tmm_? -107.52 143.11 36.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.603 ' HE1' HG21 ' A' ' 647' ' ' ILE . 2.4 t80 -132.61 -47.98 0.89 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.854 HD11 ' CD1' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -112.65 143.25 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.16 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.0 m -123.07 114.01 19.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.982 0.42 . . . . 0.0 111.053 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -106.11 109.01 20.82 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.26 99.43 52.69 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 39.0 Cg_exo -46.91 101.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.916 1.744 . . . . 0.0 109.814 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.815 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.73 157.95 85.32 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.413 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 9.0 Cg_endo -50.14 -25.46 13.07 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.768 2.978 . . . . 0.0 113.21 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -61.97 -27.37 68.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 2.7 t -95.62 153.92 17.48 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.624 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 688' ' ' PHE . 9.3 pt -56.51 -12.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.701 0.286 . . . . 0.0 111.193 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 39.9 mt -108.54 127.24 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.527 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -114.22 58.5 0.69 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.266 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.668 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 36.7 mt-10 -125.03 170.14 11.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.86 121.19 24.82 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.607 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -112.75 147.43 36.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -125.19 118.54 26.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 625' ' ' ILE . 57.6 mt -73.48 109.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.912 0.387 . . . . 0.0 110.294 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -65.1 116.4 6.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.971 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.99 -29.84 1.59 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.163 0.506 . . . . 0.0 110.471 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.23 -22.72 76.28 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.589 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.505 HG11 ' ND2' ' A' ' 610' ' ' ASN . 79.3 t -101.04 118.79 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 117.884 0.842 . . . . 0.0 111.585 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.0 t30 -139.37 122.68 10.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.765 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.11 160.43 33.82 Favored 'Cis proline' 0 N--CA 1.462 -0.373 0 C-N-CA 124.451 -1.062 . . . . 0.0 111.917 0.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.46 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.611 ' CG ' HD12 ' A' ' 730' ' ' LEU . 41.6 m-85 -92.25 138.15 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.007 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.2 mp -129.84 145.69 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.678 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.41 ' HA2' HD11 ' A' ' 618' ' ' LEU . . . 156.72 -163.36 32.14 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.013 -1.089 . . . . 0.0 114.049 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.2 OUTLIER -82.85 3.42 29.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -101.3 123.94 46.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -57.84 -22.49 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.271 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.16 -26.63 67.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.905 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 92.3 m -68.51 129.43 39.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.319 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.2 m120 -44.07 -33.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.308 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.756 ' SG ' HG23 ' A' ' 603' ' ' ILE . 53.5 t -109.73 134.88 51.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.12 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 111.99 23.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 30.6 mm -137.62 110.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.619 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 6.1 tt0 -91.6 105.9 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.274 0.559 . . . . 0.0 111.523 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 618' ' ' LEU . 13.5 t0 -130.32 108.58 10.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.702 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -47.43 -29.8 2.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.821 0.343 . . . . 0.0 111.201 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.491 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 19.7 mmt180 -77.86 -41.29 37.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -84.75 151.71 24.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.94 161.4 23.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.165 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.448 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -47.65 -38.8 15.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.444 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 24.1 t -121.24 57.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.0 t60 -50.42 -48.66 56.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.883 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.48 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.2 p -162.69 157.04 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 111.422 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.792 ' HA ' HD12 ' A' ' 603' ' ' ILE . 25.2 p90 -143.32 146.93 33.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.594 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 594' ' ' ILE . 23.9 mt -101.9 135.37 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.983 0.42 . . . . 0.0 109.914 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -127.34 134.94 49.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.746 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.2 ttmt -97.64 136.19 38.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.137 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 159.27 42.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.76 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.47 112.55 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.195 0.522 . . . . 0.0 110.595 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t-160 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.695 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.1 mp -102.47 -166.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -111.75 148.03 34.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.026 0.441 . . . . 0.0 111.926 -179.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -128.85 160.11 33.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.854 ' CD1' HD11 ' A' ' 578' ' ' LEU . 3.5 pt -110.64 121.59 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.317 0.579 . . . . 0.0 111.615 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.854 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.9 m95 -104.28 141.3 36.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.165 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.7 t80 -105.7 116.95 32.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.19 139.8 39.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.472 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 62.2 t60 -119.46 128.73 54.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.417 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 5.4 p -126.55 12.95 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.51 148.75 21.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.181 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 69.5 m -77.0 -21.89 53.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -79.9 -0.52 35.27 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.5 OUTLIER 54.9 128.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.932 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.1 p -92.74 166.36 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.986 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 679' ' ' LYS . 18.7 m-85 -133.15 120.6 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.779 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -105.3 112.57 25.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.142 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 59.03 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -139.86 7.6 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -104.22 141.06 36.93 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.924 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.1 ttt180 -79.33 141.02 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 13.9 mmm -120.96 101.27 7.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.446 HG12 HG21 ' A' ' 668' ' ' THR . 34.2 pt -88.27 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 652' ' ' THR . 34.6 tt0 -44.81 109.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.423 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.45 34.78 3.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.446 HG21 HG12 ' A' ' 665' ' ' ILE . 3.6 p -122.33 162.25 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.071 0.462 . . . . 0.0 111.667 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.419 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 4.5 ttpm? -131.61 149.71 52.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.344 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.484 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.3 143.74 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.854 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.37 137.74 53.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.437 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -110.85 104.14 12.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.235 0.54 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -90.94 137.91 32.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.197 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.566 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.4 t70 -43.52 111.32 0.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.8 37.13 4.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -93.55 122.65 36.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.469 -0.366 . . . . 0.0 111.012 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.37 108.88 21.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.186 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.779 HG23 ' HG ' ' A' ' 659' ' ' LEU . 3.7 mt -106.15 136.36 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.904 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 658' ' ' TYR . 1.7 mttt -100.83 116.27 32.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.566 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.525 HG22 ' CG2' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -78.68 -37.94 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.413 -179.008 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.52 HD11 ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -155.29 131.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.724 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -136.25 123.56 21.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.159 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -121.4 117.18 26.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.42 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -66.89 -46.51 74.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.943 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.41 -40.44 21.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.543 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -77.47 -14.0 59.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.334 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 15.09 9.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -78.6 104.76 9.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.6 p -120.18 121.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 111.972 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.585 HD12 ' OD2' ' A' ' 615' ' ' ASP . 3.4 mt -129.14 152.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.324 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 177.5 133.3 1.82 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.021 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 4.2 m-30 -112.93 150.92 31.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.553 ' HB2' HD22 ' A' ' 583' ' ' LEU . 5.7 ttpt -101.27 116.82 33.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.953 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.759 HG13 ' CD2' ' A' ' 578' ' ' LEU . 1.8 t -81.11 121.89 35.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.883 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.66 108.75 8.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.477 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 674' ' ' ASP . 11.6 mt -79.21 107.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.32 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.68 -41.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -109.76 141.09 42.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.2 OUTLIER -114.88 100.41 8.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.418 0.627 . . . . 0.0 110.046 178.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.6 m -86.79 70.47 10.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 73.33 36.12 55.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.163 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.608 HD12 ' CA ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -79.87 118.59 21.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.583 0.23 . . . . 0.0 111.171 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.695 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -32.8 -47.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.535 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -159.2 26.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.608 ' CA ' HD12 ' A' ' 702' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.543 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.897 0.38 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.924 HG21 ' O ' ' A' ' 663' ' ' ARG . 59.4 t -78.91 129.32 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.9 mt -102.64 166.13 10.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 137.99 40.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.02 159.88 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.4 p -121.11 -173.68 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.67 -28.82 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.16 -52.09 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.66 -49.32 63.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.628 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -56.35 -33.13 65.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 -38.24 89.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.8 mt -58.41 -44.01 88.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.548 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.6 p -83.18 -29.77 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -52.11 -29.31 21.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.057 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -105.29 27.22 8.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.611 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.3 tt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.679 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.9 tmm_? -102.29 126.13 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.564 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -109.2 -62.29 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.187 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.06 137.76 43.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.72 ' N ' HD23 ' A' ' 578' ' ' LEU . 4.6 m -115.98 113.96 23.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.998 0.428 . . . . 0.0 111.434 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.721 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -104.83 107.9 19.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 ptpt -114.83 100.02 52.84 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_exo -45.78 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.945 1.763 . . . . 0.0 109.565 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.16 157.83 86.3 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 73.8 Cg_exo -49.12 -25.25 8.98 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.381 2.72 . . . . 0.0 112.425 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.726 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.2 t0 -61.97 -22.61 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.0 t -95.31 153.11 17.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.847 HD11 ' OD1' ' A' ' 615' ' ' ASP . 20.7 pt -53.03 -19.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.012 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.58 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.99 142.92 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.658 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -119.47 67.74 0.81 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.589 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 89.5 mt-10 -125.16 170.86 10.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.494 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.77 124.0 34.37 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 1.084 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.26 136.51 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.571 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.3 OUTLIER -124.48 116.6 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.851 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.716 HG23 ' CD1' ' A' ' 601' ' ' PHE . 81.2 mt -74.87 108.16 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.842 0.354 . . . . 0.0 110.144 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.2 mp0 -66.16 103.14 0.92 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -29.6 -54.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.27 0.557 . . . . 0.0 111.449 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -53.03 -16.39 4.24 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.017 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.37 118.05 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 117.873 0.837 . . . . 0.0 111.604 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' ND2' ' CD2' ' A' ' 626' ' ' PHE . 0.9 OUTLIER -140.46 124.35 10.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.997 178.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 37.2 Cg_endo -91.32 159.28 27.73 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.149 0.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.716 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.3 t80 -93.61 115.77 28.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 0.0 109.962 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 730' ' ' LEU . 1.7 m-85 -92.94 138.61 31.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.917 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.804 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -127.51 144.89 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 158.35 -165.0 33.71 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.877 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.02 17.92 11.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.41 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 1.1 t -101.78 131.68 47.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.642 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -21.71 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.763 0.316 . . . . 0.0 110.63 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.29 -21.33 60.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.9 m -76.52 127.41 32.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 23.3 m120 -45.76 -31.68 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.14 0.495 . . . . 0.0 110.434 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.804 ' SG ' HG23 ' A' ' 603' ' ' ILE . 45.0 t -110.55 138.72 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 117.83 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 1.084 HD11 HD21 ' A' ' 592' ' ' LEU . 34.2 mm -138.06 108.83 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.314 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.35 101.09 11.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.413 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD1' HD11 ' A' ' 587' ' ' ILE . 1.1 m-20 -133.54 113.36 12.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.937 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -50.42 -45.81 55.98 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' A' ' 681' ' ' ILE . 2.4 mpp_? -62.66 -19.05 63.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.549 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.982 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -88.17 160.81 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.593 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.403 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 2.6 m -109.92 153.74 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -39.03 -50.68 1.81 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.76 57.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.606 ' CB ' HD23 ' A' ' 618' ' ' LEU . 54.2 t60 -52.69 -37.55 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.344 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.529 0.68 . . . . 0.0 111.939 -178.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.598 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.18 131.97 21.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.904 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 603' ' ' ILE . 21.3 mt -131.79 116.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.458 ' CD2' ' ND2' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -136.78 149.02 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -178.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 34.6 ttmt -98.9 136.76 38.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 159.79 35.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.4 tpt180 -75.68 112.75 12.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.746 -0.141 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.638 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.8 mp -110.54 -163.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.822 ' O ' HD13 ' A' ' 702' ' ' LEU . 9.8 m-20 -114.12 146.49 40.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.294 0.569 . . . . 0.0 112.197 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.434 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -128.8 160.61 32.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.647 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.092 HD13 HD12 ' A' ' 578' ' ' LEU . 0.6 OUTLIER -103.33 128.29 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.6 0.714 . . . . 0.0 112.081 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.6 m95 -113.02 120.45 41.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.27 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.647 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.6 t80 -93.62 117.77 30.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 624' ' ' PHE . 3.9 m -113.74 143.87 43.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.437 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 42.5 t60 -110.58 130.12 55.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.0 0.428 . . . . 0.0 111.049 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.428 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 20.5 p -120.56 3.83 10.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . . . . . . . . . . . -81.58 146.22 25.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.847 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 37.5 m -75.94 -15.64 60.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 656' ' ' VAL . 29.3 m-20 -85.18 3.05 41.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.16 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.438 0.637 . . . . 0.0 112.283 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.58 ' CB ' ' HH ' ' A' ' 649' ' ' TYR . 33.1 p -99.31 166.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.302 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 5.8 m-85 -129.23 120.06 25.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.718 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 1.029 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -98.64 102.58 14.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 60.93 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.4 p30 -136.84 5.7 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.672 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.533 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -107.44 139.75 41.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.626 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.1 ttp180 -76.4 141.36 41.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.423 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 25.1 mmm -124.61 97.44 5.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 45.4 pt -87.57 152.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 652' ' ' THR . 38.5 tt0 -48.7 112.05 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.91 0.386 . . . . 0.0 110.945 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.9 32.32 4.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.3 p -121.04 162.54 19.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.828 0.347 . . . . 0.0 111.203 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.9 ttpm? -133.69 147.81 51.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.769 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.69 28.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.04 133.72 48.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.593 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.88 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -108.9 104.71 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -91.35 139.26 30.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.621 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.644 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.2 t0 -41.28 112.4 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 110.708 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.28 37.08 4.43 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.78 116.11 28.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.252 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -96.26 108.72 21.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 659' ' ' LEU . 25.5 pt -105.92 129.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.798 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 27.9 mttp -89.43 115.8 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.834 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -79.26 -35.47 17.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.811 -178.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.982 HD12 HD12 ' A' ' 618' ' ' LEU . 50.2 mt -155.0 131.59 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.704 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -136.37 123.45 21.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.5 116.96 25.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.505 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -67.03 -46.61 73.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.842 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -80.91 -40.07 25.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.1 t30 -83.06 -13.36 55.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.06 17.11 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 111.0 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.04 104.62 7.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.5 p -117.48 124.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.2 0.524 . . . . 0.0 111.914 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 681' ' ' ILE . 59.5 mt -129.01 156.0 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.315 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 170.83 136.33 2.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.68 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.834 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -114.16 149.8 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.53 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.85 117.6 35.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.663 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 672' ' ' LEU . 3.5 t -80.03 124.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -133.2 109.71 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.413 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 705' ' ' GLU . 52.1 mt -78.26 106.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.76 -44.71 9.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.176 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -110.4 141.87 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.54 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -113.07 99.92 8.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.431 0.634 . . . . 0.0 109.599 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.1 m -82.88 58.84 4.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.52 13.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.173 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -80.64 134.33 35.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.56 0.219 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.638 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.8 p90 -43.36 -33.52 1.04 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.469 0.652 . . . . 0.0 110.266 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.493 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -148.1 -61.2 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.341 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.745 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.7 pt-20 . . . . . 0 N--CA 1.463 0.186 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.957 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.72 0.295 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 663' ' ' ARG . 65.0 t -85.78 121.84 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.506 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.66 172.36 8.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.37 16.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 650' ' ' CYS . 42.1 mt-30 -93.44 148.55 21.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -126.41 -175.96 3.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 111.669 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -30.15 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.198 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -56.61 -50.12 72.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.676 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.79 ' HA ' HD12 ' A' ' 726' ' ' LEU . 21.6 mm-40 -70.01 -49.5 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.57 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.477 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.43 -39.95 89.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.0 OUTLIER -63.35 -44.69 94.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.562 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.89 -19.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.254 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.98 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.039 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -108.11 24.24 13.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.677 ' O ' HD23 ' A' ' 730' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 52.1 ttp180 -106.12 141.47 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -125.66 -58.3 1.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.214 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 647' ' ' ILE . 12.8 tp -110.92 134.93 52.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.439 ' C ' HD23 ' A' ' 580' ' ' LEU . 7.5 m -115.24 114.72 25.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD11 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -105.28 108.7 20.35 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.96 100.33 52.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.2 Cg_exo -44.72 100.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.917 1.745 . . . . 0.0 109.806 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.35 158.29 85.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 7.7 Cg_endo -49.43 -24.68 9.22 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.59 2.86 . . . . 0.0 112.387 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.764 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.42 -23.09 65.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 2.2 t -95.46 153.34 17.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.75 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.534 HD13 ' HD1' ' A' ' 688' ' ' PHE . 4.0 pt -54.42 -18.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.84 142.95 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.815 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 1.0 OUTLIER -120.02 68.81 0.84 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.194 0.521 . . . . 0.0 110.286 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.3 mm-40 -124.91 171.38 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.494 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 127.33 42.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.0 0.428 . . . . 0.0 111.12 178.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.952 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.39 139.58 47.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.892 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 6.1 mp0 -124.48 117.39 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.045 HD11 HD11 ' A' ' 580' ' ' LEU . 88.0 mt -86.34 109.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.062 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -67.47 125.84 27.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.72 -28.5 3.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.123 0.487 . . . . 0.0 110.52 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.59 -17.7 80.04 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.982 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.4 t -100.94 117.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.05 0.925 . . . . 0.0 111.878 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -140.8 121.31 8.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.8 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 50.5 Cg_endo -89.63 160.65 36.32 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 124.772 -0.928 . . . . 0.0 111.499 -0.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.0 t80 -92.15 117.02 29.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 730' ' ' LEU . 35.1 m-85 -92.21 137.51 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.039 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.773 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -124.94 143.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.59 -176.67 42.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.079 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.6 ttp85 -81.21 -2.96 50.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.662 0.268 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 135.71 42.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -24.91 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.059 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -28.36 60.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 51.5 m -77.06 132.52 38.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -47.31 -29.07 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.563 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.773 ' SG ' HG23 ' A' ' 603' ' ' ILE . 38.5 t -111.58 142.45 43.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.897 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 115.92 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.952 HD11 HD21 ' A' ' 592' ' ' LEU . 17.5 mm -137.78 110.29 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.441 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 22.2 mt-10 -81.88 103.2 11.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.511 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.737 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.43 108.43 9.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.161 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -42.5 -36.73 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.2 mpp_? -77.62 -36.86 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.737 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -60.3 158.91 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 83.9 p -110.68 168.89 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.553 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -46.17 -52.98 11.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.224 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.6 t -116.76 58.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.204 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' HG23 ' A' ' 680' ' ' ILE . 35.6 t60 -49.35 -48.59 46.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.886 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -163.12 156.08 19.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.502 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.9 p90 -143.22 148.05 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.38 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -102.59 141.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 179.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.0 t80 -130.91 134.15 46.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.418 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 27.9 ttmt -97.66 136.8 37.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.91 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.68 159.44 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.443 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.27 117.78 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.436 0.636 . . . . 0.0 110.79 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.484 ' CD2' ' C ' ' A' ' 630' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.444 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.751 -0.14 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.71 HD12 ' H ' ' A' ' 703' ' ' PHE . 1.2 mm? -79.99 -160.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 m-20 -122.49 147.03 46.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.188 0.518 . . . . 0.0 112.037 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.8 ' HB3' HD21 ' A' ' 671' ' ' LEU . 1.9 m-20 -129.18 159.72 35.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -105.92 134.94 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.362 0.601 . . . . 0.0 112.23 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.625 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 67.4 m95 -117.96 127.59 53.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.313 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.656 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -90.08 117.17 28.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.1 m -102.93 131.72 49.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.601 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.444 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 67.0 t60 -109.88 128.58 55.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.3 p -124.44 -1.14 8.1 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.451 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.36 137.95 21.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.029 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 654' ' ' THR . 91.4 m -69.78 -10.84 59.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.627 0.251 . . . . 0.0 111.456 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.532 ' O ' HG13 ' A' ' 656' ' ' VAL . 55.7 m-20 -85.03 3.75 37.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.59 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.57 137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.566 0.698 . . . . 0.0 112.182 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.444 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 5.9 t -108.74 166.2 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.387 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -129.38 120.36 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -101.84 99.64 9.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.562 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.9 m120 61.06 -81.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.2 p-10 -133.79 1.81 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.643 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.434 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.5 m120 -104.21 141.65 35.89 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.859 0.361 . . . . 0.0 111.069 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.55 141.27 38.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.058 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 656' ' ' VAL . 57.4 mmm -115.66 98.68 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.3 pt -87.5 155.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.063 0.459 . . . . 0.0 111.226 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -51.41 105.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.61 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 39.64 2.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.212 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.5 p -132.39 148.9 52.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.871 0.335 . . . . 0.0 111.549 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.66 ' HE2' HD13 ' A' ' 717' ' ' LEU . 15.9 pttm -123.88 136.35 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.671 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -131.94 141.61 49.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.6 OUTLIER -69.37 141.26 54.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.945 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 694' ' ' VAL . 16.2 mt -111.87 105.39 13.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 112.018 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -77.86 156.39 30.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.878 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.7 ' CB ' HD12 ' A' ' 696' ' ' ILE . 7.0 t0 -53.2 109.7 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.83 37.92 4.29 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -88.1 115.22 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.437 . . . . 0.0 111.184 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.12 109.78 22.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.626 HG22 HD13 ' A' ' 659' ' ' LEU . 11.8 pt -105.57 120.61 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.155 0.502 . . . . 0.0 112.11 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -87.54 116.02 25.37 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -82.3 -33.46 11.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.885 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -155.15 132.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.523 ' CB ' HG23 ' A' ' 689' ' ' VAL . 9.5 t90 -136.04 124.33 23.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 687' ' ' LYS . 2.2 t0 -124.14 116.58 22.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -67.79 -46.68 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.064 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -40.36 96.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.134 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -93.69 -18.35 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.643 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.0 OUTLIER 65.91 13.06 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.0 111.029 -179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -87.51 105.56 17.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.523 HG23 ' CB ' ' A' ' 682' ' ' TRP . 1.2 p -119.78 138.78 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.357 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.616 ' CG1' HG22 ' A' ' 681' ' ' ILE . 18.4 mm -113.67 152.12 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.77 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.2 130.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.651 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 680' ' ' ILE . 1.6 m-30 -113.9 145.06 42.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.735 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.0 tttm -101.1 116.92 33.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.033 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -79.82 128.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.692 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.3 OUTLIER -133.29 108.58 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.124 0.488 . . . . 0.0 111.019 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.8 mt -76.28 105.29 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.385 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -91.9 -50.13 5.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.041 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -112.62 139.57 48.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.142 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.466 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -116.2 100.56 8.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.207 0.527 . . . . 0.0 109.692 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 62.02 0.67 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.968 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.1 47.32 88.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.54 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -112.24 32.61 5.42 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.71 ' H ' HD12 ' A' ' 644' ' ' LEU . 0.0 OUTLIER 67.85 175.67 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 703' ' ' PHE . 4.8 t30 -14.56 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.028 0.442 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 696' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.927 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.6 t -84.08 130.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.66 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -101.24 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.89 157.43 16.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 111.186 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.73 158.86 17.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.1 p -126.13 -175.29 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -33.69 57.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.27 -45.6 90.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.614 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -63.74 -50.97 66.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -54.24 -32.7 56.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.13 -37.09 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.097 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 723' ' ' GLU . 13.2 mt -58.03 -44.37 87.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.7 p -78.82 -27.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -30.13 65.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.836 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -97.51 13.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.659 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.9 tt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -89.13 114.0 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -104.58 -59.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.394 -179.116 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.145 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -106.67 142.0 37.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.352 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.735 ' N ' HD23 ' A' ' 578' ' ' LEU . 11.5 m -122.25 114.71 21.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 694' ' ' VAL . 6.2 mt -102.95 107.8 18.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 44.9 mtmt -111.6 99.46 44.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.7 Cg_exo -48.15 98.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.755 1.637 . . . . 0.0 109.535 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.749 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.73 157.63 85.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.626 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.434 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.6 Cg_exo -49.76 -28.43 17.65 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.458 2.772 . . . . 0.0 112.64 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.454 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.3 t70 -62.38 -24.99 67.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.9 t -95.44 153.97 17.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -56.2 -11.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.237 179.586 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.844 ' CD1' HG23 ' A' ' 613' ' ' ILE . 20.3 mt -112.1 126.88 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.824 0.345 . . . . 0.0 111.741 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.34 52.38 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 110.148 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 14.1 mm-40 -124.49 172.01 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.96 131.35 51.1 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.941 0.4 . . . . 0.0 111.337 179.131 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.731 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.5 OUTLIER -112.58 141.94 45.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.778 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.63 116.32 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.149 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.054 HD12 HD22 ' A' ' 578' ' ' LEU . 63.9 mt -86.56 108.98 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 8.6 mm100 -71.8 128.71 36.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.03 -30.34 1.81 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 109.877 179.084 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.43 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.74 -25.06 75.96 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.16 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.481 HG11 ' CG ' ' A' ' 610' ' ' ASN . 87.9 t -98.73 117.16 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 118.171 0.985 . . . . 0.0 111.842 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.2 t30 -141.16 121.92 8.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.034 177.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.593 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.8 Cg_endo -89.86 159.78 34.77 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.543 -1.024 . . . . 0.0 111.248 -0.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.578 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.7 t80 -91.88 114.98 27.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 25.3 m-85 -91.82 138.38 31.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.998 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.763 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.95 145.31 33.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.459 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.14 -178.3 41.37 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.573 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.451 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.8 ttp85 -76.97 -7.52 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.563 0.22 . . . . 0.0 111.466 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.48 131.96 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.758 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -56.1 -23.99 37.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.217 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.602 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.5 OUTLIER -55.04 -30.2 59.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.653 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 45.2 m -74.87 134.51 41.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 4.8 m-80 -48.11 -27.07 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 603' ' ' ILE . 36.0 t -112.13 140.46 46.8 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.542 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.59 113.03 23.84 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.844 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -137.8 109.67 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.774 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 25.8 tt0 -87.66 103.87 15.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.584 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.758 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -131.06 110.55 11.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.11 178.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -41.21 -35.65 0.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.728 0.299 . . . . 0.0 111.526 -178.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.528 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.9 mmt180 -77.69 -38.64 46.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.05 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -59.69 159.48 8.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.178 -179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 167.59 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 -50.0 19.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.134 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 727' ' ' VAL . 38.9 t -119.71 59.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.36 178.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.7 t60 -48.5 -49.18 36.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.619 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.3 p -166.34 157.35 12.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.595 ' HA ' HD12 ' A' ' 603' ' ' ILE . 44.0 p90 -143.39 146.89 33.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 603' ' ' ILE . 2.2 mp -102.17 125.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.775 179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -116.79 133.72 55.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 -179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 15.2 ttmt -98.55 136.93 37.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.64 158.78 40.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.385 -179.164 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.47 115.72 16.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.384 0.612 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.418 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 4.2 t60 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.002 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 701' ' ' GLY . 1.6 mm? -71.51 -160.82 0.06 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.662 0.231 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.32 146.46 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -179.536 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.451 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -125.23 160.21 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.775 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.145 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -110.01 121.9 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.619 0.723 . . . . 0.0 112.591 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.0 m95 -105.34 128.13 53.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.629 179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.463 ' CB ' HD21 ' A' ' 672' ' ' LEU . 22.0 t80 -90.57 117.75 29.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 36.7 m -106.35 128.09 53.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 33.8 t60 -110.29 126.34 54.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.855 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.487 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 13.4 p -123.46 7.24 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.516 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.46 146.82 25.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.954 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 32.8 m -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.611 0.243 . . . . 0.0 111.642 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.519 ' O ' HG13 ' A' ' 656' ' ' VAL . 19.2 m-20 -85.23 3.25 40.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.44 135.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.733 0.777 . . . . 0.0 112.487 179.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.427 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 3.7 t -104.16 165.85 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.188 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 679' ' ' LYS . 37.3 m-85 -128.28 119.76 25.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.46 102.44 12.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.8 m120 59.73 -82.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.898 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 659' ' ' LEU . 26.1 p30 -135.77 6.99 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.638 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -110.8 141.6 43.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.942 0.401 . . . . 0.0 110.918 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.458 ' HG2' HG23 ' A' ' 665' ' ' ILE . 8.9 ttp85 -75.19 141.19 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.462 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 23.4 mmm -122.66 86.06 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.354 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' A' ' 663' ' ' ARG . 30.7 pt -86.84 156.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.325 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.4 tt0 -49.12 107.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.234 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.16 32.44 4.02 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.586 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 665' ' ' ILE . 2.5 p -121.72 161.84 21.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.6 ttpm? -135.66 147.87 48.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.45 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.93 28.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.1 134.73 49.74 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.629 179.446 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.736 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.74 108.0 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.071 0.462 . . . . 0.0 111.783 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -95.8 157.28 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.227 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 705' ' ' GLU . 4.0 p-10 -52.38 124.57 13.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.802 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 84.42 39.63 8.92 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.997 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.16 112.31 23.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.911 0.386 . . . . 0.0 111.152 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.81 108.77 21.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 6.0 mt -109.7 128.83 65.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 0.0 112.035 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.4 OUTLIER -90.34 115.85 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.407 178.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.8 mt -77.02 -37.6 26.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.422 -179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.05 HD12 HD12 ' A' ' 618' ' ' LEU . 38.3 mt -155.39 131.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.773 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -135.87 121.09 19.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.748 178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.54 117.36 24.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -66.73 -46.67 74.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.609 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.23 -40.24 19.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.289 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.78 -11.32 59.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.8 20.59 8.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.735 0.303 . . . . 0.0 110.925 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.79 104.82 15.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -119.5 121.4 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.19 0.519 . . . . 0.0 111.81 -178.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.65 ' CD1' HG22 ' A' ' 587' ' ' ILE . 26.8 mm -128.5 150.14 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.536 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.54 127.55 1.17 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.411 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.565 ' HB2' HD22 ' A' ' 580' ' ' LEU . 8.7 m-30 -113.34 145.76 40.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.752 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.749 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.2 ttpt -101.88 117.97 35.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.086 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.884 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.43 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 34.2 tt0 -131.26 108.39 9.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.028 0.442 . . . . 0.0 110.334 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.86 HD12 ' HG3' ' A' ' 705' ' ' GLU . 27.8 mt -76.39 105.58 5.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.927 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . 0.407 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.6 m-80 -87.12 -46.14 10.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.484 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 21.2 t0 -110.77 139.4 46.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.7 p -115.72 99.99 7.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.22 0.533 . . . . 0.0 109.828 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -80.07 68.35 6.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.494 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 67.65 30.27 74.62 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.692 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -70.59 133.07 46.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.671 0.272 . . . . 0.0 111.198 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -39.15 -49.92 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.175 179.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.537 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -157.56 20.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.857 178.182 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.86 ' HG3' HD12 ' A' ' 696' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.0 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' A' ' 662' ' ' ASN . 62.4 t -86.82 130.29 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 111.391 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mt -104.84 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.17 148.54 25.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -84.8 151.17 24.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.823 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.09 -177.78 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.23 -30.54 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.193 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.82 -51.97 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.3 OUTLIER -67.55 -46.42 72.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.546 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -56.51 -32.86 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -67.82 -38.42 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 723' ' ' GLU . 26.8 mt -56.49 -44.34 80.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.636 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.5 p -73.21 -26.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.34 -34.38 66.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.809 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -98.63 29.26 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 608' ' ' ASP . 5.8 tt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 16.9 ttm180 -110.28 143.33 40.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 111.713 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.9 t80 -122.87 -40.28 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.81 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.0 tp -126.96 142.24 51.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 111.041 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 695' ' ' GLU . 22.1 m -124.9 114.19 18.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.052 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.794 ' HG ' HG22 ' A' ' 694' ' ' VAL . 2.9 mp -106.86 108.93 20.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.47 100.52 50.3 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 51.9 Cg_exo -44.53 103.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.083 1.855 . . . . 0.0 110.056 177.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.83 158.22 84.88 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.874 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.9 Cg_endo -49.71 -23.92 8.99 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.021 3.147 . . . . 0.0 113.199 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -60.37 -26.29 66.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 2.7 t -95.97 153.5 17.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.72 178.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 13.1 pt -55.04 -14.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.45 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.5 tt -112.67 131.9 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 111.822 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.411 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -113.67 69.54 0.7 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mt-10 -125.41 170.79 11.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.577 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.15 130.14 47.63 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 121.055 0.455 . . . . 0.0 111.045 178.483 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.766 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.63 136.57 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.267 179.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 13.8 mt-10 -123.95 110.7 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.08 HD11 HD12 ' A' ' 625' ' ' ILE . 63.1 mt -78.72 109.79 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.3 mp0 -67.8 115.27 7.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.73 -28.95 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 111.07 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.87 -22.31 73.78 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.484 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.48 119.45 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 117.657 0.728 . . . . 0.0 111.821 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.8 t30 -138.83 122.41 11.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.629 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.7 Cg_endo -90.33 160.59 32.84 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.632 -0.987 . . . . 0.0 111.908 0.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.89 119.58 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.595 ' CG ' HD12 ' A' ' 730' ' ' LEU . 29.2 m-85 -92.97 138.35 31.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.453 -177.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.778 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -129.69 141.14 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 163.99 -166.97 37.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.947 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 14.8 ttp85 -87.31 7.0 30.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.651 0.262 . . . . 0.0 111.275 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 2.4 t -101.35 125.79 48.03 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.52 -22.92 36.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -25.03 66.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.414 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 84.1 m -73.71 126.97 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.5 m120 -43.13 -33.71 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.778 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.4 t -106.97 136.17 47.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.606 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 115.5 25.18 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 592' ' ' LEU . 13.5 mm -137.69 109.87 6.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.058 178.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.42 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mt-10 -83.96 103.33 13.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.867 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.845 ' OD2' HD13 ' A' ' 690' ' ' ILE . 5.1 m-20 -132.08 112.98 12.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.306 178.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -42.58 -45.96 4.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.909 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.98 -30.95 69.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.382 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 1.087 HD12 HD12 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -65.26 159.08 24.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.828 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -114.31 167.34 10.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.024 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.46 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -44.48 -62.44 1.18 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.521 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.5 t -106.1 58.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.471 0.653 . . . . 0.0 109.476 178.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.581 ' CE1' HD11 ' A' ' 681' ' ' ILE . 56.0 t60 -47.09 -49.67 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.559 -179.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.2 p -162.99 157.19 20.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.9 p90 -143.56 146.95 33.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.08 HD12 HD11 ' A' ' 594' ' ' ILE . 69.6 mt -101.74 131.51 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.878 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -123.9 135.46 53.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.49 134.06 41.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.85 159.51 41.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.074 -178.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -76.67 112.47 13.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.937 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 703' ' ' PHE . 6.9 mt -113.87 -156.88 0.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.843 ' O ' HD12 ' A' ' 702' ' ' LEU . 1.7 m-20 -114.61 148.41 38.12 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 4.8 m-20 -135.7 145.99 47.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.346 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.678 ' CD1' HD22 ' A' ' 578' ' ' LEU . 3.2 pt -95.29 122.65 46.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.577 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 77.2 m95 -105.33 129.92 53.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.435 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 8.2 t80 -90.63 116.83 28.82 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 5.9 m -102.36 142.53 33.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.362 . . . . 0.0 111.253 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.47 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 64.4 t60 -122.85 127.44 49.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -123.76 0.23 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.348 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.94 147.88 31.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -25.89 63.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.446 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -68.6 -5.28 19.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.125 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.39 123.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.47 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 6.7 t -93.94 165.86 12.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.677 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 663' ' ' ARG . 2.4 m-85 -135.67 120.74 18.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.725 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.62 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.614 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 62.49 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.21 -5.36 3.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.69 132.12 43.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 658' ' ' TYR . 15.0 mtm-85 -75.23 141.69 43.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.8 mtp -119.3 110.46 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.919 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 46.0 pt -87.91 148.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -47.92 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.337 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 116.25 40.08 0.83 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.722 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.7 p -139.18 162.12 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.51 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 6.2 pttm -129.0 158.09 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.571 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.9 t80 -147.18 146.72 29.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.45 131.75 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.254 0.55 . . . . 0.0 111.671 -179.024 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -105.59 128.12 53.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.982 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.16 157.72 25.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.947 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.665 ' N ' HD12 ' A' ' 696' ' ' ILE . 7.2 t70 -57.15 99.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.182 0.515 . . . . 0.0 110.393 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.43 29.37 3.96 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.227 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.28 114.5 23.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 583' ' ' LEU . 48.1 tt0 -95.44 108.04 20.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.568 HG12 HD13 ' A' ' 659' ' ' LEU . 3.1 mt -110.57 128.5 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.954 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.08 115.82 31.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.784 ' CD1' HD21 ' A' ' 618' ' ' LEU . 4.8 pt -87.87 -16.2 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 1.087 HD12 HD12 ' A' ' 618' ' ' LEU . 20.4 mt -154.83 130.22 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.136 178.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.443 ' CZ2' ' HG2' ' A' ' 684' ' ' LYS . 8.0 t90 -137.48 132.07 32.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 682' ' ' TRP . 0.2 OUTLIER -117.46 116.22 26.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . 0.443 ' HG2' ' CZ2' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -68.04 -47.42 68.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.273 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -83.43 -40.73 18.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -19.2 60.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.409 -179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.01 10.12 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.81 104.93 16.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.9 135.34 62.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.804 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.845 HD13 ' OD2' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -119.48 131.7 71.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.495 179.317 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.74 135.02 4.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.358 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.24 148.14 37.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.542 ' HB2' HD22 ' A' ' 583' ' ' LEU . 19.1 tttm -100.94 116.67 33.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -80.05 131.24 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 579' ' ' THR . 11.2 tt0 -134.82 108.66 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.0 mt -77.33 105.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.73 -46.79 8.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 10.7 t70 -111.39 140.38 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -115.34 100.66 8.27 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.586 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -65.42 66.41 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.306 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.62 47.68 36.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.373 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 645' ' ' ASP . 1.3 pt? -115.54 179.99 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.776 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -70.48 113.39 7.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.343 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 705' ' ' GLU . 16.9 t30 53.22 -73.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.521 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.841 ' HA ' HD21 ' A' ' 702' ' ' LEU . 4.6 pt-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.542 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.72 0.295 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 716' ' ' VAL . 8.3 p -81.36 123.71 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.648 HD13 ' CZ3' ' A' ' 648' ' ' TRP . 1.3 mp -93.49 163.19 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -103.36 148.79 25.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.95 159.77 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -173.26 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.124 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.79 -28.87 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.031 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -49.67 75.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -47.77 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.582 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.2 tptt -55.89 -32.57 63.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -66.85 -36.64 82.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 11.7 mt -58.11 -44.93 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 724' ' ' LYS . 9.0 p -71.29 -24.48 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -58.29 -32.49 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -112.88 27.11 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.911 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.595 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.587 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.634 -0.186 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -84.72 -19.7 32.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.735 0.302 . . . . 0.0 111.18 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 177.49 -31.19 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.521 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -106.89 141.97 37.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -127.12 -61.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.048 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -106.38 139.51 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.249 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.608 ' N ' HD23 ' A' ' 578' ' ' LEU . 23.3 m -115.68 115.07 25.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.163 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.638 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -105.52 108.44 19.96 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.5 OUTLIER -119.96 100.19 48.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 16.8 Cg_exo -46.86 100.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.783 1.655 . . . . 0.0 109.473 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.57 157.53 86.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 10.1 Cg_endo -50.99 -29.2 26.62 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.701 2.934 . . . . 0.0 112.657 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.784 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.07 -25.1 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 1.3 t -95.76 153.48 17.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.975 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 689' ' ' VAL . 8.6 tt -53.97 -16.1 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 613' ' ' ILE . 16.5 mt -108.49 136.17 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.587 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -121.33 55.91 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.976 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.3 mm-40 -124.6 169.62 11.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.645 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.11 118.73 20.93 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 111.508 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.645 HD13 ' C ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -113.47 145.53 41.03 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.33 123.37 40.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -78.47 108.82 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -65.57 122.15 16.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.43 -28.48 2.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.166 0.508 . . . . 0.0 110.333 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.54 -22.74 78.81 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.805 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.437 HG11 ' ND2' ' A' ' 610' ' ' ASN . 62.0 t -98.94 117.74 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.093 0.947 . . . . 0.0 111.608 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -140.58 122.61 9.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -89.9 159.79 34.57 Favored 'Cis proline' 0 N--CA 1.46 -0.448 0 C-N-CA 124.299 -1.125 . . . . 0.0 111.618 -0.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 4.0 t80 -92.41 116.1 28.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 730' ' ' LEU . 40.4 m-85 -92.72 138.27 31.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.169 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.79 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.6 mp -124.94 146.27 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 158.91 -173.95 35.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.245 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.6 OUTLIER -66.84 -50.67 61.79 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.579 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -60.51 129.52 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.605 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -20.18 9.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.824 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.575 ' HB3' HD21 ' A' ' 730' ' ' LEU . 3.4 t0 -54.91 -31.72 60.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.172 0.51 . . . . 0.0 110.14 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 621' ' ' VAL . 60.6 m -71.89 126.98 31.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.517 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.5 m120 -42.94 -33.77 0.85 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.318 0.58 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.79 ' SG ' HG23 ' A' ' 603' ' ' ILE . 34.8 t -104.93 141.14 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.894 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.693 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.36 104.81 13.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 612' ' ' LYS . 9.1 mm -138.95 109.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.957 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.45 106.6 17.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 112.346 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.636 ' H ' HD11 ' A' ' 618' ' ' LEU . 0.9 OUTLIER -129.52 107.42 9.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.58 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -38.8 -30.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 681' ' ' ILE . 5.9 tpp180 -68.94 -41.99 77.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.636 HD11 ' H ' ' A' ' 615' ' ' ASP . 1.6 pp -89.21 156.76 18.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.729 0.3 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.49 162.96 28.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.558 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.6 -26.08 12.45 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.071 0.462 . . . . 0.0 110.36 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.558 HG23 ' HG2' ' A' ' 620' ' ' ARG . 41.2 t -131.31 63.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.471 ' ND1' ' CB ' ' A' ' 618' ' ' LEU . 24.9 t60 -49.73 -44.31 48.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.263 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.8 p -169.86 161.58 9.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 111.716 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.61 ' CE1' HG22 ' A' ' 727' ' ' VAL . 40.2 p90 -143.59 148.77 36.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.949 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.71 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.1 mp -102.22 130.71 51.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -121.39 134.74 55.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.53 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 29.8 ttmt -97.92 137.11 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.324 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.04 158.99 42.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.75 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.9 tpt180 -76.49 112.61 13.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 110.531 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 -74.34 125.43 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.904 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -150.74 179.44 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.356 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.6 p -168.12 160.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -55.55 -101.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.82 172.26 7.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.24 31.36 5.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.973 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.2 121.25 14.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.86 -63.78 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.88 143.85 41.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.89 102.34 50.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.43 -164.68 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.681 2.254 . . . . 0.0 112.1 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -119.49 40.09 3.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.33 -82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.578 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -168.19 76.46 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.838 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -99.83 -157.56 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.698 ' O ' HD23 ' A' ' 702' ' ' LEU . 5.1 m-20 -122.19 146.66 47.03 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.461 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -130.24 160.35 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.115 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.048 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -106.71 123.3 61.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 112.085 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.83 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.3 m95 -106.4 128.42 54.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.475 ' CB ' HD21 ' A' ' 672' ' ' LEU . 17.3 t80 -90.89 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 17.2 m -103.69 129.53 51.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.424 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.441 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 43.4 t60 -111.53 126.9 55.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 29.4 p -123.36 3.58 9.12 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.279 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.94 142.6 26.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.137 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.5 m -75.38 -19.94 59.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.418 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.576 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m-20 -82.79 3.27 30.12 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 51.59 133.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.57 0.7 . . . . 0.0 112.38 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 96.3 p -103.92 166.48 10.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.153 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -127.36 119.8 27.06 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.559 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.688 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -100.01 104.56 16.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.512 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.1 m120 60.11 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.701 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 659' ' ' LEU . 14.6 m-20 -139.35 7.99 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.65 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 716' ' ' VAL . 4.1 m120 -107.97 141.48 39.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.574 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -74.68 141.46 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.139 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.2 OUTLIER -129.08 91.41 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.085 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.3 pt -87.5 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.81 104.0 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.878 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 112.38 33.89 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.55 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 3.0 p -125.37 162.17 25.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 111.897 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -135.33 149.91 49.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.7 144.87 28.63 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.83 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.18 133.52 48.08 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.483 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.748 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -106.31 109.21 21.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.499 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 15.8 mt-30 -98.83 132.9 43.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.047 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.763 ' HB2' HD12 ' A' ' 696' ' ' ILE . 7.5 t70 -37.01 120.52 0.74 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.98 38.57 5.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.3 t0 -95.44 120.55 35.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 0.0 111.441 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -97.41 113.88 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.3 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD13 ' A' ' 659' ' ' LEU . 27.0 pt -110.06 137.18 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.045 0.45 . . . . 0.0 111.968 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.6 mttp -101.14 116.34 32.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.055 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.569 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.0 OUTLIER -81.54 -38.24 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.43 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -155.29 133.96 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -136.42 124.48 22.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -125.96 117.57 23.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.792 0.329 . . . . 0.0 110.645 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -66.8 -46.52 74.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.899 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.22 -40.52 37.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.9 -11.92 56.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.5 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt 59.93 19.29 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.403 ' CZ ' ' OD1' ' A' ' 615' ' ' ASP . 2.2 t80 -84.34 105.02 14.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 587' ' ' ILE . 0.8 OUTLIER -125.78 126.0 69.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.037 0.446 . . . . 0.0 111.925 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.49 ' HB ' HG22 ' A' ' 681' ' ' ILE . 11.8 mt -119.33 148.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.804 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -168.21 129.03 1.81 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.392 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.469 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.6 m-30 -113.3 141.84 46.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.761 0.315 . . . . 0.0 110.28 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.696 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.9 tptp -101.29 116.45 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.83 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.802 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -82.96 120.04 33.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.453 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.37 109.32 10.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.958 0.409 . . . . 0.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 674' ' ' ASP . 33.5 mt -75.99 105.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . 0.4 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.0 OUTLIER -83.67 -45.32 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 65.4 m-20 -110.39 141.59 43.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.452 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.2 p -113.52 99.88 8.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.348 0.594 . . . . 0.0 109.957 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 700' ' ' THR . 7.0 t -77.1 62.52 2.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.486 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.42 49.34 70.86 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.818 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -88.18 133.55 34.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.337 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.67 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -33.84 -36.77 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.45 179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -171.98 30.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.862 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.562 ' H ' ' HB3' ' A' ' 702' ' ' LEU . 0.3 OUTLIER 68.31 -57.93 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.113 -178.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 151.95 76.87 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.831 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.445 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 1.9 mm? -104.74 -9.44 18.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.748 -0.266 . . . . 0.0 111.494 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 100.98 62.21 0.78 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.123 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -43.12 135.06 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.922 0.392 . . . . 0.0 111.721 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -161.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 77.22 -64.17 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.92 112.88 26.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.627 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 714' ' ' ARG . 0.0 OUTLIER -82.84 99.73 9.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.997 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 713' ' ' GLN . 3.4 mmm-85 19.96 85.51 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.627 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.1 m -124.49 142.59 40.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.455 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 663' ' ' ARG . 88.8 t -80.83 122.8 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -95.47 163.22 13.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.754 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.51 146.5 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.2 160.02 14.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.84 -173.46 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.16 28.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -42.02 98.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.166 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 726' ' ' LEU . 6.6 tm-20 -69.99 -51.07 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.464 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -54.33 -32.88 57.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -36.48 81.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.605 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 723' ' ' GLU . 79.9 mt -55.8 -44.05 77.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.694 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.61 HG22 ' CE1' ' A' ' 624' ' ' PHE . 1.5 t -73.95 -23.15 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -36.53 80.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.769 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.71 -11.94 58.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.171 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.785 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.1 tt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.749 0.309 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.26 140.59 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 6.3 pt -131.56 80.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.418 ' C ' ' CD1' ' P' ' 830' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' P' ' 829' ' ' PTR . 7.4 p90 -175.82 89.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.867 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 681' ' ' ILE . 9.1 mt -85.59 89.7 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.779 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.878 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.279 -0.329 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -78.9 -7.01 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.491 0.186 . . . . 0.0 111.362 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.463 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 142.59 -8.92 2.34 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 8.2 ttm180 -108.01 143.84 36.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.998 0.428 . . . . 0.0 111.452 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -128.82 -56.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.256 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 5.7 tt -111.54 139.59 46.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.904 ' N ' HD23 ' A' ' 578' ' ' LEU . 1.9 m -120.97 114.19 21.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 111.495 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 594' ' ' ILE . 1.5 mp -103.02 108.22 19.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.68 100.88 53.97 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.5 Cg_exo -45.96 101.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.893 1.729 . . . . 0.0 109.357 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -75.12 157.42 85.22 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.59 -27.19 14.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.467 2.778 . . . . 0.0 112.491 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.438 ' HB3' HD12 ' A' ' 583' ' ' LEU . 41.8 t0 -62.16 -25.93 68.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 18.0 p -95.76 154.07 17.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.805 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.456 HD13 ' CE1' ' A' ' 688' ' ' PHE . 0.4 OUTLIER -58.87 -10.73 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.996 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.764 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.3 mt -111.11 118.58 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 111.751 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.05 57.09 0.72 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 72.7 mt-10 -124.56 171.86 9.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.286 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.0 126.79 42.03 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.771 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.16 135.56 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.416 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mt-10 -124.5 118.27 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 601' ' ' PHE . 83.8 mt -79.88 108.6 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -62.77 118.1 7.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.93 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.547 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -45.76 -28.95 1.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.936 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -78.77 -14.23 82.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.908 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.02 118.07 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.094 0.947 . . . . 0.0 111.941 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 1.1 t30 -140.46 123.52 10.11 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.736 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.505 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 36.2 Cg_endo -90.82 159.02 29.69 Favored 'Cis proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.379 -1.092 . . . . 0.0 112.157 0.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.65 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.8 t80 -93.12 117.49 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.197 0.522 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.685 ' CD2' HD12 ' A' ' 730' ' ' LEU . 3.5 m-85 -93.53 138.65 31.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.393 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.8 HD11 HD12 ' A' ' 625' ' ' ILE . 3.5 mp -129.61 142.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.43 -158.2 31.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.189 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.4 ttp85 -96.43 -0.63 48.89 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.13 133.04 46.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -56.76 -24.79 52.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.99 -27.92 63.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.698 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 56.2 m -78.14 131.02 37.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.1 m120 -47.65 -30.86 4.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.496 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.777 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.8 t -109.14 140.66 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.453 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.31 120.96 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.764 HG23 ' CD1' ' A' ' 588' ' ' ILE . 29.2 mm -137.97 109.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.745 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 tt0 -86.91 102.32 14.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.703 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.813 ' HB2' HD13 ' A' ' 618' ' ' LEU . 3.4 m-20 -133.24 111.47 10.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.37 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -42.5 -33.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.819 0.343 . . . . 0.0 111.48 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -77.76 -41.47 37.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.813 HD13 ' HB2' ' A' ' 615' ' ' ASP . 1.2 mp -59.97 158.95 9.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.97 174.19 6.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.66 -62.94 1.15 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.395 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 12.0 t -105.18 53.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.519 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 70.7 t60 -43.12 -39.96 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.515 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.36 173.15 12.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.415 0.626 . . . . 0.0 111.447 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.639 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.06 135.2 25.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.973 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.8 HD12 HD11 ' A' ' 603' ' ' ILE . 23.0 mt -131.81 117.12 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -135.16 144.49 47.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.005 0.431 . . . . 0.0 111.549 -178.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.3 ptpt -101.0 137.46 39.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.62 159.65 32.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.275 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.52 117.24 17.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.254 0.55 . . . . 0.0 110.672 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 -83.65 128.85 34.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.871 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -141.32 125.58 17.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.54 166.11 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -61.99 -80.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.539 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -126.5 162.45 25.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.789 0.328 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.76 140.05 36.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.7 130.55 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 64.2 t80 66.85 -70.47 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -76.32 144.42 40.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.765 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.7 m -101.66 93.86 3.84 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.71 -163.36 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.521 2.148 . . . . 0.0 112.288 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -45.31 -32.79 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.565 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.55 -67.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.483 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -175.78 65.56 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.805 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -101.14 -157.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.9 OUTLIER -122.36 147.11 46.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.061 0.457 . . . . 0.0 111.697 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.9 160.24 32.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.519 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -106.97 128.14 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 112.359 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.916 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.7 m95 -112.15 120.57 42.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.574 ' HB3' HD21 ' A' ' 672' ' ' LEU . 1.3 t80 -92.71 117.63 30.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.9 m -111.22 145.07 39.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 42.3 t60 -119.55 125.36 48.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.436 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.2 5.59 11.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -81.19 134.55 13.35 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.998 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 654' ' ' THR . 54.7 m -65.64 -12.8 56.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.6 OUTLIER -82.35 -2.79 53.98 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.5 0.19 . . . . 0.0 111.339 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.32 128.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.265 0.555 . . . . 0.0 112.071 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.434 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 18.2 p -99.89 166.38 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.142 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' CZ ' HG22 ' A' ' 656' ' ' VAL . 3.9 m-85 -135.54 119.5 17.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.747 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.81 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -98.88 112.25 24.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.033 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.43 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -136.26 2.43 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.889 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -100.59 141.39 33.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.83 0.348 . . . . 0.0 111.024 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 34.5 ttt180 -81.11 141.34 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.738 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.42 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 17.9 mmm -121.58 100.43 7.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.0 110.973 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.404 HG12 ' CG2' ' A' ' 668' ' ' THR . 35.9 pt -87.5 149.39 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -44.43 112.67 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.406 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.79 5.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.173 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.8 p -115.22 162.56 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 111.499 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 717' ' ' LEU . 4.6 ttpm? -134.75 147.71 50.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.127 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.5 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.52 144.28 28.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.916 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 134.72 49.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.729 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.827 HD13 HG21 ' A' ' 694' ' ' VAL . 1.3 mt -106.69 111.99 24.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.251 0.548 . . . . 0.0 111.27 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 24.6 mt-30 -98.33 143.19 29.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.172 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 706' ' ' GLY . 26.3 p30 -43.14 111.85 0.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.73 37.94 5.65 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.64 118.41 29.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.069 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -96.17 108.5 20.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.81 HG22 ' CD2' ' A' ' 659' ' ' LEU . 7.7 pt -105.66 129.16 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.111 0.482 . . . . 0.0 111.971 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 5.7 mttt -89.77 115.77 27.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.717 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.723 HD13 HD21 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -76.05 -39.38 36.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.854 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.756 HD11 HD11 ' P' ' 831' ' ' LEU . 15.6 tt -155.88 136.75 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -135.89 127.79 29.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.119 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.608 ' OD2' HD22 ' P' ' 831' ' ' LEU . 0.4 OUTLIER -124.3 116.94 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.245 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -67.03 -46.89 73.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.35 -40.32 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.404 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.38 -16.54 56.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.9 15.92 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.004 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.456 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.2 t80 -77.03 104.61 7.62 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.1 p -118.99 122.24 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.848 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.649 ' CG1' HG22 ' A' ' 681' ' ' ILE . 42.8 mm -128.29 119.7 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.572 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -146.31 133.29 4.84 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.165 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.8 m-30 -113.09 144.56 42.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 110.455 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.713 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -101.17 117.29 34.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.827 HG21 HD13 ' A' ' 672' ' ' LEU . 3.2 t -81.74 114.81 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.78 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -123.94 108.58 12.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 0.0 110.372 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.539 HD13 ' O ' ' A' ' 705' ' ' GLU . 18.4 mt -81.86 110.44 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.729 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.5 -45.29 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.54 140.43 46.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.101 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -114.65 100.37 8.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.547 HG21 ' HB2' ' A' ' 596' ' ' GLN . 9.3 t -91.08 50.74 1.82 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.479 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 108.52 33.29 2.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.502 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 1.1 mm? -93.81 120.33 33.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.579 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 4.9 p90 -40.45 -34.33 0.34 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.474 0.654 . . . . 0.0 110.339 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.5 OUTLIER -147.88 -44.69 0.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.539 ' O ' HD13 ' A' ' 696' ' ' ILE . 16.1 pt-20 136.1 -34.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.69 1.196 . . . . 0.0 108.148 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.684 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 137.71 85.06 0.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.117 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.49 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.3 OUTLIER -105.68 -9.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.275 0.538 . . . . 0.0 111.667 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.418 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 81.41 64.55 1.75 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.437 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.575 ' C ' HD23 ' A' ' 710' ' ' LEU . 1.6 mtm -116.21 114.07 23.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.575 HD23 ' C ' ' A' ' 709' ' ' MET . 1.1 pt? -179.36 170.88 1.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -59.51 -68.7 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.85 131.38 47.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.544 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -83.03 100.36 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.084 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 7.7 mmm-85 42.43 86.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.696 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.44 143.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.889 HG23 ' OD1' ' A' ' 662' ' ' ASN . 59.7 t -79.71 129.67 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.379 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.549 HD11 ' HZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -102.17 172.52 6.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -101.24 157.87 16.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 0.0 111.189 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.93 152.07 19.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.4 p -126.41 -177.82 4.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.616 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -28.9 36.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.988 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.57 -48.81 78.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.757 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.1 mp0 -69.77 -50.04 47.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.592 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -60.5 -32.05 71.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.244 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.41 -40.45 93.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.621 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.2 mt -61.91 -44.4 96.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.591 HG23 HD13 ' A' ' 730' ' ' LEU . 9.3 p -79.49 -12.75 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.24 -28.53 7.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.841 0.353 . . . . 0.0 110.984 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -102.08 -63.2 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 602' ' ' PHE . 1.1 tp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.937 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.83 0.348 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.75 149.37 32.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.82 118.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 161.03 20.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.784 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.756 HD11 HD11 ' A' ' 681' ' ' ILE . 20.3 mt -148.68 93.27 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.975 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -95.08 -20.01 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.68 0.276 . . . . 0.0 111.122 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 140.13 -10.53 3.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.765 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.426 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -106.54 143.14 35.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.725 ' CE1' HG21 ' A' ' 647' ' ' ILE . 3.7 t80 -132.69 -47.28 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.748 HD11 ' CG1' ' A' ' 694' ' ' VAL . 10.4 tp -121.27 142.44 49.93 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.896 0.379 . . . . 0.0 111.015 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.7 m -120.3 114.94 22.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -104.57 108.59 20.12 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 mtmp? -111.84 99.25 44.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.8 Cg_exo -47.66 99.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.849 1.699 . . . . 0.0 109.572 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.567 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.58 158.12 85.35 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -176.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.94 -25.17 8.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.509 2.806 . . . . 0.0 112.731 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.501 ' HB2' HD12 ' A' ' 583' ' ' LEU . 3.2 m-20 -61.64 -28.26 69.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' HD13 ' A' ' 690' ' ' ILE . 6.4 t -95.65 154.01 17.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.816 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 690' ' ' ILE . 2.2 pt -57.87 -11.49 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.738 0.304 . . . . 0.0 110.918 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.897 HD13 HG12 ' A' ' 613' ' ' ILE . 19.6 mt -107.6 118.51 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.498 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -106.03 55.73 0.67 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.155 0.503 . . . . 0.0 110.332 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.639 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 19.7 mt-10 -125.03 171.67 10.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.192 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.48 129.9 49.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.845 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.801 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.21 141.96 45.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.403 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.2 mt-10 -124.02 110.52 14.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.298 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.78 HD11 HD12 ' A' ' 625' ' ' ILE . 59.3 mt -76.83 109.3 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.6 mp0 -67.03 114.67 5.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.58 -30.61 1.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.217 0.532 . . . . 0.0 110.557 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -64.66 -23.57 68.99 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.149 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.0 119.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.489 0.644 . . . . 0.0 111.34 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 21.7 t30 -138.72 122.26 11.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.9 Cg_endo -90.5 160.34 31.87 Favored 'Cis proline' 0 C--N 1.345 0.383 0 C-N-CA 124.627 -0.989 . . . . 0.0 111.815 -0.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.695 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.5 t80 -91.36 114.7 27.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.526 ' CG ' HD12 ' A' ' 730' ' ' LEU . 13.9 m-85 -91.84 138.07 31.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.993 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.781 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -127.36 145.41 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.716 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 155.55 -172.77 33.69 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.945 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.3 OUTLIER -74.02 -6.83 49.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.496 0.319 . . . . 0.0 111.857 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.571 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -89.51 125.01 35.02 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.811 0.339 . . . . 0.0 111.12 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -59.01 -20.25 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.578 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -23.96 63.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.306 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 54.8 m -70.72 130.35 41.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -44.77 -32.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.512 . . . . 0.0 110.347 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.801 ' SG ' HD13 ' A' ' 592' ' ' LEU . 43.1 t -110.28 139.88 45.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.342 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.12 110.05 16.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.897 HG12 HD13 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -138.45 110.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.892 177.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.498 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 0.2 OUTLIER -85.73 106.41 16.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.296 0.569 . . . . 0.0 112.09 -178.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.998 ' HB2' HD22 ' A' ' 618' ' ' LEU . 1.6 m-20 -129.8 108.32 10.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.138 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -43.71 -37.65 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.327 . . . . 0.0 111.799 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.0 mmt180 -77.82 -34.18 52.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.855 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.998 HD22 ' HB2' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.16 128.11 34.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.072 0.463 . . . . 0.0 111.336 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.4 p -57.16 159.65 4.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.663 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.911 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -58.14 -31.29 67.06 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.911 HG23 ' HG2' ' A' ' 620' ' ' ARG . 45.5 t -123.39 55.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.825 ' CD2' HG23 ' A' ' 680' ' ' ILE . 9.5 t60 -49.68 -49.18 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.172 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 4.7 p -164.08 160.3 21.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.23 0.538 . . . . 0.0 111.989 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 42.1 p90 -143.4 147.61 34.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.981 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 580' ' ' LEU . 57.6 mt -102.18 132.65 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.5 t80 -123.9 131.47 53.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.499 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.9 tttt -97.73 136.33 38.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.8 157.84 45.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.981 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -77.83 113.57 15.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 -78.94 123.29 27.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.05 150.62 51.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.026 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.21 166.59 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -86.77 73.53 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.576 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 56.2 mttt 60.07 105.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.9 p -83.63 117.2 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.84 123.25 47.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.784 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 67.43 -74.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.713 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -76.94 123.72 26.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 54.2 p -93.43 109.8 42.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.022 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.01 -149.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.553 2.168 . . . . 0.0 111.956 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 703' ' ' PHE . . . -79.22 1.52 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.808 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.95 -171.92 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.601 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -85.35 92.16 1.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.722 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.648 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.67 -156.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.836 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -122.19 147.51 46.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 111.36 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -136.6 141.71 43.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.319 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.9 pt -94.67 121.19 45.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.345 0.593 . . . . 0.0 111.709 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.581 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -104.04 133.99 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.448 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 678' ' ' ILE . 12.4 t80 -93.14 117.39 30.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' CB ' ' CE1' ' A' ' 624' ' ' PHE . 0.8 OUTLIER -102.84 136.4 42.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.13 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.445 ' CE1' ' N ' ' A' ' 657' ' ' SER . 14.9 t60 -115.42 126.28 54.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.16 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.421 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -122.89 6.49 9.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.47 157.78 40.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.167 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 41.1 m -89.65 -19.56 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.411 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.0 m120 -83.59 2.92 34.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.658 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 664' ' ' MET . 0.3 OUTLIER 50.14 136.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.735 0.779 . . . . 0.0 112.588 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.445 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 88.5 p -108.55 165.96 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.062 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.52 120.65 30.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.001 0.429 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 1.033 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -102.69 100.19 10.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.897 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 15.4 m-20 60.76 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 87.3 m-20 -135.44 2.7 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 11.8 m120 -104.86 135.3 46.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.871 0.367 . . . . 0.0 111.402 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.63 141.47 46.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.713 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.618 ' O ' HG23 ' A' ' 656' ' ' VAL . 44.2 mmm -120.86 88.66 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.144 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 668' ' ' THR . 39.4 pt -87.31 153.26 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.867 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 652' ' ' THR . 13.7 tt0 -42.76 107.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.53 33.1 4.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.426 ' CG2' HG12 ' A' ' 665' ' ' ILE . 2.7 p -113.22 162.08 16.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 0.0 111.646 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.1 ttpm? -142.12 129.65 21.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.397 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -136.32 143.13 43.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.902 0.382 . . . . 0.0 111.563 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.714 HD12 ' HE1' ' A' ' 709' ' ' MET . 0.2 OUTLIER -71.42 141.04 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.906 HD13 HG21 ' A' ' 694' ' ' VAL . 5.4 mt -104.43 148.81 26.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.026 0.441 . . . . 0.0 111.122 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.93 ' HB3' HD22 ' A' ' 707' ' ' LEU . 6.6 mt-30 -120.3 162.22 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.73 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.5 t70 -65.61 95.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.55 32.73 2.86 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.2 113.17 20.9 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.711 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -95.74 108.49 20.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 1.033 HG22 HD13 ' A' ' 659' ' ' LEU . 32.9 pt -105.16 134.87 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.772 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 657' ' ' SER . 4.0 mtpt -95.36 115.42 27.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.278 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.825 HG23 ' CD2' ' A' ' 622' ' ' HIS . 32.4 mt -84.55 -34.93 9.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.648 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.57 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.77 130.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.018 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -137.2 126.48 24.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.78 116.54 22.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.496 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -46.5 72.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.727 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.71 -40.41 33.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.562 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.46 -13.56 54.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.352 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 63.43 15.56 8.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.627 0.251 . . . . 0.0 110.959 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -76.94 104.65 7.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.33 126.47 74.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 0.0 111.873 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.603 HD13 ' OG ' ' A' ' 586' ' ' SER . 21.4 mm -127.68 155.9 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.466 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 174.07 130.45 1.28 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.359 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 613' ' ' ILE . 10.7 m-30 -113.31 146.23 39.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.354 . . . . 0.0 110.503 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.567 ' HB2' HD22 ' A' ' 583' ' ' LEU . 18.6 tttp -101.35 117.0 34.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.15 126.65 39.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.667 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.9 OUTLIER -133.45 108.84 8.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.942 0.401 . . . . 0.0 110.736 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 705' ' ' GLU . 22.8 mt -73.98 105.18 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.87 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.77 -47.67 10.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.766 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.433 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -111.54 140.34 46.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.029 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.7 p -115.0 99.83 7.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.421 ' HB ' ' NZ ' ' A' ' 627' ' ' LYS . 11.6 m -76.18 69.63 2.75 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.7 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.54 49.39 74.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.867 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -85.66 133.47 34.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.53 0.205 . . . . 0.0 111.158 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.531 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.3 p90 -44.88 -32.22 1.52 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.594 0.712 . . . . 0.0 109.842 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 707' ' ' LEU . 2.3 t30 -148.4 -56.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.646 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.677 ' O ' HD13 ' A' ' 696' ' ' ILE . 2.7 pt-20 156.14 -28.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.488 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 141.5 -7.08 2.5 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.678 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.93 HD22 ' HB3' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -81.3 7.76 10.73 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.92 8.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.899 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.714 ' HE1' HD12 ' A' ' 671' ' ' LEU . 6.0 tpt -110.2 146.93 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.914 0.388 . . . . 0.0 110.568 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.466 ' H ' ' HE3' ' A' ' 709' ' ' MET . 0.6 OUTLIER -55.27 -162.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.156 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -39.58 -46.96 1.86 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.738 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -74.11 139.87 44.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.717 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.85 100.36 10.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.504 ' NH1' ' HG3' ' A' ' 673' ' ' GLN . 2.0 mmm180 40.26 83.48 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.733 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.62 142.24 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.595 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.8 p -82.88 117.67 29.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.89 171.72 10.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.686 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 157.68 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.36 154.73 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.919 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 23.7 p -126.24 -176.55 3.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.73 64.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -63.61 -52.25 61.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -64.63 -46.95 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.73 -32.77 65.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.34 -36.92 82.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 31.4 mt -59.78 -44.07 94.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.003 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.9 -20.36 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -50.56 64.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -61.66 -29.12 69.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.526 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.0 tt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.831 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.883 0.373 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 62.11 78.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.579 HG22 ' O ' ' P' ' 828' ' ' ILE . 26.4 mt -99.36 37.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.441 ' C ' ' CG ' ' P' ' 830' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.441 ' CG ' ' C ' ' P' ' 829' ' ' PTR . 0.1 OUTLIER -177.25 137.5 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 655' ' ' ASN . 55.7 mt -138.63 -178.74 5.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.971 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -75.06 -22.24 58.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.661 0.267 . . . . 0.0 111.048 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 146.32 -17.01 1.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.643 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.439 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -106.57 143.3 34.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.362 . . . . 0.0 111.123 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.711 ' HE1' HG21 ' A' ' 647' ' ' ILE . 1.1 t80 -132.96 -51.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.032 HD11 HG13 ' A' ' 694' ' ' VAL . 21.2 tp -114.52 142.59 46.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.555 HG21 ' HE2' ' A' ' 581' ' ' LYS . 7.9 m -122.62 116.6 24.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.945 ' CD2' HG23 ' A' ' 694' ' ' VAL . 5.7 mt -103.33 108.83 20.22 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 54.6 mttt -110.57 98.38 36.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -176.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.2 Cg_exo -49.67 106.86 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.793 1.662 . . . . 0.0 109.225 176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.04 157.37 87.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 12.0 Cg_endo -54.74 -24.88 39.78 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.07 3.18 . . . . 0.0 113.457 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.542 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.4 m-20 -62.11 -22.31 65.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.069 0.461 . . . . 0.0 109.818 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.457 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 2.0 t -97.69 154.01 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.683 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.527 HD11 ' CE1' ' A' ' 688' ' ' PHE . 7.3 pt -51.22 -21.55 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.497 . . . . 0.0 110.014 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 690' ' ' ILE . 38.9 mt -105.16 118.84 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -116.71 59.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.649 . . . . 0.0 110.264 -179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.66 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.78 172.56 9.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.727 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.18 131.55 53.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.758 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.62 143.96 42.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.207 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.05 116.61 23.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.726 0.298 . . . . 0.0 111.708 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.87 HD11 HD12 ' A' ' 625' ' ' ILE . 73.0 mt -81.89 109.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.879 0.371 . . . . 0.0 110.443 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 1.4 mp0 -65.08 115.63 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.34 -30.51 2.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.258 0.551 . . . . 0.0 110.681 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.13 -20.21 72.76 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.23 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.24 118.92 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 117.35 0.575 . . . . 0.0 111.65 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.9 t30 -139.35 121.53 10.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.72 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -89.99 160.46 34.45 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 124.555 -1.019 . . . . 0.0 111.63 -0.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.664 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.42 116.63 29.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 20.8 m-85 -92.62 138.57 31.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.29 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.3 mp -129.08 141.84 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.87 -170.2 38.31 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 119.964 -1.113 . . . . 0.0 113.92 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 ttp85 -80.33 1.44 28.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.356 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 14.4 t -101.19 119.78 39.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -51.72 -24.64 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.015 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -61.4 -26.71 68.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.991 0.424 . . . . 0.0 110.391 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 87.2 m -71.57 128.75 36.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.853 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 33.5 m120 -43.43 -34.63 1.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.289 0.566 . . . . 0.0 110.287 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 50.7 t -106.29 141.29 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.099 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.52 111.47 20.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.682 HG23 ' CD1' ' A' ' 588' ' ' ILE . 18.3 mm -137.73 108.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.127 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.19 106.6 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.662 . . . . 0.0 112.497 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.544 ' CB ' HD13 ' A' ' 618' ' ' LEU . 5.0 t70 -130.53 125.93 35.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.722 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -43.64 -34.18 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.778 0.323 . . . . 0.0 111.223 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB2' HD13 ' A' ' 681' ' ' ILE . 26.2 mmt180 -77.35 -39.06 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.686 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -59.54 158.21 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.06 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.07 163.92 13.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.304 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.452 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.1 OUTLIER -46.04 -55.33 7.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.053 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 730' ' ' LEU . 39.5 t -110.08 62.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.421 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.686 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.6 t60 -47.1 -48.09 22.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.576 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 680' ' ' ILE . 24.7 p -166.82 157.12 11.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.2 p90 -144.12 143.67 31.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.889 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.87 HD12 HD11 ' A' ' 594' ' ' ILE . 45.5 mt -101.59 131.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -122.46 132.52 54.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.442 ' HE2' HD21 ' A' ' 702' ' ' LEU . 7.6 ttmt -98.07 136.53 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.545 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.8 158.66 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.197 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.94 113.47 14.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.536 0.684 . . . . 0.0 110.391 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.0 t60 -70.01 122.97 20.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.269 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.492 ' HB3' ' NH1' ' A' ' 629' ' ' ARG . . . 176.42 126.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.973 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 640' ' ' PRO . 33.9 m -80.29 173.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -66.87 97.81 0.38 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.377 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.6 tttp 61.85 152.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.858 0.361 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 6.3 p -95.42 44.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.5 mtt -66.23 111.53 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.57 -62.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.79 143.13 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.04 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 96.8 p -115.29 93.28 35.24 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.533 ' HG2' HG22 ' A' ' 632' ' ' VAL . 17.3 Cg_exo -66.95 -150.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.762 2.308 . . . . 0.0 111.897 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -92.35 36.01 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.466 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 67.9 -70.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.106 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 166.68 62.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.818 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -93.95 -159.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 1.4 m-20 -119.58 146.9 45.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 112.206 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -127.05 160.16 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.777 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.837 HD13 HD22 ' A' ' 578' ' ' LEU . 2.6 pt -111.22 120.98 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.587 . . . . 0.0 111.902 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.54 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -103.05 136.28 43.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.483 ' HE2' ' HG ' ' A' ' 657' ' ' SER . 9.2 t80 -99.08 119.37 37.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.851 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 6.9 m -110.0 141.87 42.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.035 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.434 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 34.0 t60 -121.74 122.76 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 621' ' ' VAL . 0.6 OUTLIER -116.15 11.36 15.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.44 139.72 15.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.811 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 654' ' ' THR . 26.3 m -72.49 -8.17 53.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.58 ' C ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -85.43 2.78 43.05 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' C ' ' A' ' 655' ' ' ASN . 1.8 m 60.21 146.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 111.275 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.483 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 0.3 OUTLIER -116.16 162.61 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.085 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.467 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -137.44 120.37 16.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.362 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.856 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -108.6 116.67 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.131 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 13.7 t-20 60.24 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.95 2.12 2.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.861 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -102.23 141.24 35.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.638 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -94.11 141.71 28.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.505 ' HB2' ' OG1' ' A' ' 668' ' ' THR . 4.5 ptp -138.04 142.68 40.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.405 . . . . 0.0 111.139 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.443 ' H ' HG21 ' A' ' 668' ' ' THR . 17.7 pt -112.12 165.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.393 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -47.15 117.59 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.955 0.407 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 101.58 23.08 9.7 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 664' ' ' MET . 10.9 p -112.24 162.37 15.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.462 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.408 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 3.2 ttpm? -134.94 145.04 47.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.659 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -145.95 134.36 21.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.943 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.54 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -68.69 140.54 55.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 1.001 HD13 HG21 ' A' ' 694' ' ' VAL . 9.3 mt -110.07 122.79 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 0.0 111.906 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 47.0 mt-30 -104.18 137.6 41.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.593 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.618 ' HB2' HD12 ' A' ' 696' ' ' ILE . 9.7 t70 -40.52 108.82 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.975 0.417 . . . . 0.0 111.007 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.92 35.55 4.79 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 3.0 t0 -95.55 122.81 38.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.329 . . . . 0.0 111.079 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.02 108.38 20.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.856 HG22 ' CD2' ' A' ' 659' ' ' LEU . 5.5 pt -106.55 131.95 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 112.141 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 3.1 mtmt -104.01 127.03 51.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.02 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.861 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -95.11 -25.15 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.744 -178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.678 HG22 ' CG2' ' A' ' 690' ' ' ILE . 7.6 tt -155.23 131.28 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.057 0.456 . . . . 0.0 111.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -136.59 126.7 26.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.746 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.519 ' OD2' HD21 ' P' ' 831' ' ' LEU . 1.1 m-20 -116.4 117.03 28.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.644 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -67.04 -46.53 74.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.877 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -79.87 -40.41 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.601 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -79.98 -20.24 45.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.294 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 8.97 6.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.223 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 587' ' ' ILE . 1.7 t80 -77.02 105.15 7.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 1.3 p -119.64 121.87 67.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.451 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 588' ' ' ILE . 2.4 tt -120.8 121.44 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.5 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -140.39 137.95 8.69 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.331 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.3 m-30 -113.35 142.33 45.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -100.96 117.37 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.023 0.44 . . . . 0.0 110.925 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -83.66 122.51 37.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.565 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.09 109.59 9.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 705' ' ' GLU . 27.5 mt -77.32 108.62 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.937 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.36 -43.36 9.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.08 141.54 42.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.5 OUTLIER -114.23 100.56 8.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.38 0.61 . . . . 0.0 109.671 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.4 57.83 4.21 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.767 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 81.56 37.97 15.68 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.24 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.6 OUTLIER -77.47 134.55 38.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.522 0.201 . . . . 0.0 110.591 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.641 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.3 p90 -43.62 -33.27 1.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.472 0.653 . . . . 0.0 110.323 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -147.98 -61.25 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.676 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.657 ' O ' HD12 ' A' ' 696' ' ' ILE . 16.6 pt-20 145.36 33.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.043 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 71.74 68.87 1.51 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.053 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.571 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.6 OUTLIER -106.95 -9.78 16.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.087 0.443 . . . . 0.0 111.31 179.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 709' ' ' MET . . . 127.41 -116.68 2.47 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.752 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 165.22 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 111.08 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.36 -161.18 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.504 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -46.03 -94.59 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -114.86 98.81 7.05 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.871 0.367 . . . . 0.0 111.89 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 5.5 tp60 -116.58 136.23 53.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.017 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.744 ' NH2' HD22 ' A' ' 659' ' ' LEU . 1.8 mmm-85 160.37 69.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.791 0.437 . . . . 0.0 110.071 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.77 149.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.861 HG23 ' OD1' ' A' ' 662' ' ' ASN . 90.4 t -78.29 118.43 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -97.32 172.02 8.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.52 154.31 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -91.29 156.31 17.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -126.02 -173.96 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.85 -33.5 64.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.23 -50.49 73.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.758 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 726' ' ' LEU . 25.3 mm-40 -65.53 -50.26 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -57.93 -32.93 68.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -63.57 -38.69 92.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.72 HD22 ' HD3' ' A' ' 600' ' ' PRO . 9.5 mt -61.06 -44.52 97.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.3 p -73.5 -26.83 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -58.57 -30.93 67.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -86.67 -18.87 30.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.159 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.89 141.41 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.82 172.07 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -178.48 126.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 655' ' ' ASN . 15.9 mt -145.83 91.09 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.915 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.92 3.74 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.616 0.246 . . . . 0.0 111.528 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 120.72 21.65 3.21 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.717 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 9.1 ttm180 -112.09 119.56 38.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.797 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.2 t80 -100.91 -46.31 5.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 647' ' ' ILE . 7.9 tp -120.69 142.54 49.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 111.485 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 695' ' ' GLU . 15.0 m -122.26 114.56 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.488 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.735 HD11 HD11 ' A' ' 625' ' ' ILE . 0.3 OUTLIER -103.66 108.59 19.94 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 25.4 mtmt -111.65 98.77 42.33 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_exo -46.84 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.838 1.692 . . . . 0.0 109.47 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.64 157.46 85.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.435 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.5 Cg_exo -49.73 -25.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.583 2.855 . . . . 0.0 112.704 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.79 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -62.06 -27.52 68.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 4.2 t -95.63 153.94 17.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.749 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.436 HG12 ' CD1' ' A' ' 690' ' ' ILE . 8.3 pt -54.94 -13.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.725 0.298 . . . . 0.0 111.189 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.649 ' CD1' HG23 ' A' ' 613' ' ' ILE . 51.1 mt -108.78 128.7 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.802 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -113.99 56.43 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.212 0.529 . . . . 0.0 110.256 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.635 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -124.62 171.97 9.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.58 128.65 45.94 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 178.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.764 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.08 139.94 47.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.708 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.2 113.82 18.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.021 HD11 HD12 ' A' ' 625' ' ' ILE . 71.6 mt -78.71 109.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.321 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.76 116.09 6.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.814 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -44.97 -32.42 1.63 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.224 0.535 . . . . 0.0 110.293 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.508 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.7 -18.78 74.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.747 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.563 HG11 ' ND2' ' A' ' 610' ' ' ASN . 56.4 t -100.5 118.59 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 117.769 0.785 . . . . 0.0 111.686 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 8.8 t30 -139.83 121.96 9.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.914 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.1 Cg_endo -90.42 160.26 32.22 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.545 -1.023 . . . . 0.0 111.659 -0.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 2.8 t80 -91.64 116.32 28.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 59.7 m-85 -91.91 138.04 31.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.897 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.3 mp -129.87 145.0 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.831 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.36 -169.15 36.82 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.43 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -83.21 3.39 31.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.768 -0.216 . . . . 0.0 111.307 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 7.2 t -101.29 126.32 48.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -57.31 -22.72 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.855 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.61 ' HB3' HD21 ' A' ' 730' ' ' LEU . 6.0 t0 -64.12 -25.43 68.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.665 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 89.9 m -73.41 132.91 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 22.8 m-20 -48.48 -27.4 2.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.764 ' SG ' HD13 ' A' ' 592' ' ' LEU . 54.1 t -114.55 142.02 46.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.36 118.59 32.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 588' ' ' ILE . 32.5 mm -138.16 109.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.216 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 14.0 tt0 -89.94 102.98 15.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.797 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.52 112.89 12.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.212 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -43.57 -34.08 1.31 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.733 0.302 . . . . 0.0 111.392 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -77.55 -39.67 45.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.688 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.066 HD12 HD12 ' A' ' 681' ' ' ILE . 0.4 OUTLIER -61.12 159.2 12.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.541 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 16.1 m -110.29 167.21 10.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.44 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.3 OUTLIER -44.65 -55.51 5.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 110.229 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 727' ' ' VAL . 18.5 t -112.66 57.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.477 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 681' ' ' ILE . 43.1 t60 -45.57 -46.02 13.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.617 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 680' ' ' ILE . 7.0 p -167.1 155.86 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.225 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 603' ' ' ILE . 40.3 p90 -143.32 147.96 35.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 594' ' ' ILE . 86.1 mt -102.65 139.79 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.972 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -131.44 133.62 45.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.506 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.48 ' NZ ' HG21 ' A' ' 700' ' ' THR . 29.3 ttmt -97.57 136.1 38.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.559 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 159.55 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.861 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 630' ' ' HIS . 0.9 OUTLIER -76.08 139.61 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.2 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t-160 -60.08 133.19 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -89.3 56.67 3.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.164 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.755 HG21 ' C ' ' A' ' 642' ' ' GLN . 12.1 m -84.88 125.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.56 -146.94 6.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.429 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -76.85 157.21 31.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 0.0 110.754 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 1.5 t -129.83 167.13 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -123.84 112.96 17.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.638 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.74 -71.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.385 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.48 118.73 37.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.38 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.85 87.65 3.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.445 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 73.5 Cg_endo -77.31 167.19 25.05 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.538 2.158 . . . . 0.0 111.809 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 70.68 -62.73 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.092 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.755 ' C ' HG21 ' A' ' 632' ' ' VAL . 6.9 mm-40 64.24 170.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.591 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -76.4 72.77 1.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.726 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.822 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.3 OUTLIER -102.78 -153.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -122.37 147.44 46.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.277 0.56 . . . . 0.0 112.099 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -130.09 154.57 47.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.897 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 578' ' ' LEU . 4.0 pt -105.39 128.72 59.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.26 0.552 . . . . 0.0 111.844 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.868 ' CH2' HD22 ' A' ' 671' ' ' LEU . 78.8 m95 -111.74 140.79 46.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.756 ' CE2' HG21 ' A' ' 678' ' ' ILE . 13.4 t80 -104.62 117.25 33.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 624' ' ' PHE . 97.1 m -105.6 126.2 51.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.041 0.448 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.423 ' ND1' ' OG ' ' A' ' 657' ' ' SER . 23.8 t60 -104.36 122.79 46.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.67 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.479 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.44 5.24 13.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.57 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.64 146.14 20.57 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.043 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 654' ' ' THR . 37.6 m -79.6 -1.11 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.577 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -87.08 0.42 55.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.442 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.42 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.348 0.594 . . . . 0.0 111.87 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 11.9 p -102.54 165.65 10.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.669 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -137.03 119.95 16.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.783 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.76 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -97.25 106.08 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.91 -81.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -131.36 -4.27 3.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.592 ' HB3' HG23 ' A' ' 716' ' ' VAL . 6.1 m120 -97.43 138.65 34.55 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.751 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.9 ttm180 -85.26 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 2.6 mtp -130.17 122.88 29.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 0.0 111.14 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.506 ' H ' HG21 ' A' ' 668' ' ' THR . 20.7 pt -103.4 165.18 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.656 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.1 tt0 -51.16 117.64 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 110.868 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.74 8.0 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.309 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.506 HG21 ' H ' ' A' ' 665' ' ' ILE . 16.6 p -112.77 162.19 16.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.978 0.418 . . . . 0.0 111.419 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.419 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.3 ttpm? -136.48 144.06 44.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.536 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.529 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.27 144.82 29.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.868 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.65 136.72 53.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.775 HD13 HG21 ' A' ' 694' ' ' VAL . 1.6 mt -108.19 127.89 54.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.952 ' HB3' HD22 ' A' ' 707' ' ' LEU . 0.6 OUTLIER -118.1 161.26 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.132 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.486 ' HB2' HD12 ' A' ' 696' ' ' ILE . 60.1 t0 -58.37 104.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.008 0.432 . . . . 0.0 110.303 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 101.72 32.84 4.95 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -86.71 115.61 24.27 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.673 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -95.83 108.91 21.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.76 HG23 ' HG ' ' A' ' 659' ' ' LEU . 4.7 mt -105.16 131.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 0.0 112.036 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -93.32 115.54 28.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.182 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.627 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.3 OUTLIER -86.41 -37.89 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.136 -179.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.066 HD12 HD12 ' A' ' 618' ' ' LEU . 43.9 mt -155.36 130.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.392 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -136.79 127.09 26.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 4.0 t0 -126.35 116.56 21.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.37 . . . . 0.0 110.686 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -67.81 -46.2 72.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -58.55 -40.28 82.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.128 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -96.22 -20.24 18.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.5 tptp 72.04 1.91 4.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.318 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.67 105.37 7.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 586' ' ' SER . 3.6 p -110.78 138.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.913 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 587' ' ' ILE . 8.3 mm -112.65 145.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.157 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.55 128.57 1.36 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 592' ' ' LEU . 9.4 m-30 -113.2 148.31 35.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 110.323 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.676 ' HB2' HD22 ' A' ' 583' ' ' LEU . 31.4 tttt -101.62 117.02 34.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.05 0.453 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.82 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.8 t -81.66 126.11 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.4 tt0 -133.98 108.69 8.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.746 HD13 ' HB2' ' A' ' 705' ' ' GLU . 34.1 mt -74.0 105.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.674 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.92 -47.61 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.875 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.478 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 24.6 t0 -111.08 140.06 45.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -115.14 100.62 8.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.166 0.507 . . . . 0.0 109.726 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.48 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.2 t -69.79 65.34 0.22 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 56.64 57.22 20.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.754 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.822 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -95.91 149.38 21.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 112.048 -179.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.547 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.72 -26.95 6.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.189 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.74 HD21 HD23 ' A' ' 707' ' ' LEU . 2.2 t30 -160.13 -51.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.586 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.746 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.6 pt-20 159.53 -31.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.729 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 673' ' ' GLN . . . 145.26 40.68 0.05 OUTLIER Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.061 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.952 HD22 ' HB3' ' A' ' 673' ' ' GLN . 1.4 mm? -88.29 7.19 33.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.058 0.429 . . . . 0.0 112.087 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 67.45 -67.26 0.26 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.806 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 8.3 ptp 35.79 40.48 0.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.771 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 711' ' ' GLN . 0.2 OUTLIER -96.92 169.85 9.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.832 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.529 ' H ' HD23 ' A' ' 710' ' ' LEU . 4.8 mt-30 -51.53 -30.02 18.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.88 130.58 41.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.429 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.85 100.41 10.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.095 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 39.9 84.33 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.732 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.71 142.84 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 663' ' ' ARG . 53.6 t -81.95 114.38 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.093 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 717' ' ' LEU . 4.2 mp -88.1 170.16 11.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.567 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -103.75 158.1 16.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.149 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -95.4 158.2 15.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.0 p -126.31 -176.49 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.56 -30.42 41.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.17 -45.01 96.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.585 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.742 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.9 mp0 -68.84 -49.67 56.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.557 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -56.25 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -41.8 89.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.203 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 723' ' ' GLU . 7.4 mt -55.68 -44.33 77.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -76.56 -29.31 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -37.53 67.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -97.62 28.63 3.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 608' ' ' ASP . 4.3 tt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.655 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.814 0.34 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.38 109.35 9.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.0 pt -60.83 159.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -174.87 162.61 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.666 HD11 HG23 ' A' ' 681' ' ' ILE . 96.9 mt -137.9 50.93 1.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -70.13 -22.15 63.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 145.08 -14.37 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.413 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 60.2 ttp180 -100.31 128.91 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.564 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.9 -57.55 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.364 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -108.82 137.56 46.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.75 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.7 m -116.95 114.6 24.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.012 HD12 HD11 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -103.56 108.03 19.13 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.32 100.46 53.48 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 32.8 Cg_exo -47.22 103.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.736 1.624 . . . . 0.0 109.545 176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -73.85 158.36 86.09 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.46 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 7.6 Cg_endo -49.66 -26.18 12.52 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.512 2.808 . . . . 0.0 112.705 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.589 ' HB2' HD12 ' A' ' 583' ' ' LEU . 92.8 m-20 -63.5 -19.83 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.012 0.434 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 t -96.76 153.86 17.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.848 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.672 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -55.49 -20.49 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.695 HD12 HG23 ' A' ' 613' ' ' ILE . 59.7 mt -110.55 118.8 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.078 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.1 61.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.374 0.607 . . . . 0.0 110.307 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.0 mt-10 -124.93 171.95 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.835 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.28 132.61 53.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.026 0.441 . . . . 0.0 111.384 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.9 144.81 41.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.116 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 2.4 mt-10 -124.28 116.73 23.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 580' ' ' LEU . 66.7 mt -87.54 108.81 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -66.93 125.2 25.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.49 -30.02 2.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.286 0.565 . . . . 0.0 110.148 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.454 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.6 -21.4 79.58 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 114.085 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.429 HG11 ' ND2' ' A' ' 610' ' ' ASN . 63.5 t -98.95 117.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.253 1.026 . . . . 0.0 111.797 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.7 t30 -140.51 121.28 9.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.917 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 40.4 Cg_endo -90.43 159.71 31.91 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.606 -0.998 . . . . 0.0 111.375 -0.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.663 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -92.16 117.41 29.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.499 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 14.2 m-85 -92.22 137.9 31.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.173 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.644 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.8 mp -128.45 146.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.412 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.81 -165.88 37.78 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.89 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.7 OUTLIER -85.86 -6.65 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.519 -0.34 . . . . 0.0 111.767 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.0 130.79 47.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.323 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.36 -24.73 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.55 -28.96 61.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 110.528 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 92.9 m -73.65 133.09 43.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.486 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.515 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -47.91 -27.03 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 41.3 t -114.48 141.31 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.489 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.82 114.48 26.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.695 HG23 HD12 ' A' ' 588' ' ' ILE . 27.6 mm -137.9 109.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.187 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.4 pt-20 -92.01 103.02 15.58 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.846 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.672 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -132.88 110.94 10.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.318 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.97 -24.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.4 mmp_? -77.38 -41.38 40.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.937 HD23 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -84.75 158.7 20.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.01 0.433 . . . . 0.0 111.535 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.8 t -93.55 178.25 5.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.719 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -47.13 -53.99 11.6 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.425 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.496 HG21 HD22 ' A' ' 730' ' ' LEU . 33.7 t -113.87 62.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.211 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.7 ' CD2' HG23 ' A' ' 680' ' ' ILE . 59.1 t60 -48.86 -51.06 31.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.535 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 650' ' ' CYS . 3.7 p -162.55 157.49 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.446 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.508 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.5 p90 -143.52 150.53 39.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.505 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -102.08 126.59 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -120.38 133.98 55.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 577' ' ' PHE . 25.0 ttmt -98.06 137.16 37.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.235 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.55 159.21 42.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.791 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -76.21 111.95 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.344 0.592 . . . . 0.0 110.112 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 709' ' ' MET . 1.0 OUTLIER -83.17 122.94 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.536 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -159.52 109.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.59 152.55 5.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -60.14 95.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.31 177.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.11 102.8 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 3.7 mtt -92.74 128.0 38.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 9.6 t80 69.26 -66.47 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.33 138.53 31.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.727 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 20.1 m -116.46 88.17 23.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.06 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.04 -151.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.657 2.238 . . . . 0.0 112.051 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -62.86 -14.32 44.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.74 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.0 OUTLIER 82.34 -71.06 0.05 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . -170.59 72.58 0.11 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.597 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 703' ' ' PHE . 23.4 mt -106.93 -154.26 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.932 -0.158 . . . . 0.0 110.707 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 702' ' ' LEU . 4.6 m-20 -116.34 147.3 41.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.022 0.439 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.875 ' HB3' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -131.92 155.72 47.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.225 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -105.87 119.87 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 121.563 0.697 . . . . 0.0 112.346 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.657 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 80.4 m95 -103.59 128.29 50.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.636 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.565 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.7 t80 -90.16 115.72 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 624' ' ' PHE . 21.8 m -98.25 137.59 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 0.0 111.549 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 23.0 t60 -121.55 121.62 37.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.509 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 22.6 p -119.48 3.18 11.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.49 146.7 29.03 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.883 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 0.3 OUTLIER -77.33 -13.59 59.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -83.43 2.35 37.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 49.48 137.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.612 0.72 . . . . 0.0 111.992 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 680' ' ' ILE . 40.9 m -112.42 166.42 11.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.481 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.39 120.07 26.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -99.69 99.67 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.5 m120 60.51 -81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.2 t30 -131.79 -0.38 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.683 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.91 141.05 36.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -77.01 141.88 40.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.775 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 15.5 mmm -121.2 91.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.1 pt -87.39 159.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 652' ' ' THR . 19.6 tt0 -55.3 108.06 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.236 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.0 34.48 2.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.918 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.0 p -134.68 159.77 40.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 111.482 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 16.0 pttm -136.78 139.8 42.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.775 ' HB2' ' HE1' ' A' ' 664' ' ' MET . 14.3 t80 -131.64 144.61 51.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.875 HD21 ' HB3' ' A' ' 646' ' ' ASP . 1.2 mt -68.89 134.56 49.77 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.179 0.514 . . . . 0.0 111.849 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 694' ' ' VAL . 4.0 mt -104.46 135.31 46.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.219 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.938 ' HB3' HD12 ' A' ' 707' ' ' LEU . 3.6 mt-30 -119.7 146.7 45.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.307 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 696' ' ' ILE . 10.8 t70 -45.9 104.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 110.736 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.88 32.46 4.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 112.07 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -95.47 108.26 20.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 659' ' ' LEU . 36.3 pt -106.03 137.42 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.341 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.23 115.52 27.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.109 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.7 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.1 mt -81.68 -38.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.441 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.937 HD12 HD23 ' A' ' 618' ' ' LEU . 14.0 mt -155.3 131.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.931 0.396 . . . . 0.0 111.556 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.63 123.05 20.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.926 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 116.68 21.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.536 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -46.67 71.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.982 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -71.63 -40.56 69.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.799 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -89.81 -6.23 56.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.445 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 58.78 19.04 6.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.676 0.274 . . . . 0.0 110.798 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.443 ' CD2' ' CG ' ' A' ' 617' ' ' ARG . 0.1 OUTLIER -79.05 104.34 9.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.0 p -117.88 121.79 68.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.194 0.521 . . . . 0.0 111.447 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.425 HD11 HG12 ' A' ' 587' ' ' ILE . 33.3 mm -128.24 137.27 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.881 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -167.66 131.04 2.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.045 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.9 m-30 -113.14 144.72 42.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.664 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.55 ' HB2' HD22 ' A' ' 583' ' ' LEU . 22.1 ttpt -101.7 117.23 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.068 0.461 . . . . 0.0 110.563 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 672' ' ' LEU . 3.1 t -79.04 119.7 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.649 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 579' ' ' THR . 5.7 tt0 -126.45 109.16 11.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.061 0.457 . . . . 0.0 110.233 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 705' ' ' GLU . 58.2 mt -79.79 105.46 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.383 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -49.01 8.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -111.38 138.44 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.796 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 68.9 p -116.14 99.87 7.54 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 700' ' ' THR . 8.4 t -77.42 61.0 2.15 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.42 43.43 58.14 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.067 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.867 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -97.1 32.9 2.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.953 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.687 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER 61.55 109.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.729 HD21 HD13 ' A' ' 707' ' ' LEU . 7.2 t30 56.14 -69.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.145 0.498 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 702' ' ' LEU . 9.1 pt-20 172.24 -22.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.765 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 137.71 40.65 0.11 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.834 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.938 HD12 ' HB3' ' A' ' 673' ' ' GLN . 0.9 OUTLIER -82.57 -3.53 56.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.518 ' CA ' HD13 ' A' ' 671' ' ' LEU . . . 42.48 82.25 0.03 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.349 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.522 ' HE2' ' CZ ' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -98.36 29.71 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.159 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.2 OUTLIER -57.65 164.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.844 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.5 -33.64 45.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.543 ' HB2' HD12 ' A' ' 710' ' ' LEU . 2.9 mt-10 -86.09 139.89 30.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -82.65 100.14 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.027 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 15.2 mmm-85 39.85 87.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.89 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.4 141.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.51 130.22 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.414 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.58 169.73 9.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 156.43 17.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.974 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.83 150.78 25.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.1 p -126.12 -178.44 4.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.52 57.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.187 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.06 -49.22 76.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -48.29 71.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.736 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.437 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.57 -32.97 67.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.44 -36.85 85.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.42 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.1 mt -60.51 -44.15 96.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.0 p -76.55 -24.03 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.65 -46.06 66.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -64.26 -25.97 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 621' ' ' VAL . 7.2 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.052 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.8 0.333 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.73 47.47 8.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.46 105.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.84 -178.13 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.35 113.96 5.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.966 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -92.76 10.51 30.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.627 0.251 . . . . 0.0 111.171 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.517 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -158.36 -36.86 0.02 OUTLIER Glycine 0 C--O 1.225 -0.466 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.83 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.421 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 58.4 ttp180 -112.03 143.33 43.22 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.306 -0.526 . . . . 0.0 111.209 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -128.07 -62.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.549 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.016 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.46 125.68 51.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.307 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.598 HG22 ' HG3' ' A' ' 581' ' ' LYS . 6.8 m -109.23 118.49 36.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.532 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.7 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.3 OUTLIER -105.56 108.25 19.67 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.598 ' HG3' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.27 99.22 39.23 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 50.4 Cg_exo -47.47 97.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.792 1.661 . . . . 0.0 109.607 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.79 158.14 85.04 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -176.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.408 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.0 Cg_endo -49.7 -25.55 11.6 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.55 2.833 . . . . 0.0 112.549 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.464 ' CB ' HD12 ' A' ' 583' ' ' LEU . 23.7 t70 -62.1 -25.43 67.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.477 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.8 t -95.61 153.93 17.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.691 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.629 HG21 ' HD1' ' A' ' 688' ' ' PHE . 0.9 OUTLIER -57.03 -12.34 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.791 0.329 . . . . 0.0 111.284 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.718 HD13 HG23 ' A' ' 613' ' ' ILE . 30.4 mt -112.44 129.62 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.382 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -111.46 57.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.098 0.475 . . . . 0.0 110.486 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.9 mt-10 -124.64 172.04 9.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.127 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -125.9 130.47 51.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.883 0.373 . . . . 0.0 111.051 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.6 OUTLIER -112.74 142.51 45.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.101 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.421 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 3.4 mt-10 -124.27 120.43 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.865 HD12 HD22 ' A' ' 578' ' ' LEU . 78.6 mt -89.34 109.07 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 1.1 tt0 -68.14 122.47 18.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.85 -29.95 2.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.221 0.534 . . . . 0.0 110.537 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -70.55 -22.04 77.79 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.942 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.584 HG11 ' ND2' ' A' ' 610' ' ' ASN . 64.0 t -101.07 118.26 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.934 0.867 . . . . 0.0 111.841 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 19.1 t30 -139.85 122.32 10.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.742 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.2 Cg_endo -90.21 159.52 32.9 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.372 -1.095 . . . . 0.0 111.673 -0.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.612 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.2 t80 -92.07 114.28 26.78 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.617 ' CG ' HD12 ' A' ' 730' ' ' LEU . 3.3 m-85 -92.39 138.48 31.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.184 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.765 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -125.78 143.44 39.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.79 -174.08 43.39 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.375 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 8.5 ttp85 -82.03 -4.46 56.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.617 0.246 . . . . 0.0 111.455 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.98 126.43 47.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.777 0.322 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -49.94 -26.58 4.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.55 -28.85 48.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.958 0.408 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 35.2 m -75.02 133.4 41.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.5 m-20 -49.61 -26.95 4.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.457 . . . . 0.0 110.417 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.774 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.0 t -111.54 142.66 43.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 115.17 24.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.718 HG23 HD13 ' A' ' 588' ' ' ILE . 24.6 mm -137.88 109.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.011 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 28.6 tt0 -89.29 104.1 16.67 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.249 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.825 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.85 113.24 13.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.228 178.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -41.23 -38.61 1.16 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 681' ' ' ILE . 1.3 mmp_? -77.46 -35.11 54.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -58.99 157.94 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.73 164.43 12.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.96 -50.01 19.73 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.126 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 727' ' ' VAL . 54.7 t -115.67 63.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.498 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.643 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 4.9 t60 -45.78 -48.22 15.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.477 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' A' ' 649' ' ' TYR . 31.7 p -172.39 162.88 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 650' ' ' CYS . 46.0 p90 -144.18 144.2 31.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.5 mp -102.55 130.67 52.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.1 t80 -121.67 133.61 54.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.194 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 647' ' ' ILE . 3.1 tppp? -97.94 136.03 38.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.769 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' CG ' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 158.7 43.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.84 -178.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.19 112.96 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.451 0.644 . . . . 0.0 110.366 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.2 t60 -68.22 133.39 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.131 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -127.95 160.51 31.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.054 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.1 p -140.35 159.48 25.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -67.13 -93.47 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.544 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.52 138.15 54.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . 0.4 ' HB3' ' HG3' ' A' ' 640' ' ' PRO . 13.9 p -111.27 121.88 46.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.24 116.0 13.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.3 t80 72.6 -62.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.982 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -81.82 144.07 31.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 7.0 t -94.5 107.62 31.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.434 ' HG2' HG11 ' A' ' 632' ' ' VAL . 96.7 Cg_endo -80.44 -165.25 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.534 2.156 . . . . 0.0 112.377 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.716 ' O ' HD13 ' A' ' 644' ' ' LEU . . . -56.37 -30.16 62.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.491 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.406 ' HB3' ' CD1' ' A' ' 644' ' ' LEU . 0.0 OUTLIER 64.38 -165.57 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -95.02 68.6 1.17 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.172 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 641' ' ' ALA . 5.9 mp -114.68 -156.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.739 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -118.4 146.84 44.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.049 0.452 . . . . 0.0 111.65 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.429 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 3.0 t0 -133.47 160.3 37.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.589 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.016 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -109.08 122.64 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.795 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.945 ' CH2' HD22 ' A' ' 671' ' ' LEU . 93.1 m95 -109.99 126.85 54.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.399 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.57 ' HE2' ' HG ' ' A' ' 623' ' ' CYS . 9.9 t80 -90.67 122.24 33.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.162 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 7.9 m -111.02 128.14 55.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 657' ' ' SER . 70.5 t60 -106.11 130.11 54.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.382 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 1.2 p -126.24 3.63 7.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.288 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.53 141.07 20.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.043 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.516 ' O ' HG22 ' A' ' 654' ' ' THR . 87.4 m -75.6 -5.6 46.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.44 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.3 m120 -87.24 0.04 55.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.722 0.296 . . . . 0.0 111.316 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.3 t 67.59 146.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.461 ' HB3' ' CG ' ' A' ' 651' ' ' HIS . 0.9 OUTLIER -118.24 158.66 24.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.379 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -138.58 119.68 14.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.359 . . . . 0.0 110.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -108.06 112.49 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.83 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.46 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.02 0.19 1.53 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.474 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 0.5 OUTLIER -96.65 141.82 29.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -79.51 141.91 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.482 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 34.9 mmm -124.78 102.77 7.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.118 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 44.2 pt -87.99 151.43 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.634 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -47.5 107.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.955 0.407 . . . . 0.0 111.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.51 36.18 2.69 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.132 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 665' ' ' ILE . 2.9 p -122.69 162.2 22.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 0.0 111.519 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.444 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -129.42 153.23 48.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -147.02 143.31 28.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.945 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -73.23 123.08 22.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.217 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.76 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.1 mt -98.71 140.48 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.2 OUTLIER -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.432 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 706' ' ' GLY . 29.1 t0 -43.04 113.76 0.52 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 110.551 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 95.95 35.51 5.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.42 121.61 36.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.356 . . . . 0.0 110.914 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -96.15 108.62 21.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.987 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 659' ' ' LEU . 6.2 mt -108.13 136.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.07 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.499 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 20.0 mttt -107.83 116.59 32.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.812 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.652 HD11 ' CE2' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -88.02 -30.55 5.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.858 -178.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.655 HD11 HD11 ' P' ' 831' ' ' LEU . 15.8 tt -155.03 130.6 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.523 . . . . 0.0 112.193 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.636 ' CD1' HG23 ' A' ' 689' ' ' VAL . 9.0 t90 -137.43 128.34 27.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.375 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -126.72 116.38 20.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.018 0.437 . . . . 0.0 111.152 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -68.5 -46.61 69.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.992 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -58.71 -40.64 84.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.054 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.94 -15.47 22.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.451 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 70.64 3.31 4.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.072 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.629 ' HD1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.46 104.18 7.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.636 HG23 ' CD1' ' A' ' 682' ' ' TRP . 2.6 p -113.3 137.33 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.807 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 587' ' ' ILE . 28.8 mm -116.19 155.24 17.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.67 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . 179.28 124.92 0.91 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.86 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 680' ' ' ILE . 10.8 m-30 -112.67 143.26 44.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 0.0 110.552 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.4 tptt -101.09 117.55 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.113 0.482 . . . . 0.0 110.702 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.751 HG22 HD21 ' A' ' 578' ' ' LEU . 8.2 t -82.45 126.94 40.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.923 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 579' ' ' THR . 4.8 tt0 -133.76 109.44 9.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 0.0 110.812 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 674' ' ' ASP . 67.7 mt -77.55 105.68 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.869 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -80.5 -44.55 18.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.247 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -110.44 140.82 44.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.032 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.8 p -114.78 99.81 7.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.093 0.473 . . . . 0.0 109.895 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.3 t -80.69 60.31 3.95 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.481 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.96 58.93 11.6 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.925 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -85.04 144.0 28.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.551 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.644 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -37.43 -47.99 0.92 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.695 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.508 ' HB3' ' CD2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -143.51 5.74 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.19 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.737 ' CD ' HD23 ' A' ' 707' ' ' LEU . 1.2 pt-20 87.69 -41.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.194 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 116.87 34.61 1.24 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.737 HD23 ' CD ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -80.9 -8.81 59.83 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 122.587 -0.361 . . . . 0.0 111.566 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.434 ' HA3' ' OE1' ' A' ' 673' ' ' GLN . . . 46.9 101.3 0.01 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.211 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.79 96.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 711' ' ' GLN . 0.4 OUTLIER 67.32 158.79 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.765 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.607 ' H ' HD23 ' A' ' 710' ' ' LEU . 6.9 mt-30 -68.6 65.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.111 0.482 . . . . 0.0 110.26 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 710' ' ' LEU . 1.2 mm-40 -107.45 141.73 38.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.134 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -81.06 135.97 35.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.197 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.508 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -87.87 -143.3 0.13 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.281 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.91 143.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 82.2 t -99.04 113.91 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.83 172.19 8.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.89 16.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -90.79 152.61 20.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 59.9 p -126.21 -175.21 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.204 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.35 65.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.51 -47.2 82.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -66.41 -45.26 80.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -32.71 68.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.31 -37.82 83.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 723' ' ' GLU . 16.8 mt -58.61 -44.34 89.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 621' ' ' VAL . 12.0 p -81.39 -22.1 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -40.08 66.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -75.56 -15.91 60.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.617 HD12 ' CG ' ' A' ' 602' ' ' PHE . 9.9 tt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -176.57 119.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.1 mt -143.81 94.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.35 123.8 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 681' ' ' ILE . 38.9 mt -119.92 37.42 4.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.864 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -93.02 10.36 31.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.599 0.238 . . . . 0.0 111.407 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.616 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -153.34 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.661 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 ttm180 -97.7 142.03 29.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 122.501 -0.411 . . . . 0.0 110.581 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -131.3 -60.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.007 HD12 HD13 ' A' ' 647' ' ' ILE . 6.7 tt -106.55 134.68 49.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.858 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.1 m -115.5 114.66 25.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.067 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.731 ' HG ' HG22 ' A' ' 694' ' ' VAL . 1.2 mp -105.18 108.04 19.35 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.7 pttp -113.46 100.32 51.53 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.62 ' CB ' HG23 ' A' ' 588' ' ' ILE . 53.2 Cg_exo -46.07 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.91 1.74 . . . . 0.0 109.795 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 693' ' ' LYS . 0.0 OUTLIER -74.69 158.52 84.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.441 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 83.7 Cg_exo -48.03 -24.72 5.68 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.493 2.795 . . . . 0.0 112.759 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -61.45 -23.37 65.81 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 6.4 t -95.49 153.59 17.62 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.92 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.65 HD13 HD11 ' A' ' 690' ' ' ILE . 4.3 pt -54.46 -17.85 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 582' ' ' PRO . 6.4 tt -112.46 142.83 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.77 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.8 OUTLIER -120.31 65.89 0.83 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.063 0.459 . . . . 0.0 110.351 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.598 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.6 mm-40 -124.75 171.57 10.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.276 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.89 125.67 40.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.954 0.406 . . . . 0.0 111.084 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.65 138.66 49.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.771 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 8.7 mt-10 -124.25 122.4 37.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.828 HD11 HD13 ' A' ' 625' ' ' ILE . 67.8 mt -85.12 109.21 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.116 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -63.68 114.0 3.71 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.006 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.534 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.9 -32.72 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.9 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.509 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.63 -21.05 76.19 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.689 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.19 118.49 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.864 0.832 . . . . 0.0 111.917 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.18 123.08 10.14 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.981 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.567 ' HD3' HD22 ' A' ' 726' ' ' LEU . 44.6 Cg_endo -90.06 159.31 33.55 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 124.334 -1.111 . . . . 0.0 111.799 0.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 610' ' ' ASN . 2.6 t80 -92.87 117.72 30.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.673 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.3 m-85 -92.79 138.2 31.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.648 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 625' ' ' ILE . 2.4 mp -128.28 149.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.957 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 164.78 -176.69 40.55 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.962 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -79.25 -4.51 51.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.212 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 130.21 47.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.898 0.38 . . . . 0.0 111.052 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -25.13 19.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.32 -29.01 46.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.783 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 730' ' ' LEU . 58.1 m -77.77 136.88 38.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.4 OUTLIER -51.32 -23.77 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.793 ' SG ' HD13 ' A' ' 592' ' ' LEU . 51.5 t -117.29 143.38 45.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.696 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -120.43 119.77 34.01 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 592' ' ' LEU . 25.4 mm -137.57 109.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.987 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.67 102.53 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.867 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.613 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -132.18 113.55 13.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.837 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -44.04 -36.43 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.821 0.343 . . . . 0.0 111.603 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.573 ' CB ' HD13 ' A' ' 681' ' ' ILE . 1.4 mmt180 -77.53 -31.19 53.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.087 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.3 mp -59.51 159.48 8.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.25 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 21.8 p -114.02 164.52 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.173 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -45.8 -45.4 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.273 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.686 HG11 ' CG2' ' A' ' 727' ' ' VAL . 13.7 t -124.89 61.44 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.392 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.511 ' NE2' HG23 ' A' ' 680' ' ' ILE . 21.3 t60 -50.05 -48.57 52.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.951 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.545 ' SG ' HD11 ' A' ' 680' ' ' ILE . 6.5 p -166.89 158.4 12.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.621 ' HA ' HD12 ' A' ' 603' ' ' ILE . 47.9 p90 -143.39 146.89 33.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.909 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.828 HD13 HD11 ' A' ' 594' ' ' ILE . 2.6 mp -102.2 130.96 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.918 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -124.34 131.58 53.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.618 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 20.1 ttmt -98.15 135.99 39.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.01 0.433 . . . . 0.0 110.44 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.14 158.0 41.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.171 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.01 122.26 24.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 110.499 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.458 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 6.6 t60 -78.67 129.86 35.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.273 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.408 ' CB ' ' NH1' ' A' ' 629' ' ' ARG . . . -166.88 125.24 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 19.4 m -80.7 178.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -61.14 -72.83 0.57 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.483 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -132.55 141.86 48.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.81 113.6 27.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.25 123.32 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.8 t80 69.24 -66.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.028 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -82.33 142.33 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.39 102.89 15.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.06 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 -162.1 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.454 2.103 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.469 ' O ' ' CB ' ' A' ' 642' ' ' GLN . . . -50.21 -24.43 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 641' ' ' ALA . 1.3 tt0 82.81 -64.75 0.1 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 172.3 47.2 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.59 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -88.78 -155.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -122.83 147.12 46.9 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.413 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -125.65 160.26 30.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.645 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.007 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -113.34 121.21 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.39 0.614 . . . . 0.0 111.927 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.534 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.2 m95 -107.26 126.56 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.417 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.533 ' CB ' HD21 ' A' ' 672' ' ' LEU . 8.6 t80 -91.03 117.74 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 623' ' ' CYS . 12.5 m -105.74 134.27 49.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.518 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 26.2 t60 -115.51 124.18 50.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 2.0 p -118.67 6.26 11.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.395 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.26 151.12 29.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 2.6 m -81.34 -10.16 59.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.565 ' O ' HG13 ' A' ' 656' ' ' VAL . 61.1 m-20 -87.03 2.72 48.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 50.4 130.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.591 0.71 . . . . 0.0 112.337 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.502 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 1.8 t -103.01 166.21 10.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.191 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -131.0 120.15 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -96.15 99.7 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.59 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.9 m120 61.31 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.748 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 70.0 m-20 -131.65 -2.1 3.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.722 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -100.61 135.02 42.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.894 0.378 . . . . 0.0 111.325 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -73.65 141.8 46.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.42 ' O ' HG23 ' A' ' 656' ' ' VAL . 14.9 mmm -126.52 93.0 3.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.424 HG12 ' CG2' ' A' ' 668' ' ' THR . 36.4 pt -87.21 158.38 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 652' ' ' THR . 26.6 tt0 -46.42 116.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 111.193 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 96.48 28.64 8.87 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.409 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.424 ' CG2' HG12 ' A' ' 665' ' ' ILE . 17.5 p -112.93 162.34 15.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.37 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.489 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.4 ttpm? -141.91 129.66 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.647 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.645 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.5 t80 -134.04 144.25 48.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.439 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.534 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.49 140.36 53.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.3 0.571 . . . . 0.0 112.051 -179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.916 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -108.82 129.44 55.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.183 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.871 ' HB3' HD22 ' A' ' 707' ' ' LEU . 3.9 mt-30 -115.45 146.0 42.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.512 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.434 ' HB2' HD12 ' A' ' 696' ' ' ILE . 28.5 t0 -46.76 105.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.085 0.469 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 103.2 33.17 4.36 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -92.79 111.96 23.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.803 0.335 . . . . 0.0 111.263 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.8 108.53 20.87 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 1.031 HG22 HD13 ' A' ' 659' ' ' LEU . 34.2 pt -105.53 137.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.135 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -93.17 115.97 28.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.275 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -82.45 -32.07 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.722 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 618' ' ' LEU . 21.3 mt -154.4 131.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 111.44 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -136.64 124.02 22.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.17 117.06 27.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.427 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -46.94 72.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.678 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -83.2 -40.33 19.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.326 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.68 -15.16 58.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.34 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt 62.9 15.75 8.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.978 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.422 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -77.01 104.24 7.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 690' ' ' ILE . 2.6 p -116.07 123.8 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.562 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.65 HD11 HD13 ' A' ' 587' ' ' ILE . 6.4 mm -127.65 154.04 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 169.29 136.17 2.02 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.714 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -114.72 153.95 29.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.798 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.838 ' HB2' HD12 ' A' ' 583' ' ' LEU . 9.2 tttt -101.79 117.6 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.028 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.916 HG21 HD13 ' A' ' 672' ' ' LEU . 5.0 t -79.08 125.9 38.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.551 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.4 OUTLIER -133.21 109.38 9.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.025 0.441 . . . . 0.0 110.409 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 577' ' ' PHE . 58.6 mt -80.78 105.32 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.646 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -87.19 -46.08 10.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.66 140.96 44.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.715 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.9 p -113.83 99.97 8.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.316 0.579 . . . . 0.0 109.73 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 56.6 m -70.79 65.93 0.34 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.432 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.19 57.27 20.67 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.857 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.816 ' C ' HD12 ' A' ' 644' ' ' LEU . 2.9 mt -99.88 145.28 27.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.619 ' N ' HD12 ' A' ' 644' ' ' LEU . 38.9 p90 -48.31 -31.38 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 109.765 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.759 HD21 HD23 ' A' ' 707' ' ' LEU . 2.1 t30 -155.99 -53.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.787 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.516 ' O ' HD13 ' A' ' 696' ' ' ILE . 10.4 pt-20 161.47 -26.84 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.179 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 139.81 35.72 0.13 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.23 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 673' ' ' GLN . 1.7 mm? -83.83 -2.93 57.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.493 ' HA3' HD12 ' A' ' 671' ' ' LEU . . . 45.21 73.86 0.25 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.985 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.458 ' CE ' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -94.34 43.62 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.372 . . . . 0.0 111.003 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.9 OUTLIER -82.34 -177.36 6.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.899 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -57.68 12.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.32 133.96 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.736 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.92 100.39 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 15.2 mmm-85 41.68 87.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.716 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.57 142.73 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.619 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.8 p -85.15 128.36 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 171.71 7.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -103.12 157.41 17.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.161 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.8 152.0 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.781 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 2.7 p -126.11 -178.0 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.274 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.77 -35.02 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -57.86 -48.0 81.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.7 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 726' ' ' LEU . 11.1 mp0 -66.65 -48.14 70.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.795 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -59.11 -32.95 70.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -39.44 93.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.261 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 723' ' ' GLU . 5.4 mt -60.47 -44.67 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.013 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.686 ' CG2' HG11 ' A' ' 621' ' ' VAL . 11.4 p -71.27 -27.48 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -56.05 -32.6 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -97.79 28.0 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.781 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.783 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.861 0.362 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.47 165.82 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.7 mt -145.71 103.31 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -173.42 168.24 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.676 HD11 HG23 ' A' ' 681' ' ' ILE . 60.6 mt -132.98 68.65 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.878 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -90.75 -8.94 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.683 0.278 . . . . 0.0 111.309 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 134.01 -48.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.0 tmm_? -112.96 143.93 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 111.028 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.536 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.22 -63.57 1.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.05 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.058 HD12 HD13 ' A' ' 647' ' ' ILE . 7.5 tt -106.91 142.56 36.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.54 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.3 m -122.68 114.81 21.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.335 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 594' ' ' ILE . 6.6 mt -102.55 108.29 19.54 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 6.9 ptmm? -116.55 100.51 53.48 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.644 ' HB2' HG22 ' A' ' 588' ' ' ILE . 33.3 Cg_exo -47.11 105.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.635 1.557 . . . . 0.0 109.06 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.1 OUTLIER -74.39 156.24 87.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.517 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 58.4 Cg_exo -51.31 -25.84 19.11 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.589 2.859 . . . . 0.0 113.108 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.635 ' HB2' HD12 ' A' ' 583' ' ' LEU . 7.3 m-20 -63.38 -26.72 68.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.049 0.452 . . . . 0.0 110.034 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.417 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -97.58 153.66 18.03 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.235 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 690' ' ' ILE . 14.4 pt -49.09 -23.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 110.1 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 613' ' ' ILE . 51.2 mt -99.5 118.59 46.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -117.57 52.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.336 0.588 . . . . 0.0 110.453 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 16.0 mt-10 -124.58 171.82 9.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.379 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -124.64 132.31 53.42 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.122 0.487 . . . . 0.0 111.573 179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.744 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.91 143.04 44.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.724 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.7 OUTLIER -124.28 118.91 27.84 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.958 HD12 HD22 ' A' ' 578' ' ' LEU . 74.9 mt -83.8 109.05 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.214 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.9 120.84 13.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.95 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.24 -28.12 1.79 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.091 0.472 . . . . 0.0 110.67 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -73.63 -19.3 79.69 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.746 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 610' ' ' ASN . 55.0 t -100.74 117.95 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.968 0.884 . . . . 0.0 111.711 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.6 t30 -140.19 121.71 9.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.687 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.3 Cg_endo -89.96 159.86 34.31 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.493 -1.045 . . . . 0.0 111.519 -0.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.7 t80 -91.5 114.7 27.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.737 ' CG ' HD12 ' A' ' 730' ' ' LEU . 20.5 m-85 -91.68 138.45 31.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.769 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -126.32 146.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.71 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 160.09 -174.8 36.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.226 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -65.89 -48.62 70.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.831 0.348 . . . . 0.0 111.415 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.86 128.41 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.492 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.46 -17.73 23.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.766 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -56.95 -31.74 65.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.123 0.487 . . . . 0.0 110.112 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' A' ' 621' ' ' VAL . 84.3 m -70.58 134.02 47.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.501 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -48.08 -27.53 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.432 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.769 ' SG ' HG23 ' A' ' 603' ' ' ILE . 37.2 t -112.19 142.01 45.19 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 105.37 13.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.779 HD12 HD13 ' A' ' 588' ' ' ILE . 18.7 mm -138.62 108.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.764 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -106.18 105.91 16.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.469 0.652 . . . . 0.0 112.217 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.755 ' OD1' HD11 ' A' ' 587' ' ' ILE . 0.4 OUTLIER -130.08 109.88 11.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.731 177.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -37.83 -30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.614 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -74.72 -41.59 59.88 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 615' ' ' ASP . 2.4 pp -88.24 136.98 32.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.774 0.321 . . . . 0.0 111.178 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 163.84 4.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.461 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.494 ' CG ' HG23 ' A' ' 621' ' ' VAL . 1.3 ptp180 -54.08 -28.06 36.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.494 HG23 ' CG ' ' A' ' 620' ' ' ARG . 60.6 t -129.36 60.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.587 ' CD2' HG23 ' A' ' 680' ' ' ILE . 28.2 t60 -49.16 -47.25 45.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.133 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 8.2 p -168.06 161.09 12.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.119 0.485 . . . . 0.0 111.722 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.8 p90 -143.36 148.52 36.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.62 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 580' ' ' LEU . 3.9 mp -102.23 128.16 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.324 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.5 t80 -118.48 134.47 55.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.423 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 33.3 ttmt -98.1 135.28 40.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.01 0.433 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.19 159.65 41.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.588 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.4 tpt180 -75.2 112.89 11.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.27 0.557 . . . . 0.0 110.862 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.476 ' ND1' ' OD2' ' A' ' 646' ' ' ASP . 7.7 t60 -61.72 133.59 55.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.415 ' HB1' ' OE1' ' A' ' 642' ' ' GLN . . . -139.76 101.9 4.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.147 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 642' ' ' GLN . 34.0 m -60.02 -176.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -91.37 -49.56 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.638 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.73 167.9 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 82.5 p -171.72 135.91 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 59.8 mmm -118.99 115.87 25.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.51 -72.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 0.6 OUTLIER -76.36 144.34 40.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.5 m -101.31 105.16 38.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.924 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 29.6 Cg_exo -61.37 -149.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.607 2.205 . . . . 0.0 111.986 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 630' ' ' HIS . . . -45.39 -29.2 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 111.556 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.8 ' HB2' HG22 ' A' ' 632' ' ' VAL . 1.9 tp-100 -52.45 102.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.329 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 137.41 -12.78 3.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.399 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -113.32 -175.5 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.205 0.502 . . . . 0.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.0 m-20 -106.33 146.24 30.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.455 0.645 . . . . 0.0 112.251 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.476 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -128.72 160.56 32.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.549 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 578' ' ' LEU . 0.7 OUTLIER -108.35 120.85 60.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.63 0.729 . . . . 0.0 112.375 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.855 ' CH2' HD22 ' A' ' 671' ' ' LEU . 79.7 m95 -104.95 127.8 52.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.563 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.401 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.0 t80 -90.55 117.4 29.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.876 0.369 . . . . 0.0 110.094 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 12.3 m -102.3 127.78 49.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.37 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' N ' ' A' ' 657' ' ' SER . 36.8 t60 -108.84 125.98 52.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.299 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 14.3 p -121.25 2.01 10.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.211 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.81 161.07 50.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.05 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 38.6 m -91.61 -19.86 22.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.633 0.254 . . . . 0.0 111.627 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.594 ' O ' HG13 ' A' ' 656' ' ' VAL . 47.7 m-20 -82.72 2.88 31.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.659 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 52.46 130.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.453 0.644 . . . . 0.0 112.278 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.422 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 86.5 p -100.98 166.34 10.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.136 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.42 120.76 26.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.755 0.312 . . . . 0.0 111.573 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.682 HD13 HG12 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -94.55 99.75 11.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.362 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 61.57 -80.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.687 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -131.18 -3.61 3.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.711 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.478 ' CB ' ' CE1' ' A' ' 670' ' ' PHE . 4.7 m-80 -97.0 142.01 29.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 111.381 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.8 ttm105 -82.25 141.62 32.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.216 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.83 97.95 5.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 43.8 pt -88.5 156.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 652' ' ' THR . 21.3 tt0 -47.34 108.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 102.4 35.77 3.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.356 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.421 ' CG2' HG12 ' A' ' 665' ' ' ILE . 4.3 p -120.01 162.31 19.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.161 0.505 . . . . 0.0 111.964 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.0 ttpt -133.2 148.31 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.229 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.738 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.5 t80 -147.28 144.83 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.855 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 132.46 46.2 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.719 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.803 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -110.37 122.22 47.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.577 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 706' ' ' GLY . 0.7 OUTLIER -115.11 138.78 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.315 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 706' ' ' GLY . 19.2 t0 -39.04 123.33 1.31 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 37.45 8.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.21 115.13 26.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -95.81 108.58 20.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.0 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.682 HG12 HD13 ' A' ' 659' ' ' LEU . 7.8 mt -109.0 136.54 44.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.91 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -96.77 115.44 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.656 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.722 HD12 ' CE2' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -80.08 -40.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.984 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 617' ' ' ARG . 2.4 mt -155.4 131.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.001 0.429 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.618 ' HB2' HG23 ' A' ' 689' ' ' VAL . 6.5 t90 -136.12 128.23 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -122.15 116.78 24.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.403 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -46.41 72.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.868 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -60.51 -40.63 92.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.256 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.31 -20.25 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.65 0.262 . . . . 0.0 111.567 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 72.69 1.94 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.425 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -76.68 105.37 7.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 682' ' ' TRP . 2.4 p -114.71 134.13 58.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.465 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 587' ' ' ILE . 34.7 mt -119.82 120.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -143.95 141.07 9.93 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.856 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.722 ' CE2' HD12 ' A' ' 680' ' ' ILE . 9.1 m-30 -113.62 142.23 46.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.583 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -101.2 116.96 34.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.229 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.696 HG22 HD21 ' A' ' 578' ' ' LEU . 3.0 t -79.9 125.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.8 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 109.45 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.655 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.487 HG23 ' CD1' ' A' ' 577' ' ' PHE . 57.3 mt -83.89 105.76 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.67 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.91 -43.55 12.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.318 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -109.9 141.55 42.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.337 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.9 p -113.53 100.02 8.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.405 0.621 . . . . 0.0 110.142 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.9 m -82.63 60.68 5.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.518 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 73.95 49.07 14.21 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.859 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.574 ' HB3' ' H ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -83.63 127.42 33.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.654 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.2 p90 -35.77 -48.14 0.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.254 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -141.95 8.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.373 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' OE2' HD23 ' A' ' 707' ' ' LEU . 1.9 pt-20 88.68 -42.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.316 0.579 . . . . 0.0 110.085 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 121.38 26.37 2.02 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.354 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.576 HD23 ' OE2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -86.92 7.94 25.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 56.95 88.83 0.01 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.14 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.401 ' C ' HD23 ' A' ' 710' ' ' LEU . 19.8 mtm -49.03 94.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.666 0.27 . . . . 0.0 111.677 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 709' ' ' MET . 0.6 OUTLIER 34.61 88.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 54.85 58.16 5.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.6 141.07 58.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.938 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.56 135.21 35.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.259 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -156.22 120.8 4.58 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 110.564 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.04 162.45 21.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.055 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.609 HG21 ' O ' ' A' ' 663' ' ' ARG . 9.6 t -77.47 116.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.952 0.406 . . . . 0.0 111.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.99 172.22 8.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.504 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.36 155.52 17.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.076 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -92.34 150.98 20.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -126.16 -175.57 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.94 68.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.52 -53.34 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.438 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 726' ' ' LEU . 1.8 pp20? -70.81 -41.3 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.851 0.358 . . . . 0.0 110.586 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.533 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -67.61 -38.37 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.702 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 723' ' ' GLU . 18.0 mt -56.01 -44.22 78.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.2 p -78.54 -24.04 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.195 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -59.07 -37.79 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.06 -15.93 57.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.737 HD12 ' CG ' ' A' ' 602' ' ' PHE . 10.0 tt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.05 149.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.51 117.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.196 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.417 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.439 ' O ' HD23 ' P' ' 831' ' ' LEU . 8.5 p90 -175.59 157.88 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 682' ' ' TRP . 36.7 mt -132.04 123.34 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.916 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.891 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -71.3 -22.38 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.067 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -163.0 35.49 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.433 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.6 tmm_? -96.58 109.95 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 110.443 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.5 t80 -95.11 -58.29 2.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.735 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.837 HD11 ' CG1' ' A' ' 694' ' ' VAL . 7.9 tp -106.84 142.87 35.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 0.0 111.624 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 40.6 m -117.68 113.85 22.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.531 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -105.62 109.34 21.27 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 37.5 pttt -117.09 99.34 52.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 28.0 Cg_exo -45.8 99.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.918 1.746 . . . . 0.0 109.825 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.05 157.47 85.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.4 Cg_exo -49.9 -25.7 12.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 112.948 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.83 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -62.09 -28.24 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.487 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 0.4 OUTLIER -95.89 153.97 17.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.976 178.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 688' ' ' PHE . 16.7 pt -52.38 -15.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.669 0.271 . . . . 0.0 111.365 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 43.8 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 111.685 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 1.0 OUTLIER -125.71 55.25 1.45 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.618 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.3 mt-10 -124.72 170.24 11.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.052 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.49 121.06 25.09 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.8 OUTLIER -112.68 148.21 35.15 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 119.58 29.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.663 0.268 . . . . 0.0 111.697 -179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 625' ' ' ILE . 47.1 mt -74.05 109.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -65.39 111.85 3.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.023 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -43.37 -36.49 1.93 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.469 0.652 . . . . 0.0 109.942 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -61.47 -23.85 63.09 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.233 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 99.4 t -101.14 118.86 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 117.516 0.658 . . . . 0.0 111.511 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.0 t30 -139.22 122.18 10.59 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.5 Cg_endo -89.6 160.24 36.24 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 124.413 -1.078 . . . . 0.0 111.674 -0.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -90.75 116.72 28.82 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 56.1 m-85 -92.45 138.01 31.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.779 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -125.05 145.7 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.435 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.37 -174.98 41.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.566 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.456 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.4 ttp85 -80.64 -11.51 59.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.645 0.259 . . . . 0.0 111.315 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 132.23 42.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.13 -26.35 11.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 -30.78 27.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.035 0.445 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 63.7 m -77.2 128.8 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -45.24 -34.72 2.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 603' ' ' ILE . 39.8 t -101.88 138.67 38.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.059 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 113.73 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.334 0.588 . . . . 0.0 112.549 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.9 mm -137.6 109.86 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.658 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.9 pm0 -87.79 103.99 16.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.693 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.23 110.23 10.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.964 178.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -40.64 -36.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' A' ' 681' ' ' ILE . 2.0 mmt180 -77.64 -36.58 51.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.693 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -59.71 159.38 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 52.7 p -108.77 166.04 11.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.31 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -47.46 25.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.573 HG11 HG23 ' A' ' 727' ' ' VAL . 18.2 t -121.24 61.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.426 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.571 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.4 t60 -50.08 -48.42 53.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.732 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.0 p -167.28 156.17 10.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.177 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.721 ' HA ' HD12 ' A' ' 603' ' ' ILE . 28.8 p90 -143.62 149.54 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.101 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 594' ' ' ILE . 71.4 mt -101.79 134.09 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.883 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -124.7 132.99 53.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.627 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HE3' HG23 ' A' ' 647' ' ' ILE . 9.1 ttmt -97.89 137.06 37.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.574 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.94 158.89 43.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.522 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.461 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.7 112.89 13.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.386 0.612 . . . . 0.0 110.41 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 -83.74 132.45 34.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.91 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.461 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -155.46 120.35 4.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.623 HG21 ' HG3' ' A' ' 640' ' ' PRO . 9.8 m -60.2 157.96 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.71 97.58 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -171.74 112.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.79 92.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.8 mtm -107.62 118.04 35.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 70.11 -64.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.98 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -76.1 144.38 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.2 m -103.32 100.59 18.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.623 ' HG3' HG21 ' A' ' 632' ' ' VAL . 91.8 Cg_endo -84.13 -159.11 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.705 2.27 . . . . 0.0 112.107 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 1.025 ' HB1' HD12 ' A' ' 644' ' ' LEU . . . -81.63 4.73 20.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.759 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.26 -78.7 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.657 0.265 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -163.86 89.93 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 1.025 HD12 ' HB1' ' A' ' 641' ' ' ALA . 4.4 mt -116.89 -153.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 2.2 m-20 -118.22 147.27 43.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -129.32 148.81 51.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.606 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 577' ' ' PHE . 3.1 pt -102.28 122.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.897 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 88.0 m95 -102.8 138.64 39.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.241 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CB ' HD21 ' A' ' 672' ' ' LEU . 18.0 t80 -100.04 117.43 34.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 6.5 m -105.65 133.84 49.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.409 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -115.58 125.72 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.454 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 15.6 p -123.18 7.97 9.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.68 151.62 29.44 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.033 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 7.5 m -80.16 -17.3 52.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.58 ' O ' HG13 ' A' ' 656' ' ' VAL . 14.0 m-20 -83.72 2.69 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.94 128.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.43 0.633 . . . . 0.0 112.2 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.408 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 9.0 t -97.76 166.68 11.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 39.2 m-85 -131.91 120.22 22.22 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.402 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.951 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -95.03 100.58 12.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.14 -83.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.44 0.44 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.435 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.423 ' CB ' ' CE2' ' A' ' 670' ' ' PHE . 7.6 m-80 -100.6 141.51 33.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.801 ' O ' HG21 ' A' ' 716' ' ' VAL . 21.8 ttp180 -82.43 141.12 33.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.972 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.736 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -122.69 98.08 5.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 668' ' ' THR . 35.2 pt -87.77 152.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 652' ' ' THR . 29.1 tt0 -46.76 106.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 107.88 35.97 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.296 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.468 HG21 HG12 ' A' ' 665' ' ' ILE . 6.6 p -125.72 162.19 25.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 111.879 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.1 ttpm? -133.6 148.47 51.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.224 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.736 ' HB2' ' HE3' ' A' ' 664' ' ' MET . 2.6 t80 -147.69 145.87 29.06 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.897 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.52 133.79 49.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.869 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' A' ' 659' ' ' LEU . 0.8 OUTLIER -110.33 109.2 19.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.196 0.522 . . . . 0.0 111.339 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 46.1 mt-30 -97.94 153.95 18.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.333 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.6 t0 -53.31 115.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.829 0.347 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 93.28 37.48 5.62 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -90.42 116.15 28.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.951 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -95.88 108.08 20.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.951 HG22 HD13 ' A' ' 659' ' ' LEU . 29.7 pt -109.29 133.67 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.088 0.47 . . . . 0.0 112.016 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 29.4 mttt -96.91 115.19 27.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.434 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 622' ' ' HIS . 4.8 mt -75.81 -39.81 38.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.944 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.782 HD11 HD11 ' P' ' 831' ' ' LEU . 5.3 tt -155.7 133.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.714 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -136.04 125.98 25.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -118.77 116.93 27.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -67.49 -46.55 72.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.988 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.5 p-10 -69.71 -40.51 76.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.945 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.9 t-20 -86.32 -20.27 28.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.68 0.276 . . . . 0.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt 68.38 4.82 4.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.34 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.57 ' HD1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -82.24 105.2 13.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.33 137.0 49.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.097 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.452 HG21 ' HB ' ' A' ' 680' ' ' ILE . 2.5 mm -115.27 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.032 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.487 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.23 130.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.231 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 10.4 m-30 -113.09 146.16 39.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.548 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.674 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -101.03 116.82 33.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.906 179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.837 ' CG1' HD11 ' A' ' 578' ' ' LEU . 2.5 t -82.86 123.59 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.45 108.74 8.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.034 0.445 . . . . 0.0 110.987 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.832 HG21 ' HB2' ' A' ' 705' ' ' GLU . 25.1 mt -73.58 105.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.789 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -90.05 -46.04 8.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 576' ' ' ARG . 6.1 t70 -111.28 141.03 45.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.171 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.1 OUTLIER -114.94 101.67 9.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 18.8 m -68.02 62.41 0.08 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 53.66 51.39 48.91 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.183 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -117.29 174.05 6.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.973 0.415 . . . . 0.0 111.561 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -65.67 118.4 9.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.657 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.655 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 3.9 t30 51.39 -71.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.367 0.603 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.832 ' HB2' HG21 ' A' ' 696' ' ' ILE . 21.1 pt-20 163.02 -43.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.655 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 166.58 82.43 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.285 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.481 HD23 ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -105.17 -9.48 17.71 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.606 -0.349 . . . . 0.0 111.467 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.64 -110.65 3.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.533 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.709 ' C ' HD23 ' A' ' 710' ' ' LEU . 5.8 tmm? 59.01 120.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.56 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.709 HD23 ' C ' ' A' ' 709' ' ' MET . 0.3 OUTLIER 176.86 157.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.774 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -49.96 -56.74 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.441 ' CB ' HG21 ' A' ' 715' ' ' VAL . 0.4 OUTLIER -80.34 140.53 36.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.558 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -82.38 100.13 9.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.94 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 41.83 81.74 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.648 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.441 HG21 ' CB ' ' A' ' 712' ' ' GLU . 6.6 m -124.79 150.45 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 663' ' ' ARG . 29.5 t -84.53 117.48 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.063 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.3 mp -90.2 161.43 15.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 148.3 25.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.37 160.17 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 26.7 p -119.3 -173.25 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.68 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -60.7 -45.5 93.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.277 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 624' ' ' PHE . 7.7 tm-20 -67.62 -50.24 59.06 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.2 mttt -54.61 -32.52 58.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.38 -36.85 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.27 -44.61 79.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.573 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -74.97 -17.42 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.07 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -35.22 79.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.871 0.367 . . . . 0.0 110.75 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -96.79 23.98 6.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 602' ' ' PHE . 2.5 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.76 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.9 0.381 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.43 103.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.1 pt -124.2 81.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -179.33 132.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 681' ' ' ILE . 18.7 mt -139.25 179.7 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.011 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.92 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -85.1 -8.97 58.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.587 0.232 . . . . 0.0 111.337 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 99.57 -2.7 57.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.653 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -98.29 108.38 21.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.6 t80 -90.84 -46.79 8.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.84 HD11 HG13 ' A' ' 694' ' ' VAL . 7.2 tp -122.49 142.22 50.81 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.967 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 581' ' ' LYS . 17.8 m -120.06 115.7 24.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.641 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.9 mt -102.05 107.85 19.09 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 17.9 mtpp -113.33 98.97 48.09 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.4 Cg_exo -48.45 96.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.636 1.557 . . . . 0.0 109.434 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.3 OUTLIER -74.76 157.64 85.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.445 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.9 Cg_exo -49.72 -27.83 16.08 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.338 2.692 . . . . 0.0 112.43 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.484 ' CB ' HD12 ' A' ' 583' ' ' LEU . 21.9 t0 -62.48 -26.37 68.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 9.3 t -95.47 153.74 17.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.935 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 688' ' ' PHE . 10.4 tt -53.27 -14.4 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.456 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 613' ' ' ILE . 45.0 mt -111.47 133.51 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 111.876 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -114.85 51.81 0.88 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.605 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.617 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.7 mt-10 -123.94 171.75 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.795 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.09 132.7 50.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.11 0.481 . . . . 0.0 111.394 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.742 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.4 OUTLIER -112.62 142.48 45.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.01 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -123.75 111.68 16.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.919 HD11 HD12 ' A' ' 625' ' ' ILE . 66.8 mt -80.71 108.81 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.019 0.437 . . . . 0.0 110.044 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -67.0 117.67 9.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.99 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.69 -33.4 2.94 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.38 0.609 . . . . 0.0 110.016 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -68.17 -20.99 73.58 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.371 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.869 HG11 ' OD1' ' A' ' 610' ' ' ASN . 58.3 t -97.72 118.37 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 117.691 0.746 . . . . 0.0 111.396 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.3 t30 -139.97 121.49 9.62 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.032 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.2 Cg_endo -90.63 160.79 31.44 Favored 'Cis proline' 0 N--CA 1.46 -0.458 0 C-N-CA 124.699 -0.959 . . . . 0.0 111.459 -0.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.642 ' CG ' HG23 ' A' ' 594' ' ' ILE . 2.6 t80 -91.85 115.07 27.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CD2' HD12 ' A' ' 730' ' ' LEU . 10.8 m-85 -92.25 138.49 31.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.405 0.621 . . . . 0.0 112.588 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.818 HG23 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mp -123.31 140.51 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.109 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 171.74 -174.81 45.23 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.418 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 9.7 ttp85 -83.71 -5.71 59.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.251 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.33 129.75 47.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.79 0.328 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.83 -26.99 6.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.121 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.97 -29.06 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 90.2 m -76.73 133.39 39.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.917 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.869 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.2 m-80 -49.09 -28.49 4.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.818 ' SG ' HG23 ' A' ' 603' ' ' ILE . 21.0 t -109.59 138.67 45.61 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 111.72 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.71 HG23 ' CD1' ' A' ' 588' ' ' ILE . 26.0 mm -137.91 109.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.65 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.5 mt-10 -88.81 104.45 16.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.976 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.751 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -130.82 113.27 13.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.081 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -43.39 -36.13 1.82 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.735 0.302 . . . . 0.0 111.62 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.946 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -77.71 -33.09 53.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.158 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.056 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -64.18 159.35 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 167.37 10.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -55.96 6.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.054 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 727' ' ' VAL . 45.8 t -113.06 62.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 37.4 t60 -48.83 -49.24 40.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.935 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 680' ' ' ILE . 7.7 p -166.71 159.37 13.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.92 0.391 . . . . 0.0 111.212 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 650' ' ' CYS . 1.7 p90 -144.0 146.97 33.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.919 HD12 HD11 ' A' ' 594' ' ' ILE . 82.6 mt -101.87 132.3 48.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.719 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.4 t80 -123.26 133.1 54.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.578 ' HD3' HG23 ' A' ' 647' ' ' ILE . 2.4 tppp? -97.94 136.43 38.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.237 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.69 157.95 45.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.469 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.57 123.53 26.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.0 110.591 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.482 ' CE1' ' CE ' ' A' ' 709' ' ' MET . 8.8 t60 -79.1 130.92 36.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -165.07 141.47 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 9.0 m -109.01 132.2 57.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.101 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -58.88 106.19 0.84 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.601 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 5.9 tttt 63.28 133.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.914 0.387 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.2 122.97 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 37.9 mmm -129.32 138.15 51.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 67.28 -73.78 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -75.85 141.19 42.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 36.5 t -97.23 120.72 60.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.05 -161.21 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.677 2.251 . . . . 0.0 111.973 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 703' ' ' PHE . . . -86.38 12.24 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.761 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 63.23 -82.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.639 0.257 . . . . 0.0 110.926 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -167.46 74.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.88 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.835 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.1 OUTLIER -103.82 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.819 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -123.33 147.77 46.68 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.199 0.523 . . . . 0.0 112.279 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -131.88 158.3 41.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.886 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.823 HD13 HD13 ' A' ' 578' ' ' LEU . 4.9 pt -110.28 123.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 111.924 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.89 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.8 m95 -108.75 128.66 55.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.399 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -91.31 117.41 29.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 624' ' ' PHE . 8.2 m -102.57 138.15 39.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.283 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 657' ' ' SER . 84.3 t60 -116.55 129.36 56.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.418 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 3.2 p -125.61 -2.58 7.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.532 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -76.74 138.26 21.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.091 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 654' ' ' THR . 86.1 m -72.13 -8.3 53.88 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -86.93 2.55 48.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.708 0.29 . . . . 0.0 111.43 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.95 143.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 121.023 0.439 . . . . 0.0 111.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.774 ' OG ' HG22 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -115.57 162.03 17.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 664' ' ' MET . 17.1 m-85 -137.6 119.43 15.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -97.99 99.69 10.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.656 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.47 -1.73 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.549 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 17.9 m120 -96.25 141.52 29.5 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.904 0.383 . . . . 0.0 111.179 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.815 ' O ' HG21 ' A' ' 716' ' ' VAL . 5.0 mtm180 -81.49 141.57 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.158 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.52 ' HE1' HG13 ' A' ' 716' ' ' VAL . 17.4 mmm -123.03 99.34 6.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 668' ' ' THR . 35.0 pt -87.88 154.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -47.43 103.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.347 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.82 39.92 2.09 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.584 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.493 HG21 HG12 ' A' ' 665' ' ' ILE . 2.3 p -128.44 153.31 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.47 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.93 145.19 49.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.087 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 659' ' ' LEU . 4.8 t80 -140.14 145.77 37.97 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.89 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.29 131.87 46.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.756 179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.836 HD13 HG21 ' A' ' 694' ' ' VAL . 0.9 OUTLIER -107.75 120.57 42.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.138 0.494 . . . . 0.0 110.845 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.555 ' HB3' HD23 ' A' ' 707' ' ' LEU . 2.8 mt-30 -110.04 162.24 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.001 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' A' ' 696' ' ' ILE . 24.8 t0 -58.3 108.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.655 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.58 33.5 5.86 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.31 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -86.43 114.94 23.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.831 0.348 . . . . 0.0 110.691 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -95.75 108.37 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 659' ' ' LEU . 8.4 mt -108.82 134.44 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -109.01 117.77 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.072 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.774 HG22 ' OG ' ' A' ' 657' ' ' SER . 0.7 OUTLIER -90.32 -22.15 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.056 HD12 HD12 ' A' ' 618' ' ' LEU . 55.9 mt -152.87 130.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.206 0.527 . . . . 0.0 111.448 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -137.68 129.12 28.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.05 117.32 25.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.007 0.432 . . . . 0.0 110.616 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -67.12 -46.56 73.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.016 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.56 -40.47 23.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.735 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 -14.33 58.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.442 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 64.51 14.77 9.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -77.82 104.67 8.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.0 p -118.44 121.85 68.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.148 0.499 . . . . 0.0 112.059 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.648 HG21 HG13 ' A' ' 680' ' ' ILE . 4.3 mm -112.21 144.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -170.96 123.48 1.04 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.468 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.519 ' CE2' HD11 ' A' ' 592' ' ' LEU . 10.6 m-30 -113.11 146.11 39.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.341 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.742 ' HB2' HD22 ' A' ' 583' ' ' LEU . 2.0 tptt -101.56 117.06 34.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.84 HG13 HD11 ' A' ' 578' ' ' LEU . 2.4 t -81.78 124.12 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.017 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -133.12 108.72 9.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.989 0.423 . . . . 0.0 110.811 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.755 HD13 ' HB2' ' A' ' 705' ' ' GLU . 35.7 mt -73.91 104.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.16 -47.52 8.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.801 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.46 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 12.4 t0 -111.14 139.35 46.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.633 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -115.7 100.66 8.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.107 0.479 . . . . 0.0 109.712 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.4 t -70.3 63.53 0.25 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.621 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.32 59.45 10.63 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.821 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.835 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -98.8 148.18 24.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.776 -179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.639 ' N ' HD12 ' A' ' 644' ' ' LEU . 2.6 p90 -47.41 -34.67 7.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.571 0.7 . . . . 0.0 109.751 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.46 ' ND2' ' CG ' ' A' ' 705' ' ' GLU . 2.0 t30 -151.5 -51.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.762 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.755 ' HB2' HD13 ' A' ' 696' ' ' ILE . 9.0 pt-20 160.46 -30.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.146 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 145.58 34.35 0.07 OUTLIER Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.083 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 673' ' ' GLN . 13.6 mt -87.22 7.95 26.14 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.446 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 81.28 -90.3 1.41 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.459 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.522 ' HE2' ' CE2' ' A' ' 703' ' ' PHE . 0.1 OUTLIER 59.46 99.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.88 0.371 . . . . 0.0 110.429 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 712' ' ' GLU . 0.4 OUTLIER 179.02 -177.88 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.829 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -55.31 -51.83 65.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 710' ' ' LEU . 23.3 mt-10 -75.47 139.99 42.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.77 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.0 100.95 10.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 47.1 76.26 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.412 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 712' ' ' GLU . 12.4 m -124.72 143.38 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.524 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 663' ' ' ARG . 30.8 t -77.68 128.37 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.115 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.462 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -100.41 167.9 10.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -103.03 154.75 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.58 155.8 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.9 p -126.12 -176.22 3.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -56.64 -31.04 63.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -64.76 -44.85 88.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.22 -51.07 57.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.2 mtmp? -55.41 -32.69 62.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -36.82 82.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.4 -44.26 92.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.936 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -74.55 -26.58 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -34.03 66.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -97.86 33.1 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.782 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.624 HD12 ' CD2' ' A' ' 602' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.81 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.861 0.362 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -170.2 135.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.406 HG13 ' CE2' ' P' ' 830' ' ' TYR . 23.5 pt -71.76 177.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' P' ' 828' ' ' ILE . 0.2 OUTLIER -176.19 142.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.915 HD11 HG23 ' A' ' 681' ' ' ILE . 55.7 mt -141.16 71.76 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.5 p30 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.872 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -106.09 -11.37 16.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.521 0.201 . . . . 0.0 111.425 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.508 ' O ' ' NE2' ' A' ' 595' ' ' GLN . . . -138.37 -56.72 0.05 OUTLIER Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.996 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.5 tmm_? -112.65 143.75 43.31 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.516 -0.403 . . . . 0.0 111.415 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -123.59 -58.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 694' ' ' VAL . 9.9 tt -112.48 140.86 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.393 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 695' ' ' GLU . 38.0 m -113.1 122.0 46.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.269 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 625' ' ' ILE . 7.4 mt -107.83 108.96 20.38 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 2.1 pttp -119.53 98.46 50.07 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 35.3 Cg_exo -45.22 103.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.739 1.626 . . . . 0.0 108.918 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -73.94 160.47 81.76 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -175.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 82.0 Cg_exo -47.05 -30.21 9.76 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.715 2.943 . . . . 0.0 113.012 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.47 -17.82 63.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 109.677 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.558 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 38.7 t -95.22 149.22 21.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.936 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 587' ' ' ILE . 0.0 OUTLIER -55.73 -22.79 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 178.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.549 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.9 tt -113.34 122.22 67.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.627 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.5 OUTLIER -108.14 69.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 0.0 110.835 -179.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.769 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 34.5 mt-10 -127.93 170.97 12.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.173 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 35.8 t -131.23 116.43 17.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 112.028 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.733 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -103.91 139.73 38.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 5.1 mt-10 -118.02 131.35 56.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.868 HD12 HD22 ' A' ' 578' ' ' LEU . 89.9 mt -82.48 108.66 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 575' ' ' GLY . 0.7 OUTLIER -65.5 120.99 13.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.72 -28.8 1.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.842 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.32 -18.71 79.91 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.084 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.02 117.92 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.142 0.971 . . . . 0.0 111.768 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.7 t30 -140.45 122.6 9.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.553 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.9 Cg_endo -90.25 159.85 32.88 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.5 -1.041 . . . . 0.0 111.519 -0.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.613 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.4 t80 -92.04 116.36 28.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.538 ' CG ' HD12 ' A' ' 730' ' ' LEU . 27.0 m-85 -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.695 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.759 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.5 mp -128.31 147.43 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.898 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.56 -157.55 30.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.417 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.1 OUTLIER -87.61 -35.85 17.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.733 0.301 . . . . 0.0 111.506 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.6 OUTLIER -74.99 137.65 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.323 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -20.64 58.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.987 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -55.02 -31.53 61.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 98.5 m -73.22 132.08 42.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m120 -47.0 -29.71 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.079 0.466 . . . . 0.0 110.542 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.759 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.29 137.52 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.64 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 110.84 20.68 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.733 HD11 HD21 ' A' ' 592' ' ' LEU . 3.4 mm -138.3 110.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.176 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 3.2 mt-10 -85.99 104.92 16.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.448 0.642 . . . . 0.0 111.67 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.852 ' CB ' HD22 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -130.67 108.18 9.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.287 177.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -48.08 -34.9 10.37 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -78.05 -35.38 49.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.852 HD22 ' CB ' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.63 131.37 34.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.432 -178.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 8.5 t -57.24 166.33 1.17 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.49 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 1.0 OUTLIER -57.22 -34.92 69.06 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.295 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.0 t -125.96 58.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.949 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.821 ' CD2' HG23 ' A' ' 680' ' ' ILE . 13.9 t60 -49.89 -49.43 49.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.02 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 13.2 p -164.17 161.53 22.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 111.589 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 603' ' ' ILE . 53.9 p90 -143.53 147.85 35.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.589 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 603' ' ' ILE . 3.9 mp -101.93 130.68 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.9 t80 -122.54 134.17 54.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.773 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 647' ' ' ILE . 5.2 ttmt -98.19 136.44 38.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.204 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.81 159.01 41.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.894 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 643' ' ' GLY . 3.7 tpt85 -76.59 112.15 12.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.3 t60 -76.49 133.21 39.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.243 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -147.81 119.11 7.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.134 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.38 179.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -127.26 54.73 0.76 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.553 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 97.95 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.7 p -146.76 54.82 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 25.4 mtm -60.57 117.64 5.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.754 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.97 -69.51 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.796 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.66 144.24 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.5 m -111.54 98.41 40.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.18 -154.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.883 2.389 . . . . 0.0 112.096 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.883 ' HB1' HD13 ' A' ' 644' ' ' LEU . . . -86.17 68.9 10.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.196 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.48 23.65 11.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.219 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 629' ' ' ARG . . . -154.96 27.16 0.64 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.736 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.883 HD13 ' HB1' ' A' ' 641' ' ' ALA . 3.5 mp -111.78 -162.43 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 m-20 -108.08 147.06 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 112.412 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 0.4 OUTLIER -124.75 159.53 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.518 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.877 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 5.3 pt -111.49 122.37 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.451 0.643 . . . . 0.0 112.249 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 66.7 m95 -108.85 136.19 48.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.085 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.674 ' CE1' HD12 ' A' ' 678' ' ' ILE . 22.7 t80 -94.08 117.77 30.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.27 124.91 49.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 72.0 t60 -101.94 134.38 45.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.148 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 2.0 p -133.55 4.01 3.61 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.982 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -80.35 137.69 18.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.394 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 654' ' ' THR . 45.0 m -70.37 -11.94 61.25 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.755 -0.262 . . . . 0.0 111.393 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.612 ' O ' HG13 ' A' ' 656' ' ' VAL . 4.6 m-20 -87.39 3.46 46.95 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 53.56 128.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.283 0.564 . . . . 0.0 112.117 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.468 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 30.5 m -101.47 166.02 10.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.406 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 5.9 m-85 -130.68 120.19 23.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.333 . . . . 0.0 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -101.03 99.91 10.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 659' ' ' LEU . 20.4 t-20 60.4 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.924 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -134.17 1.0 3.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.73 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.483 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.6 m-80 -104.69 132.92 50.36 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 111.077 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.9 139.96 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.413 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 41.1 mmm -118.26 97.43 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.148 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.446 HG13 HG23 ' A' ' 668' ' ' THR . 49.3 pt -87.85 154.49 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.73 104.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.949 0.404 . . . . 0.0 111.478 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.08 38.59 2.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.446 HG23 HG13 ' A' ' 665' ' ' ILE . 1.1 p -116.26 162.29 17.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.546 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.494 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpm? -137.53 139.52 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.369 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -147.4 145.78 29.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.829 0.347 . . . . 0.0 111.779 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.65 137.83 55.89 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 694' ' ' VAL . 1.5 mt -110.54 99.39 8.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.192 0.52 . . . . 0.0 111.614 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 17.4 mp0 -80.45 147.32 30.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.473 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.657 ' HB3' HD12 ' A' ' 696' ' ' ILE . 13.5 p30 -48.17 112.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.305 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 94.53 36.0 5.76 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.3 117.15 28.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.891 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 109.54 21.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.725 HG22 HD13 ' A' ' 659' ' ' LEU . 21.6 pt -105.31 130.44 56.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.177 0.513 . . . . 0.0 112.066 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.43 116.63 29.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.446 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.821 HG23 ' CD2' ' A' ' 622' ' ' HIS . 9.0 mt -89.87 -34.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.295 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -154.93 131.53 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.803 -179.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -136.96 127.54 26.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.07 116.84 28.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.779 0.323 . . . . 0.0 110.325 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -67.36 -46.91 71.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -83.49 -40.49 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.84 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.4 -16.55 45.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.582 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.9 mttt 64.67 14.32 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.679 0.276 . . . . 0.0 110.91 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -78.36 105.23 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.568 ' O ' HD13 ' A' ' 587' ' ' ILE . 0.9 OUTLIER -124.88 128.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.912 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.823 HG22 HG22 ' A' ' 681' ' ' ILE . 0.5 OUTLIER -128.58 119.77 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.737 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -151.33 139.9 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.314 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.18 149.03 36.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.786 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.416 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -102.01 117.22 34.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.485 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.07 123.11 30.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.693 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.8 mt-10 -130.32 109.39 10.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 0.0 110.731 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 674' ' ' ASP . 11.2 mt -83.67 109.83 17.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.714 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -96.11 -46.51 6.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.946 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.35 140.31 46.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.527 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.54 101.44 9.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 700' ' ' THR . 8.0 t -69.23 61.47 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.179 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.28 45.95 81.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.806 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -106.49 151.19 25.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.579 0.228 . . . . 0.0 110.769 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 705' ' ' GLU . 0.0 OUTLIER -45.22 128.71 7.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.47 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 5.6 t30 43.33 -79.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.49 . . . . 0.0 111.031 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.681 ' N ' ' O ' ' A' ' 703' ' ' PHE . 13.3 pt-20 164.77 -48.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.686 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 159.04 73.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.997 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 709' ' ' MET . 1.0 OUTLIER -107.16 -3.02 20.31 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.225 -0.574 . . . . 0.0 111.793 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.432 ' N ' ' CG ' ' A' ' 673' ' ' GLN . . . 58.36 77.5 0.17 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.689 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.465 ' HE1' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -136.55 132.05 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.182 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 709' ' ' MET . 1.4 pt? 178.02 -174.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.64 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.81 -33.99 76.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 5.9 mt-10 -97.63 134.45 40.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.86 100.14 10.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.956 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.411 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 2.9 mmm-85 40.37 86.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.905 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.41 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 4.0 m -124.75 142.44 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 716' ' ' VAL . 13.9 p -93.3 125.04 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -94.74 172.29 8.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -102.48 157.88 16.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.6 156.41 18.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.3 p -126.1 -177.03 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.27 38.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -62.02 -50.93 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.549 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -65.44 -46.03 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -55.5 -32.95 63.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.55 -36.87 79.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 18.4 mt -59.08 -44.85 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.405 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.3 p -81.41 -16.66 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -32.66 74.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.74 -7.93 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.199 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 730' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.874 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.331 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.99 109.77 15.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.39 139.1 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.53 151.69 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.611 HD11 HG12 ' A' ' 681' ' ' ILE . 59.1 mt -147.46 144.13 28.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -95.5 -21.77 18.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.737 0.303 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 130.69 -37.28 2.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.501 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 6.5 tmm_? -112.95 143.85 43.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.625 0.25 . . . . 0.0 111.031 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.526 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.1 OUTLIER -124.35 -62.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.076 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -106.38 142.34 36.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 12.5 m -123.62 114.47 20.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.559 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.686 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.5 OUTLIER -103.89 108.21 19.43 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.26 100.65 52.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.6 Cg_exo -46.98 99.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.879 1.72 . . . . 0.0 109.722 176.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.33 84.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -176.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.423 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.2 Cg_endo -49.68 -25.32 11.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.642 2.894 . . . . 0.0 112.612 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 583' ' ' LEU . 22.5 m-20 -62.01 -28.03 69.28 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 7.5 t -95.38 154.1 17.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.645 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.494 HD11 ' OD1' ' A' ' 615' ' ' ASP . 2.0 pt -56.2 -12.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 0.0 111.074 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 613' ' ' ILE . 19.0 mt -108.92 123.33 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 111.783 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -108.24 54.75 0.65 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.156 0.503 . . . . 0.0 110.163 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.603 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.2 mm-40 -124.36 171.39 9.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.094 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.74 129.59 47.34 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.011 0.434 . . . . 0.0 111.262 179.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.35 140.77 46.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -124.24 116.87 23.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.73 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.76 HD12 HD22 ' A' ' 578' ' ' LEU . 89.5 mt -80.51 108.96 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.178 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.3 OUTLIER -64.57 120.48 12.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.085 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.526 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.62 -28.13 1.36 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 110.823 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.4 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -72.64 -21.25 79.7 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.867 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.412 HG11 ' CG ' ' A' ' 610' ' ' ASN . 52.9 t -101.0 118.07 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 118.015 0.908 . . . . 0.0 111.854 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 14.2 t30 -140.22 121.99 9.62 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.766 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.1 Cg_endo -89.7 159.78 35.53 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 124.465 -1.056 . . . . 0.0 111.599 -0.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.651 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.0 t80 -91.37 115.87 28.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.88 ' CG ' HD12 ' A' ' 730' ' ' LEU . 33.5 m-85 -92.26 138.11 31.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.891 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.718 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mp -127.27 146.05 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.553 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 165.03 -175.37 40.94 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.543 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.5 ttp85 -77.51 -6.79 54.83 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.741 -0.229 . . . . 0.0 111.456 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.0 129.36 45.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.847 0.355 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.37 -23.54 24.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -29.76 61.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.602 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 730' ' ' LEU . 8.9 m -74.73 134.43 41.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.765 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 26.5 m-80 -49.07 -26.79 2.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.702 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 592' ' ' LEU . 46.7 t -112.85 142.87 45.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.532 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.34 115.05 23.9 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 588' ' ' ILE . 28.5 mm -137.96 109.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.026 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 26.6 tt0 -89.01 103.85 16.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.798 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.803 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.7 OUTLIER -131.79 113.43 13.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.252 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -43.03 -35.67 1.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.771 0.319 . . . . 0.0 111.514 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.782 ' HG2' HD21 ' P' ' 831' ' ' LEU . 2.1 mpp_? -77.95 -36.31 49.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.112 HD12 HD12 ' A' ' 681' ' ' ILE . 0.3 OUTLIER -61.58 159.8 12.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.2 m -109.16 170.13 8.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -49.14 -45.48 43.78 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.27 0.557 . . . . 0.0 110.201 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.769 HG11 HG23 ' A' ' 727' ' ' VAL . 13.4 t -124.89 57.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.464 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.64 ' CE1' HD11 ' A' ' 681' ' ' ILE . 27.7 t60 -43.85 -47.48 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.747 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.9 p -166.76 156.34 11.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.445 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 603' ' ' ILE . 29.6 p90 -143.18 147.45 34.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.415 ' CD1' HD11 ' A' ' 603' ' ' ILE . 3.7 mp -102.19 130.24 52.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.04 0.448 . . . . 0.0 110.114 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.3 t80 -121.43 131.02 53.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.453 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 23.0 ttmt -97.71 136.78 37.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.536 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.68 159.72 39.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.445 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.624 ' HE ' ' HB2' ' A' ' 631' ' ' ALA . 0.9 OUTLIER -75.82 115.95 16.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.9 t60 -82.42 126.0 31.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.75 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.624 ' HB2' ' HE ' ' A' ' 629' ' ' ARG . . . -164.48 122.54 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.172 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.5 m -70.06 -178.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.07 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -65.51 -61.02 6.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -132.87 -173.52 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.375 . . . . 0.0 110.964 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.94 52.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.1 ttm -99.6 31.56 3.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -165.26 -50.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.617 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 43.4 mt-10 -90.29 144.75 25.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.626 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 17.4 t -107.07 92.36 7.67 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 638' ' ' GLU . 76.4 Cg_endo -85.55 -160.07 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.778 2.318 . . . . 0.0 111.965 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.741 ' HB3' ' HB2' ' A' ' 703' ' ' PHE . . . -95.3 26.71 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.257 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 60.86 -169.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 644' ' ' LEU . . . -86.27 91.13 1.7 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.733 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -105.3 -153.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.711 ' O ' HD13 ' A' ' 702' ' ' LEU . 3.9 m-20 -122.4 146.57 47.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.308 0.575 . . . . 0.0 112.471 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.418 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -126.74 160.14 31.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.076 HD13 HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -108.94 123.89 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.442 0.639 . . . . 0.0 112.463 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.85 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 90.0 m95 -106.19 125.68 51.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -90.63 117.53 29.36 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -102.53 139.24 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.236 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.498 ' CG ' ' OG ' ' A' ' 657' ' ' SER . 46.7 t60 -125.68 121.56 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.571 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.47 5.69 13.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.747 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.03 137.33 20.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.799 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 654' ' ' THR . 95.6 m -72.64 -10.61 60.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.411 ' OD1' ' HG ' ' P' ' 831' ' ' LEU . 63.8 m-20 -87.26 2.06 51.26 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 664' ' ' MET . 11.6 t 64.31 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.199 0.524 . . . . 0.0 112.076 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.498 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 5.3 p -120.76 160.72 22.77 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 658' ' ' TYR . 4.8 m-85 -137.48 120.07 16.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.278 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.625 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -94.46 105.19 17.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.01 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.44 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.579 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -134.99 0.42 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.698 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.455 ' HB3' HG23 ' A' ' 716' ' ' VAL . 7.5 m120 -97.77 141.21 31.05 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.831 0.348 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.912 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.0 ttp180 -88.94 139.08 30.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -135.83 110.97 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.205 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.456 ' HA ' HG13 ' A' ' 656' ' ' VAL . 18.8 pt -89.78 162.98 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.947 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -46.78 115.56 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.576 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.81 8.45 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.97 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.3 p -112.76 161.74 16.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 111.583 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.451 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -135.6 149.18 49.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.588 ' CD1' HD23 ' A' ' 659' ' ' LEU . 2.8 t80 -147.75 146.09 29.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.85 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.74 132.4 46.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.283 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.799 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.44 111.82 23.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.311 0.577 . . . . 0.0 111.421 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.514 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.8 mt-30 -104.83 136.01 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.559 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.609 ' HB2' HD12 ' A' ' 696' ' ' ILE . 12.3 t70 -37.0 118.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 111.022 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 89.26 36.52 7.52 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.85 118.13 31.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.4 ' HG3' ' HD2' ' A' ' 693' ' ' LYS . 21.8 mt-10 -96.0 109.08 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 649' ' ' TYR . 4.6 mt -105.65 130.03 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 112.004 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.63 116.15 27.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.418 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.495 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -83.8 -37.28 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.112 HD12 HD12 ' A' ' 618' ' ' LEU . 54.1 mt -154.92 131.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -136.49 127.17 27.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.74 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.655 ' CG ' HD22 ' P' ' 831' ' ' LEU . 0.8 OUTLIER -121.87 116.76 24.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.813 0.34 . . . . 0.0 110.374 179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -67.23 -46.8 72.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.798 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -83.17 -40.47 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.835 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.61 -14.5 59.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.443 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 64.94 14.07 9.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.634 0.254 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.4 OUTLIER -78.4 104.46 9.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.87 123.64 71.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.069 0.461 . . . . 0.0 111.74 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 587' ' ' ILE . 38.9 mm -125.4 153.11 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 175.84 128.61 1.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.121 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 592' ' ' LEU . 8.5 m-30 -112.82 144.49 42.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.709 0.29 . . . . 0.0 110.268 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.58 ' HB2' HD22 ' A' ' 583' ' ' LEU . 4.1 tttp -101.11 117.33 34.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.574 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.738 HG22 HD21 ' A' ' 578' ' ' LEU . 2.8 t -79.51 125.25 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -133.16 109.23 9.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 705' ' ' GLU . 50.1 mt -79.67 105.77 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.665 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -86.83 -43.96 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.15 141.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.516 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.6 p -113.62 100.09 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.404 0.621 . . . . 0.0 109.899 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 28.7 m -80.93 65.57 6.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.572 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 71.3 46.56 41.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.923 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -87.84 131.77 34.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.741 ' HB2' ' HB3' ' A' ' 641' ' ' ALA . 5.6 p90 -41.8 -34.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.457 0.646 . . . . 0.0 110.266 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -146.64 -61.09 0.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.392 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.813 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.6 pt-20 144.97 32.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.949 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 73.54 70.47 1.23 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.868 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.557 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.6 OUTLIER -106.5 -9.65 16.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.393 -0.474 . . . . 0.0 111.033 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 105.54 -120.8 6.58 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.924 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.622 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.3 OUTLIER 61.23 120.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 111.255 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 709' ' ' MET . 0.8 OUTLIER 178.25 164.24 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.66 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -55.72 -68.14 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -70.91 140.58 51.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.2 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -82.02 100.01 9.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.409 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 10.3 mmm-85 40.26 84.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.676 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.54 142.96 39.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.66 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.912 HG21 ' O ' ' A' ' 663' ' ' ARG . 39.6 t -77.88 122.27 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.69 161.58 14.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 136.77 42.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.612 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.31 150.16 24.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 67.3 p -110.54 -174.65 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.327 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.7 -30.31 43.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -50.23 74.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.518 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -45.17 76.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.352 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.519 ' O ' HG12 ' A' ' 727' ' ' VAL . 44.9 tttp -57.68 -32.93 67.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.598 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -66.73 -36.82 83.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.595 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.68 -44.25 85.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.769 HG23 HG11 ' A' ' 621' ' ' VAL . 10.8 p -76.16 -14.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.178 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -69.81 -39.4 76.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.564 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -93.79 11.24 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.88 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.659 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -138.24 132.23 31.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.823 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 42.1 mt 65.44 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.98 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' P' ' 830' ' ' TYR . 0.0 OUTLIER -179.98 79.84 0.01 OUTLIER 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.412 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.782 HD21 ' HG2' ' A' ' 617' ' ' ARG . 14.5 mt -71.03 132.98 45.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.724 0.297 . . . . 0.0 110.699 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.946 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -83.94 -22.15 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.691 0.281 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 141.29 -42.4 1.17 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.513 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 8.4 ttm105 -113.61 143.39 44.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.79 0.329 . . . . 0.0 111.26 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.794 ' CZ ' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -118.51 -57.89 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.331 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.809 HD11 ' CG1' ' A' ' 694' ' ' VAL . 5.1 tp -113.09 142.08 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.4 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 2.8 m -120.04 114.76 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.904 HD21 HG23 ' A' ' 694' ' ' VAL . 5.8 mt -102.0 108.36 19.78 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 27.4 mtmt -114.16 99.27 50.45 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 34.7 Cg_exo -47.81 98.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 121.655 1.57 . . . . 0.0 109.463 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.822 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -75.36 158.1 84.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.79 -26.53 13.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.427 2.752 . . . . 0.0 112.573 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.822 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.8 m-20 -62.76 -28.12 69.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 93.2 p -95.69 153.21 17.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.839 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.719 ' CG2' HD13 ' A' ' 690' ' ' ILE . 7.9 tt -53.15 -15.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.322 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.613 HG13 HG23 ' A' ' 587' ' ' ILE . 71.2 mt -109.03 131.7 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.936 0.398 . . . . 0.0 111.795 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -116.93 54.62 0.86 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.254 0.549 . . . . 0.0 110.65 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.656 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 7.6 mt-10 -124.11 172.07 9.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.683 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -127.69 128.39 45.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.177 0.513 . . . . 0.0 111.221 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -112.41 139.74 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.788 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.04 113.22 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.544 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 625' ' ' ILE . 76.4 mt -77.29 109.21 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.1 OUTLIER -67.34 118.13 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.022 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.27 -27.93 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.053 0.454 . . . . 0.0 110.822 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -70.85 -20.63 77.75 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.186 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.568 HG11 ' ND2' ' A' ' 610' ' ' ASN . 41.2 t -100.68 118.32 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 117.552 0.676 . . . . 0.0 111.618 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.4 t30 -139.9 121.8 9.82 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 49.5 Cg_endo -89.48 160.49 36.96 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 124.535 -1.027 . . . . 0.0 111.492 -0.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.677 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.6 t80 -91.09 115.42 28.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.745 ' CG ' HD12 ' A' ' 730' ' ' LEU . 26.0 m-85 -91.98 137.52 32.29 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.027 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.771 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -124.84 144.83 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.39 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 162.41 -173.7 38.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.298 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -68.11 -46.8 69.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.853 0.359 . . . . 0.0 111.431 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -61.72 129.23 40.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.37 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -58.06 -18.36 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.762 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.63 -30.64 67.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 110.249 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.568 ' SG ' HG22 ' A' ' 621' ' ' VAL . 94.8 m -69.95 131.55 44.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.598 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 35.3 m120 -43.99 -32.43 1.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.322 0.582 . . . . 0.0 110.453 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.771 ' SG ' HG23 ' A' ' 603' ' ' ILE . 41.5 t -109.46 142.17 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.196 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.503 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -111.3 105.0 13.52 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.8 HD11 HD21 ' A' ' 592' ' ' LEU . 38.3 mm -139.26 109.5 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.467 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.36 106.23 16.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 112.256 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.587 ' H ' HD11 ' A' ' 618' ' ' LEU . 4.7 t0 -129.88 107.69 9.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.571 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -39.44 -28.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 9.2 mmt180 -70.82 -41.77 71.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.587 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -89.3 158.74 17.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.6 m -76.71 164.61 25.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.553 ' HG2' HG23 ' A' ' 621' ' ' VAL . 0.0 OUTLIER -52.41 -27.07 14.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.132 0.491 . . . . 0.0 110.463 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.568 HG22 ' SG ' ' A' ' 609' ' ' CYS . 45.2 t -131.01 62.92 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' HG23 ' A' ' 680' ' ' ILE . 26.1 t60 -50.03 -48.66 52.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.211 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.84 162.22 26.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 603' ' ' ILE . 41.5 p90 -143.61 148.39 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 594' ' ' ILE . 81.5 mt -102.12 124.3 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.046 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.9 t80 -113.87 133.55 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.73 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 28.6 ttmt -97.88 136.52 38.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.317 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.69 158.59 44.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.827 -178.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.13 115.97 17.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.8 t60 -61.06 131.36 50.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.418 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.511 ' C ' HG13 ' A' ' 632' ' ' VAL . . . -60.27 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.889 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 631' ' ' ALA . 0.9 OUTLIER 58.77 125.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 111.394 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -139.57 -87.54 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -62.79 116.18 5.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.11 162.68 27.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.769 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 115.55 27.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 50.2 t80 63.06 -80.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.54 126.24 30.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.85 0.357 . . . . 0.0 110.714 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 3.4 p -99.6 107.83 47.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.62 -149.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.542 2.161 . . . . 0.0 112.055 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 644' ' ' LEU . . . -47.89 -25.08 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 64.26 -176.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.033 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -90.32 72.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.104 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.4 mp -115.75 -157.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.748 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.3 m-20 -117.56 146.72 43.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.08 0.467 . . . . 0.0 111.96 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -133.03 157.16 45.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.781 ' CD1' HD13 ' A' ' 578' ' ' LEU . 1.1 pt -106.8 119.23 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.543 0.687 . . . . 0.0 111.769 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.882 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.9 m95 -100.61 132.13 46.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.476 ' CB ' HD21 ' A' ' 672' ' ' LEU . 31.2 t80 -90.36 117.24 28.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -103.5 121.67 43.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.559 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.419 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 28.9 t60 -102.23 128.74 48.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 7.4 p -125.11 2.43 7.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.423 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.05 150.21 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.108 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 72.3 m -82.21 -18.97 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 111.518 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 656' ' ' VAL . 15.0 m-20 -82.56 3.35 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.79 137.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.644 0.735 . . . . 0.0 112.238 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 58.2 m -107.93 165.91 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.423 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 120.59 32.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 111.149 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.72 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -105.65 100.34 9.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.846 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 1.9 m120 60.76 -82.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.87 6.19 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.652 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 6.1 m120 -110.27 138.45 46.64 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -74.74 138.34 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.472 ' O ' HG23 ' A' ' 656' ' ' VAL . 45.7 mmm -117.68 88.01 2.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.579 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 668' ' ' THR . 48.5 pt -86.91 164.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 22.6 tt0 -54.92 105.53 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.34 40.52 2.39 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.409 HG21 HG12 ' A' ' 665' ' ' ILE . 2.6 p -124.45 162.39 24.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 6.3 ttpm? -138.07 144.93 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.4 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.491 ' CD2' ' HG ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -147.64 145.09 28.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.8 0.334 . . . . 0.0 111.758 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.882 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.7 136.61 53.16 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.217 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.579 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -107.1 112.84 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.235 0.541 . . . . 0.0 111.869 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 25.5 mt-30 -104.13 137.95 41.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.894 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.695 ' HB2' HD12 ' A' ' 696' ' ' ILE . 39.7 t0 -39.11 123.11 1.31 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.936 0.398 . . . . 0.0 111.152 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 88.91 40.6 6.17 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.432 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 1.6 t0 -93.51 113.18 25.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.979 0.418 . . . . 0.0 111.434 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.34 111.38 23.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.865 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.72 HG12 HD13 ' A' ' 659' ' ' LEU . 9.2 mt -112.41 137.16 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 689' ' ' VAL . 8.3 tptt -98.19 115.7 28.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.95 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.7 mt -82.8 -38.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.573 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 618' ' ' LEU . 6.7 mt -155.83 131.72 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.019 0.438 . . . . 0.0 111.873 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -136.24 124.75 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.669 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.18 117.88 29.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.642 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -66.36 -46.52 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.591 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -83.28 -40.36 19.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.351 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.06 -17.94 56.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.69 16.09 9.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -82.75 105.2 13.58 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 587' ' ' ILE . 1.1 p -122.83 124.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.267 0.555 . . . . 0.0 112.147 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 587' ' ' ILE . 6.6 mm -114.29 150.17 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.553 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.71 121.48 0.87 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.641 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.616 ' HB2' HD22 ' A' ' 580' ' ' LEU . 6.9 m-30 -113.78 143.18 45.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.746 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.5 tttt -101.78 117.81 35.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.904 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.69 123.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.738 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -133.67 108.99 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.287 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 674' ' ' ASP . 87.0 mt -72.93 105.76 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.76 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.75 -47.57 10.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.139 0.495 . . . . 0.0 109.949 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -111.49 141.91 44.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 72.6 p -113.63 100.09 8.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.141 0.496 . . . . 0.0 109.875 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -80.31 61.51 4.12 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.696 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 60.3 54.81 34.16 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.109 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.794 HD11 ' CZ ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -87.28 148.38 25.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.392 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.72 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -39.76 -32.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.989 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.454 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -178.95 33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.502 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER 69.28 -64.08 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 153.96 69.26 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -104.37 -9.52 18.42 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.794 -0.239 . . . . 0.0 111.446 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 103.46 60.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.263 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.81 136.12 6.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -161.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.082 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 78.46 -60.69 0.39 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.746 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -110.68 115.62 29.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.758 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.618 ' O ' HG13 ' A' ' 715' ' ' VAL . 1.2 mt-30 -82.69 100.05 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 713' ' ' GLN . 1.1 mmm-85 16.02 82.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.869 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 713' ' ' GLN . 5.8 m -123.98 141.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.181 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 716' ' ' VAL . 14.6 p -90.29 122.43 41.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.484 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.5 172.26 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -103.16 142.22 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -88.98 160.13 17.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.905 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.14 -173.49 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.74 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.81 -49.19 77.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.467 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.722 ' HA ' HD12 ' A' ' 726' ' ' LEU . 8.5 mp0 -69.18 -49.84 53.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.574 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 727' ' ' VAL . 24.7 mtmt -57.26 -32.81 66.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.735 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 723' ' ' GLU . 6.9 mt -57.81 -44.24 86.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 724' ' ' LYS . 11.8 p -75.86 -24.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.27 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -57.26 -41.14 79.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -74.1 -15.4 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.274 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.745 HD12 ' CG ' ' A' ' 602' ' ' PHE . 7.9 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.04 175.73 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 16.1 pt -67.98 176.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.657 ' O ' HD23 ' P' ' 831' ' ' LEU . 31.7 p90 -175.55 143.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.657 HD23 ' O ' ' P' ' 830' ' ' TYR . 17.8 mt -131.96 151.76 51.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.919 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.666 -0.174 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -93.78 -22.33 18.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 111.12 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 152.66 -23.48 0.83 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.434 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.2 tmm_? -105.93 140.19 39.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -129.16 -61.15 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.585 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 6.4 tt -106.56 141.36 37.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.181 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.882 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.5 m -119.48 119.67 34.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.362 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.873 HD11 HD11 ' A' ' 625' ' ' ILE . 9.1 mt -104.79 108.29 19.69 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 98.68 44.16 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.8 Cg_exo -48.98 101.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.649 1.566 . . . . 0.0 109.15 176.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.02 158.26 85.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.456 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.1 Cg_endo -49.94 -28.64 19.05 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.55 2.834 . . . . 0.0 112.594 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.48 -18.14 63.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 109.725 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.7 t -96.8 153.76 17.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.679 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.858 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.7 pt -55.62 -20.29 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.847 ' CD1' HG23 ' A' ' 613' ' ' ILE . 59.5 mt -110.27 118.66 57.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.382 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -106.74 57.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.394 0.616 . . . . 0.0 110.258 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.628 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -124.71 172.63 9.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.892 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.43 127.68 45.81 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.315 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.869 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.8 OUTLIER -113.11 147.22 37.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.083 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 7.4 mt-10 -125.35 125.56 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.872 HD11 HD12 ' A' ' 625' ' ' ILE . 68.2 mt -86.1 109.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.0 mp0 -64.18 118.06 8.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.41 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.521 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.54 -29.79 1.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.583 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.27 -22.63 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.48 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 118.93 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.773 0.787 . . . . 0.0 111.726 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 17.1 t30 -139.56 121.82 10.12 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.781 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 45.9 Cg_endo -89.6 160.28 36.28 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.563 -1.015 . . . . 0.0 111.691 -0.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.631 ' CD2' HG23 ' A' ' 594' ' ' ILE . 3.9 t80 -91.52 116.19 28.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.744 ' CG ' HD12 ' A' ' 730' ' ' LEU . 25.4 m-85 -92.36 137.94 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.15 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.74 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mp -126.47 145.89 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.423 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.42 -176.28 41.66 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.481 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 5.8 ttp85 -78.52 -7.28 57.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.33 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.78 133.25 43.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -23.71 49.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.608 ' OD1' HD21 ' A' ' 730' ' ' LEU . 6.8 p30 -57.83 -25.4 60.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 55.2 m -78.75 132.06 36.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.764 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.4 m120 -46.1 -31.35 2.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.198 0.523 . . . . 0.0 110.413 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.869 ' SG ' HD13 ' A' ' 592' ' ' LEU . 40.5 t -108.53 142.76 38.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.6 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 115.59 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -138.02 109.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.284 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 19.2 tt0 -87.09 103.41 15.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.6 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -132.11 112.81 12.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.44 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -42.98 -33.69 0.85 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.761 0.315 . . . . 0.0 111.422 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.543 ' HB2' HD13 ' A' ' 681' ' ' ILE . 31.5 mmt180 -77.55 -39.98 44.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.071 HD12 HD12 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -60.21 159.11 10.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.905 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 70.7 m -111.09 168.81 9.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.537 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.47 -43.64 24.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.228 0.537 . . . . 0.0 110.031 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.541 HG11 HG23 ' A' ' 727' ' ' VAL . 39.1 t -125.17 61.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.467 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.511 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 36.3 t60 -49.78 -48.3 50.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.791 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -167.52 157.32 10.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 111.363 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 41.2 p90 -143.14 147.37 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.873 HD11 HD11 ' A' ' 580' ' ' LEU . 34.7 mt -102.13 128.33 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.086 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.612 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -119.78 131.3 55.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 577' ' ' PHE . 20.2 ttmt -97.84 136.36 38.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.107 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.09 159.28 41.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.879 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.0 tpt180 -76.28 116.3 16.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.633 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 644' ' ' LEU . 8.4 t60 -61.47 132.39 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.209 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -69.08 -165.61 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.941 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.9 p -156.39 159.61 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.983 0.42 . . . . 0.0 111.082 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -145.66 -139.44 3.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.432 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.69 135.46 57.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 25.1 p -129.16 49.28 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.989 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -62.42 102.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.11 -62.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.83 137.61 40.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.785 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 110.37 40.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.56 -162.94 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.391 2.06 . . . . 0.0 112.027 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.473 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -46.75 -28.55 1.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.563 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.4 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 175.73 60.32 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.671 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.8 mp -106.14 -159.71 0.71 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.8 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -118.27 146.77 44.05 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.44 160.41 29.5 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.782 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.65 121.98 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.46 0.647 . . . . 0.0 112.313 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.96 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.8 m95 -105.7 125.75 51.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.632 ' CE2' HG21 ' A' ' 678' ' ' ILE . 12.0 t80 -89.71 116.49 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 624' ' ' PHE . 16.3 m -102.95 137.13 41.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.403 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 41.4 t60 -116.87 122.97 45.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.787 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.8 OUTLIER -116.35 7.92 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.272 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.78 145.18 19.94 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.832 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 4.4 m -75.29 -9.55 58.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.558 ' O ' HG13 ' A' ' 656' ' ' VAL . 36.2 m-20 -87.14 2.09 50.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.59 127.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.395 0.617 . . . . 0.0 112.158 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.403 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 16.2 p -97.73 165.55 11.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.208 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -128.52 119.7 25.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -95.22 102.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 63.42 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.11 -2.08 1.5 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.51 141.75 30.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.909 0.385 . . . . 0.0 111.222 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.1 ttp85 -85.16 141.61 30.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.747 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.5 mtp -131.11 124.74 31.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.522 HG12 HG21 ' A' ' 668' ' ' THR . 22.6 pt -95.08 156.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.779 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 652' ' ' THR . 32.9 tt0 -50.25 122.42 6.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 97.14 25.75 10.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.522 HG21 HG12 ' A' ' 665' ' ' ILE . 50.5 p -122.43 156.42 34.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 4.6 pttm -123.94 158.17 32.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.968 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.706 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.1 OUTLIER -147.29 145.92 29.55 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.96 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -66.88 130.53 43.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.624 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.743 ' CB ' HD12 ' A' ' 647' ' ' ILE . 1.0 OUTLIER -110.44 114.87 28.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.11 0.481 . . . . 0.0 111.665 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.543 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 14.9 mt-30 -99.15 135.29 40.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.849 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.3 t70 -40.96 109.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 110.584 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 101.11 34.55 4.52 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.424 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -93.45 115.17 27.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.469 -0.365 . . . . 0.0 111.087 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -96.25 108.51 21.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.838 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.632 HG21 ' CE2' ' A' ' 649' ' ' TYR . 7.1 mt -106.51 136.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 115.72 28.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.222 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.573 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -82.12 -36.16 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.197 -178.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.071 HD12 HD12 ' A' ' 618' ' ' LEU . 41.4 mt -154.9 131.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -136.57 124.77 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.123 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.61 ' OD1' HD22 ' P' ' 831' ' ' LEU . 0.7 OUTLIER -124.57 117.23 23.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.481 179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -66.8 -46.56 74.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.808 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -77.83 -40.37 40.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.602 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.4 -13.73 51.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.543 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp 61.82 17.77 9.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.64 104.96 9.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.3 p -117.54 121.83 68.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 111.695 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.5 mm -124.45 119.11 55.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.503 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -147.83 129.73 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.459 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 12.8 m-30 -113.18 142.82 45.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 110.255 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.592 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.27 116.91 33.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.332 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.88 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.73 123.97 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.73 110.22 11.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.0 110.868 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 705' ' ' GLU . 64.0 mt -81.46 105.64 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.788 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.08 -43.69 9.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.01 141.98 42.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -112.89 100.16 8.44 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.473 0.654 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 596' ' ' GLN . 0.6 OUTLIER -87.24 53.97 3.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.15 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 93.0 34.94 6.54 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.628 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -83.84 132.02 34.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.671 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.0 p90 -43.31 -33.32 0.97 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.515 0.674 . . . . 0.0 110.258 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.543 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -149.86 -55.8 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.124 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.81 ' O ' HD12 ' A' ' 696' ' ' ILE . 10.4 pt-20 141.36 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.886 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 67.24 74.17 0.59 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.257 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.543 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.24 -10.04 17.31 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 122.413 -0.463 . . . . 0.0 112.071 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 52.12 90.62 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.202 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.1 ptp -42.0 134.25 2.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.442 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 63.99 -168.41 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.746 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -96.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.641 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -114.84 97.95 6.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.864 0.364 . . . . 0.0 110.618 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.61 100.54 7.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.706 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 166.69 131.21 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.245 0.545 . . . . 0.0 110.194 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.0 158.06 27.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.486 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 663' ' ' ARG . 51.9 t -77.42 128.45 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.069 0.462 . . . . 0.0 111.4 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.403 ' H ' HD12 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -113.74 164.65 13.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.348 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.52 142.95 27.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 111.011 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.95 158.66 36.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.0 p -118.91 -178.41 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.978 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.59 -29.06 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.113 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.98 -49.96 63.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -50.71 67.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.72 -32.89 63.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.36 -36.88 84.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.07 -44.2 94.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.541 HG23 HG11 ' A' ' 621' ' ' VAL . 11.2 p -79.15 -29.26 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.87 -30.61 61.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -85.51 -24.06 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.744 HD12 ' CG ' ' A' ' 602' ' ' PHE . 8.7 tt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.055 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.731 0.3 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.26 -179.08 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 12.6 pt -112.02 71.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.807 ' O ' HD23 ' P' ' 831' ' ' LEU . 1.3 p90 -171.56 141.26 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.807 HD23 ' O ' ' P' ' 830' ' ' TYR . 12.8 mt -137.14 138.7 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.851 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -96.6 -10.67 26.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.622 0.248 . . . . 0.0 111.336 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.581 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 147.66 -49.0 0.62 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.215 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.406 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 22.9 ttp-105 -111.82 143.11 43.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.052 0.453 . . . . 0.0 111.524 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.505 ' CB ' ' HB3' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -125.69 -57.81 1.43 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.09 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -110.26 137.93 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.084 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.739 ' N ' HD23 ' A' ' 578' ' ' LEU . 7.4 m -118.55 114.18 22.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.678 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.4 OUTLIER -103.92 108.06 19.22 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 16.3 ptpt -117.09 100.54 53.29 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 48.5 Cg_exo -46.08 104.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.87 1.714 . . . . 0.0 109.62 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.12 160.29 81.95 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.547 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 5.6 Cg_endo -48.17 -31.18 16.09 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.587 2.858 . . . . 0.0 112.495 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -63.73 -16.1 60.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.156 0.503 . . . . 0.0 109.726 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.603 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 9.1 t -94.18 145.0 25.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.601 HD13 ' CZ ' ' A' ' 688' ' ' PHE . 3.5 pt -52.43 -24.26 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 110.178 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.647 HG21 HD12 ' A' ' 613' ' ' ILE . 7.3 tt -112.99 118.97 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.983 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.547 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.4 OUTLIER -100.69 71.16 1.47 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.331 0.586 . . . . 0.0 110.321 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 50.6 mt-10 -126.05 171.9 10.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.127 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.21 130.2 47.61 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 121.138 0.494 . . . . 0.0 110.962 178.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.757 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.44 140.03 47.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.936 179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.406 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.12 112.56 17.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 578' ' ' LEU . 89.7 mt -81.09 108.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 110.03 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.9 mp0 -66.87 123.63 20.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.118 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.73 -26.71 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 110.819 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -75.68 -20.39 78.28 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.041 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 44.3 t -99.45 118.02 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 117.993 0.897 . . . . 0.0 111.776 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.0 t30 -140.23 122.49 9.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.583 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 42.5 Cg_endo -90.36 160.15 32.45 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.576 -1.01 . . . . 0.0 111.679 -0.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.1 t80 -92.58 117.48 30.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 730' ' ' LEU . 19.4 m-85 -92.51 137.48 32.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.262 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.822 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.3 mp -121.93 143.61 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.585 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 167.33 -165.09 38.39 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.949 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.21 -17.27 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.131 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' CA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -80.28 131.53 35.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.824 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.5 -23.85 11.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.001 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -59.84 -27.04 66.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 9.7 m -76.0 129.36 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 30.8 m120 -46.57 -32.47 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.231 0.539 . . . . 0.0 110.225 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.822 ' SG ' HG23 ' A' ' 603' ' ' ILE . 13.2 t -107.47 135.24 49.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.315 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.98 111.94 22.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 588' ' ' ILE . 17.5 mm -137.78 110.14 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.974 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -81.57 102.85 10.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.066 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.816 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.8 OUTLIER -132.84 109.13 9.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.42 178.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -44.58 -52.88 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.989 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -60.64 -19.76 58.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.897 0.379 . . . . 0.0 110.928 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.008 HD12 HD12 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -76.2 160.66 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.575 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.456 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 19.6 t -111.22 151.96 27.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.411 ' CA ' ' HB2' ' A' ' 606' ' ' SER . 7.7 mpt_? -39.0 -38.6 0.46 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 110.675 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.539 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.9 t -128.67 60.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.418 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' ' HB ' ' A' ' 680' ' ' ILE . 21.7 t60 -50.4 -48.81 55.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.077 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.553 ' SG ' HG21 ' A' ' 680' ' ' ILE . 22.8 p -165.64 161.11 18.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.096 0.474 . . . . 0.0 111.688 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 1.6 p90 -143.83 144.95 32.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.629 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.649 HD13 HD11 ' A' ' 580' ' ' LEU . 2.4 mp -101.97 128.87 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.1 t80 -119.43 134.04 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 6.7 ttpt -97.86 136.47 38.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.223 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.2 OUTLIER -135.21 159.88 40.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.473 -178.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.551 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 3.0 tpt85 -75.72 112.46 12.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.378 0.609 . . . . 0.0 110.371 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.8 t60 -69.6 126.5 29.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.049 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.551 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -122.81 158.58 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.142 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.775 HG11 ' HB2' ' A' ' 640' ' ' PRO . 10.4 m -118.69 148.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.171 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.01 76.32 2.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 4.7 mttm 63.27 144.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.343 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 88.4 p -124.1 179.37 4.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.001 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 6.0 ptp -170.79 118.73 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.26 -66.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 640' ' ' PRO . 15.2 mp0 -79.33 144.41 34.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.509 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.39 105.48 29.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.132 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.775 ' HB2' HG11 ' A' ' 632' ' ' VAL . 8.4 Cg_exo -71.73 -155.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.742 2.295 . . . . 0.0 112.0 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 703' ' ' PHE . . . -56.72 -22.27 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 72.04 -78.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 629' ' ' ARG . . . -176.34 65.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.338 -0.935 . . . . 0.0 113.179 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.2 mp -107.05 -161.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.828 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.1 m-20 -115.63 146.85 41.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.237 0.541 . . . . 0.0 112.39 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.417 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.6 m-20 -129.95 160.55 33.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.798 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -107.54 125.61 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.494 0.664 . . . . 0.0 112.461 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.968 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.5 m95 -108.93 128.05 54.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.607 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.441 ' OH ' HG22 ' A' ' 680' ' ' ILE . 35.1 t80 -90.47 119.4 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.642 0.258 . . . . 0.0 110.325 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 28.2 m -107.59 128.38 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.215 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.407 ' HA ' ' CB ' ' A' ' 623' ' ' CYS . 20.5 t60 -108.81 125.3 51.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.47 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.2 p -118.62 4.41 11.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.613 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.01 150.54 26.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.152 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 654' ' ' THR . 76.1 m -82.4 -10.97 58.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.553 0.216 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m120 -84.65 2.89 39.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 50.67 139.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.64 0.733 . . . . 0.0 112.353 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 10.1 t -112.67 166.16 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.55 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -130.57 120.2 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.016 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.677 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -102.63 103.25 13.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.438 ' N ' HD12 ' A' ' 659' ' ' LEU . 29.6 t-20 62.53 -77.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.784 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.7 m-80 -139.89 -2.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -100.43 141.67 32.96 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 120.943 0.401 . . . . 0.0 111.406 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.618 ' O ' HG21 ' A' ' 716' ' ' VAL . 20.7 ttm180 -75.29 141.51 43.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.057 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.53 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 12.1 mmm -125.68 89.3 3.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.499 HG12 HG21 ' A' ' 668' ' ' THR . 30.0 pt -86.81 164.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.996 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 652' ' ' THR . 20.7 tt0 -50.65 117.77 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.454 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 93.22 30.26 9.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.789 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.499 HG21 HG12 ' A' ' 665' ' ' ILE . 23.8 p -114.01 162.18 16.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.5 ttpt -134.93 149.43 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.483 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 716' ' ' VAL . 0.7 OUTLIER -147.62 143.83 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.968 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -75.89 129.76 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.682 ' N ' HD12 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -99.87 143.79 29.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.329 0.585 . . . . 0.0 111.938 -179.426 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.55 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 1.2 mt-30 -130.34 136.17 48.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 696' ' ' ILE . 15.0 t70 -40.27 118.55 0.93 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.967 0.413 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 92.55 37.42 5.85 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.448 ' OD1' HD11 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -94.83 117.66 30.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 111.167 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.06 108.71 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.677 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -108.95 133.84 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -109.42 116.54 32.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.095 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.66 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 1.9 pt -89.51 -21.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.008 HD12 HD12 ' A' ' 618' ' ' LEU . 41.1 mt -154.27 130.1 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.579 . . . . 0.0 111.674 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -137.71 127.31 25.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.57 116.76 24.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.552 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -67.56 -47.62 69.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.708 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.1 -40.48 18.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.472 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -13.4 60.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.419 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.56 18.74 8.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.813 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 1.8 t80 -85.77 104.63 15.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.8 OUTLIER -122.13 121.59 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.272 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.657 HD13 ' CG ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -128.44 128.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.95 135.92 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.466 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -114.28 147.43 39.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.37 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.4 tttt -101.53 117.19 34.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.529 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 3.6 t -78.79 123.55 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.665 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.28 109.34 9.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 705' ' ' GLU . 42.9 mt -80.86 105.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.818 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.24 -43.67 10.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.115 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.199 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.3 p -112.73 100.22 8.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.576 0.703 . . . . 0.0 109.789 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.2 m -84.65 59.29 5.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 83.99 40.13 8.91 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.437 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.8 OUTLIER -86.67 132.66 33.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.533 0.206 . . . . 0.0 110.619 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -42.92 -33.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.342 0.591 . . . . 0.0 110.606 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -148.39 -58.79 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.808 ' O ' HD12 ' A' ' 696' ' ' ILE . 5.9 pt-20 146.92 28.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.146 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 73.48 68.71 1.52 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.973 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.529 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.8 OUTLIER -105.67 -11.11 16.45 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.303 -0.527 . . . . 0.0 111.477 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.55 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 40.09 31.48 0.32 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.418 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 712' ' ' GLU . 0.0 OUTLIER 62.57 93.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.764 0.316 . . . . 0.0 111.261 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 710' ' ' LEU . 1.8 pp 29.51 66.88 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 46.81 70.47 0.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.732 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 709' ' ' MET . 3.6 tt0 -114.39 142.16 46.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -80.08 135.42 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.565 ' NE ' ' CE2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -100.3 -148.66 0.36 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.081 0.467 . . . . 0.0 110.716 -178.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.48 142.72 41.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.413 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.62 HG22 ' CE1' ' A' ' 670' ' ' PHE . 15.8 t -84.11 113.73 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.154 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 669' ' ' LYS . 0.3 OUTLIER -90.72 169.65 10.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.9 140.18 37.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.69 155.39 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 32.1 p -125.64 -176.16 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.86 -33.43 56.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -51.3 70.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.454 ' HA ' HD12 ' A' ' 726' ' ' LEU . 2.7 mp0 -63.91 -48.12 77.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -58.27 -32.97 68.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -64.85 -37.01 86.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.031 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 723' ' ' GLU . 11.2 mt -62.91 -44.1 97.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.539 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.4 p -75.76 -28.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -33.17 52.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -98.68 26.23 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.485 HD12 ' CG ' ' A' ' 602' ' ' PHE . 6.2 tt . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.833 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.342 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.12 167.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' P' ' 830' ' ' TYR . 26.8 mt -111.24 133.89 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.214 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.445 ' CE2' ' HB ' ' P' ' 828' ' ' ILE . 0.1 OUTLIER 178.68 67.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.991 HD11 HG23 ' A' ' 681' ' ' ILE . 20.6 mt -76.55 83.16 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.865 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -21.09 37.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.689 0.28 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 145.41 -43.78 0.91 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.535 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 11.6 ttm180 -113.46 143.82 43.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.706 0.288 . . . . 0.0 111.521 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.883 ' CE2' HD13 ' A' ' 702' ' ' LEU . 2.3 t80 -119.97 -55.29 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.4 tp -113.34 142.43 45.87 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 695' ' ' GLU . 6.1 m -122.51 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 625' ' ' ILE . 4.7 mp -106.27 108.86 20.59 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.31 100.93 51.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 46.2 Cg_exo -45.94 99.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.98 1.787 . . . . 0.0 110.006 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.69 158.2 85.11 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -48.84 -25.29 8.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.403 2.735 . . . . 0.0 112.921 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.858 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.4 OUTLIER -61.83 -27.27 68.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.508 ' OG ' HD13 ' A' ' 690' ' ' ILE . 8.7 t -95.73 154.11 17.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.892 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.679 HD13 ' CE1' ' A' ' 688' ' ' PHE . 2.6 pt -57.11 -12.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.69 0.281 . . . . 0.0 110.962 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.646 ' CD1' HG23 ' A' ' 613' ' ' ILE . 71.2 mt -110.27 123.0 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.746 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.16 57.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.197 0.522 . . . . 0.0 110.028 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 43.3 mt-10 -124.62 171.75 9.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.226 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.02 130.1 50.49 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 178.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.748 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.3 OUTLIER -112.28 139.45 47.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.037 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 0.9 OUTLIER -124.17 112.99 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.659 0.266 . . . . 0.0 111.644 -179.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.011 HD11 HD12 ' A' ' 625' ' ' ILE . 38.0 mt -77.22 109.76 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.968 0.413 . . . . 0.0 110.705 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -67.71 114.66 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.76 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.19 -28.53 0.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.184 0.516 . . . . 0.0 110.809 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.427 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.83 -25.2 74.24 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.536 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.903 HG11 ' OD1' ' A' ' 610' ' ' ASN . 66.6 t -101.2 119.27 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 117.813 0.807 . . . . 0.0 111.61 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 18.5 t30 -139.07 122.91 11.09 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.786 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 47.3 Cg_endo -89.83 160.51 35.24 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 124.518 -1.034 . . . . 0.0 111.863 0.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 610' ' ' ASN . 3.7 t80 -91.38 114.96 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.535 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.0 m-85 -92.12 138.19 31.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.168 -177.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.1 145.77 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.83 -173.27 38.16 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.383 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.499 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.35 -53.48 29.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.656 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.6 129.82 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.292 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.39 -18.96 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -53.66 -30.02 41.25 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 30.4 m -73.55 134.45 43.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.903 ' OD1' HG11 ' A' ' 598' ' ' VAL . 2.3 m-80 -48.66 -27.36 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.973 0.415 . . . . 0.0 110.388 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.775 ' SG ' HG23 ' A' ' 603' ' ' ILE . 42.0 t -113.37 142.08 46.29 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -110.52 105.61 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.5 mm -138.52 109.91 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.161 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -103.69 106.7 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.489 0.662 . . . . 0.0 112.589 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.697 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.6 t0 -129.93 107.71 9.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.559 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -39.3 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.477 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 3.8 mmp_? -70.31 -41.42 73.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.623 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -88.12 158.72 18.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.85 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.2 t -78.26 172.37 13.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.418 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -50.27 -37.24 34.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 110.253 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.09 67.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.265 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 12.7 t60 -49.05 -48.36 44.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.811 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' A' ' 680' ' ' ILE . 2.6 p -159.99 158.77 31.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.676 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 603' ' ' ILE . 39.3 p90 -143.45 150.39 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.478 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.011 HD12 HD11 ' A' ' 594' ' ' ILE . 83.7 mt -102.53 132.42 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.215 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -124.97 132.92 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 36.2 ttmt -98.45 136.54 38.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.573 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -135.45 158.58 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.474 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -76.95 112.75 13.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.522 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.484 ' CE1' ' HE1' ' A' ' 709' ' ' MET . 3.7 t60 -78.03 131.47 37.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -133.12 161.45 34.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 640' ' ' PRO . 10.5 m -113.44 -179.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -95.81 -89.29 1.78 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -99.99 -174.93 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 110.829 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 45.9 p -176.51 110.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 34.3 mtt -101.35 108.18 19.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.7 t80 69.88 -63.99 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.55 143.59 42.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.581 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 7.4 m -104.43 104.47 45.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.137 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.579 ' HB2' HG11 ' A' ' 632' ' ' VAL . 32.5 Cg_exo -59.4 -150.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.606 2.204 . . . . 0.0 111.971 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.444 ' O ' HD12 ' A' ' 644' ' ' LEU . . . -47.92 -26.11 1.59 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.78 0.324 . . . . 0.0 111.491 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.6 -77.68 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 174.95 80.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.843 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 701' ' ' GLY . 1.2 mp -115.74 -149.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.551 ' O ' ' HG ' ' A' ' 702' ' ' LEU . 4.7 m-20 -118.21 149.37 41.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.282 0.563 . . . . 0.0 112.338 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.54 ' OD2' HD21 ' A' ' 671' ' ' LEU . 3.9 m-20 -134.03 129.32 35.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.734 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.779 HG21 ' CE1' ' A' ' 577' ' ' PHE . 7.0 pt -86.81 123.55 39.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.323 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.997 ' CH2' HD22 ' A' ' 671' ' ' LEU . 80.6 m95 -108.98 129.32 55.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.046 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.2 t80 -90.34 115.7 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 624' ' ' PHE . 60.8 m -101.63 141.88 33.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 111.473 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 664' ' ' MET . 24.8 t60 -124.13 131.64 53.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.514 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 9.3 p -124.24 2.63 8.52 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.37 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -79.84 142.48 24.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.037 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 654' ' ' THR . 28.3 m -75.55 -12.65 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.536 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.8 m120 -83.64 2.63 36.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.587 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.87 134.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.588 0.708 . . . . 0.0 112.281 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.403 ' OG ' ' ND1' ' A' ' 651' ' ' HIS . 43.5 p -105.49 165.89 10.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.355 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 20.2 m-85 -127.61 119.85 26.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 111.283 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.673 HD13 HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -100.64 99.72 10.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.702 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.33 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.8 t-20 -133.48 3.76 3.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.833 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.705 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.8 OUTLIER -110.15 130.26 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.955 0.407 . . . . 0.0 111.147 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.489 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.0 OUTLIER -69.97 141.42 53.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.787 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.513 ' HG3' ' HB3' ' A' ' 651' ' ' HIS . 34.1 tpp -125.4 101.29 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.1 pt -87.94 165.61 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 652' ' ' THR . 16.1 tt0 -58.77 109.82 0.89 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.41 34.72 3.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 716' ' ' VAL . 5.2 p -134.84 154.94 51.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.849 0.356 . . . . 0.0 111.591 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 14.2 pttm -128.23 156.08 43.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.617 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.52 145.77 29.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.501 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.997 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.38 134.57 51.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.481 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.873 HD13 HG21 ' A' ' 694' ' ' VAL . 3.3 mt -108.52 126.33 52.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.965 ' HB3' HD12 ' A' ' 707' ' ' LEU . 3.1 mt-30 -113.36 154.21 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.714 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.48 ' N ' HD12 ' A' ' 696' ' ' ILE . 56.7 t0 -52.76 101.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 108.21 30.66 3.81 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 117.11 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.536 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -96.2 109.74 22.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.282 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.673 HG22 HD13 ' A' ' 659' ' ' LEU . 23.5 pt -105.94 130.48 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 5.2 mttp -94.5 116.13 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.711 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.588 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -79.3 -38.7 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.522 -179.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.697 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -155.84 136.5 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -136.42 122.41 20.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -123.53 116.99 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.92 0.39 . . . . 0.0 110.583 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -67.27 -46.48 73.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.97 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -78.81 -40.49 32.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.793 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -83.08 -9.51 59.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 60.46 18.08 7.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.253 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.679 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -76.72 104.63 7.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.4 p -118.2 122.45 69.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.133 0.492 . . . . 0.0 111.746 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.588 HG21 ' CG2' ' A' ' 680' ' ' ILE . 22.5 mm -126.17 154.6 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.298 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.432 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 177.54 127.86 1.1 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.952 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 592' ' ' LEU . 11.1 m-30 -113.04 145.28 41.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.718 0.294 . . . . 0.0 110.43 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.693 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.2 116.53 33.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.022 0.439 . . . . 0.0 110.256 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.873 HG21 HD13 ' A' ' 672' ' ' LEU . 2.5 t -82.58 127.19 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.754 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -134.28 108.4 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.924 179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 705' ' ' GLU . 11.5 mt -74.58 104.94 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.61 -50.84 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.899 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.441 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 4.6 t0 -112.47 138.36 49.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.211 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.09 100.06 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.55 HG21 ' HG3' ' A' ' 596' ' ' GLN . 64.1 p -70.27 78.84 0.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.336 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 53.42 39.75 60.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.388 -0.91 . . . . 0.0 110.829 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.883 HD13 ' CE2' ' A' ' 577' ' ' PHE . 1.5 tt -97.08 143.65 27.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.867 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.663 ' CB ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -58.25 112.66 1.62 Allowed 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.751 HD21 HD13 ' A' ' 707' ' ' LEU . 11.4 t30 59.73 -68.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.147 0.499 . . . . 0.0 109.932 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.682 ' HB2' HD13 ' A' ' 696' ' ' ILE . 11.7 pt-20 171.39 -32.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.989 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.91 45.76 0.04 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.408 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.965 HD12 ' HB3' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -82.76 0.94 41.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.41 82.97 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.088 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.503 ' O ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -118.24 125.27 49.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.914 0.388 . . . . 0.0 111.021 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 709' ' ' MET . 0.1 OUTLIER -177.81 -175.76 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.721 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -48.57 -34.48 11.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.172 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -85.63 134.04 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -97.03 100.02 11.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.004 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 34.8 79.02 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.69 142.49 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.705 HG23 ' OD1' ' A' ' 662' ' ' ASN . 70.8 t -79.3 130.16 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.415 HD13 ' HE2' ' A' ' 669' ' ' LYS . 1.4 mp -99.42 170.65 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -98.32 155.76 17.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -96.39 158.54 15.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.3 p -126.04 -176.58 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.197 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.42 46.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.14 -47.81 84.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.37 -50.42 63.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.663 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -55.7 -32.87 63.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -37.31 87.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.786 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -44.34 93.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.3 p -78.41 -21.49 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.117 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.44 -37.75 81.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.6 -9.67 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.399 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 730' ' ' LEU . 7.5 tt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.99 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.861 0.363 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -107.03 179.65 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.455 ' O ' HD12 ' P' ' 828' ' ' ILE . 2.6 pp -131.0 36.0 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.492 ' O ' HD23 ' P' ' 831' ' ' LEU . 2.1 p90 -175.95 166.99 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 681' ' ' ILE . 56.9 mt -148.75 37.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.848 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -77.97 -21.62 50.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 161.38 -24.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.518 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.424 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.0 tmm_? -107.52 143.11 36.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.603 ' HE1' HG21 ' A' ' 647' ' ' ILE . 2.4 t80 -132.61 -47.98 0.89 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.621 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.854 HD11 ' CD1' ' A' ' 647' ' ' ILE . 1.0 OUTLIER -112.65 143.25 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.16 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.0 m -123.07 114.01 19.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.982 0.42 . . . . 0.0 111.053 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.3 OUTLIER -106.11 109.01 20.82 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -116.26 99.43 52.69 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 39.0 Cg_exo -46.91 101.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 121.916 1.744 . . . . 0.0 109.814 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.815 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.73 157.95 85.32 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.413 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 9.0 Cg_endo -50.14 -25.46 13.07 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.768 2.978 . . . . 0.0 113.21 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.8 OUTLIER -61.97 -27.37 68.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 690' ' ' ILE . 2.7 t -95.62 153.92 17.48 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.624 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.654 HD13 ' CE1' ' A' ' 688' ' ' PHE . 9.3 pt -56.51 -12.35 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.701 0.286 . . . . 0.0 111.193 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.647 ' CD1' HG23 ' A' ' 613' ' ' ILE . 39.9 mt -108.54 127.24 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.527 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.3 OUTLIER -114.22 58.5 0.69 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.266 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.668 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 36.7 mt-10 -125.03 170.14 11.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.86 121.19 24.82 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.607 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 582' ' ' PRO . 0.5 OUTLIER -112.75 147.43 36.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -125.19 118.54 26.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 625' ' ' ILE . 57.6 mt -73.48 109.21 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.912 0.387 . . . . 0.0 110.294 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -65.1 116.4 6.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.971 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -45.99 -29.84 1.59 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.163 0.506 . . . . 0.0 110.471 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.23 -22.72 76.28 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.589 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.505 HG11 ' ND2' ' A' ' 610' ' ' ASN . 79.3 t -101.04 118.79 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 117.884 0.842 . . . . 0.0 111.585 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.0 t30 -139.37 122.68 10.69 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.765 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 44.8 Cg_endo -90.11 160.43 33.82 Favored 'Cis proline' 0 N--CA 1.462 -0.373 0 C-N-CA 124.451 -1.062 . . . . 0.0 111.917 0.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.659 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.46 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.611 ' CG ' HD12 ' A' ' 730' ' ' LEU . 41.6 m-85 -92.25 138.15 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.007 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.2 mp -129.84 145.69 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.678 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.41 ' HA2' HD11 ' A' ' 618' ' ' LEU . . . 156.72 -163.36 32.14 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.013 -1.089 . . . . 0.0 114.049 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 0.2 OUTLIER -82.85 3.42 29.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -101.3 123.94 46.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.788 0.328 . . . . 0.0 111.322 -179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -57.84 -22.49 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.271 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.16 -26.63 67.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.905 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 92.3 m -68.51 129.43 39.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.319 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 36.2 m120 -44.07 -33.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.308 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.756 ' SG ' HG23 ' A' ' 603' ' ' ILE . 53.5 t -109.73 134.88 51.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.12 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 111.99 23.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.647 HG23 ' CD1' ' A' ' 588' ' ' ILE . 30.6 mm -137.62 110.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.619 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 6.1 tt0 -91.6 105.9 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.274 0.559 . . . . 0.0 111.523 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 618' ' ' LEU . 13.5 t0 -130.32 108.58 10.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.702 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -47.43 -29.8 2.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.821 0.343 . . . . 0.0 111.201 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.491 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 19.7 mmt180 -77.86 -41.29 37.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -84.75 151.71 24.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.133 0.492 . . . . 0.0 111.478 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.94 161.4 23.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.165 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.448 ' HB2' ' CB ' ' A' ' 606' ' ' SER . 0.0 OUTLIER -47.65 -38.8 15.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.444 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 24.1 t -121.24 57.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CG ' HD12 ' A' ' 618' ' ' LEU . 6.0 t60 -50.42 -48.66 56.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.883 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.48 ' SG ' HD11 ' A' ' 680' ' ' ILE . 5.2 p -162.69 157.04 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 111.422 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.792 ' HA ' HD12 ' A' ' 603' ' ' ILE . 25.2 p90 -143.32 146.93 33.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.594 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 594' ' ' ILE . 23.9 mt -101.9 135.37 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.983 0.42 . . . . 0.0 109.914 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.4 t80 -127.34 134.94 49.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.746 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.2 ttmt -97.64 136.19 38.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.137 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 159.27 42.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.76 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.3 tpt180 -76.47 112.55 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.195 0.522 . . . . 0.0 110.595 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t-160 -81.38 122.85 28.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -157.52 114.7 3.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 632' ' ' VAL . 33.5 m -92.06 122.44 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.7 -60.92 7.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.601 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -70.59 145.38 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 76.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 63.21 -80.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.24 122.82 26.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.672 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 12.6 m -107.36 87.73 3.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.193 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 71.4 Cg_endo -74.18 167.45 27.15 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.519 2.146 . . . . 0.0 111.953 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.665 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 69.49 -61.07 0.45 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.346 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 74.55 -74.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 179.25 56.52 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.778 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.695 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.1 mp -102.47 -166.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' A' ' 702' ' ' LEU . 0.1 OUTLIER -111.75 148.03 34.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.026 0.441 . . . . 0.0 111.926 -179.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.443 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -128.85 160.11 33.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.261 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.854 ' CD1' HD11 ' A' ' 578' ' ' LEU . 3.5 pt -110.64 121.59 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.317 0.579 . . . . 0.0 111.615 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.854 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.9 m95 -104.28 141.3 36.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.165 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.7 t80 -105.7 116.95 32.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.19 139.8 39.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.472 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 62.2 t60 -119.46 128.73 54.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.417 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 5.4 p -126.55 12.95 7.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.51 148.75 21.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.181 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 69.5 m -77.0 -21.89 53.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.54 ' O ' HG13 ' A' ' 656' ' ' VAL . 1.5 m120 -79.9 -0.52 35.27 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.5 OUTLIER 54.9 128.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.932 179.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.1 p -92.74 166.36 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.986 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 679' ' ' LYS . 18.7 m-85 -133.15 120.6 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 111.17 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.779 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -105.3 112.57 25.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.142 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 59.03 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -139.86 7.6 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -104.22 141.06 36.93 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.924 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.1 ttt180 -79.33 141.02 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.457 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 13.9 mmm -120.96 101.27 7.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.446 HG12 HG21 ' A' ' 668' ' ' THR . 34.2 pt -88.27 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 652' ' ' THR . 34.6 tt0 -44.81 109.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.423 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.45 34.78 3.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.446 HG21 HG12 ' A' ' 665' ' ' ILE . 3.6 p -122.33 162.25 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.071 0.462 . . . . 0.0 111.667 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.419 ' HE2' ' CE3' ' A' ' 648' ' ' TRP . 4.5 ttpm? -131.61 149.71 52.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.344 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.484 ' HB3' HD12 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -147.3 143.74 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.854 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.37 137.74 53.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.437 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -110.85 104.14 12.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.235 0.54 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.554 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 20.8 mt-30 -90.94 137.91 32.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.197 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.566 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.4 t70 -43.52 111.32 0.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 99.8 37.13 4.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -93.55 122.65 36.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.469 -0.366 . . . . 0.0 111.012 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.37 108.88 21.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.186 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.779 HG23 ' HG ' ' A' ' 659' ' ' LEU . 3.7 mt -106.15 136.36 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.904 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 658' ' ' TYR . 1.7 mttt -100.83 116.27 32.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.566 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.525 HG22 ' CG2' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -78.68 -37.94 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.413 -179.008 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.52 HD11 ' ND2' ' A' ' 655' ' ' ASN . 0.2 OUTLIER -155.29 131.66 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.724 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.638 ' O ' HD13 ' P' ' 831' ' ' LEU . 11.0 t90 -136.25 123.56 21.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.159 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.477 ' CG ' HD22 ' P' ' 831' ' ' LEU . 1.5 t0 -121.4 117.18 26.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.42 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -66.89 -46.51 74.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.943 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.41 -40.44 21.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.543 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -77.47 -14.0 59.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.334 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 15.09 9.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -78.6 104.76 9.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.6 p -120.18 121.23 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 111.972 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.585 HD12 ' OD2' ' A' ' 615' ' ' ASP . 3.4 mt -129.14 152.76 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.324 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . 177.5 133.3 1.82 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.021 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 582' ' ' PRO . 4.2 m-30 -112.93 150.92 31.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.553 ' HB2' HD22 ' A' ' 583' ' ' LEU . 5.7 ttpt -101.27 116.82 33.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.953 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.759 HG13 ' CD2' ' A' ' 578' ' ' LEU . 1.8 t -81.11 121.89 35.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.883 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.66 108.75 8.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.477 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 674' ' ' ASP . 11.6 mt -79.21 107.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.32 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.68 -41.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 110.702 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -109.76 141.09 42.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.455 179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.2 OUTLIER -114.88 100.41 8.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.418 0.627 . . . . 0.0 110.046 178.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.6 m -86.79 70.47 10.36 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 73.33 36.12 55.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.163 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.608 HD12 ' CA ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -79.87 118.59 21.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.583 0.23 . . . . 0.0 111.171 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.695 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.4 OUTLIER -32.8 -47.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.609 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.535 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -159.2 26.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.608 ' CA ' HD12 ' A' ' 702' ' ' LEU . 0.5 OUTLIER 71.55 -56.87 0.63 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.543 -178.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 149.29 81.04 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.772 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 707' ' ' LEU . 3.6 mm? -103.52 -9.54 19.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.806 -0.232 . . . . 0.0 111.476 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 82.5 65.58 1.61 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.32 118.53 26.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.851 0.358 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.404 HD11 ' O ' ' A' ' 712' ' ' GLU . 1.4 pt? -176.1 -170.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -79.63 -55.63 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.749 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.404 ' O ' HD11 ' A' ' 710' ' ' LEU . 4.3 mm-40 -80.21 134.16 36.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.688 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.83 100.17 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.096 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.766 HH21 HD22 ' A' ' 659' ' ' LEU . 5.5 mmm-85 39.36 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.76 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.61 143.24 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.924 HG21 ' O ' ' A' ' 663' ' ' ARG . 59.4 t -78.91 129.32 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.9 mt -102.64 166.13 10.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 137.99 40.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.853 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.02 159.88 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.4 p -121.11 -173.68 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.67 -28.82 35.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.16 -52.09 66.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.66 -49.32 63.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.628 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -56.35 -33.13 65.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 -38.24 89.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.8 mt -58.41 -44.01 88.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.548 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 12.6 p -83.18 -29.77 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -52.11 -29.31 21.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.057 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -105.29 27.22 8.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.611 HD12 ' CG ' ' A' ' 602' ' ' PHE . 3.3 tt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.679 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.73 73.06 0.49 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 4.1 mm -108.96 75.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.426 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 20.2 p90 179.31 150.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.789 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 682' ' ' TRP . 58.9 mt -127.98 170.37 12.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.851 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -88.05 -22.04 24.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -165.52 30.64 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.813 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.9 tmm_? -102.29 126.13 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.564 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CD1' ' C ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -109.2 -62.29 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.187 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 647' ' ' ILE . 6.8 tt -106.06 137.76 43.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.72 ' N ' HD23 ' A' ' 578' ' ' LEU . 4.6 m -115.98 113.96 23.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.998 0.428 . . . . 0.0 111.434 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.721 ' HG ' HG22 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -104.83 107.9 19.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 ptpt -114.83 100.02 52.84 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_exo -45.78 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.945 1.763 . . . . 0.0 109.565 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.16 157.83 86.3 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 73.8 Cg_exo -49.12 -25.25 8.98 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.381 2.72 . . . . 0.0 112.425 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.726 ' HB2' HD12 ' A' ' 583' ' ' LEU . 2.2 t0 -61.97 -22.61 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 4.0 t -95.31 153.11 17.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.847 HD11 ' OD1' ' A' ' 615' ' ' ASP . 20.7 pt -53.03 -19.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.012 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.58 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.99 142.92 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.658 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.6 OUTLIER -119.47 67.74 0.81 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.982 0.42 . . . . 0.0 110.429 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.589 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 89.5 mt-10 -125.16 170.86 10.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.494 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.77 124.0 34.37 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 178.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 1.084 HD21 HD11 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.26 136.51 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.571 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.3 OUTLIER -124.48 116.6 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.851 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.716 HG23 ' CD1' ' A' ' 601' ' ' PHE . 81.2 mt -74.87 108.16 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.842 0.354 . . . . 0.0 110.144 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.2 mp0 -66.16 103.14 0.92 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -29.6 -54.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.27 0.557 . . . . 0.0 111.449 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -53.03 -16.39 4.24 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.017 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.37 118.05 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 117.873 0.837 . . . . 0.0 111.604 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' ND2' ' CD2' ' A' ' 626' ' ' PHE . 0.9 OUTLIER -140.46 124.35 10.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.997 178.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 37.2 Cg_endo -91.32 159.28 27.73 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.149 0.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.716 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.3 t80 -93.61 115.77 28.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 0.0 109.962 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.608 ' CD2' HD12 ' A' ' 730' ' ' LEU . 1.7 m-85 -92.94 138.61 31.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.917 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.804 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.8 mp -127.51 144.89 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 158.35 -165.0 33.71 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.877 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.02 17.92 11.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.41 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 620' ' ' ARG . 1.1 t -101.78 131.68 47.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.642 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -21.71 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.763 0.316 . . . . 0.0 110.63 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.29 -21.33 60.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 18.9 m -76.52 127.41 32.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.728 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 23.3 m120 -45.76 -31.68 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.14 0.495 . . . . 0.0 110.434 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.804 ' SG ' HG23 ' A' ' 603' ' ' ILE . 45.0 t -110.55 138.72 46.57 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 117.83 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 1.084 HD11 HD21 ' A' ' 592' ' ' LEU . 34.2 mm -138.06 108.83 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.314 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.35 101.09 11.08 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.413 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD1' HD11 ' A' ' 587' ' ' ILE . 1.1 m-20 -133.54 113.36 12.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.937 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -50.42 -45.81 55.98 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.118 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.618 ' HB3' HD13 ' A' ' 681' ' ' ILE . 2.4 mpp_? -62.66 -19.05 63.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 110.549 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.982 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -88.17 160.81 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.593 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.403 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 2.6 m -109.92 153.74 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -39.03 -50.68 1.81 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.76 57.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.606 ' CB ' HD23 ' A' ' 618' ' ' LEU . 54.2 t60 -52.69 -37.55 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.344 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD11 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.529 0.68 . . . . 0.0 111.939 -178.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.598 ' CZ ' ' CE2' ' A' ' 602' ' ' PHE . 0.1 OUTLIER -144.18 131.97 21.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.904 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 603' ' ' ILE . 21.3 mt -131.79 116.96 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.458 ' CD2' ' ND2' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -136.78 149.02 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -178.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 34.6 ttmt -98.9 136.76 38.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.367 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 159.79 35.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.4 tpt180 -75.68 112.75 12.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.6 t60 -76.55 128.93 35.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -171.4 146.75 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.101 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 632' ' ' VAL . 4.3 m -125.46 104.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 45.49 -121.28 4.74 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.53 144.43 51.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.738 0.304 . . . . 0.0 110.635 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.32 91.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.67 103.09 9.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 78.43 -55.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.04 144.15 40.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.1 m -104.42 102.69 35.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.12 -164.55 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.723 2.282 . . . . 0.0 112.202 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -97.13 29.71 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.309 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 64.48 -164.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.893 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -107.49 85.18 0.41 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.746 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.638 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.8 mp -110.54 -163.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.822 ' O ' HD13 ' A' ' 702' ' ' LEU . 9.8 m-20 -114.12 146.49 40.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.294 0.569 . . . . 0.0 112.197 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.434 ' OD2' ' CD1' ' A' ' 703' ' ' PHE . 0.4 OUTLIER -128.8 160.61 32.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.647 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.092 HD13 HD12 ' A' ' 578' ' ' LEU . 0.6 OUTLIER -103.33 128.29 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.6 0.714 . . . . 0.0 112.081 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.908 ' CH2' HD22 ' A' ' 671' ' ' LEU . 91.6 m95 -113.02 120.45 41.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.27 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.647 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.6 t80 -93.62 117.77 30.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 624' ' ' PHE . 3.9 m -113.74 143.87 43.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.437 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 42.5 t60 -110.58 130.12 55.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.0 0.428 . . . . 0.0 111.049 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.428 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 20.5 p -120.56 3.83 10.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.109 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . . . . . . . . . . . -81.58 146.22 25.73 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.847 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' P' ' 829' ' ' PTR . 37.5 m -75.94 -15.64 60.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 656' ' ' VAL . 29.3 m-20 -85.18 3.05 41.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.16 129.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.438 0.637 . . . . 0.0 112.283 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.58 ' CB ' ' HH ' ' A' ' 649' ' ' TYR . 33.1 p -99.31 166.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.302 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 5.8 m-85 -129.23 120.06 25.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.718 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 1.029 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -98.64 102.58 14.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 60.93 -80.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.4 p30 -136.84 5.7 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.672 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.533 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -107.44 139.75 41.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.626 ' O ' HG21 ' A' ' 716' ' ' VAL . 6.1 ttp180 -76.4 141.36 41.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.423 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 25.1 mmm -124.61 97.44 5.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.41 HG12 HG21 ' A' ' 668' ' ' THR . 45.4 pt -87.57 152.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 652' ' ' THR . 38.5 tt0 -48.7 112.05 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.91 0.386 . . . . 0.0 110.945 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.9 32.32 4.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 6.3 p -121.04 162.54 19.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.828 0.347 . . . . 0.0 111.203 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.9 ttpm? -133.69 147.81 51.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.769 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.69 28.34 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.908 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.04 133.72 48.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.593 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.88 HD13 HG21 ' A' ' 694' ' ' VAL . 1.7 mt -108.9 104.71 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 11.2 mt-30 -91.35 139.26 30.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.621 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.644 ' HB2' HD12 ' A' ' 696' ' ' ILE . 44.2 t0 -41.28 112.4 0.3 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.032 0.444 . . . . 0.0 110.708 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.28 37.08 4.43 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.78 116.11 28.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.252 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -96.26 108.72 21.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 1.029 HG22 HD13 ' A' ' 659' ' ' LEU . 25.5 pt -105.92 129.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.798 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 658' ' ' TYR . 27.9 mttp -89.43 115.8 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.834 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -79.26 -35.47 17.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.811 -178.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.982 HD12 HD12 ' A' ' 618' ' ' LEU . 50.2 mt -155.0 131.59 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.704 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -136.37 123.45 21.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.5 116.96 25.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.505 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -67.03 -46.61 73.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.842 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -80.91 -40.07 25.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.479 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 1.1 t30 -83.06 -13.36 55.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.299 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 61.06 17.11 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 111.0 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.04 104.62 7.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.5 p -117.48 124.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.2 0.524 . . . . 0.0 111.914 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 681' ' ' ILE . 59.5 mt -129.01 156.0 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.315 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 170.83 136.33 2.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.68 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.834 ' CZ ' HD12 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -114.16 149.8 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.432 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.53 ' HB2' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -101.85 117.6 35.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.663 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 672' ' ' LEU . 3.5 t -80.03 124.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -133.2 109.71 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.413 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 705' ' ' GLU . 52.1 mt -78.26 106.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -89.76 -44.71 9.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.176 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -110.4 141.87 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.54 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -113.07 99.92 8.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.431 0.634 . . . . 0.0 109.599 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 9.1 m -82.88 58.84 4.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.52 13.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.173 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -80.64 134.33 35.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.56 0.219 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.638 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.8 p90 -43.36 -33.52 1.04 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.469 0.652 . . . . 0.0 110.266 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 0.1 OUTLIER -148.1 -61.2 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.341 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.745 ' O ' HD12 ' A' ' 696' ' ' ILE . 7.7 pt-20 145.42 32.97 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.957 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 68.12 74.09 0.62 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.592 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.517 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -105.41 -10.01 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.057 0.428 . . . . 0.0 111.557 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 709' ' ' MET . . . 93.15 -95.24 1.96 Allowed Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 39.36 -147.14 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.031 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 711' ' ' GLN . 0.2 OUTLIER 77.91 162.66 0.22 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.105 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.597 ' H ' HD23 ' A' ' 710' ' ' LEU . 11.9 mt-30 -56.95 -66.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.421 ' HB3' HG22 ' A' ' 715' ' ' VAL . 1.4 mp0 -63.63 123.75 19.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -82.83 100.01 10.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.437 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.3 mmm-85 41.48 89.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.842 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 712' ' ' GLU . 3.0 m -124.44 143.54 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.538 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 663' ' ' ARG . 65.0 t -85.78 121.84 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.506 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.66 172.36 8.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.605 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.37 16.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 650' ' ' CYS . 42.1 mt-30 -93.44 148.55 21.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.3 p -126.41 -175.96 3.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 111.669 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.93 -30.15 45.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.198 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 0.0 OUTLIER -56.61 -50.12 72.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.676 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.79 ' HA ' HD12 ' A' ' 726' ' ' LEU . 21.6 mm-40 -70.01 -49.5 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.57 -32.2 72.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.477 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.43 -39.95 89.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.79 HD12 ' HA ' ' A' ' 723' ' ' GLU . 1.0 OUTLIER -63.35 -44.69 94.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.562 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.89 -19.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.254 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -24.98 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.039 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -108.11 24.24 13.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.677 ' O ' HD23 ' A' ' 730' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -156.71 63.04 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 24.9 mt -98.69 130.86 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -176.04 154.1 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.526 ' CD1' HG23 ' A' ' 681' ' ' ILE . 28.3 mt -138.77 122.18 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.825 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -102.22 10.2 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.513 0.197 . . . . 0.0 111.278 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -144.71 -40.86 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.4 ' CD ' ' HB3' ' A' ' 593' ' ' GLU . 52.1 ttp180 -106.12 141.47 37.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -125.66 -58.3 1.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.214 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 647' ' ' ILE . 12.8 tp -110.92 134.93 52.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.439 ' C ' HD23 ' A' ' 580' ' ' LEU . 7.5 m -115.24 114.72 25.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.441 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD11 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -105.28 108.7 20.35 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.96 100.33 52.18 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 52.2 Cg_exo -44.72 100.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.917 1.745 . . . . 0.0 109.806 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.35 158.29 85.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.416 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 7.7 Cg_endo -49.43 -24.68 9.22 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.59 2.86 . . . . 0.0 112.387 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.764 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.5 t0 -61.42 -23.09 65.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 2.2 t -95.46 153.34 17.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.75 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.534 HD13 ' HD1' ' A' ' 688' ' ' PHE . 4.0 pt -54.42 -18.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.722 0.296 . . . . 0.0 110.816 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.6 tt -112.84 142.95 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.815 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 1.0 OUTLIER -120.02 68.81 0.84 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.194 0.521 . . . . 0.0 110.286 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.3 mm-40 -124.91 171.38 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.494 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 127.33 42.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.0 0.428 . . . . 0.0 111.12 178.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.952 HD21 HD11 ' A' ' 613' ' ' ILE . 0.2 OUTLIER -112.39 139.58 47.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.892 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 576' ' ' ARG . 6.1 mp0 -124.48 117.39 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.045 HD11 HD11 ' A' ' 580' ' ' LEU . 88.0 mt -86.34 109.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.062 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.8 mp0 -67.47 125.84 27.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.72 -28.5 3.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.123 0.487 . . . . 0.0 110.52 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -75.59 -17.7 80.04 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.982 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 64.4 t -100.94 117.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.05 0.925 . . . . 0.0 111.878 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.7 t30 -140.8 121.31 8.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.8 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.581 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 50.5 Cg_endo -89.63 160.65 36.32 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 124.772 -0.928 . . . . 0.0 111.499 -0.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.0 t80 -92.15 117.02 29.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 730' ' ' LEU . 35.1 m-85 -92.21 137.51 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.039 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.773 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.0 mp -124.94 143.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.59 -176.67 42.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.079 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 7.6 ttp85 -81.21 -2.96 50.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.662 0.268 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 135.71 42.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -24.91 60.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.059 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -28.36 60.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 51.5 m -77.06 132.52 38.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.8 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 24.4 m120 -47.31 -29.07 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.563 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.773 ' SG ' HG23 ' A' ' 603' ' ' ILE . 38.5 t -111.58 142.45 43.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.897 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 115.92 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.952 HD11 HD21 ' A' ' 592' ' ' LEU . 17.5 mm -137.78 110.29 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.441 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 22.2 mt-10 -81.88 103.2 11.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.511 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.737 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -131.43 108.43 9.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.161 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -42.5 -36.73 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 681' ' ' ILE . 1.2 mpp_? -77.62 -36.86 51.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.737 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.2 OUTLIER -60.3 158.91 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 83.9 p -110.68 168.89 9.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.553 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -46.17 -52.98 11.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.224 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.765 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.6 t -116.76 58.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.204 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.522 ' CD2' HG23 ' A' ' 680' ' ' ILE . 35.6 t60 -49.35 -48.59 46.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.886 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.9 p -163.12 156.08 19.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.502 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.9 p90 -143.22 148.05 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.38 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -102.59 141.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 179.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.0 t80 -130.91 134.15 46.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.418 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 27.9 ttmt -97.66 136.8 37.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.91 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.68 159.44 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.443 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.27 117.78 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.436 0.636 . . . . 0.0 110.79 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.484 ' C ' ' CD2' ' A' ' 630' ' ' HIS . 0.2 OUTLIER -82.47 133.78 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.444 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.08 140.53 45.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 641' ' ' ALA . 16.6 m -93.4 175.98 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -105.44 -69.69 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -96.96 157.06 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 3.3 p -165.63 78.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.27 117.49 9.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 63.82 -77.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.785 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -86.63 126.23 34.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.28 87.75 4.31 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 71.9 Cg_endo -76.84 172.97 15.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.56 2.173 . . . . 0.0 112.033 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.591 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 70.29 -62.71 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.161 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 65.05 -173.14 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -86.36 53.36 4.59 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.751 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.71 HD12 ' H ' ' A' ' 703' ' ' PHE . 1.2 mm? -79.99 -160.84 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 m-20 -122.49 147.03 46.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.188 0.518 . . . . 0.0 112.037 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.8 ' HB3' HD21 ' A' ' 671' ' ' LEU . 1.9 m-20 -129.18 159.72 35.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -105.92 134.94 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.362 0.601 . . . . 0.0 112.23 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.625 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 67.4 m95 -117.96 127.59 53.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.313 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.656 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -90.08 117.17 28.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 624' ' ' PHE . 2.1 m -102.93 131.72 49.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.601 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.444 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 67.0 t60 -109.88 128.58 55.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 1.3 p -124.44 -1.14 8.1 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.451 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.36 137.95 21.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.029 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 654' ' ' THR . 91.4 m -69.78 -10.84 59.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.627 0.251 . . . . 0.0 111.456 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.532 ' O ' HG13 ' A' ' 656' ' ' VAL . 55.7 m-20 -85.03 3.75 37.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.59 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 51.57 137.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.566 0.698 . . . . 0.0 112.182 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.444 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 5.9 t -108.74 166.2 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.387 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -129.38 120.36 25.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -101.84 99.64 9.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.562 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.9 m120 61.06 -81.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 13.2 p-10 -133.79 1.81 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.643 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.434 ' HB3' ' CG2' ' A' ' 716' ' ' VAL . 1.5 m120 -104.21 141.65 35.89 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.859 0.361 . . . . 0.0 111.069 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.55 141.27 38.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.058 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 656' ' ' VAL . 57.4 mmm -115.66 98.68 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 48.3 pt -87.5 155.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.063 0.459 . . . . 0.0 111.226 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.5 OUTLIER -51.41 105.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.61 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 39.64 2.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.212 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 3.5 p -132.39 148.9 52.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.871 0.335 . . . . 0.0 111.549 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.66 ' HE2' HD13 ' A' ' 717' ' ' LEU . 15.9 pttm -123.88 136.35 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.671 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.675 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -131.94 141.61 49.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 646' ' ' ASP . 0.6 OUTLIER -69.37 141.26 54.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.945 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 694' ' ' VAL . 16.2 mt -111.87 105.39 13.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 112.018 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 70.5 mt-30 -77.86 156.39 30.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.878 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.7 ' CB ' HD12 ' A' ' 696' ' ' ILE . 7.0 t0 -53.2 109.7 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.83 37.92 4.29 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -88.1 115.22 25.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.437 . . . . 0.0 111.184 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.12 109.78 22.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.626 HG22 HD13 ' A' ' 659' ' ' LEU . 11.8 pt -105.57 120.61 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.155 0.502 . . . . 0.0 112.11 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -87.54 116.02 25.37 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -82.3 -33.46 11.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.885 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.616 HG22 ' CG1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -155.15 132.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.523 ' CB ' HG23 ' A' ' 689' ' ' VAL . 9.5 t90 -136.04 124.33 23.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.435 ' OD2' HD22 ' P' ' 831' ' ' LEU . 2.2 t0 -124.14 116.58 22.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.353 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -67.79 -46.68 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.064 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -40.36 96.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.134 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -93.69 -18.35 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.643 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.0 OUTLIER 65.91 13.06 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.0 111.029 -179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -87.51 105.56 17.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.523 HG23 ' CB ' ' A' ' 682' ' ' TRP . 1.2 p -119.78 138.78 49.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.357 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.616 ' CG1' HG22 ' A' ' 681' ' ' ILE . 18.4 mm -113.67 152.12 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.77 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.2 130.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.651 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.504 ' CE2' HD11 ' A' ' 680' ' ' ILE . 1.6 m-30 -113.9 145.06 42.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.735 ' HB2' HD22 ' A' ' 583' ' ' LEU . 9.0 tttm -101.1 116.92 33.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.084 0.469 . . . . 0.0 110.304 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.033 HG22 HD22 ' A' ' 580' ' ' LEU . 2.5 t -79.82 128.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.692 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.3 OUTLIER -133.29 108.58 8.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.124 0.488 . . . . 0.0 111.019 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.8 mt -76.28 105.29 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.385 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -91.9 -50.13 5.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.041 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -112.62 139.57 48.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.142 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.466 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -116.2 100.56 8.01 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.207 0.527 . . . . 0.0 109.692 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 62.02 0.67 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.968 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.1 47.32 88.43 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.54 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -112.24 32.61 5.42 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.71 ' H ' HD12 ' A' ' 644' ' ' LEU . 0.0 OUTLIER 67.85 175.67 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.604 ' ND2' HD23 ' A' ' 707' ' ' LEU . 4.8 t30 -14.56 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.028 0.442 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 696' ' ' ILE . 0.7 OUTLIER 151.51 -38.16 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.927 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.532 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 164.36 81.87 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.613 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.604 HD23 ' ND2' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -105.39 -10.14 17.14 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.518 -0.401 . . . . 0.0 111.587 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.436 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 41.14 89.87 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.257 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.64 116.82 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.26 -162.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -46.78 45.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.829 0.347 . . . . 0.0 111.063 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.09 137.46 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.659 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -91.91 100.6 13.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 7.0 mmm-85 43.38 86.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.564 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.47 143.18 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.982 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 662' ' ' ASN . 78.6 t -84.08 130.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.66 HD13 ' HE2' ' A' ' 669' ' ' LYS . 0.8 OUTLIER -101.24 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.89 157.43 16.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 111.186 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.73 158.86 17.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.1 p -126.13 -175.29 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -33.69 57.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.27 -45.6 90.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.614 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.62 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -63.74 -50.97 66.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -54.24 -32.7 56.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.13 -37.09 80.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.097 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 723' ' ' GLU . 13.2 mt -58.03 -44.37 87.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.765 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.7 p -78.82 -27.2 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -30.13 65.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.836 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -97.51 13.04 31.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.659 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.9 tt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.81 0.338 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 58.72 175.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 4.9 pt -132.89 78.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.206 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.62 148.06 8.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.013 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.435 HD22 ' OD2' ' A' ' 683' ' ' ASP . 27.6 mt -151.74 83.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.947 -179.975 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.4 -22.58 59.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.732 0.301 . . . . 0.0 111.205 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 170.04 70.76 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.412 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -89.13 114.0 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -104.58 -59.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.394 -179.116 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.145 HD12 HD13 ' A' ' 647' ' ' ILE . 7.3 tt -106.67 142.0 37.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.352 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.735 ' N ' HD23 ' A' ' 578' ' ' LEU . 11.5 m -122.25 114.71 21.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 694' ' ' VAL . 6.2 mt -102.95 107.8 18.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 44.9 mtmt -111.6 99.46 44.69 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.7 Cg_exo -48.15 98.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.755 1.637 . . . . 0.0 109.535 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.749 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.2 OUTLIER -74.73 157.63 85.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.626 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.434 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 77.6 Cg_exo -49.76 -28.43 17.65 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.458 2.772 . . . . 0.0 112.64 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.454 ' HB2' HD12 ' A' ' 583' ' ' LEU . 1.3 t70 -62.38 -24.99 67.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.9 t -95.44 153.97 17.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -56.2 -11.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.237 179.586 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.844 ' CD1' HG23 ' A' ' 613' ' ' ILE . 20.3 mt -112.1 126.88 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.824 0.345 . . . . 0.0 111.741 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -109.34 52.38 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 110.148 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.599 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 14.1 mm-40 -124.49 172.01 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.046 -179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.96 131.35 51.1 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.941 0.4 . . . . 0.0 111.337 179.131 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.731 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.5 OUTLIER -112.58 141.94 45.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.778 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.8 OUTLIER -124.63 116.32 22.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.149 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.054 HD12 HD22 ' A' ' 578' ' ' LEU . 63.9 mt -86.56 108.98 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 576' ' ' ARG . 8.6 mm100 -71.8 128.71 36.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.498 ' HB3' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.03 -30.34 1.81 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 109.877 179.084 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.43 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -69.74 -25.06 75.96 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.16 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.481 HG11 ' CG ' ' A' ' 610' ' ' ASN . 87.9 t -98.73 117.16 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 118.171 0.985 . . . . 0.0 111.842 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.2 t30 -141.16 121.92 8.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.034 177.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.593 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 43.8 Cg_endo -89.86 159.78 34.77 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.543 -1.024 . . . . 0.0 111.248 -0.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.578 ' CD1' HG23 ' A' ' 594' ' ' ILE . 2.7 t80 -91.88 114.98 27.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 25.3 m-85 -91.82 138.38 31.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.998 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.763 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.9 mp -125.95 145.31 33.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.459 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 167.14 -178.3 41.37 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.573 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.451 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 4.8 ttp85 -76.97 -7.52 55.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.563 0.22 . . . . 0.0 111.466 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.48 131.96 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.758 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -56.1 -23.99 37.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.217 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.602 ' HB3' HD21 ' A' ' 730' ' ' LEU . 0.5 OUTLIER -55.04 -30.2 59.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.653 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 45.2 m -74.87 134.51 41.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 4.8 m-80 -48.11 -27.07 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.627 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 603' ' ' ILE . 36.0 t -112.13 140.46 46.8 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.542 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.59 113.03 23.84 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.844 HG23 ' CD1' ' A' ' 588' ' ' ILE . 31.0 mm -137.8 109.67 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.774 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 25.8 tt0 -87.66 103.87 15.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.584 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.758 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -131.06 110.55 11.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.11 178.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -41.21 -35.65 0.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.728 0.299 . . . . 0.0 111.526 -178.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.528 ' HB3' HD13 ' A' ' 681' ' ' ILE . 6.9 mmt180 -77.69 -38.64 46.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.05 HD12 HD12 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -59.69 159.48 8.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.178 -179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 167.59 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 -50.0 19.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.134 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 727' ' ' VAL . 38.9 t -119.71 59.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.36 178.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CD2' HG23 ' A' ' 680' ' ' ILE . 24.7 t60 -48.5 -49.18 36.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.619 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 7.3 p -166.34 157.35 12.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.595 ' HA ' HD12 ' A' ' 603' ' ' ILE . 44.0 p90 -143.39 146.89 33.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 603' ' ' ILE . 2.2 mp -102.17 125.5 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.775 179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.2 t80 -116.79 133.72 55.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 -179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 15.2 ttmt -98.55 136.93 37.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.699 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -131.64 158.78 40.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.385 -179.164 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.451 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.47 115.72 16.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.384 0.612 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.68 ' CD2' ' HB1' ' A' ' 641' ' ' ALA . 4.2 t60 -84.1 130.96 34.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.002 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.451 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -150.63 155.4 39.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 633' ' ' GLY . 9.8 p -152.7 168.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.536 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -68.04 -133.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.668 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -173.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.742 0.306 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 14.0 p -128.28 29.34 5.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.287 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . 0.402 ' O ' ' CB ' ' A' ' 637' ' ' TYR . 0.8 OUTLIER -87.02 101.89 13.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.24 179.41 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.402 ' CB ' ' O ' ' A' ' 636' ' ' MET . 0.1 OUTLIER 81.17 -15.88 0.69 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.03 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -83.35 147.05 28.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.607 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 55.5 p -86.92 156.9 55.04 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.353 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 641' ' ' ALA . 25.1 Cg_exo -35.82 158.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.373 2.716 . . . . 0.0 113.857 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.68 ' HB1' ' CD2' ' A' ' 630' ' ' HIS . . . 176.21 -53.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.799 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.26 -91.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.718 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 641' ' ' ALA . . . -156.48 27.12 0.54 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.606 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 701' ' ' GLY . 1.6 mm? -71.51 -160.82 0.06 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.662 0.231 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.9 OUTLIER -122.32 146.46 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.048 0.451 . . . . 0.0 111.795 -179.536 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.451 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -125.23 160.21 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.775 179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.145 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -110.01 121.9 63.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.619 0.723 . . . . 0.0 112.591 -179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.871 ' CH2' HD22 ' A' ' 671' ' ' LEU . 87.0 m95 -105.34 128.13 53.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.629 179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.463 ' CB ' HD21 ' A' ' 672' ' ' LEU . 22.0 t80 -90.57 117.75 29.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . . . . . . . . . 36.7 m -106.35 128.09 53.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 657' ' ' SER . 33.8 t60 -110.29 126.34 54.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.855 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.487 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 13.4 p -123.46 7.24 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.516 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -82.46 146.82 25.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.954 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 32.8 m -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.611 0.243 . . . . 0.0 111.642 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.523 ' O ' HD12 ' P' ' 831' ' ' LEU . 19.2 m-20 -85.23 3.25 40.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.44 135.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.733 0.777 . . . . 0.0 112.487 179.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.427 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 3.7 t -104.16 165.85 10.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.188 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 679' ' ' LYS . 37.3 m-85 -128.28 119.76 25.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.703 HD13 HG12 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -103.46 102.44 12.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 659' ' ' LEU . 2.8 m120 59.73 -82.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.898 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 659' ' ' LEU . 26.1 p30 -135.77 6.99 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.638 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -110.8 141.6 43.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.942 0.401 . . . . 0.0 110.918 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.458 ' HG2' HG23 ' A' ' 665' ' ' ILE . 8.9 ttp85 -75.19 141.19 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.442 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.462 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 23.4 mmm -122.66 86.06 2.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.354 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' A' ' 663' ' ' ARG . 30.7 pt -86.84 156.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 111.325 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 652' ' ' THR . 24.4 tt0 -49.12 107.1 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.234 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 105.16 32.44 4.02 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.586 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 665' ' ' ILE . 2.5 p -121.72 161.84 21.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.6 ttpm? -135.66 147.87 48.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.45 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.83 144.93 28.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.871 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.1 134.73 49.74 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.629 179.446 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.736 ' CB ' HD12 ' A' ' 647' ' ' ILE . 0.6 OUTLIER -108.74 108.0 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.071 0.462 . . . . 0.0 111.783 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.566 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 18.3 mt-30 -95.8 157.28 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.227 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 705' ' ' GLU . 4.0 p-10 -52.38 124.57 13.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.802 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 84.42 39.63 8.92 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.997 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.16 112.31 23.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.911 0.386 . . . . 0.0 111.152 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.81 108.77 21.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.703 HG12 HD13 ' A' ' 659' ' ' LEU . 6.0 mt -109.7 128.83 65.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 0.0 112.035 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.4 OUTLIER -90.34 115.85 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.407 178.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 622' ' ' HIS . 3.8 mt -77.02 -37.6 26.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.422 -179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.05 HD12 HD12 ' A' ' 618' ' ' LEU . 38.3 mt -155.39 131.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.773 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -135.87 121.09 19.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.748 178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.54 117.36 24.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttp -66.73 -46.67 74.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.609 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.23 -40.24 19.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.289 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.78 -11.32 59.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.8 20.59 8.09 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.735 0.303 . . . . 0.0 110.925 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.79 104.82 15.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 689' ' ' VAL . 1.5 p -119.5 121.4 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.19 0.519 . . . . 0.0 111.81 -178.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.65 ' CD1' HG22 ' A' ' 587' ' ' ILE . 26.8 mm -128.5 150.14 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.536 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -178.54 127.55 1.17 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.411 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.565 ' HB2' HD22 ' A' ' 580' ' ' LEU . 8.7 m-30 -113.34 145.76 40.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.752 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.749 ' HB2' HD22 ' A' ' 583' ' ' LEU . 1.2 ttpt -101.88 117.97 35.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.086 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.884 HG23 HD21 ' A' ' 580' ' ' LEU . 2.6 t -79.43 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 579' ' ' THR . 34.2 tt0 -131.26 108.39 9.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.028 0.442 . . . . 0.0 110.334 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.86 HD12 ' HG3' ' A' ' 705' ' ' GLU . 27.8 mt -76.39 105.58 5.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.927 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . 0.407 ' CB ' ' NH1' ' A' ' 576' ' ' ARG . 1.6 m-80 -87.12 -46.14 10.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.484 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 577' ' ' PHE . 21.2 t0 -110.77 139.4 46.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 3.7 p -115.72 99.99 7.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.22 0.533 . . . . 0.0 109.828 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -80.07 68.35 6.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.494 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.667 ' O ' HD12 ' A' ' 644' ' ' LEU . . . 67.65 30.27 74.62 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.692 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -70.59 133.07 46.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.671 0.272 . . . . 0.0 111.198 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -39.15 -49.92 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.175 179.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.537 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -157.56 20.83 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.857 178.182 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.86 ' HG3' HD12 ' A' ' 696' ' ' ILE . 0.3 OUTLIER 70.98 -57.52 0.6 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.0 -178.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 160.75 81.14 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.443 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 707' ' ' LEU . 3.8 mm? -104.86 -9.42 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.896 0.348 . . . . 0.0 111.592 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.47 -36.48 4.19 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.714 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.32 -147.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 711' ' ' GLN . 0.9 OUTLIER -144.92 -159.61 1.02 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.783 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.743 ' N ' HD12 ' A' ' 710' ' ' LEU . 3.5 mt-30 69.46 -65.51 0.3 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -106.35 98.4 8.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.616 178.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.65 100.32 9.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.434 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 1.7 mmm-85 34.88 90.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.652 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.42 142.25 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.079 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' A' ' 662' ' ' ASN . 62.4 t -86.82 130.29 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 111.391 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mt -104.84 167.2 9.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.17 148.54 25.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -84.8 151.17 24.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.823 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.09 -177.78 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.23 -30.54 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.193 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.82 -51.97 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.724 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.3 OUTLIER -67.55 -46.42 72.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.546 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -56.51 -32.86 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -67.82 -38.42 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 723' ' ' GLU . 26.8 mt -56.49 -44.34 80.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.636 ' CG2' HG11 ' A' ' 621' ' ' VAL . 10.5 p -73.21 -26.52 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.34 -34.38 66.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.809 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -98.63 29.26 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.638 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 608' ' ' ASP . 5.8 tt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.846 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.772 0.32 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 62.46 150.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.477 HG22 ' N ' ' P' ' 829' ' ' PTR . 22.9 mt -108.67 159.44 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.028 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.477 ' N ' HG22 ' P' ' 828' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 41.5 p90 179.8 142.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 1.024 HD11 HG23 ' A' ' 681' ' ' ILE . 45.5 mt -121.93 129.64 52.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.915 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.52 -22.26 32.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.685 0.279 . . . . 0.0 111.059 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 136.23 -32.45 2.49 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.332 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 595' ' ' GLN . 16.9 ttm180 -110.28 143.33 40.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.068 0.461 . . . . 0.0 111.713 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 647' ' ' ILE . 1.9 t80 -122.87 -40.28 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.81 HD11 ' CG1' ' A' ' 694' ' ' VAL . 12.0 tp -126.96 142.24 51.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 111.041 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 695' ' ' GLU . 22.1 m -124.9 114.19 18.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.052 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.794 ' HG ' HG22 ' A' ' 694' ' ' VAL . 2.9 mp -106.86 108.93 20.68 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.47 100.52 50.3 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 51.9 Cg_exo -44.53 103.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.083 1.855 . . . . 0.0 110.056 177.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 585' ' ' ASP . 0.2 OUTLIER -74.83 158.22 84.88 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -176.874 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.411 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 8.9 Cg_endo -49.71 -23.92 8.99 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.021 3.147 . . . . 0.0 113.199 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 583' ' ' LEU . 0.3 OUTLIER -60.37 -26.29 66.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 2.7 t -95.97 153.5 17.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.72 178.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 13.1 pt -55.04 -14.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.45 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 582' ' ' PRO . 2.5 tt -112.67 131.9 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 111.822 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.411 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.7 OUTLIER -113.67 69.54 0.7 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.562 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mt-10 -125.41 170.79 11.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.577 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.15 130.14 47.63 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 121.055 0.455 . . . . 0.0 111.045 178.483 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.766 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -112.63 136.57 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.267 179.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 13.8 mt-10 -123.95 110.7 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.08 HD11 HD12 ' A' ' 625' ' ' ILE . 63.1 mt -78.72 109.79 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 1.3 mp0 -67.8 115.27 7.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -44.73 -28.95 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 111.07 -179.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -67.87 -22.31 73.78 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.484 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.48 119.45 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 117.657 0.728 . . . . 0.0 111.821 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.8 t30 -138.83 122.41 11.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.629 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 41.7 Cg_endo -90.33 160.59 32.84 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.632 -0.987 . . . . 0.0 111.908 0.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 594' ' ' ILE . 2.9 t80 -91.89 119.58 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.595 ' CG ' HD12 ' A' ' 730' ' ' LEU . 29.2 m-85 -92.97 138.35 31.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.453 -177.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.778 HG23 ' SG ' ' A' ' 611' ' ' CYS . 3.5 mp -129.69 141.14 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.955 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 163.99 -166.97 37.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.947 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 614' ' ' GLU . 14.8 ttp85 -87.31 7.0 30.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.651 0.262 . . . . 0.0 111.275 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 620' ' ' ARG . 2.4 t -101.35 125.79 48.03 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.52 -22.92 36.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -25.03 66.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.414 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 84.1 m -73.71 126.97 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 31.5 m120 -43.13 -33.71 0.94 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.778 ' SG ' HG23 ' A' ' 603' ' ' ILE . 51.4 t -106.97 136.17 47.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.606 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 115.5 25.18 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 592' ' ' LEU . 13.5 mm -137.69 109.87 6.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.058 178.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.42 ' HA ' ' HG3' ' A' ' 605' ' ' ARG . 2.1 mt-10 -83.96 103.33 13.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.867 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.845 ' OD2' HD13 ' A' ' 690' ' ' ILE . 5.1 m-20 -132.08 112.98 12.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.306 178.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -42.58 -45.96 4.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.909 ' HB3' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -68.98 -30.95 69.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.382 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 1.087 HD12 HD12 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -65.26 159.08 24.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.828 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 2.9 p -114.31 167.34 10.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.024 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.46 ' CB ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -44.48 -62.44 1.18 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.521 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.5 t -106.1 58.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.471 0.653 . . . . 0.0 109.476 178.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.581 ' CE1' HD11 ' A' ' 681' ' ' ILE . 56.0 t60 -47.09 -49.67 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.559 -179.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 5.2 p -162.99 157.19 20.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 603' ' ' ILE . 1.9 p90 -143.56 146.95 33.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.08 HD12 HD11 ' A' ' 594' ' ' ILE . 69.6 mt -101.74 131.51 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.878 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.3 t80 -123.9 135.46 53.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -97.49 134.06 41.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.485 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.85 159.51 41.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.074 -178.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.0 OUTLIER -76.67 112.47 13.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.937 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.0 t60 -79.74 129.91 34.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.74 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -142.22 144.71 33.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.044 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.57 134.29 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -85.58 -36.01 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.356 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 119.18 38.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.792 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.0 127.37 12.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.98 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -70.91 69.86 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 63.63 -78.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -100.11 105.41 17.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.27 152.09 77.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 62.1 Cg_endo -73.24 176.0 9.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.592 2.195 . . . . 0.0 112.392 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 70.19 -65.07 0.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.16 -78.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -162.02 78.5 0.16 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.587 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 703' ' ' PHE . 6.9 mt -113.87 -156.88 0.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.843 ' O ' HD12 ' A' ' 702' ' ' LEU . 1.7 m-20 -114.61 148.41 38.12 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 630' ' ' HIS . 4.8 m-20 -135.7 145.99 47.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.346 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.678 ' CD1' HD22 ' A' ' 578' ' ' LEU . 3.2 pt -95.29 122.65 46.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.577 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.918 ' CH2' HD22 ' A' ' 671' ' ' LEU . 77.2 m95 -105.33 129.92 53.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.435 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 669' ' ' LYS . 8.2 t80 -90.63 116.83 28.82 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 5.9 m -102.36 142.53 33.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.861 0.362 . . . . 0.0 111.253 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.47 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 64.4 t60 -122.85 127.44 49.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 4.7 p -123.76 0.23 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.348 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -78.94 147.88 31.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.461 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.403 HG22 ' HD1' ' P' ' 829' ' ' PTR . 0.7 OUTLIER -70.24 -25.89 63.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.446 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.9 OUTLIER -68.6 -5.28 19.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.125 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 54.39 123.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.47 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 6.7 t -93.94 165.86 12.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.677 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 663' ' ' ARG . 2.4 m-85 -135.67 120.74 18.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.862 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.725 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -94.62 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.614 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 62.49 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.21 -5.36 3.43 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.69 132.12 43.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 0.0 111.308 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 658' ' ' TYR . 15.0 mtm-85 -75.23 141.69 43.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.8 mtp -119.3 110.46 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.919 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 46.0 pt -87.91 148.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -47.92 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.337 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 116.25 40.08 0.83 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.722 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 2.7 p -139.18 162.12 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.51 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 649' ' ' TYR . 6.2 pttm -129.0 158.09 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.571 ' HB3' HD23 ' A' ' 659' ' ' LEU . 9.9 t80 -147.18 146.72 29.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.918 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -67.45 131.75 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.254 0.55 . . . . 0.0 111.671 -179.024 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 694' ' ' VAL . 0.6 OUTLIER -105.59 128.12 53.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.982 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.695 ' HB3' HD12 ' A' ' 707' ' ' LEU . 3.3 mt-30 -117.16 157.72 25.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.947 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.665 ' N ' HD12 ' A' ' 696' ' ' ILE . 7.2 t70 -57.15 99.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.182 0.515 . . . . 0.0 110.393 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 109.43 29.37 3.96 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.227 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.28 114.5 23.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.89 0.376 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 583' ' ' LEU . 48.1 tt0 -95.44 108.04 20.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.568 HG12 HD13 ' A' ' 659' ' ' LEU . 3.1 mt -110.57 128.5 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.954 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.08 115.82 31.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.784 ' CD1' HD21 ' A' ' 618' ' ' LEU . 4.8 pt -87.87 -16.2 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 1.087 HD12 HD12 ' A' ' 618' ' ' LEU . 20.4 mt -154.83 130.22 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.136 178.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.443 ' CZ2' ' HG2' ' A' ' 684' ' ' LYS . 8.0 t90 -137.48 132.07 32.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.401 ' N ' ' CD1' ' A' ' 682' ' ' TRP . 0.2 OUTLIER -117.46 116.22 26.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . 0.443 ' HG2' ' CZ2' ' A' ' 682' ' ' TRP . 0.0 OUTLIER -68.04 -47.42 68.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.273 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -83.43 -40.73 18.94 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -19.2 60.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.409 -179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 66.01 10.12 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.81 104.93 16.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.9 135.34 62.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.804 -178.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.845 HD13 ' OD2' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -119.48 131.7 71.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.495 179.317 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.74 135.02 4.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.358 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -114.24 148.14 37.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.542 ' HB2' HD22 ' A' ' 583' ' ' LEU . 19.1 tttm -100.94 116.67 33.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 672' ' ' LEU . 2.7 t -80.05 131.24 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 579' ' ' THR . 11.2 tt0 -134.82 108.66 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 705' ' ' GLU . 13.0 mt -77.33 105.04 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.73 -46.79 8.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 10.7 t70 -111.39 140.38 46.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.121 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 702' ' ' LEU . 0.5 OUTLIER -115.34 100.66 8.27 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.586 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 700' ' ' THR . 5.8 t -65.42 66.41 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.306 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 49.62 47.68 36.92 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.373 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 645' ' ' ASP . 1.3 pt? -115.54 179.99 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.776 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -70.48 113.39 7.56 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.343 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.772 HD21 HD13 ' A' ' 707' ' ' LEU . 16.9 t30 53.22 -73.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.521 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.841 ' HA ' HD21 ' A' ' 702' ' ' LEU . 4.6 pt-20 176.66 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.542 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 145.61 44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.446 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.772 HD13 HD21 ' A' ' 704' ' ' ASN . 1.0 OUTLIER -81.99 -2.4 51.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.531 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 44.18 83.36 0.02 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.935 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.409 ' HE3' ' CE1' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -121.42 103.39 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 110.841 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -151.39 -168.62 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -54.72 -45.05 73.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.051 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.468 ' CB ' HG21 ' A' ' 715' ' ' VAL . 3.0 mm-40 -82.94 126.8 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -84.31 100.64 11.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 46.49 81.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.534 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 712' ' ' GLU . 3.0 m -124.65 142.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.512 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 716' ' ' VAL . 8.3 p -81.36 123.71 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.648 HD13 ' CZ3' ' A' ' 648' ' ' TRP . 1.3 mp -93.49 163.19 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -103.36 148.79 25.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -96.95 159.77 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -173.26 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.124 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.79 -28.87 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.031 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -49.67 75.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.331 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -47.77 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.582 ' O ' HG12 ' A' ' 727' ' ' VAL . 2.2 tptt -55.89 -32.57 63.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -66.85 -36.64 82.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 11.7 mt -58.11 -44.93 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 724' ' ' LYS . 9.0 p -71.29 -24.48 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -58.29 -32.49 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -112.88 27.11 9.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.911 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.595 HD12 ' CG ' ' A' ' 602' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.587 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.844 0.355 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.56 129.83 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 26.8 mt -117.83 134.62 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.403 ' HD1' HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -178.64 126.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.652 HD21 ' HG2' ' A' ' 617' ' ' ARG . 6.5 mt -122.74 -169.13 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.82 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 16.4 t0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.905 179.918 . . . . . . . . 0 0 . 1 stop_ save_